data_1jjx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1jjx _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 118.746 2.869 . . . . 0.0 118.746 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.81 -22.28 61.99 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 168.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -80.71 -12.66 59.44 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 168.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 82.3 m -80.36 91.87 5.73 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 122.207 2.276 . . . . 0.0 113.044 -175.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -165.78 167.0 17.37 Favored 'General case' 0 CA--C 1.569 1.701 0 CA-C-O 122.467 1.127 . . . . 0.0 113.124 -172.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.8 m -80.07 111.01 16.02 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.422 -0.799 . . . . 0.0 109.38 165.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -107.57 111.08 23.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.533 -0.729 . . . . 0.0 111.193 -173.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -102.14 132.92 47.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.209 -0.932 . . . . 0.0 110.898 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 tt -70.87 113.85 8.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.717 -0.615 . . . . 0.0 112.574 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.7 p -99.44 -35.66 9.83 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 -175.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -141.72 120.45 12.62 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 120.432 1.469 . . . . 0.0 109.58 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.4 p -108.77 104.49 13.78 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -81.11 122.39 27.28 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.896 -0.503 . . . . 0.0 110.291 164.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 54.58 70.43 0.62 Allowed 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -110.6 61.83 0.61 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.831 -1.168 . . . . 0.0 112.095 163.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -155.51 -64.92 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.237 1.015 . . . . 0.0 109.52 173.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -62.29 -37.5 85.76 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -50.5 -51.09 50.47 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.535 1.516 . . . . 0.0 114.793 167.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 73.5 mtm -57.08 -50.14 73.68 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 170.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -58.19 -40.72 82.26 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 116.134 1.902 . . . . 0.0 116.134 172.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.95 -41.97 90.59 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 169.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.2 tp -61.83 -23.3 66.16 Favored 'General case' 0 CA--C 1.574 1.875 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 176.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.86 55.58 1.61 Allowed Glycine 0 N--CA 1.485 1.906 0 C-N-CA 123.868 0.747 . . . . 0.0 114.795 -176.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.3 m -83.07 153.95 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.93 138.36 34.94 Favored Glycine 0 CA--C 1.555 2.532 0 O-C-N 120.956 -1.09 . . . . 0.0 113.494 149.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -57.56 -33.55 68.26 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -171.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.37 -41.79 66.22 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 164.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.1 m -60.1 -40.6 90.22 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 165.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.335 0.0 OUTLIER -60.18 -42.56 95.27 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 168.326 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -58.61 -51.76 68.57 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 166.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.1 t -56.02 -55.88 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 173.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.81 -24.72 57.99 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 119.854 2.702 . . . . 0.0 119.854 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -73.77 -45.66 50.41 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 164.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.7 m -78.23 -30.4 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 t -105.11 141.1 37.27 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 120.803 1.638 . . . . 0.0 114.276 -162.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -89.66 119.74 69.5 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.197 172.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.05 129.73 8.04 Favored 'Trans proline' 0 CA--C 1.564 2.02 0 C-N-CA 122.454 2.102 . . . . 0.0 114.044 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 56.6 m -95.69 106.91 19.07 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 169.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 81.0 t -99.43 95.91 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -174.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.8 mp -89.43 98.82 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.521 -1.362 . . . . 0.0 108.359 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.5 mt -84.04 116.46 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.6 p -141.78 121.27 13.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.832 -0.543 . . . . 0.0 112.36 -168.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -79.89 102.99 9.48 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.86 -1.15 . . . . 0.0 110.543 169.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -103.3 96.92 7.08 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -169.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.09 -74.8 2.46 Favored Glycine 0 N--CA 1.488 2.163 0 O-C-N 121.777 -0.577 . . . . 0.0 114.144 -173.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -132.77 -53.24 0.93 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.425 0.69 . . . . 0.0 111.927 171.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -81.3 160.18 24.27 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -173.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.2 t -84.29 114.56 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 123.635 0.774 . . . . 0.0 109.117 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.3 t -106.92 107.68 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.558 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 59.0 mt -91.6 122.18 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 172.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -106.03 106.82 17.5 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.151 0.58 . . . . 0.0 110.23 174.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.5 m -92.87 103.73 16.04 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.506 -0.746 . . . . 0.0 109.374 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 72.0 mt -121.32 117.64 27.49 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.085 0.554 . . . . 0.0 110.231 -170.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 t -127.65 171.87 11.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.026 -1.046 . . . . 0.0 111.26 165.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -70.38 24.24 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 118.585 2.809 . . . . 0.0 118.585 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -150.23 -58.14 0.18 Allowed 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 125.194 1.398 . . . . 0.0 108.705 175.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -101.49 130.89 47.84 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.185 0.994 . . . . 0.0 110.949 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -137.54 110.57 7.76 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.077 0.551 . . . . 0.0 110.834 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.3 t -137.7 155.2 49.36 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 123.569 0.748 . . . . 0.0 111.907 -176.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -140.01 146.85 39.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.808 -1.183 . . . . 0.0 113.941 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.8 pt -130.14 122.63 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-O 121.522 0.677 . . . . 0.0 111.108 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.4 p -105.1 116.93 32.78 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.287 1.035 . . . . 0.0 110.877 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -144.79 141.11 28.93 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 114.517 1.302 . . . . 0.0 114.517 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -79.32 155.52 28.43 Favored 'General case' 0 CA--C 1.571 1.781 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.619 149.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.9 mt -70.78 114.53 8.95 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.58 -1.325 . . . . 0.0 111.588 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.07 -7.61 54.92 Favored Glycine 0 CA--C 1.555 2.536 0 N-CA-C 118.567 2.187 . . . . 0.0 118.567 -162.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -68.72 122.48 18.64 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 120.734 2.267 . . . . 0.0 112.432 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -89.33 118.51 29.06 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 122.979 0.512 . . . . 0.0 110.451 169.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -136.43 135.71 38.92 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 123.433 0.693 . . . . 0.0 110.844 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.17 129.1 36.25 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.487 -1.383 . . . . 0.0 111.047 172.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -130.9 109.71 10.75 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.75 -167.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.7 m -75.24 102.17 4.92 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.65 0.738 . . . . 0.0 110.487 174.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.0 p -85.29 161.85 19.36 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -171.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.45 -23.68 4.19 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 119.015 2.969 . . . . 0.0 119.015 166.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -54.24 -30.74 51.37 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 117.629 2.455 . . . . 0.0 117.629 160.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.316 9.8 t70 78.13 63.21 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.723 0 C-N-CA 125.869 1.668 . . . . 0.0 112.172 -159.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.5 ptt-85 -152.85 136.95 16.41 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.95 0.9 . . . . 0.0 109.14 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.284 0.5 OUTLIER -90.32 112.02 23.44 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 119.535 1.062 . . . . 0.0 110.795 168.17 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.3 p -107.64 130.28 54.92 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -65.6 99.12 0.42 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.442 1.097 . . . . 0.0 110.064 168.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.1 m -107.21 119.93 40.73 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.066 -164.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 51.8 t -111.38 120.18 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.9 t -111.74 129.26 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.538 -0.726 . . . . 0.0 109.718 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 65.6 m -153.57 152.45 30.91 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.778 -1.201 . . . . 0.0 112.25 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.9 mp -83.32 123.19 29.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.063 -1.023 . . . . 0.0 110.538 167.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -84.7 -63.68 1.29 Allowed 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -149.98 80.55 0.2 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 174.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.4 t70 52.42 37.23 22.13 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -160.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -147.16 120.89 9.21 Favored 'General case' 0 CA--C 1.56 1.352 0 O-C-N 121.278 -0.889 . . . . 0.0 109.461 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.87 112.5 22.56 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.242 1.017 . . . . 0.0 110.758 -171.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.03 109.91 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -167.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -93.92 98.85 11.32 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 123.436 0.695 . . . . 0.0 110.999 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.0 mt -90.41 109.19 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 C-N-CA 124.159 0.983 . . . . 0.0 109.003 -174.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -105.46 118.35 36.33 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 118.968 0.804 . . . . 0.0 110.193 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -115.45 122.53 46.06 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 123.634 0.774 . . . . 0.0 111.199 -173.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 8.5 p90 -151.36 130.0 12.29 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.96 -1.088 . . . . 0.0 110.5 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 58.38 27.51 15.5 Favored 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 117.498 2.407 . . . . 0.0 117.498 170.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.23 -19.23 23.87 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 118.97 2.348 . . . . 0.0 118.97 -162.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -89.4 148.11 23.67 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-N 119.443 1.622 . . . . 0.0 112.541 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -132.01 141.01 49.11 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.879 0.847 . . . . 0.0 111.463 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.9 t -129.91 143.51 50.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.63 -0.669 . . . . 0.0 109.419 158.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.266 13.3 p30 -124.52 132.82 53.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 111.171 173.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -100.66 103.75 15.04 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.2 t -88.24 98.93 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 91.1 mtm-85 -89.1 114.04 25.25 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.895 0.878 . . . . 0.0 110.35 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.48 132.95 49.91 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 119.119 0.872 . . . . 0.0 112.718 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.7 mm -80.25 106.56 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.382 -0.824 . . . . 0.0 110.244 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -103.09 98.27 8.24 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 169.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.0 t70 51.46 60.8 3.6 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.32 0.1 56.24 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 120.034 2.774 . . . . 0.0 120.034 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -118.78 122.56 42.69 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 119.837 1.818 . . . . 0.0 109.71 -171.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 51.2 ttp -82.42 104.78 12.96 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 122.029 0.919 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.14 103.61 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 31.6 ttm -85.6 108.14 17.84 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 84.4 m -98.71 101.17 12.5 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.0 mp -92.2 98.95 11.84 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.568 0.747 . . . . 0.0 108.988 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.7 t -89.97 117.58 28.88 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.53 0.681 . . . . 0.0 110.322 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -100.59 75.71 1.77 Allowed 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 155.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.57 -111.24 3.3 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 114.85 0.7 . . . . 0.0 114.85 -166.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -81.2 -9.69 59.74 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 171.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 50.0 t -90.36 99.61 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 121.969 2.168 . . . . 0.0 107.422 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.6 t -113.64 119.93 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -168.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.81 130.92 54.43 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 171.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.9 t -111.79 103.83 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -114.96 118.71 34.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.353 -0.842 . . . . 0.0 109.947 -171.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -99.77 98.8 9.57 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.599 0.714 . . . . 0.0 109.982 -162.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -94.23 131.92 39.32 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.507 0.723 . . . . 0.0 110.9 -173.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -116.76 158.52 23.74 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.532 0.682 . . . . 0.0 110.754 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -75.44 103.89 5.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.023 -1.048 . . . . 0.0 111.877 -174.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . 0.286 . . . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -173.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.93 -24.44 66.04 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 117.84 2.533 . . . . 0.0 117.84 165.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -76.91 -21.65 54.57 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 168.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 80.8 m -73.81 88.86 1.8 Allowed 'General case' 0 CA--C 1.572 1.811 0 CA-C-N 121.885 2.13 . . . . 0.0 114.344 -173.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.59 168.06 20.48 Favored 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 124.552 1.141 . . . . 0.0 111.781 -174.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.6 m -77.27 134.85 38.45 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.868 -1.145 . . . . 0.0 109.319 158.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -123.91 120.75 33.46 Favored 'General case' 0 CA--C 1.562 1.412 0 O-C-N 121.519 -0.738 . . . . 0.0 110.048 -175.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 mtpm? -100.35 130.79 46.49 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.609 0.764 . . . . 0.0 111.422 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 tt -71.79 118.57 14.8 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.562 -0.711 . . . . 0.0 112.909 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 65.2 p -92.22 -49.75 6.02 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -141.18 113.91 8.33 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.757 0.823 . . . . 0.0 109.875 -173.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.0 p -98.62 98.81 9.92 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.318 0.647 . . . . 0.0 111.883 175.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -83.5 122.81 29.04 Favored 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 123.492 0.717 . . . . 0.0 111.16 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.256 1.3 t30 57.7 30.08 18.33 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 171.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -72.38 -38.36 68.51 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -54.77 -53.16 58.78 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 175.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.26 -41.78 80.33 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 171.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -58.15 -48.08 81.36 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 165.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 65.0 mtm -58.02 -48.28 80.52 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -60.78 -42.58 97.8 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 166.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.64 97.55 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 171.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.6 tp -64.25 -22.33 66.91 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 116.925 2.195 . . . . 0.0 116.925 169.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.73 55.56 1.75 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 115.615 1.006 . . . . 0.0 115.615 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 m -107.86 149.84 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 118.197 0.999 . . . . 0.0 111.553 172.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.17 165.54 21.4 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 116.647 1.419 . . . . 0.0 116.647 172.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -64.84 -40.57 95.38 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.71 -42.46 79.2 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 164.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.6 m -62.4 -43.96 97.58 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 169.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -54.4 -47.53 72.64 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 164.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -58.87 -52.33 66.19 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 119.989 1.268 . . . . 0.0 114.1 170.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.2 t -49.01 -51.5 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 167.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.33 -32.77 84.73 Favored Glycine 0 CA--C 1.55 2.234 0 N-CA-C 119.596 2.599 . . . . 0.0 119.596 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -79.69 -42.93 23.67 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 173.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.4 m -70.32 -35.07 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 117.022 2.231 . . . . 0.0 117.022 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.0 t -102.89 175.32 5.52 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -166.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.44 84.38 0.74 Allowed Pre-proline 0 CA--C 1.579 2.086 0 C-N-CA 123.703 0.801 . . . . 0.0 110.96 169.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.26 117.63 5.23 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.71 2.274 . . . . 0.0 113.395 -175.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.1 m -100.06 123.83 44.74 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.418 -161.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.8 t -106.46 105.56 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -167.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.4 mt -89.05 105.75 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.438 -1.414 . . . . 0.0 107.714 170.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 55.8 mt -89.71 124.6 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 168.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.1 p -150.71 122.19 7.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -0.914 . . . . 0.0 112.739 -169.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -78.99 104.83 9.9 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.666 -1.271 . . . . 0.0 110.512 166.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -105.95 99.8 9.37 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -171.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.13 -72.45 2.77 Favored Glycine 0 N--CA 1.491 2.328 0 O-C-N 121.689 -0.632 . . . . 0.0 114.157 -169.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -139.41 -59.87 0.57 Allowed 'General case' 0 CA--C 1.566 1.575 0 C-N-CA 123.366 0.667 . . . . 0.0 111.303 173.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.582 ' NZ ' ' HE2' ' A' ' 68' ' ' GLU . 19.0 ptmt -79.03 159.85 27.4 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -172.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.8 t -79.77 116.71 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.568 0 CA-C-O 121.725 0.774 . . . . 0.0 109.46 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 65.0 t -104.08 107.43 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 68.7 mt -89.64 120.56 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 167.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -102.88 103.82 14.02 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 166.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.4 m -90.55 99.25 12.31 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 170.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 mp -92.1 101.16 13.68 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.593 0.757 . . . . 0.0 108.978 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.9 t -78.24 26.9 0.2 Allowed 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.352 70.8 p 65.17 -53.87 0.33 Allowed 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -164.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -81.17 -31.88 33.85 Favored 'General case' 0 CA--C 1.577 2.018 0 C-N-CA 125.575 1.55 . . . . 0.0 115.163 174.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -136.62 127.05 26.7 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 119.763 1.165 . . . . 0.0 111.31 -173.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -88.48 104.33 16.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.329 -0.857 . . . . 0.0 110.611 171.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.6 p -102.03 99.95 10.17 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.5 0.667 . . . . 0.0 110.109 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -98.07 126.79 43.67 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.706 0.802 . . . . 0.0 112.259 -175.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.4 pt -131.47 116.84 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 C-N-CA 123.168 0.587 . . . . 0.0 111.159 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.8 p -98.54 129.86 45.1 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.896 0.879 . . . . 0.0 112.351 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -156.64 144.35 19.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.379 -0.826 . . . . 0.0 112.633 -175.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -84.81 158.54 20.64 Favored 'General case' 0 CA--C 1.57 1.722 0 O-C-N 120.861 -1.149 . . . . 0.0 110.935 156.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.32 116.37 9.67 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.67 -1.269 . . . . 0.0 111.839 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.05 -4.29 77.82 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 119.214 2.445 . . . . 0.0 119.214 -163.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.582 ' HE2' ' NZ ' ' A' ' 48' ' ' LYS . 33.3 tt0 -82.42 126.57 32.36 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 120.633 2.217 . . . . 0.0 111.929 -176.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -83.34 112.94 20.36 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-O 121.067 0.46 . . . . 0.0 111.424 172.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -121.53 140.45 52.19 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.763 0.825 . . . . 0.0 111.207 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.695 ' HD2' ' NZ ' ' A' ' 81' ' ' LYS . 3.6 m-20 -76.3 130.89 38.8 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.241 1.019 . . . . 0.0 111.532 171.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.452 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 19.6 tt0 -132.99 103.28 5.97 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.146 -171.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.0 m -91.23 107.19 19.04 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 174.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.7 p -80.14 162.29 24.82 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -169.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.21 -23.79 23.94 Favored 'General case' 0 CA--C 1.576 1.942 0 N-CA-C 118.825 2.898 . . . . 0.0 118.825 169.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -82.96 2.2 35.87 Favored 'General case' 0 CA--C 1.582 2.204 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 165.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.286 21.3 m-20 70.02 70.13 0.22 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 120.584 1.538 . . . . 0.0 113.128 -174.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.5 ptp85 -145.88 125.99 13.76 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 166.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -91.8 105.41 17.69 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.463 0.705 . . . . 0.0 111.132 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 72' ' ' GLU . 28.7 p -109.22 135.23 50.65 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.695 ' NZ ' ' HD2' ' A' ' 71' ' ' ASP . 68.7 mmtt -74.47 101.7 4.23 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-O 121.835 0.826 . . . . 0.0 109.441 164.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.0 m -102.63 128.85 49.14 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.542 0.737 . . . . 0.0 112.63 -170.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 49.4 t -122.98 121.91 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.9 t -104.46 109.47 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.227 -0.92 . . . . 0.0 109.594 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.3 p -110.46 130.06 55.64 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.796 0.838 . . . . 0.0 111.912 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.7 tt -87.84 99.63 12.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.147 -0.971 . . . . 0.0 110.605 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -101.3 75.72 1.65 Allowed 'General case' 0 CA--C 1.567 1.613 0 C-N-CA 123.481 0.712 . . . . 0.0 111.122 -176.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.34 68.15 1.76 Allowed Glycine 0 N--CA 1.495 2.597 0 N-CA-C 116.258 1.263 . . . . 0.0 116.258 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.256 23.7 m-20 60.38 22.33 11.89 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 117.222 2.305 . . . . 0.0 117.222 -166.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -133.58 107.52 8.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.938 -1.101 . . . . 0.0 109.893 -175.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.6 mt -83.09 103.32 12.43 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.793 0.837 . . . . 0.0 111.626 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 37.2 t -97.52 100.5 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -173.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -84.68 107.52 16.93 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.339 0.656 . . . . 0.0 110.204 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 70.3 mt -99.5 103.82 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -91.01 118.94 30.79 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 118.43 0.559 . . . . 0.0 111.317 176.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -112.53 112.03 23.29 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.019 0.528 . . . . 0.0 110.46 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -139.21 125.62 20.37 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.438 -0.789 . . . . 0.0 110.683 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 50.92 49.94 20.11 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 167.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.86 4.6 62.61 Favored Glycine 0 CA--C 1.558 2.739 0 N-CA-C 120.212 2.845 . . . . 0.0 120.212 -168.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -123.59 140.31 53.13 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 119.653 1.726 . . . . 0.0 110.266 -168.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -135.01 123.61 23.57 Favored 'General case' 0 CA--C 1.564 1.499 0 O-C-N 121.692 -0.63 . . . . 0.0 111.783 -175.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.0 t -115.89 137.34 52.19 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.294 0.569 . . . . 0.0 109.964 165.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.19 128.07 54.74 Favored 'General case' 0 CA--C 1.567 1.629 0 C-N-CA 123.109 0.564 . . . . 0.0 110.996 171.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -105.84 110.18 22.39 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 53.2 t -91.97 100.79 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -176.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.18 111.09 19.49 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.562 0.745 . . . . 0.0 110.677 173.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.57 129.83 43.28 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 118.96 0.8 . . . . 0.0 112.631 -174.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.9 mm -75.86 112.93 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.044 -1.035 . . . . 0.0 108.953 173.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -133.24 96.5 3.75 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -169.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.7 t70 50.37 61.1 3.38 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -169.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.07 -48.08 3.88 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 117.84 1.896 . . . . 0.0 117.84 -173.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -82.06 146.42 29.67 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 118.231 1.015 . . . . 0.0 113.086 -174.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -82.38 104.74 12.9 Favored 'General case' 0 CA--C 1.56 1.365 0 CA-C-O 121.966 0.888 . . . . 0.0 109.429 166.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 80.3 t -91.79 102.31 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 40.9 ttm -83.15 108.4 16.38 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.422 0.689 . . . . 0.0 109.8 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.1 m -99.82 115.07 28.72 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.871 0.843 . . . . 0.0 109.135 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mp -111.18 117.46 33.28 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -171.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.305 10.6 t -137.21 138.2 39.92 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 177.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -124.01 99.89 6.47 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.952 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 73.07 -90.76 0.6 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 115.299 0.88 . . . . 0.0 115.299 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -134.31 52.77 2.04 Favored 'General case' 0 CA--C 1.575 1.909 0 CA-C-O 121.482 0.658 . . . . 0.0 112.064 167.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.4 t -139.91 124.04 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 51.2 t -123.4 127.18 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-N 119.001 0.818 . . . . 0.0 109.837 -170.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -117.18 150.7 38.3 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 123.633 0.773 . . . . 0.0 112.329 163.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.8 t -131.92 114.22 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.192 -0.942 . . . . 0.0 108.947 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 mtp-105 -110.9 114.44 27.77 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.205 -0.934 . . . . 0.0 109.876 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -96.63 108.63 21.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.647 -0.658 . . . . 0.0 110.111 -167.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -103.55 132.47 49.78 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.108 -0.995 . . . . 0.0 112.4 -171.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.39 160.66 15.22 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 175.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -76.1 141.03 42.1 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -175.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.25 0 CA-C-O 117.404 -1.284 . . . . 0.0 112.447 176.427 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 . . . . . 0 N--CA 1.499 2.008 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.38 -23.83 66.06 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 117.755 2.502 . . . . 0.0 117.755 168.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -87.92 -21.81 24.71 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 172.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.5 t -76.83 95.63 4.11 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 121.197 1.817 . . . . 0.0 112.905 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -166.39 167.61 15.66 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-O 122.565 1.174 . . . . 0.0 112.333 -172.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.7 m -86.85 107.1 18.17 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.829 0.852 . . . . 0.0 108.718 173.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -105.22 109.42 21.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.972 . . . . 0.0 111.623 -169.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -95.36 129.33 42.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.281 -0.887 . . . . 0.0 111.089 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.0 tt -75.86 122.29 23.88 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -173.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 69.0 p -91.84 -52.47 4.72 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 176.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -137.97 114.54 10.45 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.739 0.815 . . . . 0.0 110.233 -173.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.7 p -101.18 78.03 1.86 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.409 1.1 . . . . 0.0 112.419 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -79.99 133.25 36.15 Favored 'General case' 0 CA--C 1.56 1.354 0 O-C-N 120.97 -1.081 . . . . 0.0 113.804 -171.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.252 1.1 t30 57.44 23.34 8.94 Favored 'General case' 0 CA--C 1.584 2.251 0 N-CA-C 117.189 2.292 . . . . 0.0 117.189 -174.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -69.46 -46.41 66.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.238 -1.539 . . . . 0.0 115.054 -175.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -47.64 -51.3 21.99 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -68.33 -40.02 81.76 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -50.5 -52.96 33.72 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 160.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.6 mtp -59.03 -43.46 91.63 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 175.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -47.75 83.58 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 164.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.02 -39.03 86.95 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.65 -47.57 85.67 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 163.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.88 48.22 1.51 Allowed Glycine 0 N--CA 1.482 1.738 0 CA-C-O 118.978 -0.901 . . . . 0.0 115.315 -175.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.7 m -80.56 151.63 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 118.822 1.311 . . . . 0.0 111.443 172.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.38 150.05 30.73 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 116.955 1.542 . . . . 0.0 116.955 173.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -55.53 -43.37 75.71 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.12 -44.9 68.06 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 166.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.3 m -64.04 -40.26 95.91 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 171.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -61.05 -49.16 78.48 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 121.691 2.041 . . . . 0.0 115.923 167.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.6 mp0 -71.14 -28.74 64.5 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.1 t -70.77 -62.13 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 119.536 1.062 . . . . 0.0 112.11 159.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.76 -31.37 71.41 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 119.903 2.721 . . . . 0.0 119.903 -166.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -73.4 -32.11 64.26 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 170.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.2 m -82.68 -34.7 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.0 t -81.5 126.4 31.64 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 120.857 1.662 . . . . 0.0 112.352 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -103.55 92.7 4.3 Favored Pre-proline 0 CA--C 1.573 1.828 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -71.91 155.65 57.46 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.384 2.056 . . . . 0.0 116.64 -171.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.1 m -88.73 100.31 13.03 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.371 -1.286 . . . . 0.0 107.64 169.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.6 t -95.65 98.43 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -171.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.1 mt -88.81 102.21 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -86.41 116.97 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 171.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.2 p -153.81 121.31 5.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.718 -0.614 . . . . 0.0 111.337 -165.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -80.24 128.69 33.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 0.0 113.098 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -120.24 90.28 3.3 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 174.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.9 68.99 1.48 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 115.613 1.005 . . . . 0.0 115.613 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.293 13.0 t70 70.94 -57.27 0.6 Allowed 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -169.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -72.59 147.84 45.47 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-O 122.568 1.175 . . . . 0.0 114.141 -172.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.0 t -96.2 122.54 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.857 -169.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.9 t -104.22 110.87 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.0 mt -92.73 99.76 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 172.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.0 mtm-85 -85.92 101.93 13.3 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.867 0.867 . . . . 0.0 111.022 173.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.6 m -89.81 101.05 13.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.591 -0.693 . . . . 0.0 109.708 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 73.2 mt -101.26 108.82 20.57 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.791 0.805 . . . . 0.0 111.618 -167.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.1 t -138.29 147.61 43.79 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 124.546 1.138 . . . . 0.0 109.369 173.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 51.1 p -76.94 53.38 0.93 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 120.634 -1.291 . . . . 0.0 113.857 173.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -161.37 -65.8 0.06 Allowed 'General case' 0 CA--C 1.571 1.784 0 C-N-CA 125.435 1.494 . . . . 0.0 107.898 -172.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -127.94 96.51 4.51 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -96.23 82.16 3.41 Favored 'General case' 0 CA--C 1.568 1.67 0 O-C-N 121.721 -0.612 . . . . 0.0 110.803 -176.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -108.35 146.23 33.3 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -170.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -131.77 127.83 37.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.275 -0.891 . . . . 0.0 113.151 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.4 mt -112.77 110.59 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.3 p -92.09 120.27 32.55 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.546 0.739 . . . . 0.0 112.393 170.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -143.96 147.4 33.88 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -174.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -87.52 1.78 52.56 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 118.59 2.811 . . . . 0.0 118.59 -172.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.4 mt 69.75 120.01 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 125.455 1.502 . . . . 0.0 112.775 -172.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.39 -32.08 4.27 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 118.142 2.017 . . . . 0.0 118.142 -171.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -73.97 136.42 43.22 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 119.309 1.555 . . . . 0.0 113.021 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -88.88 120.76 30.58 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.198 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -130.75 150.64 51.83 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.801 0.84 . . . . 0.0 111.65 -172.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -79.55 133.5 36.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.932 -1.105 . . . . 0.0 111.615 171.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -142.44 126.03 16.86 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.0 0.428 . . . . 0.0 111.992 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.2 m -73.36 132.4 42.99 Favored 'General case' 0 CA--C 1.57 1.731 0 CA-C-O 121.43 0.633 . . . . 0.0 110.478 162.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.9 p -108.82 166.47 10.78 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -169.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.15 -11.5 6.29 Favored 'General case' 0 CA--C 1.579 2.082 0 N-CA-C 119.452 3.13 . . . . 0.0 119.452 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -73.62 -25.33 60.26 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 159.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.305 4.8 m-20 82.1 65.87 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 120.738 1.608 . . . . 0.0 111.235 -162.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.9 ptt85 -162.87 142.2 8.89 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.162 0.985 . . . . 0.0 109.43 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -83.02 134.62 35.03 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 169.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.9 p -129.89 148.63 51.77 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 172.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -79.15 101.63 8.03 Favored 'General case' 0 CA--C 1.563 1.447 0 CA-C-O 122.145 0.974 . . . . 0.0 109.814 162.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.0 m -97.59 124.77 41.99 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.919 0.888 . . . . 0.0 111.96 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.01 124.59 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -115.43 116.38 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.446 -0.784 . . . . 0.0 109.574 -174.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.7 m -115.65 132.41 56.64 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.464 0.706 . . . . 0.0 112.554 -176.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.8 tt -89.11 102.1 14.76 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 123.286 0.634 . . . . 0.0 109.974 171.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -96.1 80.71 3.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.135 -0.978 . . . . 0.0 110.943 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.56 -86.03 1.15 Allowed Glycine 0 N--CA 1.494 2.523 0 O-C-N 121.184 -0.948 . . . . 0.0 114.042 -176.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -136.86 65.14 1.52 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.878 0.847 . . . . 0.0 110.179 154.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -145.81 106.8 4.14 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.6 100.67 13.27 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 121.432 -0.793 . . . . 0.0 110.695 -173.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.1 t -104.03 104.34 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -170.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -90.27 121.68 32.51 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.398 0.679 . . . . 0.0 109.792 173.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.5 mt -113.9 110.23 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -92.83 129.73 38.66 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 122.918 0.487 . . . . 0.0 111.536 171.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -122.07 123.41 41.52 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.553 0.741 . . . . 0.0 110.007 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 17.3 p90 -150.46 123.89 9.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.218 -0.926 . . . . 0.0 110.27 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 53.5 38.21 27.53 Favored 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 117.258 2.318 . . . . 0.0 117.258 174.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.46 -25.39 3.85 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 119.148 2.419 . . . . 0.0 119.148 -165.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -81.77 142.46 32.59 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 119.134 1.467 . . . . 0.0 112.307 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -139.21 123.48 18.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.872 -0.517 . . . . 0.0 111.86 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.3 t -112.66 144.15 42.65 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 123.383 0.673 . . . . 0.0 110.623 167.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -121.34 142.16 50.24 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 172.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -122.3 102.92 8.4 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -175.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 68.8 t -99.35 103.13 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -168.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -97.89 117.21 31.71 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.398 0.679 . . . . 0.0 111.406 -175.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -135.24 133.83 39.39 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.114 0.566 . . . . 0.0 111.378 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.2 mm -83.07 121.05 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.145 -0.972 . . . . 0.0 109.245 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.16 -77.02 0.41 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.796 0.438 . . . . 0.0 111.367 -175.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -133.98 82.83 2.0 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 77.06 -33.73 1.49 Allowed Glycine 0 N--CA 1.497 2.74 0 N-CA-C 118.66 2.224 . . . . 0.0 118.66 -166.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -92.05 142.31 27.66 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 118.329 1.065 . . . . 0.0 111.73 -173.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 9.9 tpp -84.24 115.37 22.42 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 121.802 0.811 . . . . 0.0 110.493 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.5 t -91.23 107.56 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.623 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 167.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 18.8 ttt -99.43 108.19 20.6 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.721 -0.612 . . . . 0.0 109.369 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.0 m -95.86 114.5 26.23 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.5 0.667 . . . . 0.0 109.28 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.1 mp -103.57 120.98 41.94 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.263 8.7 t -136.46 138.47 41.49 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 177.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -106.54 77.66 1.21 Allowed 'General case' 0 CA--C 1.565 1.545 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.058 168.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 69.89 -89.45 0.31 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 115.962 1.145 . . . . 0.0 115.962 -175.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -88.56 -35.49 16.89 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 175.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.8 t -87.27 129.71 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 119.677 1.126 . . . . 0.0 109.616 -170.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 44.9 t -123.79 125.89 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 C-N-CA 123.401 0.68 . . . . 0.0 109.512 -169.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.34 151.69 34.16 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.966 0.906 . . . . 0.0 111.943 164.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 92.2 t -124.19 117.07 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 120.778 -1.201 . . . . 0.0 108.915 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.2 mtp180 -96.62 108.75 21.41 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.275 0.63 . . . . 0.0 109.611 170.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -85.46 136.94 33.23 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.287 0.635 . . . . 0.0 111.753 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -134.37 132.45 39.46 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.653 -0.654 . . . . 0.0 111.799 -173.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -100.69 151.26 21.86 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.288 0.635 . . . . 0.0 112.38 169.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -71.34 128.65 36.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.597 -0.689 . . . . 0.0 111.901 170.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.487 0 C-N-CA 123.833 0.853 . . . . 0.0 112.564 177.713 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 N--CA 1.498 1.925 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.38 -30.21 62.43 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 117.754 2.502 . . . . 0.0 117.754 167.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -74.6 -17.93 60.64 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 117.184 2.29 . . . . 0.0 117.184 167.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 22.6 t -89.29 94.61 9.97 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 120.525 1.511 . . . . 0.0 112.667 -169.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.91 171.34 16.77 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-O 122.059 0.933 . . . . 0.0 112.509 -174.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.2 m -82.22 118.42 23.09 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.695 -1.253 . . . . 0.0 108.779 164.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -114.03 114.71 26.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.474 -0.766 . . . . 0.0 110.704 -172.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -98.82 131.89 44.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.455 -0.778 . . . . 0.0 110.933 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.11 117.38 11.6 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.4 p -89.71 -47.67 7.77 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -142.18 119.22 11.32 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 118.945 0.793 . . . . 0.0 109.91 -173.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.7 p -104.67 99.22 8.89 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.207 0.603 . . . . 0.0 111.559 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -81.87 122.92 28.34 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 123.438 0.695 . . . . 0.0 111.236 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.252 1.9 t30 59.07 23.99 12.24 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 117.818 2.525 . . . . 0.0 117.818 174.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -68.38 -45.53 72.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 119.77 -1.831 . . . . 0.0 115.582 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -46.92 -51.98 15.6 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 170.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.69 -43.81 95.55 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 173.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -51.01 -50.18 59.01 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 164.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.8 mtp -61.75 -39.78 92.81 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 174.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -59.75 -50.34 74.21 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 165.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.77 -38.97 83.32 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 116.933 2.197 . . . . 0.0 116.933 172.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.31 -23.99 67.49 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 171.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.66 35.42 8.49 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 118.088 1.995 . . . . 0.0 118.088 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.7 m -93.08 171.07 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 119.406 1.603 . . . . 0.0 112.062 173.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.54 162.33 54.0 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 117.125 1.61 . . . . 0.0 117.125 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -64.28 -46.06 85.34 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 173.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.67 -40.6 63.03 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 167.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.6 m -64.6 -42.79 95.33 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 169.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.9 mtm-85 -57.99 -43.05 86.36 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 164.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -56.46 -54.61 43.72 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.27 1.395 . . . . 0.0 113.941 167.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.0 t -50.6 -60.64 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 169.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.11 -20.98 58.76 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 120.181 2.832 . . . . 0.0 120.181 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -85.72 -41.12 15.41 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 165.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.254 17.6 m -75.04 -37.3 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 CA-C-N 121.421 1.918 . . . . 0.0 116.008 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 t -97.33 146.81 24.79 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 120.035 1.288 . . . . 0.0 112.682 -174.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 105.33 18.55 Favored Pre-proline 0 CA--C 1.578 2.037 0 O-C-N 121.379 -0.825 . . . . 0.0 111.362 174.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.1 141.68 29.85 Favored 'Trans proline' 0 CA--C 1.564 1.989 0 C-N-CA 122.566 2.177 . . . . 0.0 114.898 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.6 m -108.5 112.66 25.16 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.154 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.9 t -106.35 102.2 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -172.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.3 mt -85.4 103.54 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.1 mt -91.54 105.26 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 175.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.4 p -124.45 165.54 17.59 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 123.849 0.86 . . . . 0.0 112.035 -171.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -126.81 126.19 42.97 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.95 -1.094 . . . . 0.0 110.851 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -114.31 81.51 1.55 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.631 0.729 . . . . 0.0 110.024 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.9 -95.96 0.84 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -89.85 -27.52 19.87 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -102.84 149.38 24.55 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-N 119.826 1.193 . . . . 0.0 113.312 -174.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.5 t -86.64 125.37 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.772 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 165.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.0 106.17 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.2 mt -92.59 120.67 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -103.19 100.97 10.9 Favored 'General case' 0 CA--C 1.561 1.39 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 169.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 50.8 m -87.32 99.14 11.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.639 -0.663 . . . . 0.0 109.384 172.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.7 mp -97.29 97.29 9.02 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.6 t -89.26 34.09 0.8 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 174.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.347 73.0 p 67.78 -58.45 0.44 Allowed 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 -174.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -91.66 -61.27 1.67 Allowed 'General case' 0 CA--C 1.569 1.679 0 C-N-CA 124.923 1.289 . . . . 0.0 110.48 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -87.53 104.9 16.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.514 -0.741 . . . . 0.0 110.542 173.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -108.22 106.91 17.31 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.545 0.688 . . . . 0.0 109.34 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.4 p -119.66 135.52 54.78 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 123.433 0.693 . . . . 0.0 111.458 -157.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -127.02 133.68 50.48 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.096 -1.003 . . . . 0.0 113.501 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.4 pt -133.77 120.37 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 C-N-CA 123.484 0.713 . . . . 0.0 110.851 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 90.1 p -106.77 125.51 51.09 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 124.254 1.022 . . . . 0.0 111.858 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -156.54 148.62 23.09 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.297 -0.877 . . . . 0.0 112.795 -168.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -98.61 21.71 10.91 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 117.623 2.453 . . . . 0.0 117.623 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.7 mt 67.62 112.73 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 125.138 1.375 . . . . 0.0 114.027 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.19 -26.04 4.04 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 117.998 1.959 . . . . 0.0 117.998 -162.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -75.91 126.94 31.95 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 124.711 1.204 . . . . 0.0 111.941 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -72.87 141.64 47.93 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -141.76 143.61 33.57 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.934 0.894 . . . . 0.0 110.306 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.85 134.81 35.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.536 -1.352 . . . . 0.0 111.516 172.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -133.13 105.56 7.1 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.058 0.543 . . . . 0.0 110.554 -172.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.7 m -76.31 104.72 6.97 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.423 -0.798 . . . . 0.0 108.958 167.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.0 p -78.82 -178.1 5.82 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -165.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.2 -12.63 3.76 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 118.968 2.951 . . . . 0.0 118.968 168.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -120.19 43.33 2.73 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 119.572 -1.955 . . . . 0.0 113.421 155.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.285 10.5 t70 65.91 -1.22 1.15 Allowed 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 119.374 3.101 . . . . 0.0 119.374 168.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.3 ptt85 -76.46 123.21 25.67 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.37 -1.456 . . . . 0.0 110.978 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -80.12 106.06 11.85 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.888 0.875 . . . . 0.0 112.819 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.0 m -110.03 117.92 35.03 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -167.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -67.6 103.05 1.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.812 0.845 . . . . 0.0 110.338 169.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.6 m -115.92 122.48 45.44 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 121.843 -0.535 . . . . 0.0 111.68 -158.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 99.3 t -115.25 116.0 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.4 t -96.42 108.75 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 173.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.4 p -112.01 117.16 31.92 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.536 0.735 . . . . 0.0 111.599 -173.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tt -84.1 96.49 8.93 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.086 -1.009 . . . . 0.0 110.135 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -91.27 73.76 6.19 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 121.433 -0.792 . . . . 0.0 111.62 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.34 -86.88 1.49 Allowed Glycine 0 N--CA 1.49 2.274 0 O-C-N 121.828 -0.545 . . . . 0.0 113.441 -175.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -132.24 50.62 2.22 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 168.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -153.6 121.12 5.89 Favored 'General case' 0 CA--C 1.564 1.509 0 O-C-N 120.61 -1.306 . . . . 0.0 110.511 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.8 mt -83.56 106.91 15.67 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.758 0.823 . . . . 0.0 111.116 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.2 t -103.21 100.02 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -173.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -86.34 104.46 15.87 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.745 0.818 . . . . 0.0 110.895 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.4 mt -99.31 100.47 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -172.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -87.4 125.67 34.41 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 118.835 0.743 . . . . 0.0 111.53 174.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -116.54 117.88 31.11 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 123.839 0.856 . . . . 0.0 110.387 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.3 p90 -148.42 129.78 14.74 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.866 -1.146 . . . . 0.0 110.716 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 53.69 42.13 31.91 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 166.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.03 17.03 71.33 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 119.893 2.717 . . . . 0.0 119.893 -166.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -132.66 143.13 49.44 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 119.243 1.521 . . . . 0.0 110.042 -170.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -138.55 131.45 29.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.525 -0.734 . . . . 0.0 112.245 -174.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 t -128.07 129.98 47.49 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.563 0.745 . . . . 0.0 109.309 169.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.24 128.78 54.74 Favored 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 123.122 0.569 . . . . 0.0 111.111 174.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -106.58 106.95 17.72 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.1 t -88.78 109.45 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -105.69 102.23 11.69 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.989 0.916 . . . . 0.0 110.374 -174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.49 141.82 51.75 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.788 0.835 . . . . 0.0 112.532 -168.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.8 mm -80.77 117.93 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 120.82 -1.175 . . . . 0.0 109.619 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.45 89.87 3.17 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 171.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.5 t70 50.15 66.12 1.24 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.6 -48.5 3.33 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 117.435 1.734 . . . . 0.0 117.435 -171.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -83.36 142.87 30.72 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 118.904 1.352 . . . . 0.0 112.818 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.0 ttt -90.65 111.46 22.81 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.843 0.83 . . . . 0.0 110.303 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 69.4 t -93.93 108.6 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.56 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 23.9 ttt -89.65 112.52 23.79 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.704 0.802 . . . . 0.0 109.78 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.2 m -100.44 111.24 23.48 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mp -104.79 112.64 25.82 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.428 1.091 . . . . 0.0 108.139 -172.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.267 13.2 t -131.47 142.0 49.9 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -122.75 81.42 1.86 Allowed 'General case' 0 CA--C 1.564 1.507 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.76 173.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 71.18 -92.98 0.5 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 115.579 0.992 . . . . 0.0 115.579 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -86.89 -37.01 18.09 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.3 t -82.01 134.28 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-N 119.343 0.974 . . . . 0.0 110.157 -171.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.5 t -129.4 121.22 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -175.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.14 154.45 23.29 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 123.548 0.739 . . . . 0.0 112.44 164.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.3 t -132.41 113.47 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.146 -0.971 . . . . 0.0 109.25 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -106.12 124.33 49.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.176 -0.953 . . . . 0.0 110.856 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -108.62 115.68 30.55 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 123.252 0.621 . . . . 0.0 110.602 -165.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -114.69 133.21 56.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.794 -1.191 . . . . 0.0 113.22 -166.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -98.94 153.81 18.54 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 123.338 0.655 . . . . 0.0 112.626 166.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -74.27 135.29 42.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.176 0 CA-C-O 117.923 -1.037 . . . . 0.0 112.225 170.598 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.358 9.0 tt0 . . . . . 0 N--CA 1.497 1.891 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.28 -29.35 68.76 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 153.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -82.12 -6.28 59.06 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 169.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.6 t -74.86 91.34 2.44 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-N 122.194 2.27 . . . . 0.0 113.644 -172.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -168.29 169.2 10.96 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-O 122.243 1.02 . . . . 0.0 112.27 -170.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.6 m -86.71 123.09 31.49 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.238 -0.914 . . . . 0.0 108.907 167.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -118.37 118.69 32.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.427 -0.796 . . . . 0.0 111.026 -171.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -104.15 136.98 42.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.04 -1.037 . . . . 0.0 111.113 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.25 121.04 14.8 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.1 p -108.93 -26.07 10.41 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -150.61 113.82 4.85 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 121.037 1.744 . . . . 0.0 109.484 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.7 p -94.47 89.38 5.82 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 122.454 1.121 . . . . 0.0 111.936 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -88.76 110.22 20.82 Favored 'General case' 0 CA--C 1.563 1.45 0 O-C-N 121.079 -1.013 . . . . 0.0 110.93 -170.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.262 56.4 t30 62.88 35.37 13.57 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 -174.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -83.17 66.08 8.55 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 123.747 1.737 . . . . 0.0 111.845 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -165.07 -68.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.99 -1.459 . . . . 0.0 107.728 -156.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -65.61 -42.32 91.73 Favored 'General case' 0 CA--C 1.565 1.525 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 172.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -46.41 -52.41 13.04 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 163.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.8 mmt -60.22 -49.98 75.48 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 175.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.5 -46.43 76.95 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 168.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.41 -35.88 76.19 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 117.581 2.437 . . . . 0.0 117.581 175.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 tt -62.81 -39.19 93.51 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 171.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.63 55.68 1.31 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 114.808 0.683 . . . . 0.0 114.808 -169.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.9 m -90.42 163.24 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-O 122.329 1.061 . . . . 0.0 112.055 173.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.88 142.04 31.37 Favored Glycine 0 CA--C 1.55 2.249 0 O-C-N 121.007 -1.058 . . . . 0.0 113.444 160.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -59.37 -41.16 88.66 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.96 -41.15 64.26 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 165.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.0 m -58.39 -50.36 73.96 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 120.201 1.364 . . . . 0.0 114.231 170.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.269 5.7 ptt180 -62.44 -36.25 81.82 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 172.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -63.16 -50.9 68.56 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 166.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.4 t -46.57 -48.96 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.81 -30.22 66.29 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 119.404 2.521 . . . . 0.0 119.404 170.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -76.68 -46.42 25.69 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 119.8 1.8 . . . . 0.0 115.238 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.259 28.3 m -89.16 47.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 CA-C-N 121.254 1.843 . . . . 0.0 113.715 175.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.6 t -145.18 161.72 38.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.116 -0.99 . . . . 0.0 111.922 172.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -102.27 91.32 2.51 Favored Pre-proline 0 CA--C 1.574 1.868 0 O-C-N 121.38 -0.825 . . . . 0.0 109.545 162.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.44 123.68 7.23 Favored 'Trans proline' 0 C--N 1.373 1.825 0 CA-C-N 122.684 1.994 . . . . 0.0 112.827 -174.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.0 m -101.01 102.74 13.8 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -173.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.6 t -95.85 102.96 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -171.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.0 mt -90.7 110.79 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.0 mt -94.29 122.64 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 170.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.7 p -134.83 143.8 47.24 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.178 0.591 . . . . 0.0 112.298 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -99.35 113.29 25.53 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.019 -1.051 . . . . 0.0 109.157 168.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -113.33 90.55 3.37 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.468 -0.77 . . . . 0.0 110.316 -174.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.84 -77.39 1.79 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 115.317 0.887 . . . . 0.0 115.317 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -117.96 -54.94 2.3 Favored 'General case' 0 CA--C 1.567 1.614 0 C-N-CA 123.712 0.805 . . . . 0.0 111.819 171.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -79.2 157.9 27.76 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -173.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.9 t -89.81 124.7 42.62 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.601 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.0 t -114.42 105.7 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 76.9 mt -97.05 120.64 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -106.37 101.69 11.14 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.62 0.724 . . . . 0.0 109.837 171.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.3 m -84.33 98.54 10.07 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 170.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 63.9 mt -94.24 93.52 7.8 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -174.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.8 t -79.57 18.04 0.8 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 118.313 2.708 . . . . 0.0 118.313 -174.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.441 7.4 p 63.61 -60.72 0.17 Allowed 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 125.26 1.424 . . . . 0.0 114.739 -163.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -66.03 -46.17 78.83 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 173.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.69 119.78 7.73 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 119.125 0.875 . . . . 0.0 110.216 -165.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -104.52 112.52 25.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.318 -0.864 . . . . 0.0 111.901 -166.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 p -105.82 110.67 23.04 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.714 -0.616 . . . . 0.0 110.808 -170.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -109.35 107.66 17.93 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.21 1.004 . . . . 0.0 110.64 -175.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.5 pt -109.55 121.15 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 C-N-CA 123.491 0.716 . . . . 0.0 110.496 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 97.2 p -110.72 111.44 22.63 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.228 1.011 . . . . 0.0 110.882 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -148.37 151.4 35.24 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.062 0.934 . . . . 0.0 112.89 -165.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -86.3 148.7 25.5 Favored 'General case' 0 CA--C 1.571 1.765 0 O-C-N 121.211 -0.931 . . . . 0.0 111.06 162.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 73.3 mt -71.05 124.67 24.93 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.237 -1.539 . . . . 0.0 111.922 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.35 -3.45 86.57 Favored Glycine 0 CA--C 1.556 2.628 0 N-CA-C 119.081 2.392 . . . . 0.0 119.081 -162.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -86.95 124.57 33.3 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 120.066 1.933 . . . . 0.0 110.761 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -87.25 107.85 18.68 Favored 'General case' 0 CA--C 1.565 1.535 0 O-C-N 121.877 -0.515 . . . . 0.0 110.91 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -112.88 159.88 18.6 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.379 1.072 . . . . 0.0 111.825 -175.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -83.3 137.67 33.88 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.423 -1.423 . . . . 0.0 111.952 171.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -129.96 111.71 12.8 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.287 0.635 . . . . 0.0 109.798 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.8 m -74.89 96.59 3.15 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 122.023 0.916 . . . . 0.0 109.709 170.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 80.5 p -74.08 173.99 9.28 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -167.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.18 -5.43 1.08 Allowed 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 119.442 3.126 . . . . 0.0 119.442 167.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -95.17 -8.28 36.77 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 159.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.318 3.2 m-20 80.5 12.22 0.94 Allowed 'General case' 0 N--CA 1.507 2.417 0 CA-C-N 121.513 1.96 . . . . 0.0 116.18 -166.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -91.78 130.48 37.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.444 -1.41 . . . . 0.0 110.176 173.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -82.32 110.99 17.97 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.15 0.5 . . . . 0.0 110.973 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 93.4 m -103.71 118.95 37.91 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -173.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -69.81 104.95 2.6 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.906 0.86 . . . . 0.0 110.56 171.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.3 m -120.22 117.61 28.32 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.894 -156.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.2 p -109.01 118.45 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.225 0.536 . . . . 0.0 109.757 175.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.6 t -96.81 110.5 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 173.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 79.6 p -110.44 131.19 55.27 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.706 0.802 . . . . 0.0 110.906 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -83.15 120.39 25.73 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.957 -1.089 . . . . 0.0 109.787 161.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -122.91 72.55 1.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.108 -169.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.61 60.81 8.23 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 117.071 1.588 . . . . 0.0 117.071 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.347 5.5 m-20 92.08 -31.74 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 -167.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.465 ' NZ ' ' HE2' ' A' ' 107' ' ' GLU . 76.2 mttt -97.28 124.17 41.31 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 120.897 1.68 . . . . 0.0 112.322 -170.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.8 mt -81.03 103.75 11.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.162 -0.961 . . . . 0.0 110.745 170.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.0 t -104.72 106.04 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.715 -1.241 . . . . 0.0 107.733 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -93.87 105.79 17.79 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.029 0.932 . . . . 0.0 110.148 177.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.33 104.46 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 123.354 0.661 . . . . 0.0 109.383 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -85.15 125.61 32.95 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 118.887 0.767 . . . . 0.0 111.626 171.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -116.08 126.42 53.73 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.317 0.647 . . . . 0.0 110.575 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 15.6 p90 -150.18 124.49 9.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.351 -0.843 . . . . 0.0 110.492 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 55.99 33.72 22.33 Favored 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 117.087 2.254 . . . . 0.0 117.087 173.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.8 -18.23 21.84 Favored Glycine 0 CA--C 1.559 2.805 0 N-CA-C 119.325 2.49 . . . . 0.0 119.325 -164.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -89.17 145.46 25.41 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-N 119.489 1.644 . . . . 0.0 112.836 -175.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -130.25 129.29 43.12 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.747 0.819 . . . . 0.0 110.709 -174.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.2 t -123.9 129.01 50.29 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.643 -0.66 . . . . 0.0 109.327 159.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.95 127.01 56.1 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.412 0.685 . . . . 0.0 110.709 175.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -106.43 102.39 11.79 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -175.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.4 t -88.19 102.8 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -173.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -108.35 110.47 22.04 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.076 0.95 . . . . 0.0 109.015 -169.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.465 ' HE2' ' NZ ' ' A' ' 90' ' ' LYS . 12.8 pt-20 -129.73 137.68 50.7 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -170.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.1 mm -77.0 99.38 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 171.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -109.99 111.09 22.27 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.8 t70 47.12 52.83 11.45 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -171.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.02 -23.99 4.18 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 119.599 2.6 . . . . 0.0 119.599 -170.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -94.06 136.24 34.56 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 119.522 1.661 . . . . 0.0 111.454 -172.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 50.1 ttp -81.01 102.72 10.36 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.253 1.025 . . . . 0.0 110.167 172.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 87.5 t -89.52 101.76 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 46.6 ttm -87.37 101.02 13.16 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.536 0.735 . . . . 0.0 109.476 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 93.1 m -91.56 101.42 14.06 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.888 0.851 . . . . 0.0 108.737 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 mp -88.83 117.87 28.13 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.307 6.5 t -137.94 133.66 34.01 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 175.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -99.01 89.9 4.44 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.342 171.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 71.86 -86.75 0.46 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 114.952 0.741 . . . . 0.0 114.952 -172.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -127.75 3.67 6.07 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 174.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.4 125.11 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-N 121.82 2.1 . . . . 0.0 107.994 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.1 t -120.6 130.56 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.816 -0.553 . . . . 0.0 111.139 -162.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.28 148.59 35.31 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 123.484 0.714 . . . . 0.0 111.588 156.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.3 t -125.64 107.5 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 120.743 -1.223 . . . . 0.0 108.807 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -95.62 120.26 35.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.213 -0.929 . . . . 0.0 111.139 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -97.73 97.91 9.41 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.367 0.603 . . . . 0.0 110.131 -172.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -94.53 135.62 35.77 Favored 'General case' 0 CA--C 1.561 1.403 0 O-C-N 121.353 -0.842 . . . . 0.0 112.024 -174.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -122.66 154.87 37.46 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.481 0.712 . . . . 0.0 111.454 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -72.02 136.86 46.85 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -172.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.194 0 C-N-CA 124.183 0.993 . . . . 0.0 111.363 170.321 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 N--CA 1.499 2.007 0 N-CA-C 116.358 1.984 . . . . 0.0 116.358 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.11 -29.38 30.5 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 118.201 2.667 . . . . 0.0 118.201 164.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -82.49 -9.78 59.28 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 169.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.6 t -73.59 102.62 3.93 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-N 122.054 2.206 . . . . 0.0 114.004 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -172.17 163.59 5.9 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 122.211 1.005 . . . . 0.0 111.788 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.2 m -78.84 122.64 26.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.015 -1.053 . . . . 0.0 108.375 153.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -106.14 115.79 30.82 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.085 -1.01 . . . . 0.0 110.218 -175.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -92.5 129.8 38.34 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.646 0.778 . . . . 0.0 111.272 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 tt -73.05 113.21 9.84 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-O 121.353 0.597 . . . . 0.0 112.526 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.0 p -85.25 -45.84 11.6 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -148.51 117.33 6.69 Favored 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 123.785 0.834 . . . . 0.0 109.734 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.7 p -99.91 98.54 9.3 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.126 0.57 . . . . 0.0 111.535 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -80.05 122.1 26.34 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 123.437 0.695 . . . . 0.0 111.261 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 t30 55.32 38.19 29.98 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 118.15 2.648 . . . . 0.0 118.15 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -78.97 -35.94 42.27 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -176.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -50.18 -59.56 3.81 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 172.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -59.06 -37.66 77.57 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 171.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -57.66 -48.39 79.63 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 115.448 1.648 . . . . 0.0 115.448 168.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -57.85 -49.4 76.8 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 167.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -44.26 65.32 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 168.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.61 -41.33 98.32 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 170.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.37 -13.0 24.55 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 118.406 2.743 . . . . 0.0 118.406 170.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.75 55.61 1.75 Allowed Glycine 0 N--CA 1.485 1.931 0 CA-C-N 119.329 0.968 . . . . 0.0 115.342 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.3 m -95.44 146.43 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 117.565 0.682 . . . . 0.0 112.221 175.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.23 144.95 35.38 Favored Glycine 0 CA--C 1.551 2.298 0 N-CA-C 115.277 0.871 . . . . 0.0 115.277 169.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -78.92 60.75 2.95 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 123.311 1.529 . . . . 0.0 114.237 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -165.57 -55.24 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 126.418 1.887 . . . . 0.0 108.63 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.1 m -40.46 -40.0 1.12 Allowed 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 160.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.329 0.0 OUTLIER -94.01 -2.38 53.11 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 119.436 3.124 . . . . 0.0 119.436 172.767 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -65.37 -46.5 79.9 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 120.815 1.643 . . . . 0.0 112.599 151.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.7 t -52.29 -55.01 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 160.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.97 -40.64 91.3 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 120.548 2.979 . . . . 0.0 120.548 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -72.06 -33.45 67.97 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 175.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.3 m -69.81 -35.45 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.6 t -86.96 137.44 32.36 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -91.22 117.57 67.94 Favored Pre-proline 0 CA--C 1.576 1.963 0 CA-C-O 117.851 -1.071 . . . . 0.0 111.0 166.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -76.06 127.31 9.88 Favored 'Trans proline' 0 CA--C 1.562 1.907 0 CA-C-N 123.404 2.251 . . . . 0.0 115.356 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.9 m -99.28 123.24 43.41 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.079 0.952 . . . . 0.0 109.015 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.9 t -105.82 106.51 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.55 -0.718 . . . . 0.0 109.537 -168.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.8 mt -90.79 106.66 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 120.141 -1.599 . . . . 0.0 108.273 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 81.6 mt -90.38 111.55 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.2 p -135.67 119.76 17.63 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -169.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -90.9 116.72 28.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.324 -0.86 . . . . 0.0 111.842 -171.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -114.55 79.97 1.34 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.477 0.656 . . . . 0.0 110.543 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.2 -97.35 0.66 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 115.509 0.964 . . . . 0.0 115.509 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.36 -41.55 69.6 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 170.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -113.08 153.36 28.31 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-O 122.164 0.983 . . . . 0.0 113.41 -160.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.2 t -89.23 115.67 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.651 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 167.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.22 100.86 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 175.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 58.9 mt -94.28 114.25 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -98.91 102.97 14.88 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 122.979 0.512 . . . . 0.0 110.054 174.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.8 m -87.89 101.48 13.77 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.534 0.683 . . . . 0.0 109.187 173.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.6 mt -96.74 96.88 8.89 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.385 0.674 . . . . 0.0 109.396 -175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -83.73 22.38 1.12 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 175.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.418 20.5 p 63.23 -62.1 0.14 Allowed 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 125.59 1.556 . . . . 0.0 114.755 -167.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -76.76 -37.79 55.27 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 173.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -120.5 124.81 46.3 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 119.49 1.041 . . . . 0.0 110.945 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -93.83 104.33 16.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.034 -1.041 . . . . 0.0 109.207 164.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.255 13.6 t -107.57 87.07 2.42 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.013 0.911 . . . . 0.0 109.617 174.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -106.2 142.63 35.57 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -172.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.9 pt -133.83 123.01 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 C-N-CA 123.044 0.537 . . . . 0.0 111.711 -168.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.9 p -109.99 107.63 17.58 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.812 0.845 . . . . 0.0 110.742 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -140.91 150.47 43.21 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.597 0.713 . . . . 0.0 112.543 -169.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -95.8 98.23 10.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.159 -0.963 . . . . 0.0 109.819 170.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.7 mt -6.07 109.12 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 120.513 3.523 . . . . 0.0 120.513 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.92 -18.83 45.41 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 118.97 2.348 . . . . 0.0 118.97 -167.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.36 127.76 33.87 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 119.716 1.758 . . . . 0.0 111.834 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -79.03 127.77 32.42 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -137.67 150.43 47.35 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.698 0.761 . . . . 0.0 111.42 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -75.85 132.98 40.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.899 -1.126 . . . . 0.0 112.101 170.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -133.09 111.05 10.63 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.238 0.615 . . . . 0.0 110.149 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 95.0 m -82.19 109.66 16.68 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 165.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 51.2 p -82.96 -177.64 6.84 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -165.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.02 -16.6 32.36 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 118.773 2.879 . . . . 0.0 118.773 168.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -79.55 -14.93 58.51 Favored 'General case' 0 CA--C 1.579 2.068 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 157.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.331 5.0 t70 75.88 14.83 2.6 Favored 'General case' 0 CA--C 1.58 2.129 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -160.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.0 ptt-85 -83.34 124.1 30.29 Favored 'General case' 0 CA--C 1.565 1.553 0 O-C-N 120.084 -1.635 . . . . 0.0 109.737 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -85.7 118.07 24.97 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.149 0.58 . . . . 0.0 112.417 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.9 p -122.33 145.64 48.06 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -76.81 105.05 7.64 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.807 0.813 . . . . 0.0 109.709 160.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.7 m -99.53 124.92 45.15 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.536 0.735 . . . . 0.0 112.324 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.31 118.01 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 36.1 t -119.71 95.25 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.36 -0.838 . . . . 0.0 109.073 -171.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.7 m -113.64 130.32 56.42 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.648 0.779 . . . . 0.0 111.612 -169.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 tt -85.29 109.07 18.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.12 -0.988 . . . . 0.0 110.456 170.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -90.57 -16.51 28.63 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 -176.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 176.86 -88.05 0.08 OUTLIER Glycine 0 N--CA 1.49 2.235 0 CA-C-N 120.075 1.307 . . . . 0.0 110.954 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -101.92 32.12 3.58 Favored 'General case' 0 CA--C 1.579 2.071 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 158.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -146.23 114.18 6.52 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.874 0.761 . . . . 0.0 109.951 -159.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 mt -90.2 102.27 14.99 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 123.72 0.808 . . . . 0.0 109.625 172.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.6 t -100.12 105.45 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.149 -0.969 . . . . 0.0 108.603 -170.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -95.04 101.07 12.8 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.427 0.691 . . . . 0.0 110.369 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 59.4 mt -89.47 122.79 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 C-N-CA 123.959 0.903 . . . . 0.0 108.76 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -111.37 123.42 50.18 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 119.477 1.035 . . . . 0.0 110.732 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -113.34 117.84 32.93 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.959 0.904 . . . . 0.0 109.771 -176.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -150.65 127.05 10.71 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.648 -1.282 . . . . 0.0 111.496 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 56.63 32.27 20.69 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 174.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.68 -27.15 4.9 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 118.432 2.133 . . . . 0.0 118.432 -162.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -80.99 140.71 35.03 Favored 'General case' 0 CA--C 1.562 1.426 0 CA-C-N 119.121 1.461 . . . . 0.0 112.158 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -131.26 126.71 36.14 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.235 0.614 . . . . 0.0 110.128 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.7 t -122.3 156.26 34.23 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.413 0.685 . . . . 0.0 110.743 171.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.283 9.7 p30 -135.47 146.24 47.98 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 170.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -120.16 106.14 11.66 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.7 t -90.82 98.38 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -92.23 97.7 11.06 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -176.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -117.08 130.54 56.72 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -168.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.1 mm -74.94 111.04 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.12 -91.05 0.18 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 119.399 -0.334 . . . . 0.0 110.14 -173.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -104.7 70.43 0.93 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 119.342 0.974 . . . . 0.0 108.851 164.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.64 -39.95 2.85 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 118.128 2.011 . . . . 0.0 118.128 -169.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -84.34 144.9 28.54 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.256 1.028 . . . . 0.0 113.262 -173.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 55.8 ttp -84.05 100.32 11.02 Favored 'General case' 0 CA--C 1.561 1.394 0 CA-C-O 122.291 1.043 . . . . 0.0 110.204 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.1 t -85.38 102.76 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 43.1 ttm -86.89 101.36 13.31 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.213 0.605 . . . . 0.0 109.676 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.7 m -90.87 110.1 21.32 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 174.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.5 mp -99.37 119.75 38.46 Favored 'General case' 0 CA--C 1.56 1.339 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -176.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.0 t -125.56 124.2 40.75 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 119.406 1.003 . . . . 0.0 112.646 -171.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -137.19 97.14 3.42 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 123.816 0.846 . . . . 0.0 110.51 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 77.32 -94.2 1.13 Allowed Glycine 0 N--CA 1.492 2.374 0 O-C-N 121.433 -0.792 . . . . 0.0 114.084 170.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -128.39 42.84 3.25 Favored 'General case' 0 CA--C 1.578 2.033 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 160.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 81.4 t -136.88 118.94 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 -177.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.84 131.09 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.05 157.07 21.19 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 123.088 0.555 . . . . 0.0 112.481 163.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.3 t -132.58 109.21 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.032 -1.043 . . . . 0.0 108.99 175.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -100.24 114.41 27.84 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.804 0.811 . . . . 0.0 110.748 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -95.83 106.01 18.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.66 -0.65 . . . . 0.0 110.145 -170.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -105.58 128.19 53.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.889 -1.132 . . . . 0.0 113.391 -168.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -99.41 156.52 16.97 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 124.062 0.945 . . . . 0.0 113.352 173.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -77.72 130.05 36.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.152 -0.967 . . . . 0.0 113.285 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.166 0 C-N-CA 124.493 1.117 . . . . 0.0 110.859 162.693 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.12 -23.78 62.43 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 166.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -78.71 -18.07 54.89 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 167.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 71.9 m -73.94 92.16 2.08 Favored 'General case' 0 CA--C 1.568 1.671 0 CA-C-N 122.284 2.311 . . . . 0.0 113.855 -173.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.66 166.6 13.83 Favored 'General case' 0 CA--C 1.571 1.754 0 CA-C-O 122.423 1.106 . . . . 0.0 112.328 -170.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.3 m -84.86 111.87 20.03 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.342 -0.849 . . . . 0.0 109.18 166.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -105.87 118.68 37.22 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.912 0.485 . . . . 0.0 110.603 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -103.32 137.83 40.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.14 -0.975 . . . . 0.0 111.628 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -72.78 129.94 39.34 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.0 p -102.18 -37.5 8.1 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -158.15 117.57 3.21 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 119.602 1.092 . . . . 0.0 109.33 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.1 p -97.02 89.4 4.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.726 -0.609 . . . . 0.0 111.562 171.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.99 124.32 29.67 Favored 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 123.763 0.825 . . . . 0.0 111.283 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.307 11.3 t-20 61.89 10.29 3.45 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 118.316 2.71 . . . . 0.0 118.316 -174.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -62.2 -33.61 74.88 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 116.635 2.087 . . . . 0.0 116.635 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -51.99 -52.67 49.03 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 166.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -63.81 -42.98 97.56 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 172.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -52.49 -52.31 55.09 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 166.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 78.9 mtm -58.98 -48.79 80.3 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 173.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -54.24 -48.3 71.28 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 169.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.3 -38.21 82.93 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 tp -72.3 -1.92 17.17 Favored 'General case' 0 CA--C 1.579 2.061 0 N-CA-C 117.905 2.557 . . . . 0.0 117.905 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.22 48.9 5.2 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 117.101 1.6 . . . . 0.0 117.101 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.1 m -82.42 131.49 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 173.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.64 58.04 4.9 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 116.65 1.42 . . . . 0.0 116.65 173.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.288 25.8 t80 63.35 -58.33 0.17 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.647 2.091 . . . . 0.0 116.647 -175.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.33 -46.97 76.34 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 116.939 2.2 . . . . 0.0 116.939 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.2 m -63.9 -33.47 75.78 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 172.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -60.17 -53.75 53.96 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 162.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.89 -37.25 86.69 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.5 t -53.68 -62.27 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 C-N-CA 123.804 0.841 . . . . 0.0 112.684 156.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.54 -35.45 45.08 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 120.337 2.895 . . . . 0.0 120.337 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -69.47 -47.49 63.76 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 172.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.3 m -78.04 -33.35 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.5 t -83.39 147.14 28.06 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 119.274 0.943 . . . . 0.0 113.203 -172.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -107.21 91.11 6.28 Favored Pre-proline 0 CA--C 1.572 1.811 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -77.68 118.25 4.48 Favored 'Trans proline' 0 C--N 1.372 1.793 0 CA-C-N 122.463 1.915 . . . . 0.0 113.616 -169.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.4 m -88.15 123.15 32.52 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.913 0.863 . . . . 0.0 110.577 -172.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.0 t -100.48 101.64 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -173.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 64.9 mt -92.76 111.31 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.2 mt -101.84 121.36 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.2 t -143.24 -172.73 3.75 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-O 122.509 1.147 . . . . 0.0 111.819 173.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -135.28 118.19 16.26 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.334 1.054 . . . . 0.0 109.472 -176.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -100.49 91.75 4.83 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.65 0.738 . . . . 0.0 110.953 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.55 -74.8 1.48 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 115.904 1.122 . . . . 0.0 115.904 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -121.58 -45.97 2.28 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -88.3 155.94 19.45 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 120.368 1.44 . . . . 0.0 114.148 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.0 t -90.4 133.46 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 C-N-CA 123.47 0.708 . . . . 0.0 109.305 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 93.7 t -114.7 117.42 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.9 mt -95.28 107.88 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.693 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 162.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -78.91 149.75 32.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.65 -1.281 . . . . 0.0 110.161 156.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.6 m -147.63 99.52 3.12 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.282 -1.511 . . . . 0.0 107.93 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.8 mt -117.97 103.28 9.77 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.703 0.763 . . . . 0.0 110.443 -154.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.7 t -82.36 163.15 21.91 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 122.27 1.033 . . . . 0.0 112.655 168.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.8 p -57.36 15.19 0.0 OUTLIER 'General case' 0 CA--C 1.591 2.556 0 N-CA-C 118.003 2.594 . . . . 0.0 118.003 153.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -146.32 -69.09 0.26 Allowed 'General case' 0 CA--C 1.57 1.744 0 C-N-CA 124.977 1.311 . . . . 0.0 107.877 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -100.34 121.71 41.95 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.944 0.898 . . . . 0.0 111.867 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -96.54 82.26 3.33 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.848 0.832 . . . . 0.0 111.043 174.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.5 p -85.41 155.91 21.07 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -168.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -142.67 134.24 26.55 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.2 mt -128.98 102.72 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 -174.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 92.0 p -104.75 123.47 47.7 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 123.923 0.889 . . . . 0.0 111.83 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -148.77 142.37 25.44 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.116 0.96 . . . . 0.0 112.773 -168.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -84.76 11.95 8.17 Favored 'General case' 0 CA--C 1.58 2.1 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.263 65.0 mt 64.85 105.54 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 125.556 1.542 . . . . 0.0 113.35 -168.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.16 35.87 36.9 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 118.352 2.101 . . . . 0.0 118.352 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -135.4 135.49 40.66 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 118.467 1.134 . . . . 0.0 110.089 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -89.45 116.61 27.76 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -171.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -116.42 141.25 48.42 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.889 0.876 . . . . 0.0 111.054 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.61 135.38 43.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.567 -1.333 . . . . 0.0 111.907 170.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -134.11 105.21 6.57 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -171.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.2 m -79.83 100.52 8.04 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 122.106 0.955 . . . . 0.0 109.31 172.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 77.8 p -76.38 174.64 9.98 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -169.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.84 -2.53 0.57 Allowed 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 119.885 3.291 . . . . 0.0 119.885 167.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -103.02 4.1 36.92 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 115.594 1.702 . . . . 0.0 115.594 158.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.29 3.4 t70 62.65 25.9 15.37 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 -166.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.8 ptp85 -89.65 126.01 35.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.642 -1.286 . . . . 0.0 109.117 166.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -85.66 101.49 12.78 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-O 121.811 0.815 . . . . 0.0 111.384 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 99.0 m -102.19 116.79 33.4 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 121.395 0.616 . . . . 0.0 112.654 -169.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -66.19 102.47 0.84 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.24 1.016 . . . . 0.0 110.37 169.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.5 m -114.09 125.24 53.75 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 121.849 -0.532 . . . . 0.0 111.48 -156.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.78 122.15 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.8 t -109.03 121.86 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.224 -0.922 . . . . 0.0 109.337 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 94.7 p -118.0 140.92 49.05 Favored 'General case' 0 CA--C 1.564 1.504 0 C-N-CA 123.956 0.902 . . . . 0.0 111.963 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.8 tp -92.91 98.37 11.33 Favored 'General case' 0 CA--C 1.566 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 110.302 174.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -91.59 73.55 5.92 Favored 'General case' 0 CA--C 1.569 1.691 0 O-C-N 121.364 -0.835 . . . . 0.0 111.795 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.25 62.44 4.42 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 116.398 1.319 . . . . 0.0 116.398 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.256 6.6 t70 54.06 47.19 23.88 Favored 'General case' 0 CA--C 1.579 2.086 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -163.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -143.82 107.02 4.52 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.0 mt -82.08 95.2 7.39 Favored 'General case' 0 CA--C 1.568 1.648 0 CA-C-O 121.835 0.826 . . . . 0.0 111.7 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.7 t -97.03 103.18 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -84.93 125.71 32.9 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.035 0.534 . . . . 0.0 110.089 172.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.6 mt -112.39 118.12 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -101.79 126.29 48.63 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 119.296 0.953 . . . . 0.0 111.343 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -114.8 123.14 48.46 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.962 0.905 . . . . 0.0 110.496 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -149.67 122.71 8.83 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.421 -1.424 . . . . 0.0 110.581 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 54.26 39.9 31.24 Favored 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.1 -25.38 4.23 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 118.936 2.335 . . . . 0.0 118.936 -165.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -83.17 141.11 32.17 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-N 119.354 1.577 . . . . 0.0 112.115 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -134.18 125.89 28.81 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 122.969 0.507 . . . . 0.0 111.166 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.9 t -118.98 154.66 32.69 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.764 0.826 . . . . 0.0 110.612 169.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.31 10.8 p30 -134.77 152.42 51.75 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 171.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -126.87 102.91 7.22 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -169.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.8 t -95.19 94.02 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -168.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -81.9 123.67 29.04 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.95 0.9 . . . . 0.0 110.771 176.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -144.31 123.56 13.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.667 -0.646 . . . . 0.0 109.945 -167.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.3 mm -78.09 103.76 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.429 -0.795 . . . . 0.0 109.132 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -131.05 113.86 14.47 Favored 'General case' 0 CA--C 1.558 1.287 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -170.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.5 t70 47.93 50.53 15.64 Favored 'General case' 0 CA--C 1.579 2.094 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -168.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.75 -43.48 3.17 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 -169.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.2 mtmp? -85.75 150.88 24.27 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 118.463 1.132 . . . . 0.0 113.602 -171.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 59.1 ttp -85.23 98.65 10.61 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 121.83 0.824 . . . . 0.0 109.499 171.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.1 81.81 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 120.954 -1.092 . . . . 0.0 108.73 -171.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 23.2 ttp -76.97 112.94 14.13 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.078 0.551 . . . . 0.0 111.58 -166.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.4 m -98.44 114.02 26.23 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.803 0.811 . . . . 0.0 109.777 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.34 106.54 17.72 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 124.238 1.015 . . . . 0.0 108.788 -173.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.7 t -115.6 118.84 34.23 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.407 0.622 . . . . 0.0 111.754 -175.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -105.37 81.68 1.73 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 165.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 68.68 -89.25 0.22 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 115.439 0.936 . . . . 0.0 115.439 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.556 ' N ' ' HD2' ' A' ' 121' ' ' ASP . 1.4 m-20 -95.94 -25.4 15.98 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 169.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.2 110.86 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-N 121.038 1.745 . . . . 0.0 109.305 -171.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.7 t -113.07 112.42 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 123.514 0.725 . . . . 0.0 109.273 -172.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -102.16 158.86 15.87 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 165.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.3 t -131.27 110.49 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.022 -1.048 . . . . 0.0 109.14 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -95.23 108.69 20.85 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.891 0.853 . . . . 0.0 110.411 172.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -88.46 104.31 16.68 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.586 0.754 . . . . 0.0 110.497 -171.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -101.57 120.29 40.09 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -0.903 . . . . 0.0 112.639 -172.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -87.05 163.51 16.99 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 167.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -74.14 151.0 40.15 Favored 'General case' 0 CA--C 1.571 1.773 0 O-C-N 120.894 -1.129 . . . . 0.0 112.279 162.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.269 166.407 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 . . . . . 0 N--CA 1.499 2.023 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.54 -21.38 52.26 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 118.394 2.739 . . . . 0.0 118.394 169.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -83.1 -17.48 42.94 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 169.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 87.6 m -71.18 93.96 1.12 Allowed 'General case' 0 CA--C 1.566 1.56 0 CA-C-N 121.563 1.983 . . . . 0.0 113.695 -174.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -170.61 162.95 8.13 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-O 122.485 1.136 . . . . 0.0 111.958 -167.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 92.9 m -86.7 113.62 22.7 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.436 169.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -107.26 111.93 24.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.615 -0.678 . . . . 0.0 111.064 -172.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -101.18 132.97 46.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.253 -0.904 . . . . 0.0 111.501 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -72.05 133.29 45.17 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.7 p -105.7 -40.34 5.78 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 175.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -155.96 123.86 5.67 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 119.474 1.034 . . . . 0.0 109.326 -174.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.8 p -104.86 102.55 12.08 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.373 0.669 . . . . 0.0 110.986 172.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -68.46 -56.29 8.92 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 116.543 2.053 . . . . 0.0 116.543 -159.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -126.21 54.28 1.56 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 119.042 0.837 . . . . 0.0 111.671 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -78.39 -53.05 7.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -172.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -50.62 -43.21 56.86 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 117.767 2.506 . . . . 0.0 117.767 172.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.13 -49.12 78.9 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 166.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -50.73 -46.67 59.23 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 164.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.445 ' SD ' HG21 ' A' ' 25' ' ' VAL . 32.9 mmt -57.66 -42.34 83.31 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 170.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -60.29 -47.18 87.1 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 166.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.97 -39.17 93.88 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 172.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.5 tp -69.17 -23.77 63.97 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.6 45.63 6.37 Favored Glycine 0 CA--C 1.548 2.118 0 N-CA-C 117.169 1.628 . . . . 0.0 117.169 -173.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.445 HG21 ' SD ' ' A' ' 20' ' ' MET . 34.6 m -102.05 153.7 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 118.428 1.114 . . . . 0.0 111.709 173.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.08 -167.66 16.51 Favored Glycine 0 N--CA 1.491 2.303 0 O-C-N 120.646 -1.284 . . . . 0.0 115.835 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -84.84 59.73 5.75 Favored 'General case' 0 CA--C 1.576 1.967 0 O-C-N 121.433 -1.039 . . . . 0.0 112.025 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.3 -73.09 0.31 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.723 0.809 . . . . 0.0 109.702 -175.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.1 m -57.74 -34.3 69.37 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 169.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -62.63 -39.19 93.07 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 117.342 2.349 . . . . 0.0 117.342 167.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -67.14 -56.81 8.38 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.034 1.288 . . . . 0.0 112.269 165.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.5 t -56.13 -45.52 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.91 -15.04 79.95 Favored Glycine 0 CA--C 1.552 2.368 0 N-CA-C 118.79 2.276 . . . . 0.0 118.79 175.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -94.09 -52.0 4.59 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.111 1.956 . . . . 0.0 113.991 171.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.256 34.3 m -80.95 -31.14 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.468 0 CA-C-N 121.657 2.026 . . . . 0.0 115.472 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.08 140.69 32.03 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-O 122.082 0.944 . . . . 0.0 110.206 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -98.18 103.25 16.85 Favored Pre-proline 0 CA--C 1.574 1.895 0 CA-C-O 118.075 -0.964 . . . . 0.0 109.791 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.51 146.87 35.43 Favored 'Trans proline' 0 CA--C 1.561 1.841 0 C-N-CA 122.565 2.177 . . . . 0.0 115.391 -176.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 88.7 m -100.68 100.63 11.35 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.362 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.3 t -95.23 101.98 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -173.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.5 mt -91.56 106.29 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 85.2 mt -84.87 120.34 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 170.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.8 p -137.16 133.06 34.83 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.856 0.462 . . . . 0.0 111.647 -172.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -92.7 101.08 13.48 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.992 -1.068 . . . . 0.0 109.35 172.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -104.97 83.13 1.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.837 0.827 . . . . 0.0 109.713 -170.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.76 -106.35 2.52 Favored Glycine 0 N--CA 1.487 2.098 0 CA-C-N 116.006 -0.543 . . . . 0.0 113.985 -175.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -88.74 -28.11 20.74 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -110.1 153.88 24.05 Favored 'General case' 0 CA--C 1.564 1.507 0 CA-C-O 122.804 1.288 . . . . 0.0 113.818 -170.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.46 118.91 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.604 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 170.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.3 t -111.09 107.54 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.4 mt -93.93 112.81 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -100.99 98.14 8.63 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.2 m -86.8 94.59 9.58 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.4 mt -89.02 89.36 7.95 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.651 0.739 . . . . 0.0 109.356 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.3 t -97.2 27.38 4.17 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.342 66.6 p 68.87 -53.22 0.57 Allowed 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -174.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -92.96 -54.97 3.52 Favored 'General case' 0 CA--C 1.571 1.751 0 C-N-CA 124.821 1.248 . . . . 0.0 111.703 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -107.38 108.88 20.45 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.778 0.831 . . . . 0.0 109.665 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -100.29 86.76 3.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.587 -0.695 . . . . 0.0 112.116 175.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -95.62 127.08 41.35 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.366 -0.834 . . . . 0.0 112.916 -173.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -109.52 97.96 7.43 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.921 0.888 . . . . 0.0 110.834 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.3 pt -95.85 108.99 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.078 -1.014 . . . . 0.0 111.051 -174.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 85.4 p -102.43 113.04 26.04 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.12 0.968 . . . . 0.0 112.076 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -148.64 148.88 30.61 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.22 0.534 . . . . 0.0 111.954 -170.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -86.93 156.62 19.74 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.519 -1.363 . . . . 0.0 111.925 163.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.9 mt -70.51 124.13 23.47 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.373 -1.454 . . . . 0.0 112.491 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.16 -4.24 83.9 Favored Glycine 0 CA--C 1.554 2.506 0 N-CA-C 118.97 2.348 . . . . 0.0 118.97 -163.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -85.33 131.87 34.34 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-N 120.223 2.012 . . . . 0.0 112.229 -175.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -72.42 136.5 46.06 Favored 'General case' 0 CA--C 1.571 1.773 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.928 165.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -145.8 149.04 33.6 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.671 0.788 . . . . 0.0 110.937 175.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.427 ' HD2' ' N ' ' A' ' 71' ' ' ASP . 1.0 OUTLIER -84.74 134.91 34.32 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.728 -1.233 . . . . 0.0 110.864 169.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.496 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 38.5 tt0 -132.15 109.44 9.96 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.912 -174.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.2 m -78.28 107.1 10.64 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 167.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.4 p -79.91 168.81 18.75 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -167.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.23 -8.51 1.66 Allowed 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 119.716 3.228 . . . . 0.0 119.716 172.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -116.89 28.63 8.41 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 120.833 1.651 . . . . 0.0 114.875 162.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.253 17.1 m-20 63.07 42.16 7.55 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 176.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -119.52 132.22 55.72 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.989 0.916 . . . . 0.0 109.041 167.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -92.62 115.27 27.95 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.158 0.583 . . . . 0.0 110.558 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' ' 72' ' ' GLU . 25.2 p -110.69 143.38 41.25 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -76.48 100.86 5.39 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 122.272 1.034 . . . . 0.0 109.338 160.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.3 m -96.22 130.07 43.38 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 124.235 1.014 . . . . 0.0 112.735 -176.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 p -134.95 124.59 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 123.172 0.589 . . . . 0.0 109.506 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.4 t -112.67 110.9 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.486 -0.759 . . . . 0.0 109.641 -172.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.8 p -104.58 132.11 51.21 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 123.635 0.774 . . . . 0.0 112.467 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.7 tt -88.87 99.67 12.57 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.607 0.718 . . . . 0.0 109.464 168.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -97.25 76.91 2.64 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.443 -0.785 . . . . 0.0 110.587 -173.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.96 58.22 15.71 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 117.99 1.956 . . . . 0.0 117.99 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.348 5.5 m-20 91.14 -35.6 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -163.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -90.01 113.97 25.75 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-N 120.572 1.533 . . . . 0.0 112.659 -171.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.1 mt -80.7 123.42 28.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.921 -1.112 . . . . 0.0 112.006 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.4 t -124.87 106.6 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -174.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -94.28 101.29 13.25 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 123.472 0.709 . . . . 0.0 110.098 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.3 mt -87.21 112.59 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 123.89 0.876 . . . . 0.0 108.707 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -100.14 121.17 41.0 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.061 0.545 . . . . 0.0 110.189 172.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -114.32 118.15 33.1 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.2 0.6 . . . . 0.0 110.531 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 15.6 p90 -142.96 125.12 15.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.25 -0.906 . . . . 0.0 110.197 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 55.17 37.67 29.26 Favored 'General case' 0 N--CA 1.507 2.424 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 173.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.91 -22.58 6.61 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 119.142 2.417 . . . . 0.0 119.142 -165.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -86.48 142.24 28.51 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 119.024 1.412 . . . . 0.0 112.645 -175.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -131.01 123.42 28.71 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.548 0.739 . . . . 0.0 110.616 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.1 t -121.7 139.84 53.06 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 123.278 0.631 . . . . 0.0 109.911 165.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -118.49 132.66 56.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.848 -0.533 . . . . 0.0 112.079 174.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -102.29 104.86 15.42 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.8 t -87.6 96.58 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.93 116.22 28.72 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 123.964 0.906 . . . . 0.0 110.072 175.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.6 128.38 20.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.865 -0.522 . . . . 0.0 110.754 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.7 mm -80.89 121.65 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.625 -0.672 . . . . 0.0 109.664 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -101.5 -107.89 0.23 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 119.222 -0.418 . . . . 0.0 109.904 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -86.63 66.91 9.69 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 120.306 1.412 . . . . 0.0 111.06 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 79.21 -30.18 2.14 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 118.726 2.25 . . . . 0.0 118.726 -167.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.461 ' NZ ' ' HE2' ' A' ' 129' ' ' GLU . 85.3 mttt -93.77 147.33 23.15 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 118.548 1.174 . . . . 0.0 112.1 -172.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 14.6 tpp -77.48 113.08 14.92 Favored 'General case' 0 CA--C 1.563 1.476 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.606 169.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.9 t -88.64 105.53 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.638 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 164.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 22.3 ttt -101.4 103.4 14.32 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.119 0.568 . . . . 0.0 109.485 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.7 m -103.36 104.37 14.47 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.378 0.671 . . . . 0.0 109.275 -172.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mp -94.86 106.0 17.96 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.463 0.705 . . . . 0.0 109.346 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.9 t -102.7 134.12 46.59 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.736 0.779 . . . . 0.0 112.286 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -116.18 79.68 1.34 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 161.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 68.64 -94.02 0.33 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -175.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -88.22 -30.71 19.5 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 172.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.1 t -90.34 112.33 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-N 120.237 1.38 . . . . 0.0 109.363 -169.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.8 t -115.22 113.13 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 123.435 0.694 . . . . 0.0 109.525 -168.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -100.91 111.86 24.17 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.428 -0.795 . . . . 0.0 112.386 175.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.36 109.17 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.465 -0.772 . . . . 0.0 109.018 -177.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.5 mtp85 -98.19 120.37 38.48 Favored 'General case' 0 CA--C 1.563 1.446 0 CA-C-O 121.915 0.864 . . . . 0.0 110.541 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -99.56 104.99 16.83 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.398 0.679 . . . . 0.0 109.709 -169.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -109.76 125.55 52.81 Favored 'General case' 0 CA--C 1.568 1.635 0 O-C-N 121.623 -0.673 . . . . 0.0 111.458 -170.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.461 ' HE2' ' NZ ' ' A' ' 112' ' ' LYS . 86.9 mt-10 -96.62 155.84 16.6 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.374 0.67 . . . . 0.0 112.416 171.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -72.41 131.27 42.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.306 -0.871 . . . . 0.0 112.234 171.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.501 0 C-N-CA 123.254 0.622 . . . . 0.0 112.487 170.561 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.257 93.4 mt-10 . . . . . 0 N--CA 1.504 2.255 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.2 -37.3 45.9 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 116.748 2.129 . . . . 0.0 116.748 154.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -75.0 -11.74 60.17 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 168.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 66.2 m -76.7 100.53 5.44 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 122.853 2.57 . . . . 0.0 112.871 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -168.76 163.31 11.88 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-O 122.592 1.187 . . . . 0.0 112.313 -172.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.9 m -82.67 103.47 12.2 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.948 0.899 . . . . 0.0 108.796 169.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -99.0 110.32 22.94 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.694 -1.254 . . . . 0.0 112.158 -170.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -96.64 131.48 43.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.423 -0.798 . . . . 0.0 111.822 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.92 120.42 14.18 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.3 p -93.32 -46.62 7.28 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 174.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -145.62 115.21 7.23 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.826 0.851 . . . . 0.0 109.437 -171.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 76.3 p -104.15 94.18 5.24 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.434 0.694 . . . . 0.0 111.472 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -84.09 120.7 26.47 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.957 0.503 . . . . 0.0 111.194 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.297 3.8 t-20 62.58 20.67 12.16 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 118.248 2.684 . . . . 0.0 118.248 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -67.45 -38.05 83.88 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -55.57 -47.29 76.66 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 169.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -58.91 -47.91 83.32 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 169.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -51.21 -49.79 60.36 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 166.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 75.8 mtm -62.15 -44.01 97.56 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 175.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -62.86 -42.97 99.95 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 166.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.61 -43.75 98.28 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 tp -64.3 -32.81 74.56 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 168.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.85 46.94 5.78 Favored Glycine 0 CA--C 1.543 1.831 0 N-CA-C 116.231 1.252 . . . . 0.0 116.231 -171.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.266 22.9 m -83.08 64.2 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 CA-C-N 119.413 1.607 . . . . 0.0 112.15 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 56.1 -162.54 5.98 Favored Glycine 0 CA--C 1.553 2.425 0 N-CA-C 117.957 1.943 . . . . 0.0 117.957 -175.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -99.73 -43.58 6.4 Favored 'General case' 0 CA--C 1.572 1.795 0 CA-C-N 114.713 -0.744 . . . . 0.0 112.587 154.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.49 -49.8 69.93 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 174.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.0 m -59.25 -41.65 89.28 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 120.303 1.411 . . . . 0.0 114.723 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -59.43 -44.57 92.88 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 169.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -68.74 -40.56 79.77 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 172.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.7 t -50.41 -55.6 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 CA-C-N 119.798 1.181 . . . . 0.0 113.481 160.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.97 -39.68 41.19 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 119.33 2.492 . . . . 0.0 119.33 168.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -67.91 -46.25 72.09 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 170.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.0 m -75.55 -29.65 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 t -79.53 145.91 32.92 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 120.313 1.415 . . . . 0.0 114.259 -173.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -95.96 99.28 4.83 Favored Pre-proline 0 CA--C 1.574 1.883 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 159.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.14 131.23 10.73 Favored 'Trans proline' 0 CA--C 1.562 1.895 0 C-N-CA 122.499 2.132 . . . . 0.0 113.149 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.4 m -97.71 110.73 23.24 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.6 t -97.33 96.88 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -175.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.2 mt -95.22 105.6 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.5 -1.375 . . . . 0.0 108.817 -172.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.3 mt -93.1 123.21 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.5 p -146.18 149.29 33.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.345 -0.847 . . . . 0.0 112.778 169.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -90.99 121.22 32.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.511 -0.743 . . . . 0.0 111.105 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -110.95 85.73 2.17 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.347 0.594 . . . . 0.0 109.925 -175.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.54 -67.72 2.53 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 116.58 1.392 . . . . 0.0 116.58 -177.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -131.69 -44.01 0.99 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 124.137 0.975 . . . . 0.0 112.876 172.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -75.93 152.79 37.01 Favored 'General case' 0 CA--C 1.565 1.526 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.3 t -91.52 125.14 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.611 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 169.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -111.88 111.32 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.8 mt -105.96 106.11 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 54.2 mtm-85 -92.05 97.37 10.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.872 -0.517 . . . . 0.0 109.977 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.1 m -85.65 97.04 9.88 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.765 0.793 . . . . 0.0 109.553 174.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.1 mt -111.92 127.55 55.89 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.157 -165.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.6 m -123.76 164.28 19.48 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.329 0.652 . . . . 0.0 111.265 163.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 49.0 p -74.73 55.34 0.67 Allowed 'General case' 0 N--CA 1.508 2.46 0 O-C-N 120.553 -1.342 . . . . 0.0 113.194 171.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 178.86 -56.66 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.873 0 C-N-CA 125.174 1.39 . . . . 0.0 108.529 -149.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -140.07 127.25 21.09 Favored 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 124.271 1.028 . . . . 0.0 109.939 -169.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -104.91 100.16 9.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.538 -0.726 . . . . 0.0 109.388 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.9 p -114.3 91.54 3.66 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.223 0.535 . . . . 0.0 110.564 -172.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -94.65 126.91 40.26 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.06 -1.025 . . . . 0.0 113.718 -176.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.3 mt -113.92 97.84 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -173.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 95.5 p -102.73 116.37 32.44 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.996 0.919 . . . . 0.0 112.038 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -151.45 149.38 29.19 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -172.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -87.21 150.7 23.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.697 -1.252 . . . . 0.0 110.423 152.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 27.2 mt -62.16 121.37 12.92 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.285 -1.509 . . . . 0.0 113.628 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.83 -9.88 72.45 Favored Glycine 0 CA--C 1.558 2.734 0 N-CA-C 119.129 2.411 . . . . 0.0 119.129 -165.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.91 125.23 30.49 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 120.041 1.92 . . . . 0.0 111.003 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -84.48 129.08 34.89 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -129.72 154.51 47.11 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.174 0.99 . . . . 0.0 111.701 -175.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.55 135.01 35.58 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.37 -1.456 . . . . 0.0 111.473 166.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -127.7 106.72 9.34 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.5 m -79.97 100.77 8.26 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.724 0.773 . . . . 0.0 109.915 174.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.7 p -85.07 167.02 16.18 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -169.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.4 -14.01 10.56 Favored 'General case' 0 CA--C 1.576 1.978 0 N-CA-C 118.9 2.926 . . . . 0.0 118.9 167.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -73.48 -13.49 61.06 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 160.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.287 21.7 t70 68.96 69.72 0.28 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 121.267 1.849 . . . . 0.0 112.931 -166.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.2 ptt85 -160.89 127.71 4.11 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -86.03 90.1 8.0 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 123.11 0.564 . . . . 0.0 111.472 172.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.4 p -81.86 129.12 34.65 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -72.75 97.16 2.15 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 123.101 1.429 . . . . 0.0 110.157 173.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.9 m -109.91 123.86 50.35 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.96 -159.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.0 p -121.72 134.65 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.173 0.511 . . . . 0.0 110.144 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.5 t -123.49 123.48 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -175.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.0 m -131.73 146.46 52.18 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.948 0.88 . . . . 0.0 111.842 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.6 mt -84.92 112.57 20.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.874 . . . . 0.0 111.604 172.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -106.11 76.53 1.17 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.398 0.679 . . . . 0.0 111.041 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.64 61.89 5.52 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 116.686 1.434 . . . . 0.0 116.686 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.259 6.5 t70 52.36 43.5 30.78 Favored 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -162.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -137.15 112.41 9.17 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 mt -82.64 87.04 6.73 Favored 'General case' 0 CA--C 1.567 1.622 0 O-C-N 121.381 -0.824 . . . . 0.0 111.2 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.4 t -87.66 107.92 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -170.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -84.64 136.73 33.63 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.787 0.435 . . . . 0.0 110.413 168.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 59.7 mt -126.76 112.86 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -101.76 121.09 41.41 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.578 1.081 . . . . 0.0 110.186 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -116.74 126.67 53.48 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.307 0.575 . . . . 0.0 111.463 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.6 p90 -152.96 133.4 13.65 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.158 -0.964 . . . . 0.0 109.967 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 59.24 23.37 11.73 Favored 'General case' 0 N--CA 1.51 2.567 0 N-CA-C 118.439 2.755 . . . . 0.0 118.439 166.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.9 10.62 82.76 Favored Glycine 0 CA--C 1.558 2.72 0 N-CA-C 119.28 2.472 . . . . 0.0 119.28 -162.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -121.17 141.73 50.56 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-N 119.676 1.738 . . . . 0.0 110.44 -176.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -130.6 122.78 28.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.765 -0.584 . . . . 0.0 110.922 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.7 t -116.7 140.36 49.5 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 123.133 0.573 . . . . 0.0 110.759 166.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.16 140.68 49.98 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.99 -0.444 . . . . 0.0 110.99 -170.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -130.99 101.15 5.49 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.057 -1.027 . . . . 0.0 108.392 -163.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.3 t -93.56 97.18 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -170.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -90.33 108.51 19.81 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 123.55 0.74 . . . . 0.0 110.79 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.86 134.06 53.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.492 -0.755 . . . . 0.0 112.55 -172.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.4 mm -75.11 104.7 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.259 -0.901 . . . . 0.0 109.772 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -103.62 88.12 3.0 Favored 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.0 t70 51.16 59.41 4.63 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.662 1.726 . . . . 0.0 115.662 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.28 -40.36 2.62 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 117.678 1.831 . . . . 0.0 117.678 -171.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -93.47 136.83 33.36 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.276 1.538 . . . . 0.0 113.02 -173.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 56.1 ttp -82.74 104.49 13.02 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.897 0.856 . . . . 0.0 109.765 171.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 84.1 t -93.85 103.55 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 5.2 ttp -93.41 110.11 21.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.41 0.684 . . . . 0.0 110.862 -175.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 96.0 m -96.8 112.5 24.23 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mp -99.62 101.83 13.14 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 124.131 0.973 . . . . 0.0 109.771 -171.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.4 t -101.15 112.82 25.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.591 -0.693 . . . . 0.0 109.965 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -96.25 78.57 3.09 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 152.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.78 -116.33 9.12 Favored Glycine 0 CA--C 1.549 2.204 0 N-CA-C 114.778 0.671 . . . . 0.0 114.778 -168.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -73.31 -19.56 61.01 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 117.02 2.229 . . . . 0.0 117.02 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.2 t -84.75 105.48 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-N 121.143 1.792 . . . . 0.0 108.519 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.4 t -115.67 110.69 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -171.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -99.46 159.21 15.19 Favored 'General case' 0 CA--C 1.562 1.405 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 167.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.1 t -132.17 111.42 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.067 -1.02 . . . . 0.0 109.059 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 56.9 mtm180 -102.17 121.26 41.88 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.75 0.786 . . . . 0.0 111.595 174.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -101.58 111.1 23.23 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.289 0.635 . . . . 0.0 110.525 -171.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -107.48 130.09 54.88 Favored 'General case' 0 CA--C 1.565 1.547 0 O-C-N 121.143 -0.973 . . . . 0.0 112.612 -170.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -97.53 152.74 18.71 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 169.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -75.46 127.94 34.22 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.605 -0.684 . . . . 0.0 112.014 172.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.047 -0.978 . . . . 0.0 112.788 -178.258 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.17 -22.21 38.78 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 171.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -82.85 -19.91 36.61 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 168.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 44.4 t -73.33 96.46 2.32 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-N 122.663 2.483 . . . . 0.0 113.569 -172.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -174.84 171.04 3.22 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 124.719 1.208 . . . . 0.0 111.466 -168.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 94.3 m -84.1 141.67 30.94 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.802 -1.186 . . . . 0.0 110.021 162.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -133.59 120.66 21.01 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.722 -1.236 . . . . 0.0 110.847 -170.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -108.2 117.91 35.38 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.779 0.832 . . . . 0.0 109.8 -168.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 tt -70.54 115.86 10.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.397 -0.814 . . . . 0.0 112.851 -173.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.8 p -90.22 -49.35 6.6 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -140.88 129.43 22.67 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.936 0.895 . . . . 0.0 109.684 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.8 p -106.33 93.73 4.77 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.077 0.551 . . . . 0.0 110.587 170.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -72.05 124.85 25.84 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.713 0.805 . . . . 0.0 112.026 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 4.9 t-20 52.19 27.99 5.14 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 118.72 2.859 . . . . 0.0 118.72 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -70.46 -44.05 68.57 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -174.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -49.27 -48.57 45.86 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 168.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -59.66 -50.11 75.14 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 170.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -49.28 -49.36 43.95 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 164.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.1 mtp -60.17 -46.25 90.33 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 175.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -55.39 -46.71 76.53 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 167.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.67 -37.34 86.99 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 117.063 2.245 . . . . 0.0 117.063 170.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.4 tp -67.42 -21.69 65.56 Favored 'General case' 0 CA--C 1.573 1.862 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 175.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.24 70.36 1.25 Allowed Glycine 0 N--CA 1.482 1.741 0 CA-C-N 119.026 0.83 . . . . 0.0 113.349 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.2 m -97.1 141.68 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 172.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.03 48.35 4.04 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 117.849 1.9 . . . . 0.0 117.849 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.336 16.6 t80 60.58 -56.69 0.08 Allowed 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 177.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.12 -44.06 64.28 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 173.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.4 m -66.67 -35.21 79.6 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.268 9.7 ptm180 -66.14 -40.85 90.94 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 121.858 2.117 . . . . 0.0 116.301 164.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -60.11 -42.89 95.7 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 169.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.72 -60.75 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-N 119.237 0.926 . . . . 0.0 112.692 166.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.19 -26.24 58.44 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 121.138 3.215 . . . . 0.0 121.138 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -73.68 -38.79 64.8 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 119.527 1.664 . . . . 0.0 115.166 166.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.0 m -77.11 -34.74 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 172.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.0 t -90.65 127.5 36.31 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 120.28 1.4 . . . . 0.0 112.801 -174.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.93 94.88 4.05 Favored Pre-proline 0 CA--C 1.575 1.934 0 CA-C-O 118.119 -0.943 . . . . 0.0 108.881 173.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.66 144.94 56.18 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.52 2.147 . . . . 0.0 116.022 -174.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.2 m -86.86 111.42 20.76 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 114.766 -1.107 . . . . 0.0 109.335 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.3 t -95.65 104.9 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -175.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.9 mt -94.85 104.09 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 80.1 mt -91.21 114.97 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 85.9 p -128.25 128.01 43.89 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 122.869 0.467 . . . . 0.0 111.881 -174.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -85.79 125.19 33.06 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.896 -1.128 . . . . 0.0 109.371 168.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -133.34 90.25 2.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.796 -1.19 . . . . 0.0 110.792 -166.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.76 -68.93 3.13 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 115.783 1.073 . . . . 0.0 115.783 176.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -131.02 -46.94 1.01 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.83 0.852 . . . . 0.0 112.101 168.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -88.31 161.56 17.08 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -173.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.8 t -94.9 124.89 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.1 t -120.12 105.91 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -172.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 61.0 mt -103.62 121.91 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -103.57 113.89 27.75 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 122.709 0.404 . . . . 0.0 111.309 173.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.0 m -94.61 103.4 15.34 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 123.366 0.666 . . . . 0.0 109.351 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.9 mt -112.03 101.45 9.74 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.599 0.714 . . . . 0.0 111.445 -167.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.5 t -87.44 156.0 19.76 Favored 'General case' 0 CA--C 1.563 1.459 0 O-C-N 121.846 -0.534 . . . . 0.0 111.874 162.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.0 t -67.73 34.35 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 157.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -150.63 -61.89 0.19 Allowed 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 125.364 1.465 . . . . 0.0 108.774 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -122.44 122.75 39.71 Favored 'General case' 0 CA--C 1.568 1.636 0 C-N-CA 123.949 0.9 . . . . 0.0 110.239 -177.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -84.48 115.6 22.66 Favored 'General case' 0 CA--C 1.567 1.628 0 C-N-CA 123.422 0.689 . . . . 0.0 110.222 167.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -131.97 144.91 51.15 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.985 0.898 . . . . 0.0 111.198 172.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.57 149.84 30.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.992 -1.068 . . . . 0.0 113.421 -175.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.4 pt -125.67 130.97 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 124.051 0.94 . . . . 0.0 110.259 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.9 p -122.25 114.57 21.0 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.658 0.783 . . . . 0.0 109.773 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -145.6 143.6 29.97 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -166.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -98.76 22.37 10.15 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 174.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 70.4 mt 68.82 110.7 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 125.17 1.388 . . . . 0.0 113.568 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.82 -7.22 56.01 Favored Glycine 0 CA--C 1.557 2.71 0 N-CA-C 119.255 2.462 . . . . 0.0 119.255 -167.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -82.85 125.95 31.9 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-N 119.201 1.501 . . . . 0.0 110.77 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -80.91 126.08 30.92 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -137.19 137.07 38.76 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 123.514 0.726 . . . . 0.0 110.761 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.67 130.2 38.35 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.501 -1.375 . . . . 0.0 111.431 173.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -130.55 106.46 8.53 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 122.725 0.41 . . . . 0.0 111.124 -171.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 54.5 m -68.94 106.91 2.9 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.324 1.059 . . . . 0.0 110.908 176.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.7 p -78.88 173.24 12.73 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.478 -173.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.73 3.37 0.15 Allowed 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 119.169 3.026 . . . . 0.0 119.169 168.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -109.37 -0.29 19.09 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 159.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.347 4.7 m-20 88.82 -5.59 0.46 Allowed 'General case' 0 N--CA 1.508 2.453 0 N-CA-C 116.748 2.129 . . . . 0.0 116.748 -173.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.94 122.36 24.75 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 120.621 1.555 . . . . 0.0 110.622 176.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.281 5.1 p30 -90.94 97.44 11.18 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.392 0.615 . . . . 0.0 111.458 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 82.5 m -93.73 131.55 38.96 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-O 121.486 0.66 . . . . 0.0 112.673 -168.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -69.9 102.24 1.93 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.579 1.151 . . . . 0.0 109.698 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.2 m -110.74 123.31 49.8 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.611 -157.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.1 t -122.98 113.33 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.8 t -99.32 116.91 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.153 -0.967 . . . . 0.0 109.937 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.1 t -112.49 131.61 55.49 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.279 0.632 . . . . 0.0 112.332 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 tt -91.61 100.48 13.21 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.419 0.688 . . . . 0.0 110.383 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -93.76 84.21 4.56 Favored 'General case' 0 CA--C 1.567 1.601 0 O-C-N 121.35 -0.843 . . . . 0.0 110.111 175.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.73 -82.34 0.96 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 115.411 0.924 . . . . 0.0 115.411 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -138.89 53.8 1.75 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.56 0.695 . . . . 0.0 112.293 161.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -142.37 121.25 12.75 Favored 'General case' 0 CA--C 1.561 1.388 0 O-C-N 121.299 -0.875 . . . . 0.0 110.468 168.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.5 mt -89.46 106.9 18.76 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.424 0.63 . . . . 0.0 110.112 176.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 52.4 t -96.72 100.33 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -85.57 101.22 12.5 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.458 0.703 . . . . 0.0 110.21 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 56.5 mt -90.78 110.53 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -175.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -102.84 118.34 36.6 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 119.077 0.853 . . . . 0.0 110.766 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -109.17 129.94 55.49 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 124.191 0.996 . . . . 0.0 111.216 -177.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.6 p90 -152.09 123.16 7.6 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.556 -1.34 . . . . 0.0 110.611 177.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 54.48 37.04 27.06 Favored 'General case' 0 N--CA 1.507 2.391 0 N-CA-C 117.306 2.335 . . . . 0.0 117.306 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.26 -26.57 4.39 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 118.757 2.263 . . . . 0.0 118.757 -164.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -82.24 142.99 31.66 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-N 119.11 1.455 . . . . 0.0 112.158 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -138.71 129.44 26.33 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.229 0.538 . . . . 0.0 111.547 -176.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.1 t -114.8 150.95 34.64 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.266 0.627 . . . . 0.0 109.754 162.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.293 11.1 p30 -127.32 135.84 51.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.015 -1.053 . . . . 0.0 112.582 166.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -105.09 100.85 10.43 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -176.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.1 t -85.21 98.03 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -174.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.9 ttm-85 -91.08 106.66 18.68 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.434 0.694 . . . . 0.0 109.909 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -123.9 141.11 52.33 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 119.235 0.925 . . . . 0.0 112.555 -175.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.5 mm -79.2 119.66 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.057 -1.027 . . . . 0.0 109.317 172.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -137.15 113.25 9.81 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.034 0.534 . . . . 0.0 109.617 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.6 t70 45.39 55.91 6.11 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.5 -36.78 3.07 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 118.314 2.086 . . . . 0.0 118.314 -169.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -82.94 152.94 25.29 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 119.02 1.41 . . . . 0.0 114.011 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.3 tmm? -91.65 109.0 20.3 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.848 158.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 82.5 t -94.79 106.27 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 38.0 ttm -89.41 106.67 18.6 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 173.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.1 m -95.98 110.64 22.82 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mp -98.61 102.94 14.83 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.981 0.912 . . . . 0.0 109.164 -170.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.1 t -108.92 112.97 25.48 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.332 0.587 . . . . 0.0 111.205 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -98.18 80.13 2.65 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 164.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 64.29 -100.84 0.44 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 114.891 0.716 . . . . 0.0 114.891 -172.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -85.7 -23.56 27.33 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 171.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.6 t -89.48 113.77 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-N 120.907 1.685 . . . . 0.0 109.242 -173.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.7 t -117.43 118.37 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 123.271 0.628 . . . . 0.0 109.59 -170.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -104.22 161.14 14.29 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 163.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.9 t -133.26 112.59 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 120.785 -1.197 . . . . 0.0 109.827 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -99.6 116.34 31.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.026 -1.046 . . . . 0.0 110.305 174.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -102.84 108.49 19.72 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.434 0.694 . . . . 0.0 111.06 -167.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -107.9 127.2 53.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.907 -1.121 . . . . 0.0 112.025 -170.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -90.15 153.53 20.46 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 171.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -88.12 137.41 32.35 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -166.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.257 0 CA-C-O 117.444 -1.265 . . . . 0.0 111.646 176.509 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 N--CA 1.498 1.953 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.68 -26.19 63.59 Favored 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 117.938 2.57 . . . . 0.0 117.938 167.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -81.19 -17.0 51.19 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 165.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.7 t -77.37 90.09 3.79 Favored 'General case' 0 CA--C 1.569 1.674 0 CA-C-N 122.105 2.229 . . . . 0.0 113.365 -173.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -166.27 172.55 10.99 Favored 'General case' 0 CA--C 1.572 1.796 0 C-N-CA 124.509 1.123 . . . . 0.0 111.736 -173.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 m -85.51 130.4 34.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.944 -1.098 . . . . 0.0 109.677 164.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -124.44 116.36 22.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.647 -0.658 . . . . 0.0 111.327 -170.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -101.95 127.25 48.88 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.468 0.707 . . . . 0.0 110.93 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.7 119.78 15.35 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -176.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.3 p -92.32 -47.4 7.21 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 176.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -140.16 110.81 6.78 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.876 0.87 . . . . 0.0 109.08 -174.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -94.03 80.24 4.09 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.905 1.336 . . . . 0.0 111.807 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -85.77 108.38 18.06 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.186 -0.946 . . . . 0.0 111.104 -161.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.29 1.8 t30 69.27 28.7 4.78 Favored 'General case' 0 CA--C 1.584 2.261 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -168.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -73.07 -41.0 64.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 119.709 -1.87 . . . . 0.0 115.897 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -48.86 -53.72 18.25 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 171.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.45 -43.57 98.5 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 173.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -54.75 -47.39 73.91 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 166.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 71.2 mtm -60.19 -37.62 80.79 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 172.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -62.41 -50.28 72.14 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 161.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.07 -44.16 91.83 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 176.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.3 tp -75.35 -14.07 60.45 Favored 'General case' 0 CA--C 1.58 2.124 0 N-CA-C 116.28 1.956 . . . . 0.0 116.28 169.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.01 32.12 15.4 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 119.511 2.564 . . . . 0.0 119.511 172.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.5 m -79.64 69.24 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 CA-C-N 120.806 2.303 . . . . 0.0 113.54 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 58.85 -160.96 13.7 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -96.36 -51.27 4.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 122.027 -0.69 . . . . 0.0 111.864 148.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.61 -39.37 84.02 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 33.7 m -68.94 -33.33 73.55 Favored 'General case' 0 CA--C 1.577 1.985 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 171.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -57.06 -49.99 74.14 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-N 121.235 1.834 . . . . 0.0 115.085 159.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -54.24 -51.37 64.7 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 171.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.7 t -51.32 -60.92 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 C-N-CA 124.488 1.115 . . . . 0.0 113.991 166.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.83 -29.06 54.17 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 119.78 2.672 . . . . 0.0 119.78 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -74.61 -47.29 33.1 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 167.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 m -75.88 -34.05 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.5 t -91.99 144.19 25.71 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 120.229 1.377 . . . . 0.0 113.648 -170.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -92.87 112.9 58.01 Favored Pre-proline 0 CA--C 1.574 1.867 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.402 170.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.16 123.28 9.1 Favored 'Trans proline' 0 CA--C 1.561 1.84 0 CA-C-N 122.878 2.064 . . . . 0.0 113.425 170.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 91.0 m -92.61 97.43 10.8 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 172.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.9 t -93.56 101.17 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -168.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.6 mt -88.91 104.08 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 177.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -90.2 114.41 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 172.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.7 p -136.52 129.91 31.69 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.728 0.411 . . . . 0.0 111.573 -170.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -87.21 95.05 9.84 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.159 -0.963 . . . . 0.0 110.39 174.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -101.19 76.18 1.7 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.414 0.626 . . . . 0.0 110.698 -171.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.4 80.72 0.33 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 115.107 0.803 . . . . 0.0 115.107 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.326 34.4 t70 72.0 -56.24 0.65 Allowed 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -175.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -76.26 146.2 39.15 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -177.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.1 t -88.56 125.26 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 173.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.3 t -112.56 111.9 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.501 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.1 mt -90.63 115.56 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -108.46 95.64 5.8 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.5 m -84.9 91.7 8.1 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.399 0.619 . . . . 0.0 109.353 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.9 mt -103.65 95.8 6.29 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -172.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 p -111.03 27.27 9.85 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 -173.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.404 8.5 t 47.27 18.61 0.1 Allowed 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 119.891 3.293 . . . . 0.0 119.891 -164.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -155.39 -61.87 0.11 Allowed 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.724 1.21 . . . . 0.0 109.667 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -70.9 -61.49 1.74 Allowed 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.05 0.94 . . . . 0.0 113.439 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 59.62 63.77 1.45 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.4 t -118.88 122.72 42.96 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.268 0.627 . . . . 0.0 111.503 -170.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -109.15 112.93 25.36 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.526 0.731 . . . . 0.0 111.96 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 pt -112.53 114.75 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 C-N-CA 123.476 0.711 . . . . 0.0 110.84 -174.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 92.9 p -105.86 118.65 37.14 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.112 0.965 . . . . 0.0 112.648 -174.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -149.3 156.35 41.95 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.769 0.795 . . . . 0.0 112.206 -169.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -92.59 150.97 20.39 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.125 0.964 . . . . 0.0 110.876 161.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 41.1 mt -67.83 127.35 32.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.099 -1.001 . . . . 0.0 113.481 -176.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.13 -6.36 71.9 Favored Glycine 0 CA--C 1.556 2.605 0 N-CA-C 118.969 2.348 . . . . 0.0 118.969 -164.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.22 127.11 34.69 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 120.332 2.066 . . . . 0.0 110.953 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.408 ' HE2' ' NZ ' ' A' ' 96' ' ' LYS . 24.8 tt0 -78.88 124.78 28.57 Favored 'General case' 0 CA--C 1.569 1.708 0 CA-C-O 121.477 0.656 . . . . 0.0 111.609 171.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -131.01 145.14 51.95 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.947 0.899 . . . . 0.0 110.698 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -73.88 134.28 43.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.242 -1.536 . . . . 0.0 111.961 170.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -133.62 124.54 27.01 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.248 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.1 m -70.16 128.46 36.36 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-O 122.835 1.302 . . . . 0.0 110.361 158.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 80.7 p -97.88 170.36 9.01 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 122.042 0.925 . . . . 0.0 112.491 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.54 -23.9 4.66 Favored 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 119.205 3.039 . . . . 0.0 119.205 168.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -76.49 -15.77 59.81 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 166.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.321 34.9 m-20 66.66 33.97 6.1 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -156.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.73 133.63 46.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.027 -1.046 . . . . 0.0 108.668 162.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -94.01 112.61 24.47 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.002 0.521 . . . . 0.0 110.595 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.2 m -110.48 141.37 43.69 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.456 0.702 . . . . 0.0 112.626 -173.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -73.76 109.79 7.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.523 -0.736 . . . . 0.0 110.356 166.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.2 m -109.26 125.98 52.85 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.921 0.888 . . . . 0.0 111.315 -169.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 p -126.05 126.0 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-O 121.213 0.53 . . . . 0.0 109.916 174.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.0 t -114.17 116.08 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -176.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.5 p -129.86 148.11 51.7 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 20.1 mt -86.02 117.39 24.83 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.499 0.666 . . . . 0.0 112.626 174.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -106.31 62.69 0.65 Allowed 'General case' 0 CA--C 1.574 1.869 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.901 174.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.51 66.61 1.97 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 115.786 1.074 . . . . 0.0 115.786 -174.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.266 18.3 t70 50.77 49.84 20.19 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 115.718 1.748 . . . . 0.0 115.718 -163.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -147.15 103.44 3.59 Favored 'General case' 0 CA--C 1.558 1.255 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -174.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 53.1 mt -84.18 105.79 15.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.659 -0.651 . . . . 0.0 110.969 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.15 103.33 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -174.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.16 106.43 18.48 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.341 0.656 . . . . 0.0 110.36 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.1 mt -99.29 108.7 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -173.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -98.07 120.75 39.03 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 119.19 0.905 . . . . 0.0 110.088 176.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.408 ' NZ ' ' HE2' ' A' ' 69' ' ' GLU . 43.3 mtmt -117.75 121.27 40.37 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.666 0.787 . . . . 0.0 110.528 -174.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -149.12 133.1 17.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.319 -0.863 . . . . 0.0 110.368 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 59.79 24.82 13.8 Favored 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 118.598 2.814 . . . . 0.0 118.598 166.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.73 10.02 85.66 Favored Glycine 0 CA--C 1.558 2.763 0 N-CA-C 119.201 2.441 . . . . 0.0 119.201 -162.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -120.62 142.11 49.71 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-N 119.393 1.597 . . . . 0.0 110.199 -176.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -132.31 130.04 40.31 Favored 'General case' 0 CA--C 1.562 1.432 0 O-C-N 121.738 -0.601 . . . . 0.0 111.024 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.0 t -120.53 133.98 55.33 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 123.072 0.549 . . . . 0.0 109.715 163.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -116.46 134.44 54.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.773 -0.579 . . . . 0.0 112.167 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -107.59 97.82 7.5 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -174.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 78.2 t -85.85 99.92 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -172.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -101.78 113.9 27.49 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.084 0.554 . . . . 0.0 110.992 -172.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -127.27 143.84 51.16 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.1 mm -86.01 109.09 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.146 -0.971 . . . . 0.0 109.403 175.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.01 89.91 3.29 Favored 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 123.758 0.823 . . . . 0.0 109.29 176.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.9 t70 51.53 57.68 6.31 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 94.82 -38.29 3.17 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 117.942 1.937 . . . . 0.0 117.942 -170.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.9 mtmm -92.7 140.44 29.53 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 119.526 1.663 . . . . 0.0 113.35 -176.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 57.9 ttp -90.46 108.39 19.76 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 121.978 0.894 . . . . 0.0 109.984 175.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.1 t -94.54 107.01 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 23.2 ttt -101.98 106.51 17.45 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.048 0.539 . . . . 0.0 110.542 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.5 m -99.02 99.07 10.05 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.657 0.783 . . . . 0.0 109.37 -174.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.9 mp -90.67 108.22 19.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.873 0.869 . . . . 0.0 110.12 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.0 t -108.26 135.11 50.14 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.571 0.7 . . . . 0.0 112.35 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -127.13 98.43 5.3 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.392 0.677 . . . . 0.0 109.176 166.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 73.68 -91.67 0.68 Allowed Glycine 0 N--CA 1.49 2.249 0 O-C-N 121.861 -0.524 . . . . 0.0 113.901 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -124.25 11.62 8.78 Favored 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 160.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 36.2 t -92.02 107.77 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-N 121.56 1.982 . . . . 0.0 107.825 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.5 t -112.57 115.76 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 123.259 0.624 . . . . 0.0 109.568 -169.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -104.17 123.44 47.31 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.597 -0.689 . . . . 0.0 112.604 169.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.7 t -105.32 104.66 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -93.56 115.72 28.22 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.636 0.732 . . . . 0.0 110.765 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -99.12 109.79 22.45 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.208 0.603 . . . . 0.0 110.4 -171.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -108.73 128.48 54.91 Favored 'General case' 0 CA--C 1.565 1.525 0 O-C-N 121.188 -0.945 . . . . 0.0 111.937 -170.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -95.52 153.55 17.65 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.656 0.741 . . . . 0.0 112.337 167.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -72.08 134.78 46.0 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.49 0 C-N-CA 123.328 0.651 . . . . 0.0 111.17 159.842 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 N--CA 1.499 2.022 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.55 -24.3 63.59 Favored 'General case' 0 CA--C 1.574 1.87 0 N-CA-C 117.904 2.557 . . . . 0.0 117.904 167.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -85.97 -13.24 48.23 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 172.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.7 t -79.43 96.62 6.1 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 121.157 1.799 . . . . 0.0 112.667 -170.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -169.41 163.65 10.55 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.133 0.968 . . . . 0.0 112.492 -166.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.4 m -81.08 119.0 22.99 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.355 -0.84 . . . . 0.0 109.363 163.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -111.48 107.43 16.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.498 -0.751 . . . . 0.0 111.264 -172.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -91.7 129.74 37.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.511 -0.743 . . . . 0.0 111.272 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -68.85 133.63 48.54 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-O 122.524 1.154 . . . . 0.0 113.904 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.1 p -110.29 -34.73 6.27 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -156.9 112.46 2.89 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 119.69 1.132 . . . . 0.0 108.45 -172.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.9 p -104.05 91.0 3.77 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.916 0.865 . . . . 0.0 111.577 175.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -80.26 125.8 30.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 111.869 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.252 1.7 t30 61.92 21.32 12.21 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 117.565 2.432 . . . . 0.0 117.565 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -72.93 -34.5 66.63 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -175.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -55.04 -56.12 23.34 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 165.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.45 -31.86 71.83 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 173.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -61.65 -51.36 68.77 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 162.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.439 ' SD ' ' HA ' ' A' ' 30' ' ' ARG . 7.4 mtt -58.62 -44.5 89.99 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 116.797 2.147 . . . . 0.0 116.797 177.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -40.48 95.06 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 116.858 2.169 . . . . 0.0 116.858 164.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.72 -46.44 88.1 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 168.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.8 tp -61.66 -27.97 69.06 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.27 49.94 2.51 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 115.866 1.106 . . . . 0.0 115.866 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.2 m -107.52 140.08 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-N 118.944 1.372 . . . . 0.0 110.341 165.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.65 -168.63 9.84 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 116.814 1.486 . . . . 0.0 116.814 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -80.74 61.91 4.58 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.533 1.159 . . . . 0.0 112.709 177.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -148.05 -69.49 0.23 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.111 0.964 . . . . 0.0 109.16 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.2 m -58.7 -35.63 72.94 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 170.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.439 ' HA ' ' SD ' ' A' ' 20' ' ' MET . 11.8 ptp180 -61.79 -32.96 73.28 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 165.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -83.51 14.72 3.52 Favored 'General case' 0 CA--C 1.58 2.105 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 164.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.3 t -118.58 -61.85 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 C-N-CA 125.419 1.488 . . . . 0.0 108.614 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.21 -23.54 68.16 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 119.668 2.627 . . . . 0.0 119.668 -177.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -88.74 -37.26 15.62 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 174.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.4 m -80.34 -33.21 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.4 t -107.91 177.16 4.9 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 119.709 1.141 . . . . 0.0 112.669 -178.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -97.69 99.67 7.02 Favored Pre-proline 0 CA--C 1.573 1.849 0 CA-C-O 118.042 -0.98 . . . . 0.0 111.003 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.92 127.24 15.77 Favored 'Trans proline' 0 CA--C 1.564 2.022 0 CA-C-N 122.903 2.072 . . . . 0.0 113.965 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.0 m -110.45 102.86 11.44 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.004 -172.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.3 t -102.82 101.32 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.553 -0.717 . . . . 0.0 109.141 -164.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.9 mt -87.47 103.35 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.242 -0.911 . . . . 0.0 108.812 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.6 mt -88.04 111.81 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.8 p -136.15 117.96 15.12 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.671 0.389 . . . . 0.0 111.853 -169.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -83.38 116.46 22.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.099 -1.001 . . . . 0.0 111.432 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -116.62 96.23 5.41 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.269 0.557 . . . . 0.0 109.639 -172.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.48 -75.75 2.32 Favored Glycine 0 N--CA 1.492 2.371 0 O-C-N 121.694 -0.629 . . . . 0.0 114.265 -172.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -133.43 -52.14 0.88 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 169.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -62.69 154.34 29.69 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.6 t -94.06 109.73 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.53 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.367 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.5 t -93.88 101.4 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 176.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.2 mt -95.05 116.61 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -101.64 99.74 10.06 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.157 0.583 . . . . 0.0 110.102 175.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.2 m -86.35 96.15 9.89 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.757 0.789 . . . . 0.0 109.4 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 71.3 mt -102.31 86.54 2.84 Favored 'General case' 0 CA--C 1.559 1.318 0 CA-C-O 121.856 0.836 . . . . 0.0 110.329 -170.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.2 t -79.38 144.64 33.96 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.56 -0.713 . . . . 0.0 110.326 159.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.4 p -70.09 33.62 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.463 0 N-CA-C 116.823 2.156 . . . . 0.0 116.823 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -155.89 -57.39 0.09 Allowed 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 126.194 1.797 . . . . 0.0 108.189 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -107.75 100.57 9.94 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 123.978 0.911 . . . . 0.0 109.394 177.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -96.77 88.18 4.52 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.53 -0.731 . . . . 0.0 110.314 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.8 t -105.22 139.55 39.7 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 123.475 0.71 . . . . 0.0 112.444 -171.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -134.68 145.74 48.83 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.8 pt -134.15 129.5 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 C-N-CA 123.771 0.828 . . . . 0.0 110.347 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.0 m -118.37 117.79 30.03 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.843 -0.536 . . . . 0.0 110.371 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -150.65 152.54 34.14 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.675 0.75 . . . . 0.0 112.3 -165.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -94.73 151.02 19.61 Favored 'General case' 0 CA--C 1.573 1.831 0 O-C-N 120.972 -1.08 . . . . 0.0 110.888 169.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.6 mt -67.55 123.39 20.3 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.26 -1.525 . . . . 0.0 112.872 -177.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.06 -20.02 23.07 Favored Glycine 0 CA--C 1.555 2.555 0 N-CA-C 118.678 2.231 . . . . 0.0 118.678 -166.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -79.64 126.64 31.17 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-N 119.387 1.594 . . . . 0.0 111.653 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -81.14 144.24 31.82 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-O 121.563 0.696 . . . . 0.0 112.423 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -142.38 141.26 32.27 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.107 0.963 . . . . 0.0 110.459 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -78.95 129.04 34.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.525 -1.359 . . . . 0.0 111.19 171.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.411 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 80.1 tt0 -125.34 103.25 7.82 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.852 -172.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.4 m -79.7 103.28 9.49 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 170.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 71.4 p -78.15 167.88 20.73 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -168.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.98 -11.85 0.72 Allowed 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 120.236 3.421 . . . . 0.0 120.236 170.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -122.22 35.84 4.78 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 120.892 1.678 . . . . 0.0 114.555 160.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.269 31.0 m-20 63.07 54.63 2.09 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 116.543 2.053 . . . . 0.0 116.543 168.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -120.38 128.4 53.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.528 -0.732 . . . . 0.0 109.207 159.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -90.26 90.56 8.13 Favored 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 123.535 0.734 . . . . 0.0 111.189 173.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.411 ' SG ' ' HB3' ' A' ' 72' ' ' GLU . 28.5 p -96.85 134.72 39.8 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -173.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.68 94.17 2.66 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-O 122.524 1.154 . . . . 0.0 109.284 172.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.1 m -100.94 119.34 38.56 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.676 -165.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.1 p -121.7 125.36 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 123.182 0.593 . . . . 0.0 109.707 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.3 t -109.23 118.38 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -175.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.9 p -118.75 133.86 55.55 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.668 0.787 . . . . 0.0 112.055 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 tt -89.66 98.16 11.61 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 109.933 175.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -94.11 81.07 4.07 Favored 'General case' 0 CA--C 1.567 1.62 0 O-C-N 121.512 -0.743 . . . . 0.0 110.796 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.88 -90.79 0.5 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 115.563 0.985 . . . . 0.0 115.563 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -99.13 4.57 46.93 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 166.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -121.85 119.88 32.91 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 120.452 1.478 . . . . 0.0 111.086 -162.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.2 mt -82.97 100.47 10.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.92 -1.112 . . . . 0.0 110.222 167.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 41.0 t -101.13 101.45 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -170.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.34 107.24 19.02 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.506 0.722 . . . . 0.0 110.791 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 53.9 mt -100.14 103.28 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -173.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -94.66 123.1 37.9 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 118.7 0.682 . . . . 0.0 110.839 176.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -116.39 121.15 41.05 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 123.44 0.696 . . . . 0.0 111.943 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.3 p90 -150.65 128.89 11.97 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.53 -1.357 . . . . 0.0 110.969 -177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 50.52 48.09 23.08 Favored 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 166.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.86 16.23 72.23 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 119.995 2.758 . . . . 0.0 119.995 -168.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -133.59 140.46 47.15 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 119.531 1.666 . . . . 0.0 109.858 -170.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -134.65 130.49 36.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.669 -0.644 . . . . 0.0 111.543 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.8 t -119.4 123.5 44.26 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.358 0.663 . . . . 0.0 109.368 167.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -107.52 122.01 45.79 Favored 'General case' 0 CA--C 1.563 1.475 0 C-N-CA 123.26 0.624 . . . . 0.0 110.605 172.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -103.62 108.38 19.63 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -175.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 82.4 t -93.44 104.08 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -169.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -110.34 99.15 8.23 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.03 0.532 . . . . 0.0 110.314 -166.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.12 149.97 43.83 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -171.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.4 mm -82.18 111.38 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.872 -0.517 . . . . 0.0 110.01 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -105.19 86.98 2.52 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 171.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.9 t70 48.23 60.19 3.78 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.65 -37.86 3.29 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 117.95 1.94 . . . . 0.0 117.95 -171.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -88.02 140.96 28.96 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 119.659 1.73 . . . . 0.0 112.979 -177.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 34.1 ttm -84.83 112.41 20.51 Favored 'General case' 0 CA--C 1.564 1.503 0 O-C-N 121.266 -0.897 . . . . 0.0 109.297 165.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.8 t -89.64 104.36 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 169.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 28.1 ttt -90.95 101.38 14.15 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.998 0.519 . . . . 0.0 109.777 172.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.6 m -92.05 111.06 22.46 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 175.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.9 mp -95.93 121.21 37.43 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.4 t -126.12 122.64 36.32 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-N 120.31 1.414 . . . . 0.0 112.357 174.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -114.38 80.68 1.43 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.824 0.85 . . . . 0.0 108.786 174.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 66.97 -98.55 0.43 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 115.062 0.785 . . . . 0.0 115.062 -174.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -83.98 -30.85 25.89 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 171.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.5 t -89.38 119.86 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 119.715 1.143 . . . . 0.0 109.443 -169.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.5 t -115.97 124.94 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -175.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -117.58 156.22 28.47 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.483 0.713 . . . . 0.0 112.742 167.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.3 t -134.01 112.44 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.318 -0.863 . . . . 0.0 109.074 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -99.63 122.5 42.75 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.52 0.676 . . . . 0.0 111.769 172.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -104.46 114.36 28.54 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.322 0.649 . . . . 0.0 110.663 -172.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -114.97 131.39 56.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.437 -0.79 . . . . 0.0 112.11 -169.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -101.51 152.3 20.93 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 123.452 0.701 . . . . 0.0 112.405 169.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -74.1 131.83 41.69 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.296 -0.877 . . . . 0.0 112.815 175.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.518 0 C-N-CA 124.188 0.995 . . . . 0.0 111.995 175.205 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.94 -27.09 40.79 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 117.592 2.442 . . . . 0.0 117.592 166.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -85.7 -6.68 59.1 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 171.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 52.8 t -80.56 93.22 6.04 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-N 121.876 2.125 . . . . 0.0 113.85 -172.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.69 172.32 9.37 Favored 'General case' 0 CA--C 1.571 1.787 0 CA-C-O 122.425 1.107 . . . . 0.0 112.435 -177.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.0 m -89.87 116.72 28.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.175 -0.953 . . . . 0.0 108.998 165.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -114.76 108.52 16.88 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 122.956 0.502 . . . . 0.0 110.38 -169.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -95.45 136.55 35.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.05 -1.031 . . . . 0.0 111.651 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.96 130.61 43.71 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.666 0.988 . . . . 0.0 113.666 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 45.8 p -116.34 -24.83 7.75 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -157.22 121.66 4.37 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 120.574 1.534 . . . . 0.0 108.922 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.3 p -113.07 92.82 4.14 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.967 0.889 . . . . 0.0 111.805 178.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -88.34 116.34 26.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.967 -1.083 . . . . 0.0 110.513 -170.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.291 3.8 t-20 68.63 25.86 6.43 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -173.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -72.76 -48.23 40.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 119.994 -1.691 . . . . 0.0 115.392 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -46.97 -50.66 18.67 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.739 2.125 . . . . 0.0 116.739 169.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -58.69 -45.32 89.74 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 171.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -55.73 -48.55 75.01 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 165.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 31.0 mmm -58.56 -49.61 76.82 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -60.3 -42.26 95.15 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 167.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.53 -40.26 95.28 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 172.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.4 tp -61.31 -25.13 66.91 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 168.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.91 56.17 1.33 Allowed Glycine 0 N--CA 1.484 1.893 0 N-CA-C 115.72 1.048 . . . . 0.0 115.72 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.255 4.5 m -100.25 148.03 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-N 118.451 1.126 . . . . 0.0 112.875 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.96 170.12 14.86 Favored Glycine 0 CA--C 1.551 2.329 0 N-CA-C 117.357 1.703 . . . . 0.0 117.357 171.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -67.95 -43.35 79.3 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.32 -44.97 94.98 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 164.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.0 m -61.36 -42.63 99.02 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 175.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -63.76 -39.68 94.85 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 116.512 2.041 . . . . 0.0 116.512 167.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.72 -48.81 80.13 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 120.035 1.289 . . . . 0.0 114.337 167.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.5 t -57.22 -60.94 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-N 119.627 1.103 . . . . 0.0 113.445 170.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.74 -27.81 70.61 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 120.115 2.806 . . . . 0.0 120.115 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -73.48 -42.01 62.43 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 167.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.4 m -70.46 -36.88 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.2 t -88.31 138.92 31.01 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 119.815 1.189 . . . . 0.0 113.194 -174.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -85.68 114.41 56.55 Favored Pre-proline 0 CA--C 1.575 1.92 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.665 167.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -69.11 130.35 19.97 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 CA-C-N 123.345 2.23 . . . . 0.0 114.813 176.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 93.4 m -97.12 101.47 13.04 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.8 t -99.71 99.45 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -166.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.6 mt -86.34 105.98 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.9 mt -99.02 115.03 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 174.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.5 t -144.76 159.59 42.61 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 123.539 1.637 . . . . 0.0 112.65 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -98.67 135.29 40.39 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.206 177.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.13 103.62 6.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.619 -0.676 . . . . 0.0 109.987 175.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.28 -78.57 0.96 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 115.977 1.151 . . . . 0.0 115.977 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -127.6 -39.16 1.85 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 170.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -77.12 154.05 33.64 Favored 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.9 t -94.79 129.97 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.64 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.7 t -109.29 119.08 58.03 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.3 mt -102.29 115.44 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 168.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -104.16 96.07 6.4 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.904 0.859 . . . . 0.0 109.888 170.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.6 m -83.25 92.83 7.56 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.52 174.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.3 mt -104.52 101.47 11.13 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.547 0.739 . . . . 0.0 109.438 -170.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.6 p -99.46 26.98 5.57 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 117.16 2.281 . . . . 0.0 117.16 -175.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.492 2.0 t 63.03 -54.07 0.18 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -169.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -82.71 -60.46 2.17 Favored 'General case' 0 CA--C 1.569 1.698 0 C-N-CA 124.025 0.93 . . . . 0.0 111.582 173.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -98.14 103.16 15.08 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -105.84 93.16 4.49 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.677 0.751 . . . . 0.0 110.186 -171.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 39.1 p -100.94 149.09 24.26 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -167.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -145.16 120.95 10.56 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.112 -0.992 . . . . 0.0 112.5 176.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.2 pt -122.97 129.59 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 C-N-CA 123.699 0.8 . . . . 0.0 110.792 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 85.1 p -120.8 116.39 25.12 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.889 0.876 . . . . 0.0 111.641 -175.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -145.77 146.1 31.08 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.91 0.862 . . . . 0.0 113.073 -164.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -101.62 76.32 1.65 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.138 -0.976 . . . . 0.0 110.816 177.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.4 mt 17.81 96.93 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 120.158 3.392 . . . . 0.0 120.158 174.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.15 -12.73 63.66 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 118.374 2.109 . . . . 0.0 118.374 -166.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -77.62 136.24 38.22 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 119.718 1.759 . . . . 0.0 112.45 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -80.21 115.19 19.63 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.146 171.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -118.99 152.24 36.74 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 122.05 0.929 . . . . 0.0 110.95 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.523 ' HD2' ' N ' ' A' ' 71' ' ' ASP . 1.0 OUTLIER -90.06 138.08 31.81 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.877 -1.14 . . . . 0.0 111.465 174.141 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -145.24 124.34 12.86 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.369 0.604 . . . . 0.0 110.53 169.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 84.9 m -77.04 121.42 23.51 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 158.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.5 p -87.43 -179.99 6.47 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -169.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.68 -29.33 38.28 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 118.698 2.851 . . . . 0.0 118.698 165.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -84.66 10.46 11.16 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 163.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.281 3.1 t0 60.95 22.06 12.29 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 -174.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -95.42 129.72 42.48 Favored 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 124.697 1.199 . . . . 0.0 110.168 175.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -84.88 105.09 15.39 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.157 0.983 . . . . 0.0 112.942 -176.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 4.8 p -99.86 127.52 46.03 Favored 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -76.01 104.43 6.54 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 159.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.0 m -111.37 123.6 50.55 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.23 0.612 . . . . 0.0 112.206 -164.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.4 t -110.99 113.03 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 172.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.6 t -95.97 104.74 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 169.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.9 t -109.74 137.0 48.19 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.65 0.738 . . . . 0.0 112.111 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 tt -85.93 103.72 14.91 Favored 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 123.057 0.543 . . . . 0.0 110.474 174.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -96.11 80.66 3.29 Favored 'General case' 0 CA--C 1.567 1.627 0 O-C-N 121.399 -0.813 . . . . 0.0 111.015 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.74 -83.49 1.14 Allowed Glycine 0 N--CA 1.493 2.451 0 O-C-N 121.013 -1.055 . . . . 0.0 114.26 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -137.9 53.89 1.82 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.106 0.479 . . . . 0.0 112.19 162.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -150.57 130.14 13.07 Favored 'General case' 0 CA--C 1.567 1.626 0 O-C-N 120.754 -1.216 . . . . 0.0 111.673 173.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 16.6 mt -93.29 108.22 19.9 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.33 1.052 . . . . 0.0 111.438 -174.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.02 103.6 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.314 -0.866 . . . . 0.0 108.902 -167.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -89.51 94.3 9.82 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 123.321 0.649 . . . . 0.0 112.413 -178.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 61.2 mt -87.26 98.11 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.7 0.8 . . . . 0.0 109.141 -172.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -92.65 117.94 30.51 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 118.984 0.811 . . . . 0.0 109.958 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -117.46 122.57 44.11 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.148 0.579 . . . . 0.0 110.607 -175.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.7 p90 -153.35 126.93 8.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.503 -0.748 . . . . 0.0 110.509 -172.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 48.46 49.97 17.46 Favored 'General case' 0 N--CA 1.507 2.387 0 N-CA-C 117.214 2.301 . . . . 0.0 117.214 169.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.04 7.08 69.96 Favored Glycine 0 CA--C 1.558 2.758 0 N-CA-C 120.332 2.893 . . . . 0.0 120.332 -168.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -123.73 143.62 50.17 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 120.031 1.916 . . . . 0.0 110.901 -169.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -133.02 131.21 40.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.685 -0.635 . . . . 0.0 111.238 -177.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.4 t -130.88 137.44 49.35 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 123.236 0.614 . . . . 0.0 110.296 166.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.276 11.5 p30 -119.41 128.88 54.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.566 -0.709 . . . . 0.0 112.499 175.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 m-30 -99.77 105.32 17.09 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 84.5 t -90.0 97.52 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -174.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.96 108.37 19.53 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.227 1.011 . . . . 0.0 111.495 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -118.29 148.87 42.01 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.6 mm -85.58 99.77 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 170.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.72 93.25 5.47 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.556 0.742 . . . . 0.0 109.55 -178.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.7 t70 51.51 55.89 8.72 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -174.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.31 -28.57 4.66 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 119.008 2.363 . . . . 0.0 119.008 -169.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -92.18 145.21 24.68 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 119.883 1.841 . . . . 0.0 112.905 -172.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -85.98 100.77 12.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.174 -0.954 . . . . 0.0 110.42 175.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.8 t -100.49 110.9 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 26.7 ttp -100.13 115.08 28.97 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.19 0.596 . . . . 0.0 110.095 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 96.2 m -103.1 104.96 15.17 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mp -96.66 101.51 13.13 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.444 0.698 . . . . 0.0 109.759 -174.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.7 t -90.09 125.07 35.3 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.449 -0.782 . . . . 0.0 111.757 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -109.5 77.24 1.05 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 156.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 64.78 -112.45 5.02 Favored Glycine 0 CA--C 1.548 2.141 0 N-CA-C 114.485 0.554 . . . . 0.0 114.485 -170.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -78.24 -21.05 50.49 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 172.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.6 t -87.93 111.71 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 120.868 1.667 . . . . 0.0 108.662 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 58.2 t -123.07 114.1 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -168.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -94.22 118.01 30.94 Favored 'General case' 0 CA--C 1.562 1.439 0 O-C-N 121.724 -0.61 . . . . 0.0 112.458 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.4 t -100.82 106.48 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -109.96 117.84 34.85 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.427 0.632 . . . . 0.0 111.008 -173.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -91.87 119.97 32.13 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.368 0.604 . . . . 0.0 111.01 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -117.34 133.4 56.03 Favored 'General case' 0 CA--C 1.561 1.404 0 CA-C-O 121.931 0.872 . . . . 0.0 109.51 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -122.95 153.7 39.37 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.671 0.748 . . . . 0.0 110.659 -176.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -68.16 132.29 46.92 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -172.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.231 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.396 172.717 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.338 22.4 tt0 . . . . . 0 N--CA 1.497 1.913 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.2 -31.1 41.23 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.638 2.459 . . . . 0.0 117.638 161.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -73.67 -18.51 61.01 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 117.322 2.341 . . . . 0.0 117.322 167.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 44.3 t -75.59 90.94 2.8 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-N 122.331 2.332 . . . . 0.0 114.112 -169.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -168.03 170.47 10.41 Favored 'General case' 0 CA--C 1.569 1.705 0 C-N-CA 124.317 1.047 . . . . 0.0 111.902 -171.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.0 m -78.02 135.23 37.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.819 -1.176 . . . . 0.0 109.162 160.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -120.02 116.7 26.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.775 -1.203 . . . . 0.0 109.682 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -102.2 128.09 48.86 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.662 0.785 . . . . 0.0 110.513 -174.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tt -69.89 117.91 12.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.537 -0.727 . . . . 0.0 112.816 -174.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 46.2 p -97.71 -44.7 6.65 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -147.78 118.04 7.34 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 119.513 1.051 . . . . 0.0 110.232 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.7 p -97.38 95.56 7.76 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.212 0.605 . . . . 0.0 111.951 174.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -79.89 117.52 20.83 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 123.526 0.73 . . . . 0.0 111.027 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.6 t30 60.73 23.26 13.16 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -66.37 -39.12 88.91 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -175.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -52.98 -55.67 21.79 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 171.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -66.73 -34.68 78.37 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -53.6 -53.98 44.0 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-N 120.442 1.473 . . . . 0.0 113.695 161.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 79.4 mtm -57.59 -46.53 83.91 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 115.556 1.688 . . . . 0.0 115.556 174.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -57.32 -46.92 82.74 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 168.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.53 -41.73 99.06 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 171.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.1 tp -57.02 -18.84 15.45 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 168.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.03 60.37 1.77 Allowed Glycine 0 N--CA 1.481 1.665 0 O-C-N 121.3 -0.875 . . . . 0.0 114.402 -176.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.6 m -95.05 155.47 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 CA-C-O 121.886 0.85 . . . . 0.0 111.856 167.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.53 164.47 54.12 Favored Glycine 0 CA--C 1.552 2.349 0 O-C-N 121.326 -0.859 . . . . 0.0 114.279 154.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -55.48 -38.22 68.84 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.7 -48.87 66.29 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.0 m -65.23 -41.31 94.51 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 173.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.284 22.7 ptt180 -66.25 -42.26 88.81 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 121.617 2.008 . . . . 0.0 115.644 169.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -59.21 -48.66 80.79 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 171.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.4 t -57.89 -60.66 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 124.334 1.053 . . . . 0.0 113.141 166.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.54 -30.6 50.82 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 120.392 2.917 . . . . 0.0 120.392 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.23 -42.4 31.36 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 168.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.251 20.8 m -73.54 -42.47 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 CA-C-N 120.765 1.621 . . . . 0.0 115.125 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.1 t -91.42 148.09 22.56 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 119.46 1.027 . . . . 0.0 111.836 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -99.62 98.42 7.03 Favored Pre-proline 0 CA--C 1.571 1.778 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.493 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.17 117.48 5.07 Favored 'Trans proline' 0 CA--C 1.56 1.798 0 C-N-CA 122.547 2.165 . . . . 0.0 113.729 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.1 m -91.79 125.5 36.53 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.139 0.975 . . . . 0.0 109.323 -176.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.1 t -108.29 100.07 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -165.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.9 mt -90.32 109.38 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.521 -1.362 . . . . 0.0 108.322 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.1 mt -88.95 110.17 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 174.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 82.1 p -124.77 117.46 24.23 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.032 0.533 . . . . 0.0 111.769 -171.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -85.27 122.11 28.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.312 -0.868 . . . . 0.0 111.454 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.23 89.59 2.88 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.488 0.661 . . . . 0.0 110.706 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.64 -106.64 2.46 Favored Glycine 0 N--CA 1.487 2.069 0 O-C-N 121.781 -0.575 . . . . 0.0 113.604 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -95.67 -34.85 11.81 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 171.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -86.01 146.49 26.63 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-O 123.368 1.556 . . . . 0.0 114.491 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 64.4 t -96.22 115.61 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.584 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.7 t -102.05 102.8 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.7 mt -91.36 118.19 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.2 mtt-85 -109.4 107.61 17.84 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.447 0.699 . . . . 0.0 109.345 -173.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.2 m -89.84 100.43 13.24 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.5 mt -115.76 119.41 35.94 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.476 0.71 . . . . 0.0 109.856 -169.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 m -121.08 -177.62 3.55 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 122.116 0.96 . . . . 0.0 111.906 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.3 p -61.73 -30.31 70.69 Favored 'General case' 0 N--CA 1.505 2.317 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 158.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -120.69 -54.04 2.07 Favored 'General case' 0 CA--C 1.572 1.8 0 C-N-CA 124.115 0.966 . . . . 0.0 112.174 -175.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -83.32 138.26 33.62 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -137.3 108.62 6.86 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 171.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.0 t -143.21 140.79 30.88 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.632 -0.667 . . . . 0.0 111.508 173.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -136.74 137.93 40.41 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.0 -1.063 . . . . 0.0 113.263 -174.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.3 pt -123.21 124.79 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 C-N-CA 123.16 0.584 . . . . 0.0 112.261 -169.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.3 p -110.69 106.64 15.94 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 123.607 0.763 . . . . 0.0 112.47 -174.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -134.25 140.28 46.34 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -169.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -101.9 39.05 1.52 Allowed 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.0 mt 60.55 97.58 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 125.031 1.332 . . . . 0.0 114.334 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.91 -0.61 82.46 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 118.902 2.321 . . . . 0.0 118.902 -165.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -70.93 125.05 25.8 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 119.341 1.571 . . . . 0.0 111.825 173.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -91.47 123.54 34.96 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.785 0.434 . . . . 0.0 110.664 169.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -147.16 144.43 28.97 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.336 0.654 . . . . 0.0 111.998 -172.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.66 142.16 44.54 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.416 -1.428 . . . . 0.0 112.586 166.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -149.27 137.05 20.42 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.461 0.648 . . . . 0.0 112.596 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.4 m -82.25 103.47 11.86 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 122.066 0.936 . . . . 0.0 110.206 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.3 p -72.91 174.83 7.22 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.98 -9.36 3.0 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 119.762 3.245 . . . . 0.0 119.762 170.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -110.39 20.33 17.88 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 120.741 1.61 . . . . 0.0 114.518 159.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.273 6.6 m-20 54.68 31.56 15.52 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 117.658 2.466 . . . . 0.0 117.658 -174.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 ptp85 -87.32 128.59 35.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.873 -1.142 . . . . 0.0 108.967 165.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -79.05 92.55 5.01 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.679 0.752 . . . . 0.0 111.558 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 68.7 m -85.99 118.43 25.46 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -171.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -69.72 99.43 1.33 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.148 0.979 . . . . 0.0 109.558 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.7 m -115.54 120.4 39.34 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.595 -155.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.1 p -117.45 116.11 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 123.11 0.564 . . . . 0.0 109.733 176.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.6 t -102.92 112.7 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.432 -0.793 . . . . 0.0 109.372 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 86.0 p -113.45 123.11 49.26 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.63 0.772 . . . . 0.0 111.395 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tt -89.65 98.76 11.95 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 118.992 0.815 . . . . 0.0 111.601 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -97.15 68.7 2.27 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 123.353 0.661 . . . . 0.0 111.955 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.09 82.41 0.13 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 116.075 1.19 . . . . 0.0 116.075 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.269 24.2 t0 63.64 0.52 0.89 Allowed 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 -164.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -118.12 99.73 7.07 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 121.119 1.782 . . . . 0.0 110.373 -172.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.8 mt -76.72 99.43 5.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.303 -0.873 . . . . 0.0 110.722 171.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.1 t -99.66 99.41 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.866 -1.146 . . . . 0.0 108.265 -172.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -85.49 100.6 12.01 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.297 0.639 . . . . 0.0 110.814 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.2 mt -90.65 105.48 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -176.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -93.61 122.82 36.46 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 118.45 0.568 . . . . 0.0 110.865 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -112.01 132.8 54.57 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.859 0.863 . . . . 0.0 110.5 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -157.5 124.94 5.22 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.675 -1.266 . . . . 0.0 110.362 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 58.2 24.82 11.83 Favored 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 172.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.93 -24.14 17.01 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 118.425 2.13 . . . . 0.0 118.425 -162.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -82.67 144.72 30.06 Favored 'General case' 0 CA--C 1.565 1.548 0 CA-C-N 119.486 1.643 . . . . 0.0 112.247 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -138.9 129.97 26.66 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.19 0.519 . . . . 0.0 111.543 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.4 t -117.88 154.64 31.51 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 123.577 0.751 . . . . 0.0 110.401 165.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.282 11.6 p30 -130.12 141.26 50.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.131 -0.981 . . . . 0.0 113.54 165.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -111.07 103.49 11.95 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -177.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.7 t -85.82 102.52 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -104.97 108.7 20.36 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.849 0.86 . . . . 0.0 108.857 -169.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -135.74 136.41 40.77 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -169.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 26.7 mm -82.7 113.92 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.718 -0.614 . . . . 0.0 109.52 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -120.79 108.83 14.43 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.7 t70 50.3 54.34 11.31 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 116.582 2.067 . . . . 0.0 116.582 -176.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 64.05 19.64 63.86 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 119.662 2.625 . . . . 0.0 119.662 -169.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -129.27 129.75 45.32 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 119.246 1.523 . . . . 0.0 108.908 -175.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 ttt -82.66 104.78 13.17 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-O 122.067 0.937 . . . . 0.0 109.922 176.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.1 t -86.88 104.41 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 174.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 55.2 ttm -93.48 104.25 16.4 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.8 m -93.69 110.17 21.79 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.526 0.679 . . . . 0.0 109.329 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mp -95.82 105.61 17.64 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 124.184 0.994 . . . . 0.0 108.897 -173.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.7 t -115.26 114.91 25.82 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 119.229 0.922 . . . . 0.0 111.949 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -98.45 74.8 2.18 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.473 0.654 . . . . 0.0 109.251 164.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 66.37 -91.94 0.17 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 115.444 0.938 . . . . 0.0 115.444 -175.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.98 -34.96 20.69 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 172.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.9 t -87.17 117.95 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-N 120.099 1.318 . . . . 0.0 109.732 -171.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.4 t -116.28 127.08 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 C-N-CA 123.493 0.717 . . . . 0.0 109.772 -173.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.67 160.24 18.11 Favored 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 123.264 0.626 . . . . 0.0 112.593 161.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.5 t -131.28 110.7 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.976 -1.078 . . . . 0.0 108.753 176.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -94.56 119.19 32.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.129 -0.982 . . . . 0.0 110.613 169.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -92.54 105.24 17.45 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.387 0.675 . . . . 0.0 109.542 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -106.27 122.98 47.32 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.438 0.695 . . . . 0.0 111.057 -172.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -95.65 157.28 15.97 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.982 -1.073 . . . . 0.0 113.618 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -81.05 141.13 34.66 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -173.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.307 0 CA-C-O 117.364 -1.303 . . . . 0.0 111.975 -179.062 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.26 -27.18 54.28 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 166.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -83.4 -23.81 32.21 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 172.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 71.7 m -78.12 99.48 6.18 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 121.758 2.072 . . . . 0.0 112.998 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.66 168.77 12.37 Favored 'General case' 0 CA--C 1.57 1.717 0 CA-C-O 122.284 1.04 . . . . 0.0 112.245 -173.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.0 m -85.39 102.65 13.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.203 -0.936 . . . . 0.0 108.901 173.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -101.59 108.66 20.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.788 -1.195 . . . . 0.0 112.027 -169.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -94.13 128.36 40.49 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.428 -0.795 . . . . 0.0 110.94 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.95 117.35 14.56 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.528 0.68 . . . . 0.0 112.704 -175.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.7 p -88.68 -47.82 7.98 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -145.17 112.17 5.98 Favored 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 123.51 0.724 . . . . 0.0 109.662 -171.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.0 p -101.25 95.25 6.4 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.474 0.709 . . . . 0.0 111.406 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -91.0 116.39 28.75 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 122.893 0.477 . . . . 0.0 110.736 -166.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 0.7 OUTLIER 64.01 39.82 7.64 Favored 'General case' 0 CA--C 1.582 2.174 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -173.825 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -78.87 -44.58 22.52 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -53.67 -51.12 64.21 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 116.763 2.134 . . . . 0.0 116.763 175.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -66.52 -38.96 88.32 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -50.14 -53.94 24.11 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 160.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 31.5 mtp -58.41 -42.28 86.86 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 174.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -59.33 -51.4 70.11 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 165.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.4 -38.07 89.73 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 116.743 2.127 . . . . 0.0 116.743 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 tt -61.92 -32.59 73.0 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 165.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.71 49.95 1.89 Allowed Glycine 0 N--CA 1.484 1.88 0 N-CA-C 115.919 1.128 . . . . 0.0 115.919 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 m -93.16 156.69 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-N 118.792 1.296 . . . . 0.0 112.173 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.44 156.85 50.46 Favored Glycine 0 CA--C 1.551 2.318 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 171.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -62.07 -41.27 97.99 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.94 -41.78 71.47 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 165.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.5 m -60.7 -46.62 89.68 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 168.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.5 mtm180 -54.36 -48.75 71.11 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 165.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -60.48 -42.12 95.61 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.8 t -52.95 -60.38 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-N 119.909 1.231 . . . . 0.0 113.101 163.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.0 -31.51 68.71 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 119.822 2.689 . . . . 0.0 119.822 176.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -67.48 -45.7 75.15 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 167.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.6 m -79.33 -32.59 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.23 146.56 34.02 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 120.19 1.359 . . . . 0.0 113.798 -163.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -91.66 116.86 67.27 Favored Pre-proline 0 CA--C 1.577 1.994 0 O-C-N 121.665 -0.647 . . . . 0.0 110.902 161.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.91 128.51 9.26 Favored 'Trans proline' 0 CA--C 1.561 1.836 0 C-N-CA 122.492 2.128 . . . . 0.0 112.735 168.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 56.2 m -85.68 115.93 23.65 Favored 'General case' 0 CA--C 1.562 1.441 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.9 t -102.83 94.25 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -173.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.52 102.58 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.957 -1.089 . . . . 0.0 108.108 -175.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.5 mt -91.15 128.41 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.3 p -142.62 157.49 44.64 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.388 0.675 . . . . 0.0 111.917 -177.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -114.91 111.12 20.68 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.246 -0.909 . . . . 0.0 108.644 166.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -82.01 -57.45 3.4 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -177.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.24 87.61 0.14 Allowed Glycine 0 N--CA 1.483 1.83 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.292 12.0 t70 70.93 -57.43 0.6 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -164.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -78.89 152.92 30.92 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -175.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.1 t -89.48 126.07 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.6 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.872 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.7 t -112.23 109.73 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.3 mt -99.85 130.11 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 174.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.8 mtt85 -107.8 107.8 18.72 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.344 0.658 . . . . 0.0 110.072 173.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.1 m -91.63 103.51 16.09 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.519 -0.738 . . . . 0.0 109.302 173.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 65.2 mt -125.73 119.96 29.35 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 122.817 0.447 . . . . 0.0 110.873 -169.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.26 178.44 6.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.987 -1.071 . . . . 0.0 110.498 159.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.7 p -77.99 48.56 0.73 Allowed 'General case' 0 N--CA 1.51 2.572 0 O-C-N 119.594 -1.941 . . . . 0.0 114.089 173.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -165.79 -58.12 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 125.152 1.381 . . . . 0.0 109.419 -165.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -131.84 132.14 43.43 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.206 1.002 . . . . 0.0 109.285 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -134.06 97.77 3.96 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -172.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.2 t -127.93 128.7 45.58 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 123.178 0.591 . . . . 0.0 111.076 -175.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -119.76 138.85 53.08 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.2 pt -135.28 116.37 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-O 121.313 0.578 . . . . 0.0 111.055 -163.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.1 p -100.63 121.93 42.45 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.064 0.946 . . . . 0.0 112.048 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -147.86 139.2 23.6 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -173.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -81.59 6.86 13.72 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.258 50.9 mt 70.29 105.63 0.06 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 125.188 1.395 . . . . 0.0 111.746 -168.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.69 0.88 89.22 Favored Glycine 0 CA--C 1.556 2.636 0 N-CA-C 119.139 2.416 . . . . 0.0 119.139 -161.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -81.97 122.77 28.2 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-N 120.179 1.99 . . . . 0.0 111.136 174.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -86.45 113.37 22.33 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 122.711 0.405 . . . . 0.0 110.944 172.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -125.25 146.33 49.58 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.842 0.857 . . . . 0.0 111.541 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.98 139.9 36.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.743 -1.223 . . . . 0.0 112.507 168.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -146.5 130.78 17.53 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.192 0.52 . . . . 0.0 110.516 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.4 m -71.47 124.91 25.68 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-O 121.694 0.759 . . . . 0.0 110.656 164.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.1 p -96.65 174.94 6.57 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -176.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.52 -17.63 14.78 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 119.386 3.106 . . . . 0.0 119.386 166.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -81.59 -5.64 58.23 Favored 'General case' 0 CA--C 1.58 2.118 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 161.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.273 23.2 t70 65.34 66.16 0.55 Allowed 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 121.151 1.796 . . . . 0.0 112.992 -170.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -154.55 138.47 16.32 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.87 0.868 . . . . 0.0 109.467 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -79.52 114.9 18.81 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 174.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 2.4 p -99.64 122.83 43.25 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.854 -0.529 . . . . 0.0 112.241 173.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -72.83 96.95 2.15 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.7 m -109.17 118.23 36.21 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.025 -160.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.5 p -121.79 119.88 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.2 t -107.29 118.22 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.486 -0.759 . . . . 0.0 109.686 -173.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.9 m -111.95 125.99 54.64 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.36 0.664 . . . . 0.0 111.568 -177.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.4 tt -83.73 99.66 10.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.428 -0.795 . . . . 0.0 109.825 170.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -91.51 78.44 5.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.454 -0.779 . . . . 0.0 110.651 -175.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.88 -79.24 1.6 Allowed Glycine 0 N--CA 1.492 2.424 0 O-C-N 121.3 -0.875 . . . . 0.0 114.541 -174.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -139.9 60.17 1.56 Allowed 'General case' 0 CA--C 1.572 1.796 0 C-N-CA 122.877 0.471 . . . . 0.0 110.063 164.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -156.9 106.98 2.28 Favored 'General case' 0 CA--C 1.566 1.559 0 O-C-N 121.315 -0.866 . . . . 0.0 109.307 -168.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.0 mt -86.94 101.0 13.0 Favored 'General case' 0 CA--C 1.57 1.719 0 O-C-N 121.349 -0.845 . . . . 0.0 112.373 -174.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.9 t -102.45 102.82 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.132 -0.98 . . . . 0.0 109.025 -171.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -88.12 106.24 18.04 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 123.197 0.599 . . . . 0.0 110.759 177.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.6 mt -92.81 107.23 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -90.88 125.25 35.69 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 118.948 0.794 . . . . 0.0 110.951 171.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -120.77 126.27 49.71 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.396 0.679 . . . . 0.0 110.832 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.0 p90 -152.73 123.72 7.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.943 -1.098 . . . . 0.0 110.483 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 54.31 33.46 18.41 Favored 'General case' 0 N--CA 1.51 2.566 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.93 -26.34 4.88 Favored Glycine 0 CA--C 1.557 2.702 0 N-CA-C 118.809 2.284 . . . . 0.0 118.809 -164.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -75.92 143.59 41.57 Favored 'General case' 0 CA--C 1.566 1.583 0 CA-C-N 119.494 1.647 . . . . 0.0 113.002 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -132.48 134.21 44.76 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.361 0.664 . . . . 0.0 111.039 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.8 t -132.94 130.85 40.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.676 -0.64 . . . . 0.0 111.455 162.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -107.73 130.66 54.93 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 123.16 0.584 . . . . 0.0 112.299 174.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -107.34 103.81 13.26 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.8 t -92.22 94.14 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -170.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.9 mtt85 -81.86 115.2 20.95 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.997 0.919 . . . . 0.0 111.294 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.544 ' HE2' ' NZ ' ' A' ' 109' ' ' LYS . 3.5 pt-20 -127.26 144.46 51.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.681 -0.637 . . . . 0.0 111.637 172.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.2 mm -83.75 116.12 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.186 -0.946 . . . . 0.0 109.054 174.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.544 ' NZ ' ' HE2' ' A' ' 107' ' ' GLU . 1.0 OUTLIER -114.72 85.4 2.24 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.9 t70 49.69 61.54 3.11 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -178.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.92 -44.07 1.86 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 117.135 1.614 . . . . 0.0 117.135 -173.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -85.8 151.56 23.72 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 118.655 1.227 . . . . 0.0 113.121 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 38.7 tpp -85.73 116.96 24.31 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 160.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.4 t -94.09 106.8 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 165.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 18.2 ttt -102.05 111.51 23.81 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.5 m -100.75 106.8 18.25 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -177.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.0 mp -101.02 105.82 17.06 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -174.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.3 t -106.07 139.15 41.05 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.772 0.796 . . . . 0.0 112.052 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -101.09 79.61 2.03 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 162.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 70.37 -94.6 0.48 Allowed Glycine 0 N--CA 1.489 2.211 0 O-C-N 121.663 -0.648 . . . . 0.0 113.322 -163.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -127.99 57.16 1.56 Allowed 'General case' 0 CA--C 1.573 1.845 0 C-N-CA 122.972 0.509 . . . . 0.0 111.938 169.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.2 t -136.13 110.41 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 170.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.3 t -117.63 125.18 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.671 -0.643 . . . . 0.0 111.203 -151.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -107.37 124.97 50.6 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.317 0.647 . . . . 0.0 112.054 165.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.2 t -109.19 105.4 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.318 -0.864 . . . . 0.0 108.809 -174.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 -103.49 114.1 28.11 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 123.898 0.879 . . . . 0.0 111.495 -173.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -96.61 116.54 29.27 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.53 0.732 . . . . 0.0 111.244 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -110.37 138.68 46.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.528 -0.733 . . . . 0.0 111.283 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -99.18 152.78 19.5 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.682 0.753 . . . . 0.0 112.453 167.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -72.46 128.98 37.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.795 -0.566 . . . . 0.0 111.998 171.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.631 179.964 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 . . . . . 0 N--CA 1.497 1.89 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.58 -25.36 52.26 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 117.963 2.579 . . . . 0.0 117.963 168.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -82.92 -15.81 49.91 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 171.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 41.5 t -79.98 92.79 5.61 Favored 'General case' 0 CA--C 1.565 1.531 0 CA-C-N 121.472 1.942 . . . . 0.0 113.725 -169.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -166.61 168.53 14.46 Favored 'General case' 0 CA--C 1.569 1.687 0 C-N-CA 124.118 0.967 . . . . 0.0 111.826 -174.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.1 m -78.32 124.05 27.66 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.973 -1.079 . . . . 0.0 108.884 159.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -113.09 119.66 38.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 110.66 -177.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -99.85 129.93 45.99 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.81 0.844 . . . . 0.0 111.023 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tt -73.18 121.25 19.99 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -176.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.3 p -92.41 -50.29 5.71 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 175.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -141.74 117.35 10.32 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 119.254 0.934 . . . . 0.0 109.934 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.1 p -107.01 109.04 20.83 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.486 0.714 . . . . 0.0 112.82 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -94.16 131.15 39.99 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.468 0.707 . . . . 0.0 111.454 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.284 3.9 t-20 61.31 25.82 15.73 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 118.359 2.726 . . . . 0.0 118.359 176.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -70.23 -42.8 71.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 119.794 -1.817 . . . . 0.0 115.537 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -49.51 -53.63 22.32 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 169.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.69 -39.06 84.45 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -53.22 -55.77 21.72 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 162.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 74.3 mtm -54.51 -48.57 71.76 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 173.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -41.93 90.07 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 172.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.77 -35.67 81.37 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 117.251 2.315 . . . . 0.0 117.251 167.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 tp -67.72 -27.09 66.51 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.81 65.41 0.65 Allowed Glycine 0 N--CA 1.484 1.863 0 C-N-CA 123.675 0.655 . . . . 0.0 114.202 -173.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.8 m -105.56 145.82 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 C-N-CA 123.501 0.721 . . . . 0.0 111.865 168.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.54 176.07 51.07 Favored Glycine 0 N--CA 1.49 2.281 0 O-C-N 121.367 -0.833 . . . . 0.0 114.276 152.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -77.3 61.62 2.19 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 123.071 1.415 . . . . 0.0 113.384 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -158.21 -61.75 0.08 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.049 1.34 . . . . 0.0 109.055 -175.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.8 m -57.44 -42.0 81.57 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 164.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -61.44 -38.53 87.53 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 164.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -62.9 -42.32 99.74 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 120.469 1.486 . . . . 0.0 114.902 170.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 70.4 t -48.12 -65.28 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 CA-C-N 119.84 1.2 . . . . 0.0 112.796 160.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.19 -33.91 61.9 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 119.782 2.673 . . . . 0.0 119.782 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -67.97 -46.46 71.3 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 169.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.8 m -79.7 -30.8 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.4 t -120.77 153.78 36.57 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 120.293 1.406 . . . . 0.0 113.579 -167.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.0 111.83 60.28 Favored Pre-proline 0 CA--C 1.575 1.933 0 CA-C-O 117.883 -1.056 . . . . 0.0 111.494 178.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.57 123.99 8.51 Favored 'Trans proline' 0 CA--C 1.559 1.763 0 CA-C-N 123.523 2.294 . . . . 0.0 115.424 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.4 m -96.69 118.76 33.84 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.097 0.959 . . . . 0.0 108.483 -175.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.5 t -106.11 105.44 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -169.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.5 mt -95.35 103.45 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -85.5 111.46 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 171.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.5 p -127.71 122.81 33.87 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.097 0.559 . . . . 0.0 111.358 -172.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -89.21 99.06 12.13 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -98.15 -44.52 6.57 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -161.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.06 104.83 0.19 Allowed Glycine 0 N--CA 1.483 1.82 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -173.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.292 13.8 t70 71.66 -52.34 0.69 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -165.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -126.59 162.09 26.51 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 122.562 1.172 . . . . 0.0 113.881 -163.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.9 t -86.06 122.8 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.6 t -115.47 108.15 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 -175.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 56.6 mt -91.85 117.35 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 173.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -97.58 102.16 13.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 169.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.4 m -88.56 104.78 17.15 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.2 mt -102.94 99.46 9.36 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.6 t -87.74 39.3 0.88 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 171.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.328 69.8 p 64.0 -58.71 0.2 Allowed 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -172.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -93.47 -44.35 8.28 Favored 'General case' 0 CA--C 1.574 1.872 0 C-N-CA 125.413 1.485 . . . . 0.0 112.652 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -100.02 117.81 35.08 Favored 'General case' 0 CA--C 1.566 1.588 0 C-N-CA 124.094 0.958 . . . . 0.0 110.817 -176.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -98.57 104.08 16.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.59 -0.694 . . . . 0.0 109.86 168.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.252 5.0 t -103.15 82.6 2.09 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.902 0.858 . . . . 0.0 110.495 169.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.95 131.19 34.7 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 pt -131.62 130.55 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 123.366 0.666 . . . . 0.0 111.364 -170.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 90.2 p -116.87 131.64 56.9 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 123.881 0.872 . . . . 0.0 111.922 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -158.84 144.86 16.72 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.141 -0.974 . . . . 0.0 113.307 -169.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -94.4 26.5 3.36 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 175.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 69.2 mt 69.02 108.31 0.05 Allowed 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 125.203 1.401 . . . . 0.0 113.547 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.41 -10.49 58.85 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 118.656 2.222 . . . . 0.0 118.656 -162.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -73.72 123.85 24.9 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 118.962 1.381 . . . . 0.0 112.327 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -76.0 122.08 23.68 Favored 'General case' 0 CA--C 1.566 1.558 0 CA-C-O 121.306 0.574 . . . . 0.0 111.317 168.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -124.81 154.54 40.82 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.84 0.856 . . . . 0.0 110.586 173.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.516 ' HD2' ' N ' ' A' ' 71' ' ' ASP . 1.0 OUTLIER -88.09 136.7 32.85 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.951 -1.093 . . . . 0.0 110.973 171.131 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -134.45 108.79 8.34 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.904 0.482 . . . . 0.0 110.194 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 88.5 m -79.51 102.37 8.77 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 167.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.9 p -82.08 171.04 14.82 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -167.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.56 -13.53 2.45 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 119.834 3.272 . . . . 0.0 119.834 169.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.42 -16.09 50.27 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 163.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.306 28.6 m-20 73.94 72.17 0.12 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 125.073 1.349 . . . . 0.0 111.995 -160.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -157.01 129.12 7.28 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 124.128 0.971 . . . . 0.0 108.427 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -84.93 115.28 22.7 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 123.268 0.627 . . . . 0.0 112.077 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 72.8 m -110.58 119.72 40.08 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -174.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -71.06 105.87 3.5 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.381 0.61 . . . . 0.0 109.754 165.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.1 m -117.89 119.09 33.81 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.779 -158.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.2 t -117.23 117.77 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.75 108.19 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.391 -0.818 . . . . 0.0 109.598 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 86.5 p -106.78 126.36 52.19 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 123.682 0.793 . . . . 0.0 112.697 -177.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.8 tt -83.33 102.83 12.26 Favored 'General case' 0 CA--C 1.569 1.698 0 C-N-CA 123.21 0.604 . . . . 0.0 110.824 172.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -92.47 76.41 5.12 Favored 'General case' 0 CA--C 1.57 1.719 0 O-C-N 121.107 -0.995 . . . . 0.0 111.443 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.07 -74.67 2.4 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 115.022 0.769 . . . . 0.0 115.022 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.09 65.66 1.21 Allowed 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 122.415 1.102 . . . . 0.0 110.632 153.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -147.5 106.61 3.87 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 mt -89.04 100.1 12.95 Favored 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 123.443 0.697 . . . . 0.0 110.684 -172.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.7 t -106.21 104.01 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -167.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -87.44 102.11 14.23 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 123.387 0.675 . . . . 0.0 111.419 176.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.3 mt -91.23 103.63 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -177.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -90.06 127.42 36.07 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 118.788 0.722 . . . . 0.0 111.114 171.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -121.18 120.39 35.08 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 123.193 0.597 . . . . 0.0 110.887 176.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -145.46 126.91 15.0 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.369 -0.832 . . . . 0.0 110.242 -175.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 55.14 31.92 17.34 Favored 'General case' 0 N--CA 1.511 2.58 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 174.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.9 -21.29 7.99 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 119.166 2.426 . . . . 0.0 119.166 -163.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -86.01 141.38 29.53 Favored 'General case' 0 CA--C 1.57 1.712 0 CA-C-N 119.016 1.408 . . . . 0.0 111.509 -177.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -134.88 125.19 26.27 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.482 0.713 . . . . 0.0 111.023 -173.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.4 t -122.48 144.33 49.13 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.335 0.654 . . . . 0.0 110.733 167.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.279 9.7 p30 -124.9 127.95 47.89 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-O 121.321 0.581 . . . . 0.0 112.415 174.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.3 101.24 12.64 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -174.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.5 t -92.43 96.55 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -168.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 -85.03 107.69 17.27 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.499 0.72 . . . . 0.0 110.181 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.91 129.62 48.54 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 123.035 0.534 . . . . 0.0 111.723 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.2 mm -81.45 120.2 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.339 -0.851 . . . . 0.0 110.177 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.75 89.52 3.13 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.7 t70 51.12 67.1 1.0 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.0 -48.46 3.23 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 117.38 1.712 . . . . 0.0 117.38 -174.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -86.32 143.94 27.63 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 118.643 1.222 . . . . 0.0 112.309 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 32.5 ttm -88.35 118.81 28.23 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-O 121.714 0.769 . . . . 0.0 109.823 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.6 t -89.08 100.51 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 169.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 36.5 ttm -94.94 100.41 12.27 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.369 0.604 . . . . 0.0 110.182 -173.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 84.3 m -98.02 99.79 11.08 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.813 0.816 . . . . 0.0 108.976 -172.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.5 mp -89.98 105.17 17.63 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.8 t -108.3 116.34 31.78 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.52 0.676 . . . . 0.0 110.993 -176.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -97.13 79.75 2.87 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 121.267 0.556 . . . . 0.0 109.509 166.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 63.16 -98.04 0.21 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 115.434 0.934 . . . . 0.0 115.434 -175.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -86.7 -17.21 34.25 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 169.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.8 t -91.96 101.63 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-N 121.774 2.079 . . . . 0.0 108.481 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 57.8 t -104.07 115.19 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -171.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.64 129.16 55.99 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.809 -0.557 . . . . 0.0 112.015 177.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.5 t -115.8 118.56 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.483 -0.761 . . . . 0.0 109.157 -168.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -111.25 125.55 53.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.415 -0.803 . . . . 0.0 111.505 175.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -95.84 109.47 21.8 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.893 0.477 . . . . 0.0 110.291 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -109.63 129.12 55.62 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 123.551 0.74 . . . . 0.0 112.295 -168.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -97.23 150.92 20.37 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 124.2 1.0 . . . . 0.0 112.836 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -74.78 134.52 41.8 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.3 -0.875 . . . . 0.0 113.134 172.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.519 0 C-N-CA 124.101 0.961 . . . . 0.0 111.63 161.441 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 . . . . . 0 CA--C 1.571 1.766 0 N-CA-C 117.206 2.299 . . . . 0.0 117.206 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.81 -31.33 48.73 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 117.964 2.579 . . . . 0.0 117.964 164.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -75.5 -18.21 59.89 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.779 2.141 . . . . 0.0 116.779 168.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 93.8 m -76.47 97.72 4.4 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 122.383 2.356 . . . . 0.0 113.417 -175.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.09 167.65 14.3 Favored 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 124.376 1.07 . . . . 0.0 111.556 -174.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 98.6 m -81.53 114.54 20.32 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.195 -0.941 . . . . 0.0 109.162 163.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -106.03 115.06 29.58 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.758 -0.589 . . . . 0.0 110.204 -176.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -95.98 132.97 40.75 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.328 0.651 . . . . 0.0 110.842 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -71.07 127.84 33.92 Favored 'General case' 0 CA--C 1.565 1.526 0 CA-C-O 122.303 1.049 . . . . 0.0 113.322 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.1 p -98.92 -39.98 8.3 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 176.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -154.73 121.29 5.4 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 119.534 1.061 . . . . 0.0 109.598 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.2 p -101.39 96.32 7.08 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.23 0.612 . . . . 0.0 111.741 174.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -72.62 124.52 25.44 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.386 0.675 . . . . 0.0 111.805 174.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.274 4.4 t-20 51.04 27.37 3.25 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 119.133 3.012 . . . . 0.0 119.133 177.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -70.92 -46.04 63.2 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -173.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -49.79 -50.06 46.22 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 168.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -58.19 -42.28 85.78 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 170.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -58.55 -48.61 80.3 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 165.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.2 mtp -57.39 -47.04 82.72 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -61.07 -42.28 98.2 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 166.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.52 -43.53 98.69 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 171.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.1 tp -62.24 -17.27 57.9 Favored 'General case' 0 CA--C 1.58 2.105 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 166.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.92 52.15 3.2 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 116.287 1.275 . . . . 0.0 116.287 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.268 9.5 m -92.65 143.51 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 118.57 1.185 . . . . 0.0 113.028 176.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.64 166.22 17.06 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 116.99 1.556 . . . . 0.0 116.99 166.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -64.51 -43.95 92.47 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.85 -46.6 87.35 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 166.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.4 m -58.14 -39.36 78.56 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 172.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.347 0.2 OUTLIER -62.38 -37.74 86.93 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 167.689 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -57.93 -47.19 83.59 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 120.999 1.727 . . . . 0.0 114.592 162.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 70.0 t -56.87 -34.26 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 117.125 2.268 . . . . 0.0 117.125 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.67 -16.64 41.59 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 119.377 2.511 . . . . 0.0 119.377 166.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -88.23 -44.22 11.02 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.573 2.187 . . . . 0.0 114.43 171.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.0 m -93.78 42.71 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 CA-C-N 122.032 2.196 . . . . 0.0 114.041 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.3 m -175.97 145.69 0.66 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.244 1.418 . . . . 0.0 107.892 -176.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -86.8 104.56 6.09 Favored Pre-proline 0 CA--C 1.576 1.977 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.574 170.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.63 113.22 3.74 Favored 'Trans proline' 0 C--N 1.374 1.883 0 CA-C-N 123.158 2.164 . . . . 0.0 112.298 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 93.1 m -95.95 115.29 27.21 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.501 -161.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -92.25 99.69 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -169.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.7 mt -93.21 99.91 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 62.0 mt -89.11 124.97 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.2 p -146.87 116.61 7.16 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.842 -0.536 . . . . 0.0 111.552 -168.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -84.27 117.97 23.89 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.945 -1.097 . . . . 0.0 112.024 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -109.4 82.58 1.62 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.936 0.874 . . . . 0.0 109.424 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.9 -100.58 1.48 Allowed Glycine 0 N--CA 1.489 2.18 0 O-C-N 121.884 -0.51 . . . . 0.0 114.219 -175.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -94.58 -24.44 17.22 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 173.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -98.37 146.32 25.82 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 120.786 1.63 . . . . 0.0 112.941 -174.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.65 115.11 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.671 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 170.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.9 t -99.85 106.35 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.0 mt -95.71 117.84 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 175.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -106.38 95.61 5.88 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.946 174.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.7 m -89.69 101.52 14.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.658 -0.651 . . . . 0.0 109.601 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.4 mt -107.47 105.25 15.07 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.275 -168.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 m -79.96 152.0 29.76 Favored 'General case' 0 CA--C 1.568 1.642 0 O-C-N 121.424 -0.798 . . . . 0.0 110.425 151.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.5 p -38.39 -51.13 1.54 Allowed 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 160.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -80.45 -47.51 14.22 Favored 'General case' 0 CA--C 1.572 1.804 0 C-N-CA 124.379 1.072 . . . . 0.0 113.599 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -115.0 109.77 18.6 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.845 0.858 . . . . 0.0 111.062 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -95.14 89.84 5.68 Favored 'General case' 0 CA--C 1.566 1.568 0 C-N-CA 123.193 0.597 . . . . 0.0 110.366 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.3 p -92.93 146.9 23.28 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -171.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -150.21 116.28 5.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.196 -0.94 . . . . 0.0 112.036 -166.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.2 pt -129.27 116.51 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.668 -0.645 . . . . 0.0 111.93 -175.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.8 p -103.58 113.17 26.48 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.24 1.016 . . . . 0.0 111.975 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -147.29 150.15 34.24 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.829 0.823 . . . . 0.0 113.119 -169.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -86.92 149.37 24.85 Favored 'General case' 0 CA--C 1.572 1.808 0 O-C-N 121.028 -1.045 . . . . 0.0 111.018 162.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.8 mt -68.21 123.97 22.16 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.059 -1.651 . . . . 0.0 112.546 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.38 -16.76 60.63 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 118.707 2.243 . . . . 0.0 118.707 -162.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -80.91 125.82 30.6 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-N 119.935 1.867 . . . . 0.0 112.005 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.613 ' HE2' ' NZ ' ' A' ' 96' ' ' LYS . 28.1 tt0 -86.62 127.69 34.94 Favored 'General case' 0 CA--C 1.569 1.693 0 CA-C-O 121.291 0.567 . . . . 0.0 111.901 171.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -133.93 148.64 51.22 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.154 0.982 . . . . 0.0 111.331 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.09 131.99 37.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.482 -1.387 . . . . 0.0 111.435 171.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -126.46 104.11 7.97 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.041 0.537 . . . . 0.0 110.139 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.4 m -74.1 104.52 4.95 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.223 1.011 . . . . 0.0 110.033 171.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 75.3 p -84.48 172.79 11.38 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -168.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.56 -6.73 0.76 Allowed 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 119.589 3.181 . . . . 0.0 119.589 166.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -96.45 0.43 50.37 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 160.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.313 18.3 t70 63.48 27.2 15.08 Favored 'General case' 0 CA--C 1.582 2.19 0 N-CA-C 116.949 2.203 . . . . 0.0 116.949 -166.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 -94.02 131.6 39.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.574 -1.329 . . . . 0.0 109.196 162.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.298 0.3 OUTLIER -88.72 108.93 19.74 Favored 'General case' 0 CA--C 1.569 1.676 0 CA-C-O 121.041 0.448 . . . . 0.0 110.361 171.493 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 92.4 m -95.33 120.82 36.23 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -173.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -69.88 100.12 1.51 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.811 0.815 . . . . 0.0 109.953 171.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.4 m -114.89 112.67 23.08 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.114 -156.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.8 p -111.71 119.12 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.368 0.604 . . . . 0.0 109.618 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.4 t -105.1 119.85 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -174.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.4 p -130.26 127.68 40.05 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.414 0.685 . . . . 0.0 111.661 -177.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 tt -91.12 111.28 22.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.133 -0.979 . . . . 0.0 110.632 177.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -113.7 74.92 0.89 Allowed 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 123.203 0.601 . . . . 0.0 111.373 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 65.84 77.9 0.25 Allowed Glycine 0 N--CA 1.496 2.678 0 N-CA-C 116.623 1.409 . . . . 0.0 116.623 172.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.271 23.4 t0 62.81 11.87 5.29 Favored 'General case' 0 CA--C 1.582 2.194 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 -164.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.7 mtmt -128.2 105.58 8.45 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 120.914 1.688 . . . . 0.0 109.532 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.78 93.45 8.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -0.968 . . . . 0.0 109.965 177.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 22.3 t -97.03 107.87 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.036 -1.04 . . . . 0.0 108.973 -166.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -93.26 103.25 15.52 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.576 0.75 . . . . 0.0 110.38 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.2 mt -92.84 105.04 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -176.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -94.29 122.06 36.45 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 118.561 0.619 . . . . 0.0 110.672 173.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.613 ' NZ ' ' HE2' ' A' ' 69' ' ' GLU . 8.1 mtmp? -118.36 127.18 53.44 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.366 0.666 . . . . 0.0 110.442 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.4 p90 -149.49 122.68 8.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.03 -1.044 . . . . 0.0 110.055 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 54.85 36.65 27.05 Favored 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 176.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.92 -24.94 4.93 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 118.985 2.354 . . . . 0.0 118.985 -164.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -81.2 144.4 31.64 Favored 'General case' 0 CA--C 1.565 1.552 0 CA-C-N 119.075 1.437 . . . . 0.0 112.84 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -134.45 132.72 39.65 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.316 0.646 . . . . 0.0 111.287 -176.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.7 t -126.2 134.15 51.33 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 161.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.97 123.5 43.66 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.934 0.494 . . . . 0.0 110.813 176.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -102.72 108.9 20.32 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -171.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.0 t -92.8 96.39 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -174.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -88.32 116.88 26.85 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -133.3 133.53 42.7 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.8 mm -76.69 114.74 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -148.38 124.11 10.51 Favored 'General case' 0 CA--C 1.565 1.544 0 C-N-CA 124.225 1.01 . . . . 0.0 108.717 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 t70 55.85 50.5 13.93 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.27 18.68 65.47 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 119.66 2.624 . . . . 0.0 119.66 -172.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -144.31 152.02 40.18 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.486 1.143 . . . . 0.0 110.184 -169.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 7.7 ttm -85.2 115.32 22.92 Favored 'General case' 0 CA--C 1.564 1.516 0 O-C-N 121.26 -0.9 . . . . 0.0 108.984 159.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.9 t -88.46 105.42 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 27.2 ttt -95.22 103.22 15.07 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.771 -0.58 . . . . 0.0 110.3 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 92.1 m -92.33 115.19 27.87 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.656 0.741 . . . . 0.0 109.405 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mp -105.41 105.82 16.04 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -174.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.9 t -121.95 125.79 47.15 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 119.098 0.863 . . . . 0.0 113.321 -175.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -109.04 92.29 3.99 Favored 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 123.802 0.841 . . . . 0.0 108.758 171.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 69.5 -82.26 0.28 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 115.9 1.12 . . . . 0.0 115.9 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -121.72 -7.21 9.08 Favored 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 167.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.7 t -87.66 116.36 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-N 121.748 2.067 . . . . 0.0 108.565 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.1 t -115.4 121.0 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 C-N-CA 123.482 0.713 . . . . 0.0 109.655 -169.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -107.29 157.9 17.56 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 123.281 0.633 . . . . 0.0 112.446 161.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.4 t -132.44 110.59 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.01 -1.056 . . . . 0.0 109.274 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -97.5 121.26 39.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.028 -1.045 . . . . 0.0 111.273 174.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -99.37 110.56 23.05 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.427 0.691 . . . . 0.0 109.937 -171.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -110.61 128.01 55.49 Favored 'General case' 0 CA--C 1.563 1.454 0 O-C-N 121.378 -0.826 . . . . 0.0 111.99 -168.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -103.07 154.26 19.45 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 123.246 0.618 . . . . 0.0 112.543 168.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -74.1 134.97 42.93 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.251 -0.906 . . . . 0.0 113.027 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.519 0 C-N-CA 123.799 0.84 . . . . 0.0 111.837 168.948 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.329 17.5 tt0 . . . . . 0 N--CA 1.497 1.899 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.31 -26.57 61.12 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 165.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -71.18 -22.75 61.99 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 116.801 2.149 . . . . 0.0 116.801 165.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.7 m -83.67 100.42 10.85 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 120.83 1.65 . . . . 0.0 113.218 -174.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -165.38 171.93 12.84 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-O 122.222 1.011 . . . . 0.0 111.802 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 94.8 m -81.89 118.24 22.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.013 -1.054 . . . . 0.0 109.274 165.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -113.57 121.86 45.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.403 -0.811 . . . . 0.0 112.333 -170.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -96.79 124.97 40.92 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.467 1.107 . . . . 0.0 110.459 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tt -71.82 112.9 8.31 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.079 -1.013 . . . . 0.0 112.484 176.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.4 p -90.42 -46.22 8.49 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -143.93 136.19 26.7 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 119.193 0.906 . . . . 0.0 110.276 -175.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.3 p -118.8 136.98 53.71 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -94.2 -126.44 0.11 Allowed 'General case' 0 CA--C 1.573 1.848 0 O-C-N 121.611 -0.681 . . . . 0.0 110.326 172.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -83.82 54.05 2.76 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 119.571 -1.956 . . . . 0.0 114.848 -172.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -74.04 -36.18 64.37 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -48.35 -56.24 8.62 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 174.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -65.59 -42.32 91.81 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 169.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -52.91 -47.48 67.95 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 171.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 78.1 mtm -59.74 -48.68 80.72 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.06 -46.99 72.09 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 167.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.2 90.2 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 173.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mp -63.25 -35.9 81.88 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 166.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.11 41.42 0.9 Allowed Glycine 0 N--CA 1.487 2.051 0 N-CA-C 117.197 1.639 . . . . 0.0 117.197 177.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.5 m -71.22 158.06 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-N 119.323 1.561 . . . . 0.0 113.288 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.5 157.83 49.69 Favored Glycine 0 CA--C 1.553 2.437 0 O-C-N 120.767 -1.208 . . . . 0.0 115.89 162.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -64.57 -38.49 91.2 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.28 -44.33 97.41 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 160.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.7 m -58.54 -43.35 89.25 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -57.81 -47.98 81.06 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 167.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -63.04 -43.78 97.7 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 172.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.9 t -49.84 -61.15 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 163.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.93 -34.92 62.25 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 119.173 2.429 . . . . 0.0 119.173 174.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -66.33 -43.14 86.98 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 170.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.0 m -78.53 -33.35 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 116.361 1.985 . . . . 0.0 116.361 176.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 t -94.46 136.05 35.2 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 120.318 1.417 . . . . 0.0 113.997 -162.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -92.93 109.26 38.2 Favored Pre-proline 0 CA--C 1.576 1.96 0 CA-C-O 118.338 -0.839 . . . . 0.0 110.937 167.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.55 138.68 24.56 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 C-N-CA 122.635 2.223 . . . . 0.0 113.854 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.4 m -85.62 102.49 13.61 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.71 100.2 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -169.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.9 mt -90.82 102.75 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.175 -0.953 . . . . 0.0 108.529 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.5 mt -93.01 125.96 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.9 p -148.91 126.79 11.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.41 -0.806 . . . . 0.0 112.298 -169.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -81.42 109.32 15.79 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.682 -1.261 . . . . 0.0 110.426 168.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -104.11 86.66 2.6 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -173.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.19 -73.69 2.31 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 115.5 0.96 . . . . 0.0 115.5 -174.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -122.52 -53.85 1.88 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.889 0.876 . . . . 0.0 112.088 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -80.66 151.92 28.72 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -172.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.2 t -85.21 121.12 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.2 t -111.5 108.18 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.3 mt -89.75 116.11 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 172.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.8 mtm-85 -100.11 104.3 15.84 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 119.493 1.042 . . . . 0.0 109.73 169.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.7 m -90.11 102.52 15.24 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 77.3 mt -120.08 94.82 4.51 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 122.585 0.354 . . . . 0.0 110.397 -169.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.0 p -93.05 171.04 9.2 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.86 -1.15 . . . . 0.0 112.021 165.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.5 t -72.2 31.59 0.06 Allowed 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 165.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -155.68 -60.57 0.11 Allowed 'General case' 0 CA--C 1.571 1.756 0 C-N-CA 125.182 1.393 . . . . 0.0 109.404 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 46.7 mmtt -109.9 123.37 49.49 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.403 1.081 . . . . 0.0 109.902 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -124.14 98.29 5.71 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 123.337 0.655 . . . . 0.0 110.683 176.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.0 t -129.98 166.97 18.98 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 123.507 0.723 . . . . 0.0 112.054 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -138.18 153.0 49.2 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.9 mt -124.02 104.36 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.629 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -177.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 91.2 p -99.95 114.9 28.49 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.79 0.836 . . . . 0.0 112.178 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -145.14 152.93 40.81 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -171.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -103.68 141.98 35.12 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 123.463 0.705 . . . . 0.0 109.325 168.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -67.38 129.25 39.32 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.634 -1.291 . . . . 0.0 113.908 -173.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.79 -15.69 45.98 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 119.141 2.416 . . . . 0.0 119.141 -167.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -91.53 127.3 36.92 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 119.945 1.873 . . . . 0.0 111.58 -173.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -79.71 126.66 31.23 Favored 'General case' 0 CA--C 1.569 1.68 0 C-N-CA 122.885 0.474 . . . . 0.0 111.917 177.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -140.25 149.6 43.05 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.447 0.699 . . . . 0.0 111.916 -171.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -78.81 138.11 38.03 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.788 -1.195 . . . . 0.0 113.035 174.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -146.3 132.41 19.34 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.198 0.599 . . . . 0.0 110.959 174.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.3 m -98.51 119.77 37.78 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.487 0.66 . . . . 0.0 109.457 170.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 44.7 p -90.34 172.24 8.89 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -168.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.27 -21.37 33.91 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 118.595 2.813 . . . . 0.0 118.595 165.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.435 ' HD2' ' C ' ' A' ' 76' ' ' ASP . 19.9 t0 -65.73 -14.68 61.78 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 158.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.291 10.1 m-20 62.38 46.86 5.58 Favored 'General case' 0 CA--C 1.574 1.873 0 CA-C-N 120.245 1.384 . . . . 0.0 114.69 -164.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.18 131.83 53.83 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.666 1.186 . . . . 0.0 108.702 172.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -86.78 120.31 27.94 Favored 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 122.806 0.442 . . . . 0.0 111.716 173.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.6 p -119.72 143.8 47.58 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.49 0.662 . . . . 0.0 112.725 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -79.13 105.11 10.23 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 121.966 0.889 . . . . 0.0 109.15 157.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.2 m -98.55 136.76 38.2 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.636 0.775 . . . . 0.0 112.245 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.6 p -134.3 129.89 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 123.537 0.735 . . . . 0.0 109.35 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.4 t -118.41 119.14 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.104 -0.998 . . . . 0.0 109.428 -169.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.7 p -117.69 131.62 56.6 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.576 0.75 . . . . 0.0 112.191 -176.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 tt -99.93 108.21 20.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.903 . . . . 0.0 110.301 177.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -88.78 -21.38 23.82 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 116.946 2.202 . . . . 0.0 116.946 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -178.43 -93.53 0.09 OUTLIER Glycine 0 N--CA 1.49 2.251 0 CA-C-N 120.289 1.404 . . . . 0.0 111.108 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -107.41 60.54 0.62 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 117.842 0.821 . . . . 0.0 109.915 151.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -155.25 114.76 3.67 Favored 'General case' 0 CA--C 1.563 1.46 0 O-C-N 121.416 -0.803 . . . . 0.0 110.576 174.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.5 mt -84.7 118.87 24.68 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.722 -0.611 . . . . 0.0 109.57 166.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.2 t -105.98 99.65 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -178.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -90.68 103.66 16.34 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.411 0.684 . . . . 0.0 110.151 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.3 mt -93.91 117.06 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -175.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -108.68 120.56 42.84 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 119.005 0.82 . . . . 0.0 110.464 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -112.41 120.82 42.98 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.889 0.876 . . . . 0.0 110.663 -176.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -151.58 134.28 15.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.395 -0.815 . . . . 0.0 110.591 -175.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 50.48 43.02 27.19 Favored 'General case' 0 N--CA 1.509 2.489 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 166.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.67 22.2 76.64 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 119.82 2.688 . . . . 0.0 119.82 -167.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -137.25 137.4 39.01 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 119.257 1.529 . . . . 0.0 109.506 -168.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -131.66 125.57 32.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.609 -0.682 . . . . 0.0 111.197 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.8 t -125.76 137.86 53.83 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.56 0.744 . . . . 0.0 110.377 175.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.258 11.6 p30 -120.11 135.34 54.99 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.81 105.19 15.55 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -174.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.5 t -89.91 95.88 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 CA-C-N 119.681 1.128 . . . . 0.0 108.199 -178.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.4 ' CG ' ' SD ' ' A' ' 113' ' ' MET . 41.8 ttm180 -95.35 106.25 18.28 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.021 0.928 . . . . 0.0 111.059 -173.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -126.34 144.38 50.83 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.179 0.592 . . . . 0.0 112.568 -176.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.6 mm -82.99 120.35 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -127.91 98.48 5.17 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.7 t70 53.15 58.26 5.46 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -176.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.19 -48.97 3.22 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 116.883 1.513 . . . . 0.0 116.883 -172.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -80.84 145.37 31.43 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 118.265 1.033 . . . . 0.0 113.085 -173.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.4 ' SD ' ' CG ' ' A' ' 106' ' ' ARG . 25.0 tpp -80.18 108.26 13.64 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 121.618 0.723 . . . . 0.0 109.378 161.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 93.6 t -100.75 100.41 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 30.4 ttm -98.49 102.84 14.7 Favored 'General case' 0 CA--C 1.561 1.372 0 O-C-N 122.049 -0.407 . . . . 0.0 110.751 -165.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.9 m -97.41 96.21 8.2 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.579 1.181 . . . . 0.0 110.119 -170.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.581 HD12 HH22 ' A' ' 126' ' ' ARG . 11.0 mp -93.83 106.83 18.78 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.217 1.007 . . . . 0.0 111.137 -176.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.0 t -101.45 118.04 36.15 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.582 0.753 . . . . 0.0 111.11 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -103.14 77.11 1.51 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 159.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 63.97 -109.52 2.84 Favored Glycine 0 CA--C 1.547 2.093 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 -170.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -76.54 -22.11 54.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 171.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.9 t -86.21 102.82 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 120.777 1.626 . . . . 0.0 108.867 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 61.6 t -110.26 108.56 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -172.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.45 135.86 39.41 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.477 0.711 . . . . 0.0 111.696 174.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.0 t -131.95 115.68 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.581 HH22 HD12 ' A' ' 117' ' ' LEU . 3.6 mtm105 -120.8 140.85 51.14 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 122.363 1.078 . . . . 0.0 113.013 176.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -110.21 100.16 9.1 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.541 -1.208 . . . . 0.0 108.662 -164.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -103.52 132.3 49.9 Favored 'General case' 0 CA--C 1.565 1.543 0 O-C-N 121.429 -0.795 . . . . 0.0 111.802 -169.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -103.16 151.53 22.49 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 172.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -74.09 135.25 42.96 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.295 -0.878 . . . . 0.0 113.177 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.079 -0.962 . . . . 0.0 111.491 164.851 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 . . . . . 0 N--CA 1.495 1.811 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.96 -28.67 64.54 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 169.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -77.39 -15.94 59.11 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 166.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.2 t -76.77 98.64 4.87 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 122.478 2.399 . . . . 0.0 114.302 -172.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -168.4 167.6 11.78 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.161 0.982 . . . . 0.0 112.23 -177.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.7 m -81.64 116.87 21.58 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.846 -1.159 . . . . 0.0 108.661 159.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -107.34 119.67 40.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.346 -0.847 . . . . 0.0 110.672 -174.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -101.93 131.92 48.04 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.638 0.732 . . . . 0.0 110.917 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -69.13 132.63 46.87 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.3 p -102.15 -41.29 6.46 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 173.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -156.76 129.47 7.68 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 119.552 1.069 . . . . 0.0 109.807 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.1 p -110.86 106.0 15.0 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.503 0.721 . . . . 0.0 110.913 172.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -70.65 -58.82 3.26 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 -160.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -120.57 46.4 2.01 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.318 -0.864 . . . . 0.0 112.287 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -75.79 -43.65 45.28 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -167.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -46.96 -52.64 14.17 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 163.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.55 -43.16 85.85 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 176.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -52.77 -53.25 50.86 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 120.203 1.365 . . . . 0.0 114.42 162.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 76.9 mtm -62.03 -43.7 98.28 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 176.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.5 -40.8 92.67 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 168.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.03 -39.97 95.27 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 165.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.5 tp -59.08 -37.29 76.75 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 172.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.45 50.8 0.84 Allowed Glycine 0 N--CA 1.485 1.938 0 N-CA-C 115.434 0.934 . . . . 0.0 115.434 -176.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.3 m -91.21 157.81 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 118.379 1.089 . . . . 0.0 112.545 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.6 158.68 53.61 Favored Glycine 0 CA--C 1.552 2.348 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 162.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -59.13 -41.05 87.33 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.92 -38.98 73.61 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 168.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.9 m -61.23 -48.2 82.56 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 169.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.257 8.2 ptm180 -63.22 -32.67 74.12 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 173.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -62.75 -58.02 8.92 Favored 'General case' 0 CA--C 1.571 1.758 0 CA-C-N 119.066 0.848 . . . . 0.0 113.182 162.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.6 t -54.06 -58.51 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.07 -21.24 58.99 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 120.253 2.861 . . . . 0.0 120.253 -177.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -91.11 -38.41 12.78 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 169.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -68.88 -39.87 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 CA-C-N 121.326 1.876 . . . . 0.0 115.846 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.7 t -85.03 153.32 22.81 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 119.474 1.034 . . . . 0.0 113.274 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -98.66 93.96 2.21 Favored Pre-proline 0 CA--C 1.575 1.906 0 O-C-N 121.46 -0.775 . . . . 0.0 110.335 169.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.19 118.49 5.64 Favored 'Trans proline' 0 C--N 1.374 1.904 0 CA-C-N 123.109 2.146 . . . . 0.0 113.466 -175.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 91.2 m -88.82 122.16 31.92 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.395 -173.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.7 t -105.32 100.75 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.711 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -166.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.0 mt -89.1 105.84 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.7 mt -97.27 115.05 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 92.1 p -144.48 124.82 13.82 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.748 0.419 . . . . 0.0 111.219 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -78.97 115.62 18.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.593 -0.692 . . . . 0.0 111.677 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -126.2 84.08 2.23 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.223 0.535 . . . . 0.0 110.371 -170.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.75 72.25 1.05 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 115.435 0.934 . . . . 0.0 115.435 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.29 7.3 t70 70.71 -51.94 0.67 Allowed 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -171.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -76.18 148.98 37.37 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.1 t -88.91 116.61 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.55 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 172.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.0 t -99.55 114.69 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.9 mt -103.43 112.94 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 173.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.6 116.24 30.41 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.284 1.034 . . . . 0.0 110.668 -177.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.1 m -102.22 100.5 10.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.69 -0.631 . . . . 0.0 109.44 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.3 mt -99.64 100.63 11.65 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.101 0.56 . . . . 0.0 109.998 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.1 p -98.36 1.9 47.45 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 118.24 2.681 . . . . 0.0 118.24 176.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.396 31.8 p 78.69 -57.35 0.44 Allowed 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 124.871 1.268 . . . . 0.0 113.316 -167.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -77.92 -61.88 1.85 Allowed 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 124.354 1.062 . . . . 0.0 112.267 177.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -105.62 117.58 34.38 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.988 0.915 . . . . 0.0 109.428 176.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -121.07 85.5 2.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.412 -0.805 . . . . 0.0 109.833 -172.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.2 t -113.18 176.37 5.05 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 122.3 1.048 . . . . 0.0 113.478 -173.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -146.66 156.08 42.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.847 -1.158 . . . . 0.0 113.093 173.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.3 pt -121.68 132.0 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 123.899 0.88 . . . . 0.0 109.508 171.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 92.6 p -124.17 109.49 13.5 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.509 0.723 . . . . 0.0 110.408 -176.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -141.49 139.48 33.31 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -165.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -93.34 23.91 4.21 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.7 mt 67.41 105.21 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 125.179 1.392 . . . . 0.0 113.769 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.58 -20.09 12.69 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 118.483 2.153 . . . . 0.0 118.483 -166.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -78.66 123.37 27.07 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 119.158 1.479 . . . . 0.0 111.666 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.661 ' HE2' ' NZ ' ' A' ' 96' ' ' LYS . 23.1 tt0 -84.77 131.48 34.54 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 121.86 0.838 . . . . 0.0 112.24 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -131.52 157.31 43.9 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 124.247 1.019 . . . . 0.0 111.181 -173.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.517 ' HD2' ' N ' ' A' ' 71' ' ' ASP . 1.0 OUTLIER -91.65 136.07 33.41 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.63 -1.294 . . . . 0.0 110.98 175.065 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -140.71 118.72 11.88 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 122.533 0.333 . . . . 0.0 111.114 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 85.1 m -82.96 113.13 20.34 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 163.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.6 p -87.08 164.9 16.17 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -165.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.54 -24.35 8.0 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 118.824 2.898 . . . . 0.0 118.824 164.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -78.56 -0.51 29.96 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 167.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.262 10.7 t70 68.01 65.97 0.36 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 120.358 1.436 . . . . 0.0 113.151 -171.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -161.04 130.34 4.75 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.821 0.848 . . . . 0.0 109.146 -177.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -89.94 127.23 35.98 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.234 0.614 . . . . 0.0 112.392 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 21.0 p -132.0 148.76 52.53 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -81.2 101.63 9.81 Favored 'General case' 0 CA--C 1.565 1.537 0 CA-C-N 115.018 -0.992 . . . . 0.0 108.784 164.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.6 m -100.77 130.41 46.79 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.228 1.011 . . . . 0.0 112.35 -171.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.2 p -137.57 131.49 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.67 -0.644 . . . . 0.0 110.333 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 t -115.69 121.28 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.272 -0.893 . . . . 0.0 109.571 -176.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.9 p -110.77 130.07 55.67 Favored 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 123.612 0.765 . . . . 0.0 112.015 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 tt -92.68 100.86 13.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 110.584 176.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -93.1 75.6 4.69 Favored 'General case' 0 CA--C 1.568 1.657 0 O-C-N 121.325 -0.859 . . . . 0.0 111.681 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.75 -84.27 1.59 Allowed Glycine 0 N--CA 1.492 2.411 0 O-C-N 121.718 -0.613 . . . . 0.0 113.674 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -136.39 53.9 1.91 Allowed 'General case' 0 CA--C 1.571 1.78 0 CA-C-O 121.131 0.491 . . . . 0.0 111.911 161.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -145.64 119.54 9.32 Favored 'General case' 0 CA--C 1.562 1.411 0 O-C-N 121.072 -1.017 . . . . 0.0 111.303 172.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 47.2 mt -87.32 105.32 17.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.788 -0.57 . . . . 0.0 110.62 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.4 t -95.27 102.0 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -177.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -89.97 107.64 19.24 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.255 0.622 . . . . 0.0 110.61 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.3 mt -96.41 121.07 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 124.297 1.039 . . . . 0.0 108.493 -177.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -112.71 120.57 41.96 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 118.754 0.706 . . . . 0.0 110.23 173.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.661 ' NZ ' ' HE2' ' A' ' 69' ' ' GLU . 51.3 mtmt -111.42 123.03 49.39 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.639 0.776 . . . . 0.0 110.654 -177.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -156.23 133.52 10.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.498 -0.751 . . . . 0.0 110.192 -175.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.457 ' HD2' ' NZ ' ' A' ' 100' ' ' LYS . 27.4 m-20 64.39 15.07 9.27 Favored 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 117.446 2.387 . . . . 0.0 117.446 176.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.32 -3.13 82.89 Favored Glycine 0 CA--C 1.559 2.808 0 N-CA-C 119.082 2.393 . . . . 0.0 119.082 -158.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.457 ' NZ ' ' HD2' ' A' ' 98' ' ' ASP . 8.5 mtmp? -105.55 147.51 28.3 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-N 119.337 1.569 . . . . 0.0 111.013 -176.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -136.06 127.07 27.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.738 -0.601 . . . . 0.0 112.075 -175.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.9 t -112.67 138.39 49.54 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.524 0.73 . . . . 0.0 109.47 164.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.88 122.39 40.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.242 0.617 . . . . 0.0 110.025 175.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -105.25 106.0 16.29 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -172.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.3 t -90.65 98.45 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -171.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 25.8 ttm105 -93.58 111.12 22.73 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.291 0.636 . . . . 0.0 110.641 -177.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -129.63 134.63 47.8 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 119.3 0.955 . . . . 0.0 112.621 -175.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.3 mm -81.46 127.11 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.206 -0.934 . . . . 0.0 109.528 174.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -101.6 -86.61 0.41 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.982 -0.449 . . . . 0.0 110.098 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -143.33 95.4 2.75 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 171.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.17 -41.97 2.96 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 117.354 1.701 . . . . 0.0 117.354 -167.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -92.81 148.57 21.92 Favored 'General case' 0 CA--C 1.558 1.28 0 CA-C-N 118.549 1.175 . . . . 0.0 113.219 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -90.76 109.56 20.75 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.704 158.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.6 t -85.28 104.27 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 170.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 39.5 ttm -93.97 114.52 26.73 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.6 m -101.7 99.46 9.72 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.9 mp -93.33 107.31 19.16 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -174.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.261 13.5 t -131.79 134.61 46.01 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -172.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -110.76 80.03 1.26 Allowed 'General case' 0 CA--C 1.564 1.511 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.994 174.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 69.89 -90.25 0.32 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 115.92 1.128 . . . . 0.0 115.92 -177.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -87.6 -34.49 18.5 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.4 t -87.65 132.35 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 119.459 1.027 . . . . 0.0 109.823 -170.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.7 t -128.42 112.83 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 C-N-CA 123.288 0.635 . . . . 0.0 109.453 -169.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -105.24 114.5 28.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.423 -0.798 . . . . 0.0 112.135 171.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.9 t -92.93 112.58 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.428 -0.795 . . . . 0.0 109.032 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -101.12 120.74 40.65 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.974 0.892 . . . . 0.0 111.219 175.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -102.66 102.92 13.16 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.464 0.706 . . . . 0.0 109.44 -168.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -105.77 127.58 53.18 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.132 -0.98 . . . . 0.0 112.413 -171.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -98.21 155.71 17.04 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 123.798 0.839 . . . . 0.0 112.808 169.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -77.55 135.17 38.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.176 -0.952 . . . . 0.0 113.238 176.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.019 -0.991 . . . . 0.0 111.04 162.803 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.326 19.7 tt0 . . . . . 0 N--CA 1.496 1.874 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.56 -31.89 57.45 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 117.246 2.313 . . . . 0.0 117.246 161.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -72.27 -26.08 61.85 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 165.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.5 t -78.97 95.59 5.51 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-N 121.167 1.803 . . . . 0.0 113.269 -173.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -169.11 172.37 7.49 Favored 'General case' 0 CA--C 1.571 1.755 0 CA-C-O 122.702 1.239 . . . . 0.0 111.928 -174.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.6 m -78.83 127.38 31.97 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.135 -0.978 . . . . 0.0 110.109 165.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 99.9 m95 -124.6 111.73 15.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.856 -0.528 . . . . 0.0 110.267 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -104.53 129.6 52.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.58 -0.7 . . . . 0.0 110.811 -175.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -70.72 134.54 47.56 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 60.9 p -106.9 -39.97 5.62 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 175.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -153.77 123.04 6.54 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 119.528 1.058 . . . . 0.0 109.607 -174.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.4 p -103.07 100.22 10.13 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 122.925 0.49 . . . . 0.0 111.705 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -76.68 120.61 22.1 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 123.664 0.786 . . . . 0.0 111.405 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 4.8 t-20 60.12 38.08 20.56 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -76.0 -41.02 52.45 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.35 -50.76 70.58 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 174.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -55.47 -48.29 74.75 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 167.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -51.94 -47.1 64.88 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 169.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.49 ' SD ' ' HA ' ' A' ' 30' ' ' ARG . 72.7 mtm -64.06 -40.77 96.99 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 174.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -58.67 -51.52 69.59 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 161.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.54 -43.83 96.76 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 tt -66.31 -32.13 73.35 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.861 1.801 . . . . 0.0 115.861 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.69 55.45 1.9 Allowed Glycine 0 N--CA 1.485 1.923 0 N-CA-C 115.604 1.002 . . . . 0.0 115.604 -172.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.7 m -87.82 154.27 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 CA-C-N 118.129 0.964 . . . . 0.0 111.005 168.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.83 168.66 31.97 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 116.662 1.425 . . . . 0.0 116.662 174.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -83.54 59.43 5.1 Favored 'General case' 0 CA--C 1.577 1.991 0 CA-C-O 122.681 1.229 . . . . 0.0 112.812 177.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -160.76 -58.32 0.05 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.064 1.346 . . . . 0.0 109.758 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.8 m -61.0 -31.53 71.13 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 169.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.49 ' HA ' ' SD ' ' A' ' 20' ' ' MET . 18.5 ptp180 -57.29 -42.77 82.32 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 164.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -60.62 -48.53 81.37 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 167.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.5 t -49.94 -60.56 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 167.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.81 -38.31 53.74 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 119.349 2.5 . . . . 0.0 119.349 175.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -66.84 -42.44 85.76 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 168.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -77.96 -35.32 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 177.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 t -95.73 138.55 33.23 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 120.277 1.399 . . . . 0.0 113.846 -164.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -103.82 101.36 24.39 Favored Pre-proline 0 CA--C 1.575 1.91 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.335 173.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.55 150.82 46.39 Favored 'Trans proline' 0 CA--C 1.564 1.998 0 CA-C-N 123.011 2.111 . . . . 0.0 117.086 -170.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.7 m -102.9 103.85 14.03 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.113 173.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.2 t -96.58 102.26 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -174.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.2 mt -93.94 102.68 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.4 mt -87.91 113.52 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.4 p -129.58 120.44 25.29 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.839 0.456 . . . . 0.0 111.91 -170.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -85.55 103.52 14.47 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.04 -1.038 . . . . 0.0 110.146 176.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -106.3 88.16 2.72 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.36 0.6 . . . . 0.0 109.801 -168.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.75 -76.33 2.02 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 115.147 0.819 . . . . 0.0 115.147 -176.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -123.89 -50.34 1.83 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.514 0.725 . . . . 0.0 112.647 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -81.11 157.81 25.22 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -176.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.76 115.49 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.595 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 173.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.0 t -105.91 104.98 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.2 mt -94.18 118.78 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -101.59 101.96 12.6 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.1 m -85.38 95.8 9.36 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.9 mt -99.06 92.57 5.55 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -173.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.4 p -85.57 11.22 11.11 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 175.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.391 39.7 p 74.05 -57.97 0.6 Allowed 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 125.136 1.375 . . . . 0.0 113.536 -168.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -76.7 -62.08 1.75 Allowed 'General case' 0 CA--C 1.571 1.776 0 C-N-CA 124.498 1.119 . . . . 0.0 112.285 176.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -106.2 120.93 43.12 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.93 0.892 . . . . 0.0 109.583 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -123.73 84.32 2.26 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -169.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.9 t -108.74 147.65 31.66 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -166.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.43 135.31 47.06 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 124.134 0.974 . . . . 0.0 113.136 -174.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.0 mt -124.66 101.32 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -174.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 90.1 p -110.24 112.87 25.11 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.693 0.797 . . . . 0.0 111.833 -173.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -141.2 139.29 33.79 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.007 0.908 . . . . 0.0 113.423 -173.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -88.33 26.15 1.49 Allowed 'General case' 0 CA--C 1.582 2.194 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 173.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 75.4 mt 63.42 100.49 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 125.347 1.459 . . . . 0.0 113.094 -172.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.71 2.38 88.72 Favored Glycine 0 CA--C 1.556 2.635 0 N-CA-C 119.111 2.405 . . . . 0.0 119.111 -167.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -89.28 129.4 35.84 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-N 119.537 1.669 . . . . 0.0 111.205 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -89.61 111.57 22.56 Favored 'General case' 0 CA--C 1.563 1.447 0 CA-C-O 121.288 0.566 . . . . 0.0 111.374 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -113.8 150.18 33.85 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.27 1.028 . . . . 0.0 110.606 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.517 ' HD2' ' N ' ' A' ' 71' ' ' ASP . 1.2 m-20 -83.45 131.18 35.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.266 -1.521 . . . . 0.0 111.59 171.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -122.56 108.25 12.91 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.596 0.758 . . . . 0.0 109.74 -172.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.7 m -77.97 100.99 6.66 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.219 1.009 . . . . 0.0 109.26 172.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 74.4 p -79.18 -178.69 6.3 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -164.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.45 -8.64 0.56 Allowed 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 119.823 3.268 . . . . 0.0 119.823 162.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -109.5 19.02 19.75 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 158.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.438 2.2 p30 56.36 12.25 0.99 Allowed 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 119.794 3.257 . . . . 0.0 119.794 -171.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -77.11 126.14 30.47 Favored 'General case' 0 CA--C 1.561 1.403 0 O-C-N 120.888 -1.132 . . . . 0.0 110.053 170.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -83.99 101.34 11.66 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.476 0.711 . . . . 0.0 111.314 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 83.4 m -100.83 128.2 46.96 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.617 -0.677 . . . . 0.0 112.492 -171.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -72.46 99.4 2.47 Favored 'General case' 0 CA--C 1.563 1.456 0 CA-C-O 122.275 1.036 . . . . 0.0 109.382 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.2 m -115.96 117.23 29.58 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.916 -156.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 p -122.13 129.53 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 123.379 0.672 . . . . 0.0 109.895 -176.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.1 t -121.96 113.36 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -171.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 63.3 m -112.44 131.13 55.72 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.396 0.678 . . . . 0.0 110.923 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.0 tt -91.36 103.37 16.02 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.571 0.701 . . . . 0.0 110.244 175.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -87.28 80.09 8.33 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 123.46 0.704 . . . . 0.0 111.382 -177.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.9 -81.01 1.54 Allowed Glycine 0 N--CA 1.493 2.47 0 O-C-N 121.564 -0.71 . . . . 0.0 114.338 -176.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -135.33 56.12 1.85 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.271 0.558 . . . . 0.0 111.767 163.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -153.28 100.56 2.46 Favored 'General case' 0 CA--C 1.564 1.498 0 O-C-N 121.218 -0.926 . . . . 0.0 110.277 -170.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 24.4 mt -77.68 114.49 16.57 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.093 -1.004 . . . . 0.0 111.835 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.06 102.31 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -87.59 110.03 20.08 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.065 0.546 . . . . 0.0 110.606 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 69.1 mt -102.09 110.5 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -95.62 124.67 39.76 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 118.671 0.669 . . . . 0.0 111.517 172.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -111.38 124.05 51.47 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.977 0.911 . . . . 0.0 110.321 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.6 p90 -154.49 126.97 7.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.806 -1.184 . . . . 0.0 110.595 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 58.53 31.9 21.54 Favored 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 117.244 2.312 . . . . 0.0 117.244 169.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.09 -20.14 8.87 Favored Glycine 0 CA--C 1.556 2.649 0 N-CA-C 119.012 2.365 . . . . 0.0 119.012 -163.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -91.18 143.49 26.61 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 119.667 1.734 . . . . 0.0 111.657 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -133.42 134.24 43.38 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.174 0.59 . . . . 0.0 111.032 -178.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.0 t -126.48 134.75 50.85 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 123.072 0.549 . . . . 0.0 111.065 173.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -116.03 129.56 56.42 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 123.258 0.623 . . . . 0.0 111.997 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -111.34 102.15 10.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.233 -0.917 . . . . 0.0 108.623 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.9 t -91.77 111.12 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -171.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -110.45 119.41 39.12 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.416 0.686 . . . . 0.0 111.18 -171.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -129.41 144.78 51.39 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 122.996 0.518 . . . . 0.0 112.043 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.6 mm -88.18 106.0 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -103.49 101.09 10.97 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 123.511 0.725 . . . . 0.0 109.221 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.3 t70 50.74 53.95 12.08 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 -175.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.45 -35.15 3.65 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 118.645 2.218 . . . . 0.0 118.645 -170.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -95.76 146.39 24.57 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 119.373 1.587 . . . . 0.0 112.056 -172.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 34.1 ttm -86.06 116.08 24.05 Favored 'General case' 0 CA--C 1.566 1.568 0 O-C-N 120.868 -1.145 . . . . 0.0 111.61 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.4 t -94.79 108.11 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 169.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 13.7 ttt -110.17 101.63 10.39 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.506 0.67 . . . . 0.0 109.607 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.8 m -94.8 106.7 18.7 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.527 0.731 . . . . 0.0 109.355 -174.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.4 mp -91.53 113.9 26.29 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.8 m -120.89 119.78 33.62 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.544 0.688 . . . . 0.0 109.869 -167.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -107.61 77.85 1.16 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.372 0.606 . . . . 0.0 109.367 170.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 64.21 -94.98 0.16 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 115.306 0.882 . . . . 0.0 115.306 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -83.54 -32.73 25.71 Favored 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 170.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.2 t -87.05 109.95 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 120.444 1.475 . . . . 0.0 109.406 -171.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.3 t -114.19 118.27 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 124.086 0.954 . . . . 0.0 108.489 -169.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -123.21 127.63 48.89 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 123.265 0.626 . . . . 0.0 111.878 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 37.7 t -105.74 115.56 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.956 -1.09 . . . . 0.0 110.306 -172.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.8 124.06 40.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.054 -1.029 . . . . 0.0 111.716 169.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -102.05 105.78 16.57 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.726 0.81 . . . . 0.0 109.724 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -107.59 129.68 54.96 Favored 'General case' 0 CA--C 1.563 1.474 0 O-C-N 121.303 -0.873 . . . . 0.0 111.731 -169.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -98.35 158.09 15.79 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.399 1.095 . . . . 0.0 112.499 170.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -89.9 130.58 36.1 Favored 'General case' 0 CA--C 1.563 1.471 0 O-C-N 121.394 -0.816 . . . . 0.0 112.758 -169.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . 0.309 . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.277 8.1 p . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -55.71 -39.17 70.71 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 118.746 2.869 . . . . 0.0 118.746 -173.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.81 -22.28 61.99 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 168.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -80.71 -12.66 59.44 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 168.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 82.3 m -80.36 91.87 5.73 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 122.207 2.276 . . . . 0.0 113.044 -175.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -165.78 167.0 17.37 Favored 'General case' 0 CA--C 1.569 1.701 0 CA-C-O 122.467 1.127 . . . . 0.0 113.124 -172.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.8 m -80.07 111.01 16.02 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.422 -0.799 . . . . 0.0 109.38 165.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -107.57 111.08 23.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.533 -0.729 . . . . 0.0 111.193 -173.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -102.14 132.92 47.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.209 -0.932 . . . . 0.0 110.898 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 tt -70.87 113.85 8.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.717 -0.615 . . . . 0.0 112.574 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.7 p -99.44 -35.66 9.83 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 -175.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -141.72 120.45 12.62 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 120.432 1.469 . . . . 0.0 109.58 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.4 p -108.77 104.49 13.78 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -81.11 122.39 27.28 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.896 -0.503 . . . . 0.0 110.291 164.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 54.58 70.43 0.62 Allowed 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -110.6 61.83 0.61 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.831 -1.168 . . . . 0.0 112.095 163.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -155.51 -64.92 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.237 1.015 . . . . 0.0 109.52 173.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -62.29 -37.5 85.76 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -50.5 -51.09 50.47 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.535 1.516 . . . . 0.0 114.793 167.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 73.5 mtm -57.08 -50.14 73.68 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 170.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -58.19 -40.72 82.26 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 116.134 1.902 . . . . 0.0 116.134 172.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.95 -41.97 90.59 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 169.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.2 tp -61.83 -23.3 66.16 Favored 'General case' 0 CA--C 1.574 1.875 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 176.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.86 55.58 1.61 Allowed Glycine 0 N--CA 1.485 1.906 0 C-N-CA 123.868 0.747 . . . . 0.0 114.795 -176.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.3 m -83.07 153.95 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.93 138.36 34.94 Favored Glycine 0 CA--C 1.555 2.532 0 O-C-N 120.956 -1.09 . . . . 0.0 113.494 149.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -57.56 -33.55 68.26 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -171.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.37 -41.79 66.22 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 164.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.1 m -60.1 -40.6 90.22 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 165.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.335 0.0 OUTLIER -60.18 -42.56 95.27 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 168.326 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -58.61 -51.76 68.57 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 166.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.1 t -56.02 -55.88 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 173.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.81 -24.72 57.99 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 119.854 2.702 . . . . 0.0 119.854 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -73.77 -45.66 50.41 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 164.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.7 m -78.23 -30.4 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 t -105.11 141.1 37.27 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 120.803 1.638 . . . . 0.0 114.276 -162.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -89.66 119.74 69.5 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.197 172.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.05 129.73 8.04 Favored 'Trans proline' 0 CA--C 1.564 2.02 0 C-N-CA 122.454 2.102 . . . . 0.0 114.044 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 56.6 m -95.69 106.91 19.07 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 169.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 81.0 t -99.43 95.91 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -174.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.8 mp -89.43 98.82 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.521 -1.362 . . . . 0.0 108.359 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.5 mt -84.04 116.46 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.6 p -141.78 121.27 13.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.832 -0.543 . . . . 0.0 112.36 -168.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -79.89 102.99 9.48 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.86 -1.15 . . . . 0.0 110.543 169.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -103.3 96.92 7.08 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -169.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.09 -74.8 2.46 Favored Glycine 0 N--CA 1.488 2.163 0 O-C-N 121.777 -0.577 . . . . 0.0 114.144 -173.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -132.77 -53.24 0.93 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.425 0.69 . . . . 0.0 111.927 171.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -81.3 160.18 24.27 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -173.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.2 t -84.29 114.56 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 123.635 0.774 . . . . 0.0 109.117 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.3 t -106.92 107.68 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.558 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 59.0 mt -91.6 122.18 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 172.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -106.03 106.82 17.5 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.151 0.58 . . . . 0.0 110.23 174.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.5 m -92.87 103.73 16.04 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.506 -0.746 . . . . 0.0 109.374 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 72.0 mt -121.32 117.64 27.49 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.085 0.554 . . . . 0.0 110.231 -170.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 t -127.65 171.87 11.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.026 -1.046 . . . . 0.0 111.26 165.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -70.38 24.24 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 118.585 2.809 . . . . 0.0 118.585 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -150.23 -58.14 0.18 Allowed 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 125.194 1.398 . . . . 0.0 108.705 175.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -101.49 130.89 47.84 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.185 0.994 . . . . 0.0 110.949 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -137.54 110.57 7.76 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.077 0.551 . . . . 0.0 110.834 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.3 t -137.7 155.2 49.36 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 123.569 0.748 . . . . 0.0 111.907 -176.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -140.01 146.85 39.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.808 -1.183 . . . . 0.0 113.941 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.8 pt -130.14 122.63 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-O 121.522 0.677 . . . . 0.0 111.108 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.4 p -105.1 116.93 32.78 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.287 1.035 . . . . 0.0 110.877 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -144.79 141.11 28.93 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 114.517 1.302 . . . . 0.0 114.517 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -79.32 155.52 28.43 Favored 'General case' 0 CA--C 1.571 1.781 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.619 149.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.9 mt -70.78 114.53 8.95 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.58 -1.325 . . . . 0.0 111.588 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.07 -7.61 54.92 Favored Glycine 0 CA--C 1.555 2.536 0 N-CA-C 118.567 2.187 . . . . 0.0 118.567 -162.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -68.72 122.48 18.64 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 120.734 2.267 . . . . 0.0 112.432 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -89.33 118.51 29.06 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 122.979 0.512 . . . . 0.0 110.451 169.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -136.43 135.71 38.92 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 123.433 0.693 . . . . 0.0 110.844 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.17 129.1 36.25 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.487 -1.383 . . . . 0.0 111.047 172.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -130.9 109.71 10.75 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.75 -167.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.7 m -75.24 102.17 4.92 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.65 0.738 . . . . 0.0 110.487 174.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.0 p -85.29 161.85 19.36 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -171.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.45 -23.68 4.19 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 119.015 2.969 . . . . 0.0 119.015 166.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -54.24 -30.74 51.37 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 117.629 2.455 . . . . 0.0 117.629 160.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.316 9.8 t70 78.13 63.21 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.723 0 C-N-CA 125.869 1.668 . . . . 0.0 112.172 -159.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.5 ptt-85 -152.85 136.95 16.41 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.95 0.9 . . . . 0.0 109.14 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.284 0.5 OUTLIER -90.32 112.02 23.44 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 119.535 1.062 . . . . 0.0 110.795 168.17 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.3 p -107.64 130.28 54.92 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -65.6 99.12 0.42 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.442 1.097 . . . . 0.0 110.064 168.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.1 m -107.21 119.93 40.73 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.066 -164.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 51.8 t -111.38 120.18 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.9 t -111.74 129.26 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.538 -0.726 . . . . 0.0 109.718 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 65.6 m -153.57 152.45 30.91 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.778 -1.201 . . . . 0.0 112.25 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.9 mp -83.32 123.19 29.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.063 -1.023 . . . . 0.0 110.538 167.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -84.7 -63.68 1.29 Allowed 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -149.98 80.55 0.2 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 174.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.4 t70 52.42 37.23 22.13 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -160.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -147.16 120.89 9.21 Favored 'General case' 0 CA--C 1.56 1.352 0 O-C-N 121.278 -0.889 . . . . 0.0 109.461 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.87 112.5 22.56 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.242 1.017 . . . . 0.0 110.758 -171.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.03 109.91 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -167.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -93.92 98.85 11.32 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 123.436 0.695 . . . . 0.0 110.999 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.0 mt -90.41 109.19 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 C-N-CA 124.159 0.983 . . . . 0.0 109.003 -174.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -105.46 118.35 36.33 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 118.968 0.804 . . . . 0.0 110.193 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -115.45 122.53 46.06 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 123.634 0.774 . . . . 0.0 111.199 -173.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 8.5 p90 -151.36 130.0 12.29 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.96 -1.088 . . . . 0.0 110.5 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 58.38 27.51 15.5 Favored 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 117.498 2.407 . . . . 0.0 117.498 170.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.23 -19.23 23.87 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 118.97 2.348 . . . . 0.0 118.97 -162.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -89.4 148.11 23.67 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-N 119.443 1.622 . . . . 0.0 112.541 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -132.01 141.01 49.11 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.879 0.847 . . . . 0.0 111.463 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.9 t -129.91 143.51 50.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.63 -0.669 . . . . 0.0 109.419 158.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.266 13.3 p30 -124.52 132.82 53.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 111.171 173.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -100.66 103.75 15.04 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.2 t -88.24 98.93 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 91.1 mtm-85 -89.1 114.04 25.25 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.895 0.878 . . . . 0.0 110.35 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.48 132.95 49.91 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 119.119 0.872 . . . . 0.0 112.718 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.7 mm -80.25 106.56 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.382 -0.824 . . . . 0.0 110.244 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -103.09 98.27 8.24 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 169.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.0 t70 51.46 60.8 3.6 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.32 0.1 56.24 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 120.034 2.774 . . . . 0.0 120.034 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -118.78 122.56 42.69 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 119.837 1.818 . . . . 0.0 109.71 -171.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 51.2 ttp -82.42 104.78 12.96 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 122.029 0.919 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.14 103.61 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 31.6 ttm -85.6 108.14 17.84 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 84.4 m -98.71 101.17 12.5 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.0 mp -92.2 98.95 11.84 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.568 0.747 . . . . 0.0 108.988 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.7 t -89.97 117.58 28.88 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.53 0.681 . . . . 0.0 110.322 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -100.59 75.71 1.77 Allowed 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 155.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.57 -111.24 3.3 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 114.85 0.7 . . . . 0.0 114.85 -166.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -81.2 -9.69 59.74 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 171.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 50.0 t -90.36 99.61 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 121.969 2.168 . . . . 0.0 107.422 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.6 t -113.64 119.93 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -168.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.81 130.92 54.43 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 171.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.9 t -111.79 103.83 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -114.96 118.71 34.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.353 -0.842 . . . . 0.0 109.947 -171.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -99.77 98.8 9.57 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.599 0.714 . . . . 0.0 109.982 -162.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -94.23 131.92 39.32 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.507 0.723 . . . . 0.0 110.9 -173.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -116.76 158.52 23.74 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.532 0.682 . . . . 0.0 110.754 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -75.44 103.89 5.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.023 -1.048 . . . . 0.0 111.877 -174.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . 0.286 . . . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -173.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.311 9.8 p . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.05 -42.04 97.73 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.93 -24.44 66.04 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 117.84 2.533 . . . . 0.0 117.84 165.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -76.91 -21.65 54.57 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 168.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 80.8 m -73.81 88.86 1.8 Allowed 'General case' 0 CA--C 1.572 1.811 0 CA-C-N 121.885 2.13 . . . . 0.0 114.344 -173.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.59 168.06 20.48 Favored 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 124.552 1.141 . . . . 0.0 111.781 -174.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.6 m -77.27 134.85 38.45 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.868 -1.145 . . . . 0.0 109.319 158.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -123.91 120.75 33.46 Favored 'General case' 0 CA--C 1.562 1.412 0 O-C-N 121.519 -0.738 . . . . 0.0 110.048 -175.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 mtpm? -100.35 130.79 46.49 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.609 0.764 . . . . 0.0 111.422 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 tt -71.79 118.57 14.8 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.562 -0.711 . . . . 0.0 112.909 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 65.2 p -92.22 -49.75 6.02 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -141.18 113.91 8.33 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.757 0.823 . . . . 0.0 109.875 -173.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.0 p -98.62 98.81 9.92 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.318 0.647 . . . . 0.0 111.883 175.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -83.5 122.81 29.04 Favored 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 123.492 0.717 . . . . 0.0 111.16 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.256 1.3 t30 57.7 30.08 18.33 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 171.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -72.38 -38.36 68.51 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -54.77 -53.16 58.78 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 175.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.26 -41.78 80.33 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 171.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -58.15 -48.08 81.36 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 165.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 65.0 mtm -58.02 -48.28 80.52 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -60.78 -42.58 97.8 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 166.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.64 97.55 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 171.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.6 tp -64.25 -22.33 66.91 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 116.925 2.195 . . . . 0.0 116.925 169.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.73 55.56 1.75 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 115.615 1.006 . . . . 0.0 115.615 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 m -107.86 149.84 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 118.197 0.999 . . . . 0.0 111.553 172.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.17 165.54 21.4 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 116.647 1.419 . . . . 0.0 116.647 172.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -64.84 -40.57 95.38 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.71 -42.46 79.2 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 164.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.6 m -62.4 -43.96 97.58 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 169.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -54.4 -47.53 72.64 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 164.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -58.87 -52.33 66.19 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 119.989 1.268 . . . . 0.0 114.1 170.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.2 t -49.01 -51.5 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 167.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.33 -32.77 84.73 Favored Glycine 0 CA--C 1.55 2.234 0 N-CA-C 119.596 2.599 . . . . 0.0 119.596 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -79.69 -42.93 23.67 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 173.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.4 m -70.32 -35.07 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 117.022 2.231 . . . . 0.0 117.022 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.0 t -102.89 175.32 5.52 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -166.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.44 84.38 0.74 Allowed Pre-proline 0 CA--C 1.579 2.086 0 C-N-CA 123.703 0.801 . . . . 0.0 110.96 169.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.26 117.63 5.23 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.71 2.274 . . . . 0.0 113.395 -175.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.1 m -100.06 123.83 44.74 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.418 -161.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.8 t -106.46 105.56 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -167.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.4 mt -89.05 105.75 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.438 -1.414 . . . . 0.0 107.714 170.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 55.8 mt -89.71 124.6 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 168.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.1 p -150.71 122.19 7.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -0.914 . . . . 0.0 112.739 -169.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -78.99 104.83 9.9 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.666 -1.271 . . . . 0.0 110.512 166.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -105.95 99.8 9.37 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -171.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.13 -72.45 2.77 Favored Glycine 0 N--CA 1.491 2.328 0 O-C-N 121.689 -0.632 . . . . 0.0 114.157 -169.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -139.41 -59.87 0.57 Allowed 'General case' 0 CA--C 1.566 1.575 0 C-N-CA 123.366 0.667 . . . . 0.0 111.303 173.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.582 ' NZ ' ' HE2' ' A' ' 68' ' ' GLU . 19.0 ptmt -79.03 159.85 27.4 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -172.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.8 t -79.77 116.71 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.568 0 CA-C-O 121.725 0.774 . . . . 0.0 109.46 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 65.0 t -104.08 107.43 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 68.7 mt -89.64 120.56 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 167.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -102.88 103.82 14.02 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 166.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.4 m -90.55 99.25 12.31 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 170.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 mp -92.1 101.16 13.68 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.593 0.757 . . . . 0.0 108.978 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.9 t -78.24 26.9 0.2 Allowed 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.352 70.8 p 65.17 -53.87 0.33 Allowed 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -164.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -81.17 -31.88 33.85 Favored 'General case' 0 CA--C 1.577 2.018 0 C-N-CA 125.575 1.55 . . . . 0.0 115.163 174.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -136.62 127.05 26.7 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 119.763 1.165 . . . . 0.0 111.31 -173.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -88.48 104.33 16.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.329 -0.857 . . . . 0.0 110.611 171.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.6 p -102.03 99.95 10.17 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.5 0.667 . . . . 0.0 110.109 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -98.07 126.79 43.67 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.706 0.802 . . . . 0.0 112.259 -175.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.4 pt -131.47 116.84 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 C-N-CA 123.168 0.587 . . . . 0.0 111.159 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.8 p -98.54 129.86 45.1 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.896 0.879 . . . . 0.0 112.351 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -156.64 144.35 19.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.379 -0.826 . . . . 0.0 112.633 -175.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -84.81 158.54 20.64 Favored 'General case' 0 CA--C 1.57 1.722 0 O-C-N 120.861 -1.149 . . . . 0.0 110.935 156.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.32 116.37 9.67 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.67 -1.269 . . . . 0.0 111.839 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.05 -4.29 77.82 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 119.214 2.445 . . . . 0.0 119.214 -163.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.582 ' HE2' ' NZ ' ' A' ' 48' ' ' LYS . 33.3 tt0 -82.42 126.57 32.36 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 120.633 2.217 . . . . 0.0 111.929 -176.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -83.34 112.94 20.36 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-O 121.067 0.46 . . . . 0.0 111.424 172.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -121.53 140.45 52.19 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.763 0.825 . . . . 0.0 111.207 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.695 ' HD2' ' NZ ' ' A' ' 81' ' ' LYS . 3.6 m-20 -76.3 130.89 38.8 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.241 1.019 . . . . 0.0 111.532 171.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.452 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 19.6 tt0 -132.99 103.28 5.97 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.146 -171.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.0 m -91.23 107.19 19.04 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 174.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.7 p -80.14 162.29 24.82 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -169.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.21 -23.79 23.94 Favored 'General case' 0 CA--C 1.576 1.942 0 N-CA-C 118.825 2.898 . . . . 0.0 118.825 169.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -82.96 2.2 35.87 Favored 'General case' 0 CA--C 1.582 2.204 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 165.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.286 21.3 m-20 70.02 70.13 0.22 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 120.584 1.538 . . . . 0.0 113.128 -174.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.5 ptp85 -145.88 125.99 13.76 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 166.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -91.8 105.41 17.69 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.463 0.705 . . . . 0.0 111.132 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 72' ' ' GLU . 28.7 p -109.22 135.23 50.65 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.695 ' NZ ' ' HD2' ' A' ' 71' ' ' ASP . 68.7 mmtt -74.47 101.7 4.23 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-O 121.835 0.826 . . . . 0.0 109.441 164.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.0 m -102.63 128.85 49.14 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.542 0.737 . . . . 0.0 112.63 -170.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 49.4 t -122.98 121.91 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.9 t -104.46 109.47 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.227 -0.92 . . . . 0.0 109.594 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.3 p -110.46 130.06 55.64 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.796 0.838 . . . . 0.0 111.912 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.7 tt -87.84 99.63 12.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.147 -0.971 . . . . 0.0 110.605 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -101.3 75.72 1.65 Allowed 'General case' 0 CA--C 1.567 1.613 0 C-N-CA 123.481 0.712 . . . . 0.0 111.122 -176.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.34 68.15 1.76 Allowed Glycine 0 N--CA 1.495 2.597 0 N-CA-C 116.258 1.263 . . . . 0.0 116.258 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.256 23.7 m-20 60.38 22.33 11.89 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 117.222 2.305 . . . . 0.0 117.222 -166.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -133.58 107.52 8.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.938 -1.101 . . . . 0.0 109.893 -175.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.6 mt -83.09 103.32 12.43 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.793 0.837 . . . . 0.0 111.626 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 37.2 t -97.52 100.5 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -173.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -84.68 107.52 16.93 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.339 0.656 . . . . 0.0 110.204 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 70.3 mt -99.5 103.82 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -91.01 118.94 30.79 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 118.43 0.559 . . . . 0.0 111.317 176.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -112.53 112.03 23.29 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.019 0.528 . . . . 0.0 110.46 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -139.21 125.62 20.37 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.438 -0.789 . . . . 0.0 110.683 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 50.92 49.94 20.11 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 167.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.86 4.6 62.61 Favored Glycine 0 CA--C 1.558 2.739 0 N-CA-C 120.212 2.845 . . . . 0.0 120.212 -168.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -123.59 140.31 53.13 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 119.653 1.726 . . . . 0.0 110.266 -168.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -135.01 123.61 23.57 Favored 'General case' 0 CA--C 1.564 1.499 0 O-C-N 121.692 -0.63 . . . . 0.0 111.783 -175.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.0 t -115.89 137.34 52.19 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.294 0.569 . . . . 0.0 109.964 165.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.19 128.07 54.74 Favored 'General case' 0 CA--C 1.567 1.629 0 C-N-CA 123.109 0.564 . . . . 0.0 110.996 171.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -105.84 110.18 22.39 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 53.2 t -91.97 100.79 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -176.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.18 111.09 19.49 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.562 0.745 . . . . 0.0 110.677 173.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.57 129.83 43.28 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 118.96 0.8 . . . . 0.0 112.631 -174.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.9 mm -75.86 112.93 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.044 -1.035 . . . . 0.0 108.953 173.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -133.24 96.5 3.75 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -169.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.7 t70 50.37 61.1 3.38 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -169.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.07 -48.08 3.88 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 117.84 1.896 . . . . 0.0 117.84 -173.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -82.06 146.42 29.67 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 118.231 1.015 . . . . 0.0 113.086 -174.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -82.38 104.74 12.9 Favored 'General case' 0 CA--C 1.56 1.365 0 CA-C-O 121.966 0.888 . . . . 0.0 109.429 166.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 80.3 t -91.79 102.31 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 40.9 ttm -83.15 108.4 16.38 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.422 0.689 . . . . 0.0 109.8 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.1 m -99.82 115.07 28.72 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.871 0.843 . . . . 0.0 109.135 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mp -111.18 117.46 33.28 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -171.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.305 10.6 t -137.21 138.2 39.92 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 177.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -124.01 99.89 6.47 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.952 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 73.07 -90.76 0.6 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 115.299 0.88 . . . . 0.0 115.299 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -134.31 52.77 2.04 Favored 'General case' 0 CA--C 1.575 1.909 0 CA-C-O 121.482 0.658 . . . . 0.0 112.064 167.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.4 t -139.91 124.04 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 51.2 t -123.4 127.18 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-N 119.001 0.818 . . . . 0.0 109.837 -170.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -117.18 150.7 38.3 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 123.633 0.773 . . . . 0.0 112.329 163.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.8 t -131.92 114.22 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.192 -0.942 . . . . 0.0 108.947 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 mtp-105 -110.9 114.44 27.77 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.205 -0.934 . . . . 0.0 109.876 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -96.63 108.63 21.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.647 -0.658 . . . . 0.0 110.111 -167.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -103.55 132.47 49.78 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.108 -0.995 . . . . 0.0 112.4 -171.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.39 160.66 15.22 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 175.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -76.1 141.03 42.1 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -175.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.25 0 CA-C-O 117.404 -1.284 . . . . 0.0 112.447 176.427 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.8 m . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -67.22 -51.0 58.67 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -171.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.38 -23.83 66.06 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 117.755 2.502 . . . . 0.0 117.755 168.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -87.92 -21.81 24.71 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 172.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.5 t -76.83 95.63 4.11 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 121.197 1.817 . . . . 0.0 112.905 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -166.39 167.61 15.66 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-O 122.565 1.174 . . . . 0.0 112.333 -172.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.7 m -86.85 107.1 18.17 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.829 0.852 . . . . 0.0 108.718 173.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -105.22 109.42 21.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.972 . . . . 0.0 111.623 -169.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -95.36 129.33 42.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.281 -0.887 . . . . 0.0 111.089 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.0 tt -75.86 122.29 23.88 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -173.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 69.0 p -91.84 -52.47 4.72 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 176.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -137.97 114.54 10.45 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.739 0.815 . . . . 0.0 110.233 -173.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.7 p -101.18 78.03 1.86 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.409 1.1 . . . . 0.0 112.419 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -79.99 133.25 36.15 Favored 'General case' 0 CA--C 1.56 1.354 0 O-C-N 120.97 -1.081 . . . . 0.0 113.804 -171.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.252 1.1 t30 57.44 23.34 8.94 Favored 'General case' 0 CA--C 1.584 2.251 0 N-CA-C 117.189 2.292 . . . . 0.0 117.189 -174.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -69.46 -46.41 66.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.238 -1.539 . . . . 0.0 115.054 -175.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -47.64 -51.3 21.99 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -68.33 -40.02 81.76 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -50.5 -52.96 33.72 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 160.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.6 mtp -59.03 -43.46 91.63 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 175.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -47.75 83.58 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 164.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.02 -39.03 86.95 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.65 -47.57 85.67 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 163.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.88 48.22 1.51 Allowed Glycine 0 N--CA 1.482 1.738 0 CA-C-O 118.978 -0.901 . . . . 0.0 115.315 -175.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.7 m -80.56 151.63 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 118.822 1.311 . . . . 0.0 111.443 172.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.38 150.05 30.73 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 116.955 1.542 . . . . 0.0 116.955 173.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -55.53 -43.37 75.71 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.12 -44.9 68.06 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 166.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.3 m -64.04 -40.26 95.91 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 171.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -61.05 -49.16 78.48 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 121.691 2.041 . . . . 0.0 115.923 167.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.6 mp0 -71.14 -28.74 64.5 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.1 t -70.77 -62.13 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 119.536 1.062 . . . . 0.0 112.11 159.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.76 -31.37 71.41 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 119.903 2.721 . . . . 0.0 119.903 -166.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -73.4 -32.11 64.26 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 170.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.2 m -82.68 -34.7 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.0 t -81.5 126.4 31.64 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 120.857 1.662 . . . . 0.0 112.352 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -103.55 92.7 4.3 Favored Pre-proline 0 CA--C 1.573 1.828 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -71.91 155.65 57.46 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.384 2.056 . . . . 0.0 116.64 -171.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.1 m -88.73 100.31 13.03 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.371 -1.286 . . . . 0.0 107.64 169.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.6 t -95.65 98.43 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -171.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.1 mt -88.81 102.21 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -86.41 116.97 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 171.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.2 p -153.81 121.31 5.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.718 -0.614 . . . . 0.0 111.337 -165.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -80.24 128.69 33.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 0.0 113.098 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -120.24 90.28 3.3 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 174.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.9 68.99 1.48 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 115.613 1.005 . . . . 0.0 115.613 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.293 13.0 t70 70.94 -57.27 0.6 Allowed 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -169.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -72.59 147.84 45.47 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-O 122.568 1.175 . . . . 0.0 114.141 -172.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.0 t -96.2 122.54 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.857 -169.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.9 t -104.22 110.87 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.0 mt -92.73 99.76 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 172.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.0 mtm-85 -85.92 101.93 13.3 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.867 0.867 . . . . 0.0 111.022 173.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.6 m -89.81 101.05 13.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.591 -0.693 . . . . 0.0 109.708 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 73.2 mt -101.26 108.82 20.57 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.791 0.805 . . . . 0.0 111.618 -167.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.1 t -138.29 147.61 43.79 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 124.546 1.138 . . . . 0.0 109.369 173.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 51.1 p -76.94 53.38 0.93 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 120.634 -1.291 . . . . 0.0 113.857 173.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -161.37 -65.8 0.06 Allowed 'General case' 0 CA--C 1.571 1.784 0 C-N-CA 125.435 1.494 . . . . 0.0 107.898 -172.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -127.94 96.51 4.51 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -96.23 82.16 3.41 Favored 'General case' 0 CA--C 1.568 1.67 0 O-C-N 121.721 -0.612 . . . . 0.0 110.803 -176.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -108.35 146.23 33.3 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -170.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -131.77 127.83 37.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.275 -0.891 . . . . 0.0 113.151 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.4 mt -112.77 110.59 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.3 p -92.09 120.27 32.55 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.546 0.739 . . . . 0.0 112.393 170.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -143.96 147.4 33.88 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -174.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -87.52 1.78 52.56 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 118.59 2.811 . . . . 0.0 118.59 -172.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.4 mt 69.75 120.01 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 125.455 1.502 . . . . 0.0 112.775 -172.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.39 -32.08 4.27 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 118.142 2.017 . . . . 0.0 118.142 -171.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -73.97 136.42 43.22 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 119.309 1.555 . . . . 0.0 113.021 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -88.88 120.76 30.58 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.198 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -130.75 150.64 51.83 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.801 0.84 . . . . 0.0 111.65 -172.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -79.55 133.5 36.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.932 -1.105 . . . . 0.0 111.615 171.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -142.44 126.03 16.86 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.0 0.428 . . . . 0.0 111.992 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.2 m -73.36 132.4 42.99 Favored 'General case' 0 CA--C 1.57 1.731 0 CA-C-O 121.43 0.633 . . . . 0.0 110.478 162.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.9 p -108.82 166.47 10.78 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -169.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.15 -11.5 6.29 Favored 'General case' 0 CA--C 1.579 2.082 0 N-CA-C 119.452 3.13 . . . . 0.0 119.452 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -73.62 -25.33 60.26 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 159.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.305 4.8 m-20 82.1 65.87 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 120.738 1.608 . . . . 0.0 111.235 -162.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.9 ptt85 -162.87 142.2 8.89 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.162 0.985 . . . . 0.0 109.43 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -83.02 134.62 35.03 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 169.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.9 p -129.89 148.63 51.77 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 172.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -79.15 101.63 8.03 Favored 'General case' 0 CA--C 1.563 1.447 0 CA-C-O 122.145 0.974 . . . . 0.0 109.814 162.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.0 m -97.59 124.77 41.99 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.919 0.888 . . . . 0.0 111.96 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.01 124.59 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -115.43 116.38 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.446 -0.784 . . . . 0.0 109.574 -174.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.7 m -115.65 132.41 56.64 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.464 0.706 . . . . 0.0 112.554 -176.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.8 tt -89.11 102.1 14.76 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 123.286 0.634 . . . . 0.0 109.974 171.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -96.1 80.71 3.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.135 -0.978 . . . . 0.0 110.943 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.56 -86.03 1.15 Allowed Glycine 0 N--CA 1.494 2.523 0 O-C-N 121.184 -0.948 . . . . 0.0 114.042 -176.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -136.86 65.14 1.52 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.878 0.847 . . . . 0.0 110.179 154.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -145.81 106.8 4.14 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.6 100.67 13.27 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 121.432 -0.793 . . . . 0.0 110.695 -173.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.1 t -104.03 104.34 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -170.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -90.27 121.68 32.51 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.398 0.679 . . . . 0.0 109.792 173.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.5 mt -113.9 110.23 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -92.83 129.73 38.66 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 122.918 0.487 . . . . 0.0 111.536 171.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -122.07 123.41 41.52 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.553 0.741 . . . . 0.0 110.007 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 17.3 p90 -150.46 123.89 9.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.218 -0.926 . . . . 0.0 110.27 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 53.5 38.21 27.53 Favored 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 117.258 2.318 . . . . 0.0 117.258 174.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.46 -25.39 3.85 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 119.148 2.419 . . . . 0.0 119.148 -165.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -81.77 142.46 32.59 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 119.134 1.467 . . . . 0.0 112.307 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -139.21 123.48 18.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.872 -0.517 . . . . 0.0 111.86 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.3 t -112.66 144.15 42.65 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 123.383 0.673 . . . . 0.0 110.623 167.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -121.34 142.16 50.24 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 172.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -122.3 102.92 8.4 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -175.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 68.8 t -99.35 103.13 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -168.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -97.89 117.21 31.71 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.398 0.679 . . . . 0.0 111.406 -175.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -135.24 133.83 39.39 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.114 0.566 . . . . 0.0 111.378 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.2 mm -83.07 121.05 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.145 -0.972 . . . . 0.0 109.245 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.16 -77.02 0.41 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.796 0.438 . . . . 0.0 111.367 -175.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -133.98 82.83 2.0 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 77.06 -33.73 1.49 Allowed Glycine 0 N--CA 1.497 2.74 0 N-CA-C 118.66 2.224 . . . . 0.0 118.66 -166.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -92.05 142.31 27.66 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 118.329 1.065 . . . . 0.0 111.73 -173.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 9.9 tpp -84.24 115.37 22.42 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 121.802 0.811 . . . . 0.0 110.493 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.5 t -91.23 107.56 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.623 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 167.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 18.8 ttt -99.43 108.19 20.6 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.721 -0.612 . . . . 0.0 109.369 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.0 m -95.86 114.5 26.23 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.5 0.667 . . . . 0.0 109.28 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.1 mp -103.57 120.98 41.94 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.263 8.7 t -136.46 138.47 41.49 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 177.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -106.54 77.66 1.21 Allowed 'General case' 0 CA--C 1.565 1.545 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.058 168.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 69.89 -89.45 0.31 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 115.962 1.145 . . . . 0.0 115.962 -175.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -88.56 -35.49 16.89 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 175.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.8 t -87.27 129.71 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 119.677 1.126 . . . . 0.0 109.616 -170.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 44.9 t -123.79 125.89 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 C-N-CA 123.401 0.68 . . . . 0.0 109.512 -169.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.34 151.69 34.16 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.966 0.906 . . . . 0.0 111.943 164.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 92.2 t -124.19 117.07 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 120.778 -1.201 . . . . 0.0 108.915 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.2 mtp180 -96.62 108.75 21.41 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.275 0.63 . . . . 0.0 109.611 170.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -85.46 136.94 33.23 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.287 0.635 . . . . 0.0 111.753 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -134.37 132.45 39.46 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.653 -0.654 . . . . 0.0 111.799 -173.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -100.69 151.26 21.86 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.288 0.635 . . . . 0.0 112.38 169.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -71.34 128.65 36.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.597 -0.689 . . . . 0.0 111.901 170.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.487 0 C-N-CA 123.833 0.853 . . . . 0.0 112.564 177.713 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.293 8.6 p . . . . . 0 CA--C 1.569 1.709 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.72 -40.47 95.4 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 -175.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.38 -30.21 62.43 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 117.754 2.502 . . . . 0.0 117.754 167.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -74.6 -17.93 60.64 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 117.184 2.29 . . . . 0.0 117.184 167.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 22.6 t -89.29 94.61 9.97 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 120.525 1.511 . . . . 0.0 112.667 -169.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.91 171.34 16.77 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-O 122.059 0.933 . . . . 0.0 112.509 -174.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.2 m -82.22 118.42 23.09 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.695 -1.253 . . . . 0.0 108.779 164.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -114.03 114.71 26.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.474 -0.766 . . . . 0.0 110.704 -172.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -98.82 131.89 44.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.455 -0.778 . . . . 0.0 110.933 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.11 117.38 11.6 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.4 p -89.71 -47.67 7.77 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -142.18 119.22 11.32 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 118.945 0.793 . . . . 0.0 109.91 -173.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.7 p -104.67 99.22 8.89 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.207 0.603 . . . . 0.0 111.559 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -81.87 122.92 28.34 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 123.438 0.695 . . . . 0.0 111.236 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.252 1.9 t30 59.07 23.99 12.24 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 117.818 2.525 . . . . 0.0 117.818 174.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -68.38 -45.53 72.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 119.77 -1.831 . . . . 0.0 115.582 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -46.92 -51.98 15.6 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 170.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.69 -43.81 95.55 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 173.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -51.01 -50.18 59.01 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 164.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.8 mtp -61.75 -39.78 92.81 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 174.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -59.75 -50.34 74.21 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 165.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.77 -38.97 83.32 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 116.933 2.197 . . . . 0.0 116.933 172.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.31 -23.99 67.49 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 171.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.66 35.42 8.49 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 118.088 1.995 . . . . 0.0 118.088 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.7 m -93.08 171.07 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 119.406 1.603 . . . . 0.0 112.062 173.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.54 162.33 54.0 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 117.125 1.61 . . . . 0.0 117.125 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -64.28 -46.06 85.34 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 173.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.67 -40.6 63.03 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 167.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.6 m -64.6 -42.79 95.33 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 169.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.9 mtm-85 -57.99 -43.05 86.36 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 164.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -56.46 -54.61 43.72 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.27 1.395 . . . . 0.0 113.941 167.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.0 t -50.6 -60.64 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 169.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.11 -20.98 58.76 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 120.181 2.832 . . . . 0.0 120.181 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -85.72 -41.12 15.41 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 165.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.254 17.6 m -75.04 -37.3 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 CA-C-N 121.421 1.918 . . . . 0.0 116.008 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 t -97.33 146.81 24.79 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 120.035 1.288 . . . . 0.0 112.682 -174.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 105.33 18.55 Favored Pre-proline 0 CA--C 1.578 2.037 0 O-C-N 121.379 -0.825 . . . . 0.0 111.362 174.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.1 141.68 29.85 Favored 'Trans proline' 0 CA--C 1.564 1.989 0 C-N-CA 122.566 2.177 . . . . 0.0 114.898 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.6 m -108.5 112.66 25.16 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.154 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.9 t -106.35 102.2 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -172.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.3 mt -85.4 103.54 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.1 mt -91.54 105.26 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 175.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.4 p -124.45 165.54 17.59 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 123.849 0.86 . . . . 0.0 112.035 -171.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -126.81 126.19 42.97 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.95 -1.094 . . . . 0.0 110.851 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -114.31 81.51 1.55 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.631 0.729 . . . . 0.0 110.024 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.9 -95.96 0.84 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -89.85 -27.52 19.87 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -102.84 149.38 24.55 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-N 119.826 1.193 . . . . 0.0 113.312 -174.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.5 t -86.64 125.37 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.772 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 165.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.0 106.17 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.2 mt -92.59 120.67 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -103.19 100.97 10.9 Favored 'General case' 0 CA--C 1.561 1.39 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 169.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 50.8 m -87.32 99.14 11.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.639 -0.663 . . . . 0.0 109.384 172.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.7 mp -97.29 97.29 9.02 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.6 t -89.26 34.09 0.8 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 174.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.347 73.0 p 67.78 -58.45 0.44 Allowed 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 -174.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -91.66 -61.27 1.67 Allowed 'General case' 0 CA--C 1.569 1.679 0 C-N-CA 124.923 1.289 . . . . 0.0 110.48 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -87.53 104.9 16.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.514 -0.741 . . . . 0.0 110.542 173.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -108.22 106.91 17.31 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.545 0.688 . . . . 0.0 109.34 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.4 p -119.66 135.52 54.78 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 123.433 0.693 . . . . 0.0 111.458 -157.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -127.02 133.68 50.48 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.096 -1.003 . . . . 0.0 113.501 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.4 pt -133.77 120.37 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 C-N-CA 123.484 0.713 . . . . 0.0 110.851 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 90.1 p -106.77 125.51 51.09 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 124.254 1.022 . . . . 0.0 111.858 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -156.54 148.62 23.09 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.297 -0.877 . . . . 0.0 112.795 -168.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -98.61 21.71 10.91 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 117.623 2.453 . . . . 0.0 117.623 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.7 mt 67.62 112.73 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 125.138 1.375 . . . . 0.0 114.027 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.19 -26.04 4.04 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 117.998 1.959 . . . . 0.0 117.998 -162.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -75.91 126.94 31.95 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 124.711 1.204 . . . . 0.0 111.941 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -72.87 141.64 47.93 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -141.76 143.61 33.57 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.934 0.894 . . . . 0.0 110.306 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.85 134.81 35.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.536 -1.352 . . . . 0.0 111.516 172.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -133.13 105.56 7.1 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.058 0.543 . . . . 0.0 110.554 -172.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.7 m -76.31 104.72 6.97 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.423 -0.798 . . . . 0.0 108.958 167.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.0 p -78.82 -178.1 5.82 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -165.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.2 -12.63 3.76 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 118.968 2.951 . . . . 0.0 118.968 168.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -120.19 43.33 2.73 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 119.572 -1.955 . . . . 0.0 113.421 155.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.285 10.5 t70 65.91 -1.22 1.15 Allowed 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 119.374 3.101 . . . . 0.0 119.374 168.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.3 ptt85 -76.46 123.21 25.67 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.37 -1.456 . . . . 0.0 110.978 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -80.12 106.06 11.85 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.888 0.875 . . . . 0.0 112.819 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.0 m -110.03 117.92 35.03 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -167.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -67.6 103.05 1.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.812 0.845 . . . . 0.0 110.338 169.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.6 m -115.92 122.48 45.44 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 121.843 -0.535 . . . . 0.0 111.68 -158.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 99.3 t -115.25 116.0 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.4 t -96.42 108.75 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 173.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.4 p -112.01 117.16 31.92 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.536 0.735 . . . . 0.0 111.599 -173.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tt -84.1 96.49 8.93 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.086 -1.009 . . . . 0.0 110.135 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -91.27 73.76 6.19 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 121.433 -0.792 . . . . 0.0 111.62 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.34 -86.88 1.49 Allowed Glycine 0 N--CA 1.49 2.274 0 O-C-N 121.828 -0.545 . . . . 0.0 113.441 -175.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -132.24 50.62 2.22 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 168.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -153.6 121.12 5.89 Favored 'General case' 0 CA--C 1.564 1.509 0 O-C-N 120.61 -1.306 . . . . 0.0 110.511 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.8 mt -83.56 106.91 15.67 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.758 0.823 . . . . 0.0 111.116 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.2 t -103.21 100.02 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -173.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -86.34 104.46 15.87 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.745 0.818 . . . . 0.0 110.895 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.4 mt -99.31 100.47 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -172.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -87.4 125.67 34.41 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 118.835 0.743 . . . . 0.0 111.53 174.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -116.54 117.88 31.11 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 123.839 0.856 . . . . 0.0 110.387 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.3 p90 -148.42 129.78 14.74 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.866 -1.146 . . . . 0.0 110.716 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 53.69 42.13 31.91 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 166.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.03 17.03 71.33 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 119.893 2.717 . . . . 0.0 119.893 -166.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -132.66 143.13 49.44 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 119.243 1.521 . . . . 0.0 110.042 -170.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -138.55 131.45 29.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.525 -0.734 . . . . 0.0 112.245 -174.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 t -128.07 129.98 47.49 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.563 0.745 . . . . 0.0 109.309 169.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.24 128.78 54.74 Favored 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 123.122 0.569 . . . . 0.0 111.111 174.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -106.58 106.95 17.72 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.1 t -88.78 109.45 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -105.69 102.23 11.69 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.989 0.916 . . . . 0.0 110.374 -174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.49 141.82 51.75 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.788 0.835 . . . . 0.0 112.532 -168.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.8 mm -80.77 117.93 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 120.82 -1.175 . . . . 0.0 109.619 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.45 89.87 3.17 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 171.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.5 t70 50.15 66.12 1.24 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.6 -48.5 3.33 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 117.435 1.734 . . . . 0.0 117.435 -171.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -83.36 142.87 30.72 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 118.904 1.352 . . . . 0.0 112.818 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.0 ttt -90.65 111.46 22.81 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.843 0.83 . . . . 0.0 110.303 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 69.4 t -93.93 108.6 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.56 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 23.9 ttt -89.65 112.52 23.79 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.704 0.802 . . . . 0.0 109.78 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.2 m -100.44 111.24 23.48 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mp -104.79 112.64 25.82 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.428 1.091 . . . . 0.0 108.139 -172.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.267 13.2 t -131.47 142.0 49.9 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -122.75 81.42 1.86 Allowed 'General case' 0 CA--C 1.564 1.507 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.76 173.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 71.18 -92.98 0.5 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 115.579 0.992 . . . . 0.0 115.579 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -86.89 -37.01 18.09 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.3 t -82.01 134.28 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-N 119.343 0.974 . . . . 0.0 110.157 -171.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.5 t -129.4 121.22 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -175.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.14 154.45 23.29 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 123.548 0.739 . . . . 0.0 112.44 164.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.3 t -132.41 113.47 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.146 -0.971 . . . . 0.0 109.25 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -106.12 124.33 49.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.176 -0.953 . . . . 0.0 110.856 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -108.62 115.68 30.55 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 123.252 0.621 . . . . 0.0 110.602 -165.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -114.69 133.21 56.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.794 -1.191 . . . . 0.0 113.22 -166.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -98.94 153.81 18.54 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 123.338 0.655 . . . . 0.0 112.626 166.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -74.27 135.29 42.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.176 0 CA-C-O 117.923 -1.037 . . . . 0.0 112.225 170.598 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 2' ' ' GLU 0.302 4.1 p . . . . . 0 CA--C 1.575 1.926 0 CA-C-O 121.734 0.778 . . . . 0.0 112.102 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.415 ' H ' HG22 ' A' ' 1' ' ' VAL 0.358 9.0 tt0 77.07 -57.95 0.51 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 172.128 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.28 -29.35 68.76 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 153.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -82.12 -6.28 59.06 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 169.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.6 t -74.86 91.34 2.44 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-N 122.194 2.27 . . . . 0.0 113.644 -172.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -168.29 169.2 10.96 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-O 122.243 1.02 . . . . 0.0 112.27 -170.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.6 m -86.71 123.09 31.49 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.238 -0.914 . . . . 0.0 108.907 167.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -118.37 118.69 32.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.427 -0.796 . . . . 0.0 111.026 -171.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -104.15 136.98 42.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.04 -1.037 . . . . 0.0 111.113 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.25 121.04 14.8 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.1 p -108.93 -26.07 10.41 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -150.61 113.82 4.85 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 121.037 1.744 . . . . 0.0 109.484 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.7 p -94.47 89.38 5.82 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 122.454 1.121 . . . . 0.0 111.936 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -88.76 110.22 20.82 Favored 'General case' 0 CA--C 1.563 1.45 0 O-C-N 121.079 -1.013 . . . . 0.0 110.93 -170.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.262 56.4 t30 62.88 35.37 13.57 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 -174.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -83.17 66.08 8.55 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 123.747 1.737 . . . . 0.0 111.845 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -165.07 -68.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.99 -1.459 . . . . 0.0 107.728 -156.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -65.61 -42.32 91.73 Favored 'General case' 0 CA--C 1.565 1.525 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 172.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -46.41 -52.41 13.04 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 163.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.8 mmt -60.22 -49.98 75.48 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 175.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.5 -46.43 76.95 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 168.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.41 -35.88 76.19 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 117.581 2.437 . . . . 0.0 117.581 175.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 tt -62.81 -39.19 93.51 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 171.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.63 55.68 1.31 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 114.808 0.683 . . . . 0.0 114.808 -169.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.9 m -90.42 163.24 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-O 122.329 1.061 . . . . 0.0 112.055 173.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.88 142.04 31.37 Favored Glycine 0 CA--C 1.55 2.249 0 O-C-N 121.007 -1.058 . . . . 0.0 113.444 160.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -59.37 -41.16 88.66 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.96 -41.15 64.26 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 165.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.0 m -58.39 -50.36 73.96 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 120.201 1.364 . . . . 0.0 114.231 170.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.269 5.7 ptt180 -62.44 -36.25 81.82 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 172.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -63.16 -50.9 68.56 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 166.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.4 t -46.57 -48.96 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.81 -30.22 66.29 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 119.404 2.521 . . . . 0.0 119.404 170.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -76.68 -46.42 25.69 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 119.8 1.8 . . . . 0.0 115.238 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.259 28.3 m -89.16 47.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 CA-C-N 121.254 1.843 . . . . 0.0 113.715 175.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.6 t -145.18 161.72 38.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.116 -0.99 . . . . 0.0 111.922 172.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -102.27 91.32 2.51 Favored Pre-proline 0 CA--C 1.574 1.868 0 O-C-N 121.38 -0.825 . . . . 0.0 109.545 162.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.44 123.68 7.23 Favored 'Trans proline' 0 C--N 1.373 1.825 0 CA-C-N 122.684 1.994 . . . . 0.0 112.827 -174.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.0 m -101.01 102.74 13.8 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -173.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.6 t -95.85 102.96 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -171.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.0 mt -90.7 110.79 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.0 mt -94.29 122.64 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 170.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.7 p -134.83 143.8 47.24 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.178 0.591 . . . . 0.0 112.298 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -99.35 113.29 25.53 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.019 -1.051 . . . . 0.0 109.157 168.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -113.33 90.55 3.37 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.468 -0.77 . . . . 0.0 110.316 -174.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.84 -77.39 1.79 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 115.317 0.887 . . . . 0.0 115.317 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -117.96 -54.94 2.3 Favored 'General case' 0 CA--C 1.567 1.614 0 C-N-CA 123.712 0.805 . . . . 0.0 111.819 171.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -79.2 157.9 27.76 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -173.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.9 t -89.81 124.7 42.62 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.601 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.0 t -114.42 105.7 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 76.9 mt -97.05 120.64 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -106.37 101.69 11.14 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.62 0.724 . . . . 0.0 109.837 171.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.3 m -84.33 98.54 10.07 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 170.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 63.9 mt -94.24 93.52 7.8 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -174.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.8 t -79.57 18.04 0.8 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 118.313 2.708 . . . . 0.0 118.313 -174.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.441 7.4 p 63.61 -60.72 0.17 Allowed 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 125.26 1.424 . . . . 0.0 114.739 -163.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -66.03 -46.17 78.83 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 173.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.69 119.78 7.73 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 119.125 0.875 . . . . 0.0 110.216 -165.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -104.52 112.52 25.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.318 -0.864 . . . . 0.0 111.901 -166.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 p -105.82 110.67 23.04 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.714 -0.616 . . . . 0.0 110.808 -170.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -109.35 107.66 17.93 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.21 1.004 . . . . 0.0 110.64 -175.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.5 pt -109.55 121.15 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 C-N-CA 123.491 0.716 . . . . 0.0 110.496 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 97.2 p -110.72 111.44 22.63 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.228 1.011 . . . . 0.0 110.882 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -148.37 151.4 35.24 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.062 0.934 . . . . 0.0 112.89 -165.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -86.3 148.7 25.5 Favored 'General case' 0 CA--C 1.571 1.765 0 O-C-N 121.211 -0.931 . . . . 0.0 111.06 162.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 73.3 mt -71.05 124.67 24.93 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.237 -1.539 . . . . 0.0 111.922 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.35 -3.45 86.57 Favored Glycine 0 CA--C 1.556 2.628 0 N-CA-C 119.081 2.392 . . . . 0.0 119.081 -162.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -86.95 124.57 33.3 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 120.066 1.933 . . . . 0.0 110.761 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -87.25 107.85 18.68 Favored 'General case' 0 CA--C 1.565 1.535 0 O-C-N 121.877 -0.515 . . . . 0.0 110.91 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -112.88 159.88 18.6 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.379 1.072 . . . . 0.0 111.825 -175.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -83.3 137.67 33.88 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.423 -1.423 . . . . 0.0 111.952 171.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -129.96 111.71 12.8 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.287 0.635 . . . . 0.0 109.798 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.8 m -74.89 96.59 3.15 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 122.023 0.916 . . . . 0.0 109.709 170.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 80.5 p -74.08 173.99 9.28 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -167.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.18 -5.43 1.08 Allowed 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 119.442 3.126 . . . . 0.0 119.442 167.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -95.17 -8.28 36.77 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 159.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.318 3.2 m-20 80.5 12.22 0.94 Allowed 'General case' 0 N--CA 1.507 2.417 0 CA-C-N 121.513 1.96 . . . . 0.0 116.18 -166.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -91.78 130.48 37.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.444 -1.41 . . . . 0.0 110.176 173.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -82.32 110.99 17.97 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.15 0.5 . . . . 0.0 110.973 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 93.4 m -103.71 118.95 37.91 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -173.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -69.81 104.95 2.6 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.906 0.86 . . . . 0.0 110.56 171.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.3 m -120.22 117.61 28.32 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.894 -156.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.2 p -109.01 118.45 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.225 0.536 . . . . 0.0 109.757 175.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.6 t -96.81 110.5 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 173.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 79.6 p -110.44 131.19 55.27 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.706 0.802 . . . . 0.0 110.906 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -83.15 120.39 25.73 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.957 -1.089 . . . . 0.0 109.787 161.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -122.91 72.55 1.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.108 -169.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.61 60.81 8.23 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 117.071 1.588 . . . . 0.0 117.071 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.347 5.5 m-20 92.08 -31.74 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 -167.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.465 ' NZ ' ' HE2' ' A' ' 107' ' ' GLU . 76.2 mttt -97.28 124.17 41.31 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 120.897 1.68 . . . . 0.0 112.322 -170.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.8 mt -81.03 103.75 11.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.162 -0.961 . . . . 0.0 110.745 170.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.0 t -104.72 106.04 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.715 -1.241 . . . . 0.0 107.733 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -93.87 105.79 17.79 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.029 0.932 . . . . 0.0 110.148 177.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.33 104.46 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 123.354 0.661 . . . . 0.0 109.383 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -85.15 125.61 32.95 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 118.887 0.767 . . . . 0.0 111.626 171.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -116.08 126.42 53.73 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.317 0.647 . . . . 0.0 110.575 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 15.6 p90 -150.18 124.49 9.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.351 -0.843 . . . . 0.0 110.492 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 55.99 33.72 22.33 Favored 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 117.087 2.254 . . . . 0.0 117.087 173.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.8 -18.23 21.84 Favored Glycine 0 CA--C 1.559 2.805 0 N-CA-C 119.325 2.49 . . . . 0.0 119.325 -164.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -89.17 145.46 25.41 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-N 119.489 1.644 . . . . 0.0 112.836 -175.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -130.25 129.29 43.12 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.747 0.819 . . . . 0.0 110.709 -174.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.2 t -123.9 129.01 50.29 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.643 -0.66 . . . . 0.0 109.327 159.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.95 127.01 56.1 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.412 0.685 . . . . 0.0 110.709 175.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -106.43 102.39 11.79 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -175.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.4 t -88.19 102.8 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -173.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -108.35 110.47 22.04 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.076 0.95 . . . . 0.0 109.015 -169.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.465 ' HE2' ' NZ ' ' A' ' 90' ' ' LYS . 12.8 pt-20 -129.73 137.68 50.7 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -170.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.1 mm -77.0 99.38 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 171.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -109.99 111.09 22.27 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.8 t70 47.12 52.83 11.45 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -171.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.02 -23.99 4.18 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 119.599 2.6 . . . . 0.0 119.599 -170.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -94.06 136.24 34.56 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 119.522 1.661 . . . . 0.0 111.454 -172.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 50.1 ttp -81.01 102.72 10.36 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.253 1.025 . . . . 0.0 110.167 172.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 87.5 t -89.52 101.76 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 46.6 ttm -87.37 101.02 13.16 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.536 0.735 . . . . 0.0 109.476 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 93.1 m -91.56 101.42 14.06 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.888 0.851 . . . . 0.0 108.737 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 mp -88.83 117.87 28.13 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.307 6.5 t -137.94 133.66 34.01 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 175.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -99.01 89.9 4.44 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.342 171.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 71.86 -86.75 0.46 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 114.952 0.741 . . . . 0.0 114.952 -172.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -127.75 3.67 6.07 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 174.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.4 125.11 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-N 121.82 2.1 . . . . 0.0 107.994 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.1 t -120.6 130.56 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.816 -0.553 . . . . 0.0 111.139 -162.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.28 148.59 35.31 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 123.484 0.714 . . . . 0.0 111.588 156.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.3 t -125.64 107.5 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 120.743 -1.223 . . . . 0.0 108.807 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -95.62 120.26 35.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.213 -0.929 . . . . 0.0 111.139 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -97.73 97.91 9.41 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.367 0.603 . . . . 0.0 110.131 -172.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -94.53 135.62 35.77 Favored 'General case' 0 CA--C 1.561 1.403 0 O-C-N 121.353 -0.842 . . . . 0.0 112.024 -174.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -122.66 154.87 37.46 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.481 0.712 . . . . 0.0 111.454 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -72.02 136.86 46.85 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -172.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.194 0 C-N-CA 124.183 0.993 . . . . 0.0 111.363 170.321 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.276 4.1 p . . . . . 0 CA--C 1.577 1.99 0 N-CA-C 116.617 2.081 . . . . 0.0 116.617 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -59.53 -39.68 84.72 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 116.358 1.984 . . . . 0.0 116.358 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.11 -29.38 30.5 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 118.201 2.667 . . . . 0.0 118.201 164.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -82.49 -9.78 59.28 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 169.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.6 t -73.59 102.62 3.93 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-N 122.054 2.206 . . . . 0.0 114.004 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -172.17 163.59 5.9 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 122.211 1.005 . . . . 0.0 111.788 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.2 m -78.84 122.64 26.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.015 -1.053 . . . . 0.0 108.375 153.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -106.14 115.79 30.82 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.085 -1.01 . . . . 0.0 110.218 -175.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -92.5 129.8 38.34 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.646 0.778 . . . . 0.0 111.272 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 tt -73.05 113.21 9.84 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-O 121.353 0.597 . . . . 0.0 112.526 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.0 p -85.25 -45.84 11.6 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -148.51 117.33 6.69 Favored 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 123.785 0.834 . . . . 0.0 109.734 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.7 p -99.91 98.54 9.3 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.126 0.57 . . . . 0.0 111.535 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -80.05 122.1 26.34 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 123.437 0.695 . . . . 0.0 111.261 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 t30 55.32 38.19 29.98 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 118.15 2.648 . . . . 0.0 118.15 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -78.97 -35.94 42.27 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -176.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -50.18 -59.56 3.81 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 172.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -59.06 -37.66 77.57 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 171.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -57.66 -48.39 79.63 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 115.448 1.648 . . . . 0.0 115.448 168.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -57.85 -49.4 76.8 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 167.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -44.26 65.32 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 168.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.61 -41.33 98.32 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 170.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.37 -13.0 24.55 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 118.406 2.743 . . . . 0.0 118.406 170.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.75 55.61 1.75 Allowed Glycine 0 N--CA 1.485 1.931 0 CA-C-N 119.329 0.968 . . . . 0.0 115.342 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.3 m -95.44 146.43 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 117.565 0.682 . . . . 0.0 112.221 175.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.23 144.95 35.38 Favored Glycine 0 CA--C 1.551 2.298 0 N-CA-C 115.277 0.871 . . . . 0.0 115.277 169.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -78.92 60.75 2.95 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 123.311 1.529 . . . . 0.0 114.237 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -165.57 -55.24 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 126.418 1.887 . . . . 0.0 108.63 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.1 m -40.46 -40.0 1.12 Allowed 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 160.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.329 0.0 OUTLIER -94.01 -2.38 53.11 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 119.436 3.124 . . . . 0.0 119.436 172.767 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -65.37 -46.5 79.9 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 120.815 1.643 . . . . 0.0 112.599 151.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.7 t -52.29 -55.01 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 160.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.97 -40.64 91.3 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 120.548 2.979 . . . . 0.0 120.548 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -72.06 -33.45 67.97 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 175.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.3 m -69.81 -35.45 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.6 t -86.96 137.44 32.36 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -91.22 117.57 67.94 Favored Pre-proline 0 CA--C 1.576 1.963 0 CA-C-O 117.851 -1.071 . . . . 0.0 111.0 166.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -76.06 127.31 9.88 Favored 'Trans proline' 0 CA--C 1.562 1.907 0 CA-C-N 123.404 2.251 . . . . 0.0 115.356 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.9 m -99.28 123.24 43.41 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.079 0.952 . . . . 0.0 109.015 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.9 t -105.82 106.51 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.55 -0.718 . . . . 0.0 109.537 -168.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.8 mt -90.79 106.66 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 120.141 -1.599 . . . . 0.0 108.273 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 81.6 mt -90.38 111.55 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.2 p -135.67 119.76 17.63 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -169.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -90.9 116.72 28.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.324 -0.86 . . . . 0.0 111.842 -171.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -114.55 79.97 1.34 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.477 0.656 . . . . 0.0 110.543 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.2 -97.35 0.66 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 115.509 0.964 . . . . 0.0 115.509 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.36 -41.55 69.6 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 170.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -113.08 153.36 28.31 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-O 122.164 0.983 . . . . 0.0 113.41 -160.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.2 t -89.23 115.67 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.651 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 167.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.22 100.86 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 175.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 58.9 mt -94.28 114.25 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -98.91 102.97 14.88 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 122.979 0.512 . . . . 0.0 110.054 174.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.8 m -87.89 101.48 13.77 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.534 0.683 . . . . 0.0 109.187 173.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.6 mt -96.74 96.88 8.89 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.385 0.674 . . . . 0.0 109.396 -175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -83.73 22.38 1.12 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 175.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.418 20.5 p 63.23 -62.1 0.14 Allowed 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 125.59 1.556 . . . . 0.0 114.755 -167.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -76.76 -37.79 55.27 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 173.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -120.5 124.81 46.3 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 119.49 1.041 . . . . 0.0 110.945 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -93.83 104.33 16.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.034 -1.041 . . . . 0.0 109.207 164.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.255 13.6 t -107.57 87.07 2.42 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.013 0.911 . . . . 0.0 109.617 174.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -106.2 142.63 35.57 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -172.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.9 pt -133.83 123.01 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 C-N-CA 123.044 0.537 . . . . 0.0 111.711 -168.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.9 p -109.99 107.63 17.58 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.812 0.845 . . . . 0.0 110.742 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -140.91 150.47 43.21 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.597 0.713 . . . . 0.0 112.543 -169.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -95.8 98.23 10.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.159 -0.963 . . . . 0.0 109.819 170.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.7 mt -6.07 109.12 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 120.513 3.523 . . . . 0.0 120.513 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.92 -18.83 45.41 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 118.97 2.348 . . . . 0.0 118.97 -167.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.36 127.76 33.87 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 119.716 1.758 . . . . 0.0 111.834 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -79.03 127.77 32.42 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -137.67 150.43 47.35 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.698 0.761 . . . . 0.0 111.42 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -75.85 132.98 40.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.899 -1.126 . . . . 0.0 112.101 170.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -133.09 111.05 10.63 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.238 0.615 . . . . 0.0 110.149 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 95.0 m -82.19 109.66 16.68 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 165.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 51.2 p -82.96 -177.64 6.84 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -165.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.02 -16.6 32.36 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 118.773 2.879 . . . . 0.0 118.773 168.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -79.55 -14.93 58.51 Favored 'General case' 0 CA--C 1.579 2.068 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 157.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.331 5.0 t70 75.88 14.83 2.6 Favored 'General case' 0 CA--C 1.58 2.129 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -160.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.0 ptt-85 -83.34 124.1 30.29 Favored 'General case' 0 CA--C 1.565 1.553 0 O-C-N 120.084 -1.635 . . . . 0.0 109.737 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -85.7 118.07 24.97 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.149 0.58 . . . . 0.0 112.417 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.9 p -122.33 145.64 48.06 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -76.81 105.05 7.64 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.807 0.813 . . . . 0.0 109.709 160.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.7 m -99.53 124.92 45.15 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.536 0.735 . . . . 0.0 112.324 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.31 118.01 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 36.1 t -119.71 95.25 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.36 -0.838 . . . . 0.0 109.073 -171.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.7 m -113.64 130.32 56.42 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.648 0.779 . . . . 0.0 111.612 -169.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 tt -85.29 109.07 18.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.12 -0.988 . . . . 0.0 110.456 170.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -90.57 -16.51 28.63 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 -176.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 176.86 -88.05 0.08 OUTLIER Glycine 0 N--CA 1.49 2.235 0 CA-C-N 120.075 1.307 . . . . 0.0 110.954 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -101.92 32.12 3.58 Favored 'General case' 0 CA--C 1.579 2.071 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 158.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -146.23 114.18 6.52 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.874 0.761 . . . . 0.0 109.951 -159.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 mt -90.2 102.27 14.99 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 123.72 0.808 . . . . 0.0 109.625 172.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.6 t -100.12 105.45 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.149 -0.969 . . . . 0.0 108.603 -170.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -95.04 101.07 12.8 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.427 0.691 . . . . 0.0 110.369 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 59.4 mt -89.47 122.79 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 C-N-CA 123.959 0.903 . . . . 0.0 108.76 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -111.37 123.42 50.18 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 119.477 1.035 . . . . 0.0 110.732 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -113.34 117.84 32.93 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.959 0.904 . . . . 0.0 109.771 -176.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -150.65 127.05 10.71 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.648 -1.282 . . . . 0.0 111.496 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 56.63 32.27 20.69 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 174.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.68 -27.15 4.9 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 118.432 2.133 . . . . 0.0 118.432 -162.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -80.99 140.71 35.03 Favored 'General case' 0 CA--C 1.562 1.426 0 CA-C-N 119.121 1.461 . . . . 0.0 112.158 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -131.26 126.71 36.14 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.235 0.614 . . . . 0.0 110.128 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.7 t -122.3 156.26 34.23 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.413 0.685 . . . . 0.0 110.743 171.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.283 9.7 p30 -135.47 146.24 47.98 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 170.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -120.16 106.14 11.66 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.7 t -90.82 98.38 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -92.23 97.7 11.06 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -176.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -117.08 130.54 56.72 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -168.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.1 mm -74.94 111.04 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.12 -91.05 0.18 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 119.399 -0.334 . . . . 0.0 110.14 -173.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -104.7 70.43 0.93 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 119.342 0.974 . . . . 0.0 108.851 164.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.64 -39.95 2.85 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 118.128 2.011 . . . . 0.0 118.128 -169.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -84.34 144.9 28.54 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.256 1.028 . . . . 0.0 113.262 -173.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 55.8 ttp -84.05 100.32 11.02 Favored 'General case' 0 CA--C 1.561 1.394 0 CA-C-O 122.291 1.043 . . . . 0.0 110.204 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.1 t -85.38 102.76 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 43.1 ttm -86.89 101.36 13.31 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.213 0.605 . . . . 0.0 109.676 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.7 m -90.87 110.1 21.32 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 174.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.5 mp -99.37 119.75 38.46 Favored 'General case' 0 CA--C 1.56 1.339 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -176.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.0 t -125.56 124.2 40.75 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 119.406 1.003 . . . . 0.0 112.646 -171.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -137.19 97.14 3.42 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 123.816 0.846 . . . . 0.0 110.51 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 77.32 -94.2 1.13 Allowed Glycine 0 N--CA 1.492 2.374 0 O-C-N 121.433 -0.792 . . . . 0.0 114.084 170.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -128.39 42.84 3.25 Favored 'General case' 0 CA--C 1.578 2.033 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 160.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 81.4 t -136.88 118.94 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 -177.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.84 131.09 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.05 157.07 21.19 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 123.088 0.555 . . . . 0.0 112.481 163.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.3 t -132.58 109.21 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.032 -1.043 . . . . 0.0 108.99 175.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -100.24 114.41 27.84 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.804 0.811 . . . . 0.0 110.748 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -95.83 106.01 18.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.66 -0.65 . . . . 0.0 110.145 -170.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -105.58 128.19 53.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.889 -1.132 . . . . 0.0 113.391 -168.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -99.41 156.52 16.97 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 124.062 0.945 . . . . 0.0 113.352 173.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -77.72 130.05 36.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.152 -0.967 . . . . 0.0 113.285 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.166 0 C-N-CA 124.493 1.117 . . . . 0.0 110.859 162.693 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.295 8.8 p . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -61.48 -46.9 88.06 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.12 -23.78 62.43 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 166.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -78.71 -18.07 54.89 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 167.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 71.9 m -73.94 92.16 2.08 Favored 'General case' 0 CA--C 1.568 1.671 0 CA-C-N 122.284 2.311 . . . . 0.0 113.855 -173.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.66 166.6 13.83 Favored 'General case' 0 CA--C 1.571 1.754 0 CA-C-O 122.423 1.106 . . . . 0.0 112.328 -170.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.3 m -84.86 111.87 20.03 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.342 -0.849 . . . . 0.0 109.18 166.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -105.87 118.68 37.22 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.912 0.485 . . . . 0.0 110.603 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -103.32 137.83 40.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.14 -0.975 . . . . 0.0 111.628 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -72.78 129.94 39.34 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.0 p -102.18 -37.5 8.1 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -158.15 117.57 3.21 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 119.602 1.092 . . . . 0.0 109.33 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.1 p -97.02 89.4 4.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.726 -0.609 . . . . 0.0 111.562 171.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.99 124.32 29.67 Favored 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 123.763 0.825 . . . . 0.0 111.283 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.307 11.3 t-20 61.89 10.29 3.45 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 118.316 2.71 . . . . 0.0 118.316 -174.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -62.2 -33.61 74.88 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 116.635 2.087 . . . . 0.0 116.635 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -51.99 -52.67 49.03 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 166.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -63.81 -42.98 97.56 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 172.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -52.49 -52.31 55.09 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 166.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 78.9 mtm -58.98 -48.79 80.3 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 173.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -54.24 -48.3 71.28 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 169.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.3 -38.21 82.93 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 tp -72.3 -1.92 17.17 Favored 'General case' 0 CA--C 1.579 2.061 0 N-CA-C 117.905 2.557 . . . . 0.0 117.905 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.22 48.9 5.2 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 117.101 1.6 . . . . 0.0 117.101 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.1 m -82.42 131.49 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 173.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.64 58.04 4.9 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 116.65 1.42 . . . . 0.0 116.65 173.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.288 25.8 t80 63.35 -58.33 0.17 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.647 2.091 . . . . 0.0 116.647 -175.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.33 -46.97 76.34 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 116.939 2.2 . . . . 0.0 116.939 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.2 m -63.9 -33.47 75.78 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 172.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -60.17 -53.75 53.96 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 162.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.89 -37.25 86.69 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.5 t -53.68 -62.27 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 C-N-CA 123.804 0.841 . . . . 0.0 112.684 156.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.54 -35.45 45.08 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 120.337 2.895 . . . . 0.0 120.337 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -69.47 -47.49 63.76 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 172.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.3 m -78.04 -33.35 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.5 t -83.39 147.14 28.06 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 119.274 0.943 . . . . 0.0 113.203 -172.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -107.21 91.11 6.28 Favored Pre-proline 0 CA--C 1.572 1.811 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -77.68 118.25 4.48 Favored 'Trans proline' 0 C--N 1.372 1.793 0 CA-C-N 122.463 1.915 . . . . 0.0 113.616 -169.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.4 m -88.15 123.15 32.52 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.913 0.863 . . . . 0.0 110.577 -172.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.0 t -100.48 101.64 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -173.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 64.9 mt -92.76 111.31 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.2 mt -101.84 121.36 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.2 t -143.24 -172.73 3.75 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-O 122.509 1.147 . . . . 0.0 111.819 173.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -135.28 118.19 16.26 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.334 1.054 . . . . 0.0 109.472 -176.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -100.49 91.75 4.83 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.65 0.738 . . . . 0.0 110.953 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.55 -74.8 1.48 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 115.904 1.122 . . . . 0.0 115.904 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -121.58 -45.97 2.28 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -88.3 155.94 19.45 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 120.368 1.44 . . . . 0.0 114.148 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.0 t -90.4 133.46 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 C-N-CA 123.47 0.708 . . . . 0.0 109.305 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 93.7 t -114.7 117.42 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.9 mt -95.28 107.88 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.693 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 162.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -78.91 149.75 32.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.65 -1.281 . . . . 0.0 110.161 156.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.6 m -147.63 99.52 3.12 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.282 -1.511 . . . . 0.0 107.93 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.8 mt -117.97 103.28 9.77 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.703 0.763 . . . . 0.0 110.443 -154.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.7 t -82.36 163.15 21.91 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 122.27 1.033 . . . . 0.0 112.655 168.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.8 p -57.36 15.19 0.0 OUTLIER 'General case' 0 CA--C 1.591 2.556 0 N-CA-C 118.003 2.594 . . . . 0.0 118.003 153.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -146.32 -69.09 0.26 Allowed 'General case' 0 CA--C 1.57 1.744 0 C-N-CA 124.977 1.311 . . . . 0.0 107.877 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -100.34 121.71 41.95 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.944 0.898 . . . . 0.0 111.867 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -96.54 82.26 3.33 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.848 0.832 . . . . 0.0 111.043 174.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.5 p -85.41 155.91 21.07 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -168.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -142.67 134.24 26.55 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.2 mt -128.98 102.72 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 -174.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 92.0 p -104.75 123.47 47.7 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 123.923 0.889 . . . . 0.0 111.83 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -148.77 142.37 25.44 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.116 0.96 . . . . 0.0 112.773 -168.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -84.76 11.95 8.17 Favored 'General case' 0 CA--C 1.58 2.1 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.263 65.0 mt 64.85 105.54 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 125.556 1.542 . . . . 0.0 113.35 -168.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.16 35.87 36.9 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 118.352 2.101 . . . . 0.0 118.352 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -135.4 135.49 40.66 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 118.467 1.134 . . . . 0.0 110.089 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -89.45 116.61 27.76 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -171.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -116.42 141.25 48.42 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.889 0.876 . . . . 0.0 111.054 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.61 135.38 43.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.567 -1.333 . . . . 0.0 111.907 170.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -134.11 105.21 6.57 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -171.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.2 m -79.83 100.52 8.04 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 122.106 0.955 . . . . 0.0 109.31 172.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 77.8 p -76.38 174.64 9.98 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -169.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.84 -2.53 0.57 Allowed 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 119.885 3.291 . . . . 0.0 119.885 167.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -103.02 4.1 36.92 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 115.594 1.702 . . . . 0.0 115.594 158.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.29 3.4 t70 62.65 25.9 15.37 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 -166.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.8 ptp85 -89.65 126.01 35.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.642 -1.286 . . . . 0.0 109.117 166.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -85.66 101.49 12.78 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-O 121.811 0.815 . . . . 0.0 111.384 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 99.0 m -102.19 116.79 33.4 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 121.395 0.616 . . . . 0.0 112.654 -169.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -66.19 102.47 0.84 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.24 1.016 . . . . 0.0 110.37 169.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.5 m -114.09 125.24 53.75 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 121.849 -0.532 . . . . 0.0 111.48 -156.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.78 122.15 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.8 t -109.03 121.86 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.224 -0.922 . . . . 0.0 109.337 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 94.7 p -118.0 140.92 49.05 Favored 'General case' 0 CA--C 1.564 1.504 0 C-N-CA 123.956 0.902 . . . . 0.0 111.963 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.8 tp -92.91 98.37 11.33 Favored 'General case' 0 CA--C 1.566 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 110.302 174.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -91.59 73.55 5.92 Favored 'General case' 0 CA--C 1.569 1.691 0 O-C-N 121.364 -0.835 . . . . 0.0 111.795 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.25 62.44 4.42 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 116.398 1.319 . . . . 0.0 116.398 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.256 6.6 t70 54.06 47.19 23.88 Favored 'General case' 0 CA--C 1.579 2.086 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -163.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -143.82 107.02 4.52 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.0 mt -82.08 95.2 7.39 Favored 'General case' 0 CA--C 1.568 1.648 0 CA-C-O 121.835 0.826 . . . . 0.0 111.7 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.7 t -97.03 103.18 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -84.93 125.71 32.9 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.035 0.534 . . . . 0.0 110.089 172.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.6 mt -112.39 118.12 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -101.79 126.29 48.63 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 119.296 0.953 . . . . 0.0 111.343 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -114.8 123.14 48.46 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.962 0.905 . . . . 0.0 110.496 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -149.67 122.71 8.83 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.421 -1.424 . . . . 0.0 110.581 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 54.26 39.9 31.24 Favored 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.1 -25.38 4.23 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 118.936 2.335 . . . . 0.0 118.936 -165.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -83.17 141.11 32.17 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-N 119.354 1.577 . . . . 0.0 112.115 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -134.18 125.89 28.81 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 122.969 0.507 . . . . 0.0 111.166 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.9 t -118.98 154.66 32.69 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.764 0.826 . . . . 0.0 110.612 169.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.31 10.8 p30 -134.77 152.42 51.75 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 171.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -126.87 102.91 7.22 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -169.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.8 t -95.19 94.02 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -168.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -81.9 123.67 29.04 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.95 0.9 . . . . 0.0 110.771 176.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -144.31 123.56 13.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.667 -0.646 . . . . 0.0 109.945 -167.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.3 mm -78.09 103.76 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.429 -0.795 . . . . 0.0 109.132 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -131.05 113.86 14.47 Favored 'General case' 0 CA--C 1.558 1.287 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -170.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.5 t70 47.93 50.53 15.64 Favored 'General case' 0 CA--C 1.579 2.094 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -168.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.75 -43.48 3.17 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 -169.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.2 mtmp? -85.75 150.88 24.27 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 118.463 1.132 . . . . 0.0 113.602 -171.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 59.1 ttp -85.23 98.65 10.61 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 121.83 0.824 . . . . 0.0 109.499 171.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.1 81.81 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 120.954 -1.092 . . . . 0.0 108.73 -171.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 23.2 ttp -76.97 112.94 14.13 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.078 0.551 . . . . 0.0 111.58 -166.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.4 m -98.44 114.02 26.23 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.803 0.811 . . . . 0.0 109.777 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.34 106.54 17.72 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 124.238 1.015 . . . . 0.0 108.788 -173.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.7 t -115.6 118.84 34.23 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.407 0.622 . . . . 0.0 111.754 -175.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -105.37 81.68 1.73 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 165.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 68.68 -89.25 0.22 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 115.439 0.936 . . . . 0.0 115.439 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.556 ' N ' ' HD2' ' A' ' 121' ' ' ASP . 1.4 m-20 -95.94 -25.4 15.98 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 169.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.2 110.86 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-N 121.038 1.745 . . . . 0.0 109.305 -171.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.7 t -113.07 112.42 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 123.514 0.725 . . . . 0.0 109.273 -172.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -102.16 158.86 15.87 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 165.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.3 t -131.27 110.49 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.022 -1.048 . . . . 0.0 109.14 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -95.23 108.69 20.85 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.891 0.853 . . . . 0.0 110.411 172.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -88.46 104.31 16.68 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.586 0.754 . . . . 0.0 110.497 -171.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -101.57 120.29 40.09 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -0.903 . . . . 0.0 112.639 -172.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -87.05 163.51 16.99 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 167.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -74.14 151.0 40.15 Favored 'General case' 0 CA--C 1.571 1.773 0 O-C-N 120.894 -1.129 . . . . 0.0 112.279 162.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.269 166.407 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 N--CA 1.499 1.992 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -62.75 -52.16 64.33 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 -170.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.54 -21.38 52.26 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 118.394 2.739 . . . . 0.0 118.394 169.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -83.1 -17.48 42.94 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 169.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 87.6 m -71.18 93.96 1.12 Allowed 'General case' 0 CA--C 1.566 1.56 0 CA-C-N 121.563 1.983 . . . . 0.0 113.695 -174.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -170.61 162.95 8.13 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-O 122.485 1.136 . . . . 0.0 111.958 -167.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 92.9 m -86.7 113.62 22.7 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.436 169.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -107.26 111.93 24.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.615 -0.678 . . . . 0.0 111.064 -172.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -101.18 132.97 46.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.253 -0.904 . . . . 0.0 111.501 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -72.05 133.29 45.17 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.7 p -105.7 -40.34 5.78 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 175.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -155.96 123.86 5.67 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 119.474 1.034 . . . . 0.0 109.326 -174.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.8 p -104.86 102.55 12.08 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.373 0.669 . . . . 0.0 110.986 172.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -68.46 -56.29 8.92 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 116.543 2.053 . . . . 0.0 116.543 -159.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -126.21 54.28 1.56 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 119.042 0.837 . . . . 0.0 111.671 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -78.39 -53.05 7.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -172.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -50.62 -43.21 56.86 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 117.767 2.506 . . . . 0.0 117.767 172.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.13 -49.12 78.9 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 166.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -50.73 -46.67 59.23 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 164.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.445 ' SD ' HG21 ' A' ' 25' ' ' VAL . 32.9 mmt -57.66 -42.34 83.31 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 170.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -60.29 -47.18 87.1 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 166.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.97 -39.17 93.88 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 172.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.5 tp -69.17 -23.77 63.97 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.6 45.63 6.37 Favored Glycine 0 CA--C 1.548 2.118 0 N-CA-C 117.169 1.628 . . . . 0.0 117.169 -173.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.445 HG21 ' SD ' ' A' ' 20' ' ' MET . 34.6 m -102.05 153.7 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 118.428 1.114 . . . . 0.0 111.709 173.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.08 -167.66 16.51 Favored Glycine 0 N--CA 1.491 2.303 0 O-C-N 120.646 -1.284 . . . . 0.0 115.835 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -84.84 59.73 5.75 Favored 'General case' 0 CA--C 1.576 1.967 0 O-C-N 121.433 -1.039 . . . . 0.0 112.025 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.3 -73.09 0.31 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.723 0.809 . . . . 0.0 109.702 -175.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.1 m -57.74 -34.3 69.37 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 169.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -62.63 -39.19 93.07 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 117.342 2.349 . . . . 0.0 117.342 167.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -67.14 -56.81 8.38 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.034 1.288 . . . . 0.0 112.269 165.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.5 t -56.13 -45.52 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.91 -15.04 79.95 Favored Glycine 0 CA--C 1.552 2.368 0 N-CA-C 118.79 2.276 . . . . 0.0 118.79 175.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -94.09 -52.0 4.59 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.111 1.956 . . . . 0.0 113.991 171.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.256 34.3 m -80.95 -31.14 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.468 0 CA-C-N 121.657 2.026 . . . . 0.0 115.472 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.08 140.69 32.03 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-O 122.082 0.944 . . . . 0.0 110.206 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -98.18 103.25 16.85 Favored Pre-proline 0 CA--C 1.574 1.895 0 CA-C-O 118.075 -0.964 . . . . 0.0 109.791 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.51 146.87 35.43 Favored 'Trans proline' 0 CA--C 1.561 1.841 0 C-N-CA 122.565 2.177 . . . . 0.0 115.391 -176.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 88.7 m -100.68 100.63 11.35 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.362 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.3 t -95.23 101.98 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -173.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.5 mt -91.56 106.29 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 85.2 mt -84.87 120.34 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 170.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.8 p -137.16 133.06 34.83 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.856 0.462 . . . . 0.0 111.647 -172.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -92.7 101.08 13.48 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.992 -1.068 . . . . 0.0 109.35 172.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -104.97 83.13 1.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.837 0.827 . . . . 0.0 109.713 -170.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.76 -106.35 2.52 Favored Glycine 0 N--CA 1.487 2.098 0 CA-C-N 116.006 -0.543 . . . . 0.0 113.985 -175.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -88.74 -28.11 20.74 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -110.1 153.88 24.05 Favored 'General case' 0 CA--C 1.564 1.507 0 CA-C-O 122.804 1.288 . . . . 0.0 113.818 -170.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.46 118.91 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.604 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 170.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.3 t -111.09 107.54 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.4 mt -93.93 112.81 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -100.99 98.14 8.63 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.2 m -86.8 94.59 9.58 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.4 mt -89.02 89.36 7.95 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.651 0.739 . . . . 0.0 109.356 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.3 t -97.2 27.38 4.17 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.342 66.6 p 68.87 -53.22 0.57 Allowed 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -174.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -92.96 -54.97 3.52 Favored 'General case' 0 CA--C 1.571 1.751 0 C-N-CA 124.821 1.248 . . . . 0.0 111.703 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -107.38 108.88 20.45 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.778 0.831 . . . . 0.0 109.665 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -100.29 86.76 3.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.587 -0.695 . . . . 0.0 112.116 175.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -95.62 127.08 41.35 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.366 -0.834 . . . . 0.0 112.916 -173.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -109.52 97.96 7.43 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.921 0.888 . . . . 0.0 110.834 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.3 pt -95.85 108.99 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.078 -1.014 . . . . 0.0 111.051 -174.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 85.4 p -102.43 113.04 26.04 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.12 0.968 . . . . 0.0 112.076 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -148.64 148.88 30.61 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.22 0.534 . . . . 0.0 111.954 -170.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -86.93 156.62 19.74 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.519 -1.363 . . . . 0.0 111.925 163.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.9 mt -70.51 124.13 23.47 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.373 -1.454 . . . . 0.0 112.491 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.16 -4.24 83.9 Favored Glycine 0 CA--C 1.554 2.506 0 N-CA-C 118.97 2.348 . . . . 0.0 118.97 -163.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -85.33 131.87 34.34 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-N 120.223 2.012 . . . . 0.0 112.229 -175.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -72.42 136.5 46.06 Favored 'General case' 0 CA--C 1.571 1.773 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.928 165.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -145.8 149.04 33.6 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.671 0.788 . . . . 0.0 110.937 175.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.427 ' HD2' ' N ' ' A' ' 71' ' ' ASP . 1.0 OUTLIER -84.74 134.91 34.32 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.728 -1.233 . . . . 0.0 110.864 169.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.496 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 38.5 tt0 -132.15 109.44 9.96 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.912 -174.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.2 m -78.28 107.1 10.64 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 167.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.4 p -79.91 168.81 18.75 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -167.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.23 -8.51 1.66 Allowed 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 119.716 3.228 . . . . 0.0 119.716 172.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -116.89 28.63 8.41 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 120.833 1.651 . . . . 0.0 114.875 162.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.253 17.1 m-20 63.07 42.16 7.55 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 176.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -119.52 132.22 55.72 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.989 0.916 . . . . 0.0 109.041 167.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -92.62 115.27 27.95 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.158 0.583 . . . . 0.0 110.558 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' ' 72' ' ' GLU . 25.2 p -110.69 143.38 41.25 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -76.48 100.86 5.39 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 122.272 1.034 . . . . 0.0 109.338 160.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.3 m -96.22 130.07 43.38 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 124.235 1.014 . . . . 0.0 112.735 -176.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 p -134.95 124.59 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 123.172 0.589 . . . . 0.0 109.506 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.4 t -112.67 110.9 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.486 -0.759 . . . . 0.0 109.641 -172.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.8 p -104.58 132.11 51.21 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 123.635 0.774 . . . . 0.0 112.467 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.7 tt -88.87 99.67 12.57 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.607 0.718 . . . . 0.0 109.464 168.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -97.25 76.91 2.64 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.443 -0.785 . . . . 0.0 110.587 -173.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.96 58.22 15.71 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 117.99 1.956 . . . . 0.0 117.99 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.348 5.5 m-20 91.14 -35.6 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -163.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -90.01 113.97 25.75 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-N 120.572 1.533 . . . . 0.0 112.659 -171.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.1 mt -80.7 123.42 28.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.921 -1.112 . . . . 0.0 112.006 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.4 t -124.87 106.6 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -174.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -94.28 101.29 13.25 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 123.472 0.709 . . . . 0.0 110.098 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.3 mt -87.21 112.59 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 123.89 0.876 . . . . 0.0 108.707 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -100.14 121.17 41.0 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.061 0.545 . . . . 0.0 110.189 172.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -114.32 118.15 33.1 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.2 0.6 . . . . 0.0 110.531 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 15.6 p90 -142.96 125.12 15.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.25 -0.906 . . . . 0.0 110.197 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 55.17 37.67 29.26 Favored 'General case' 0 N--CA 1.507 2.424 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 173.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.91 -22.58 6.61 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 119.142 2.417 . . . . 0.0 119.142 -165.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -86.48 142.24 28.51 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 119.024 1.412 . . . . 0.0 112.645 -175.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -131.01 123.42 28.71 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.548 0.739 . . . . 0.0 110.616 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.1 t -121.7 139.84 53.06 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 123.278 0.631 . . . . 0.0 109.911 165.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -118.49 132.66 56.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.848 -0.533 . . . . 0.0 112.079 174.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -102.29 104.86 15.42 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.8 t -87.6 96.58 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.93 116.22 28.72 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 123.964 0.906 . . . . 0.0 110.072 175.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.6 128.38 20.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.865 -0.522 . . . . 0.0 110.754 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.7 mm -80.89 121.65 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.625 -0.672 . . . . 0.0 109.664 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -101.5 -107.89 0.23 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 119.222 -0.418 . . . . 0.0 109.904 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -86.63 66.91 9.69 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 120.306 1.412 . . . . 0.0 111.06 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 79.21 -30.18 2.14 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 118.726 2.25 . . . . 0.0 118.726 -167.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.461 ' NZ ' ' HE2' ' A' ' 129' ' ' GLU . 85.3 mttt -93.77 147.33 23.15 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 118.548 1.174 . . . . 0.0 112.1 -172.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 14.6 tpp -77.48 113.08 14.92 Favored 'General case' 0 CA--C 1.563 1.476 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.606 169.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.9 t -88.64 105.53 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.638 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 164.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 22.3 ttt -101.4 103.4 14.32 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.119 0.568 . . . . 0.0 109.485 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.7 m -103.36 104.37 14.47 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.378 0.671 . . . . 0.0 109.275 -172.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mp -94.86 106.0 17.96 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.463 0.705 . . . . 0.0 109.346 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.9 t -102.7 134.12 46.59 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.736 0.779 . . . . 0.0 112.286 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -116.18 79.68 1.34 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 161.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 68.64 -94.02 0.33 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -175.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -88.22 -30.71 19.5 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 172.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.1 t -90.34 112.33 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-N 120.237 1.38 . . . . 0.0 109.363 -169.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.8 t -115.22 113.13 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 123.435 0.694 . . . . 0.0 109.525 -168.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -100.91 111.86 24.17 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.428 -0.795 . . . . 0.0 112.386 175.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.36 109.17 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.465 -0.772 . . . . 0.0 109.018 -177.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.5 mtp85 -98.19 120.37 38.48 Favored 'General case' 0 CA--C 1.563 1.446 0 CA-C-O 121.915 0.864 . . . . 0.0 110.541 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -99.56 104.99 16.83 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.398 0.679 . . . . 0.0 109.709 -169.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -109.76 125.55 52.81 Favored 'General case' 0 CA--C 1.568 1.635 0 O-C-N 121.623 -0.673 . . . . 0.0 111.458 -170.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.461 ' HE2' ' NZ ' ' A' ' 112' ' ' LYS . 86.9 mt-10 -96.62 155.84 16.6 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.374 0.67 . . . . 0.0 112.416 171.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -72.41 131.27 42.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.306 -0.871 . . . . 0.0 112.234 171.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.501 0 C-N-CA 123.254 0.622 . . . . 0.0 112.487 170.561 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 94.1 t . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.257 93.4 mt-10 -135.01 -42.03 0.74 Allowed 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 176.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.2 -37.3 45.9 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 116.748 2.129 . . . . 0.0 116.748 154.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -75.0 -11.74 60.17 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 168.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 66.2 m -76.7 100.53 5.44 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 122.853 2.57 . . . . 0.0 112.871 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -168.76 163.31 11.88 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-O 122.592 1.187 . . . . 0.0 112.313 -172.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.9 m -82.67 103.47 12.2 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.948 0.899 . . . . 0.0 108.796 169.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -99.0 110.32 22.94 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.694 -1.254 . . . . 0.0 112.158 -170.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -96.64 131.48 43.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.423 -0.798 . . . . 0.0 111.822 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.92 120.42 14.18 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.3 p -93.32 -46.62 7.28 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 174.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -145.62 115.21 7.23 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.826 0.851 . . . . 0.0 109.437 -171.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 76.3 p -104.15 94.18 5.24 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.434 0.694 . . . . 0.0 111.472 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -84.09 120.7 26.47 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.957 0.503 . . . . 0.0 111.194 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.297 3.8 t-20 62.58 20.67 12.16 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 118.248 2.684 . . . . 0.0 118.248 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -67.45 -38.05 83.88 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -55.57 -47.29 76.66 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 169.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -58.91 -47.91 83.32 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 169.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -51.21 -49.79 60.36 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 166.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 75.8 mtm -62.15 -44.01 97.56 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 175.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -62.86 -42.97 99.95 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 166.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.61 -43.75 98.28 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 tp -64.3 -32.81 74.56 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 168.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.85 46.94 5.78 Favored Glycine 0 CA--C 1.543 1.831 0 N-CA-C 116.231 1.252 . . . . 0.0 116.231 -171.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.266 22.9 m -83.08 64.2 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 CA-C-N 119.413 1.607 . . . . 0.0 112.15 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 56.1 -162.54 5.98 Favored Glycine 0 CA--C 1.553 2.425 0 N-CA-C 117.957 1.943 . . . . 0.0 117.957 -175.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -99.73 -43.58 6.4 Favored 'General case' 0 CA--C 1.572 1.795 0 CA-C-N 114.713 -0.744 . . . . 0.0 112.587 154.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.49 -49.8 69.93 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 174.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.0 m -59.25 -41.65 89.28 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 120.303 1.411 . . . . 0.0 114.723 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -59.43 -44.57 92.88 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 169.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -68.74 -40.56 79.77 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 172.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.7 t -50.41 -55.6 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 CA-C-N 119.798 1.181 . . . . 0.0 113.481 160.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.97 -39.68 41.19 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 119.33 2.492 . . . . 0.0 119.33 168.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -67.91 -46.25 72.09 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 170.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.0 m -75.55 -29.65 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 t -79.53 145.91 32.92 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 120.313 1.415 . . . . 0.0 114.259 -173.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -95.96 99.28 4.83 Favored Pre-proline 0 CA--C 1.574 1.883 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 159.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.14 131.23 10.73 Favored 'Trans proline' 0 CA--C 1.562 1.895 0 C-N-CA 122.499 2.132 . . . . 0.0 113.149 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.4 m -97.71 110.73 23.24 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.6 t -97.33 96.88 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -175.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.2 mt -95.22 105.6 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.5 -1.375 . . . . 0.0 108.817 -172.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.3 mt -93.1 123.21 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.5 p -146.18 149.29 33.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.345 -0.847 . . . . 0.0 112.778 169.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -90.99 121.22 32.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.511 -0.743 . . . . 0.0 111.105 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -110.95 85.73 2.17 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.347 0.594 . . . . 0.0 109.925 -175.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.54 -67.72 2.53 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 116.58 1.392 . . . . 0.0 116.58 -177.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -131.69 -44.01 0.99 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 124.137 0.975 . . . . 0.0 112.876 172.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -75.93 152.79 37.01 Favored 'General case' 0 CA--C 1.565 1.526 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.3 t -91.52 125.14 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.611 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 169.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -111.88 111.32 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.8 mt -105.96 106.11 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 54.2 mtm-85 -92.05 97.37 10.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.872 -0.517 . . . . 0.0 109.977 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.1 m -85.65 97.04 9.88 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.765 0.793 . . . . 0.0 109.553 174.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.1 mt -111.92 127.55 55.89 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.157 -165.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.6 m -123.76 164.28 19.48 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.329 0.652 . . . . 0.0 111.265 163.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 49.0 p -74.73 55.34 0.67 Allowed 'General case' 0 N--CA 1.508 2.46 0 O-C-N 120.553 -1.342 . . . . 0.0 113.194 171.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 178.86 -56.66 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.873 0 C-N-CA 125.174 1.39 . . . . 0.0 108.529 -149.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -140.07 127.25 21.09 Favored 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 124.271 1.028 . . . . 0.0 109.939 -169.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -104.91 100.16 9.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.538 -0.726 . . . . 0.0 109.388 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.9 p -114.3 91.54 3.66 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.223 0.535 . . . . 0.0 110.564 -172.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -94.65 126.91 40.26 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.06 -1.025 . . . . 0.0 113.718 -176.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.3 mt -113.92 97.84 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -173.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 95.5 p -102.73 116.37 32.44 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.996 0.919 . . . . 0.0 112.038 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -151.45 149.38 29.19 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -172.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -87.21 150.7 23.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.697 -1.252 . . . . 0.0 110.423 152.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 27.2 mt -62.16 121.37 12.92 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.285 -1.509 . . . . 0.0 113.628 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.83 -9.88 72.45 Favored Glycine 0 CA--C 1.558 2.734 0 N-CA-C 119.129 2.411 . . . . 0.0 119.129 -165.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.91 125.23 30.49 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 120.041 1.92 . . . . 0.0 111.003 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -84.48 129.08 34.89 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -129.72 154.51 47.11 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.174 0.99 . . . . 0.0 111.701 -175.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.55 135.01 35.58 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.37 -1.456 . . . . 0.0 111.473 166.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -127.7 106.72 9.34 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.5 m -79.97 100.77 8.26 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.724 0.773 . . . . 0.0 109.915 174.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.7 p -85.07 167.02 16.18 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -169.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.4 -14.01 10.56 Favored 'General case' 0 CA--C 1.576 1.978 0 N-CA-C 118.9 2.926 . . . . 0.0 118.9 167.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -73.48 -13.49 61.06 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 160.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.287 21.7 t70 68.96 69.72 0.28 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 121.267 1.849 . . . . 0.0 112.931 -166.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.2 ptt85 -160.89 127.71 4.11 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -86.03 90.1 8.0 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 123.11 0.564 . . . . 0.0 111.472 172.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.4 p -81.86 129.12 34.65 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -72.75 97.16 2.15 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 123.101 1.429 . . . . 0.0 110.157 173.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.9 m -109.91 123.86 50.35 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.96 -159.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.0 p -121.72 134.65 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.173 0.511 . . . . 0.0 110.144 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.5 t -123.49 123.48 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -175.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.0 m -131.73 146.46 52.18 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.948 0.88 . . . . 0.0 111.842 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.6 mt -84.92 112.57 20.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.874 . . . . 0.0 111.604 172.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -106.11 76.53 1.17 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.398 0.679 . . . . 0.0 111.041 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.64 61.89 5.52 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 116.686 1.434 . . . . 0.0 116.686 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.259 6.5 t70 52.36 43.5 30.78 Favored 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -162.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -137.15 112.41 9.17 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 mt -82.64 87.04 6.73 Favored 'General case' 0 CA--C 1.567 1.622 0 O-C-N 121.381 -0.824 . . . . 0.0 111.2 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.4 t -87.66 107.92 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -170.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -84.64 136.73 33.63 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.787 0.435 . . . . 0.0 110.413 168.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 59.7 mt -126.76 112.86 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -101.76 121.09 41.41 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.578 1.081 . . . . 0.0 110.186 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -116.74 126.67 53.48 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.307 0.575 . . . . 0.0 111.463 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.6 p90 -152.96 133.4 13.65 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.158 -0.964 . . . . 0.0 109.967 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 59.24 23.37 11.73 Favored 'General case' 0 N--CA 1.51 2.567 0 N-CA-C 118.439 2.755 . . . . 0.0 118.439 166.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.9 10.62 82.76 Favored Glycine 0 CA--C 1.558 2.72 0 N-CA-C 119.28 2.472 . . . . 0.0 119.28 -162.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -121.17 141.73 50.56 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-N 119.676 1.738 . . . . 0.0 110.44 -176.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -130.6 122.78 28.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.765 -0.584 . . . . 0.0 110.922 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.7 t -116.7 140.36 49.5 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 123.133 0.573 . . . . 0.0 110.759 166.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.16 140.68 49.98 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.99 -0.444 . . . . 0.0 110.99 -170.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -130.99 101.15 5.49 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.057 -1.027 . . . . 0.0 108.392 -163.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.3 t -93.56 97.18 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -170.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -90.33 108.51 19.81 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 123.55 0.74 . . . . 0.0 110.79 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.86 134.06 53.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.492 -0.755 . . . . 0.0 112.55 -172.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.4 mm -75.11 104.7 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.259 -0.901 . . . . 0.0 109.772 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -103.62 88.12 3.0 Favored 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.0 t70 51.16 59.41 4.63 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.662 1.726 . . . . 0.0 115.662 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.28 -40.36 2.62 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 117.678 1.831 . . . . 0.0 117.678 -171.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -93.47 136.83 33.36 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.276 1.538 . . . . 0.0 113.02 -173.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 56.1 ttp -82.74 104.49 13.02 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.897 0.856 . . . . 0.0 109.765 171.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 84.1 t -93.85 103.55 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 5.2 ttp -93.41 110.11 21.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.41 0.684 . . . . 0.0 110.862 -175.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 96.0 m -96.8 112.5 24.23 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mp -99.62 101.83 13.14 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 124.131 0.973 . . . . 0.0 109.771 -171.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.4 t -101.15 112.82 25.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.591 -0.693 . . . . 0.0 109.965 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -96.25 78.57 3.09 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 152.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.78 -116.33 9.12 Favored Glycine 0 CA--C 1.549 2.204 0 N-CA-C 114.778 0.671 . . . . 0.0 114.778 -168.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -73.31 -19.56 61.01 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 117.02 2.229 . . . . 0.0 117.02 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.2 t -84.75 105.48 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-N 121.143 1.792 . . . . 0.0 108.519 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.4 t -115.67 110.69 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -171.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -99.46 159.21 15.19 Favored 'General case' 0 CA--C 1.562 1.405 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 167.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.1 t -132.17 111.42 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.067 -1.02 . . . . 0.0 109.059 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 56.9 mtm180 -102.17 121.26 41.88 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.75 0.786 . . . . 0.0 111.595 174.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -101.58 111.1 23.23 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.289 0.635 . . . . 0.0 110.525 -171.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -107.48 130.09 54.88 Favored 'General case' 0 CA--C 1.565 1.547 0 O-C-N 121.143 -0.973 . . . . 0.0 112.612 -170.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -97.53 152.74 18.71 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 169.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -75.46 127.94 34.22 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.605 -0.684 . . . . 0.0 112.014 172.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.047 -0.978 . . . . 0.0 112.788 -178.258 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 96.0 t . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 121.504 0.668 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -97.47 -58.74 1.93 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.086 -1.008 . . . . 0.0 113.11 -175.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.17 -22.21 38.78 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 171.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -82.85 -19.91 36.61 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 168.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 44.4 t -73.33 96.46 2.32 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-N 122.663 2.483 . . . . 0.0 113.569 -172.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -174.84 171.04 3.22 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 124.719 1.208 . . . . 0.0 111.466 -168.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 94.3 m -84.1 141.67 30.94 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.802 -1.186 . . . . 0.0 110.021 162.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -133.59 120.66 21.01 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.722 -1.236 . . . . 0.0 110.847 -170.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -108.2 117.91 35.38 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.779 0.832 . . . . 0.0 109.8 -168.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 tt -70.54 115.86 10.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.397 -0.814 . . . . 0.0 112.851 -173.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.8 p -90.22 -49.35 6.6 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -140.88 129.43 22.67 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.936 0.895 . . . . 0.0 109.684 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.8 p -106.33 93.73 4.77 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.077 0.551 . . . . 0.0 110.587 170.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -72.05 124.85 25.84 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.713 0.805 . . . . 0.0 112.026 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 4.9 t-20 52.19 27.99 5.14 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 118.72 2.859 . . . . 0.0 118.72 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -70.46 -44.05 68.57 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -174.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -49.27 -48.57 45.86 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 168.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -59.66 -50.11 75.14 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 170.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -49.28 -49.36 43.95 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 164.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.1 mtp -60.17 -46.25 90.33 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 175.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -55.39 -46.71 76.53 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 167.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.67 -37.34 86.99 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 117.063 2.245 . . . . 0.0 117.063 170.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.4 tp -67.42 -21.69 65.56 Favored 'General case' 0 CA--C 1.573 1.862 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 175.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.24 70.36 1.25 Allowed Glycine 0 N--CA 1.482 1.741 0 CA-C-N 119.026 0.83 . . . . 0.0 113.349 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.2 m -97.1 141.68 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 172.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.03 48.35 4.04 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 117.849 1.9 . . . . 0.0 117.849 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.336 16.6 t80 60.58 -56.69 0.08 Allowed 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 177.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.12 -44.06 64.28 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 173.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.4 m -66.67 -35.21 79.6 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.268 9.7 ptm180 -66.14 -40.85 90.94 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 121.858 2.117 . . . . 0.0 116.301 164.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -60.11 -42.89 95.7 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 169.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.72 -60.75 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-N 119.237 0.926 . . . . 0.0 112.692 166.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.19 -26.24 58.44 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 121.138 3.215 . . . . 0.0 121.138 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -73.68 -38.79 64.8 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 119.527 1.664 . . . . 0.0 115.166 166.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.0 m -77.11 -34.74 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 172.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.0 t -90.65 127.5 36.31 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 120.28 1.4 . . . . 0.0 112.801 -174.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.93 94.88 4.05 Favored Pre-proline 0 CA--C 1.575 1.934 0 CA-C-O 118.119 -0.943 . . . . 0.0 108.881 173.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.66 144.94 56.18 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.52 2.147 . . . . 0.0 116.022 -174.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.2 m -86.86 111.42 20.76 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 114.766 -1.107 . . . . 0.0 109.335 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.3 t -95.65 104.9 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -175.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.9 mt -94.85 104.09 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 80.1 mt -91.21 114.97 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 85.9 p -128.25 128.01 43.89 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 122.869 0.467 . . . . 0.0 111.881 -174.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -85.79 125.19 33.06 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.896 -1.128 . . . . 0.0 109.371 168.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -133.34 90.25 2.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.796 -1.19 . . . . 0.0 110.792 -166.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.76 -68.93 3.13 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 115.783 1.073 . . . . 0.0 115.783 176.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -131.02 -46.94 1.01 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.83 0.852 . . . . 0.0 112.101 168.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -88.31 161.56 17.08 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -173.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.8 t -94.9 124.89 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.1 t -120.12 105.91 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -172.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 61.0 mt -103.62 121.91 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -103.57 113.89 27.75 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 122.709 0.404 . . . . 0.0 111.309 173.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.0 m -94.61 103.4 15.34 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 123.366 0.666 . . . . 0.0 109.351 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.9 mt -112.03 101.45 9.74 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.599 0.714 . . . . 0.0 111.445 -167.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.5 t -87.44 156.0 19.76 Favored 'General case' 0 CA--C 1.563 1.459 0 O-C-N 121.846 -0.534 . . . . 0.0 111.874 162.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.0 t -67.73 34.35 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 157.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -150.63 -61.89 0.19 Allowed 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 125.364 1.465 . . . . 0.0 108.774 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -122.44 122.75 39.71 Favored 'General case' 0 CA--C 1.568 1.636 0 C-N-CA 123.949 0.9 . . . . 0.0 110.239 -177.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -84.48 115.6 22.66 Favored 'General case' 0 CA--C 1.567 1.628 0 C-N-CA 123.422 0.689 . . . . 0.0 110.222 167.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -131.97 144.91 51.15 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.985 0.898 . . . . 0.0 111.198 172.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.57 149.84 30.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.992 -1.068 . . . . 0.0 113.421 -175.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.4 pt -125.67 130.97 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 124.051 0.94 . . . . 0.0 110.259 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.9 p -122.25 114.57 21.0 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.658 0.783 . . . . 0.0 109.773 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -145.6 143.6 29.97 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -166.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -98.76 22.37 10.15 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 174.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 70.4 mt 68.82 110.7 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 125.17 1.388 . . . . 0.0 113.568 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.82 -7.22 56.01 Favored Glycine 0 CA--C 1.557 2.71 0 N-CA-C 119.255 2.462 . . . . 0.0 119.255 -167.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -82.85 125.95 31.9 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-N 119.201 1.501 . . . . 0.0 110.77 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -80.91 126.08 30.92 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -137.19 137.07 38.76 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 123.514 0.726 . . . . 0.0 110.761 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.67 130.2 38.35 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.501 -1.375 . . . . 0.0 111.431 173.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -130.55 106.46 8.53 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 122.725 0.41 . . . . 0.0 111.124 -171.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 54.5 m -68.94 106.91 2.9 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.324 1.059 . . . . 0.0 110.908 176.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.7 p -78.88 173.24 12.73 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.478 -173.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.73 3.37 0.15 Allowed 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 119.169 3.026 . . . . 0.0 119.169 168.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -109.37 -0.29 19.09 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 159.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.347 4.7 m-20 88.82 -5.59 0.46 Allowed 'General case' 0 N--CA 1.508 2.453 0 N-CA-C 116.748 2.129 . . . . 0.0 116.748 -173.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.94 122.36 24.75 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 120.621 1.555 . . . . 0.0 110.622 176.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.281 5.1 p30 -90.94 97.44 11.18 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.392 0.615 . . . . 0.0 111.458 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 82.5 m -93.73 131.55 38.96 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-O 121.486 0.66 . . . . 0.0 112.673 -168.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -69.9 102.24 1.93 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.579 1.151 . . . . 0.0 109.698 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.2 m -110.74 123.31 49.8 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.611 -157.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.1 t -122.98 113.33 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.8 t -99.32 116.91 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.153 -0.967 . . . . 0.0 109.937 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.1 t -112.49 131.61 55.49 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.279 0.632 . . . . 0.0 112.332 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 tt -91.61 100.48 13.21 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.419 0.688 . . . . 0.0 110.383 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -93.76 84.21 4.56 Favored 'General case' 0 CA--C 1.567 1.601 0 O-C-N 121.35 -0.843 . . . . 0.0 110.111 175.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.73 -82.34 0.96 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 115.411 0.924 . . . . 0.0 115.411 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -138.89 53.8 1.75 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.56 0.695 . . . . 0.0 112.293 161.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -142.37 121.25 12.75 Favored 'General case' 0 CA--C 1.561 1.388 0 O-C-N 121.299 -0.875 . . . . 0.0 110.468 168.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.5 mt -89.46 106.9 18.76 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.424 0.63 . . . . 0.0 110.112 176.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 52.4 t -96.72 100.33 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -85.57 101.22 12.5 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.458 0.703 . . . . 0.0 110.21 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 56.5 mt -90.78 110.53 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -175.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -102.84 118.34 36.6 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 119.077 0.853 . . . . 0.0 110.766 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -109.17 129.94 55.49 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 124.191 0.996 . . . . 0.0 111.216 -177.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.6 p90 -152.09 123.16 7.6 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.556 -1.34 . . . . 0.0 110.611 177.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 54.48 37.04 27.06 Favored 'General case' 0 N--CA 1.507 2.391 0 N-CA-C 117.306 2.335 . . . . 0.0 117.306 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.26 -26.57 4.39 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 118.757 2.263 . . . . 0.0 118.757 -164.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -82.24 142.99 31.66 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-N 119.11 1.455 . . . . 0.0 112.158 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -138.71 129.44 26.33 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.229 0.538 . . . . 0.0 111.547 -176.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.1 t -114.8 150.95 34.64 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.266 0.627 . . . . 0.0 109.754 162.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.293 11.1 p30 -127.32 135.84 51.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.015 -1.053 . . . . 0.0 112.582 166.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -105.09 100.85 10.43 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -176.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.1 t -85.21 98.03 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -174.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.9 ttm-85 -91.08 106.66 18.68 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.434 0.694 . . . . 0.0 109.909 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -123.9 141.11 52.33 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 119.235 0.925 . . . . 0.0 112.555 -175.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.5 mm -79.2 119.66 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.057 -1.027 . . . . 0.0 109.317 172.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -137.15 113.25 9.81 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.034 0.534 . . . . 0.0 109.617 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.6 t70 45.39 55.91 6.11 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.5 -36.78 3.07 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 118.314 2.086 . . . . 0.0 118.314 -169.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -82.94 152.94 25.29 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 119.02 1.41 . . . . 0.0 114.011 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.3 tmm? -91.65 109.0 20.3 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.848 158.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 82.5 t -94.79 106.27 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 38.0 ttm -89.41 106.67 18.6 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 173.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.1 m -95.98 110.64 22.82 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mp -98.61 102.94 14.83 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.981 0.912 . . . . 0.0 109.164 -170.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.1 t -108.92 112.97 25.48 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.332 0.587 . . . . 0.0 111.205 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -98.18 80.13 2.65 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 164.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 64.29 -100.84 0.44 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 114.891 0.716 . . . . 0.0 114.891 -172.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -85.7 -23.56 27.33 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 171.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.6 t -89.48 113.77 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-N 120.907 1.685 . . . . 0.0 109.242 -173.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.7 t -117.43 118.37 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 123.271 0.628 . . . . 0.0 109.59 -170.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -104.22 161.14 14.29 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 163.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.9 t -133.26 112.59 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 120.785 -1.197 . . . . 0.0 109.827 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -99.6 116.34 31.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.026 -1.046 . . . . 0.0 110.305 174.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -102.84 108.49 19.72 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.434 0.694 . . . . 0.0 111.06 -167.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -107.9 127.2 53.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.907 -1.121 . . . . 0.0 112.025 -170.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -90.15 153.53 20.46 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 171.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -88.12 137.41 32.35 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -166.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.257 0 CA-C-O 117.444 -1.265 . . . . 0.0 111.646 176.509 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.285 6.2 p . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -61.82 -37.13 83.29 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -176.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.68 -26.19 63.59 Favored 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 117.938 2.57 . . . . 0.0 117.938 167.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -81.19 -17.0 51.19 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 165.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.7 t -77.37 90.09 3.79 Favored 'General case' 0 CA--C 1.569 1.674 0 CA-C-N 122.105 2.229 . . . . 0.0 113.365 -173.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -166.27 172.55 10.99 Favored 'General case' 0 CA--C 1.572 1.796 0 C-N-CA 124.509 1.123 . . . . 0.0 111.736 -173.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 m -85.51 130.4 34.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.944 -1.098 . . . . 0.0 109.677 164.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -124.44 116.36 22.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.647 -0.658 . . . . 0.0 111.327 -170.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -101.95 127.25 48.88 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.468 0.707 . . . . 0.0 110.93 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.7 119.78 15.35 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -176.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.3 p -92.32 -47.4 7.21 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 176.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -140.16 110.81 6.78 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.876 0.87 . . . . 0.0 109.08 -174.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -94.03 80.24 4.09 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.905 1.336 . . . . 0.0 111.807 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -85.77 108.38 18.06 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.186 -0.946 . . . . 0.0 111.104 -161.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.29 1.8 t30 69.27 28.7 4.78 Favored 'General case' 0 CA--C 1.584 2.261 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -168.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -73.07 -41.0 64.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 119.709 -1.87 . . . . 0.0 115.897 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -48.86 -53.72 18.25 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 171.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.45 -43.57 98.5 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 173.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -54.75 -47.39 73.91 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 166.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 71.2 mtm -60.19 -37.62 80.79 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 172.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -62.41 -50.28 72.14 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 161.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.07 -44.16 91.83 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 176.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.3 tp -75.35 -14.07 60.45 Favored 'General case' 0 CA--C 1.58 2.124 0 N-CA-C 116.28 1.956 . . . . 0.0 116.28 169.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.01 32.12 15.4 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 119.511 2.564 . . . . 0.0 119.511 172.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.5 m -79.64 69.24 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 CA-C-N 120.806 2.303 . . . . 0.0 113.54 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 58.85 -160.96 13.7 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -96.36 -51.27 4.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 122.027 -0.69 . . . . 0.0 111.864 148.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.61 -39.37 84.02 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 33.7 m -68.94 -33.33 73.55 Favored 'General case' 0 CA--C 1.577 1.985 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 171.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -57.06 -49.99 74.14 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-N 121.235 1.834 . . . . 0.0 115.085 159.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -54.24 -51.37 64.7 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 171.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.7 t -51.32 -60.92 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 C-N-CA 124.488 1.115 . . . . 0.0 113.991 166.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.83 -29.06 54.17 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 119.78 2.672 . . . . 0.0 119.78 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -74.61 -47.29 33.1 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 167.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 m -75.88 -34.05 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.5 t -91.99 144.19 25.71 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 120.229 1.377 . . . . 0.0 113.648 -170.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -92.87 112.9 58.01 Favored Pre-proline 0 CA--C 1.574 1.867 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.402 170.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.16 123.28 9.1 Favored 'Trans proline' 0 CA--C 1.561 1.84 0 CA-C-N 122.878 2.064 . . . . 0.0 113.425 170.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 91.0 m -92.61 97.43 10.8 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 172.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.9 t -93.56 101.17 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -168.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.6 mt -88.91 104.08 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 177.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -90.2 114.41 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 172.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.7 p -136.52 129.91 31.69 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.728 0.411 . . . . 0.0 111.573 -170.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -87.21 95.05 9.84 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.159 -0.963 . . . . 0.0 110.39 174.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -101.19 76.18 1.7 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.414 0.626 . . . . 0.0 110.698 -171.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.4 80.72 0.33 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 115.107 0.803 . . . . 0.0 115.107 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.326 34.4 t70 72.0 -56.24 0.65 Allowed 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -175.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -76.26 146.2 39.15 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -177.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.1 t -88.56 125.26 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 173.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.3 t -112.56 111.9 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.501 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.1 mt -90.63 115.56 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -108.46 95.64 5.8 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.5 m -84.9 91.7 8.1 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.399 0.619 . . . . 0.0 109.353 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.9 mt -103.65 95.8 6.29 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -172.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 p -111.03 27.27 9.85 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 -173.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.404 8.5 t 47.27 18.61 0.1 Allowed 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 119.891 3.293 . . . . 0.0 119.891 -164.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -155.39 -61.87 0.11 Allowed 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.724 1.21 . . . . 0.0 109.667 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -70.9 -61.49 1.74 Allowed 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.05 0.94 . . . . 0.0 113.439 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 59.62 63.77 1.45 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.4 t -118.88 122.72 42.96 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.268 0.627 . . . . 0.0 111.503 -170.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -109.15 112.93 25.36 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.526 0.731 . . . . 0.0 111.96 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 pt -112.53 114.75 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 C-N-CA 123.476 0.711 . . . . 0.0 110.84 -174.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 92.9 p -105.86 118.65 37.14 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.112 0.965 . . . . 0.0 112.648 -174.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -149.3 156.35 41.95 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.769 0.795 . . . . 0.0 112.206 -169.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -92.59 150.97 20.39 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.125 0.964 . . . . 0.0 110.876 161.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 41.1 mt -67.83 127.35 32.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.099 -1.001 . . . . 0.0 113.481 -176.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.13 -6.36 71.9 Favored Glycine 0 CA--C 1.556 2.605 0 N-CA-C 118.969 2.348 . . . . 0.0 118.969 -164.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.22 127.11 34.69 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 120.332 2.066 . . . . 0.0 110.953 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.408 ' HE2' ' NZ ' ' A' ' 96' ' ' LYS . 24.8 tt0 -78.88 124.78 28.57 Favored 'General case' 0 CA--C 1.569 1.708 0 CA-C-O 121.477 0.656 . . . . 0.0 111.609 171.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -131.01 145.14 51.95 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.947 0.899 . . . . 0.0 110.698 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -73.88 134.28 43.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.242 -1.536 . . . . 0.0 111.961 170.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -133.62 124.54 27.01 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.248 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.1 m -70.16 128.46 36.36 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-O 122.835 1.302 . . . . 0.0 110.361 158.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 80.7 p -97.88 170.36 9.01 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 122.042 0.925 . . . . 0.0 112.491 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.54 -23.9 4.66 Favored 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 119.205 3.039 . . . . 0.0 119.205 168.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -76.49 -15.77 59.81 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 166.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.321 34.9 m-20 66.66 33.97 6.1 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -156.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.73 133.63 46.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.027 -1.046 . . . . 0.0 108.668 162.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -94.01 112.61 24.47 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.002 0.521 . . . . 0.0 110.595 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.2 m -110.48 141.37 43.69 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.456 0.702 . . . . 0.0 112.626 -173.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -73.76 109.79 7.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.523 -0.736 . . . . 0.0 110.356 166.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.2 m -109.26 125.98 52.85 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.921 0.888 . . . . 0.0 111.315 -169.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 p -126.05 126.0 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-O 121.213 0.53 . . . . 0.0 109.916 174.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.0 t -114.17 116.08 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -176.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.5 p -129.86 148.11 51.7 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 20.1 mt -86.02 117.39 24.83 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.499 0.666 . . . . 0.0 112.626 174.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -106.31 62.69 0.65 Allowed 'General case' 0 CA--C 1.574 1.869 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.901 174.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.51 66.61 1.97 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 115.786 1.074 . . . . 0.0 115.786 -174.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.266 18.3 t70 50.77 49.84 20.19 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 115.718 1.748 . . . . 0.0 115.718 -163.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -147.15 103.44 3.59 Favored 'General case' 0 CA--C 1.558 1.255 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -174.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 53.1 mt -84.18 105.79 15.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.659 -0.651 . . . . 0.0 110.969 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.15 103.33 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -174.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.16 106.43 18.48 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.341 0.656 . . . . 0.0 110.36 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.1 mt -99.29 108.7 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -173.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -98.07 120.75 39.03 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 119.19 0.905 . . . . 0.0 110.088 176.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.408 ' NZ ' ' HE2' ' A' ' 69' ' ' GLU . 43.3 mtmt -117.75 121.27 40.37 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.666 0.787 . . . . 0.0 110.528 -174.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -149.12 133.1 17.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.319 -0.863 . . . . 0.0 110.368 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 59.79 24.82 13.8 Favored 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 118.598 2.814 . . . . 0.0 118.598 166.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.73 10.02 85.66 Favored Glycine 0 CA--C 1.558 2.763 0 N-CA-C 119.201 2.441 . . . . 0.0 119.201 -162.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -120.62 142.11 49.71 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-N 119.393 1.597 . . . . 0.0 110.199 -176.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -132.31 130.04 40.31 Favored 'General case' 0 CA--C 1.562 1.432 0 O-C-N 121.738 -0.601 . . . . 0.0 111.024 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.0 t -120.53 133.98 55.33 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 123.072 0.549 . . . . 0.0 109.715 163.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -116.46 134.44 54.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.773 -0.579 . . . . 0.0 112.167 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -107.59 97.82 7.5 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -174.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 78.2 t -85.85 99.92 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -172.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -101.78 113.9 27.49 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.084 0.554 . . . . 0.0 110.992 -172.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -127.27 143.84 51.16 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.1 mm -86.01 109.09 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.146 -0.971 . . . . 0.0 109.403 175.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.01 89.91 3.29 Favored 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 123.758 0.823 . . . . 0.0 109.29 176.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.9 t70 51.53 57.68 6.31 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 94.82 -38.29 3.17 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 117.942 1.937 . . . . 0.0 117.942 -170.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.9 mtmm -92.7 140.44 29.53 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 119.526 1.663 . . . . 0.0 113.35 -176.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 57.9 ttp -90.46 108.39 19.76 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 121.978 0.894 . . . . 0.0 109.984 175.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.1 t -94.54 107.01 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 23.2 ttt -101.98 106.51 17.45 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.048 0.539 . . . . 0.0 110.542 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.5 m -99.02 99.07 10.05 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.657 0.783 . . . . 0.0 109.37 -174.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.9 mp -90.67 108.22 19.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.873 0.869 . . . . 0.0 110.12 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.0 t -108.26 135.11 50.14 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.571 0.7 . . . . 0.0 112.35 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -127.13 98.43 5.3 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.392 0.677 . . . . 0.0 109.176 166.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 73.68 -91.67 0.68 Allowed Glycine 0 N--CA 1.49 2.249 0 O-C-N 121.861 -0.524 . . . . 0.0 113.901 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -124.25 11.62 8.78 Favored 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 160.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 36.2 t -92.02 107.77 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-N 121.56 1.982 . . . . 0.0 107.825 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.5 t -112.57 115.76 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 123.259 0.624 . . . . 0.0 109.568 -169.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -104.17 123.44 47.31 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.597 -0.689 . . . . 0.0 112.604 169.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.7 t -105.32 104.66 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -93.56 115.72 28.22 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.636 0.732 . . . . 0.0 110.765 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -99.12 109.79 22.45 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.208 0.603 . . . . 0.0 110.4 -171.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -108.73 128.48 54.91 Favored 'General case' 0 CA--C 1.565 1.525 0 O-C-N 121.188 -0.945 . . . . 0.0 111.937 -170.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -95.52 153.55 17.65 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.656 0.741 . . . . 0.0 112.337 167.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -72.08 134.78 46.0 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.49 0 C-N-CA 123.328 0.651 . . . . 0.0 111.17 159.842 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.497 1.891 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.95 -52.41 36.36 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -166.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.55 -24.3 63.59 Favored 'General case' 0 CA--C 1.574 1.87 0 N-CA-C 117.904 2.557 . . . . 0.0 117.904 167.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -85.97 -13.24 48.23 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 172.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.7 t -79.43 96.62 6.1 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 121.157 1.799 . . . . 0.0 112.667 -170.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -169.41 163.65 10.55 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.133 0.968 . . . . 0.0 112.492 -166.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.4 m -81.08 119.0 22.99 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.355 -0.84 . . . . 0.0 109.363 163.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -111.48 107.43 16.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.498 -0.751 . . . . 0.0 111.264 -172.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -91.7 129.74 37.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.511 -0.743 . . . . 0.0 111.272 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -68.85 133.63 48.54 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-O 122.524 1.154 . . . . 0.0 113.904 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.1 p -110.29 -34.73 6.27 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -156.9 112.46 2.89 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 119.69 1.132 . . . . 0.0 108.45 -172.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.9 p -104.05 91.0 3.77 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.916 0.865 . . . . 0.0 111.577 175.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -80.26 125.8 30.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 111.869 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.252 1.7 t30 61.92 21.32 12.21 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 117.565 2.432 . . . . 0.0 117.565 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -72.93 -34.5 66.63 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -175.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -55.04 -56.12 23.34 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 165.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.45 -31.86 71.83 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 173.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -61.65 -51.36 68.77 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 162.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.439 ' SD ' ' HA ' ' A' ' 30' ' ' ARG . 7.4 mtt -58.62 -44.5 89.99 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 116.797 2.147 . . . . 0.0 116.797 177.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -40.48 95.06 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 116.858 2.169 . . . . 0.0 116.858 164.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.72 -46.44 88.1 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 168.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.8 tp -61.66 -27.97 69.06 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.27 49.94 2.51 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 115.866 1.106 . . . . 0.0 115.866 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.2 m -107.52 140.08 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-N 118.944 1.372 . . . . 0.0 110.341 165.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.65 -168.63 9.84 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 116.814 1.486 . . . . 0.0 116.814 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -80.74 61.91 4.58 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.533 1.159 . . . . 0.0 112.709 177.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -148.05 -69.49 0.23 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.111 0.964 . . . . 0.0 109.16 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.2 m -58.7 -35.63 72.94 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 170.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.439 ' HA ' ' SD ' ' A' ' 20' ' ' MET . 11.8 ptp180 -61.79 -32.96 73.28 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 165.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -83.51 14.72 3.52 Favored 'General case' 0 CA--C 1.58 2.105 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 164.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.3 t -118.58 -61.85 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 C-N-CA 125.419 1.488 . . . . 0.0 108.614 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.21 -23.54 68.16 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 119.668 2.627 . . . . 0.0 119.668 -177.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -88.74 -37.26 15.62 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 174.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.4 m -80.34 -33.21 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.4 t -107.91 177.16 4.9 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 119.709 1.141 . . . . 0.0 112.669 -178.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -97.69 99.67 7.02 Favored Pre-proline 0 CA--C 1.573 1.849 0 CA-C-O 118.042 -0.98 . . . . 0.0 111.003 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.92 127.24 15.77 Favored 'Trans proline' 0 CA--C 1.564 2.022 0 CA-C-N 122.903 2.072 . . . . 0.0 113.965 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.0 m -110.45 102.86 11.44 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.004 -172.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.3 t -102.82 101.32 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.553 -0.717 . . . . 0.0 109.141 -164.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.9 mt -87.47 103.35 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.242 -0.911 . . . . 0.0 108.812 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.6 mt -88.04 111.81 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.8 p -136.15 117.96 15.12 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.671 0.389 . . . . 0.0 111.853 -169.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -83.38 116.46 22.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.099 -1.001 . . . . 0.0 111.432 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -116.62 96.23 5.41 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.269 0.557 . . . . 0.0 109.639 -172.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.48 -75.75 2.32 Favored Glycine 0 N--CA 1.492 2.371 0 O-C-N 121.694 -0.629 . . . . 0.0 114.265 -172.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -133.43 -52.14 0.88 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 169.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -62.69 154.34 29.69 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.6 t -94.06 109.73 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.53 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.367 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.5 t -93.88 101.4 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 176.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.2 mt -95.05 116.61 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -101.64 99.74 10.06 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.157 0.583 . . . . 0.0 110.102 175.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.2 m -86.35 96.15 9.89 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.757 0.789 . . . . 0.0 109.4 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 71.3 mt -102.31 86.54 2.84 Favored 'General case' 0 CA--C 1.559 1.318 0 CA-C-O 121.856 0.836 . . . . 0.0 110.329 -170.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.2 t -79.38 144.64 33.96 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.56 -0.713 . . . . 0.0 110.326 159.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.4 p -70.09 33.62 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.463 0 N-CA-C 116.823 2.156 . . . . 0.0 116.823 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -155.89 -57.39 0.09 Allowed 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 126.194 1.797 . . . . 0.0 108.189 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -107.75 100.57 9.94 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 123.978 0.911 . . . . 0.0 109.394 177.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -96.77 88.18 4.52 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.53 -0.731 . . . . 0.0 110.314 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.8 t -105.22 139.55 39.7 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 123.475 0.71 . . . . 0.0 112.444 -171.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -134.68 145.74 48.83 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.8 pt -134.15 129.5 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 C-N-CA 123.771 0.828 . . . . 0.0 110.347 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.0 m -118.37 117.79 30.03 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.843 -0.536 . . . . 0.0 110.371 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -150.65 152.54 34.14 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.675 0.75 . . . . 0.0 112.3 -165.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -94.73 151.02 19.61 Favored 'General case' 0 CA--C 1.573 1.831 0 O-C-N 120.972 -1.08 . . . . 0.0 110.888 169.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.6 mt -67.55 123.39 20.3 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.26 -1.525 . . . . 0.0 112.872 -177.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.06 -20.02 23.07 Favored Glycine 0 CA--C 1.555 2.555 0 N-CA-C 118.678 2.231 . . . . 0.0 118.678 -166.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -79.64 126.64 31.17 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-N 119.387 1.594 . . . . 0.0 111.653 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -81.14 144.24 31.82 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-O 121.563 0.696 . . . . 0.0 112.423 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -142.38 141.26 32.27 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.107 0.963 . . . . 0.0 110.459 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -78.95 129.04 34.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.525 -1.359 . . . . 0.0 111.19 171.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.411 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 80.1 tt0 -125.34 103.25 7.82 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.852 -172.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.4 m -79.7 103.28 9.49 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 170.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 71.4 p -78.15 167.88 20.73 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -168.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.98 -11.85 0.72 Allowed 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 120.236 3.421 . . . . 0.0 120.236 170.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -122.22 35.84 4.78 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 120.892 1.678 . . . . 0.0 114.555 160.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.269 31.0 m-20 63.07 54.63 2.09 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 116.543 2.053 . . . . 0.0 116.543 168.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -120.38 128.4 53.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.528 -0.732 . . . . 0.0 109.207 159.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -90.26 90.56 8.13 Favored 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 123.535 0.734 . . . . 0.0 111.189 173.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.411 ' SG ' ' HB3' ' A' ' 72' ' ' GLU . 28.5 p -96.85 134.72 39.8 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -173.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.68 94.17 2.66 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-O 122.524 1.154 . . . . 0.0 109.284 172.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.1 m -100.94 119.34 38.56 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.676 -165.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.1 p -121.7 125.36 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 123.182 0.593 . . . . 0.0 109.707 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.3 t -109.23 118.38 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -175.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.9 p -118.75 133.86 55.55 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.668 0.787 . . . . 0.0 112.055 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 tt -89.66 98.16 11.61 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 109.933 175.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -94.11 81.07 4.07 Favored 'General case' 0 CA--C 1.567 1.62 0 O-C-N 121.512 -0.743 . . . . 0.0 110.796 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.88 -90.79 0.5 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 115.563 0.985 . . . . 0.0 115.563 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -99.13 4.57 46.93 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 166.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -121.85 119.88 32.91 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 120.452 1.478 . . . . 0.0 111.086 -162.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.2 mt -82.97 100.47 10.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.92 -1.112 . . . . 0.0 110.222 167.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 41.0 t -101.13 101.45 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -170.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.34 107.24 19.02 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.506 0.722 . . . . 0.0 110.791 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 53.9 mt -100.14 103.28 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -173.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -94.66 123.1 37.9 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 118.7 0.682 . . . . 0.0 110.839 176.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -116.39 121.15 41.05 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 123.44 0.696 . . . . 0.0 111.943 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.3 p90 -150.65 128.89 11.97 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.53 -1.357 . . . . 0.0 110.969 -177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 50.52 48.09 23.08 Favored 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 166.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.86 16.23 72.23 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 119.995 2.758 . . . . 0.0 119.995 -168.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -133.59 140.46 47.15 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 119.531 1.666 . . . . 0.0 109.858 -170.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -134.65 130.49 36.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.669 -0.644 . . . . 0.0 111.543 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.8 t -119.4 123.5 44.26 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.358 0.663 . . . . 0.0 109.368 167.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -107.52 122.01 45.79 Favored 'General case' 0 CA--C 1.563 1.475 0 C-N-CA 123.26 0.624 . . . . 0.0 110.605 172.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -103.62 108.38 19.63 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -175.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 82.4 t -93.44 104.08 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -169.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -110.34 99.15 8.23 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.03 0.532 . . . . 0.0 110.314 -166.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.12 149.97 43.83 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -171.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.4 mm -82.18 111.38 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.872 -0.517 . . . . 0.0 110.01 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -105.19 86.98 2.52 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 171.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.9 t70 48.23 60.19 3.78 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.65 -37.86 3.29 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 117.95 1.94 . . . . 0.0 117.95 -171.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -88.02 140.96 28.96 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 119.659 1.73 . . . . 0.0 112.979 -177.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 34.1 ttm -84.83 112.41 20.51 Favored 'General case' 0 CA--C 1.564 1.503 0 O-C-N 121.266 -0.897 . . . . 0.0 109.297 165.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.8 t -89.64 104.36 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 169.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 28.1 ttt -90.95 101.38 14.15 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.998 0.519 . . . . 0.0 109.777 172.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.6 m -92.05 111.06 22.46 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 175.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.9 mp -95.93 121.21 37.43 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.4 t -126.12 122.64 36.32 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-N 120.31 1.414 . . . . 0.0 112.357 174.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -114.38 80.68 1.43 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.824 0.85 . . . . 0.0 108.786 174.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 66.97 -98.55 0.43 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 115.062 0.785 . . . . 0.0 115.062 -174.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -83.98 -30.85 25.89 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 171.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.5 t -89.38 119.86 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 119.715 1.143 . . . . 0.0 109.443 -169.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.5 t -115.97 124.94 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -175.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -117.58 156.22 28.47 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.483 0.713 . . . . 0.0 112.742 167.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.3 t -134.01 112.44 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.318 -0.863 . . . . 0.0 109.074 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -99.63 122.5 42.75 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.52 0.676 . . . . 0.0 111.769 172.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -104.46 114.36 28.54 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.322 0.649 . . . . 0.0 110.663 -172.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -114.97 131.39 56.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.437 -0.79 . . . . 0.0 112.11 -169.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -101.51 152.3 20.93 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 123.452 0.701 . . . . 0.0 112.405 169.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -74.1 131.83 41.69 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.296 -0.877 . . . . 0.0 112.815 175.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.518 0 C-N-CA 124.188 0.995 . . . . 0.0 111.995 175.205 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.268 35.0 m . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.669 0.747 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -74.61 -51.73 13.69 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -172.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.94 -27.09 40.79 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 117.592 2.442 . . . . 0.0 117.592 166.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -85.7 -6.68 59.1 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 171.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 52.8 t -80.56 93.22 6.04 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-N 121.876 2.125 . . . . 0.0 113.85 -172.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.69 172.32 9.37 Favored 'General case' 0 CA--C 1.571 1.787 0 CA-C-O 122.425 1.107 . . . . 0.0 112.435 -177.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.0 m -89.87 116.72 28.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.175 -0.953 . . . . 0.0 108.998 165.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -114.76 108.52 16.88 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 122.956 0.502 . . . . 0.0 110.38 -169.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -95.45 136.55 35.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.05 -1.031 . . . . 0.0 111.651 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.96 130.61 43.71 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.666 0.988 . . . . 0.0 113.666 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 45.8 p -116.34 -24.83 7.75 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -157.22 121.66 4.37 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 120.574 1.534 . . . . 0.0 108.922 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.3 p -113.07 92.82 4.14 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.967 0.889 . . . . 0.0 111.805 178.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -88.34 116.34 26.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.967 -1.083 . . . . 0.0 110.513 -170.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.291 3.8 t-20 68.63 25.86 6.43 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -173.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -72.76 -48.23 40.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 119.994 -1.691 . . . . 0.0 115.392 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -46.97 -50.66 18.67 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.739 2.125 . . . . 0.0 116.739 169.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -58.69 -45.32 89.74 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 171.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -55.73 -48.55 75.01 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 165.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 31.0 mmm -58.56 -49.61 76.82 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -60.3 -42.26 95.15 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 167.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.53 -40.26 95.28 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 172.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.4 tp -61.31 -25.13 66.91 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 168.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.91 56.17 1.33 Allowed Glycine 0 N--CA 1.484 1.893 0 N-CA-C 115.72 1.048 . . . . 0.0 115.72 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.255 4.5 m -100.25 148.03 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-N 118.451 1.126 . . . . 0.0 112.875 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.96 170.12 14.86 Favored Glycine 0 CA--C 1.551 2.329 0 N-CA-C 117.357 1.703 . . . . 0.0 117.357 171.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -67.95 -43.35 79.3 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.32 -44.97 94.98 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 164.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.0 m -61.36 -42.63 99.02 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 175.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -63.76 -39.68 94.85 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 116.512 2.041 . . . . 0.0 116.512 167.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.72 -48.81 80.13 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 120.035 1.289 . . . . 0.0 114.337 167.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.5 t -57.22 -60.94 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-N 119.627 1.103 . . . . 0.0 113.445 170.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.74 -27.81 70.61 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 120.115 2.806 . . . . 0.0 120.115 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -73.48 -42.01 62.43 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 167.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.4 m -70.46 -36.88 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.2 t -88.31 138.92 31.01 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 119.815 1.189 . . . . 0.0 113.194 -174.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -85.68 114.41 56.55 Favored Pre-proline 0 CA--C 1.575 1.92 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.665 167.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -69.11 130.35 19.97 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 CA-C-N 123.345 2.23 . . . . 0.0 114.813 176.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 93.4 m -97.12 101.47 13.04 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.8 t -99.71 99.45 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -166.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.6 mt -86.34 105.98 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.9 mt -99.02 115.03 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 174.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.5 t -144.76 159.59 42.61 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 123.539 1.637 . . . . 0.0 112.65 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -98.67 135.29 40.39 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.206 177.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.13 103.62 6.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.619 -0.676 . . . . 0.0 109.987 175.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.28 -78.57 0.96 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 115.977 1.151 . . . . 0.0 115.977 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -127.6 -39.16 1.85 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 170.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -77.12 154.05 33.64 Favored 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.9 t -94.79 129.97 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.64 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.7 t -109.29 119.08 58.03 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.3 mt -102.29 115.44 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 168.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -104.16 96.07 6.4 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.904 0.859 . . . . 0.0 109.888 170.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.6 m -83.25 92.83 7.56 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.52 174.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.3 mt -104.52 101.47 11.13 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.547 0.739 . . . . 0.0 109.438 -170.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.6 p -99.46 26.98 5.57 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 117.16 2.281 . . . . 0.0 117.16 -175.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.492 2.0 t 63.03 -54.07 0.18 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -169.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -82.71 -60.46 2.17 Favored 'General case' 0 CA--C 1.569 1.698 0 C-N-CA 124.025 0.93 . . . . 0.0 111.582 173.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -98.14 103.16 15.08 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -105.84 93.16 4.49 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.677 0.751 . . . . 0.0 110.186 -171.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 39.1 p -100.94 149.09 24.26 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -167.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -145.16 120.95 10.56 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.112 -0.992 . . . . 0.0 112.5 176.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.2 pt -122.97 129.59 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 C-N-CA 123.699 0.8 . . . . 0.0 110.792 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 85.1 p -120.8 116.39 25.12 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.889 0.876 . . . . 0.0 111.641 -175.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -145.77 146.1 31.08 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.91 0.862 . . . . 0.0 113.073 -164.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -101.62 76.32 1.65 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.138 -0.976 . . . . 0.0 110.816 177.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.4 mt 17.81 96.93 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 120.158 3.392 . . . . 0.0 120.158 174.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.15 -12.73 63.66 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 118.374 2.109 . . . . 0.0 118.374 -166.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -77.62 136.24 38.22 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 119.718 1.759 . . . . 0.0 112.45 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -80.21 115.19 19.63 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.146 171.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -118.99 152.24 36.74 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 122.05 0.929 . . . . 0.0 110.95 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.523 ' HD2' ' N ' ' A' ' 71' ' ' ASP . 1.0 OUTLIER -90.06 138.08 31.81 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.877 -1.14 . . . . 0.0 111.465 174.141 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -145.24 124.34 12.86 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.369 0.604 . . . . 0.0 110.53 169.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 84.9 m -77.04 121.42 23.51 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 158.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.5 p -87.43 -179.99 6.47 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -169.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.68 -29.33 38.28 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 118.698 2.851 . . . . 0.0 118.698 165.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -84.66 10.46 11.16 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 163.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.281 3.1 t0 60.95 22.06 12.29 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 -174.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -95.42 129.72 42.48 Favored 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 124.697 1.199 . . . . 0.0 110.168 175.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -84.88 105.09 15.39 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.157 0.983 . . . . 0.0 112.942 -176.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 4.8 p -99.86 127.52 46.03 Favored 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -76.01 104.43 6.54 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 159.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.0 m -111.37 123.6 50.55 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.23 0.612 . . . . 0.0 112.206 -164.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.4 t -110.99 113.03 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 172.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.6 t -95.97 104.74 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 169.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.9 t -109.74 137.0 48.19 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.65 0.738 . . . . 0.0 112.111 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 tt -85.93 103.72 14.91 Favored 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 123.057 0.543 . . . . 0.0 110.474 174.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -96.11 80.66 3.29 Favored 'General case' 0 CA--C 1.567 1.627 0 O-C-N 121.399 -0.813 . . . . 0.0 111.015 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.74 -83.49 1.14 Allowed Glycine 0 N--CA 1.493 2.451 0 O-C-N 121.013 -1.055 . . . . 0.0 114.26 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -137.9 53.89 1.82 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.106 0.479 . . . . 0.0 112.19 162.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -150.57 130.14 13.07 Favored 'General case' 0 CA--C 1.567 1.626 0 O-C-N 120.754 -1.216 . . . . 0.0 111.673 173.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 16.6 mt -93.29 108.22 19.9 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.33 1.052 . . . . 0.0 111.438 -174.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.02 103.6 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.314 -0.866 . . . . 0.0 108.902 -167.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -89.51 94.3 9.82 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 123.321 0.649 . . . . 0.0 112.413 -178.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 61.2 mt -87.26 98.11 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.7 0.8 . . . . 0.0 109.141 -172.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -92.65 117.94 30.51 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 118.984 0.811 . . . . 0.0 109.958 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -117.46 122.57 44.11 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.148 0.579 . . . . 0.0 110.607 -175.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.7 p90 -153.35 126.93 8.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.503 -0.748 . . . . 0.0 110.509 -172.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 48.46 49.97 17.46 Favored 'General case' 0 N--CA 1.507 2.387 0 N-CA-C 117.214 2.301 . . . . 0.0 117.214 169.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.04 7.08 69.96 Favored Glycine 0 CA--C 1.558 2.758 0 N-CA-C 120.332 2.893 . . . . 0.0 120.332 -168.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -123.73 143.62 50.17 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 120.031 1.916 . . . . 0.0 110.901 -169.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -133.02 131.21 40.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.685 -0.635 . . . . 0.0 111.238 -177.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.4 t -130.88 137.44 49.35 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 123.236 0.614 . . . . 0.0 110.296 166.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.276 11.5 p30 -119.41 128.88 54.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.566 -0.709 . . . . 0.0 112.499 175.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 m-30 -99.77 105.32 17.09 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 84.5 t -90.0 97.52 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -174.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.96 108.37 19.53 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.227 1.011 . . . . 0.0 111.495 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -118.29 148.87 42.01 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.6 mm -85.58 99.77 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 170.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.72 93.25 5.47 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.556 0.742 . . . . 0.0 109.55 -178.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.7 t70 51.51 55.89 8.72 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -174.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.31 -28.57 4.66 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 119.008 2.363 . . . . 0.0 119.008 -169.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -92.18 145.21 24.68 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 119.883 1.841 . . . . 0.0 112.905 -172.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -85.98 100.77 12.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.174 -0.954 . . . . 0.0 110.42 175.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.8 t -100.49 110.9 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 26.7 ttp -100.13 115.08 28.97 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.19 0.596 . . . . 0.0 110.095 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 96.2 m -103.1 104.96 15.17 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mp -96.66 101.51 13.13 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.444 0.698 . . . . 0.0 109.759 -174.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.7 t -90.09 125.07 35.3 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.449 -0.782 . . . . 0.0 111.757 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -109.5 77.24 1.05 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 156.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 64.78 -112.45 5.02 Favored Glycine 0 CA--C 1.548 2.141 0 N-CA-C 114.485 0.554 . . . . 0.0 114.485 -170.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -78.24 -21.05 50.49 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 172.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.6 t -87.93 111.71 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 120.868 1.667 . . . . 0.0 108.662 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 58.2 t -123.07 114.1 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -168.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -94.22 118.01 30.94 Favored 'General case' 0 CA--C 1.562 1.439 0 O-C-N 121.724 -0.61 . . . . 0.0 112.458 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.4 t -100.82 106.48 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -109.96 117.84 34.85 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.427 0.632 . . . . 0.0 111.008 -173.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -91.87 119.97 32.13 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.368 0.604 . . . . 0.0 111.01 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -117.34 133.4 56.03 Favored 'General case' 0 CA--C 1.561 1.404 0 CA-C-O 121.931 0.872 . . . . 0.0 109.51 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -122.95 153.7 39.37 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.671 0.748 . . . . 0.0 110.659 -176.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -68.16 132.29 46.92 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -172.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.231 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.396 172.717 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.254 5.1 p . . . . . 0 CA--C 1.571 1.785 0 CA-C-O 121.828 0.823 . . . . 0.0 112.274 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.338 22.4 tt0 74.46 -53.14 0.68 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -175.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.2 -31.1 41.23 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.638 2.459 . . . . 0.0 117.638 161.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -73.67 -18.51 61.01 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 117.322 2.341 . . . . 0.0 117.322 167.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 44.3 t -75.59 90.94 2.8 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-N 122.331 2.332 . . . . 0.0 114.112 -169.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -168.03 170.47 10.41 Favored 'General case' 0 CA--C 1.569 1.705 0 C-N-CA 124.317 1.047 . . . . 0.0 111.902 -171.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.0 m -78.02 135.23 37.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.819 -1.176 . . . . 0.0 109.162 160.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -120.02 116.7 26.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.775 -1.203 . . . . 0.0 109.682 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -102.2 128.09 48.86 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.662 0.785 . . . . 0.0 110.513 -174.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tt -69.89 117.91 12.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.537 -0.727 . . . . 0.0 112.816 -174.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 46.2 p -97.71 -44.7 6.65 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -147.78 118.04 7.34 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 119.513 1.051 . . . . 0.0 110.232 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.7 p -97.38 95.56 7.76 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.212 0.605 . . . . 0.0 111.951 174.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -79.89 117.52 20.83 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 123.526 0.73 . . . . 0.0 111.027 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.6 t30 60.73 23.26 13.16 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -66.37 -39.12 88.91 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -175.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -52.98 -55.67 21.79 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 171.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -66.73 -34.68 78.37 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -53.6 -53.98 44.0 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-N 120.442 1.473 . . . . 0.0 113.695 161.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 79.4 mtm -57.59 -46.53 83.91 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 115.556 1.688 . . . . 0.0 115.556 174.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -57.32 -46.92 82.74 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 168.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.53 -41.73 99.06 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 171.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.1 tp -57.02 -18.84 15.45 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 168.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.03 60.37 1.77 Allowed Glycine 0 N--CA 1.481 1.665 0 O-C-N 121.3 -0.875 . . . . 0.0 114.402 -176.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.6 m -95.05 155.47 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 CA-C-O 121.886 0.85 . . . . 0.0 111.856 167.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.53 164.47 54.12 Favored Glycine 0 CA--C 1.552 2.349 0 O-C-N 121.326 -0.859 . . . . 0.0 114.279 154.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -55.48 -38.22 68.84 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.7 -48.87 66.29 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.0 m -65.23 -41.31 94.51 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 173.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.284 22.7 ptt180 -66.25 -42.26 88.81 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 121.617 2.008 . . . . 0.0 115.644 169.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -59.21 -48.66 80.79 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 171.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.4 t -57.89 -60.66 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 124.334 1.053 . . . . 0.0 113.141 166.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.54 -30.6 50.82 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 120.392 2.917 . . . . 0.0 120.392 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.23 -42.4 31.36 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 168.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.251 20.8 m -73.54 -42.47 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 CA-C-N 120.765 1.621 . . . . 0.0 115.125 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.1 t -91.42 148.09 22.56 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 119.46 1.027 . . . . 0.0 111.836 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -99.62 98.42 7.03 Favored Pre-proline 0 CA--C 1.571 1.778 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.493 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.17 117.48 5.07 Favored 'Trans proline' 0 CA--C 1.56 1.798 0 C-N-CA 122.547 2.165 . . . . 0.0 113.729 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.1 m -91.79 125.5 36.53 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.139 0.975 . . . . 0.0 109.323 -176.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.1 t -108.29 100.07 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -165.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.9 mt -90.32 109.38 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.521 -1.362 . . . . 0.0 108.322 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.1 mt -88.95 110.17 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 174.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 82.1 p -124.77 117.46 24.23 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.032 0.533 . . . . 0.0 111.769 -171.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -85.27 122.11 28.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.312 -0.868 . . . . 0.0 111.454 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.23 89.59 2.88 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.488 0.661 . . . . 0.0 110.706 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.64 -106.64 2.46 Favored Glycine 0 N--CA 1.487 2.069 0 O-C-N 121.781 -0.575 . . . . 0.0 113.604 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -95.67 -34.85 11.81 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 171.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -86.01 146.49 26.63 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-O 123.368 1.556 . . . . 0.0 114.491 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 64.4 t -96.22 115.61 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.584 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.7 t -102.05 102.8 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.7 mt -91.36 118.19 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.2 mtt-85 -109.4 107.61 17.84 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.447 0.699 . . . . 0.0 109.345 -173.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.2 m -89.84 100.43 13.24 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.5 mt -115.76 119.41 35.94 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.476 0.71 . . . . 0.0 109.856 -169.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 m -121.08 -177.62 3.55 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 122.116 0.96 . . . . 0.0 111.906 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.3 p -61.73 -30.31 70.69 Favored 'General case' 0 N--CA 1.505 2.317 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 158.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -120.69 -54.04 2.07 Favored 'General case' 0 CA--C 1.572 1.8 0 C-N-CA 124.115 0.966 . . . . 0.0 112.174 -175.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -83.32 138.26 33.62 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -137.3 108.62 6.86 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 171.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.0 t -143.21 140.79 30.88 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.632 -0.667 . . . . 0.0 111.508 173.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -136.74 137.93 40.41 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.0 -1.063 . . . . 0.0 113.263 -174.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.3 pt -123.21 124.79 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 C-N-CA 123.16 0.584 . . . . 0.0 112.261 -169.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.3 p -110.69 106.64 15.94 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 123.607 0.763 . . . . 0.0 112.47 -174.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -134.25 140.28 46.34 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -169.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -101.9 39.05 1.52 Allowed 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.0 mt 60.55 97.58 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 125.031 1.332 . . . . 0.0 114.334 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.91 -0.61 82.46 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 118.902 2.321 . . . . 0.0 118.902 -165.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -70.93 125.05 25.8 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 119.341 1.571 . . . . 0.0 111.825 173.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -91.47 123.54 34.96 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.785 0.434 . . . . 0.0 110.664 169.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -147.16 144.43 28.97 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.336 0.654 . . . . 0.0 111.998 -172.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.66 142.16 44.54 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.416 -1.428 . . . . 0.0 112.586 166.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -149.27 137.05 20.42 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.461 0.648 . . . . 0.0 112.596 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.4 m -82.25 103.47 11.86 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 122.066 0.936 . . . . 0.0 110.206 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.3 p -72.91 174.83 7.22 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.98 -9.36 3.0 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 119.762 3.245 . . . . 0.0 119.762 170.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -110.39 20.33 17.88 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 120.741 1.61 . . . . 0.0 114.518 159.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.273 6.6 m-20 54.68 31.56 15.52 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 117.658 2.466 . . . . 0.0 117.658 -174.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 ptp85 -87.32 128.59 35.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.873 -1.142 . . . . 0.0 108.967 165.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -79.05 92.55 5.01 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.679 0.752 . . . . 0.0 111.558 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 68.7 m -85.99 118.43 25.46 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -171.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -69.72 99.43 1.33 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.148 0.979 . . . . 0.0 109.558 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.7 m -115.54 120.4 39.34 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.595 -155.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.1 p -117.45 116.11 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 123.11 0.564 . . . . 0.0 109.733 176.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.6 t -102.92 112.7 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.432 -0.793 . . . . 0.0 109.372 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 86.0 p -113.45 123.11 49.26 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.63 0.772 . . . . 0.0 111.395 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tt -89.65 98.76 11.95 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 118.992 0.815 . . . . 0.0 111.601 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -97.15 68.7 2.27 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 123.353 0.661 . . . . 0.0 111.955 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.09 82.41 0.13 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 116.075 1.19 . . . . 0.0 116.075 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.269 24.2 t0 63.64 0.52 0.89 Allowed 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 -164.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -118.12 99.73 7.07 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 121.119 1.782 . . . . 0.0 110.373 -172.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.8 mt -76.72 99.43 5.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.303 -0.873 . . . . 0.0 110.722 171.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.1 t -99.66 99.41 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.866 -1.146 . . . . 0.0 108.265 -172.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -85.49 100.6 12.01 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.297 0.639 . . . . 0.0 110.814 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.2 mt -90.65 105.48 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -176.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -93.61 122.82 36.46 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 118.45 0.568 . . . . 0.0 110.865 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -112.01 132.8 54.57 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.859 0.863 . . . . 0.0 110.5 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -157.5 124.94 5.22 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.675 -1.266 . . . . 0.0 110.362 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 58.2 24.82 11.83 Favored 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 172.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.93 -24.14 17.01 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 118.425 2.13 . . . . 0.0 118.425 -162.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -82.67 144.72 30.06 Favored 'General case' 0 CA--C 1.565 1.548 0 CA-C-N 119.486 1.643 . . . . 0.0 112.247 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -138.9 129.97 26.66 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.19 0.519 . . . . 0.0 111.543 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.4 t -117.88 154.64 31.51 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 123.577 0.751 . . . . 0.0 110.401 165.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.282 11.6 p30 -130.12 141.26 50.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.131 -0.981 . . . . 0.0 113.54 165.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -111.07 103.49 11.95 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -177.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.7 t -85.82 102.52 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -104.97 108.7 20.36 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.849 0.86 . . . . 0.0 108.857 -169.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -135.74 136.41 40.77 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -169.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 26.7 mm -82.7 113.92 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.718 -0.614 . . . . 0.0 109.52 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -120.79 108.83 14.43 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.7 t70 50.3 54.34 11.31 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 116.582 2.067 . . . . 0.0 116.582 -176.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 64.05 19.64 63.86 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 119.662 2.625 . . . . 0.0 119.662 -169.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -129.27 129.75 45.32 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 119.246 1.523 . . . . 0.0 108.908 -175.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 ttt -82.66 104.78 13.17 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-O 122.067 0.937 . . . . 0.0 109.922 176.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.1 t -86.88 104.41 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 174.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 55.2 ttm -93.48 104.25 16.4 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.8 m -93.69 110.17 21.79 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.526 0.679 . . . . 0.0 109.329 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mp -95.82 105.61 17.64 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 124.184 0.994 . . . . 0.0 108.897 -173.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.7 t -115.26 114.91 25.82 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 119.229 0.922 . . . . 0.0 111.949 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -98.45 74.8 2.18 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.473 0.654 . . . . 0.0 109.251 164.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 66.37 -91.94 0.17 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 115.444 0.938 . . . . 0.0 115.444 -175.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.98 -34.96 20.69 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 172.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.9 t -87.17 117.95 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-N 120.099 1.318 . . . . 0.0 109.732 -171.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.4 t -116.28 127.08 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 C-N-CA 123.493 0.717 . . . . 0.0 109.772 -173.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.67 160.24 18.11 Favored 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 123.264 0.626 . . . . 0.0 112.593 161.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.5 t -131.28 110.7 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.976 -1.078 . . . . 0.0 108.753 176.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -94.56 119.19 32.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.129 -0.982 . . . . 0.0 110.613 169.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -92.54 105.24 17.45 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.387 0.675 . . . . 0.0 109.542 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -106.27 122.98 47.32 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.438 0.695 . . . . 0.0 111.057 -172.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -95.65 157.28 15.97 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.982 -1.073 . . . . 0.0 113.618 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -81.05 141.13 34.66 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -173.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.307 0 CA-C-O 117.364 -1.303 . . . . 0.0 111.975 -179.062 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.35 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.034 0 CA-C-O 122.137 0.97 . . . . 0.0 112.478 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -66.74 -48.44 69.14 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 -165.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.26 -27.18 54.28 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 166.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -83.4 -23.81 32.21 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 172.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 71.7 m -78.12 99.48 6.18 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 121.758 2.072 . . . . 0.0 112.998 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.66 168.77 12.37 Favored 'General case' 0 CA--C 1.57 1.717 0 CA-C-O 122.284 1.04 . . . . 0.0 112.245 -173.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.0 m -85.39 102.65 13.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.203 -0.936 . . . . 0.0 108.901 173.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -101.59 108.66 20.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.788 -1.195 . . . . 0.0 112.027 -169.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -94.13 128.36 40.49 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.428 -0.795 . . . . 0.0 110.94 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.95 117.35 14.56 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.528 0.68 . . . . 0.0 112.704 -175.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.7 p -88.68 -47.82 7.98 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -145.17 112.17 5.98 Favored 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 123.51 0.724 . . . . 0.0 109.662 -171.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.0 p -101.25 95.25 6.4 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.474 0.709 . . . . 0.0 111.406 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -91.0 116.39 28.75 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 122.893 0.477 . . . . 0.0 110.736 -166.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 0.7 OUTLIER 64.01 39.82 7.64 Favored 'General case' 0 CA--C 1.582 2.174 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -173.825 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -78.87 -44.58 22.52 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -53.67 -51.12 64.21 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 116.763 2.134 . . . . 0.0 116.763 175.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -66.52 -38.96 88.32 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -50.14 -53.94 24.11 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 160.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 31.5 mtp -58.41 -42.28 86.86 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 174.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -59.33 -51.4 70.11 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 165.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.4 -38.07 89.73 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 116.743 2.127 . . . . 0.0 116.743 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 tt -61.92 -32.59 73.0 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 165.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.71 49.95 1.89 Allowed Glycine 0 N--CA 1.484 1.88 0 N-CA-C 115.919 1.128 . . . . 0.0 115.919 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 m -93.16 156.69 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-N 118.792 1.296 . . . . 0.0 112.173 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.44 156.85 50.46 Favored Glycine 0 CA--C 1.551 2.318 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 171.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -62.07 -41.27 97.99 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.94 -41.78 71.47 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 165.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.5 m -60.7 -46.62 89.68 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 168.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.5 mtm180 -54.36 -48.75 71.11 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 165.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -60.48 -42.12 95.61 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.8 t -52.95 -60.38 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-N 119.909 1.231 . . . . 0.0 113.101 163.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.0 -31.51 68.71 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 119.822 2.689 . . . . 0.0 119.822 176.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -67.48 -45.7 75.15 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 167.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.6 m -79.33 -32.59 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.23 146.56 34.02 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 120.19 1.359 . . . . 0.0 113.798 -163.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -91.66 116.86 67.27 Favored Pre-proline 0 CA--C 1.577 1.994 0 O-C-N 121.665 -0.647 . . . . 0.0 110.902 161.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.91 128.51 9.26 Favored 'Trans proline' 0 CA--C 1.561 1.836 0 C-N-CA 122.492 2.128 . . . . 0.0 112.735 168.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 56.2 m -85.68 115.93 23.65 Favored 'General case' 0 CA--C 1.562 1.441 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.9 t -102.83 94.25 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -173.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.52 102.58 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.957 -1.089 . . . . 0.0 108.108 -175.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.5 mt -91.15 128.41 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.3 p -142.62 157.49 44.64 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.388 0.675 . . . . 0.0 111.917 -177.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -114.91 111.12 20.68 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.246 -0.909 . . . . 0.0 108.644 166.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -82.01 -57.45 3.4 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -177.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.24 87.61 0.14 Allowed Glycine 0 N--CA 1.483 1.83 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.292 12.0 t70 70.93 -57.43 0.6 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -164.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -78.89 152.92 30.92 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -175.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.1 t -89.48 126.07 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.6 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.872 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.7 t -112.23 109.73 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.3 mt -99.85 130.11 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 174.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.8 mtt85 -107.8 107.8 18.72 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.344 0.658 . . . . 0.0 110.072 173.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.1 m -91.63 103.51 16.09 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.519 -0.738 . . . . 0.0 109.302 173.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 65.2 mt -125.73 119.96 29.35 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 122.817 0.447 . . . . 0.0 110.873 -169.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.26 178.44 6.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.987 -1.071 . . . . 0.0 110.498 159.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.7 p -77.99 48.56 0.73 Allowed 'General case' 0 N--CA 1.51 2.572 0 O-C-N 119.594 -1.941 . . . . 0.0 114.089 173.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -165.79 -58.12 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 125.152 1.381 . . . . 0.0 109.419 -165.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -131.84 132.14 43.43 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.206 1.002 . . . . 0.0 109.285 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -134.06 97.77 3.96 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -172.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.2 t -127.93 128.7 45.58 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 123.178 0.591 . . . . 0.0 111.076 -175.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -119.76 138.85 53.08 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.2 pt -135.28 116.37 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-O 121.313 0.578 . . . . 0.0 111.055 -163.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.1 p -100.63 121.93 42.45 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.064 0.946 . . . . 0.0 112.048 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -147.86 139.2 23.6 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -173.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -81.59 6.86 13.72 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.258 50.9 mt 70.29 105.63 0.06 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 125.188 1.395 . . . . 0.0 111.746 -168.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.69 0.88 89.22 Favored Glycine 0 CA--C 1.556 2.636 0 N-CA-C 119.139 2.416 . . . . 0.0 119.139 -161.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -81.97 122.77 28.2 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-N 120.179 1.99 . . . . 0.0 111.136 174.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -86.45 113.37 22.33 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 122.711 0.405 . . . . 0.0 110.944 172.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -125.25 146.33 49.58 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.842 0.857 . . . . 0.0 111.541 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.98 139.9 36.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.743 -1.223 . . . . 0.0 112.507 168.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -146.5 130.78 17.53 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.192 0.52 . . . . 0.0 110.516 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.4 m -71.47 124.91 25.68 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-O 121.694 0.759 . . . . 0.0 110.656 164.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.1 p -96.65 174.94 6.57 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -176.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.52 -17.63 14.78 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 119.386 3.106 . . . . 0.0 119.386 166.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -81.59 -5.64 58.23 Favored 'General case' 0 CA--C 1.58 2.118 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 161.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.273 23.2 t70 65.34 66.16 0.55 Allowed 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 121.151 1.796 . . . . 0.0 112.992 -170.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -154.55 138.47 16.32 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.87 0.868 . . . . 0.0 109.467 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -79.52 114.9 18.81 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 174.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 2.4 p -99.64 122.83 43.25 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.854 -0.529 . . . . 0.0 112.241 173.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -72.83 96.95 2.15 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.7 m -109.17 118.23 36.21 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.025 -160.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.5 p -121.79 119.88 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.2 t -107.29 118.22 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.486 -0.759 . . . . 0.0 109.686 -173.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.9 m -111.95 125.99 54.64 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.36 0.664 . . . . 0.0 111.568 -177.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.4 tt -83.73 99.66 10.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.428 -0.795 . . . . 0.0 109.825 170.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -91.51 78.44 5.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.454 -0.779 . . . . 0.0 110.651 -175.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.88 -79.24 1.6 Allowed Glycine 0 N--CA 1.492 2.424 0 O-C-N 121.3 -0.875 . . . . 0.0 114.541 -174.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -139.9 60.17 1.56 Allowed 'General case' 0 CA--C 1.572 1.796 0 C-N-CA 122.877 0.471 . . . . 0.0 110.063 164.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -156.9 106.98 2.28 Favored 'General case' 0 CA--C 1.566 1.559 0 O-C-N 121.315 -0.866 . . . . 0.0 109.307 -168.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.0 mt -86.94 101.0 13.0 Favored 'General case' 0 CA--C 1.57 1.719 0 O-C-N 121.349 -0.845 . . . . 0.0 112.373 -174.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.9 t -102.45 102.82 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.132 -0.98 . . . . 0.0 109.025 -171.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -88.12 106.24 18.04 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 123.197 0.599 . . . . 0.0 110.759 177.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.6 mt -92.81 107.23 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -90.88 125.25 35.69 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 118.948 0.794 . . . . 0.0 110.951 171.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -120.77 126.27 49.71 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.396 0.679 . . . . 0.0 110.832 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.0 p90 -152.73 123.72 7.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.943 -1.098 . . . . 0.0 110.483 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 54.31 33.46 18.41 Favored 'General case' 0 N--CA 1.51 2.566 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.93 -26.34 4.88 Favored Glycine 0 CA--C 1.557 2.702 0 N-CA-C 118.809 2.284 . . . . 0.0 118.809 -164.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -75.92 143.59 41.57 Favored 'General case' 0 CA--C 1.566 1.583 0 CA-C-N 119.494 1.647 . . . . 0.0 113.002 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -132.48 134.21 44.76 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.361 0.664 . . . . 0.0 111.039 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.8 t -132.94 130.85 40.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.676 -0.64 . . . . 0.0 111.455 162.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -107.73 130.66 54.93 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 123.16 0.584 . . . . 0.0 112.299 174.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -107.34 103.81 13.26 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.8 t -92.22 94.14 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -170.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.9 mtt85 -81.86 115.2 20.95 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.997 0.919 . . . . 0.0 111.294 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.544 ' HE2' ' NZ ' ' A' ' 109' ' ' LYS . 3.5 pt-20 -127.26 144.46 51.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.681 -0.637 . . . . 0.0 111.637 172.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.2 mm -83.75 116.12 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.186 -0.946 . . . . 0.0 109.054 174.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.544 ' NZ ' ' HE2' ' A' ' 107' ' ' GLU . 1.0 OUTLIER -114.72 85.4 2.24 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.9 t70 49.69 61.54 3.11 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -178.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.92 -44.07 1.86 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 117.135 1.614 . . . . 0.0 117.135 -173.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -85.8 151.56 23.72 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 118.655 1.227 . . . . 0.0 113.121 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 38.7 tpp -85.73 116.96 24.31 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 160.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.4 t -94.09 106.8 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 165.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 18.2 ttt -102.05 111.51 23.81 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.5 m -100.75 106.8 18.25 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -177.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.0 mp -101.02 105.82 17.06 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -174.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.3 t -106.07 139.15 41.05 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.772 0.796 . . . . 0.0 112.052 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -101.09 79.61 2.03 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 162.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 70.37 -94.6 0.48 Allowed Glycine 0 N--CA 1.489 2.211 0 O-C-N 121.663 -0.648 . . . . 0.0 113.322 -163.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -127.99 57.16 1.56 Allowed 'General case' 0 CA--C 1.573 1.845 0 C-N-CA 122.972 0.509 . . . . 0.0 111.938 169.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.2 t -136.13 110.41 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 170.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.3 t -117.63 125.18 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.671 -0.643 . . . . 0.0 111.203 -151.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -107.37 124.97 50.6 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.317 0.647 . . . . 0.0 112.054 165.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.2 t -109.19 105.4 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.318 -0.864 . . . . 0.0 108.809 -174.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 -103.49 114.1 28.11 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 123.898 0.879 . . . . 0.0 111.495 -173.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -96.61 116.54 29.27 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.53 0.732 . . . . 0.0 111.244 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -110.37 138.68 46.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.528 -0.733 . . . . 0.0 111.283 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -99.18 152.78 19.5 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.682 0.753 . . . . 0.0 112.453 167.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -72.46 128.98 37.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.795 -0.566 . . . . 0.0 111.998 171.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.631 179.964 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.507 0.67 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -74.34 -52.68 11.5 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -171.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.58 -25.36 52.26 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 117.963 2.579 . . . . 0.0 117.963 168.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -82.92 -15.81 49.91 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 171.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 41.5 t -79.98 92.79 5.61 Favored 'General case' 0 CA--C 1.565 1.531 0 CA-C-N 121.472 1.942 . . . . 0.0 113.725 -169.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -166.61 168.53 14.46 Favored 'General case' 0 CA--C 1.569 1.687 0 C-N-CA 124.118 0.967 . . . . 0.0 111.826 -174.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.1 m -78.32 124.05 27.66 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.973 -1.079 . . . . 0.0 108.884 159.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -113.09 119.66 38.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 110.66 -177.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -99.85 129.93 45.99 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.81 0.844 . . . . 0.0 111.023 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tt -73.18 121.25 19.99 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -176.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.3 p -92.41 -50.29 5.71 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 175.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -141.74 117.35 10.32 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 119.254 0.934 . . . . 0.0 109.934 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.1 p -107.01 109.04 20.83 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.486 0.714 . . . . 0.0 112.82 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -94.16 131.15 39.99 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.468 0.707 . . . . 0.0 111.454 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.284 3.9 t-20 61.31 25.82 15.73 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 118.359 2.726 . . . . 0.0 118.359 176.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -70.23 -42.8 71.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 119.794 -1.817 . . . . 0.0 115.537 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -49.51 -53.63 22.32 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 169.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.69 -39.06 84.45 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -53.22 -55.77 21.72 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 162.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 74.3 mtm -54.51 -48.57 71.76 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 173.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -41.93 90.07 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 172.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.77 -35.67 81.37 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 117.251 2.315 . . . . 0.0 117.251 167.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 tp -67.72 -27.09 66.51 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.81 65.41 0.65 Allowed Glycine 0 N--CA 1.484 1.863 0 C-N-CA 123.675 0.655 . . . . 0.0 114.202 -173.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.8 m -105.56 145.82 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 C-N-CA 123.501 0.721 . . . . 0.0 111.865 168.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.54 176.07 51.07 Favored Glycine 0 N--CA 1.49 2.281 0 O-C-N 121.367 -0.833 . . . . 0.0 114.276 152.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -77.3 61.62 2.19 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 123.071 1.415 . . . . 0.0 113.384 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -158.21 -61.75 0.08 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.049 1.34 . . . . 0.0 109.055 -175.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.8 m -57.44 -42.0 81.57 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 164.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -61.44 -38.53 87.53 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 164.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -62.9 -42.32 99.74 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 120.469 1.486 . . . . 0.0 114.902 170.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 70.4 t -48.12 -65.28 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 CA-C-N 119.84 1.2 . . . . 0.0 112.796 160.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.19 -33.91 61.9 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 119.782 2.673 . . . . 0.0 119.782 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -67.97 -46.46 71.3 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 169.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.8 m -79.7 -30.8 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.4 t -120.77 153.78 36.57 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 120.293 1.406 . . . . 0.0 113.579 -167.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.0 111.83 60.28 Favored Pre-proline 0 CA--C 1.575 1.933 0 CA-C-O 117.883 -1.056 . . . . 0.0 111.494 178.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.57 123.99 8.51 Favored 'Trans proline' 0 CA--C 1.559 1.763 0 CA-C-N 123.523 2.294 . . . . 0.0 115.424 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.4 m -96.69 118.76 33.84 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.097 0.959 . . . . 0.0 108.483 -175.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.5 t -106.11 105.44 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -169.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.5 mt -95.35 103.45 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -85.5 111.46 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 171.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.5 p -127.71 122.81 33.87 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.097 0.559 . . . . 0.0 111.358 -172.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -89.21 99.06 12.13 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -98.15 -44.52 6.57 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -161.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.06 104.83 0.19 Allowed Glycine 0 N--CA 1.483 1.82 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -173.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.292 13.8 t70 71.66 -52.34 0.69 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -165.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -126.59 162.09 26.51 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 122.562 1.172 . . . . 0.0 113.881 -163.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.9 t -86.06 122.8 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.6 t -115.47 108.15 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 -175.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 56.6 mt -91.85 117.35 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 173.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -97.58 102.16 13.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 169.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.4 m -88.56 104.78 17.15 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.2 mt -102.94 99.46 9.36 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.6 t -87.74 39.3 0.88 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 171.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.328 69.8 p 64.0 -58.71 0.2 Allowed 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -172.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -93.47 -44.35 8.28 Favored 'General case' 0 CA--C 1.574 1.872 0 C-N-CA 125.413 1.485 . . . . 0.0 112.652 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -100.02 117.81 35.08 Favored 'General case' 0 CA--C 1.566 1.588 0 C-N-CA 124.094 0.958 . . . . 0.0 110.817 -176.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -98.57 104.08 16.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.59 -0.694 . . . . 0.0 109.86 168.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.252 5.0 t -103.15 82.6 2.09 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.902 0.858 . . . . 0.0 110.495 169.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.95 131.19 34.7 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 pt -131.62 130.55 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 123.366 0.666 . . . . 0.0 111.364 -170.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 90.2 p -116.87 131.64 56.9 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 123.881 0.872 . . . . 0.0 111.922 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -158.84 144.86 16.72 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.141 -0.974 . . . . 0.0 113.307 -169.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -94.4 26.5 3.36 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 175.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 69.2 mt 69.02 108.31 0.05 Allowed 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 125.203 1.401 . . . . 0.0 113.547 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.41 -10.49 58.85 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 118.656 2.222 . . . . 0.0 118.656 -162.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -73.72 123.85 24.9 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 118.962 1.381 . . . . 0.0 112.327 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -76.0 122.08 23.68 Favored 'General case' 0 CA--C 1.566 1.558 0 CA-C-O 121.306 0.574 . . . . 0.0 111.317 168.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -124.81 154.54 40.82 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.84 0.856 . . . . 0.0 110.586 173.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.516 ' HD2' ' N ' ' A' ' 71' ' ' ASP . 1.0 OUTLIER -88.09 136.7 32.85 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.951 -1.093 . . . . 0.0 110.973 171.131 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -134.45 108.79 8.34 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.904 0.482 . . . . 0.0 110.194 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 88.5 m -79.51 102.37 8.77 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 167.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.9 p -82.08 171.04 14.82 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -167.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.56 -13.53 2.45 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 119.834 3.272 . . . . 0.0 119.834 169.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.42 -16.09 50.27 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 163.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.306 28.6 m-20 73.94 72.17 0.12 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 125.073 1.349 . . . . 0.0 111.995 -160.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -157.01 129.12 7.28 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 124.128 0.971 . . . . 0.0 108.427 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -84.93 115.28 22.7 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 123.268 0.627 . . . . 0.0 112.077 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 72.8 m -110.58 119.72 40.08 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -174.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -71.06 105.87 3.5 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.381 0.61 . . . . 0.0 109.754 165.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.1 m -117.89 119.09 33.81 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.779 -158.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.2 t -117.23 117.77 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.75 108.19 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.391 -0.818 . . . . 0.0 109.598 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 86.5 p -106.78 126.36 52.19 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 123.682 0.793 . . . . 0.0 112.697 -177.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.8 tt -83.33 102.83 12.26 Favored 'General case' 0 CA--C 1.569 1.698 0 C-N-CA 123.21 0.604 . . . . 0.0 110.824 172.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -92.47 76.41 5.12 Favored 'General case' 0 CA--C 1.57 1.719 0 O-C-N 121.107 -0.995 . . . . 0.0 111.443 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.07 -74.67 2.4 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 115.022 0.769 . . . . 0.0 115.022 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.09 65.66 1.21 Allowed 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 122.415 1.102 . . . . 0.0 110.632 153.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -147.5 106.61 3.87 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 mt -89.04 100.1 12.95 Favored 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 123.443 0.697 . . . . 0.0 110.684 -172.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.7 t -106.21 104.01 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -167.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -87.44 102.11 14.23 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 123.387 0.675 . . . . 0.0 111.419 176.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.3 mt -91.23 103.63 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -177.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -90.06 127.42 36.07 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 118.788 0.722 . . . . 0.0 111.114 171.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -121.18 120.39 35.08 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 123.193 0.597 . . . . 0.0 110.887 176.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -145.46 126.91 15.0 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.369 -0.832 . . . . 0.0 110.242 -175.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 55.14 31.92 17.34 Favored 'General case' 0 N--CA 1.511 2.58 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 174.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.9 -21.29 7.99 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 119.166 2.426 . . . . 0.0 119.166 -163.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -86.01 141.38 29.53 Favored 'General case' 0 CA--C 1.57 1.712 0 CA-C-N 119.016 1.408 . . . . 0.0 111.509 -177.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -134.88 125.19 26.27 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.482 0.713 . . . . 0.0 111.023 -173.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.4 t -122.48 144.33 49.13 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.335 0.654 . . . . 0.0 110.733 167.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.279 9.7 p30 -124.9 127.95 47.89 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-O 121.321 0.581 . . . . 0.0 112.415 174.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.3 101.24 12.64 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -174.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.5 t -92.43 96.55 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -168.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 -85.03 107.69 17.27 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.499 0.72 . . . . 0.0 110.181 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.91 129.62 48.54 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 123.035 0.534 . . . . 0.0 111.723 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.2 mm -81.45 120.2 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.339 -0.851 . . . . 0.0 110.177 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.75 89.52 3.13 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.7 t70 51.12 67.1 1.0 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.0 -48.46 3.23 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 117.38 1.712 . . . . 0.0 117.38 -174.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -86.32 143.94 27.63 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 118.643 1.222 . . . . 0.0 112.309 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 32.5 ttm -88.35 118.81 28.23 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-O 121.714 0.769 . . . . 0.0 109.823 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.6 t -89.08 100.51 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 169.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 36.5 ttm -94.94 100.41 12.27 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.369 0.604 . . . . 0.0 110.182 -173.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 84.3 m -98.02 99.79 11.08 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.813 0.816 . . . . 0.0 108.976 -172.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.5 mp -89.98 105.17 17.63 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.8 t -108.3 116.34 31.78 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.52 0.676 . . . . 0.0 110.993 -176.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -97.13 79.75 2.87 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 121.267 0.556 . . . . 0.0 109.509 166.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 63.16 -98.04 0.21 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 115.434 0.934 . . . . 0.0 115.434 -175.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -86.7 -17.21 34.25 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 169.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.8 t -91.96 101.63 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-N 121.774 2.079 . . . . 0.0 108.481 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 57.8 t -104.07 115.19 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -171.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.64 129.16 55.99 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.809 -0.557 . . . . 0.0 112.015 177.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.5 t -115.8 118.56 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.483 -0.761 . . . . 0.0 109.157 -168.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -111.25 125.55 53.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.415 -0.803 . . . . 0.0 111.505 175.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -95.84 109.47 21.8 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.893 0.477 . . . . 0.0 110.291 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -109.63 129.12 55.62 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 123.551 0.74 . . . . 0.0 112.295 -168.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -97.23 150.92 20.37 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 124.2 1.0 . . . . 0.0 112.836 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -74.78 134.52 41.8 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.3 -0.875 . . . . 0.0 113.134 172.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.519 0 C-N-CA 124.101 0.961 . . . . 0.0 111.63 161.441 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.309 8.6 p . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -64.06 -32.26 73.75 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 117.206 2.299 . . . . 0.0 117.206 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.81 -31.33 48.73 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 117.964 2.579 . . . . 0.0 117.964 164.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -75.5 -18.21 59.89 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.779 2.141 . . . . 0.0 116.779 168.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 93.8 m -76.47 97.72 4.4 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 122.383 2.356 . . . . 0.0 113.417 -175.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.09 167.65 14.3 Favored 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 124.376 1.07 . . . . 0.0 111.556 -174.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 98.6 m -81.53 114.54 20.32 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.195 -0.941 . . . . 0.0 109.162 163.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -106.03 115.06 29.58 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.758 -0.589 . . . . 0.0 110.204 -176.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -95.98 132.97 40.75 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.328 0.651 . . . . 0.0 110.842 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -71.07 127.84 33.92 Favored 'General case' 0 CA--C 1.565 1.526 0 CA-C-O 122.303 1.049 . . . . 0.0 113.322 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.1 p -98.92 -39.98 8.3 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 176.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -154.73 121.29 5.4 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 119.534 1.061 . . . . 0.0 109.598 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.2 p -101.39 96.32 7.08 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.23 0.612 . . . . 0.0 111.741 174.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -72.62 124.52 25.44 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.386 0.675 . . . . 0.0 111.805 174.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.274 4.4 t-20 51.04 27.37 3.25 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 119.133 3.012 . . . . 0.0 119.133 177.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -70.92 -46.04 63.2 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -173.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -49.79 -50.06 46.22 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 168.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -58.19 -42.28 85.78 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 170.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -58.55 -48.61 80.3 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 165.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.2 mtp -57.39 -47.04 82.72 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -61.07 -42.28 98.2 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 166.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.52 -43.53 98.69 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 171.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.1 tp -62.24 -17.27 57.9 Favored 'General case' 0 CA--C 1.58 2.105 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 166.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.92 52.15 3.2 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 116.287 1.275 . . . . 0.0 116.287 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.268 9.5 m -92.65 143.51 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 118.57 1.185 . . . . 0.0 113.028 176.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.64 166.22 17.06 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 116.99 1.556 . . . . 0.0 116.99 166.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -64.51 -43.95 92.47 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.85 -46.6 87.35 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 166.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.4 m -58.14 -39.36 78.56 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 172.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.347 0.2 OUTLIER -62.38 -37.74 86.93 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 167.689 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -57.93 -47.19 83.59 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 120.999 1.727 . . . . 0.0 114.592 162.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 70.0 t -56.87 -34.26 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 117.125 2.268 . . . . 0.0 117.125 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.67 -16.64 41.59 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 119.377 2.511 . . . . 0.0 119.377 166.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -88.23 -44.22 11.02 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.573 2.187 . . . . 0.0 114.43 171.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.0 m -93.78 42.71 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 CA-C-N 122.032 2.196 . . . . 0.0 114.041 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.3 m -175.97 145.69 0.66 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.244 1.418 . . . . 0.0 107.892 -176.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -86.8 104.56 6.09 Favored Pre-proline 0 CA--C 1.576 1.977 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.574 170.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.63 113.22 3.74 Favored 'Trans proline' 0 C--N 1.374 1.883 0 CA-C-N 123.158 2.164 . . . . 0.0 112.298 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 93.1 m -95.95 115.29 27.21 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.501 -161.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -92.25 99.69 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -169.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.7 mt -93.21 99.91 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 62.0 mt -89.11 124.97 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.2 p -146.87 116.61 7.16 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.842 -0.536 . . . . 0.0 111.552 -168.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -84.27 117.97 23.89 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.945 -1.097 . . . . 0.0 112.024 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -109.4 82.58 1.62 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.936 0.874 . . . . 0.0 109.424 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.9 -100.58 1.48 Allowed Glycine 0 N--CA 1.489 2.18 0 O-C-N 121.884 -0.51 . . . . 0.0 114.219 -175.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -94.58 -24.44 17.22 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 173.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -98.37 146.32 25.82 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 120.786 1.63 . . . . 0.0 112.941 -174.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.65 115.11 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.671 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 170.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.9 t -99.85 106.35 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.0 mt -95.71 117.84 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 175.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -106.38 95.61 5.88 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.946 174.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.7 m -89.69 101.52 14.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.658 -0.651 . . . . 0.0 109.601 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.4 mt -107.47 105.25 15.07 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.275 -168.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 m -79.96 152.0 29.76 Favored 'General case' 0 CA--C 1.568 1.642 0 O-C-N 121.424 -0.798 . . . . 0.0 110.425 151.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.5 p -38.39 -51.13 1.54 Allowed 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 160.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -80.45 -47.51 14.22 Favored 'General case' 0 CA--C 1.572 1.804 0 C-N-CA 124.379 1.072 . . . . 0.0 113.599 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -115.0 109.77 18.6 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.845 0.858 . . . . 0.0 111.062 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -95.14 89.84 5.68 Favored 'General case' 0 CA--C 1.566 1.568 0 C-N-CA 123.193 0.597 . . . . 0.0 110.366 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.3 p -92.93 146.9 23.28 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -171.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -150.21 116.28 5.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.196 -0.94 . . . . 0.0 112.036 -166.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.2 pt -129.27 116.51 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.668 -0.645 . . . . 0.0 111.93 -175.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.8 p -103.58 113.17 26.48 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.24 1.016 . . . . 0.0 111.975 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -147.29 150.15 34.24 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.829 0.823 . . . . 0.0 113.119 -169.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -86.92 149.37 24.85 Favored 'General case' 0 CA--C 1.572 1.808 0 O-C-N 121.028 -1.045 . . . . 0.0 111.018 162.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.8 mt -68.21 123.97 22.16 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.059 -1.651 . . . . 0.0 112.546 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.38 -16.76 60.63 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 118.707 2.243 . . . . 0.0 118.707 -162.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -80.91 125.82 30.6 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-N 119.935 1.867 . . . . 0.0 112.005 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.613 ' HE2' ' NZ ' ' A' ' 96' ' ' LYS . 28.1 tt0 -86.62 127.69 34.94 Favored 'General case' 0 CA--C 1.569 1.693 0 CA-C-O 121.291 0.567 . . . . 0.0 111.901 171.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -133.93 148.64 51.22 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.154 0.982 . . . . 0.0 111.331 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.09 131.99 37.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.482 -1.387 . . . . 0.0 111.435 171.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -126.46 104.11 7.97 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.041 0.537 . . . . 0.0 110.139 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.4 m -74.1 104.52 4.95 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.223 1.011 . . . . 0.0 110.033 171.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 75.3 p -84.48 172.79 11.38 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -168.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.56 -6.73 0.76 Allowed 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 119.589 3.181 . . . . 0.0 119.589 166.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -96.45 0.43 50.37 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 160.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.313 18.3 t70 63.48 27.2 15.08 Favored 'General case' 0 CA--C 1.582 2.19 0 N-CA-C 116.949 2.203 . . . . 0.0 116.949 -166.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 -94.02 131.6 39.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.574 -1.329 . . . . 0.0 109.196 162.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.298 0.3 OUTLIER -88.72 108.93 19.74 Favored 'General case' 0 CA--C 1.569 1.676 0 CA-C-O 121.041 0.448 . . . . 0.0 110.361 171.493 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 92.4 m -95.33 120.82 36.23 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -173.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -69.88 100.12 1.51 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.811 0.815 . . . . 0.0 109.953 171.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.4 m -114.89 112.67 23.08 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.114 -156.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.8 p -111.71 119.12 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.368 0.604 . . . . 0.0 109.618 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.4 t -105.1 119.85 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -174.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.4 p -130.26 127.68 40.05 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.414 0.685 . . . . 0.0 111.661 -177.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 tt -91.12 111.28 22.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.133 -0.979 . . . . 0.0 110.632 177.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -113.7 74.92 0.89 Allowed 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 123.203 0.601 . . . . 0.0 111.373 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 65.84 77.9 0.25 Allowed Glycine 0 N--CA 1.496 2.678 0 N-CA-C 116.623 1.409 . . . . 0.0 116.623 172.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.271 23.4 t0 62.81 11.87 5.29 Favored 'General case' 0 CA--C 1.582 2.194 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 -164.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.7 mtmt -128.2 105.58 8.45 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 120.914 1.688 . . . . 0.0 109.532 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.78 93.45 8.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -0.968 . . . . 0.0 109.965 177.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 22.3 t -97.03 107.87 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.036 -1.04 . . . . 0.0 108.973 -166.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -93.26 103.25 15.52 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.576 0.75 . . . . 0.0 110.38 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.2 mt -92.84 105.04 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -176.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -94.29 122.06 36.45 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 118.561 0.619 . . . . 0.0 110.672 173.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.613 ' NZ ' ' HE2' ' A' ' 69' ' ' GLU . 8.1 mtmp? -118.36 127.18 53.44 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.366 0.666 . . . . 0.0 110.442 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.4 p90 -149.49 122.68 8.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.03 -1.044 . . . . 0.0 110.055 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 54.85 36.65 27.05 Favored 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 176.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.92 -24.94 4.93 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 118.985 2.354 . . . . 0.0 118.985 -164.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -81.2 144.4 31.64 Favored 'General case' 0 CA--C 1.565 1.552 0 CA-C-N 119.075 1.437 . . . . 0.0 112.84 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -134.45 132.72 39.65 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.316 0.646 . . . . 0.0 111.287 -176.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.7 t -126.2 134.15 51.33 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 161.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.97 123.5 43.66 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.934 0.494 . . . . 0.0 110.813 176.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -102.72 108.9 20.32 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -171.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.0 t -92.8 96.39 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -174.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -88.32 116.88 26.85 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -133.3 133.53 42.7 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.8 mm -76.69 114.74 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -148.38 124.11 10.51 Favored 'General case' 0 CA--C 1.565 1.544 0 C-N-CA 124.225 1.01 . . . . 0.0 108.717 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 t70 55.85 50.5 13.93 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.27 18.68 65.47 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 119.66 2.624 . . . . 0.0 119.66 -172.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -144.31 152.02 40.18 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.486 1.143 . . . . 0.0 110.184 -169.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 7.7 ttm -85.2 115.32 22.92 Favored 'General case' 0 CA--C 1.564 1.516 0 O-C-N 121.26 -0.9 . . . . 0.0 108.984 159.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.9 t -88.46 105.42 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 27.2 ttt -95.22 103.22 15.07 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.771 -0.58 . . . . 0.0 110.3 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 92.1 m -92.33 115.19 27.87 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.656 0.741 . . . . 0.0 109.405 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mp -105.41 105.82 16.04 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -174.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.9 t -121.95 125.79 47.15 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 119.098 0.863 . . . . 0.0 113.321 -175.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -109.04 92.29 3.99 Favored 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 123.802 0.841 . . . . 0.0 108.758 171.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 69.5 -82.26 0.28 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 115.9 1.12 . . . . 0.0 115.9 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -121.72 -7.21 9.08 Favored 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 167.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.7 t -87.66 116.36 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-N 121.748 2.067 . . . . 0.0 108.565 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.1 t -115.4 121.0 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 C-N-CA 123.482 0.713 . . . . 0.0 109.655 -169.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -107.29 157.9 17.56 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 123.281 0.633 . . . . 0.0 112.446 161.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.4 t -132.44 110.59 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.01 -1.056 . . . . 0.0 109.274 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -97.5 121.26 39.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.028 -1.045 . . . . 0.0 111.273 174.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -99.37 110.56 23.05 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.427 0.691 . . . . 0.0 109.937 -171.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -110.61 128.01 55.49 Favored 'General case' 0 CA--C 1.563 1.454 0 O-C-N 121.378 -0.826 . . . . 0.0 111.99 -168.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -103.07 154.26 19.45 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 123.246 0.618 . . . . 0.0 112.543 168.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -74.1 134.97 42.93 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.251 -0.906 . . . . 0.0 113.027 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.519 0 C-N-CA 123.799 0.84 . . . . 0.0 111.837 168.948 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 CA--C 1.569 1.68 0 CA-C-O 121.615 0.722 . . . . 0.0 112.073 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.329 17.5 tt0 73.6 -55.51 0.67 Allowed 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.31 -26.57 61.12 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 165.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -71.18 -22.75 61.99 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 116.801 2.149 . . . . 0.0 116.801 165.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.7 m -83.67 100.42 10.85 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 120.83 1.65 . . . . 0.0 113.218 -174.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -165.38 171.93 12.84 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-O 122.222 1.011 . . . . 0.0 111.802 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 94.8 m -81.89 118.24 22.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.013 -1.054 . . . . 0.0 109.274 165.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -113.57 121.86 45.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.403 -0.811 . . . . 0.0 112.333 -170.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -96.79 124.97 40.92 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.467 1.107 . . . . 0.0 110.459 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tt -71.82 112.9 8.31 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.079 -1.013 . . . . 0.0 112.484 176.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.4 p -90.42 -46.22 8.49 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -143.93 136.19 26.7 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 119.193 0.906 . . . . 0.0 110.276 -175.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.3 p -118.8 136.98 53.71 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -94.2 -126.44 0.11 Allowed 'General case' 0 CA--C 1.573 1.848 0 O-C-N 121.611 -0.681 . . . . 0.0 110.326 172.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -83.82 54.05 2.76 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 119.571 -1.956 . . . . 0.0 114.848 -172.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -74.04 -36.18 64.37 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -48.35 -56.24 8.62 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 174.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -65.59 -42.32 91.81 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 169.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -52.91 -47.48 67.95 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 171.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 78.1 mtm -59.74 -48.68 80.72 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.06 -46.99 72.09 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 167.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.2 90.2 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 173.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mp -63.25 -35.9 81.88 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 166.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.11 41.42 0.9 Allowed Glycine 0 N--CA 1.487 2.051 0 N-CA-C 117.197 1.639 . . . . 0.0 117.197 177.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.5 m -71.22 158.06 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-N 119.323 1.561 . . . . 0.0 113.288 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.5 157.83 49.69 Favored Glycine 0 CA--C 1.553 2.437 0 O-C-N 120.767 -1.208 . . . . 0.0 115.89 162.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -64.57 -38.49 91.2 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.28 -44.33 97.41 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 160.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.7 m -58.54 -43.35 89.25 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -57.81 -47.98 81.06 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 167.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -63.04 -43.78 97.7 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 172.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.9 t -49.84 -61.15 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 163.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.93 -34.92 62.25 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 119.173 2.429 . . . . 0.0 119.173 174.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -66.33 -43.14 86.98 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 170.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.0 m -78.53 -33.35 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 116.361 1.985 . . . . 0.0 116.361 176.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 t -94.46 136.05 35.2 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 120.318 1.417 . . . . 0.0 113.997 -162.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -92.93 109.26 38.2 Favored Pre-proline 0 CA--C 1.576 1.96 0 CA-C-O 118.338 -0.839 . . . . 0.0 110.937 167.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.55 138.68 24.56 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 C-N-CA 122.635 2.223 . . . . 0.0 113.854 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.4 m -85.62 102.49 13.61 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.71 100.2 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -169.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.9 mt -90.82 102.75 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.175 -0.953 . . . . 0.0 108.529 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.5 mt -93.01 125.96 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.9 p -148.91 126.79 11.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.41 -0.806 . . . . 0.0 112.298 -169.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -81.42 109.32 15.79 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.682 -1.261 . . . . 0.0 110.426 168.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -104.11 86.66 2.6 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -173.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.19 -73.69 2.31 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 115.5 0.96 . . . . 0.0 115.5 -174.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -122.52 -53.85 1.88 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.889 0.876 . . . . 0.0 112.088 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -80.66 151.92 28.72 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -172.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.2 t -85.21 121.12 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.2 t -111.5 108.18 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.3 mt -89.75 116.11 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 172.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.8 mtm-85 -100.11 104.3 15.84 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 119.493 1.042 . . . . 0.0 109.73 169.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.7 m -90.11 102.52 15.24 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 77.3 mt -120.08 94.82 4.51 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 122.585 0.354 . . . . 0.0 110.397 -169.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.0 p -93.05 171.04 9.2 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.86 -1.15 . . . . 0.0 112.021 165.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.5 t -72.2 31.59 0.06 Allowed 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 165.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -155.68 -60.57 0.11 Allowed 'General case' 0 CA--C 1.571 1.756 0 C-N-CA 125.182 1.393 . . . . 0.0 109.404 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 46.7 mmtt -109.9 123.37 49.49 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.403 1.081 . . . . 0.0 109.902 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -124.14 98.29 5.71 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 123.337 0.655 . . . . 0.0 110.683 176.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.0 t -129.98 166.97 18.98 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 123.507 0.723 . . . . 0.0 112.054 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -138.18 153.0 49.2 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.9 mt -124.02 104.36 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.629 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -177.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 91.2 p -99.95 114.9 28.49 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.79 0.836 . . . . 0.0 112.178 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -145.14 152.93 40.81 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -171.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -103.68 141.98 35.12 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 123.463 0.705 . . . . 0.0 109.325 168.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -67.38 129.25 39.32 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.634 -1.291 . . . . 0.0 113.908 -173.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.79 -15.69 45.98 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 119.141 2.416 . . . . 0.0 119.141 -167.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -91.53 127.3 36.92 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 119.945 1.873 . . . . 0.0 111.58 -173.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -79.71 126.66 31.23 Favored 'General case' 0 CA--C 1.569 1.68 0 C-N-CA 122.885 0.474 . . . . 0.0 111.917 177.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -140.25 149.6 43.05 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.447 0.699 . . . . 0.0 111.916 -171.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -78.81 138.11 38.03 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.788 -1.195 . . . . 0.0 113.035 174.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -146.3 132.41 19.34 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.198 0.599 . . . . 0.0 110.959 174.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.3 m -98.51 119.77 37.78 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.487 0.66 . . . . 0.0 109.457 170.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 44.7 p -90.34 172.24 8.89 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -168.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.27 -21.37 33.91 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 118.595 2.813 . . . . 0.0 118.595 165.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.435 ' HD2' ' C ' ' A' ' 76' ' ' ASP . 19.9 t0 -65.73 -14.68 61.78 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 158.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.291 10.1 m-20 62.38 46.86 5.58 Favored 'General case' 0 CA--C 1.574 1.873 0 CA-C-N 120.245 1.384 . . . . 0.0 114.69 -164.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.18 131.83 53.83 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.666 1.186 . . . . 0.0 108.702 172.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -86.78 120.31 27.94 Favored 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 122.806 0.442 . . . . 0.0 111.716 173.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.6 p -119.72 143.8 47.58 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.49 0.662 . . . . 0.0 112.725 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -79.13 105.11 10.23 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 121.966 0.889 . . . . 0.0 109.15 157.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.2 m -98.55 136.76 38.2 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.636 0.775 . . . . 0.0 112.245 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.6 p -134.3 129.89 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 123.537 0.735 . . . . 0.0 109.35 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.4 t -118.41 119.14 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.104 -0.998 . . . . 0.0 109.428 -169.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.7 p -117.69 131.62 56.6 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.576 0.75 . . . . 0.0 112.191 -176.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 tt -99.93 108.21 20.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.903 . . . . 0.0 110.301 177.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -88.78 -21.38 23.82 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 116.946 2.202 . . . . 0.0 116.946 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -178.43 -93.53 0.09 OUTLIER Glycine 0 N--CA 1.49 2.251 0 CA-C-N 120.289 1.404 . . . . 0.0 111.108 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -107.41 60.54 0.62 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 117.842 0.821 . . . . 0.0 109.915 151.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -155.25 114.76 3.67 Favored 'General case' 0 CA--C 1.563 1.46 0 O-C-N 121.416 -0.803 . . . . 0.0 110.576 174.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.5 mt -84.7 118.87 24.68 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.722 -0.611 . . . . 0.0 109.57 166.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.2 t -105.98 99.65 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -178.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -90.68 103.66 16.34 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.411 0.684 . . . . 0.0 110.151 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.3 mt -93.91 117.06 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -175.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -108.68 120.56 42.84 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 119.005 0.82 . . . . 0.0 110.464 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -112.41 120.82 42.98 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.889 0.876 . . . . 0.0 110.663 -176.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -151.58 134.28 15.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.395 -0.815 . . . . 0.0 110.591 -175.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 50.48 43.02 27.19 Favored 'General case' 0 N--CA 1.509 2.489 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 166.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.67 22.2 76.64 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 119.82 2.688 . . . . 0.0 119.82 -167.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -137.25 137.4 39.01 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 119.257 1.529 . . . . 0.0 109.506 -168.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -131.66 125.57 32.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.609 -0.682 . . . . 0.0 111.197 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.8 t -125.76 137.86 53.83 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.56 0.744 . . . . 0.0 110.377 175.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.258 11.6 p30 -120.11 135.34 54.99 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.81 105.19 15.55 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -174.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.5 t -89.91 95.88 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 CA-C-N 119.681 1.128 . . . . 0.0 108.199 -178.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.4 ' CG ' ' SD ' ' A' ' 113' ' ' MET . 41.8 ttm180 -95.35 106.25 18.28 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.021 0.928 . . . . 0.0 111.059 -173.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -126.34 144.38 50.83 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.179 0.592 . . . . 0.0 112.568 -176.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.6 mm -82.99 120.35 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -127.91 98.48 5.17 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.7 t70 53.15 58.26 5.46 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -176.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.19 -48.97 3.22 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 116.883 1.513 . . . . 0.0 116.883 -172.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -80.84 145.37 31.43 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 118.265 1.033 . . . . 0.0 113.085 -173.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.4 ' SD ' ' CG ' ' A' ' 106' ' ' ARG . 25.0 tpp -80.18 108.26 13.64 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 121.618 0.723 . . . . 0.0 109.378 161.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 93.6 t -100.75 100.41 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 30.4 ttm -98.49 102.84 14.7 Favored 'General case' 0 CA--C 1.561 1.372 0 O-C-N 122.049 -0.407 . . . . 0.0 110.751 -165.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.9 m -97.41 96.21 8.2 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.579 1.181 . . . . 0.0 110.119 -170.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.581 HD12 HH22 ' A' ' 126' ' ' ARG . 11.0 mp -93.83 106.83 18.78 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.217 1.007 . . . . 0.0 111.137 -176.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.0 t -101.45 118.04 36.15 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.582 0.753 . . . . 0.0 111.11 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -103.14 77.11 1.51 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 159.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 63.97 -109.52 2.84 Favored Glycine 0 CA--C 1.547 2.093 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 -170.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -76.54 -22.11 54.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 171.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.9 t -86.21 102.82 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 120.777 1.626 . . . . 0.0 108.867 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 61.6 t -110.26 108.56 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -172.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.45 135.86 39.41 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.477 0.711 . . . . 0.0 111.696 174.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.0 t -131.95 115.68 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.581 HH22 HD12 ' A' ' 117' ' ' LEU . 3.6 mtm105 -120.8 140.85 51.14 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 122.363 1.078 . . . . 0.0 113.013 176.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -110.21 100.16 9.1 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.541 -1.208 . . . . 0.0 108.662 -164.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -103.52 132.3 49.9 Favored 'General case' 0 CA--C 1.565 1.543 0 O-C-N 121.429 -0.795 . . . . 0.0 111.802 -169.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -103.16 151.53 22.49 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 172.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -74.09 135.25 42.96 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.295 -0.878 . . . . 0.0 113.177 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.079 -0.962 . . . . 0.0 111.491 164.851 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.293 8.4 p . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -65.56 -38.47 89.65 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 174.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.96 -28.67 64.54 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 169.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -77.39 -15.94 59.11 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 166.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.2 t -76.77 98.64 4.87 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 122.478 2.399 . . . . 0.0 114.302 -172.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -168.4 167.6 11.78 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.161 0.982 . . . . 0.0 112.23 -177.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.7 m -81.64 116.87 21.58 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.846 -1.159 . . . . 0.0 108.661 159.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -107.34 119.67 40.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.346 -0.847 . . . . 0.0 110.672 -174.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -101.93 131.92 48.04 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.638 0.732 . . . . 0.0 110.917 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -69.13 132.63 46.87 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.3 p -102.15 -41.29 6.46 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 173.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -156.76 129.47 7.68 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 119.552 1.069 . . . . 0.0 109.807 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.1 p -110.86 106.0 15.0 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.503 0.721 . . . . 0.0 110.913 172.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -70.65 -58.82 3.26 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 -160.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -120.57 46.4 2.01 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.318 -0.864 . . . . 0.0 112.287 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -75.79 -43.65 45.28 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -167.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -46.96 -52.64 14.17 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 163.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.55 -43.16 85.85 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 176.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -52.77 -53.25 50.86 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 120.203 1.365 . . . . 0.0 114.42 162.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 76.9 mtm -62.03 -43.7 98.28 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 176.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.5 -40.8 92.67 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 168.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.03 -39.97 95.27 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 165.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.5 tp -59.08 -37.29 76.75 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 172.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.45 50.8 0.84 Allowed Glycine 0 N--CA 1.485 1.938 0 N-CA-C 115.434 0.934 . . . . 0.0 115.434 -176.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.3 m -91.21 157.81 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 118.379 1.089 . . . . 0.0 112.545 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.6 158.68 53.61 Favored Glycine 0 CA--C 1.552 2.348 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 162.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -59.13 -41.05 87.33 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.92 -38.98 73.61 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 168.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.9 m -61.23 -48.2 82.56 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 169.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.257 8.2 ptm180 -63.22 -32.67 74.12 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 173.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -62.75 -58.02 8.92 Favored 'General case' 0 CA--C 1.571 1.758 0 CA-C-N 119.066 0.848 . . . . 0.0 113.182 162.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.6 t -54.06 -58.51 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.07 -21.24 58.99 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 120.253 2.861 . . . . 0.0 120.253 -177.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -91.11 -38.41 12.78 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 169.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -68.88 -39.87 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 CA-C-N 121.326 1.876 . . . . 0.0 115.846 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.7 t -85.03 153.32 22.81 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 119.474 1.034 . . . . 0.0 113.274 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -98.66 93.96 2.21 Favored Pre-proline 0 CA--C 1.575 1.906 0 O-C-N 121.46 -0.775 . . . . 0.0 110.335 169.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.19 118.49 5.64 Favored 'Trans proline' 0 C--N 1.374 1.904 0 CA-C-N 123.109 2.146 . . . . 0.0 113.466 -175.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 91.2 m -88.82 122.16 31.92 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.395 -173.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.7 t -105.32 100.75 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.711 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -166.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.0 mt -89.1 105.84 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.7 mt -97.27 115.05 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 92.1 p -144.48 124.82 13.82 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.748 0.419 . . . . 0.0 111.219 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -78.97 115.62 18.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.593 -0.692 . . . . 0.0 111.677 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -126.2 84.08 2.23 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.223 0.535 . . . . 0.0 110.371 -170.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.75 72.25 1.05 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 115.435 0.934 . . . . 0.0 115.435 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.29 7.3 t70 70.71 -51.94 0.67 Allowed 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -171.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -76.18 148.98 37.37 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.1 t -88.91 116.61 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.55 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 172.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.0 t -99.55 114.69 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.9 mt -103.43 112.94 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 173.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.6 116.24 30.41 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.284 1.034 . . . . 0.0 110.668 -177.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.1 m -102.22 100.5 10.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.69 -0.631 . . . . 0.0 109.44 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.3 mt -99.64 100.63 11.65 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.101 0.56 . . . . 0.0 109.998 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.1 p -98.36 1.9 47.45 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 118.24 2.681 . . . . 0.0 118.24 176.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.396 31.8 p 78.69 -57.35 0.44 Allowed 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 124.871 1.268 . . . . 0.0 113.316 -167.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -77.92 -61.88 1.85 Allowed 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 124.354 1.062 . . . . 0.0 112.267 177.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -105.62 117.58 34.38 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.988 0.915 . . . . 0.0 109.428 176.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -121.07 85.5 2.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.412 -0.805 . . . . 0.0 109.833 -172.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.2 t -113.18 176.37 5.05 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 122.3 1.048 . . . . 0.0 113.478 -173.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -146.66 156.08 42.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.847 -1.158 . . . . 0.0 113.093 173.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.3 pt -121.68 132.0 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 123.899 0.88 . . . . 0.0 109.508 171.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 92.6 p -124.17 109.49 13.5 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.509 0.723 . . . . 0.0 110.408 -176.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -141.49 139.48 33.31 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -165.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -93.34 23.91 4.21 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.7 mt 67.41 105.21 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 125.179 1.392 . . . . 0.0 113.769 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.58 -20.09 12.69 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 118.483 2.153 . . . . 0.0 118.483 -166.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -78.66 123.37 27.07 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 119.158 1.479 . . . . 0.0 111.666 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.661 ' HE2' ' NZ ' ' A' ' 96' ' ' LYS . 23.1 tt0 -84.77 131.48 34.54 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 121.86 0.838 . . . . 0.0 112.24 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -131.52 157.31 43.9 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 124.247 1.019 . . . . 0.0 111.181 -173.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.517 ' HD2' ' N ' ' A' ' 71' ' ' ASP . 1.0 OUTLIER -91.65 136.07 33.41 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.63 -1.294 . . . . 0.0 110.98 175.065 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -140.71 118.72 11.88 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 122.533 0.333 . . . . 0.0 111.114 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 85.1 m -82.96 113.13 20.34 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 163.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.6 p -87.08 164.9 16.17 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -165.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.54 -24.35 8.0 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 118.824 2.898 . . . . 0.0 118.824 164.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -78.56 -0.51 29.96 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 167.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.262 10.7 t70 68.01 65.97 0.36 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 120.358 1.436 . . . . 0.0 113.151 -171.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -161.04 130.34 4.75 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.821 0.848 . . . . 0.0 109.146 -177.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -89.94 127.23 35.98 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.234 0.614 . . . . 0.0 112.392 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 21.0 p -132.0 148.76 52.53 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -81.2 101.63 9.81 Favored 'General case' 0 CA--C 1.565 1.537 0 CA-C-N 115.018 -0.992 . . . . 0.0 108.784 164.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.6 m -100.77 130.41 46.79 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.228 1.011 . . . . 0.0 112.35 -171.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.2 p -137.57 131.49 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.67 -0.644 . . . . 0.0 110.333 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 t -115.69 121.28 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.272 -0.893 . . . . 0.0 109.571 -176.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.9 p -110.77 130.07 55.67 Favored 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 123.612 0.765 . . . . 0.0 112.015 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 tt -92.68 100.86 13.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 110.584 176.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -93.1 75.6 4.69 Favored 'General case' 0 CA--C 1.568 1.657 0 O-C-N 121.325 -0.859 . . . . 0.0 111.681 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.75 -84.27 1.59 Allowed Glycine 0 N--CA 1.492 2.411 0 O-C-N 121.718 -0.613 . . . . 0.0 113.674 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -136.39 53.9 1.91 Allowed 'General case' 0 CA--C 1.571 1.78 0 CA-C-O 121.131 0.491 . . . . 0.0 111.911 161.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -145.64 119.54 9.32 Favored 'General case' 0 CA--C 1.562 1.411 0 O-C-N 121.072 -1.017 . . . . 0.0 111.303 172.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 47.2 mt -87.32 105.32 17.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.788 -0.57 . . . . 0.0 110.62 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.4 t -95.27 102.0 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -177.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -89.97 107.64 19.24 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.255 0.622 . . . . 0.0 110.61 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.3 mt -96.41 121.07 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 124.297 1.039 . . . . 0.0 108.493 -177.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -112.71 120.57 41.96 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 118.754 0.706 . . . . 0.0 110.23 173.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.661 ' NZ ' ' HE2' ' A' ' 69' ' ' GLU . 51.3 mtmt -111.42 123.03 49.39 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.639 0.776 . . . . 0.0 110.654 -177.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -156.23 133.52 10.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.498 -0.751 . . . . 0.0 110.192 -175.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.457 ' HD2' ' NZ ' ' A' ' 100' ' ' LYS . 27.4 m-20 64.39 15.07 9.27 Favored 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 117.446 2.387 . . . . 0.0 117.446 176.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.32 -3.13 82.89 Favored Glycine 0 CA--C 1.559 2.808 0 N-CA-C 119.082 2.393 . . . . 0.0 119.082 -158.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.457 ' NZ ' ' HD2' ' A' ' 98' ' ' ASP . 8.5 mtmp? -105.55 147.51 28.3 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-N 119.337 1.569 . . . . 0.0 111.013 -176.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -136.06 127.07 27.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.738 -0.601 . . . . 0.0 112.075 -175.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.9 t -112.67 138.39 49.54 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.524 0.73 . . . . 0.0 109.47 164.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.88 122.39 40.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.242 0.617 . . . . 0.0 110.025 175.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -105.25 106.0 16.29 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -172.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.3 t -90.65 98.45 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -171.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 25.8 ttm105 -93.58 111.12 22.73 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.291 0.636 . . . . 0.0 110.641 -177.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -129.63 134.63 47.8 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 119.3 0.955 . . . . 0.0 112.621 -175.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.3 mm -81.46 127.11 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.206 -0.934 . . . . 0.0 109.528 174.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -101.6 -86.61 0.41 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.982 -0.449 . . . . 0.0 110.098 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -143.33 95.4 2.75 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 171.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.17 -41.97 2.96 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 117.354 1.701 . . . . 0.0 117.354 -167.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -92.81 148.57 21.92 Favored 'General case' 0 CA--C 1.558 1.28 0 CA-C-N 118.549 1.175 . . . . 0.0 113.219 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -90.76 109.56 20.75 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.704 158.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.6 t -85.28 104.27 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 170.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 39.5 ttm -93.97 114.52 26.73 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.6 m -101.7 99.46 9.72 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.9 mp -93.33 107.31 19.16 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -174.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.261 13.5 t -131.79 134.61 46.01 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -172.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -110.76 80.03 1.26 Allowed 'General case' 0 CA--C 1.564 1.511 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.994 174.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 69.89 -90.25 0.32 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 115.92 1.128 . . . . 0.0 115.92 -177.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -87.6 -34.49 18.5 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.4 t -87.65 132.35 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 119.459 1.027 . . . . 0.0 109.823 -170.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.7 t -128.42 112.83 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 C-N-CA 123.288 0.635 . . . . 0.0 109.453 -169.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -105.24 114.5 28.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.423 -0.798 . . . . 0.0 112.135 171.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.9 t -92.93 112.58 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.428 -0.795 . . . . 0.0 109.032 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -101.12 120.74 40.65 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.974 0.892 . . . . 0.0 111.219 175.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -102.66 102.92 13.16 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.464 0.706 . . . . 0.0 109.44 -168.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -105.77 127.58 53.18 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.132 -0.98 . . . . 0.0 112.413 -171.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -98.21 155.71 17.04 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 123.798 0.839 . . . . 0.0 112.808 169.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -77.55 135.17 38.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.176 -0.952 . . . . 0.0 113.238 176.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.019 -0.991 . . . . 0.0 111.04 162.803 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 CA--C 1.569 1.692 0 CA-C-O 121.653 0.74 . . . . 0.0 112.057 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.326 19.7 tt0 74.01 -52.81 0.69 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.56 -31.89 57.45 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 117.246 2.313 . . . . 0.0 117.246 161.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -72.27 -26.08 61.85 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 165.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.5 t -78.97 95.59 5.51 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-N 121.167 1.803 . . . . 0.0 113.269 -173.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -169.11 172.37 7.49 Favored 'General case' 0 CA--C 1.571 1.755 0 CA-C-O 122.702 1.239 . . . . 0.0 111.928 -174.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.6 m -78.83 127.38 31.97 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.135 -0.978 . . . . 0.0 110.109 165.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 99.9 m95 -124.6 111.73 15.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.856 -0.528 . . . . 0.0 110.267 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -104.53 129.6 52.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.58 -0.7 . . . . 0.0 110.811 -175.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -70.72 134.54 47.56 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 60.9 p -106.9 -39.97 5.62 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 175.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -153.77 123.04 6.54 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 119.528 1.058 . . . . 0.0 109.607 -174.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.4 p -103.07 100.22 10.13 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 122.925 0.49 . . . . 0.0 111.705 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -76.68 120.61 22.1 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 123.664 0.786 . . . . 0.0 111.405 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 4.8 t-20 60.12 38.08 20.56 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -76.0 -41.02 52.45 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.35 -50.76 70.58 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 174.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -55.47 -48.29 74.75 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 167.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -51.94 -47.1 64.88 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 169.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.49 ' SD ' ' HA ' ' A' ' 30' ' ' ARG . 72.7 mtm -64.06 -40.77 96.99 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 174.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -58.67 -51.52 69.59 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 161.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.54 -43.83 96.76 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 tt -66.31 -32.13 73.35 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.861 1.801 . . . . 0.0 115.861 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.69 55.45 1.9 Allowed Glycine 0 N--CA 1.485 1.923 0 N-CA-C 115.604 1.002 . . . . 0.0 115.604 -172.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.7 m -87.82 154.27 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 CA-C-N 118.129 0.964 . . . . 0.0 111.005 168.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.83 168.66 31.97 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 116.662 1.425 . . . . 0.0 116.662 174.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -83.54 59.43 5.1 Favored 'General case' 0 CA--C 1.577 1.991 0 CA-C-O 122.681 1.229 . . . . 0.0 112.812 177.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -160.76 -58.32 0.05 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.064 1.346 . . . . 0.0 109.758 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.8 m -61.0 -31.53 71.13 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 169.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.49 ' HA ' ' SD ' ' A' ' 20' ' ' MET . 18.5 ptp180 -57.29 -42.77 82.32 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 164.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -60.62 -48.53 81.37 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 167.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.5 t -49.94 -60.56 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 167.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.81 -38.31 53.74 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 119.349 2.5 . . . . 0.0 119.349 175.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -66.84 -42.44 85.76 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 168.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -77.96 -35.32 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 177.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 t -95.73 138.55 33.23 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 120.277 1.399 . . . . 0.0 113.846 -164.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -103.82 101.36 24.39 Favored Pre-proline 0 CA--C 1.575 1.91 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.335 173.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.55 150.82 46.39 Favored 'Trans proline' 0 CA--C 1.564 1.998 0 CA-C-N 123.011 2.111 . . . . 0.0 117.086 -170.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.7 m -102.9 103.85 14.03 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.113 173.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.2 t -96.58 102.26 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -174.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.2 mt -93.94 102.68 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.4 mt -87.91 113.52 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.4 p -129.58 120.44 25.29 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.839 0.456 . . . . 0.0 111.91 -170.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -85.55 103.52 14.47 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.04 -1.038 . . . . 0.0 110.146 176.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -106.3 88.16 2.72 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.36 0.6 . . . . 0.0 109.801 -168.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.75 -76.33 2.02 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 115.147 0.819 . . . . 0.0 115.147 -176.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -123.89 -50.34 1.83 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.514 0.725 . . . . 0.0 112.647 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -81.11 157.81 25.22 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -176.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.76 115.49 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.595 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 173.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.0 t -105.91 104.98 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.2 mt -94.18 118.78 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -101.59 101.96 12.6 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.1 m -85.38 95.8 9.36 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.9 mt -99.06 92.57 5.55 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -173.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.4 p -85.57 11.22 11.11 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 175.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.391 39.7 p 74.05 -57.97 0.6 Allowed 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 125.136 1.375 . . . . 0.0 113.536 -168.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -76.7 -62.08 1.75 Allowed 'General case' 0 CA--C 1.571 1.776 0 C-N-CA 124.498 1.119 . . . . 0.0 112.285 176.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -106.2 120.93 43.12 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.93 0.892 . . . . 0.0 109.583 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -123.73 84.32 2.26 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -169.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.9 t -108.74 147.65 31.66 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -166.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.43 135.31 47.06 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 124.134 0.974 . . . . 0.0 113.136 -174.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.0 mt -124.66 101.32 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -174.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 90.1 p -110.24 112.87 25.11 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.693 0.797 . . . . 0.0 111.833 -173.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -141.2 139.29 33.79 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.007 0.908 . . . . 0.0 113.423 -173.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -88.33 26.15 1.49 Allowed 'General case' 0 CA--C 1.582 2.194 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 173.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 75.4 mt 63.42 100.49 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 125.347 1.459 . . . . 0.0 113.094 -172.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.71 2.38 88.72 Favored Glycine 0 CA--C 1.556 2.635 0 N-CA-C 119.111 2.405 . . . . 0.0 119.111 -167.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -89.28 129.4 35.84 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-N 119.537 1.669 . . . . 0.0 111.205 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -89.61 111.57 22.56 Favored 'General case' 0 CA--C 1.563 1.447 0 CA-C-O 121.288 0.566 . . . . 0.0 111.374 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -113.8 150.18 33.85 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.27 1.028 . . . . 0.0 110.606 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.517 ' HD2' ' N ' ' A' ' 71' ' ' ASP . 1.2 m-20 -83.45 131.18 35.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.266 -1.521 . . . . 0.0 111.59 171.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -122.56 108.25 12.91 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.596 0.758 . . . . 0.0 109.74 -172.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.7 m -77.97 100.99 6.66 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.219 1.009 . . . . 0.0 109.26 172.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 74.4 p -79.18 -178.69 6.3 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -164.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.45 -8.64 0.56 Allowed 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 119.823 3.268 . . . . 0.0 119.823 162.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -109.5 19.02 19.75 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 158.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.438 2.2 p30 56.36 12.25 0.99 Allowed 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 119.794 3.257 . . . . 0.0 119.794 -171.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -77.11 126.14 30.47 Favored 'General case' 0 CA--C 1.561 1.403 0 O-C-N 120.888 -1.132 . . . . 0.0 110.053 170.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -83.99 101.34 11.66 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.476 0.711 . . . . 0.0 111.314 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 83.4 m -100.83 128.2 46.96 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.617 -0.677 . . . . 0.0 112.492 -171.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -72.46 99.4 2.47 Favored 'General case' 0 CA--C 1.563 1.456 0 CA-C-O 122.275 1.036 . . . . 0.0 109.382 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.2 m -115.96 117.23 29.58 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.916 -156.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 p -122.13 129.53 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 123.379 0.672 . . . . 0.0 109.895 -176.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.1 t -121.96 113.36 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -171.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 63.3 m -112.44 131.13 55.72 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.396 0.678 . . . . 0.0 110.923 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.0 tt -91.36 103.37 16.02 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.571 0.701 . . . . 0.0 110.244 175.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -87.28 80.09 8.33 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 123.46 0.704 . . . . 0.0 111.382 -177.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.9 -81.01 1.54 Allowed Glycine 0 N--CA 1.493 2.47 0 O-C-N 121.564 -0.71 . . . . 0.0 114.338 -176.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -135.33 56.12 1.85 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.271 0.558 . . . . 0.0 111.767 163.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -153.28 100.56 2.46 Favored 'General case' 0 CA--C 1.564 1.498 0 O-C-N 121.218 -0.926 . . . . 0.0 110.277 -170.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 24.4 mt -77.68 114.49 16.57 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.093 -1.004 . . . . 0.0 111.835 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.06 102.31 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -87.59 110.03 20.08 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.065 0.546 . . . . 0.0 110.606 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 69.1 mt -102.09 110.5 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -95.62 124.67 39.76 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 118.671 0.669 . . . . 0.0 111.517 172.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -111.38 124.05 51.47 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.977 0.911 . . . . 0.0 110.321 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.6 p90 -154.49 126.97 7.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.806 -1.184 . . . . 0.0 110.595 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 58.53 31.9 21.54 Favored 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 117.244 2.312 . . . . 0.0 117.244 169.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.09 -20.14 8.87 Favored Glycine 0 CA--C 1.556 2.649 0 N-CA-C 119.012 2.365 . . . . 0.0 119.012 -163.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -91.18 143.49 26.61 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 119.667 1.734 . . . . 0.0 111.657 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -133.42 134.24 43.38 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.174 0.59 . . . . 0.0 111.032 -178.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.0 t -126.48 134.75 50.85 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 123.072 0.549 . . . . 0.0 111.065 173.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -116.03 129.56 56.42 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 123.258 0.623 . . . . 0.0 111.997 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -111.34 102.15 10.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.233 -0.917 . . . . 0.0 108.623 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.9 t -91.77 111.12 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -171.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -110.45 119.41 39.12 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.416 0.686 . . . . 0.0 111.18 -171.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -129.41 144.78 51.39 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 122.996 0.518 . . . . 0.0 112.043 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.6 mm -88.18 106.0 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -103.49 101.09 10.97 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 123.511 0.725 . . . . 0.0 109.221 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.3 t70 50.74 53.95 12.08 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 -175.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.45 -35.15 3.65 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 118.645 2.218 . . . . 0.0 118.645 -170.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -95.76 146.39 24.57 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 119.373 1.587 . . . . 0.0 112.056 -172.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 34.1 ttm -86.06 116.08 24.05 Favored 'General case' 0 CA--C 1.566 1.568 0 O-C-N 120.868 -1.145 . . . . 0.0 111.61 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.4 t -94.79 108.11 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 169.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 13.7 ttt -110.17 101.63 10.39 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.506 0.67 . . . . 0.0 109.607 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.8 m -94.8 106.7 18.7 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.527 0.731 . . . . 0.0 109.355 -174.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.4 mp -91.53 113.9 26.29 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.8 m -120.89 119.78 33.62 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.544 0.688 . . . . 0.0 109.869 -167.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -107.61 77.85 1.16 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.372 0.606 . . . . 0.0 109.367 170.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 64.21 -94.98 0.16 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 115.306 0.882 . . . . 0.0 115.306 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -83.54 -32.73 25.71 Favored 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 170.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.2 t -87.05 109.95 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 120.444 1.475 . . . . 0.0 109.406 -171.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.3 t -114.19 118.27 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 124.086 0.954 . . . . 0.0 108.489 -169.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -123.21 127.63 48.89 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 123.265 0.626 . . . . 0.0 111.878 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 37.7 t -105.74 115.56 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.956 -1.09 . . . . 0.0 110.306 -172.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.8 124.06 40.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.054 -1.029 . . . . 0.0 111.716 169.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -102.05 105.78 16.57 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.726 0.81 . . . . 0.0 109.724 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -107.59 129.68 54.96 Favored 'General case' 0 CA--C 1.563 1.474 0 O-C-N 121.303 -0.873 . . . . 0.0 111.731 -169.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -98.35 158.09 15.79 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.399 1.095 . . . . 0.0 112.499 170.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -89.9 130.58 36.1 Favored 'General case' 0 CA--C 1.563 1.471 0 O-C-N 121.394 -0.816 . . . . 0.0 112.758 -169.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . 0.309 . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 118.746 2.869 . . . . 0.0 118.746 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.81 -22.28 61.99 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 168.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -80.71 -12.66 59.44 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 168.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 82.3 m -80.36 91.87 5.73 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 122.207 2.276 . . . . 0.0 113.044 -175.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -165.78 167.0 17.37 Favored 'General case' 0 CA--C 1.569 1.701 0 CA-C-O 122.467 1.127 . . . . 0.0 113.124 -172.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.8 m -80.07 111.01 16.02 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.422 -0.799 . . . . 0.0 109.38 165.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -107.57 111.08 23.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.533 -0.729 . . . . 0.0 111.193 -173.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -102.14 132.92 47.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.209 -0.932 . . . . 0.0 110.898 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 tt -70.87 113.85 8.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.717 -0.615 . . . . 0.0 112.574 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.7 p -99.44 -35.66 9.83 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 -175.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -141.72 120.45 12.62 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 120.432 1.469 . . . . 0.0 109.58 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.4 p -108.77 104.49 13.78 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -81.11 122.39 27.28 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.896 -0.503 . . . . 0.0 110.291 164.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 54.58 70.43 0.62 Allowed 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -110.6 61.83 0.61 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.831 -1.168 . . . . 0.0 112.095 163.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -155.51 -64.92 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.237 1.015 . . . . 0.0 109.52 173.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -62.29 -37.5 85.76 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -50.5 -51.09 50.47 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.535 1.516 . . . . 0.0 114.793 167.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 73.5 mtm -57.08 -50.14 73.68 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 170.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -58.19 -40.72 82.26 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 116.134 1.902 . . . . 0.0 116.134 172.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.95 -41.97 90.59 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 169.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.2 tp -61.83 -23.3 66.16 Favored 'General case' 0 CA--C 1.574 1.875 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 176.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.86 55.58 1.61 Allowed Glycine 0 N--CA 1.485 1.906 0 C-N-CA 123.868 0.747 . . . . 0.0 114.795 -176.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.3 m -83.07 153.95 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.93 138.36 34.94 Favored Glycine 0 CA--C 1.555 2.532 0 O-C-N 120.956 -1.09 . . . . 0.0 113.494 149.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -57.56 -33.55 68.26 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -171.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.37 -41.79 66.22 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 164.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.1 m -60.1 -40.6 90.22 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 165.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.335 0.0 OUTLIER -60.18 -42.56 95.27 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 168.326 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -58.61 -51.76 68.57 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 166.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.1 t -56.02 -55.88 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 173.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.81 -24.72 57.99 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 119.854 2.702 . . . . 0.0 119.854 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -73.77 -45.66 50.41 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 164.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.7 m -78.23 -30.4 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 t -105.11 141.1 37.27 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 120.803 1.638 . . . . 0.0 114.276 -162.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -89.66 119.74 69.5 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.197 172.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.05 129.73 8.04 Favored 'Trans proline' 0 CA--C 1.564 2.02 0 C-N-CA 122.454 2.102 . . . . 0.0 114.044 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 56.6 m -95.69 106.91 19.07 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 169.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 81.0 t -99.43 95.91 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -174.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.8 mp -89.43 98.82 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.521 -1.362 . . . . 0.0 108.359 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.5 mt -84.04 116.46 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.6 p -141.78 121.27 13.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.832 -0.543 . . . . 0.0 112.36 -168.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -79.89 102.99 9.48 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.86 -1.15 . . . . 0.0 110.543 169.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -103.3 96.92 7.08 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -169.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.09 -74.8 2.46 Favored Glycine 0 N--CA 1.488 2.163 0 O-C-N 121.777 -0.577 . . . . 0.0 114.144 -173.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -132.77 -53.24 0.93 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.425 0.69 . . . . 0.0 111.927 171.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -81.3 160.18 24.27 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -173.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.2 t -84.29 114.56 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 123.635 0.774 . . . . 0.0 109.117 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.3 t -106.92 107.68 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.558 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 59.0 mt -91.6 122.18 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 172.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -106.03 106.82 17.5 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.151 0.58 . . . . 0.0 110.23 174.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.5 m -92.87 103.73 16.04 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.506 -0.746 . . . . 0.0 109.374 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 72.0 mt -121.32 117.64 27.49 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.085 0.554 . . . . 0.0 110.231 -170.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 t -127.65 171.87 11.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.026 -1.046 . . . . 0.0 111.26 165.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -70.38 24.24 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 118.585 2.809 . . . . 0.0 118.585 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -150.23 -58.14 0.18 Allowed 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 125.194 1.398 . . . . 0.0 108.705 175.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -101.49 130.89 47.84 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.185 0.994 . . . . 0.0 110.949 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -137.54 110.57 7.76 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.077 0.551 . . . . 0.0 110.834 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.3 t -137.7 155.2 49.36 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 123.569 0.748 . . . . 0.0 111.907 -176.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -140.01 146.85 39.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.808 -1.183 . . . . 0.0 113.941 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.8 pt -130.14 122.63 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-O 121.522 0.677 . . . . 0.0 111.108 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.4 p -105.1 116.93 32.78 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.287 1.035 . . . . 0.0 110.877 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -144.79 141.11 28.93 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 114.517 1.302 . . . . 0.0 114.517 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -79.32 155.52 28.43 Favored 'General case' 0 CA--C 1.571 1.781 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.619 149.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.9 mt -70.78 114.53 8.95 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.58 -1.325 . . . . 0.0 111.588 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.07 -7.61 54.92 Favored Glycine 0 CA--C 1.555 2.536 0 N-CA-C 118.567 2.187 . . . . 0.0 118.567 -162.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -68.72 122.48 18.64 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 120.734 2.267 . . . . 0.0 112.432 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -89.33 118.51 29.06 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 122.979 0.512 . . . . 0.0 110.451 169.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -136.43 135.71 38.92 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 123.433 0.693 . . . . 0.0 110.844 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.17 129.1 36.25 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.487 -1.383 . . . . 0.0 111.047 172.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -130.9 109.71 10.75 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.75 -167.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.7 m -75.24 102.17 4.92 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.65 0.738 . . . . 0.0 110.487 174.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.0 p -85.29 161.85 19.36 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -171.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.45 -23.68 4.19 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 119.015 2.969 . . . . 0.0 119.015 166.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -54.24 -30.74 51.37 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 117.629 2.455 . . . . 0.0 117.629 160.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.316 9.8 t70 78.13 63.21 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.723 0 C-N-CA 125.869 1.668 . . . . 0.0 112.172 -159.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.5 ptt-85 -152.85 136.95 16.41 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.95 0.9 . . . . 0.0 109.14 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.284 0.5 OUTLIER -90.32 112.02 23.44 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 119.535 1.062 . . . . 0.0 110.795 168.17 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.3 p -107.64 130.28 54.92 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -65.6 99.12 0.42 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.442 1.097 . . . . 0.0 110.064 168.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.1 m -107.21 119.93 40.73 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.066 -164.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 51.8 t -111.38 120.18 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.9 t -111.74 129.26 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.538 -0.726 . . . . 0.0 109.718 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 65.6 m -153.57 152.45 30.91 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.778 -1.201 . . . . 0.0 112.25 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.9 mp -83.32 123.19 29.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.063 -1.023 . . . . 0.0 110.538 167.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -84.7 -63.68 1.29 Allowed 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -149.98 80.55 0.2 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 174.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.4 t70 52.42 37.23 22.13 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -160.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -147.16 120.89 9.21 Favored 'General case' 0 CA--C 1.56 1.352 0 O-C-N 121.278 -0.889 . . . . 0.0 109.461 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.87 112.5 22.56 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.242 1.017 . . . . 0.0 110.758 -171.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.03 109.91 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -167.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -93.92 98.85 11.32 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 123.436 0.695 . . . . 0.0 110.999 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.0 mt -90.41 109.19 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 C-N-CA 124.159 0.983 . . . . 0.0 109.003 -174.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -105.46 118.35 36.33 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 118.968 0.804 . . . . 0.0 110.193 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -115.45 122.53 46.06 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 123.634 0.774 . . . . 0.0 111.199 -173.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 8.5 p90 -151.36 130.0 12.29 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.96 -1.088 . . . . 0.0 110.5 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 58.38 27.51 15.5 Favored 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 117.498 2.407 . . . . 0.0 117.498 170.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.23 -19.23 23.87 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 118.97 2.348 . . . . 0.0 118.97 -162.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -89.4 148.11 23.67 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-N 119.443 1.622 . . . . 0.0 112.541 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -132.01 141.01 49.11 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.879 0.847 . . . . 0.0 111.463 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.9 t -129.91 143.51 50.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.63 -0.669 . . . . 0.0 109.419 158.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.266 13.3 p30 -124.52 132.82 53.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 111.171 173.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -100.66 103.75 15.04 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.2 t -88.24 98.93 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 91.1 mtm-85 -89.1 114.04 25.25 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.895 0.878 . . . . 0.0 110.35 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.48 132.95 49.91 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 119.119 0.872 . . . . 0.0 112.718 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.7 mm -80.25 106.56 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.382 -0.824 . . . . 0.0 110.244 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -103.09 98.27 8.24 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 169.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.0 t70 51.46 60.8 3.6 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.32 0.1 56.24 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 120.034 2.774 . . . . 0.0 120.034 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -118.78 122.56 42.69 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 119.837 1.818 . . . . 0.0 109.71 -171.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 51.2 ttp -82.42 104.78 12.96 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 122.029 0.919 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.14 103.61 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 31.6 ttm -85.6 108.14 17.84 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 84.4 m -98.71 101.17 12.5 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.0 mp -92.2 98.95 11.84 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.568 0.747 . . . . 0.0 108.988 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.7 t -89.97 117.58 28.88 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.53 0.681 . . . . 0.0 110.322 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -100.59 75.71 1.77 Allowed 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 155.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.57 -111.24 3.3 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 114.85 0.7 . . . . 0.0 114.85 -166.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -81.2 -9.69 59.74 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 171.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 50.0 t -90.36 99.61 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 121.969 2.168 . . . . 0.0 107.422 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.6 t -113.64 119.93 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -168.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.81 130.92 54.43 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 171.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.9 t -111.79 103.83 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -114.96 118.71 34.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.353 -0.842 . . . . 0.0 109.947 -171.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -99.77 98.8 9.57 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.599 0.714 . . . . 0.0 109.982 -162.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -94.23 131.92 39.32 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.507 0.723 . . . . 0.0 110.9 -173.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -116.76 158.52 23.74 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.532 0.682 . . . . 0.0 110.754 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -75.44 103.89 5.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.023 -1.048 . . . . 0.0 111.877 -174.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . 0.286 . . . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -173.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.93 -24.44 66.04 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 117.84 2.533 . . . . 0.0 117.84 165.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -76.91 -21.65 54.57 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 168.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 80.8 m -73.81 88.86 1.8 Allowed 'General case' 0 CA--C 1.572 1.811 0 CA-C-N 121.885 2.13 . . . . 0.0 114.344 -173.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.59 168.06 20.48 Favored 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 124.552 1.141 . . . . 0.0 111.781 -174.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.6 m -77.27 134.85 38.45 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.868 -1.145 . . . . 0.0 109.319 158.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -123.91 120.75 33.46 Favored 'General case' 0 CA--C 1.562 1.412 0 O-C-N 121.519 -0.738 . . . . 0.0 110.048 -175.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 mtpm? -100.35 130.79 46.49 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.609 0.764 . . . . 0.0 111.422 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 tt -71.79 118.57 14.8 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.562 -0.711 . . . . 0.0 112.909 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 65.2 p -92.22 -49.75 6.02 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -141.18 113.91 8.33 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.757 0.823 . . . . 0.0 109.875 -173.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.0 p -98.62 98.81 9.92 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.318 0.647 . . . . 0.0 111.883 175.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -83.5 122.81 29.04 Favored 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 123.492 0.717 . . . . 0.0 111.16 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.256 1.3 t30 57.7 30.08 18.33 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 171.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -72.38 -38.36 68.51 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -54.77 -53.16 58.78 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 175.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.26 -41.78 80.33 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 171.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -58.15 -48.08 81.36 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 165.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 65.0 mtm -58.02 -48.28 80.52 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -60.78 -42.58 97.8 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 166.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.64 97.55 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 171.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.6 tp -64.25 -22.33 66.91 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 116.925 2.195 . . . . 0.0 116.925 169.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.73 55.56 1.75 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 115.615 1.006 . . . . 0.0 115.615 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 m -107.86 149.84 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 118.197 0.999 . . . . 0.0 111.553 172.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.17 165.54 21.4 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 116.647 1.419 . . . . 0.0 116.647 172.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -64.84 -40.57 95.38 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.71 -42.46 79.2 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 164.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.6 m -62.4 -43.96 97.58 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 169.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -54.4 -47.53 72.64 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 164.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -58.87 -52.33 66.19 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 119.989 1.268 . . . . 0.0 114.1 170.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.2 t -49.01 -51.5 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 167.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.33 -32.77 84.73 Favored Glycine 0 CA--C 1.55 2.234 0 N-CA-C 119.596 2.599 . . . . 0.0 119.596 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -79.69 -42.93 23.67 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 173.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.4 m -70.32 -35.07 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 117.022 2.231 . . . . 0.0 117.022 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.0 t -102.89 175.32 5.52 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -166.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.44 84.38 0.74 Allowed Pre-proline 0 CA--C 1.579 2.086 0 C-N-CA 123.703 0.801 . . . . 0.0 110.96 169.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.26 117.63 5.23 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.71 2.274 . . . . 0.0 113.395 -175.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.1 m -100.06 123.83 44.74 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.418 -161.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.8 t -106.46 105.56 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -167.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.4 mt -89.05 105.75 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.438 -1.414 . . . . 0.0 107.714 170.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 55.8 mt -89.71 124.6 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 168.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.1 p -150.71 122.19 7.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -0.914 . . . . 0.0 112.739 -169.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -78.99 104.83 9.9 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.666 -1.271 . . . . 0.0 110.512 166.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -105.95 99.8 9.37 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -171.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.13 -72.45 2.77 Favored Glycine 0 N--CA 1.491 2.328 0 O-C-N 121.689 -0.632 . . . . 0.0 114.157 -169.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -139.41 -59.87 0.57 Allowed 'General case' 0 CA--C 1.566 1.575 0 C-N-CA 123.366 0.667 . . . . 0.0 111.303 173.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -79.03 159.85 27.4 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -172.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.8 t -79.77 116.71 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.568 0 CA-C-O 121.725 0.774 . . . . 0.0 109.46 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 65.0 t -104.08 107.43 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 68.7 mt -89.64 120.56 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 167.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -102.88 103.82 14.02 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 166.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.4 m -90.55 99.25 12.31 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 170.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 mp -92.1 101.16 13.68 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.593 0.757 . . . . 0.0 108.978 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.9 t -78.24 26.9 0.2 Allowed 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.352 70.8 p 65.17 -53.87 0.33 Allowed 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -164.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -81.17 -31.88 33.85 Favored 'General case' 0 CA--C 1.577 2.018 0 C-N-CA 125.575 1.55 . . . . 0.0 115.163 174.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -136.62 127.05 26.7 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 119.763 1.165 . . . . 0.0 111.31 -173.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -88.48 104.33 16.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.329 -0.857 . . . . 0.0 110.611 171.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.6 p -102.03 99.95 10.17 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.5 0.667 . . . . 0.0 110.109 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -98.07 126.79 43.67 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.706 0.802 . . . . 0.0 112.259 -175.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.4 pt -131.47 116.84 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 C-N-CA 123.168 0.587 . . . . 0.0 111.159 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.8 p -98.54 129.86 45.1 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.896 0.879 . . . . 0.0 112.351 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -156.64 144.35 19.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.379 -0.826 . . . . 0.0 112.633 -175.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -84.81 158.54 20.64 Favored 'General case' 0 CA--C 1.57 1.722 0 O-C-N 120.861 -1.149 . . . . 0.0 110.935 156.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.32 116.37 9.67 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.67 -1.269 . . . . 0.0 111.839 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.05 -4.29 77.82 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 119.214 2.445 . . . . 0.0 119.214 -163.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -82.42 126.57 32.36 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 120.633 2.217 . . . . 0.0 111.929 -176.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -83.34 112.94 20.36 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-O 121.067 0.46 . . . . 0.0 111.424 172.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -121.53 140.45 52.19 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.763 0.825 . . . . 0.0 111.207 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.3 130.89 38.8 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.241 1.019 . . . . 0.0 111.532 171.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.447 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 19.6 tt0 -132.99 103.28 5.97 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.146 -171.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.0 m -91.23 107.19 19.04 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 174.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.7 p -80.14 162.29 24.82 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -169.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.21 -23.79 23.94 Favored 'General case' 0 CA--C 1.576 1.942 0 N-CA-C 118.825 2.898 . . . . 0.0 118.825 169.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -82.96 2.2 35.87 Favored 'General case' 0 CA--C 1.582 2.204 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 165.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.286 21.3 m-20 70.02 70.13 0.22 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 120.584 1.538 . . . . 0.0 113.128 -174.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.5 ptp85 -145.88 125.99 13.76 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 166.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -91.8 105.41 17.69 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.463 0.705 . . . . 0.0 111.132 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 72' ' ' GLU . 28.7 p -109.22 135.23 50.65 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -74.47 101.7 4.23 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-O 121.835 0.826 . . . . 0.0 109.441 164.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.0 m -102.63 128.85 49.14 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.542 0.737 . . . . 0.0 112.63 -170.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 49.4 t -122.98 121.91 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.9 t -104.46 109.47 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.227 -0.92 . . . . 0.0 109.594 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.3 p -110.46 130.06 55.64 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.796 0.838 . . . . 0.0 111.912 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.7 tt -87.84 99.63 12.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.147 -0.971 . . . . 0.0 110.605 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -101.3 75.72 1.65 Allowed 'General case' 0 CA--C 1.567 1.613 0 C-N-CA 123.481 0.712 . . . . 0.0 111.122 -176.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.34 68.15 1.76 Allowed Glycine 0 N--CA 1.495 2.597 0 N-CA-C 116.258 1.263 . . . . 0.0 116.258 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.256 23.7 m-20 60.38 22.33 11.89 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 117.222 2.305 . . . . 0.0 117.222 -166.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -133.58 107.52 8.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.938 -1.101 . . . . 0.0 109.893 -175.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.6 mt -83.09 103.32 12.43 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.793 0.837 . . . . 0.0 111.626 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 37.2 t -97.52 100.5 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -173.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -84.68 107.52 16.93 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.339 0.656 . . . . 0.0 110.204 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 70.3 mt -99.5 103.82 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -91.01 118.94 30.79 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 118.43 0.559 . . . . 0.0 111.317 176.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -112.53 112.03 23.29 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.019 0.528 . . . . 0.0 110.46 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -139.21 125.62 20.37 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.438 -0.789 . . . . 0.0 110.683 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 50.92 49.94 20.11 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 167.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.86 4.6 62.61 Favored Glycine 0 CA--C 1.558 2.739 0 N-CA-C 120.212 2.845 . . . . 0.0 120.212 -168.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -123.59 140.31 53.13 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 119.653 1.726 . . . . 0.0 110.266 -168.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -135.01 123.61 23.57 Favored 'General case' 0 CA--C 1.564 1.499 0 O-C-N 121.692 -0.63 . . . . 0.0 111.783 -175.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.0 t -115.89 137.34 52.19 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.294 0.569 . . . . 0.0 109.964 165.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.19 128.07 54.74 Favored 'General case' 0 CA--C 1.567 1.629 0 C-N-CA 123.109 0.564 . . . . 0.0 110.996 171.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -105.84 110.18 22.39 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 53.2 t -91.97 100.79 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -176.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.18 111.09 19.49 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.562 0.745 . . . . 0.0 110.677 173.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.57 129.83 43.28 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 118.96 0.8 . . . . 0.0 112.631 -174.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.9 mm -75.86 112.93 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.044 -1.035 . . . . 0.0 108.953 173.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -133.24 96.5 3.75 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -169.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.7 t70 50.37 61.1 3.38 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -169.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.07 -48.08 3.88 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 117.84 1.896 . . . . 0.0 117.84 -173.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -82.06 146.42 29.67 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 118.231 1.015 . . . . 0.0 113.086 -174.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -82.38 104.74 12.9 Favored 'General case' 0 CA--C 1.56 1.365 0 CA-C-O 121.966 0.888 . . . . 0.0 109.429 166.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 80.3 t -91.79 102.31 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 40.9 ttm -83.15 108.4 16.38 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.422 0.689 . . . . 0.0 109.8 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.1 m -99.82 115.07 28.72 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.871 0.843 . . . . 0.0 109.135 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mp -111.18 117.46 33.28 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -171.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.305 10.6 t -137.21 138.2 39.92 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 177.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -124.01 99.89 6.47 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.952 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 73.07 -90.76 0.6 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 115.299 0.88 . . . . 0.0 115.299 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -134.31 52.77 2.04 Favored 'General case' 0 CA--C 1.575 1.909 0 CA-C-O 121.482 0.658 . . . . 0.0 112.064 167.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.4 t -139.91 124.04 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 51.2 t -123.4 127.18 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-N 119.001 0.818 . . . . 0.0 109.837 -170.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -117.18 150.7 38.3 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 123.633 0.773 . . . . 0.0 112.329 163.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.8 t -131.92 114.22 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.192 -0.942 . . . . 0.0 108.947 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 mtp-105 -110.9 114.44 27.77 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.205 -0.934 . . . . 0.0 109.876 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -96.63 108.63 21.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.647 -0.658 . . . . 0.0 110.111 -167.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -103.55 132.47 49.78 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.108 -0.995 . . . . 0.0 112.4 -171.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.39 160.66 15.22 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 175.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -76.1 141.03 42.1 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -175.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.25 0 CA-C-O 117.404 -1.284 . . . . 0.0 112.447 176.427 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 . . . . . 0 N--CA 1.499 2.008 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.38 -23.83 66.06 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 117.755 2.502 . . . . 0.0 117.755 168.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -87.92 -21.81 24.71 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 172.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.5 t -76.83 95.63 4.11 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 121.197 1.817 . . . . 0.0 112.905 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -166.39 167.61 15.66 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-O 122.565 1.174 . . . . 0.0 112.333 -172.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.7 m -86.85 107.1 18.17 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.829 0.852 . . . . 0.0 108.718 173.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -105.22 109.42 21.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.972 . . . . 0.0 111.623 -169.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -95.36 129.33 42.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.281 -0.887 . . . . 0.0 111.089 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.0 tt -75.86 122.29 23.88 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -173.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 69.0 p -91.84 -52.47 4.72 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 176.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -137.97 114.54 10.45 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.739 0.815 . . . . 0.0 110.233 -173.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.7 p -101.18 78.03 1.86 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.409 1.1 . . . . 0.0 112.419 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -79.99 133.25 36.15 Favored 'General case' 0 CA--C 1.56 1.354 0 O-C-N 120.97 -1.081 . . . . 0.0 113.804 -171.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.252 1.1 t30 57.44 23.34 8.94 Favored 'General case' 0 CA--C 1.584 2.251 0 N-CA-C 117.189 2.292 . . . . 0.0 117.189 -174.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -69.46 -46.41 66.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.238 -1.539 . . . . 0.0 115.054 -175.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -47.64 -51.3 21.99 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -68.33 -40.02 81.76 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -50.5 -52.96 33.72 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 160.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.6 mtp -59.03 -43.46 91.63 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 175.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -47.75 83.58 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 164.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.02 -39.03 86.95 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.65 -47.57 85.67 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 163.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.88 48.22 1.51 Allowed Glycine 0 N--CA 1.482 1.738 0 CA-C-O 118.978 -0.901 . . . . 0.0 115.315 -175.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.7 m -80.56 151.63 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 118.822 1.311 . . . . 0.0 111.443 172.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.38 150.05 30.73 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 116.955 1.542 . . . . 0.0 116.955 173.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -55.53 -43.37 75.71 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.12 -44.9 68.06 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 166.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.3 m -64.04 -40.26 95.91 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 171.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -61.05 -49.16 78.48 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 121.691 2.041 . . . . 0.0 115.923 167.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.6 mp0 -71.14 -28.74 64.5 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.1 t -70.77 -62.13 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 119.536 1.062 . . . . 0.0 112.11 159.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.76 -31.37 71.41 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 119.903 2.721 . . . . 0.0 119.903 -166.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -73.4 -32.11 64.26 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 170.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.2 m -82.68 -34.7 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.0 t -81.5 126.4 31.64 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 120.857 1.662 . . . . 0.0 112.352 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -103.55 92.7 4.3 Favored Pre-proline 0 CA--C 1.573 1.828 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -71.91 155.65 57.46 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.384 2.056 . . . . 0.0 116.64 -171.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.1 m -88.73 100.31 13.03 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.371 -1.286 . . . . 0.0 107.64 169.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.6 t -95.65 98.43 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -171.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.1 mt -88.81 102.21 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -86.41 116.97 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 171.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.2 p -153.81 121.31 5.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.718 -0.614 . . . . 0.0 111.337 -165.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -80.24 128.69 33.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 0.0 113.098 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -120.24 90.28 3.3 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 174.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.9 68.99 1.48 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 115.613 1.005 . . . . 0.0 115.613 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.293 13.0 t70 70.94 -57.27 0.6 Allowed 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -169.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -72.59 147.84 45.47 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-O 122.568 1.175 . . . . 0.0 114.141 -172.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.0 t -96.2 122.54 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.857 -169.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.9 t -104.22 110.87 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.0 mt -92.73 99.76 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 172.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.0 mtm-85 -85.92 101.93 13.3 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.867 0.867 . . . . 0.0 111.022 173.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.6 m -89.81 101.05 13.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.591 -0.693 . . . . 0.0 109.708 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 73.2 mt -101.26 108.82 20.57 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.791 0.805 . . . . 0.0 111.618 -167.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.1 t -138.29 147.61 43.79 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 124.546 1.138 . . . . 0.0 109.369 173.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 51.1 p -76.94 53.38 0.93 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 120.634 -1.291 . . . . 0.0 113.857 173.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -161.37 -65.8 0.06 Allowed 'General case' 0 CA--C 1.571 1.784 0 C-N-CA 125.435 1.494 . . . . 0.0 107.898 -172.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -127.94 96.51 4.51 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -96.23 82.16 3.41 Favored 'General case' 0 CA--C 1.568 1.67 0 O-C-N 121.721 -0.612 . . . . 0.0 110.803 -176.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -108.35 146.23 33.3 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -170.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -131.77 127.83 37.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.275 -0.891 . . . . 0.0 113.151 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.4 mt -112.77 110.59 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.3 p -92.09 120.27 32.55 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.546 0.739 . . . . 0.0 112.393 170.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -143.96 147.4 33.88 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -174.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -87.52 1.78 52.56 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 118.59 2.811 . . . . 0.0 118.59 -172.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.4 mt 69.75 120.01 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 125.455 1.502 . . . . 0.0 112.775 -172.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.39 -32.08 4.27 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 118.142 2.017 . . . . 0.0 118.142 -171.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -73.97 136.42 43.22 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 119.309 1.555 . . . . 0.0 113.021 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -88.88 120.76 30.58 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.198 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -130.75 150.64 51.83 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.801 0.84 . . . . 0.0 111.65 -172.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -79.55 133.5 36.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.932 -1.105 . . . . 0.0 111.615 171.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -142.44 126.03 16.86 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.0 0.428 . . . . 0.0 111.992 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.2 m -73.36 132.4 42.99 Favored 'General case' 0 CA--C 1.57 1.731 0 CA-C-O 121.43 0.633 . . . . 0.0 110.478 162.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.9 p -108.82 166.47 10.78 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -169.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.15 -11.5 6.29 Favored 'General case' 0 CA--C 1.579 2.082 0 N-CA-C 119.452 3.13 . . . . 0.0 119.452 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -73.62 -25.33 60.26 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 159.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.305 4.8 m-20 82.1 65.87 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 120.738 1.608 . . . . 0.0 111.235 -162.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.9 ptt85 -162.87 142.2 8.89 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.162 0.985 . . . . 0.0 109.43 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -83.02 134.62 35.03 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 169.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.9 p -129.89 148.63 51.77 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 172.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -79.15 101.63 8.03 Favored 'General case' 0 CA--C 1.563 1.447 0 CA-C-O 122.145 0.974 . . . . 0.0 109.814 162.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.0 m -97.59 124.77 41.99 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.919 0.888 . . . . 0.0 111.96 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.01 124.59 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -115.43 116.38 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.446 -0.784 . . . . 0.0 109.574 -174.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.7 m -115.65 132.41 56.64 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.464 0.706 . . . . 0.0 112.554 -176.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.8 tt -89.11 102.1 14.76 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 123.286 0.634 . . . . 0.0 109.974 171.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -96.1 80.71 3.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.135 -0.978 . . . . 0.0 110.943 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.56 -86.03 1.15 Allowed Glycine 0 N--CA 1.494 2.523 0 O-C-N 121.184 -0.948 . . . . 0.0 114.042 -176.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -136.86 65.14 1.52 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.878 0.847 . . . . 0.0 110.179 154.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -145.81 106.8 4.14 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.6 100.67 13.27 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 121.432 -0.793 . . . . 0.0 110.695 -173.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.1 t -104.03 104.34 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -170.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -90.27 121.68 32.51 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.398 0.679 . . . . 0.0 109.792 173.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.5 mt -113.9 110.23 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -92.83 129.73 38.66 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 122.918 0.487 . . . . 0.0 111.536 171.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -122.07 123.41 41.52 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.553 0.741 . . . . 0.0 110.007 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 17.3 p90 -150.46 123.89 9.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.218 -0.926 . . . . 0.0 110.27 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 53.5 38.21 27.53 Favored 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 117.258 2.318 . . . . 0.0 117.258 174.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.46 -25.39 3.85 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 119.148 2.419 . . . . 0.0 119.148 -165.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -81.77 142.46 32.59 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 119.134 1.467 . . . . 0.0 112.307 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -139.21 123.48 18.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.872 -0.517 . . . . 0.0 111.86 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.3 t -112.66 144.15 42.65 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 123.383 0.673 . . . . 0.0 110.623 167.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -121.34 142.16 50.24 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 172.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -122.3 102.92 8.4 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -175.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 68.8 t -99.35 103.13 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -168.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -97.89 117.21 31.71 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.398 0.679 . . . . 0.0 111.406 -175.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -135.24 133.83 39.39 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.114 0.566 . . . . 0.0 111.378 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.2 mm -83.07 121.05 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.145 -0.972 . . . . 0.0 109.245 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.16 -77.02 0.41 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.796 0.438 . . . . 0.0 111.367 -175.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -133.98 82.83 2.0 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 77.06 -33.73 1.49 Allowed Glycine 0 N--CA 1.497 2.74 0 N-CA-C 118.66 2.224 . . . . 0.0 118.66 -166.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -92.05 142.31 27.66 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 118.329 1.065 . . . . 0.0 111.73 -173.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 9.9 tpp -84.24 115.37 22.42 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 121.802 0.811 . . . . 0.0 110.493 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.5 t -91.23 107.56 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.623 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 167.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 18.8 ttt -99.43 108.19 20.6 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.721 -0.612 . . . . 0.0 109.369 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.0 m -95.86 114.5 26.23 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.5 0.667 . . . . 0.0 109.28 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.1 mp -103.57 120.98 41.94 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.263 8.7 t -136.46 138.47 41.49 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 177.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -106.54 77.66 1.21 Allowed 'General case' 0 CA--C 1.565 1.545 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.058 168.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 69.89 -89.45 0.31 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 115.962 1.145 . . . . 0.0 115.962 -175.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -88.56 -35.49 16.89 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 175.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.8 t -87.27 129.71 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 119.677 1.126 . . . . 0.0 109.616 -170.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 44.9 t -123.79 125.89 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 C-N-CA 123.401 0.68 . . . . 0.0 109.512 -169.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.34 151.69 34.16 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.966 0.906 . . . . 0.0 111.943 164.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 92.2 t -124.19 117.07 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 120.778 -1.201 . . . . 0.0 108.915 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.2 mtp180 -96.62 108.75 21.41 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.275 0.63 . . . . 0.0 109.611 170.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -85.46 136.94 33.23 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.287 0.635 . . . . 0.0 111.753 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -134.37 132.45 39.46 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.653 -0.654 . . . . 0.0 111.799 -173.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -100.69 151.26 21.86 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.288 0.635 . . . . 0.0 112.38 169.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -71.34 128.65 36.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.597 -0.689 . . . . 0.0 111.901 170.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.487 0 C-N-CA 123.833 0.853 . . . . 0.0 112.564 177.713 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 N--CA 1.498 1.925 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.38 -30.21 62.43 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 117.754 2.502 . . . . 0.0 117.754 167.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -74.6 -17.93 60.64 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 117.184 2.29 . . . . 0.0 117.184 167.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 22.6 t -89.29 94.61 9.97 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 120.525 1.511 . . . . 0.0 112.667 -169.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.91 171.34 16.77 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-O 122.059 0.933 . . . . 0.0 112.509 -174.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.2 m -82.22 118.42 23.09 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.695 -1.253 . . . . 0.0 108.779 164.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -114.03 114.71 26.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.474 -0.766 . . . . 0.0 110.704 -172.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -98.82 131.89 44.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.455 -0.778 . . . . 0.0 110.933 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.11 117.38 11.6 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.4 p -89.71 -47.67 7.77 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -142.18 119.22 11.32 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 118.945 0.793 . . . . 0.0 109.91 -173.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.7 p -104.67 99.22 8.89 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.207 0.603 . . . . 0.0 111.559 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -81.87 122.92 28.34 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 123.438 0.695 . . . . 0.0 111.236 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.252 1.9 t30 59.07 23.99 12.24 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 117.818 2.525 . . . . 0.0 117.818 174.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -68.38 -45.53 72.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 119.77 -1.831 . . . . 0.0 115.582 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -46.92 -51.98 15.6 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 170.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.69 -43.81 95.55 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 173.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -51.01 -50.18 59.01 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 164.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.8 mtp -61.75 -39.78 92.81 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 174.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -59.75 -50.34 74.21 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 165.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.77 -38.97 83.32 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 116.933 2.197 . . . . 0.0 116.933 172.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.31 -23.99 67.49 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 171.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.66 35.42 8.49 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 118.088 1.995 . . . . 0.0 118.088 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.7 m -93.08 171.07 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 119.406 1.603 . . . . 0.0 112.062 173.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.54 162.33 54.0 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 117.125 1.61 . . . . 0.0 117.125 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -64.28 -46.06 85.34 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 173.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.67 -40.6 63.03 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 167.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.6 m -64.6 -42.79 95.33 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 169.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.9 mtm-85 -57.99 -43.05 86.36 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 164.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -56.46 -54.61 43.72 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.27 1.395 . . . . 0.0 113.941 167.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.0 t -50.6 -60.64 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 169.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.11 -20.98 58.76 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 120.181 2.832 . . . . 0.0 120.181 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -85.72 -41.12 15.41 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 165.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.254 17.6 m -75.04 -37.3 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 CA-C-N 121.421 1.918 . . . . 0.0 116.008 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 t -97.33 146.81 24.79 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 120.035 1.288 . . . . 0.0 112.682 -174.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 105.33 18.55 Favored Pre-proline 0 CA--C 1.578 2.037 0 O-C-N 121.379 -0.825 . . . . 0.0 111.362 174.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.1 141.68 29.85 Favored 'Trans proline' 0 CA--C 1.564 1.989 0 C-N-CA 122.566 2.177 . . . . 0.0 114.898 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.6 m -108.5 112.66 25.16 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.154 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.9 t -106.35 102.2 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -172.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.3 mt -85.4 103.54 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.1 mt -91.54 105.26 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 175.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.4 p -124.45 165.54 17.59 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 123.849 0.86 . . . . 0.0 112.035 -171.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -126.81 126.19 42.97 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.95 -1.094 . . . . 0.0 110.851 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -114.31 81.51 1.55 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.631 0.729 . . . . 0.0 110.024 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.9 -95.96 0.84 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -89.85 -27.52 19.87 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -102.84 149.38 24.55 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-N 119.826 1.193 . . . . 0.0 113.312 -174.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.5 t -86.64 125.37 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.772 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 165.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.0 106.17 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.2 mt -92.59 120.67 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -103.19 100.97 10.9 Favored 'General case' 0 CA--C 1.561 1.39 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 169.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 50.8 m -87.32 99.14 11.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.639 -0.663 . . . . 0.0 109.384 172.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.7 mp -97.29 97.29 9.02 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.6 t -89.26 34.09 0.8 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 174.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.347 73.0 p 67.78 -58.45 0.44 Allowed 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 -174.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -91.66 -61.27 1.67 Allowed 'General case' 0 CA--C 1.569 1.679 0 C-N-CA 124.923 1.289 . . . . 0.0 110.48 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -87.53 104.9 16.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.514 -0.741 . . . . 0.0 110.542 173.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -108.22 106.91 17.31 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.545 0.688 . . . . 0.0 109.34 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.4 p -119.66 135.52 54.78 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 123.433 0.693 . . . . 0.0 111.458 -157.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -127.02 133.68 50.48 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.096 -1.003 . . . . 0.0 113.501 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.4 pt -133.77 120.37 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 C-N-CA 123.484 0.713 . . . . 0.0 110.851 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 90.1 p -106.77 125.51 51.09 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 124.254 1.022 . . . . 0.0 111.858 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -156.54 148.62 23.09 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.297 -0.877 . . . . 0.0 112.795 -168.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -98.61 21.71 10.91 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 117.623 2.453 . . . . 0.0 117.623 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.7 mt 67.62 112.73 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 125.138 1.375 . . . . 0.0 114.027 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.19 -26.04 4.04 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 117.998 1.959 . . . . 0.0 117.998 -162.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -75.91 126.94 31.95 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 124.711 1.204 . . . . 0.0 111.941 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -72.87 141.64 47.93 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -141.76 143.61 33.57 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.934 0.894 . . . . 0.0 110.306 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.85 134.81 35.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.536 -1.352 . . . . 0.0 111.516 172.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -133.13 105.56 7.1 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.058 0.543 . . . . 0.0 110.554 -172.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.7 m -76.31 104.72 6.97 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.423 -0.798 . . . . 0.0 108.958 167.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.0 p -78.82 -178.1 5.82 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -165.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.2 -12.63 3.76 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 118.968 2.951 . . . . 0.0 118.968 168.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -120.19 43.33 2.73 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 119.572 -1.955 . . . . 0.0 113.421 155.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.285 10.5 t70 65.91 -1.22 1.15 Allowed 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 119.374 3.101 . . . . 0.0 119.374 168.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.3 ptt85 -76.46 123.21 25.67 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.37 -1.456 . . . . 0.0 110.978 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -80.12 106.06 11.85 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.888 0.875 . . . . 0.0 112.819 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.0 m -110.03 117.92 35.03 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -167.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -67.6 103.05 1.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.812 0.845 . . . . 0.0 110.338 169.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.6 m -115.92 122.48 45.44 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 121.843 -0.535 . . . . 0.0 111.68 -158.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 99.3 t -115.25 116.0 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.4 t -96.42 108.75 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 173.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.4 p -112.01 117.16 31.92 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.536 0.735 . . . . 0.0 111.599 -173.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tt -84.1 96.49 8.93 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.086 -1.009 . . . . 0.0 110.135 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -91.27 73.76 6.19 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 121.433 -0.792 . . . . 0.0 111.62 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.34 -86.88 1.49 Allowed Glycine 0 N--CA 1.49 2.274 0 O-C-N 121.828 -0.545 . . . . 0.0 113.441 -175.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -132.24 50.62 2.22 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 168.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -153.6 121.12 5.89 Favored 'General case' 0 CA--C 1.564 1.509 0 O-C-N 120.61 -1.306 . . . . 0.0 110.511 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.8 mt -83.56 106.91 15.67 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.758 0.823 . . . . 0.0 111.116 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.2 t -103.21 100.02 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -173.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -86.34 104.46 15.87 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.745 0.818 . . . . 0.0 110.895 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.4 mt -99.31 100.47 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -172.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -87.4 125.67 34.41 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 118.835 0.743 . . . . 0.0 111.53 174.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -116.54 117.88 31.11 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 123.839 0.856 . . . . 0.0 110.387 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.3 p90 -148.42 129.78 14.74 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.866 -1.146 . . . . 0.0 110.716 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 53.69 42.13 31.91 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 166.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.03 17.03 71.33 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 119.893 2.717 . . . . 0.0 119.893 -166.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -132.66 143.13 49.44 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 119.243 1.521 . . . . 0.0 110.042 -170.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -138.55 131.45 29.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.525 -0.734 . . . . 0.0 112.245 -174.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 t -128.07 129.98 47.49 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.563 0.745 . . . . 0.0 109.309 169.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.24 128.78 54.74 Favored 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 123.122 0.569 . . . . 0.0 111.111 174.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -106.58 106.95 17.72 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.1 t -88.78 109.45 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -105.69 102.23 11.69 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.989 0.916 . . . . 0.0 110.374 -174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.49 141.82 51.75 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.788 0.835 . . . . 0.0 112.532 -168.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.8 mm -80.77 117.93 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 120.82 -1.175 . . . . 0.0 109.619 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.45 89.87 3.17 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 171.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.5 t70 50.15 66.12 1.24 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.6 -48.5 3.33 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 117.435 1.734 . . . . 0.0 117.435 -171.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -83.36 142.87 30.72 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 118.904 1.352 . . . . 0.0 112.818 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.0 ttt -90.65 111.46 22.81 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.843 0.83 . . . . 0.0 110.303 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 69.4 t -93.93 108.6 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.56 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 23.9 ttt -89.65 112.52 23.79 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.704 0.802 . . . . 0.0 109.78 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.2 m -100.44 111.24 23.48 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mp -104.79 112.64 25.82 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.428 1.091 . . . . 0.0 108.139 -172.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.267 13.2 t -131.47 142.0 49.9 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -122.75 81.42 1.86 Allowed 'General case' 0 CA--C 1.564 1.507 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.76 173.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 71.18 -92.98 0.5 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 115.579 0.992 . . . . 0.0 115.579 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -86.89 -37.01 18.09 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.3 t -82.01 134.28 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-N 119.343 0.974 . . . . 0.0 110.157 -171.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.5 t -129.4 121.22 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -175.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.14 154.45 23.29 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 123.548 0.739 . . . . 0.0 112.44 164.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.3 t -132.41 113.47 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.146 -0.971 . . . . 0.0 109.25 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -106.12 124.33 49.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.176 -0.953 . . . . 0.0 110.856 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -108.62 115.68 30.55 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 123.252 0.621 . . . . 0.0 110.602 -165.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -114.69 133.21 56.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.794 -1.191 . . . . 0.0 113.22 -166.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -98.94 153.81 18.54 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 123.338 0.655 . . . . 0.0 112.626 166.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -74.27 135.29 42.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.176 0 CA-C-O 117.923 -1.037 . . . . 0.0 112.225 170.598 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.358 9.0 tt0 . . . . . 0 N--CA 1.497 1.891 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.28 -29.35 68.76 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 153.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -82.12 -6.28 59.06 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 169.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.6 t -74.86 91.34 2.44 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-N 122.194 2.27 . . . . 0.0 113.644 -172.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -168.29 169.2 10.96 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-O 122.243 1.02 . . . . 0.0 112.27 -170.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.6 m -86.71 123.09 31.49 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.238 -0.914 . . . . 0.0 108.907 167.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -118.37 118.69 32.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.427 -0.796 . . . . 0.0 111.026 -171.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -104.15 136.98 42.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.04 -1.037 . . . . 0.0 111.113 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.25 121.04 14.8 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.1 p -108.93 -26.07 10.41 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -150.61 113.82 4.85 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 121.037 1.744 . . . . 0.0 109.484 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.7 p -94.47 89.38 5.82 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 122.454 1.121 . . . . 0.0 111.936 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -88.76 110.22 20.82 Favored 'General case' 0 CA--C 1.563 1.45 0 O-C-N 121.079 -1.013 . . . . 0.0 110.93 -170.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.262 56.4 t30 62.88 35.37 13.57 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 -174.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -83.17 66.08 8.55 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 123.747 1.737 . . . . 0.0 111.845 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -165.07 -68.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.99 -1.459 . . . . 0.0 107.728 -156.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -65.61 -42.32 91.73 Favored 'General case' 0 CA--C 1.565 1.525 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 172.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -46.41 -52.41 13.04 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 163.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.481 ' SD ' HG11 ' A' ' 25' ' ' VAL . 22.8 mmt -60.22 -49.98 75.48 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 175.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.5 -46.43 76.95 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 168.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.41 -35.88 76.19 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 117.581 2.437 . . . . 0.0 117.581 175.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 tt -62.81 -39.19 93.51 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 171.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.63 55.68 1.31 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 114.808 0.683 . . . . 0.0 114.808 -169.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.481 HG11 ' SD ' ' A' ' 20' ' ' MET . 26.9 m -90.42 163.24 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-O 122.329 1.061 . . . . 0.0 112.055 173.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.88 142.04 31.37 Favored Glycine 0 CA--C 1.55 2.249 0 O-C-N 121.007 -1.058 . . . . 0.0 113.444 160.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -59.37 -41.16 88.66 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.96 -41.15 64.26 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 165.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.0 m -58.39 -50.36 73.96 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 120.201 1.364 . . . . 0.0 114.231 170.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.269 5.7 ptt180 -62.44 -36.25 81.82 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 172.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -63.16 -50.9 68.56 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 166.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.4 t -46.57 -48.96 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.81 -30.22 66.29 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 119.404 2.521 . . . . 0.0 119.404 170.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -76.68 -46.42 25.69 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 119.8 1.8 . . . . 0.0 115.238 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.259 28.3 m -89.16 47.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 CA-C-N 121.254 1.843 . . . . 0.0 113.715 175.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.6 t -145.18 161.72 38.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.116 -0.99 . . . . 0.0 111.922 172.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -102.27 91.32 2.51 Favored Pre-proline 0 CA--C 1.574 1.868 0 O-C-N 121.38 -0.825 . . . . 0.0 109.545 162.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.44 123.68 7.23 Favored 'Trans proline' 0 C--N 1.373 1.825 0 CA-C-N 122.684 1.994 . . . . 0.0 112.827 -174.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.0 m -101.01 102.74 13.8 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -173.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.6 t -95.85 102.96 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -171.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.0 mt -90.7 110.79 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.0 mt -94.29 122.64 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 170.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.7 p -134.83 143.8 47.24 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.178 0.591 . . . . 0.0 112.298 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -99.35 113.29 25.53 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.019 -1.051 . . . . 0.0 109.157 168.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -113.33 90.55 3.37 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.468 -0.77 . . . . 0.0 110.316 -174.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.84 -77.39 1.79 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 115.317 0.887 . . . . 0.0 115.317 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -117.96 -54.94 2.3 Favored 'General case' 0 CA--C 1.567 1.614 0 C-N-CA 123.712 0.805 . . . . 0.0 111.819 171.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -79.2 157.9 27.76 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -173.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.9 t -89.81 124.7 42.62 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.601 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.0 t -114.42 105.7 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 76.9 mt -97.05 120.64 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -106.37 101.69 11.14 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.62 0.724 . . . . 0.0 109.837 171.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.3 m -84.33 98.54 10.07 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 170.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 63.9 mt -94.24 93.52 7.8 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -174.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.8 t -79.57 18.04 0.8 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 118.313 2.708 . . . . 0.0 118.313 -174.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.441 7.4 p 63.61 -60.72 0.17 Allowed 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 125.26 1.424 . . . . 0.0 114.739 -163.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -66.03 -46.17 78.83 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 173.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.69 119.78 7.73 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 119.125 0.875 . . . . 0.0 110.216 -165.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -104.52 112.52 25.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.318 -0.864 . . . . 0.0 111.901 -166.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 p -105.82 110.67 23.04 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.714 -0.616 . . . . 0.0 110.808 -170.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -109.35 107.66 17.93 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.21 1.004 . . . . 0.0 110.64 -175.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.5 pt -109.55 121.15 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 C-N-CA 123.491 0.716 . . . . 0.0 110.496 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 97.2 p -110.72 111.44 22.63 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.228 1.011 . . . . 0.0 110.882 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -148.37 151.4 35.24 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.062 0.934 . . . . 0.0 112.89 -165.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -86.3 148.7 25.5 Favored 'General case' 0 CA--C 1.571 1.765 0 O-C-N 121.211 -0.931 . . . . 0.0 111.06 162.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 73.3 mt -71.05 124.67 24.93 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.237 -1.539 . . . . 0.0 111.922 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.35 -3.45 86.57 Favored Glycine 0 CA--C 1.556 2.628 0 N-CA-C 119.081 2.392 . . . . 0.0 119.081 -162.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -86.95 124.57 33.3 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 120.066 1.933 . . . . 0.0 110.761 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -87.25 107.85 18.68 Favored 'General case' 0 CA--C 1.565 1.535 0 O-C-N 121.877 -0.515 . . . . 0.0 110.91 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -112.88 159.88 18.6 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.379 1.072 . . . . 0.0 111.825 -175.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -83.3 137.67 33.88 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.423 -1.423 . . . . 0.0 111.952 171.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -129.96 111.71 12.8 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.287 0.635 . . . . 0.0 109.798 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.8 m -74.89 96.59 3.15 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 122.023 0.916 . . . . 0.0 109.709 170.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 80.5 p -74.08 173.99 9.28 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -167.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.18 -5.43 1.08 Allowed 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 119.442 3.126 . . . . 0.0 119.442 167.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -95.17 -8.28 36.77 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 159.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.318 3.2 m-20 80.5 12.22 0.94 Allowed 'General case' 0 N--CA 1.507 2.417 0 CA-C-N 121.513 1.96 . . . . 0.0 116.18 -166.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -91.78 130.48 37.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.444 -1.41 . . . . 0.0 110.176 173.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -82.32 110.99 17.97 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.15 0.5 . . . . 0.0 110.973 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 93.4 m -103.71 118.95 37.91 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -173.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -69.81 104.95 2.6 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.906 0.86 . . . . 0.0 110.56 171.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.3 m -120.22 117.61 28.32 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.894 -156.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.2 p -109.01 118.45 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.225 0.536 . . . . 0.0 109.757 175.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.6 t -96.81 110.5 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 173.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 79.6 p -110.44 131.19 55.27 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.706 0.802 . . . . 0.0 110.906 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -83.15 120.39 25.73 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.957 -1.089 . . . . 0.0 109.787 161.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -122.91 72.55 1.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.108 -169.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.61 60.81 8.23 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 117.071 1.588 . . . . 0.0 117.071 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.347 5.5 m-20 92.08 -31.74 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 -167.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -97.28 124.17 41.31 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 120.897 1.68 . . . . 0.0 112.322 -170.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.8 mt -81.03 103.75 11.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.162 -0.961 . . . . 0.0 110.745 170.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.0 t -104.72 106.04 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.715 -1.241 . . . . 0.0 107.733 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -93.87 105.79 17.79 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.029 0.932 . . . . 0.0 110.148 177.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.33 104.46 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 123.354 0.661 . . . . 0.0 109.383 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -85.15 125.61 32.95 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 118.887 0.767 . . . . 0.0 111.626 171.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -116.08 126.42 53.73 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.317 0.647 . . . . 0.0 110.575 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 15.6 p90 -150.18 124.49 9.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.351 -0.843 . . . . 0.0 110.492 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 55.99 33.72 22.33 Favored 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 117.087 2.254 . . . . 0.0 117.087 173.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.8 -18.23 21.84 Favored Glycine 0 CA--C 1.559 2.805 0 N-CA-C 119.325 2.49 . . . . 0.0 119.325 -164.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -89.17 145.46 25.41 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-N 119.489 1.644 . . . . 0.0 112.836 -175.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -130.25 129.29 43.12 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.747 0.819 . . . . 0.0 110.709 -174.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.2 t -123.9 129.01 50.29 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.643 -0.66 . . . . 0.0 109.327 159.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -112.95 127.01 56.1 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.412 0.685 . . . . 0.0 110.709 175.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -106.43 102.39 11.79 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -175.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.4 t -88.19 102.8 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -173.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -108.35 110.47 22.04 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.076 0.95 . . . . 0.0 109.015 -169.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -129.73 137.68 50.7 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -170.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.1 mm -77.0 99.38 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 171.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -109.99 111.09 22.27 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.8 t70 47.12 52.83 11.45 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -171.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.02 -23.99 4.18 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 119.599 2.6 . . . . 0.0 119.599 -170.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -94.06 136.24 34.56 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 119.522 1.661 . . . . 0.0 111.454 -172.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 50.1 ttp -81.01 102.72 10.36 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.253 1.025 . . . . 0.0 110.167 172.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 87.5 t -89.52 101.76 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 46.6 ttm -87.37 101.02 13.16 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.536 0.735 . . . . 0.0 109.476 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 93.1 m -91.56 101.42 14.06 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.888 0.851 . . . . 0.0 108.737 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 mp -88.83 117.87 28.13 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.307 6.5 t -137.94 133.66 34.01 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 175.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -99.01 89.9 4.44 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.342 171.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 71.86 -86.75 0.46 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 114.952 0.741 . . . . 0.0 114.952 -172.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -127.75 3.67 6.07 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 174.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.4 125.11 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-N 121.82 2.1 . . . . 0.0 107.994 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.1 t -120.6 130.56 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.816 -0.553 . . . . 0.0 111.139 -162.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.28 148.59 35.31 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 123.484 0.714 . . . . 0.0 111.588 156.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.3 t -125.64 107.5 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 120.743 -1.223 . . . . 0.0 108.807 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -95.62 120.26 35.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.213 -0.929 . . . . 0.0 111.139 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -97.73 97.91 9.41 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.367 0.603 . . . . 0.0 110.131 -172.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -94.53 135.62 35.77 Favored 'General case' 0 CA--C 1.561 1.403 0 O-C-N 121.353 -0.842 . . . . 0.0 112.024 -174.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -122.66 154.87 37.46 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.481 0.712 . . . . 0.0 111.454 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -72.02 136.86 46.85 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -172.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.194 0 C-N-CA 124.183 0.993 . . . . 0.0 111.363 170.321 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 N--CA 1.499 2.007 0 N-CA-C 116.358 1.984 . . . . 0.0 116.358 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.11 -29.38 30.5 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 118.201 2.667 . . . . 0.0 118.201 164.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -82.49 -9.78 59.28 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 169.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.6 t -73.59 102.62 3.93 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-N 122.054 2.206 . . . . 0.0 114.004 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -172.17 163.59 5.9 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 122.211 1.005 . . . . 0.0 111.788 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.2 m -78.84 122.64 26.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.015 -1.053 . . . . 0.0 108.375 153.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -106.14 115.79 30.82 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.085 -1.01 . . . . 0.0 110.218 -175.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -92.5 129.8 38.34 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.646 0.778 . . . . 0.0 111.272 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 tt -73.05 113.21 9.84 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-O 121.353 0.597 . . . . 0.0 112.526 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.0 p -85.25 -45.84 11.6 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -148.51 117.33 6.69 Favored 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 123.785 0.834 . . . . 0.0 109.734 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.7 p -99.91 98.54 9.3 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.126 0.57 . . . . 0.0 111.535 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -80.05 122.1 26.34 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 123.437 0.695 . . . . 0.0 111.261 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 t30 55.32 38.19 29.98 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 118.15 2.648 . . . . 0.0 118.15 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -78.97 -35.94 42.27 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -176.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -50.18 -59.56 3.81 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 172.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -59.06 -37.66 77.57 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 171.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -57.66 -48.39 79.63 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 115.448 1.648 . . . . 0.0 115.448 168.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -57.85 -49.4 76.8 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 167.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -44.26 65.32 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 168.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.61 -41.33 98.32 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 170.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.37 -13.0 24.55 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 118.406 2.743 . . . . 0.0 118.406 170.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.75 55.61 1.75 Allowed Glycine 0 N--CA 1.485 1.931 0 CA-C-N 119.329 0.968 . . . . 0.0 115.342 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.3 m -95.44 146.43 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 117.565 0.682 . . . . 0.0 112.221 175.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.23 144.95 35.38 Favored Glycine 0 CA--C 1.551 2.298 0 N-CA-C 115.277 0.871 . . . . 0.0 115.277 169.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -78.92 60.75 2.95 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 123.311 1.529 . . . . 0.0 114.237 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -165.57 -55.24 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 126.418 1.887 . . . . 0.0 108.63 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.1 m -40.46 -40.0 1.12 Allowed 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 160.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.329 0.0 OUTLIER -94.01 -2.38 53.11 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 119.436 3.124 . . . . 0.0 119.436 172.767 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -65.37 -46.5 79.9 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 120.815 1.643 . . . . 0.0 112.599 151.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.7 t -52.29 -55.01 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 160.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.97 -40.64 91.3 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 120.548 2.979 . . . . 0.0 120.548 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -72.06 -33.45 67.97 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 175.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.3 m -69.81 -35.45 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.6 t -86.96 137.44 32.36 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -91.22 117.57 67.94 Favored Pre-proline 0 CA--C 1.576 1.963 0 CA-C-O 117.851 -1.071 . . . . 0.0 111.0 166.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -76.06 127.31 9.88 Favored 'Trans proline' 0 CA--C 1.562 1.907 0 CA-C-N 123.404 2.251 . . . . 0.0 115.356 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.9 m -99.28 123.24 43.41 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.079 0.952 . . . . 0.0 109.015 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.9 t -105.82 106.51 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.55 -0.718 . . . . 0.0 109.537 -168.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.8 mt -90.79 106.66 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 120.141 -1.599 . . . . 0.0 108.273 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 81.6 mt -90.38 111.55 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.2 p -135.67 119.76 17.63 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -169.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -90.9 116.72 28.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.324 -0.86 . . . . 0.0 111.842 -171.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -114.55 79.97 1.34 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.477 0.656 . . . . 0.0 110.543 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.2 -97.35 0.66 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 115.509 0.964 . . . . 0.0 115.509 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.36 -41.55 69.6 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 170.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -113.08 153.36 28.31 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-O 122.164 0.983 . . . . 0.0 113.41 -160.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.2 t -89.23 115.67 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.651 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 167.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.22 100.86 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 175.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 58.9 mt -94.28 114.25 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -98.91 102.97 14.88 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 122.979 0.512 . . . . 0.0 110.054 174.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.8 m -87.89 101.48 13.77 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.534 0.683 . . . . 0.0 109.187 173.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.6 mt -96.74 96.88 8.89 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.385 0.674 . . . . 0.0 109.396 -175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -83.73 22.38 1.12 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 175.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.418 20.5 p 63.23 -62.1 0.14 Allowed 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 125.59 1.556 . . . . 0.0 114.755 -167.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -76.76 -37.79 55.27 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 173.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -120.5 124.81 46.3 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 119.49 1.041 . . . . 0.0 110.945 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -93.83 104.33 16.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.034 -1.041 . . . . 0.0 109.207 164.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.255 13.6 t -107.57 87.07 2.42 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.013 0.911 . . . . 0.0 109.617 174.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -106.2 142.63 35.57 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -172.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.9 pt -133.83 123.01 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 C-N-CA 123.044 0.537 . . . . 0.0 111.711 -168.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.9 p -109.99 107.63 17.58 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.812 0.845 . . . . 0.0 110.742 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -140.91 150.47 43.21 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.597 0.713 . . . . 0.0 112.543 -169.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -95.8 98.23 10.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.159 -0.963 . . . . 0.0 109.819 170.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.7 mt -6.07 109.12 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 120.513 3.523 . . . . 0.0 120.513 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.92 -18.83 45.41 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 118.97 2.348 . . . . 0.0 118.97 -167.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.36 127.76 33.87 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 119.716 1.758 . . . . 0.0 111.834 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -79.03 127.77 32.42 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -137.67 150.43 47.35 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.698 0.761 . . . . 0.0 111.42 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -75.85 132.98 40.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.899 -1.126 . . . . 0.0 112.101 170.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -133.09 111.05 10.63 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.238 0.615 . . . . 0.0 110.149 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 95.0 m -82.19 109.66 16.68 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 165.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 51.2 p -82.96 -177.64 6.84 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -165.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.02 -16.6 32.36 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 118.773 2.879 . . . . 0.0 118.773 168.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -79.55 -14.93 58.51 Favored 'General case' 0 CA--C 1.579 2.068 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 157.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.331 5.0 t70 75.88 14.83 2.6 Favored 'General case' 0 CA--C 1.58 2.129 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -160.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.0 ptt-85 -83.34 124.1 30.29 Favored 'General case' 0 CA--C 1.565 1.553 0 O-C-N 120.084 -1.635 . . . . 0.0 109.737 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -85.7 118.07 24.97 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.149 0.58 . . . . 0.0 112.417 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.9 p -122.33 145.64 48.06 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -76.81 105.05 7.64 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.807 0.813 . . . . 0.0 109.709 160.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.7 m -99.53 124.92 45.15 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.536 0.735 . . . . 0.0 112.324 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.31 118.01 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 36.1 t -119.71 95.25 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.36 -0.838 . . . . 0.0 109.073 -171.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.7 m -113.64 130.32 56.42 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.648 0.779 . . . . 0.0 111.612 -169.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 tt -85.29 109.07 18.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.12 -0.988 . . . . 0.0 110.456 170.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -90.57 -16.51 28.63 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 -176.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 176.86 -88.05 0.08 OUTLIER Glycine 0 N--CA 1.49 2.235 0 CA-C-N 120.075 1.307 . . . . 0.0 110.954 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -101.92 32.12 3.58 Favored 'General case' 0 CA--C 1.579 2.071 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 158.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -146.23 114.18 6.52 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.874 0.761 . . . . 0.0 109.951 -159.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 mt -90.2 102.27 14.99 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 123.72 0.808 . . . . 0.0 109.625 172.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.6 t -100.12 105.45 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.149 -0.969 . . . . 0.0 108.603 -170.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -95.04 101.07 12.8 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.427 0.691 . . . . 0.0 110.369 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 59.4 mt -89.47 122.79 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 C-N-CA 123.959 0.903 . . . . 0.0 108.76 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -111.37 123.42 50.18 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 119.477 1.035 . . . . 0.0 110.732 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -113.34 117.84 32.93 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.959 0.904 . . . . 0.0 109.771 -176.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -150.65 127.05 10.71 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.648 -1.282 . . . . 0.0 111.496 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 56.63 32.27 20.69 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 174.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.68 -27.15 4.9 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 118.432 2.133 . . . . 0.0 118.432 -162.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -80.99 140.71 35.03 Favored 'General case' 0 CA--C 1.562 1.426 0 CA-C-N 119.121 1.461 . . . . 0.0 112.158 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -131.26 126.71 36.14 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.235 0.614 . . . . 0.0 110.128 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.7 t -122.3 156.26 34.23 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.413 0.685 . . . . 0.0 110.743 171.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.283 9.7 p30 -135.47 146.24 47.98 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 170.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -120.16 106.14 11.66 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.7 t -90.82 98.38 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -92.23 97.7 11.06 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -176.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -117.08 130.54 56.72 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -168.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.1 mm -74.94 111.04 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.12 -91.05 0.18 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 119.399 -0.334 . . . . 0.0 110.14 -173.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -104.7 70.43 0.93 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 119.342 0.974 . . . . 0.0 108.851 164.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.64 -39.95 2.85 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 118.128 2.011 . . . . 0.0 118.128 -169.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -84.34 144.9 28.54 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.256 1.028 . . . . 0.0 113.262 -173.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 55.8 ttp -84.05 100.32 11.02 Favored 'General case' 0 CA--C 1.561 1.394 0 CA-C-O 122.291 1.043 . . . . 0.0 110.204 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.1 t -85.38 102.76 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 43.1 ttm -86.89 101.36 13.31 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.213 0.605 . . . . 0.0 109.676 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.7 m -90.87 110.1 21.32 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 174.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.5 mp -99.37 119.75 38.46 Favored 'General case' 0 CA--C 1.56 1.339 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -176.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.0 t -125.56 124.2 40.75 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 119.406 1.003 . . . . 0.0 112.646 -171.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -137.19 97.14 3.42 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 123.816 0.846 . . . . 0.0 110.51 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 77.32 -94.2 1.13 Allowed Glycine 0 N--CA 1.492 2.374 0 O-C-N 121.433 -0.792 . . . . 0.0 114.084 170.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -128.39 42.84 3.25 Favored 'General case' 0 CA--C 1.578 2.033 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 160.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 81.4 t -136.88 118.94 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 -177.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.84 131.09 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.05 157.07 21.19 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 123.088 0.555 . . . . 0.0 112.481 163.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.3 t -132.58 109.21 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.032 -1.043 . . . . 0.0 108.99 175.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -100.24 114.41 27.84 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.804 0.811 . . . . 0.0 110.748 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -95.83 106.01 18.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.66 -0.65 . . . . 0.0 110.145 -170.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -105.58 128.19 53.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.889 -1.132 . . . . 0.0 113.391 -168.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -99.41 156.52 16.97 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 124.062 0.945 . . . . 0.0 113.352 173.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -77.72 130.05 36.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.152 -0.967 . . . . 0.0 113.285 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.166 0 C-N-CA 124.493 1.117 . . . . 0.0 110.859 162.693 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.12 -23.78 62.43 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 166.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -78.71 -18.07 54.89 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 167.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 71.9 m -73.94 92.16 2.08 Favored 'General case' 0 CA--C 1.568 1.671 0 CA-C-N 122.284 2.311 . . . . 0.0 113.855 -173.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.66 166.6 13.83 Favored 'General case' 0 CA--C 1.571 1.754 0 CA-C-O 122.423 1.106 . . . . 0.0 112.328 -170.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.3 m -84.86 111.87 20.03 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.342 -0.849 . . . . 0.0 109.18 166.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -105.87 118.68 37.22 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.912 0.485 . . . . 0.0 110.603 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -103.32 137.83 40.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.14 -0.975 . . . . 0.0 111.628 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -72.78 129.94 39.34 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.0 p -102.18 -37.5 8.1 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -158.15 117.57 3.21 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 119.602 1.092 . . . . 0.0 109.33 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.1 p -97.02 89.4 4.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.726 -0.609 . . . . 0.0 111.562 171.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.99 124.32 29.67 Favored 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 123.763 0.825 . . . . 0.0 111.283 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.307 11.3 t-20 61.89 10.29 3.45 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 118.316 2.71 . . . . 0.0 118.316 -174.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -62.2 -33.61 74.88 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 116.635 2.087 . . . . 0.0 116.635 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -51.99 -52.67 49.03 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 166.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -63.81 -42.98 97.56 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 172.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -52.49 -52.31 55.09 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 166.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 78.9 mtm -58.98 -48.79 80.3 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 173.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -54.24 -48.3 71.28 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 169.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.3 -38.21 82.93 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 tp -72.3 -1.92 17.17 Favored 'General case' 0 CA--C 1.579 2.061 0 N-CA-C 117.905 2.557 . . . . 0.0 117.905 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.22 48.9 5.2 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 117.101 1.6 . . . . 0.0 117.101 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.468 HG21 ' HB2' ' A' ' 30' ' ' ARG . 24.1 m -82.42 131.49 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 173.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.64 58.04 4.9 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 116.65 1.42 . . . . 0.0 116.65 173.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.288 25.8 t80 63.35 -58.33 0.17 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.647 2.091 . . . . 0.0 116.647 -175.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.33 -46.97 76.34 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 116.939 2.2 . . . . 0.0 116.939 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.2 m -63.9 -33.47 75.78 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 172.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.468 ' HB2' HG21 ' A' ' 25' ' ' VAL . 3.7 tmt_? -60.17 -53.75 53.96 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 162.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.89 -37.25 86.69 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.5 t -53.68 -62.27 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 C-N-CA 123.804 0.841 . . . . 0.0 112.684 156.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.54 -35.45 45.08 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 120.337 2.895 . . . . 0.0 120.337 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -69.47 -47.49 63.76 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 172.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.3 m -78.04 -33.35 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.5 t -83.39 147.14 28.06 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 119.274 0.943 . . . . 0.0 113.203 -172.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -107.21 91.11 6.28 Favored Pre-proline 0 CA--C 1.572 1.811 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -77.68 118.25 4.48 Favored 'Trans proline' 0 C--N 1.372 1.793 0 CA-C-N 122.463 1.915 . . . . 0.0 113.616 -169.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.4 m -88.15 123.15 32.52 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.913 0.863 . . . . 0.0 110.577 -172.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.0 t -100.48 101.64 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -173.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 64.9 mt -92.76 111.31 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.2 mt -101.84 121.36 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.2 t -143.24 -172.73 3.75 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-O 122.509 1.147 . . . . 0.0 111.819 173.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -135.28 118.19 16.26 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.334 1.054 . . . . 0.0 109.472 -176.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -100.49 91.75 4.83 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.65 0.738 . . . . 0.0 110.953 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.55 -74.8 1.48 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 115.904 1.122 . . . . 0.0 115.904 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -121.58 -45.97 2.28 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -88.3 155.94 19.45 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 120.368 1.44 . . . . 0.0 114.148 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.0 t -90.4 133.46 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 C-N-CA 123.47 0.708 . . . . 0.0 109.305 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 93.7 t -114.7 117.42 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.9 mt -95.28 107.88 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.693 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 162.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -78.91 149.75 32.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.65 -1.281 . . . . 0.0 110.161 156.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.6 m -147.63 99.52 3.12 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.282 -1.511 . . . . 0.0 107.93 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.8 mt -117.97 103.28 9.77 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.703 0.763 . . . . 0.0 110.443 -154.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.7 t -82.36 163.15 21.91 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 122.27 1.033 . . . . 0.0 112.655 168.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.8 p -57.36 15.19 0.0 OUTLIER 'General case' 0 CA--C 1.591 2.556 0 N-CA-C 118.003 2.594 . . . . 0.0 118.003 153.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -146.32 -69.09 0.26 Allowed 'General case' 0 CA--C 1.57 1.744 0 C-N-CA 124.977 1.311 . . . . 0.0 107.877 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -100.34 121.71 41.95 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.944 0.898 . . . . 0.0 111.867 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -96.54 82.26 3.33 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.848 0.832 . . . . 0.0 111.043 174.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.5 p -85.41 155.91 21.07 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -168.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -142.67 134.24 26.55 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.479 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 8.2 mt -128.98 102.72 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 -174.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 92.0 p -104.75 123.47 47.7 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 123.923 0.889 . . . . 0.0 111.83 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -148.77 142.37 25.44 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.116 0.96 . . . . 0.0 112.773 -168.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -84.76 11.95 8.17 Favored 'General case' 0 CA--C 1.58 2.1 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.263 65.0 mt 64.85 105.54 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 125.556 1.542 . . . . 0.0 113.35 -168.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.16 35.87 36.9 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 118.352 2.101 . . . . 0.0 118.352 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -135.4 135.49 40.66 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 118.467 1.134 . . . . 0.0 110.089 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -89.45 116.61 27.76 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -171.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.479 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 46.4 p90 -116.42 141.25 48.42 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.889 0.876 . . . . 0.0 111.054 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.61 135.38 43.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.567 -1.333 . . . . 0.0 111.907 170.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -134.11 105.21 6.57 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -171.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.2 m -79.83 100.52 8.04 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 122.106 0.955 . . . . 0.0 109.31 172.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 77.8 p -76.38 174.64 9.98 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -169.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.84 -2.53 0.57 Allowed 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 119.885 3.291 . . . . 0.0 119.885 167.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -103.02 4.1 36.92 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 115.594 1.702 . . . . 0.0 115.594 158.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.29 3.4 t70 62.65 25.9 15.37 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 -166.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.8 ptp85 -89.65 126.01 35.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.642 -1.286 . . . . 0.0 109.117 166.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -85.66 101.49 12.78 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-O 121.811 0.815 . . . . 0.0 111.384 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 99.0 m -102.19 116.79 33.4 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 121.395 0.616 . . . . 0.0 112.654 -169.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -66.19 102.47 0.84 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.24 1.016 . . . . 0.0 110.37 169.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.5 m -114.09 125.24 53.75 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 121.849 -0.532 . . . . 0.0 111.48 -156.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.78 122.15 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.8 t -109.03 121.86 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.224 -0.922 . . . . 0.0 109.337 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 94.7 p -118.0 140.92 49.05 Favored 'General case' 0 CA--C 1.564 1.504 0 C-N-CA 123.956 0.902 . . . . 0.0 111.963 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.8 tp -92.91 98.37 11.33 Favored 'General case' 0 CA--C 1.566 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 110.302 174.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -91.59 73.55 5.92 Favored 'General case' 0 CA--C 1.569 1.691 0 O-C-N 121.364 -0.835 . . . . 0.0 111.795 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.25 62.44 4.42 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 116.398 1.319 . . . . 0.0 116.398 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.256 6.6 t70 54.06 47.19 23.88 Favored 'General case' 0 CA--C 1.579 2.086 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -163.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -143.82 107.02 4.52 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.0 mt -82.08 95.2 7.39 Favored 'General case' 0 CA--C 1.568 1.648 0 CA-C-O 121.835 0.826 . . . . 0.0 111.7 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.7 t -97.03 103.18 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -84.93 125.71 32.9 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.035 0.534 . . . . 0.0 110.089 172.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.6 mt -112.39 118.12 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -101.79 126.29 48.63 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 119.296 0.953 . . . . 0.0 111.343 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -114.8 123.14 48.46 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.962 0.905 . . . . 0.0 110.496 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -149.67 122.71 8.83 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.421 -1.424 . . . . 0.0 110.581 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 54.26 39.9 31.24 Favored 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.1 -25.38 4.23 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 118.936 2.335 . . . . 0.0 118.936 -165.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -83.17 141.11 32.17 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-N 119.354 1.577 . . . . 0.0 112.115 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -134.18 125.89 28.81 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 122.969 0.507 . . . . 0.0 111.166 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.9 t -118.98 154.66 32.69 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.764 0.826 . . . . 0.0 110.612 169.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.31 10.8 p30 -134.77 152.42 51.75 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 171.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -126.87 102.91 7.22 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -169.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.8 t -95.19 94.02 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -168.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -81.9 123.67 29.04 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.95 0.9 . . . . 0.0 110.771 176.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -144.31 123.56 13.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.667 -0.646 . . . . 0.0 109.945 -167.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.3 mm -78.09 103.76 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.429 -0.795 . . . . 0.0 109.132 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -131.05 113.86 14.47 Favored 'General case' 0 CA--C 1.558 1.287 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -170.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.5 t70 47.93 50.53 15.64 Favored 'General case' 0 CA--C 1.579 2.094 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -168.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.75 -43.48 3.17 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 -169.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.2 mtmp? -85.75 150.88 24.27 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 118.463 1.132 . . . . 0.0 113.602 -171.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 59.1 ttp -85.23 98.65 10.61 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 121.83 0.824 . . . . 0.0 109.499 171.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.1 81.81 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 120.954 -1.092 . . . . 0.0 108.73 -171.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 23.2 ttp -76.97 112.94 14.13 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.078 0.551 . . . . 0.0 111.58 -166.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.4 m -98.44 114.02 26.23 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.803 0.811 . . . . 0.0 109.777 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.34 106.54 17.72 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 124.238 1.015 . . . . 0.0 108.788 -173.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.7 t -115.6 118.84 34.23 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.407 0.622 . . . . 0.0 111.754 -175.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -105.37 81.68 1.73 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 165.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 68.68 -89.25 0.22 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 115.439 0.936 . . . . 0.0 115.439 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -95.94 -25.4 15.98 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 169.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.2 110.86 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-N 121.038 1.745 . . . . 0.0 109.305 -171.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.7 t -113.07 112.42 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 123.514 0.725 . . . . 0.0 109.273 -172.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -102.16 158.86 15.87 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 165.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.3 t -131.27 110.49 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.022 -1.048 . . . . 0.0 109.14 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -95.23 108.69 20.85 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.891 0.853 . . . . 0.0 110.411 172.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -88.46 104.31 16.68 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.586 0.754 . . . . 0.0 110.497 -171.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -101.57 120.29 40.09 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -0.903 . . . . 0.0 112.639 -172.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -87.05 163.51 16.99 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 167.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -74.14 151.0 40.15 Favored 'General case' 0 CA--C 1.571 1.773 0 O-C-N 120.894 -1.129 . . . . 0.0 112.279 162.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.269 166.407 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 . . . . . 0 N--CA 1.499 2.023 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.54 -21.38 52.26 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 118.394 2.739 . . . . 0.0 118.394 169.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -83.1 -17.48 42.94 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 169.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 87.6 m -71.18 93.96 1.12 Allowed 'General case' 0 CA--C 1.566 1.56 0 CA-C-N 121.563 1.983 . . . . 0.0 113.695 -174.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -170.61 162.95 8.13 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-O 122.485 1.136 . . . . 0.0 111.958 -167.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 92.9 m -86.7 113.62 22.7 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.436 169.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -107.26 111.93 24.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.615 -0.678 . . . . 0.0 111.064 -172.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -101.18 132.97 46.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.253 -0.904 . . . . 0.0 111.501 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -72.05 133.29 45.17 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.7 p -105.7 -40.34 5.78 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 175.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -155.96 123.86 5.67 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 119.474 1.034 . . . . 0.0 109.326 -174.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.8 p -104.86 102.55 12.08 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.373 0.669 . . . . 0.0 110.986 172.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -68.46 -56.29 8.92 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 116.543 2.053 . . . . 0.0 116.543 -159.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -126.21 54.28 1.56 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 119.042 0.837 . . . . 0.0 111.671 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -78.39 -53.05 7.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -172.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -50.62 -43.21 56.86 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 117.767 2.506 . . . . 0.0 117.767 172.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.13 -49.12 78.9 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 166.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -50.73 -46.67 59.23 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 164.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.501 ' SD ' HG21 ' A' ' 25' ' ' VAL . 32.9 mmt -57.66 -42.34 83.31 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 170.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -60.29 -47.18 87.1 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 166.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.97 -39.17 93.88 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 172.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.5 tp -69.17 -23.77 63.97 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.6 45.63 6.37 Favored Glycine 0 CA--C 1.548 2.118 0 N-CA-C 117.169 1.628 . . . . 0.0 117.169 -173.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.501 HG21 ' SD ' ' A' ' 20' ' ' MET . 34.6 m -102.05 153.7 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 118.428 1.114 . . . . 0.0 111.709 173.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.08 -167.66 16.51 Favored Glycine 0 N--CA 1.491 2.303 0 O-C-N 120.646 -1.284 . . . . 0.0 115.835 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -84.84 59.73 5.75 Favored 'General case' 0 CA--C 1.576 1.967 0 O-C-N 121.433 -1.039 . . . . 0.0 112.025 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.3 -73.09 0.31 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.723 0.809 . . . . 0.0 109.702 -175.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.1 m -57.74 -34.3 69.37 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 169.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -62.63 -39.19 93.07 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 117.342 2.349 . . . . 0.0 117.342 167.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -67.14 -56.81 8.38 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.034 1.288 . . . . 0.0 112.269 165.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.5 t -56.13 -45.52 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.91 -15.04 79.95 Favored Glycine 0 CA--C 1.552 2.368 0 N-CA-C 118.79 2.276 . . . . 0.0 118.79 175.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -94.09 -52.0 4.59 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.111 1.956 . . . . 0.0 113.991 171.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.256 34.3 m -80.95 -31.14 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.468 0 CA-C-N 121.657 2.026 . . . . 0.0 115.472 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.08 140.69 32.03 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-O 122.082 0.944 . . . . 0.0 110.206 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -98.18 103.25 16.85 Favored Pre-proline 0 CA--C 1.574 1.895 0 CA-C-O 118.075 -0.964 . . . . 0.0 109.791 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.51 146.87 35.43 Favored 'Trans proline' 0 CA--C 1.561 1.841 0 C-N-CA 122.565 2.177 . . . . 0.0 115.391 -176.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 88.7 m -100.68 100.63 11.35 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.362 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.3 t -95.23 101.98 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -173.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.5 mt -91.56 106.29 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 85.2 mt -84.87 120.34 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 170.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.8 p -137.16 133.06 34.83 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.856 0.462 . . . . 0.0 111.647 -172.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -92.7 101.08 13.48 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.992 -1.068 . . . . 0.0 109.35 172.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -104.97 83.13 1.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.837 0.827 . . . . 0.0 109.713 -170.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.76 -106.35 2.52 Favored Glycine 0 N--CA 1.487 2.098 0 CA-C-N 116.006 -0.543 . . . . 0.0 113.985 -175.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -88.74 -28.11 20.74 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -110.1 153.88 24.05 Favored 'General case' 0 CA--C 1.564 1.507 0 CA-C-O 122.804 1.288 . . . . 0.0 113.818 -170.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.46 118.91 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.604 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 170.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.3 t -111.09 107.54 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.4 mt -93.93 112.81 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -100.99 98.14 8.63 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.2 m -86.8 94.59 9.58 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.4 mt -89.02 89.36 7.95 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.651 0.739 . . . . 0.0 109.356 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.3 t -97.2 27.38 4.17 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.342 66.6 p 68.87 -53.22 0.57 Allowed 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -174.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -92.96 -54.97 3.52 Favored 'General case' 0 CA--C 1.571 1.751 0 C-N-CA 124.821 1.248 . . . . 0.0 111.703 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -107.38 108.88 20.45 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.778 0.831 . . . . 0.0 109.665 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -100.29 86.76 3.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.587 -0.695 . . . . 0.0 112.116 175.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -95.62 127.08 41.35 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.366 -0.834 . . . . 0.0 112.916 -173.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -109.52 97.96 7.43 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.921 0.888 . . . . 0.0 110.834 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.3 pt -95.85 108.99 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.078 -1.014 . . . . 0.0 111.051 -174.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 85.4 p -102.43 113.04 26.04 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.12 0.968 . . . . 0.0 112.076 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -148.64 148.88 30.61 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.22 0.534 . . . . 0.0 111.954 -170.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -86.93 156.62 19.74 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.519 -1.363 . . . . 0.0 111.925 163.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.9 mt -70.51 124.13 23.47 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.373 -1.454 . . . . 0.0 112.491 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.16 -4.24 83.9 Favored Glycine 0 CA--C 1.554 2.506 0 N-CA-C 118.97 2.348 . . . . 0.0 118.97 -163.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -85.33 131.87 34.34 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-N 120.223 2.012 . . . . 0.0 112.229 -175.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -72.42 136.5 46.06 Favored 'General case' 0 CA--C 1.571 1.773 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.928 165.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -145.8 149.04 33.6 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.671 0.788 . . . . 0.0 110.937 175.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.74 134.91 34.32 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.728 -1.233 . . . . 0.0 110.864 169.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.49 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 38.5 tt0 -132.15 109.44 9.96 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.912 -174.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.2 m -78.28 107.1 10.64 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 167.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.4 p -79.91 168.81 18.75 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -167.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.23 -8.51 1.66 Allowed 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 119.716 3.228 . . . . 0.0 119.716 172.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -116.89 28.63 8.41 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 120.833 1.651 . . . . 0.0 114.875 162.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.253 17.1 m-20 63.07 42.16 7.55 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 176.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -119.52 132.22 55.72 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.989 0.916 . . . . 0.0 109.041 167.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -92.62 115.27 27.95 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.158 0.583 . . . . 0.0 110.558 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 72' ' ' GLU . 25.2 p -110.69 143.38 41.25 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -76.48 100.86 5.39 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 122.272 1.034 . . . . 0.0 109.338 160.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.3 m -96.22 130.07 43.38 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 124.235 1.014 . . . . 0.0 112.735 -176.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 p -134.95 124.59 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 123.172 0.589 . . . . 0.0 109.506 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.4 t -112.67 110.9 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.486 -0.759 . . . . 0.0 109.641 -172.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.8 p -104.58 132.11 51.21 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 123.635 0.774 . . . . 0.0 112.467 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.7 tt -88.87 99.67 12.57 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.607 0.718 . . . . 0.0 109.464 168.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -97.25 76.91 2.64 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.443 -0.785 . . . . 0.0 110.587 -173.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.96 58.22 15.71 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 117.99 1.956 . . . . 0.0 117.99 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.348 5.5 m-20 91.14 -35.6 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -163.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -90.01 113.97 25.75 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-N 120.572 1.533 . . . . 0.0 112.659 -171.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.1 mt -80.7 123.42 28.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.921 -1.112 . . . . 0.0 112.006 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.4 t -124.87 106.6 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -174.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -94.28 101.29 13.25 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 123.472 0.709 . . . . 0.0 110.098 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.3 mt -87.21 112.59 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 123.89 0.876 . . . . 0.0 108.707 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -100.14 121.17 41.0 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.061 0.545 . . . . 0.0 110.189 172.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -114.32 118.15 33.1 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.2 0.6 . . . . 0.0 110.531 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 15.6 p90 -142.96 125.12 15.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.25 -0.906 . . . . 0.0 110.197 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 55.17 37.67 29.26 Favored 'General case' 0 N--CA 1.507 2.424 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 173.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.91 -22.58 6.61 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 119.142 2.417 . . . . 0.0 119.142 -165.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -86.48 142.24 28.51 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 119.024 1.412 . . . . 0.0 112.645 -175.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -131.01 123.42 28.71 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.548 0.739 . . . . 0.0 110.616 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.1 t -121.7 139.84 53.06 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 123.278 0.631 . . . . 0.0 109.911 165.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -118.49 132.66 56.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.848 -0.533 . . . . 0.0 112.079 174.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -102.29 104.86 15.42 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.8 t -87.6 96.58 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.93 116.22 28.72 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 123.964 0.906 . . . . 0.0 110.072 175.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.6 128.38 20.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.865 -0.522 . . . . 0.0 110.754 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.7 mm -80.89 121.65 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.625 -0.672 . . . . 0.0 109.664 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -101.5 -107.89 0.23 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 119.222 -0.418 . . . . 0.0 109.904 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -86.63 66.91 9.69 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 120.306 1.412 . . . . 0.0 111.06 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 79.21 -30.18 2.14 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 118.726 2.25 . . . . 0.0 118.726 -167.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -93.77 147.33 23.15 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 118.548 1.174 . . . . 0.0 112.1 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 14.6 tpp -77.48 113.08 14.92 Favored 'General case' 0 CA--C 1.563 1.476 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.606 169.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.9 t -88.64 105.53 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.638 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 164.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 22.3 ttt -101.4 103.4 14.32 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.119 0.568 . . . . 0.0 109.485 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.7 m -103.36 104.37 14.47 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.378 0.671 . . . . 0.0 109.275 -172.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mp -94.86 106.0 17.96 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.463 0.705 . . . . 0.0 109.346 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.9 t -102.7 134.12 46.59 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.736 0.779 . . . . 0.0 112.286 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -116.18 79.68 1.34 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 161.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 68.64 -94.02 0.33 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -175.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -88.22 -30.71 19.5 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 172.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.1 t -90.34 112.33 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-N 120.237 1.38 . . . . 0.0 109.363 -169.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.8 t -115.22 113.13 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 123.435 0.694 . . . . 0.0 109.525 -168.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -100.91 111.86 24.17 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.428 -0.795 . . . . 0.0 112.386 175.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.36 109.17 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.465 -0.772 . . . . 0.0 109.018 -177.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.5 mtp85 -98.19 120.37 38.48 Favored 'General case' 0 CA--C 1.563 1.446 0 CA-C-O 121.915 0.864 . . . . 0.0 110.541 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -99.56 104.99 16.83 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.398 0.679 . . . . 0.0 109.709 -169.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -109.76 125.55 52.81 Favored 'General case' 0 CA--C 1.568 1.635 0 O-C-N 121.623 -0.673 . . . . 0.0 111.458 -170.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -96.62 155.84 16.6 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.374 0.67 . . . . 0.0 112.416 171.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -72.41 131.27 42.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.306 -0.871 . . . . 0.0 112.234 171.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.501 0 C-N-CA 123.254 0.622 . . . . 0.0 112.487 170.561 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.257 93.4 mt-10 . . . . . 0 N--CA 1.504 2.255 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.2 -37.3 45.9 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 116.748 2.129 . . . . 0.0 116.748 154.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -75.0 -11.74 60.17 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 168.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 66.2 m -76.7 100.53 5.44 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 122.853 2.57 . . . . 0.0 112.871 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -168.76 163.31 11.88 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-O 122.592 1.187 . . . . 0.0 112.313 -172.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.9 m -82.67 103.47 12.2 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.948 0.899 . . . . 0.0 108.796 169.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -99.0 110.32 22.94 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.694 -1.254 . . . . 0.0 112.158 -170.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -96.64 131.48 43.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.423 -0.798 . . . . 0.0 111.822 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.92 120.42 14.18 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.3 p -93.32 -46.62 7.28 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 174.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -145.62 115.21 7.23 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.826 0.851 . . . . 0.0 109.437 -171.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 76.3 p -104.15 94.18 5.24 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.434 0.694 . . . . 0.0 111.472 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -84.09 120.7 26.47 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.957 0.503 . . . . 0.0 111.194 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.297 3.8 t-20 62.58 20.67 12.16 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 118.248 2.684 . . . . 0.0 118.248 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -67.45 -38.05 83.88 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -55.57 -47.29 76.66 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 169.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -58.91 -47.91 83.32 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 169.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -51.21 -49.79 60.36 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 166.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 75.8 mtm -62.15 -44.01 97.56 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 175.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -62.86 -42.97 99.95 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 166.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.61 -43.75 98.28 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 tp -64.3 -32.81 74.56 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 168.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.85 46.94 5.78 Favored Glycine 0 CA--C 1.543 1.831 0 N-CA-C 116.231 1.252 . . . . 0.0 116.231 -171.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.266 22.9 m -83.08 64.2 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 CA-C-N 119.413 1.607 . . . . 0.0 112.15 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 56.1 -162.54 5.98 Favored Glycine 0 CA--C 1.553 2.425 0 N-CA-C 117.957 1.943 . . . . 0.0 117.957 -175.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -99.73 -43.58 6.4 Favored 'General case' 0 CA--C 1.572 1.795 0 CA-C-N 114.713 -0.744 . . . . 0.0 112.587 154.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.49 -49.8 69.93 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 174.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.0 m -59.25 -41.65 89.28 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 120.303 1.411 . . . . 0.0 114.723 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -59.43 -44.57 92.88 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 169.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -68.74 -40.56 79.77 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 172.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.7 t -50.41 -55.6 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 CA-C-N 119.798 1.181 . . . . 0.0 113.481 160.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.97 -39.68 41.19 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 119.33 2.492 . . . . 0.0 119.33 168.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -67.91 -46.25 72.09 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 170.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.0 m -75.55 -29.65 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 t -79.53 145.91 32.92 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 120.313 1.415 . . . . 0.0 114.259 -173.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -95.96 99.28 4.83 Favored Pre-proline 0 CA--C 1.574 1.883 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 159.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.14 131.23 10.73 Favored 'Trans proline' 0 CA--C 1.562 1.895 0 C-N-CA 122.499 2.132 . . . . 0.0 113.149 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.4 m -97.71 110.73 23.24 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.6 t -97.33 96.88 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -175.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.2 mt -95.22 105.6 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.5 -1.375 . . . . 0.0 108.817 -172.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.3 mt -93.1 123.21 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.5 p -146.18 149.29 33.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.345 -0.847 . . . . 0.0 112.778 169.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -90.99 121.22 32.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.511 -0.743 . . . . 0.0 111.105 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -110.95 85.73 2.17 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.347 0.594 . . . . 0.0 109.925 -175.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.54 -67.72 2.53 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 116.58 1.392 . . . . 0.0 116.58 -177.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -131.69 -44.01 0.99 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 124.137 0.975 . . . . 0.0 112.876 172.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -75.93 152.79 37.01 Favored 'General case' 0 CA--C 1.565 1.526 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.3 t -91.52 125.14 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.611 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 169.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -111.88 111.32 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.8 mt -105.96 106.11 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 54.2 mtm-85 -92.05 97.37 10.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.872 -0.517 . . . . 0.0 109.977 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.1 m -85.65 97.04 9.88 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.765 0.793 . . . . 0.0 109.553 174.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.1 mt -111.92 127.55 55.89 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.157 -165.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.6 m -123.76 164.28 19.48 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.329 0.652 . . . . 0.0 111.265 163.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 49.0 p -74.73 55.34 0.67 Allowed 'General case' 0 N--CA 1.508 2.46 0 O-C-N 120.553 -1.342 . . . . 0.0 113.194 171.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 178.86 -56.66 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.873 0 C-N-CA 125.174 1.39 . . . . 0.0 108.529 -149.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -140.07 127.25 21.09 Favored 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 124.271 1.028 . . . . 0.0 109.939 -169.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -104.91 100.16 9.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.538 -0.726 . . . . 0.0 109.388 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.9 p -114.3 91.54 3.66 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.223 0.535 . . . . 0.0 110.564 -172.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -94.65 126.91 40.26 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.06 -1.025 . . . . 0.0 113.718 -176.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.487 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 11.3 mt -113.92 97.84 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -173.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 95.5 p -102.73 116.37 32.44 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.996 0.919 . . . . 0.0 112.038 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -151.45 149.38 29.19 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -172.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -87.21 150.7 23.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.697 -1.252 . . . . 0.0 110.423 152.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 27.2 mt -62.16 121.37 12.92 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.285 -1.509 . . . . 0.0 113.628 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.83 -9.88 72.45 Favored Glycine 0 CA--C 1.558 2.734 0 N-CA-C 119.129 2.411 . . . . 0.0 119.129 -165.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.91 125.23 30.49 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 120.041 1.92 . . . . 0.0 111.003 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -84.48 129.08 34.89 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.487 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 42.7 p90 -129.72 154.51 47.11 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.174 0.99 . . . . 0.0 111.701 -175.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.55 135.01 35.58 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.37 -1.456 . . . . 0.0 111.473 166.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -127.7 106.72 9.34 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.5 m -79.97 100.77 8.26 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.724 0.773 . . . . 0.0 109.915 174.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.7 p -85.07 167.02 16.18 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -169.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.4 -14.01 10.56 Favored 'General case' 0 CA--C 1.576 1.978 0 N-CA-C 118.9 2.926 . . . . 0.0 118.9 167.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -73.48 -13.49 61.06 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 160.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.287 21.7 t70 68.96 69.72 0.28 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 121.267 1.849 . . . . 0.0 112.931 -166.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.2 ptt85 -160.89 127.71 4.11 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -86.03 90.1 8.0 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 123.11 0.564 . . . . 0.0 111.472 172.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.4 p -81.86 129.12 34.65 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -72.75 97.16 2.15 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 123.101 1.429 . . . . 0.0 110.157 173.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.9 m -109.91 123.86 50.35 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.96 -159.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.0 p -121.72 134.65 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.173 0.511 . . . . 0.0 110.144 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.5 t -123.49 123.48 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -175.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.0 m -131.73 146.46 52.18 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.948 0.88 . . . . 0.0 111.842 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.6 mt -84.92 112.57 20.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.874 . . . . 0.0 111.604 172.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -106.11 76.53 1.17 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.398 0.679 . . . . 0.0 111.041 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.64 61.89 5.52 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 116.686 1.434 . . . . 0.0 116.686 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.259 6.5 t70 52.36 43.5 30.78 Favored 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -162.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -137.15 112.41 9.17 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 mt -82.64 87.04 6.73 Favored 'General case' 0 CA--C 1.567 1.622 0 O-C-N 121.381 -0.824 . . . . 0.0 111.2 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.4 t -87.66 107.92 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -170.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -84.64 136.73 33.63 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.787 0.435 . . . . 0.0 110.413 168.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 59.7 mt -126.76 112.86 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -101.76 121.09 41.41 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.578 1.081 . . . . 0.0 110.186 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -116.74 126.67 53.48 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.307 0.575 . . . . 0.0 111.463 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.6 p90 -152.96 133.4 13.65 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.158 -0.964 . . . . 0.0 109.967 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 59.24 23.37 11.73 Favored 'General case' 0 N--CA 1.51 2.567 0 N-CA-C 118.439 2.755 . . . . 0.0 118.439 166.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.9 10.62 82.76 Favored Glycine 0 CA--C 1.558 2.72 0 N-CA-C 119.28 2.472 . . . . 0.0 119.28 -162.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -121.17 141.73 50.56 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-N 119.676 1.738 . . . . 0.0 110.44 -176.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -130.6 122.78 28.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.765 -0.584 . . . . 0.0 110.922 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.7 t -116.7 140.36 49.5 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 123.133 0.573 . . . . 0.0 110.759 166.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.16 140.68 49.98 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.99 -0.444 . . . . 0.0 110.99 -170.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -130.99 101.15 5.49 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.057 -1.027 . . . . 0.0 108.392 -163.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.3 t -93.56 97.18 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -170.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -90.33 108.51 19.81 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 123.55 0.74 . . . . 0.0 110.79 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.86 134.06 53.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.492 -0.755 . . . . 0.0 112.55 -172.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.4 mm -75.11 104.7 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.259 -0.901 . . . . 0.0 109.772 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -103.62 88.12 3.0 Favored 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.0 t70 51.16 59.41 4.63 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.662 1.726 . . . . 0.0 115.662 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.28 -40.36 2.62 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 117.678 1.831 . . . . 0.0 117.678 -171.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -93.47 136.83 33.36 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.276 1.538 . . . . 0.0 113.02 -173.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 56.1 ttp -82.74 104.49 13.02 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.897 0.856 . . . . 0.0 109.765 171.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 84.1 t -93.85 103.55 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 5.2 ttp -93.41 110.11 21.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.41 0.684 . . . . 0.0 110.862 -175.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 96.0 m -96.8 112.5 24.23 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mp -99.62 101.83 13.14 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 124.131 0.973 . . . . 0.0 109.771 -171.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.4 t -101.15 112.82 25.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.591 -0.693 . . . . 0.0 109.965 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -96.25 78.57 3.09 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 152.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.78 -116.33 9.12 Favored Glycine 0 CA--C 1.549 2.204 0 N-CA-C 114.778 0.671 . . . . 0.0 114.778 -168.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -73.31 -19.56 61.01 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 117.02 2.229 . . . . 0.0 117.02 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.2 t -84.75 105.48 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-N 121.143 1.792 . . . . 0.0 108.519 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.4 t -115.67 110.69 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -171.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -99.46 159.21 15.19 Favored 'General case' 0 CA--C 1.562 1.405 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 167.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.1 t -132.17 111.42 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.067 -1.02 . . . . 0.0 109.059 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 56.9 mtm180 -102.17 121.26 41.88 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.75 0.786 . . . . 0.0 111.595 174.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -101.58 111.1 23.23 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.289 0.635 . . . . 0.0 110.525 -171.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -107.48 130.09 54.88 Favored 'General case' 0 CA--C 1.565 1.547 0 O-C-N 121.143 -0.973 . . . . 0.0 112.612 -170.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -97.53 152.74 18.71 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 169.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -75.46 127.94 34.22 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.605 -0.684 . . . . 0.0 112.014 172.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.047 -0.978 . . . . 0.0 112.788 -178.258 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.17 -22.21 38.78 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 171.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -82.85 -19.91 36.61 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 168.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 44.4 t -73.33 96.46 2.32 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-N 122.663 2.483 . . . . 0.0 113.569 -172.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -174.84 171.04 3.22 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 124.719 1.208 . . . . 0.0 111.466 -168.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 94.3 m -84.1 141.67 30.94 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.802 -1.186 . . . . 0.0 110.021 162.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -133.59 120.66 21.01 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.722 -1.236 . . . . 0.0 110.847 -170.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -108.2 117.91 35.38 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.779 0.832 . . . . 0.0 109.8 -168.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 tt -70.54 115.86 10.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.397 -0.814 . . . . 0.0 112.851 -173.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.8 p -90.22 -49.35 6.6 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -140.88 129.43 22.67 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.936 0.895 . . . . 0.0 109.684 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.8 p -106.33 93.73 4.77 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.077 0.551 . . . . 0.0 110.587 170.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -72.05 124.85 25.84 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.713 0.805 . . . . 0.0 112.026 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 4.9 t-20 52.19 27.99 5.14 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 118.72 2.859 . . . . 0.0 118.72 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -70.46 -44.05 68.57 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -174.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -49.27 -48.57 45.86 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 168.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -59.66 -50.11 75.14 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 170.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -49.28 -49.36 43.95 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 164.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.1 mtp -60.17 -46.25 90.33 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 175.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -55.39 -46.71 76.53 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 167.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.67 -37.34 86.99 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 117.063 2.245 . . . . 0.0 117.063 170.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.4 tp -67.42 -21.69 65.56 Favored 'General case' 0 CA--C 1.573 1.862 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 175.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.24 70.36 1.25 Allowed Glycine 0 N--CA 1.482 1.741 0 CA-C-N 119.026 0.83 . . . . 0.0 113.349 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.2 m -97.1 141.68 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 172.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.03 48.35 4.04 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 117.849 1.9 . . . . 0.0 117.849 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.336 16.6 t80 60.58 -56.69 0.08 Allowed 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 177.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.12 -44.06 64.28 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 173.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.4 m -66.67 -35.21 79.6 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.268 9.7 ptm180 -66.14 -40.85 90.94 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 121.858 2.117 . . . . 0.0 116.301 164.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -60.11 -42.89 95.7 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 169.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.72 -60.75 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-N 119.237 0.926 . . . . 0.0 112.692 166.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.19 -26.24 58.44 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 121.138 3.215 . . . . 0.0 121.138 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -73.68 -38.79 64.8 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 119.527 1.664 . . . . 0.0 115.166 166.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.0 m -77.11 -34.74 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 172.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.0 t -90.65 127.5 36.31 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 120.28 1.4 . . . . 0.0 112.801 -174.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.93 94.88 4.05 Favored Pre-proline 0 CA--C 1.575 1.934 0 CA-C-O 118.119 -0.943 . . . . 0.0 108.881 173.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.66 144.94 56.18 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.52 2.147 . . . . 0.0 116.022 -174.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.2 m -86.86 111.42 20.76 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 114.766 -1.107 . . . . 0.0 109.335 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.3 t -95.65 104.9 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -175.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.9 mt -94.85 104.09 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 80.1 mt -91.21 114.97 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 85.9 p -128.25 128.01 43.89 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 122.869 0.467 . . . . 0.0 111.881 -174.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -85.79 125.19 33.06 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.896 -1.128 . . . . 0.0 109.371 168.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -133.34 90.25 2.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.796 -1.19 . . . . 0.0 110.792 -166.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.76 -68.93 3.13 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 115.783 1.073 . . . . 0.0 115.783 176.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -131.02 -46.94 1.01 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.83 0.852 . . . . 0.0 112.101 168.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -88.31 161.56 17.08 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -173.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.8 t -94.9 124.89 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.1 t -120.12 105.91 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -172.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 61.0 mt -103.62 121.91 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -103.57 113.89 27.75 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 122.709 0.404 . . . . 0.0 111.309 173.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.0 m -94.61 103.4 15.34 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 123.366 0.666 . . . . 0.0 109.351 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.9 mt -112.03 101.45 9.74 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.599 0.714 . . . . 0.0 111.445 -167.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.5 t -87.44 156.0 19.76 Favored 'General case' 0 CA--C 1.563 1.459 0 O-C-N 121.846 -0.534 . . . . 0.0 111.874 162.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.0 t -67.73 34.35 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 157.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -150.63 -61.89 0.19 Allowed 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 125.364 1.465 . . . . 0.0 108.774 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -122.44 122.75 39.71 Favored 'General case' 0 CA--C 1.568 1.636 0 C-N-CA 123.949 0.9 . . . . 0.0 110.239 -177.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -84.48 115.6 22.66 Favored 'General case' 0 CA--C 1.567 1.628 0 C-N-CA 123.422 0.689 . . . . 0.0 110.222 167.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -131.97 144.91 51.15 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.985 0.898 . . . . 0.0 111.198 172.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.57 149.84 30.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.992 -1.068 . . . . 0.0 113.421 -175.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.4 pt -125.67 130.97 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 124.051 0.94 . . . . 0.0 110.259 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.9 p -122.25 114.57 21.0 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.658 0.783 . . . . 0.0 109.773 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -145.6 143.6 29.97 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -166.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -98.76 22.37 10.15 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 174.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 70.4 mt 68.82 110.7 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 125.17 1.388 . . . . 0.0 113.568 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.82 -7.22 56.01 Favored Glycine 0 CA--C 1.557 2.71 0 N-CA-C 119.255 2.462 . . . . 0.0 119.255 -167.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -82.85 125.95 31.9 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-N 119.201 1.501 . . . . 0.0 110.77 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -80.91 126.08 30.92 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -137.19 137.07 38.76 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 123.514 0.726 . . . . 0.0 110.761 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.67 130.2 38.35 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.501 -1.375 . . . . 0.0 111.431 173.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -130.55 106.46 8.53 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 122.725 0.41 . . . . 0.0 111.124 -171.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 54.5 m -68.94 106.91 2.9 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.324 1.059 . . . . 0.0 110.908 176.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.7 p -78.88 173.24 12.73 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.478 -173.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.73 3.37 0.15 Allowed 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 119.169 3.026 . . . . 0.0 119.169 168.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -109.37 -0.29 19.09 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 159.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.347 4.7 m-20 88.82 -5.59 0.46 Allowed 'General case' 0 N--CA 1.508 2.453 0 N-CA-C 116.748 2.129 . . . . 0.0 116.748 -173.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.94 122.36 24.75 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 120.621 1.555 . . . . 0.0 110.622 176.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.281 5.1 p30 -90.94 97.44 11.18 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.392 0.615 . . . . 0.0 111.458 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 82.5 m -93.73 131.55 38.96 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-O 121.486 0.66 . . . . 0.0 112.673 -168.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -69.9 102.24 1.93 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.579 1.151 . . . . 0.0 109.698 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.2 m -110.74 123.31 49.8 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.611 -157.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.1 t -122.98 113.33 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.8 t -99.32 116.91 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.153 -0.967 . . . . 0.0 109.937 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.1 t -112.49 131.61 55.49 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.279 0.632 . . . . 0.0 112.332 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 tt -91.61 100.48 13.21 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.419 0.688 . . . . 0.0 110.383 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -93.76 84.21 4.56 Favored 'General case' 0 CA--C 1.567 1.601 0 O-C-N 121.35 -0.843 . . . . 0.0 110.111 175.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.73 -82.34 0.96 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 115.411 0.924 . . . . 0.0 115.411 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -138.89 53.8 1.75 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.56 0.695 . . . . 0.0 112.293 161.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -142.37 121.25 12.75 Favored 'General case' 0 CA--C 1.561 1.388 0 O-C-N 121.299 -0.875 . . . . 0.0 110.468 168.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.5 mt -89.46 106.9 18.76 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.424 0.63 . . . . 0.0 110.112 176.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 52.4 t -96.72 100.33 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -85.57 101.22 12.5 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.458 0.703 . . . . 0.0 110.21 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 56.5 mt -90.78 110.53 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -175.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -102.84 118.34 36.6 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 119.077 0.853 . . . . 0.0 110.766 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -109.17 129.94 55.49 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 124.191 0.996 . . . . 0.0 111.216 -177.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.6 p90 -152.09 123.16 7.6 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.556 -1.34 . . . . 0.0 110.611 177.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 54.48 37.04 27.06 Favored 'General case' 0 N--CA 1.507 2.391 0 N-CA-C 117.306 2.335 . . . . 0.0 117.306 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.26 -26.57 4.39 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 118.757 2.263 . . . . 0.0 118.757 -164.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -82.24 142.99 31.66 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-N 119.11 1.455 . . . . 0.0 112.158 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -138.71 129.44 26.33 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.229 0.538 . . . . 0.0 111.547 -176.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.1 t -114.8 150.95 34.64 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.266 0.627 . . . . 0.0 109.754 162.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.293 11.1 p30 -127.32 135.84 51.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.015 -1.053 . . . . 0.0 112.582 166.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -105.09 100.85 10.43 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -176.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.1 t -85.21 98.03 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -174.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.9 ttm-85 -91.08 106.66 18.68 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.434 0.694 . . . . 0.0 109.909 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -123.9 141.11 52.33 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 119.235 0.925 . . . . 0.0 112.555 -175.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.5 mm -79.2 119.66 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.057 -1.027 . . . . 0.0 109.317 172.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -137.15 113.25 9.81 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.034 0.534 . . . . 0.0 109.617 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.6 t70 45.39 55.91 6.11 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.5 -36.78 3.07 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 118.314 2.086 . . . . 0.0 118.314 -169.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -82.94 152.94 25.29 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 119.02 1.41 . . . . 0.0 114.011 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.3 tmm? -91.65 109.0 20.3 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.848 158.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 82.5 t -94.79 106.27 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 38.0 ttm -89.41 106.67 18.6 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 173.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.1 m -95.98 110.64 22.82 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mp -98.61 102.94 14.83 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.981 0.912 . . . . 0.0 109.164 -170.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.1 t -108.92 112.97 25.48 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.332 0.587 . . . . 0.0 111.205 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -98.18 80.13 2.65 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 164.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 64.29 -100.84 0.44 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 114.891 0.716 . . . . 0.0 114.891 -172.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -85.7 -23.56 27.33 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 171.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.6 t -89.48 113.77 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-N 120.907 1.685 . . . . 0.0 109.242 -173.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.7 t -117.43 118.37 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 123.271 0.628 . . . . 0.0 109.59 -170.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -104.22 161.14 14.29 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 163.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.9 t -133.26 112.59 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 120.785 -1.197 . . . . 0.0 109.827 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -99.6 116.34 31.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.026 -1.046 . . . . 0.0 110.305 174.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -102.84 108.49 19.72 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.434 0.694 . . . . 0.0 111.06 -167.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -107.9 127.2 53.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.907 -1.121 . . . . 0.0 112.025 -170.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -90.15 153.53 20.46 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 171.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -88.12 137.41 32.35 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -166.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.257 0 CA-C-O 117.444 -1.265 . . . . 0.0 111.646 176.509 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 N--CA 1.498 1.953 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.68 -26.19 63.59 Favored 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 117.938 2.57 . . . . 0.0 117.938 167.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -81.19 -17.0 51.19 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 165.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.7 t -77.37 90.09 3.79 Favored 'General case' 0 CA--C 1.569 1.674 0 CA-C-N 122.105 2.229 . . . . 0.0 113.365 -173.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -166.27 172.55 10.99 Favored 'General case' 0 CA--C 1.572 1.796 0 C-N-CA 124.509 1.123 . . . . 0.0 111.736 -173.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 m -85.51 130.4 34.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.944 -1.098 . . . . 0.0 109.677 164.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -124.44 116.36 22.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.647 -0.658 . . . . 0.0 111.327 -170.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -101.95 127.25 48.88 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.468 0.707 . . . . 0.0 110.93 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.7 119.78 15.35 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -176.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.3 p -92.32 -47.4 7.21 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 176.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -140.16 110.81 6.78 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.876 0.87 . . . . 0.0 109.08 -174.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -94.03 80.24 4.09 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.905 1.336 . . . . 0.0 111.807 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -85.77 108.38 18.06 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.186 -0.946 . . . . 0.0 111.104 -161.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.29 1.8 t30 69.27 28.7 4.78 Favored 'General case' 0 CA--C 1.584 2.261 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -168.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -73.07 -41.0 64.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 119.709 -1.87 . . . . 0.0 115.897 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -48.86 -53.72 18.25 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 171.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.45 -43.57 98.5 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 173.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -54.75 -47.39 73.91 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 166.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 71.2 mtm -60.19 -37.62 80.79 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 172.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -62.41 -50.28 72.14 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 161.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.07 -44.16 91.83 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 176.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.3 tp -75.35 -14.07 60.45 Favored 'General case' 0 CA--C 1.58 2.124 0 N-CA-C 116.28 1.956 . . . . 0.0 116.28 169.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.01 32.12 15.4 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 119.511 2.564 . . . . 0.0 119.511 172.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.5 m -79.64 69.24 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 CA-C-N 120.806 2.303 . . . . 0.0 113.54 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 58.85 -160.96 13.7 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -96.36 -51.27 4.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 122.027 -0.69 . . . . 0.0 111.864 148.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.61 -39.37 84.02 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 33.7 m -68.94 -33.33 73.55 Favored 'General case' 0 CA--C 1.577 1.985 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 171.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -57.06 -49.99 74.14 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-N 121.235 1.834 . . . . 0.0 115.085 159.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -54.24 -51.37 64.7 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 171.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.7 t -51.32 -60.92 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 C-N-CA 124.488 1.115 . . . . 0.0 113.991 166.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.83 -29.06 54.17 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 119.78 2.672 . . . . 0.0 119.78 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -74.61 -47.29 33.1 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 167.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 m -75.88 -34.05 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.5 t -91.99 144.19 25.71 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 120.229 1.377 . . . . 0.0 113.648 -170.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -92.87 112.9 58.01 Favored Pre-proline 0 CA--C 1.574 1.867 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.402 170.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.16 123.28 9.1 Favored 'Trans proline' 0 CA--C 1.561 1.84 0 CA-C-N 122.878 2.064 . . . . 0.0 113.425 170.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 91.0 m -92.61 97.43 10.8 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 172.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.9 t -93.56 101.17 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -168.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.6 mt -88.91 104.08 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 177.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -90.2 114.41 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 172.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.7 p -136.52 129.91 31.69 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.728 0.411 . . . . 0.0 111.573 -170.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -87.21 95.05 9.84 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.159 -0.963 . . . . 0.0 110.39 174.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -101.19 76.18 1.7 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.414 0.626 . . . . 0.0 110.698 -171.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.4 80.72 0.33 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 115.107 0.803 . . . . 0.0 115.107 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.326 34.4 t70 72.0 -56.24 0.65 Allowed 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -175.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -76.26 146.2 39.15 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -177.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.1 t -88.56 125.26 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 173.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.3 t -112.56 111.9 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.501 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.1 mt -90.63 115.56 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -108.46 95.64 5.8 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.5 m -84.9 91.7 8.1 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.399 0.619 . . . . 0.0 109.353 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.9 mt -103.65 95.8 6.29 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -172.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 p -111.03 27.27 9.85 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 -173.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.404 8.5 t 47.27 18.61 0.1 Allowed 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 119.891 3.293 . . . . 0.0 119.891 -164.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -155.39 -61.87 0.11 Allowed 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.724 1.21 . . . . 0.0 109.667 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -70.9 -61.49 1.74 Allowed 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.05 0.94 . . . . 0.0 113.439 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 59.62 63.77 1.45 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.4 t -118.88 122.72 42.96 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.268 0.627 . . . . 0.0 111.503 -170.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -109.15 112.93 25.36 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.526 0.731 . . . . 0.0 111.96 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 pt -112.53 114.75 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 C-N-CA 123.476 0.711 . . . . 0.0 110.84 -174.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 92.9 p -105.86 118.65 37.14 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.112 0.965 . . . . 0.0 112.648 -174.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -149.3 156.35 41.95 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.769 0.795 . . . . 0.0 112.206 -169.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -92.59 150.97 20.39 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.125 0.964 . . . . 0.0 110.876 161.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 41.1 mt -67.83 127.35 32.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.099 -1.001 . . . . 0.0 113.481 -176.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.13 -6.36 71.9 Favored Glycine 0 CA--C 1.556 2.605 0 N-CA-C 118.969 2.348 . . . . 0.0 118.969 -164.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.22 127.11 34.69 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 120.332 2.066 . . . . 0.0 110.953 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -78.88 124.78 28.57 Favored 'General case' 0 CA--C 1.569 1.708 0 CA-C-O 121.477 0.656 . . . . 0.0 111.609 171.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -131.01 145.14 51.95 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.947 0.899 . . . . 0.0 110.698 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -73.88 134.28 43.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.242 -1.536 . . . . 0.0 111.961 170.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -133.62 124.54 27.01 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.248 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.1 m -70.16 128.46 36.36 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-O 122.835 1.302 . . . . 0.0 110.361 158.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 80.7 p -97.88 170.36 9.01 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 122.042 0.925 . . . . 0.0 112.491 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.54 -23.9 4.66 Favored 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 119.205 3.039 . . . . 0.0 119.205 168.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -76.49 -15.77 59.81 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 166.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.321 34.9 m-20 66.66 33.97 6.1 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -156.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.73 133.63 46.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.027 -1.046 . . . . 0.0 108.668 162.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -94.01 112.61 24.47 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.002 0.521 . . . . 0.0 110.595 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.2 m -110.48 141.37 43.69 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.456 0.702 . . . . 0.0 112.626 -173.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -73.76 109.79 7.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.523 -0.736 . . . . 0.0 110.356 166.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.2 m -109.26 125.98 52.85 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.921 0.888 . . . . 0.0 111.315 -169.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 p -126.05 126.0 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-O 121.213 0.53 . . . . 0.0 109.916 174.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.0 t -114.17 116.08 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -176.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.5 p -129.86 148.11 51.7 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 20.1 mt -86.02 117.39 24.83 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.499 0.666 . . . . 0.0 112.626 174.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -106.31 62.69 0.65 Allowed 'General case' 0 CA--C 1.574 1.869 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.901 174.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.51 66.61 1.97 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 115.786 1.074 . . . . 0.0 115.786 -174.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.266 18.3 t70 50.77 49.84 20.19 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 115.718 1.748 . . . . 0.0 115.718 -163.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -147.15 103.44 3.59 Favored 'General case' 0 CA--C 1.558 1.255 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -174.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.454 HD13 HH21 ' A' ' 106' ' ' ARG . 53.1 mt -84.18 105.79 15.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.659 -0.651 . . . . 0.0 110.969 -177.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.15 103.33 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -174.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.16 106.43 18.48 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.341 0.656 . . . . 0.0 110.36 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.1 mt -99.29 108.7 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -173.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -98.07 120.75 39.03 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 119.19 0.905 . . . . 0.0 110.088 176.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -117.75 121.27 40.37 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.666 0.787 . . . . 0.0 110.528 -174.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -149.12 133.1 17.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.319 -0.863 . . . . 0.0 110.368 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 59.79 24.82 13.8 Favored 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 118.598 2.814 . . . . 0.0 118.598 166.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.73 10.02 85.66 Favored Glycine 0 CA--C 1.558 2.763 0 N-CA-C 119.201 2.441 . . . . 0.0 119.201 -162.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -120.62 142.11 49.71 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-N 119.393 1.597 . . . . 0.0 110.199 -176.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -132.31 130.04 40.31 Favored 'General case' 0 CA--C 1.562 1.432 0 O-C-N 121.738 -0.601 . . . . 0.0 111.024 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.0 t -120.53 133.98 55.33 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 123.072 0.549 . . . . 0.0 109.715 163.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -116.46 134.44 54.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.773 -0.579 . . . . 0.0 112.167 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -107.59 97.82 7.5 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -174.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 78.2 t -85.85 99.92 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -172.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.454 HH21 HD13 ' A' ' 91' ' ' LEU . 31.3 ttp180 -101.78 113.9 27.49 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.084 0.554 . . . . 0.0 110.992 -172.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -127.27 143.84 51.16 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.1 mm -86.01 109.09 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.146 -0.971 . . . . 0.0 109.403 175.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.01 89.91 3.29 Favored 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 123.758 0.823 . . . . 0.0 109.29 176.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.9 t70 51.53 57.68 6.31 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 94.82 -38.29 3.17 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 117.942 1.937 . . . . 0.0 117.942 -170.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.9 mtmm -92.7 140.44 29.53 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 119.526 1.663 . . . . 0.0 113.35 -176.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 57.9 ttp -90.46 108.39 19.76 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 121.978 0.894 . . . . 0.0 109.984 175.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.1 t -94.54 107.01 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 23.2 ttt -101.98 106.51 17.45 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.048 0.539 . . . . 0.0 110.542 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.5 m -99.02 99.07 10.05 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.657 0.783 . . . . 0.0 109.37 -174.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.9 mp -90.67 108.22 19.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.873 0.869 . . . . 0.0 110.12 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.0 t -108.26 135.11 50.14 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.571 0.7 . . . . 0.0 112.35 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -127.13 98.43 5.3 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.392 0.677 . . . . 0.0 109.176 166.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 73.68 -91.67 0.68 Allowed Glycine 0 N--CA 1.49 2.249 0 O-C-N 121.861 -0.524 . . . . 0.0 113.901 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -124.25 11.62 8.78 Favored 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 160.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 36.2 t -92.02 107.77 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-N 121.56 1.982 . . . . 0.0 107.825 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.5 t -112.57 115.76 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 123.259 0.624 . . . . 0.0 109.568 -169.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -104.17 123.44 47.31 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.597 -0.689 . . . . 0.0 112.604 169.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.7 t -105.32 104.66 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -93.56 115.72 28.22 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.636 0.732 . . . . 0.0 110.765 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -99.12 109.79 22.45 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.208 0.603 . . . . 0.0 110.4 -171.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -108.73 128.48 54.91 Favored 'General case' 0 CA--C 1.565 1.525 0 O-C-N 121.188 -0.945 . . . . 0.0 111.937 -170.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -95.52 153.55 17.65 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.656 0.741 . . . . 0.0 112.337 167.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -72.08 134.78 46.0 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.49 0 C-N-CA 123.328 0.651 . . . . 0.0 111.17 159.842 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 N--CA 1.499 2.022 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.55 -24.3 63.59 Favored 'General case' 0 CA--C 1.574 1.87 0 N-CA-C 117.904 2.557 . . . . 0.0 117.904 167.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -85.97 -13.24 48.23 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 172.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.7 t -79.43 96.62 6.1 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 121.157 1.799 . . . . 0.0 112.667 -170.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -169.41 163.65 10.55 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.133 0.968 . . . . 0.0 112.492 -166.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.4 m -81.08 119.0 22.99 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.355 -0.84 . . . . 0.0 109.363 163.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -111.48 107.43 16.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.498 -0.751 . . . . 0.0 111.264 -172.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -91.7 129.74 37.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.511 -0.743 . . . . 0.0 111.272 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -68.85 133.63 48.54 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-O 122.524 1.154 . . . . 0.0 113.904 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.1 p -110.29 -34.73 6.27 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -156.9 112.46 2.89 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 119.69 1.132 . . . . 0.0 108.45 -172.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.9 p -104.05 91.0 3.77 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.916 0.865 . . . . 0.0 111.577 175.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -80.26 125.8 30.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 111.869 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.252 1.7 t30 61.92 21.32 12.21 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 117.565 2.432 . . . . 0.0 117.565 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -72.93 -34.5 66.63 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -175.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -55.04 -56.12 23.34 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 165.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.45 -31.86 71.83 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 173.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -61.65 -51.36 68.77 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 162.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.4 mtt -58.62 -44.5 89.99 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 116.797 2.147 . . . . 0.0 116.797 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -40.48 95.06 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 116.858 2.169 . . . . 0.0 116.858 164.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.72 -46.44 88.1 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 168.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.8 tp -61.66 -27.97 69.06 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.27 49.94 2.51 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 115.866 1.106 . . . . 0.0 115.866 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.2 m -107.52 140.08 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-N 118.944 1.372 . . . . 0.0 110.341 165.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.65 -168.63 9.84 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 116.814 1.486 . . . . 0.0 116.814 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -80.74 61.91 4.58 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.533 1.159 . . . . 0.0 112.709 177.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -148.05 -69.49 0.23 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.111 0.964 . . . . 0.0 109.16 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.2 m -58.7 -35.63 72.94 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 170.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -61.79 -32.96 73.28 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 165.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -83.51 14.72 3.52 Favored 'General case' 0 CA--C 1.58 2.105 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 164.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.3 t -118.58 -61.85 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 C-N-CA 125.419 1.488 . . . . 0.0 108.614 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.21 -23.54 68.16 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 119.668 2.627 . . . . 0.0 119.668 -177.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -88.74 -37.26 15.62 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 174.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.4 m -80.34 -33.21 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.4 t -107.91 177.16 4.9 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 119.709 1.141 . . . . 0.0 112.669 -178.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -97.69 99.67 7.02 Favored Pre-proline 0 CA--C 1.573 1.849 0 CA-C-O 118.042 -0.98 . . . . 0.0 111.003 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.92 127.24 15.77 Favored 'Trans proline' 0 CA--C 1.564 2.022 0 CA-C-N 122.903 2.072 . . . . 0.0 113.965 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.0 m -110.45 102.86 11.44 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.004 -172.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.3 t -102.82 101.32 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.553 -0.717 . . . . 0.0 109.141 -164.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.9 mt -87.47 103.35 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.242 -0.911 . . . . 0.0 108.812 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.6 mt -88.04 111.81 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.8 p -136.15 117.96 15.12 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.671 0.389 . . . . 0.0 111.853 -169.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -83.38 116.46 22.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.099 -1.001 . . . . 0.0 111.432 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -116.62 96.23 5.41 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.269 0.557 . . . . 0.0 109.639 -172.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.48 -75.75 2.32 Favored Glycine 0 N--CA 1.492 2.371 0 O-C-N 121.694 -0.629 . . . . 0.0 114.265 -172.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -133.43 -52.14 0.88 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 169.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -62.69 154.34 29.69 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.6 t -94.06 109.73 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.53 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.367 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.5 t -93.88 101.4 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 176.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.2 mt -95.05 116.61 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -101.64 99.74 10.06 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.157 0.583 . . . . 0.0 110.102 175.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.2 m -86.35 96.15 9.89 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.757 0.789 . . . . 0.0 109.4 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 71.3 mt -102.31 86.54 2.84 Favored 'General case' 0 CA--C 1.559 1.318 0 CA-C-O 121.856 0.836 . . . . 0.0 110.329 -170.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.2 t -79.38 144.64 33.96 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.56 -0.713 . . . . 0.0 110.326 159.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.4 p -70.09 33.62 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.463 0 N-CA-C 116.823 2.156 . . . . 0.0 116.823 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -155.89 -57.39 0.09 Allowed 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 126.194 1.797 . . . . 0.0 108.189 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -107.75 100.57 9.94 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 123.978 0.911 . . . . 0.0 109.394 177.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -96.77 88.18 4.52 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.53 -0.731 . . . . 0.0 110.314 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.8 t -105.22 139.55 39.7 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 123.475 0.71 . . . . 0.0 112.444 -171.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -134.68 145.74 48.83 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.8 pt -134.15 129.5 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 C-N-CA 123.771 0.828 . . . . 0.0 110.347 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.0 m -118.37 117.79 30.03 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.843 -0.536 . . . . 0.0 110.371 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -150.65 152.54 34.14 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.675 0.75 . . . . 0.0 112.3 -165.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -94.73 151.02 19.61 Favored 'General case' 0 CA--C 1.573 1.831 0 O-C-N 120.972 -1.08 . . . . 0.0 110.888 169.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.6 mt -67.55 123.39 20.3 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.26 -1.525 . . . . 0.0 112.872 -177.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.06 -20.02 23.07 Favored Glycine 0 CA--C 1.555 2.555 0 N-CA-C 118.678 2.231 . . . . 0.0 118.678 -166.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -79.64 126.64 31.17 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-N 119.387 1.594 . . . . 0.0 111.653 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -81.14 144.24 31.82 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-O 121.563 0.696 . . . . 0.0 112.423 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -142.38 141.26 32.27 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.107 0.963 . . . . 0.0 110.459 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -78.95 129.04 34.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.525 -1.359 . . . . 0.0 111.19 171.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -125.34 103.25 7.82 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.852 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.4 m -79.7 103.28 9.49 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 170.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 71.4 p -78.15 167.88 20.73 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -168.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.98 -11.85 0.72 Allowed 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 120.236 3.421 . . . . 0.0 120.236 170.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -122.22 35.84 4.78 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 120.892 1.678 . . . . 0.0 114.555 160.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.269 31.0 m-20 63.07 54.63 2.09 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 116.543 2.053 . . . . 0.0 116.543 168.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -120.38 128.4 53.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.528 -0.732 . . . . 0.0 109.207 159.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -90.26 90.56 8.13 Favored 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 123.535 0.734 . . . . 0.0 111.189 173.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.5 p -96.85 134.72 39.8 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -173.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.68 94.17 2.66 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-O 122.524 1.154 . . . . 0.0 109.284 172.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.1 m -100.94 119.34 38.56 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.676 -165.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.1 p -121.7 125.36 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 123.182 0.593 . . . . 0.0 109.707 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.3 t -109.23 118.38 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -175.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.9 p -118.75 133.86 55.55 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.668 0.787 . . . . 0.0 112.055 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 tt -89.66 98.16 11.61 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 109.933 175.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -94.11 81.07 4.07 Favored 'General case' 0 CA--C 1.567 1.62 0 O-C-N 121.512 -0.743 . . . . 0.0 110.796 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.88 -90.79 0.5 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 115.563 0.985 . . . . 0.0 115.563 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -99.13 4.57 46.93 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 166.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -121.85 119.88 32.91 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 120.452 1.478 . . . . 0.0 111.086 -162.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.2 mt -82.97 100.47 10.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.92 -1.112 . . . . 0.0 110.222 167.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 41.0 t -101.13 101.45 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -170.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.34 107.24 19.02 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.506 0.722 . . . . 0.0 110.791 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 53.9 mt -100.14 103.28 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -173.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -94.66 123.1 37.9 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 118.7 0.682 . . . . 0.0 110.839 176.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -116.39 121.15 41.05 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 123.44 0.696 . . . . 0.0 111.943 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.3 p90 -150.65 128.89 11.97 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.53 -1.357 . . . . 0.0 110.969 -177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 50.52 48.09 23.08 Favored 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 166.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.86 16.23 72.23 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 119.995 2.758 . . . . 0.0 119.995 -168.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -133.59 140.46 47.15 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 119.531 1.666 . . . . 0.0 109.858 -170.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -134.65 130.49 36.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.669 -0.644 . . . . 0.0 111.543 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.8 t -119.4 123.5 44.26 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.358 0.663 . . . . 0.0 109.368 167.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -107.52 122.01 45.79 Favored 'General case' 0 CA--C 1.563 1.475 0 C-N-CA 123.26 0.624 . . . . 0.0 110.605 172.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -103.62 108.38 19.63 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -175.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 82.4 t -93.44 104.08 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -169.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -110.34 99.15 8.23 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.03 0.532 . . . . 0.0 110.314 -166.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.12 149.97 43.83 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -171.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.4 mm -82.18 111.38 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.872 -0.517 . . . . 0.0 110.01 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -105.19 86.98 2.52 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 171.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.9 t70 48.23 60.19 3.78 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.65 -37.86 3.29 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 117.95 1.94 . . . . 0.0 117.95 -171.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -88.02 140.96 28.96 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 119.659 1.73 . . . . 0.0 112.979 -177.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 34.1 ttm -84.83 112.41 20.51 Favored 'General case' 0 CA--C 1.564 1.503 0 O-C-N 121.266 -0.897 . . . . 0.0 109.297 165.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.8 t -89.64 104.36 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 169.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 28.1 ttt -90.95 101.38 14.15 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.998 0.519 . . . . 0.0 109.777 172.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.6 m -92.05 111.06 22.46 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 175.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.9 mp -95.93 121.21 37.43 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.4 t -126.12 122.64 36.32 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-N 120.31 1.414 . . . . 0.0 112.357 174.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -114.38 80.68 1.43 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.824 0.85 . . . . 0.0 108.786 174.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 66.97 -98.55 0.43 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 115.062 0.785 . . . . 0.0 115.062 -174.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -83.98 -30.85 25.89 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 171.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.5 t -89.38 119.86 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 119.715 1.143 . . . . 0.0 109.443 -169.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.5 t -115.97 124.94 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -175.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -117.58 156.22 28.47 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.483 0.713 . . . . 0.0 112.742 167.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.3 t -134.01 112.44 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.318 -0.863 . . . . 0.0 109.074 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -99.63 122.5 42.75 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.52 0.676 . . . . 0.0 111.769 172.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -104.46 114.36 28.54 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.322 0.649 . . . . 0.0 110.663 -172.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -114.97 131.39 56.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.437 -0.79 . . . . 0.0 112.11 -169.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -101.51 152.3 20.93 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 123.452 0.701 . . . . 0.0 112.405 169.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -74.1 131.83 41.69 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.296 -0.877 . . . . 0.0 112.815 175.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.518 0 C-N-CA 124.188 0.995 . . . . 0.0 111.995 175.205 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.94 -27.09 40.79 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 117.592 2.442 . . . . 0.0 117.592 166.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -85.7 -6.68 59.1 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 171.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 52.8 t -80.56 93.22 6.04 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-N 121.876 2.125 . . . . 0.0 113.85 -172.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.69 172.32 9.37 Favored 'General case' 0 CA--C 1.571 1.787 0 CA-C-O 122.425 1.107 . . . . 0.0 112.435 -177.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.0 m -89.87 116.72 28.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.175 -0.953 . . . . 0.0 108.998 165.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -114.76 108.52 16.88 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 122.956 0.502 . . . . 0.0 110.38 -169.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -95.45 136.55 35.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.05 -1.031 . . . . 0.0 111.651 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.96 130.61 43.71 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.666 0.988 . . . . 0.0 113.666 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 45.8 p -116.34 -24.83 7.75 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -157.22 121.66 4.37 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 120.574 1.534 . . . . 0.0 108.922 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.3 p -113.07 92.82 4.14 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.967 0.889 . . . . 0.0 111.805 178.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -88.34 116.34 26.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.967 -1.083 . . . . 0.0 110.513 -170.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.291 3.8 t-20 68.63 25.86 6.43 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -173.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -72.76 -48.23 40.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 119.994 -1.691 . . . . 0.0 115.392 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -46.97 -50.66 18.67 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.739 2.125 . . . . 0.0 116.739 169.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -58.69 -45.32 89.74 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 171.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -55.73 -48.55 75.01 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 165.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 31.0 mmm -58.56 -49.61 76.82 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -60.3 -42.26 95.15 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 167.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.53 -40.26 95.28 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 172.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.4 tp -61.31 -25.13 66.91 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 168.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.91 56.17 1.33 Allowed Glycine 0 N--CA 1.484 1.893 0 N-CA-C 115.72 1.048 . . . . 0.0 115.72 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.255 4.5 m -100.25 148.03 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-N 118.451 1.126 . . . . 0.0 112.875 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.96 170.12 14.86 Favored Glycine 0 CA--C 1.551 2.329 0 N-CA-C 117.357 1.703 . . . . 0.0 117.357 171.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -67.95 -43.35 79.3 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.32 -44.97 94.98 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 164.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.0 m -61.36 -42.63 99.02 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 175.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -63.76 -39.68 94.85 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 116.512 2.041 . . . . 0.0 116.512 167.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.72 -48.81 80.13 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 120.035 1.289 . . . . 0.0 114.337 167.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.5 t -57.22 -60.94 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-N 119.627 1.103 . . . . 0.0 113.445 170.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.74 -27.81 70.61 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 120.115 2.806 . . . . 0.0 120.115 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -73.48 -42.01 62.43 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 167.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.4 m -70.46 -36.88 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.2 t -88.31 138.92 31.01 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 119.815 1.189 . . . . 0.0 113.194 -174.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -85.68 114.41 56.55 Favored Pre-proline 0 CA--C 1.575 1.92 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.665 167.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -69.11 130.35 19.97 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 CA-C-N 123.345 2.23 . . . . 0.0 114.813 176.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 93.4 m -97.12 101.47 13.04 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.8 t -99.71 99.45 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -166.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.6 mt -86.34 105.98 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.9 mt -99.02 115.03 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 174.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.5 t -144.76 159.59 42.61 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 123.539 1.637 . . . . 0.0 112.65 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.67 135.29 40.39 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.206 177.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.13 103.62 6.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.619 -0.676 . . . . 0.0 109.987 175.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.28 -78.57 0.96 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 115.977 1.151 . . . . 0.0 115.977 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -127.6 -39.16 1.85 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 170.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -77.12 154.05 33.64 Favored 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.9 t -94.79 129.97 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.64 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.7 t -109.29 119.08 58.03 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.3 mt -102.29 115.44 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 168.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -104.16 96.07 6.4 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.904 0.859 . . . . 0.0 109.888 170.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.6 m -83.25 92.83 7.56 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.52 174.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.3 mt -104.52 101.47 11.13 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.547 0.739 . . . . 0.0 109.438 -170.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.6 p -99.46 26.98 5.57 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 117.16 2.281 . . . . 0.0 117.16 -175.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.492 2.0 t 63.03 -54.07 0.18 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -169.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -82.71 -60.46 2.17 Favored 'General case' 0 CA--C 1.569 1.698 0 C-N-CA 124.025 0.93 . . . . 0.0 111.582 173.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -98.14 103.16 15.08 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -105.84 93.16 4.49 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.677 0.751 . . . . 0.0 110.186 -171.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 39.1 p -100.94 149.09 24.26 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -167.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -145.16 120.95 10.56 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.112 -0.992 . . . . 0.0 112.5 176.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.2 pt -122.97 129.59 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 C-N-CA 123.699 0.8 . . . . 0.0 110.792 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 85.1 p -120.8 116.39 25.12 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.889 0.876 . . . . 0.0 111.641 -175.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -145.77 146.1 31.08 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.91 0.862 . . . . 0.0 113.073 -164.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -101.62 76.32 1.65 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.138 -0.976 . . . . 0.0 110.816 177.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.4 mt 17.81 96.93 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 120.158 3.392 . . . . 0.0 120.158 174.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.15 -12.73 63.66 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 118.374 2.109 . . . . 0.0 118.374 -166.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -77.62 136.24 38.22 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 119.718 1.759 . . . . 0.0 112.45 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -80.21 115.19 19.63 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.146 171.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -118.99 152.24 36.74 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 122.05 0.929 . . . . 0.0 110.95 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.06 138.08 31.81 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.877 -1.14 . . . . 0.0 111.465 174.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -145.24 124.34 12.86 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.369 0.604 . . . . 0.0 110.53 169.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 84.9 m -77.04 121.42 23.51 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 158.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.5 p -87.43 -179.99 6.47 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -169.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.68 -29.33 38.28 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 118.698 2.851 . . . . 0.0 118.698 165.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -84.66 10.46 11.16 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 163.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.281 3.1 t0 60.95 22.06 12.29 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 -174.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -95.42 129.72 42.48 Favored 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 124.697 1.199 . . . . 0.0 110.168 175.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -84.88 105.09 15.39 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.157 0.983 . . . . 0.0 112.942 -176.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 4.8 p -99.86 127.52 46.03 Favored 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -76.01 104.43 6.54 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 159.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.0 m -111.37 123.6 50.55 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.23 0.612 . . . . 0.0 112.206 -164.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.4 t -110.99 113.03 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 172.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.6 t -95.97 104.74 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 169.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.9 t -109.74 137.0 48.19 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.65 0.738 . . . . 0.0 112.111 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 tt -85.93 103.72 14.91 Favored 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 123.057 0.543 . . . . 0.0 110.474 174.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -96.11 80.66 3.29 Favored 'General case' 0 CA--C 1.567 1.627 0 O-C-N 121.399 -0.813 . . . . 0.0 111.015 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.74 -83.49 1.14 Allowed Glycine 0 N--CA 1.493 2.451 0 O-C-N 121.013 -1.055 . . . . 0.0 114.26 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -137.9 53.89 1.82 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.106 0.479 . . . . 0.0 112.19 162.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -150.57 130.14 13.07 Favored 'General case' 0 CA--C 1.567 1.626 0 O-C-N 120.754 -1.216 . . . . 0.0 111.673 173.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 16.6 mt -93.29 108.22 19.9 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.33 1.052 . . . . 0.0 111.438 -174.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.02 103.6 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.314 -0.866 . . . . 0.0 108.902 -167.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -89.51 94.3 9.82 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 123.321 0.649 . . . . 0.0 112.413 -178.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 61.2 mt -87.26 98.11 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.7 0.8 . . . . 0.0 109.141 -172.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -92.65 117.94 30.51 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 118.984 0.811 . . . . 0.0 109.958 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -117.46 122.57 44.11 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.148 0.579 . . . . 0.0 110.607 -175.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.7 p90 -153.35 126.93 8.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.503 -0.748 . . . . 0.0 110.509 -172.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 48.46 49.97 17.46 Favored 'General case' 0 N--CA 1.507 2.387 0 N-CA-C 117.214 2.301 . . . . 0.0 117.214 169.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.04 7.08 69.96 Favored Glycine 0 CA--C 1.558 2.758 0 N-CA-C 120.332 2.893 . . . . 0.0 120.332 -168.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -123.73 143.62 50.17 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 120.031 1.916 . . . . 0.0 110.901 -169.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -133.02 131.21 40.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.685 -0.635 . . . . 0.0 111.238 -177.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.4 t -130.88 137.44 49.35 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 123.236 0.614 . . . . 0.0 110.296 166.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.276 11.5 p30 -119.41 128.88 54.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.566 -0.709 . . . . 0.0 112.499 175.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 m-30 -99.77 105.32 17.09 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 84.5 t -90.0 97.52 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -174.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.96 108.37 19.53 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.227 1.011 . . . . 0.0 111.495 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -118.29 148.87 42.01 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.6 mm -85.58 99.77 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 170.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.72 93.25 5.47 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.556 0.742 . . . . 0.0 109.55 -178.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.7 t70 51.51 55.89 8.72 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -174.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.31 -28.57 4.66 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 119.008 2.363 . . . . 0.0 119.008 -169.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -92.18 145.21 24.68 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 119.883 1.841 . . . . 0.0 112.905 -172.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -85.98 100.77 12.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.174 -0.954 . . . . 0.0 110.42 175.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.8 t -100.49 110.9 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 26.7 ttp -100.13 115.08 28.97 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.19 0.596 . . . . 0.0 110.095 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 96.2 m -103.1 104.96 15.17 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mp -96.66 101.51 13.13 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.444 0.698 . . . . 0.0 109.759 -174.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.7 t -90.09 125.07 35.3 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.449 -0.782 . . . . 0.0 111.757 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -109.5 77.24 1.05 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 156.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 64.78 -112.45 5.02 Favored Glycine 0 CA--C 1.548 2.141 0 N-CA-C 114.485 0.554 . . . . 0.0 114.485 -170.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -78.24 -21.05 50.49 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 172.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.6 t -87.93 111.71 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 120.868 1.667 . . . . 0.0 108.662 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 58.2 t -123.07 114.1 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -168.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -94.22 118.01 30.94 Favored 'General case' 0 CA--C 1.562 1.439 0 O-C-N 121.724 -0.61 . . . . 0.0 112.458 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.4 t -100.82 106.48 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -109.96 117.84 34.85 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.427 0.632 . . . . 0.0 111.008 -173.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -91.87 119.97 32.13 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.368 0.604 . . . . 0.0 111.01 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -117.34 133.4 56.03 Favored 'General case' 0 CA--C 1.561 1.404 0 CA-C-O 121.931 0.872 . . . . 0.0 109.51 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -122.95 153.7 39.37 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.671 0.748 . . . . 0.0 110.659 -176.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -68.16 132.29 46.92 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -172.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.231 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.396 172.717 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.338 22.4 tt0 . . . . . 0 N--CA 1.497 1.913 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.2 -31.1 41.23 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.638 2.459 . . . . 0.0 117.638 161.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -73.67 -18.51 61.01 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 117.322 2.341 . . . . 0.0 117.322 167.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 44.3 t -75.59 90.94 2.8 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-N 122.331 2.332 . . . . 0.0 114.112 -169.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -168.03 170.47 10.41 Favored 'General case' 0 CA--C 1.569 1.705 0 C-N-CA 124.317 1.047 . . . . 0.0 111.902 -171.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.0 m -78.02 135.23 37.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.819 -1.176 . . . . 0.0 109.162 160.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -120.02 116.7 26.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.775 -1.203 . . . . 0.0 109.682 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -102.2 128.09 48.86 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.662 0.785 . . . . 0.0 110.513 -174.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tt -69.89 117.91 12.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.537 -0.727 . . . . 0.0 112.816 -174.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 46.2 p -97.71 -44.7 6.65 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -147.78 118.04 7.34 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 119.513 1.051 . . . . 0.0 110.232 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.7 p -97.38 95.56 7.76 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.212 0.605 . . . . 0.0 111.951 174.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -79.89 117.52 20.83 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 123.526 0.73 . . . . 0.0 111.027 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.6 t30 60.73 23.26 13.16 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -66.37 -39.12 88.91 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -175.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -52.98 -55.67 21.79 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 171.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -66.73 -34.68 78.37 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -53.6 -53.98 44.0 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-N 120.442 1.473 . . . . 0.0 113.695 161.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 79.4 mtm -57.59 -46.53 83.91 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 115.556 1.688 . . . . 0.0 115.556 174.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -57.32 -46.92 82.74 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 168.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.53 -41.73 99.06 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 171.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.1 tp -57.02 -18.84 15.45 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 168.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.03 60.37 1.77 Allowed Glycine 0 N--CA 1.481 1.665 0 O-C-N 121.3 -0.875 . . . . 0.0 114.402 -176.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.6 m -95.05 155.47 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 CA-C-O 121.886 0.85 . . . . 0.0 111.856 167.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.53 164.47 54.12 Favored Glycine 0 CA--C 1.552 2.349 0 O-C-N 121.326 -0.859 . . . . 0.0 114.279 154.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -55.48 -38.22 68.84 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.7 -48.87 66.29 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.0 m -65.23 -41.31 94.51 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 173.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.284 22.7 ptt180 -66.25 -42.26 88.81 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 121.617 2.008 . . . . 0.0 115.644 169.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -59.21 -48.66 80.79 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 171.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.4 t -57.89 -60.66 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 124.334 1.053 . . . . 0.0 113.141 166.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.54 -30.6 50.82 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 120.392 2.917 . . . . 0.0 120.392 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.23 -42.4 31.36 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 168.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.251 20.8 m -73.54 -42.47 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 CA-C-N 120.765 1.621 . . . . 0.0 115.125 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.1 t -91.42 148.09 22.56 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 119.46 1.027 . . . . 0.0 111.836 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -99.62 98.42 7.03 Favored Pre-proline 0 CA--C 1.571 1.778 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.493 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.17 117.48 5.07 Favored 'Trans proline' 0 CA--C 1.56 1.798 0 C-N-CA 122.547 2.165 . . . . 0.0 113.729 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.1 m -91.79 125.5 36.53 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.139 0.975 . . . . 0.0 109.323 -176.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.1 t -108.29 100.07 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -165.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.9 mt -90.32 109.38 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.521 -1.362 . . . . 0.0 108.322 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.1 mt -88.95 110.17 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 174.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 82.1 p -124.77 117.46 24.23 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.032 0.533 . . . . 0.0 111.769 -171.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -85.27 122.11 28.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.312 -0.868 . . . . 0.0 111.454 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.23 89.59 2.88 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.488 0.661 . . . . 0.0 110.706 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.64 -106.64 2.46 Favored Glycine 0 N--CA 1.487 2.069 0 O-C-N 121.781 -0.575 . . . . 0.0 113.604 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -95.67 -34.85 11.81 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 171.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -86.01 146.49 26.63 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-O 123.368 1.556 . . . . 0.0 114.491 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 64.4 t -96.22 115.61 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.584 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.7 t -102.05 102.8 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.7 mt -91.36 118.19 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.2 mtt-85 -109.4 107.61 17.84 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.447 0.699 . . . . 0.0 109.345 -173.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.2 m -89.84 100.43 13.24 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.5 mt -115.76 119.41 35.94 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.476 0.71 . . . . 0.0 109.856 -169.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 m -121.08 -177.62 3.55 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 122.116 0.96 . . . . 0.0 111.906 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.3 p -61.73 -30.31 70.69 Favored 'General case' 0 N--CA 1.505 2.317 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 158.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -120.69 -54.04 2.07 Favored 'General case' 0 CA--C 1.572 1.8 0 C-N-CA 124.115 0.966 . . . . 0.0 112.174 -175.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -83.32 138.26 33.62 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -137.3 108.62 6.86 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 171.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.0 t -143.21 140.79 30.88 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.632 -0.667 . . . . 0.0 111.508 173.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -136.74 137.93 40.41 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.0 -1.063 . . . . 0.0 113.263 -174.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.3 pt -123.21 124.79 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 C-N-CA 123.16 0.584 . . . . 0.0 112.261 -169.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.3 p -110.69 106.64 15.94 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 123.607 0.763 . . . . 0.0 112.47 -174.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -134.25 140.28 46.34 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -169.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -101.9 39.05 1.52 Allowed 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.0 mt 60.55 97.58 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 125.031 1.332 . . . . 0.0 114.334 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.91 -0.61 82.46 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 118.902 2.321 . . . . 0.0 118.902 -165.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -70.93 125.05 25.8 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 119.341 1.571 . . . . 0.0 111.825 173.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -91.47 123.54 34.96 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.785 0.434 . . . . 0.0 110.664 169.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -147.16 144.43 28.97 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.336 0.654 . . . . 0.0 111.998 -172.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.66 142.16 44.54 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.416 -1.428 . . . . 0.0 112.586 166.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -149.27 137.05 20.42 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.461 0.648 . . . . 0.0 112.596 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.4 m -82.25 103.47 11.86 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 122.066 0.936 . . . . 0.0 110.206 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.3 p -72.91 174.83 7.22 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.98 -9.36 3.0 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 119.762 3.245 . . . . 0.0 119.762 170.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -110.39 20.33 17.88 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 120.741 1.61 . . . . 0.0 114.518 159.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.273 6.6 m-20 54.68 31.56 15.52 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 117.658 2.466 . . . . 0.0 117.658 -174.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 ptp85 -87.32 128.59 35.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.873 -1.142 . . . . 0.0 108.967 165.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -79.05 92.55 5.01 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.679 0.752 . . . . 0.0 111.558 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 68.7 m -85.99 118.43 25.46 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -171.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -69.72 99.43 1.33 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.148 0.979 . . . . 0.0 109.558 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.7 m -115.54 120.4 39.34 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.595 -155.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.1 p -117.45 116.11 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 123.11 0.564 . . . . 0.0 109.733 176.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.6 t -102.92 112.7 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.432 -0.793 . . . . 0.0 109.372 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 86.0 p -113.45 123.11 49.26 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.63 0.772 . . . . 0.0 111.395 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tt -89.65 98.76 11.95 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 118.992 0.815 . . . . 0.0 111.601 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -97.15 68.7 2.27 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 123.353 0.661 . . . . 0.0 111.955 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.09 82.41 0.13 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 116.075 1.19 . . . . 0.0 116.075 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.269 24.2 t0 63.64 0.52 0.89 Allowed 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 -164.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -118.12 99.73 7.07 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 121.119 1.782 . . . . 0.0 110.373 -172.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.8 mt -76.72 99.43 5.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.303 -0.873 . . . . 0.0 110.722 171.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.1 t -99.66 99.41 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.866 -1.146 . . . . 0.0 108.265 -172.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -85.49 100.6 12.01 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.297 0.639 . . . . 0.0 110.814 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.2 mt -90.65 105.48 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -176.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -93.61 122.82 36.46 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 118.45 0.568 . . . . 0.0 110.865 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -112.01 132.8 54.57 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.859 0.863 . . . . 0.0 110.5 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -157.5 124.94 5.22 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.675 -1.266 . . . . 0.0 110.362 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 58.2 24.82 11.83 Favored 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 172.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.93 -24.14 17.01 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 118.425 2.13 . . . . 0.0 118.425 -162.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -82.67 144.72 30.06 Favored 'General case' 0 CA--C 1.565 1.548 0 CA-C-N 119.486 1.643 . . . . 0.0 112.247 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -138.9 129.97 26.66 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.19 0.519 . . . . 0.0 111.543 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.4 t -117.88 154.64 31.51 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 123.577 0.751 . . . . 0.0 110.401 165.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.282 11.6 p30 -130.12 141.26 50.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.131 -0.981 . . . . 0.0 113.54 165.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -111.07 103.49 11.95 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -177.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.7 t -85.82 102.52 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -104.97 108.7 20.36 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.849 0.86 . . . . 0.0 108.857 -169.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -135.74 136.41 40.77 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -169.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 26.7 mm -82.7 113.92 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.718 -0.614 . . . . 0.0 109.52 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -120.79 108.83 14.43 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.7 t70 50.3 54.34 11.31 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 116.582 2.067 . . . . 0.0 116.582 -176.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 64.05 19.64 63.86 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 119.662 2.625 . . . . 0.0 119.662 -169.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -129.27 129.75 45.32 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 119.246 1.523 . . . . 0.0 108.908 -175.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 ttt -82.66 104.78 13.17 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-O 122.067 0.937 . . . . 0.0 109.922 176.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.1 t -86.88 104.41 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 174.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 55.2 ttm -93.48 104.25 16.4 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.8 m -93.69 110.17 21.79 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.526 0.679 . . . . 0.0 109.329 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mp -95.82 105.61 17.64 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 124.184 0.994 . . . . 0.0 108.897 -173.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.7 t -115.26 114.91 25.82 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 119.229 0.922 . . . . 0.0 111.949 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -98.45 74.8 2.18 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.473 0.654 . . . . 0.0 109.251 164.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 66.37 -91.94 0.17 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 115.444 0.938 . . . . 0.0 115.444 -175.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.98 -34.96 20.69 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 172.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.9 t -87.17 117.95 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-N 120.099 1.318 . . . . 0.0 109.732 -171.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.4 t -116.28 127.08 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 C-N-CA 123.493 0.717 . . . . 0.0 109.772 -173.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.67 160.24 18.11 Favored 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 123.264 0.626 . . . . 0.0 112.593 161.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.5 t -131.28 110.7 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.976 -1.078 . . . . 0.0 108.753 176.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -94.56 119.19 32.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.129 -0.982 . . . . 0.0 110.613 169.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -92.54 105.24 17.45 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.387 0.675 . . . . 0.0 109.542 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -106.27 122.98 47.32 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.438 0.695 . . . . 0.0 111.057 -172.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -95.65 157.28 15.97 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.982 -1.073 . . . . 0.0 113.618 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -81.05 141.13 34.66 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -173.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.307 0 CA-C-O 117.364 -1.303 . . . . 0.0 111.975 -179.062 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.26 -27.18 54.28 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 166.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -83.4 -23.81 32.21 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 172.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 71.7 m -78.12 99.48 6.18 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 121.758 2.072 . . . . 0.0 112.998 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.66 168.77 12.37 Favored 'General case' 0 CA--C 1.57 1.717 0 CA-C-O 122.284 1.04 . . . . 0.0 112.245 -173.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.0 m -85.39 102.65 13.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.203 -0.936 . . . . 0.0 108.901 173.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -101.59 108.66 20.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.788 -1.195 . . . . 0.0 112.027 -169.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -94.13 128.36 40.49 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.428 -0.795 . . . . 0.0 110.94 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.95 117.35 14.56 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.528 0.68 . . . . 0.0 112.704 -175.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.7 p -88.68 -47.82 7.98 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -145.17 112.17 5.98 Favored 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 123.51 0.724 . . . . 0.0 109.662 -171.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.0 p -101.25 95.25 6.4 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.474 0.709 . . . . 0.0 111.406 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -91.0 116.39 28.75 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 122.893 0.477 . . . . 0.0 110.736 -166.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 0.7 OUTLIER 64.01 39.82 7.64 Favored 'General case' 0 CA--C 1.582 2.174 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -173.825 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -78.87 -44.58 22.52 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -53.67 -51.12 64.21 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 116.763 2.134 . . . . 0.0 116.763 175.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -66.52 -38.96 88.32 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -50.14 -53.94 24.11 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 160.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 31.5 mtp -58.41 -42.28 86.86 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 174.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -59.33 -51.4 70.11 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 165.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.4 -38.07 89.73 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 116.743 2.127 . . . . 0.0 116.743 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 tt -61.92 -32.59 73.0 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 165.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.71 49.95 1.89 Allowed Glycine 0 N--CA 1.484 1.88 0 N-CA-C 115.919 1.128 . . . . 0.0 115.919 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 m -93.16 156.69 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-N 118.792 1.296 . . . . 0.0 112.173 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.44 156.85 50.46 Favored Glycine 0 CA--C 1.551 2.318 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 171.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -62.07 -41.27 97.99 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.94 -41.78 71.47 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 165.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.5 m -60.7 -46.62 89.68 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 168.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.5 mtm180 -54.36 -48.75 71.11 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 165.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -60.48 -42.12 95.61 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.8 t -52.95 -60.38 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-N 119.909 1.231 . . . . 0.0 113.101 163.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.0 -31.51 68.71 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 119.822 2.689 . . . . 0.0 119.822 176.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -67.48 -45.7 75.15 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 167.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.6 m -79.33 -32.59 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.23 146.56 34.02 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 120.19 1.359 . . . . 0.0 113.798 -163.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -91.66 116.86 67.27 Favored Pre-proline 0 CA--C 1.577 1.994 0 O-C-N 121.665 -0.647 . . . . 0.0 110.902 161.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.91 128.51 9.26 Favored 'Trans proline' 0 CA--C 1.561 1.836 0 C-N-CA 122.492 2.128 . . . . 0.0 112.735 168.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 56.2 m -85.68 115.93 23.65 Favored 'General case' 0 CA--C 1.562 1.441 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.9 t -102.83 94.25 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -173.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.52 102.58 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.957 -1.089 . . . . 0.0 108.108 -175.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.5 mt -91.15 128.41 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.3 p -142.62 157.49 44.64 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.388 0.675 . . . . 0.0 111.917 -177.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -114.91 111.12 20.68 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.246 -0.909 . . . . 0.0 108.644 166.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -82.01 -57.45 3.4 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -177.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.24 87.61 0.14 Allowed Glycine 0 N--CA 1.483 1.83 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.292 12.0 t70 70.93 -57.43 0.6 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -164.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -78.89 152.92 30.92 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -175.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.1 t -89.48 126.07 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.6 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.872 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.7 t -112.23 109.73 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.3 mt -99.85 130.11 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 174.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.8 mtt85 -107.8 107.8 18.72 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.344 0.658 . . . . 0.0 110.072 173.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.1 m -91.63 103.51 16.09 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.519 -0.738 . . . . 0.0 109.302 173.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 65.2 mt -125.73 119.96 29.35 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 122.817 0.447 . . . . 0.0 110.873 -169.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.26 178.44 6.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.987 -1.071 . . . . 0.0 110.498 159.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.7 p -77.99 48.56 0.73 Allowed 'General case' 0 N--CA 1.51 2.572 0 O-C-N 119.594 -1.941 . . . . 0.0 114.089 173.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -165.79 -58.12 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 125.152 1.381 . . . . 0.0 109.419 -165.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -131.84 132.14 43.43 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.206 1.002 . . . . 0.0 109.285 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -134.06 97.77 3.96 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -172.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.2 t -127.93 128.7 45.58 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 123.178 0.591 . . . . 0.0 111.076 -175.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -119.76 138.85 53.08 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.2 pt -135.28 116.37 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-O 121.313 0.578 . . . . 0.0 111.055 -163.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.1 p -100.63 121.93 42.45 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.064 0.946 . . . . 0.0 112.048 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -147.86 139.2 23.6 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -173.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -81.59 6.86 13.72 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.258 50.9 mt 70.29 105.63 0.06 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 125.188 1.395 . . . . 0.0 111.746 -168.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.69 0.88 89.22 Favored Glycine 0 CA--C 1.556 2.636 0 N-CA-C 119.139 2.416 . . . . 0.0 119.139 -161.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -81.97 122.77 28.2 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-N 120.179 1.99 . . . . 0.0 111.136 174.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -86.45 113.37 22.33 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 122.711 0.405 . . . . 0.0 110.944 172.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -125.25 146.33 49.58 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.842 0.857 . . . . 0.0 111.541 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.98 139.9 36.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.743 -1.223 . . . . 0.0 112.507 168.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -146.5 130.78 17.53 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.192 0.52 . . . . 0.0 110.516 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.4 m -71.47 124.91 25.68 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-O 121.694 0.759 . . . . 0.0 110.656 164.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.1 p -96.65 174.94 6.57 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -176.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.52 -17.63 14.78 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 119.386 3.106 . . . . 0.0 119.386 166.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -81.59 -5.64 58.23 Favored 'General case' 0 CA--C 1.58 2.118 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 161.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.273 23.2 t70 65.34 66.16 0.55 Allowed 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 121.151 1.796 . . . . 0.0 112.992 -170.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -154.55 138.47 16.32 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.87 0.868 . . . . 0.0 109.467 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -79.52 114.9 18.81 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 174.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 2.4 p -99.64 122.83 43.25 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.854 -0.529 . . . . 0.0 112.241 173.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -72.83 96.95 2.15 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.7 m -109.17 118.23 36.21 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.025 -160.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.5 p -121.79 119.88 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.2 t -107.29 118.22 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.486 -0.759 . . . . 0.0 109.686 -173.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.9 m -111.95 125.99 54.64 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.36 0.664 . . . . 0.0 111.568 -177.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.4 tt -83.73 99.66 10.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.428 -0.795 . . . . 0.0 109.825 170.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -91.51 78.44 5.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.454 -0.779 . . . . 0.0 110.651 -175.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.88 -79.24 1.6 Allowed Glycine 0 N--CA 1.492 2.424 0 O-C-N 121.3 -0.875 . . . . 0.0 114.541 -174.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -139.9 60.17 1.56 Allowed 'General case' 0 CA--C 1.572 1.796 0 C-N-CA 122.877 0.471 . . . . 0.0 110.063 164.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -156.9 106.98 2.28 Favored 'General case' 0 CA--C 1.566 1.559 0 O-C-N 121.315 -0.866 . . . . 0.0 109.307 -168.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.0 mt -86.94 101.0 13.0 Favored 'General case' 0 CA--C 1.57 1.719 0 O-C-N 121.349 -0.845 . . . . 0.0 112.373 -174.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.9 t -102.45 102.82 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.132 -0.98 . . . . 0.0 109.025 -171.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -88.12 106.24 18.04 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 123.197 0.599 . . . . 0.0 110.759 177.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.6 mt -92.81 107.23 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -90.88 125.25 35.69 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 118.948 0.794 . . . . 0.0 110.951 171.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -120.77 126.27 49.71 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.396 0.679 . . . . 0.0 110.832 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.0 p90 -152.73 123.72 7.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.943 -1.098 . . . . 0.0 110.483 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 54.31 33.46 18.41 Favored 'General case' 0 N--CA 1.51 2.566 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.93 -26.34 4.88 Favored Glycine 0 CA--C 1.557 2.702 0 N-CA-C 118.809 2.284 . . . . 0.0 118.809 -164.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -75.92 143.59 41.57 Favored 'General case' 0 CA--C 1.566 1.583 0 CA-C-N 119.494 1.647 . . . . 0.0 113.002 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -132.48 134.21 44.76 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.361 0.664 . . . . 0.0 111.039 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.8 t -132.94 130.85 40.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.676 -0.64 . . . . 0.0 111.455 162.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -107.73 130.66 54.93 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 123.16 0.584 . . . . 0.0 112.299 174.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -107.34 103.81 13.26 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.8 t -92.22 94.14 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -170.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.9 mtt85 -81.86 115.2 20.95 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.997 0.919 . . . . 0.0 111.294 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -127.26 144.46 51.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.681 -0.637 . . . . 0.0 111.637 172.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.2 mm -83.75 116.12 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.186 -0.946 . . . . 0.0 109.054 174.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.72 85.4 2.24 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.9 t70 49.69 61.54 3.11 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -178.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.92 -44.07 1.86 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 117.135 1.614 . . . . 0.0 117.135 -173.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -85.8 151.56 23.72 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 118.655 1.227 . . . . 0.0 113.121 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 38.7 tpp -85.73 116.96 24.31 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 160.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.4 t -94.09 106.8 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 165.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 18.2 ttt -102.05 111.51 23.81 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.5 m -100.75 106.8 18.25 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -177.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.0 mp -101.02 105.82 17.06 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -174.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.3 t -106.07 139.15 41.05 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.772 0.796 . . . . 0.0 112.052 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -101.09 79.61 2.03 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 162.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 70.37 -94.6 0.48 Allowed Glycine 0 N--CA 1.489 2.211 0 O-C-N 121.663 -0.648 . . . . 0.0 113.322 -163.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -127.99 57.16 1.56 Allowed 'General case' 0 CA--C 1.573 1.845 0 C-N-CA 122.972 0.509 . . . . 0.0 111.938 169.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.2 t -136.13 110.41 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 170.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.3 t -117.63 125.18 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.671 -0.643 . . . . 0.0 111.203 -151.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -107.37 124.97 50.6 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.317 0.647 . . . . 0.0 112.054 165.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.2 t -109.19 105.4 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.318 -0.864 . . . . 0.0 108.809 -174.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 -103.49 114.1 28.11 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 123.898 0.879 . . . . 0.0 111.495 -173.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -96.61 116.54 29.27 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.53 0.732 . . . . 0.0 111.244 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -110.37 138.68 46.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.528 -0.733 . . . . 0.0 111.283 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -99.18 152.78 19.5 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.682 0.753 . . . . 0.0 112.453 167.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -72.46 128.98 37.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.795 -0.566 . . . . 0.0 111.998 171.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.631 179.964 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 . . . . . 0 N--CA 1.497 1.89 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.58 -25.36 52.26 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 117.963 2.579 . . . . 0.0 117.963 168.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -82.92 -15.81 49.91 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 171.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 41.5 t -79.98 92.79 5.61 Favored 'General case' 0 CA--C 1.565 1.531 0 CA-C-N 121.472 1.942 . . . . 0.0 113.725 -169.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -166.61 168.53 14.46 Favored 'General case' 0 CA--C 1.569 1.687 0 C-N-CA 124.118 0.967 . . . . 0.0 111.826 -174.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.1 m -78.32 124.05 27.66 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.973 -1.079 . . . . 0.0 108.884 159.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -113.09 119.66 38.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 110.66 -177.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -99.85 129.93 45.99 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.81 0.844 . . . . 0.0 111.023 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tt -73.18 121.25 19.99 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -176.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.3 p -92.41 -50.29 5.71 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 175.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -141.74 117.35 10.32 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 119.254 0.934 . . . . 0.0 109.934 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.1 p -107.01 109.04 20.83 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.486 0.714 . . . . 0.0 112.82 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -94.16 131.15 39.99 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.468 0.707 . . . . 0.0 111.454 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.284 3.9 t-20 61.31 25.82 15.73 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 118.359 2.726 . . . . 0.0 118.359 176.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -70.23 -42.8 71.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 119.794 -1.817 . . . . 0.0 115.537 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -49.51 -53.63 22.32 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 169.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.69 -39.06 84.45 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -53.22 -55.77 21.72 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 162.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 74.3 mtm -54.51 -48.57 71.76 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 173.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -41.93 90.07 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 172.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.77 -35.67 81.37 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 117.251 2.315 . . . . 0.0 117.251 167.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 tp -67.72 -27.09 66.51 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.81 65.41 0.65 Allowed Glycine 0 N--CA 1.484 1.863 0 C-N-CA 123.675 0.655 . . . . 0.0 114.202 -173.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.429 HG21 ' HB3' ' A' ' 30' ' ' ARG . 23.8 m -105.56 145.82 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 C-N-CA 123.501 0.721 . . . . 0.0 111.865 168.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.54 176.07 51.07 Favored Glycine 0 N--CA 1.49 2.281 0 O-C-N 121.367 -0.833 . . . . 0.0 114.276 152.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -77.3 61.62 2.19 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 123.071 1.415 . . . . 0.0 113.384 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -158.21 -61.75 0.08 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.049 1.34 . . . . 0.0 109.055 -175.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.8 m -57.44 -42.0 81.57 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 164.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.429 ' HB3' HG21 ' A' ' 25' ' ' VAL . 7.2 ptm180 -61.44 -38.53 87.53 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 164.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -62.9 -42.32 99.74 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 120.469 1.486 . . . . 0.0 114.902 170.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 70.4 t -48.12 -65.28 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 CA-C-N 119.84 1.2 . . . . 0.0 112.796 160.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.19 -33.91 61.9 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 119.782 2.673 . . . . 0.0 119.782 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -67.97 -46.46 71.3 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 169.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.8 m -79.7 -30.8 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.4 t -120.77 153.78 36.57 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 120.293 1.406 . . . . 0.0 113.579 -167.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.0 111.83 60.28 Favored Pre-proline 0 CA--C 1.575 1.933 0 CA-C-O 117.883 -1.056 . . . . 0.0 111.494 178.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.57 123.99 8.51 Favored 'Trans proline' 0 CA--C 1.559 1.763 0 CA-C-N 123.523 2.294 . . . . 0.0 115.424 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.4 m -96.69 118.76 33.84 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.097 0.959 . . . . 0.0 108.483 -175.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.5 t -106.11 105.44 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -169.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.5 mt -95.35 103.45 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -85.5 111.46 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 171.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.5 p -127.71 122.81 33.87 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.097 0.559 . . . . 0.0 111.358 -172.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -89.21 99.06 12.13 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -98.15 -44.52 6.57 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -161.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.06 104.83 0.19 Allowed Glycine 0 N--CA 1.483 1.82 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -173.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.292 13.8 t70 71.66 -52.34 0.69 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -165.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -126.59 162.09 26.51 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 122.562 1.172 . . . . 0.0 113.881 -163.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.9 t -86.06 122.8 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.6 t -115.47 108.15 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 -175.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 56.6 mt -91.85 117.35 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 173.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -97.58 102.16 13.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 169.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.4 m -88.56 104.78 17.15 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.2 mt -102.94 99.46 9.36 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.6 t -87.74 39.3 0.88 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 171.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.328 69.8 p 64.0 -58.71 0.2 Allowed 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -172.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -93.47 -44.35 8.28 Favored 'General case' 0 CA--C 1.574 1.872 0 C-N-CA 125.413 1.485 . . . . 0.0 112.652 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -100.02 117.81 35.08 Favored 'General case' 0 CA--C 1.566 1.588 0 C-N-CA 124.094 0.958 . . . . 0.0 110.817 -176.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -98.57 104.08 16.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.59 -0.694 . . . . 0.0 109.86 168.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.252 5.0 t -103.15 82.6 2.09 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.902 0.858 . . . . 0.0 110.495 169.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.95 131.19 34.7 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 pt -131.62 130.55 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 123.366 0.666 . . . . 0.0 111.364 -170.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 90.2 p -116.87 131.64 56.9 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 123.881 0.872 . . . . 0.0 111.922 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -158.84 144.86 16.72 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.141 -0.974 . . . . 0.0 113.307 -169.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -94.4 26.5 3.36 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 175.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 69.2 mt 69.02 108.31 0.05 Allowed 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 125.203 1.401 . . . . 0.0 113.547 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.41 -10.49 58.85 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 118.656 2.222 . . . . 0.0 118.656 -162.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -73.72 123.85 24.9 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 118.962 1.381 . . . . 0.0 112.327 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -76.0 122.08 23.68 Favored 'General case' 0 CA--C 1.566 1.558 0 CA-C-O 121.306 0.574 . . . . 0.0 111.317 168.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -124.81 154.54 40.82 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.84 0.856 . . . . 0.0 110.586 173.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.09 136.7 32.85 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.951 -1.093 . . . . 0.0 110.973 171.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -134.45 108.79 8.34 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.904 0.482 . . . . 0.0 110.194 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 88.5 m -79.51 102.37 8.77 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 167.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.9 p -82.08 171.04 14.82 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -167.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.56 -13.53 2.45 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 119.834 3.272 . . . . 0.0 119.834 169.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.42 -16.09 50.27 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 163.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.306 28.6 m-20 73.94 72.17 0.12 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 125.073 1.349 . . . . 0.0 111.995 -160.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -157.01 129.12 7.28 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 124.128 0.971 . . . . 0.0 108.427 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -84.93 115.28 22.7 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 123.268 0.627 . . . . 0.0 112.077 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 72.8 m -110.58 119.72 40.08 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -174.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -71.06 105.87 3.5 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.381 0.61 . . . . 0.0 109.754 165.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.1 m -117.89 119.09 33.81 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.779 -158.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.2 t -117.23 117.77 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.75 108.19 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.391 -0.818 . . . . 0.0 109.598 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 86.5 p -106.78 126.36 52.19 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 123.682 0.793 . . . . 0.0 112.697 -177.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.8 tt -83.33 102.83 12.26 Favored 'General case' 0 CA--C 1.569 1.698 0 C-N-CA 123.21 0.604 . . . . 0.0 110.824 172.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -92.47 76.41 5.12 Favored 'General case' 0 CA--C 1.57 1.719 0 O-C-N 121.107 -0.995 . . . . 0.0 111.443 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.07 -74.67 2.4 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 115.022 0.769 . . . . 0.0 115.022 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.09 65.66 1.21 Allowed 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 122.415 1.102 . . . . 0.0 110.632 153.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -147.5 106.61 3.87 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 mt -89.04 100.1 12.95 Favored 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 123.443 0.697 . . . . 0.0 110.684 -172.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.7 t -106.21 104.01 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -167.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -87.44 102.11 14.23 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 123.387 0.675 . . . . 0.0 111.419 176.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.3 mt -91.23 103.63 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -177.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -90.06 127.42 36.07 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 118.788 0.722 . . . . 0.0 111.114 171.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -121.18 120.39 35.08 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 123.193 0.597 . . . . 0.0 110.887 176.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -145.46 126.91 15.0 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.369 -0.832 . . . . 0.0 110.242 -175.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 55.14 31.92 17.34 Favored 'General case' 0 N--CA 1.511 2.58 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 174.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.9 -21.29 7.99 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 119.166 2.426 . . . . 0.0 119.166 -163.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -86.01 141.38 29.53 Favored 'General case' 0 CA--C 1.57 1.712 0 CA-C-N 119.016 1.408 . . . . 0.0 111.509 -177.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -134.88 125.19 26.27 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.482 0.713 . . . . 0.0 111.023 -173.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.4 t -122.48 144.33 49.13 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.335 0.654 . . . . 0.0 110.733 167.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.279 9.7 p30 -124.9 127.95 47.89 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-O 121.321 0.581 . . . . 0.0 112.415 174.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.3 101.24 12.64 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -174.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.5 t -92.43 96.55 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -168.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 -85.03 107.69 17.27 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.499 0.72 . . . . 0.0 110.181 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.91 129.62 48.54 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 123.035 0.534 . . . . 0.0 111.723 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.2 mm -81.45 120.2 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.339 -0.851 . . . . 0.0 110.177 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.75 89.52 3.13 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.7 t70 51.12 67.1 1.0 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.0 -48.46 3.23 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 117.38 1.712 . . . . 0.0 117.38 -174.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -86.32 143.94 27.63 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 118.643 1.222 . . . . 0.0 112.309 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 32.5 ttm -88.35 118.81 28.23 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-O 121.714 0.769 . . . . 0.0 109.823 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.6 t -89.08 100.51 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 169.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 36.5 ttm -94.94 100.41 12.27 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.369 0.604 . . . . 0.0 110.182 -173.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 84.3 m -98.02 99.79 11.08 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.813 0.816 . . . . 0.0 108.976 -172.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.5 mp -89.98 105.17 17.63 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.8 t -108.3 116.34 31.78 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.52 0.676 . . . . 0.0 110.993 -176.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -97.13 79.75 2.87 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 121.267 0.556 . . . . 0.0 109.509 166.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 63.16 -98.04 0.21 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 115.434 0.934 . . . . 0.0 115.434 -175.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -86.7 -17.21 34.25 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 169.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.8 t -91.96 101.63 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-N 121.774 2.079 . . . . 0.0 108.481 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 57.8 t -104.07 115.19 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -171.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.64 129.16 55.99 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.809 -0.557 . . . . 0.0 112.015 177.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.5 t -115.8 118.56 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.483 -0.761 . . . . 0.0 109.157 -168.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -111.25 125.55 53.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.415 -0.803 . . . . 0.0 111.505 175.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -95.84 109.47 21.8 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.893 0.477 . . . . 0.0 110.291 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -109.63 129.12 55.62 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 123.551 0.74 . . . . 0.0 112.295 -168.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -97.23 150.92 20.37 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 124.2 1.0 . . . . 0.0 112.836 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -74.78 134.52 41.8 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.3 -0.875 . . . . 0.0 113.134 172.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.519 0 C-N-CA 124.101 0.961 . . . . 0.0 111.63 161.441 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 . . . . . 0 CA--C 1.571 1.766 0 N-CA-C 117.206 2.299 . . . . 0.0 117.206 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.81 -31.33 48.73 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 117.964 2.579 . . . . 0.0 117.964 164.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -75.5 -18.21 59.89 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.779 2.141 . . . . 0.0 116.779 168.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 93.8 m -76.47 97.72 4.4 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 122.383 2.356 . . . . 0.0 113.417 -175.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.09 167.65 14.3 Favored 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 124.376 1.07 . . . . 0.0 111.556 -174.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 98.6 m -81.53 114.54 20.32 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.195 -0.941 . . . . 0.0 109.162 163.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -106.03 115.06 29.58 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.758 -0.589 . . . . 0.0 110.204 -176.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -95.98 132.97 40.75 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.328 0.651 . . . . 0.0 110.842 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -71.07 127.84 33.92 Favored 'General case' 0 CA--C 1.565 1.526 0 CA-C-O 122.303 1.049 . . . . 0.0 113.322 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.1 p -98.92 -39.98 8.3 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 176.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -154.73 121.29 5.4 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 119.534 1.061 . . . . 0.0 109.598 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.2 p -101.39 96.32 7.08 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.23 0.612 . . . . 0.0 111.741 174.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -72.62 124.52 25.44 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.386 0.675 . . . . 0.0 111.805 174.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.274 4.4 t-20 51.04 27.37 3.25 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 119.133 3.012 . . . . 0.0 119.133 177.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -70.92 -46.04 63.2 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -173.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -49.79 -50.06 46.22 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 168.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -58.19 -42.28 85.78 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 170.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -58.55 -48.61 80.3 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 165.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.2 mtp -57.39 -47.04 82.72 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -61.07 -42.28 98.2 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 166.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.52 -43.53 98.69 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 171.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.1 tp -62.24 -17.27 57.9 Favored 'General case' 0 CA--C 1.58 2.105 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 166.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.92 52.15 3.2 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 116.287 1.275 . . . . 0.0 116.287 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.268 9.5 m -92.65 143.51 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 118.57 1.185 . . . . 0.0 113.028 176.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.64 166.22 17.06 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 116.99 1.556 . . . . 0.0 116.99 166.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -64.51 -43.95 92.47 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.85 -46.6 87.35 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 166.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.4 m -58.14 -39.36 78.56 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 172.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.347 0.2 OUTLIER -62.38 -37.74 86.93 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 167.689 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -57.93 -47.19 83.59 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 120.999 1.727 . . . . 0.0 114.592 162.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 70.0 t -56.87 -34.26 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 117.125 2.268 . . . . 0.0 117.125 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.67 -16.64 41.59 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 119.377 2.511 . . . . 0.0 119.377 166.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -88.23 -44.22 11.02 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.573 2.187 . . . . 0.0 114.43 171.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.0 m -93.78 42.71 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 CA-C-N 122.032 2.196 . . . . 0.0 114.041 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.3 m -175.97 145.69 0.66 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.244 1.418 . . . . 0.0 107.892 -176.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -86.8 104.56 6.09 Favored Pre-proline 0 CA--C 1.576 1.977 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.574 170.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.63 113.22 3.74 Favored 'Trans proline' 0 C--N 1.374 1.883 0 CA-C-N 123.158 2.164 . . . . 0.0 112.298 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 93.1 m -95.95 115.29 27.21 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.501 -161.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -92.25 99.69 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -169.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.7 mt -93.21 99.91 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 62.0 mt -89.11 124.97 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.2 p -146.87 116.61 7.16 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.842 -0.536 . . . . 0.0 111.552 -168.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -84.27 117.97 23.89 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.945 -1.097 . . . . 0.0 112.024 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -109.4 82.58 1.62 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.936 0.874 . . . . 0.0 109.424 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.9 -100.58 1.48 Allowed Glycine 0 N--CA 1.489 2.18 0 O-C-N 121.884 -0.51 . . . . 0.0 114.219 -175.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -94.58 -24.44 17.22 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 173.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -98.37 146.32 25.82 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 120.786 1.63 . . . . 0.0 112.941 -174.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.65 115.11 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.671 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 170.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.9 t -99.85 106.35 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.0 mt -95.71 117.84 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 175.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -106.38 95.61 5.88 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.946 174.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.7 m -89.69 101.52 14.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.658 -0.651 . . . . 0.0 109.601 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.4 mt -107.47 105.25 15.07 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.275 -168.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 m -79.96 152.0 29.76 Favored 'General case' 0 CA--C 1.568 1.642 0 O-C-N 121.424 -0.798 . . . . 0.0 110.425 151.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.5 p -38.39 -51.13 1.54 Allowed 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 160.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -80.45 -47.51 14.22 Favored 'General case' 0 CA--C 1.572 1.804 0 C-N-CA 124.379 1.072 . . . . 0.0 113.599 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -115.0 109.77 18.6 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.845 0.858 . . . . 0.0 111.062 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -95.14 89.84 5.68 Favored 'General case' 0 CA--C 1.566 1.568 0 C-N-CA 123.193 0.597 . . . . 0.0 110.366 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.3 p -92.93 146.9 23.28 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -171.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -150.21 116.28 5.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.196 -0.94 . . . . 0.0 112.036 -166.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.2 pt -129.27 116.51 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.668 -0.645 . . . . 0.0 111.93 -175.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.8 p -103.58 113.17 26.48 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.24 1.016 . . . . 0.0 111.975 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -147.29 150.15 34.24 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.829 0.823 . . . . 0.0 113.119 -169.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -86.92 149.37 24.85 Favored 'General case' 0 CA--C 1.572 1.808 0 O-C-N 121.028 -1.045 . . . . 0.0 111.018 162.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.8 mt -68.21 123.97 22.16 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.059 -1.651 . . . . 0.0 112.546 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.38 -16.76 60.63 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 118.707 2.243 . . . . 0.0 118.707 -162.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -80.91 125.82 30.6 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-N 119.935 1.867 . . . . 0.0 112.005 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -86.62 127.69 34.94 Favored 'General case' 0 CA--C 1.569 1.693 0 CA-C-O 121.291 0.567 . . . . 0.0 111.901 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -133.93 148.64 51.22 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.154 0.982 . . . . 0.0 111.331 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.09 131.99 37.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.482 -1.387 . . . . 0.0 111.435 171.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -126.46 104.11 7.97 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.041 0.537 . . . . 0.0 110.139 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.4 m -74.1 104.52 4.95 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.223 1.011 . . . . 0.0 110.033 171.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 75.3 p -84.48 172.79 11.38 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -168.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.56 -6.73 0.76 Allowed 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 119.589 3.181 . . . . 0.0 119.589 166.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -96.45 0.43 50.37 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 160.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.313 18.3 t70 63.48 27.2 15.08 Favored 'General case' 0 CA--C 1.582 2.19 0 N-CA-C 116.949 2.203 . . . . 0.0 116.949 -166.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 -94.02 131.6 39.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.574 -1.329 . . . . 0.0 109.196 162.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.298 0.3 OUTLIER -88.72 108.93 19.74 Favored 'General case' 0 CA--C 1.569 1.676 0 CA-C-O 121.041 0.448 . . . . 0.0 110.361 171.493 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 92.4 m -95.33 120.82 36.23 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -173.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -69.88 100.12 1.51 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.811 0.815 . . . . 0.0 109.953 171.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.4 m -114.89 112.67 23.08 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.114 -156.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.8 p -111.71 119.12 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.368 0.604 . . . . 0.0 109.618 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.4 t -105.1 119.85 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -174.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.4 p -130.26 127.68 40.05 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.414 0.685 . . . . 0.0 111.661 -177.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 tt -91.12 111.28 22.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.133 -0.979 . . . . 0.0 110.632 177.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -113.7 74.92 0.89 Allowed 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 123.203 0.601 . . . . 0.0 111.373 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 65.84 77.9 0.25 Allowed Glycine 0 N--CA 1.496 2.678 0 N-CA-C 116.623 1.409 . . . . 0.0 116.623 172.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.271 23.4 t0 62.81 11.87 5.29 Favored 'General case' 0 CA--C 1.582 2.194 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 -164.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.7 mtmt -128.2 105.58 8.45 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 120.914 1.688 . . . . 0.0 109.532 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.78 93.45 8.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -0.968 . . . . 0.0 109.965 177.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 22.3 t -97.03 107.87 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.036 -1.04 . . . . 0.0 108.973 -166.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -93.26 103.25 15.52 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.576 0.75 . . . . 0.0 110.38 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.2 mt -92.84 105.04 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -176.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -94.29 122.06 36.45 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 118.561 0.619 . . . . 0.0 110.672 173.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -118.36 127.18 53.44 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.366 0.666 . . . . 0.0 110.442 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.4 p90 -149.49 122.68 8.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.03 -1.044 . . . . 0.0 110.055 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 54.85 36.65 27.05 Favored 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 176.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.92 -24.94 4.93 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 118.985 2.354 . . . . 0.0 118.985 -164.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -81.2 144.4 31.64 Favored 'General case' 0 CA--C 1.565 1.552 0 CA-C-N 119.075 1.437 . . . . 0.0 112.84 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -134.45 132.72 39.65 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.316 0.646 . . . . 0.0 111.287 -176.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.7 t -126.2 134.15 51.33 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 161.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -119.97 123.5 43.66 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.934 0.494 . . . . 0.0 110.813 176.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -102.72 108.9 20.32 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -171.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.0 t -92.8 96.39 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -174.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -88.32 116.88 26.85 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -133.3 133.53 42.7 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.8 mm -76.69 114.74 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -148.38 124.11 10.51 Favored 'General case' 0 CA--C 1.565 1.544 0 C-N-CA 124.225 1.01 . . . . 0.0 108.717 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 t70 55.85 50.5 13.93 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.27 18.68 65.47 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 119.66 2.624 . . . . 0.0 119.66 -172.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -144.31 152.02 40.18 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.486 1.143 . . . . 0.0 110.184 -169.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 7.7 ttm -85.2 115.32 22.92 Favored 'General case' 0 CA--C 1.564 1.516 0 O-C-N 121.26 -0.9 . . . . 0.0 108.984 159.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.9 t -88.46 105.42 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 27.2 ttt -95.22 103.22 15.07 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.771 -0.58 . . . . 0.0 110.3 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 92.1 m -92.33 115.19 27.87 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.656 0.741 . . . . 0.0 109.405 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mp -105.41 105.82 16.04 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -174.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.9 t -121.95 125.79 47.15 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 119.098 0.863 . . . . 0.0 113.321 -175.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -109.04 92.29 3.99 Favored 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 123.802 0.841 . . . . 0.0 108.758 171.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 69.5 -82.26 0.28 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 115.9 1.12 . . . . 0.0 115.9 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -121.72 -7.21 9.08 Favored 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 167.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.7 t -87.66 116.36 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-N 121.748 2.067 . . . . 0.0 108.565 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.1 t -115.4 121.0 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 C-N-CA 123.482 0.713 . . . . 0.0 109.655 -169.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -107.29 157.9 17.56 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 123.281 0.633 . . . . 0.0 112.446 161.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.4 t -132.44 110.59 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.01 -1.056 . . . . 0.0 109.274 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -97.5 121.26 39.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.028 -1.045 . . . . 0.0 111.273 174.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -99.37 110.56 23.05 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.427 0.691 . . . . 0.0 109.937 -171.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -110.61 128.01 55.49 Favored 'General case' 0 CA--C 1.563 1.454 0 O-C-N 121.378 -0.826 . . . . 0.0 111.99 -168.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -103.07 154.26 19.45 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 123.246 0.618 . . . . 0.0 112.543 168.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -74.1 134.97 42.93 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.251 -0.906 . . . . 0.0 113.027 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.519 0 C-N-CA 123.799 0.84 . . . . 0.0 111.837 168.948 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.329 17.5 tt0 . . . . . 0 N--CA 1.497 1.899 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.31 -26.57 61.12 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 165.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -71.18 -22.75 61.99 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 116.801 2.149 . . . . 0.0 116.801 165.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.7 m -83.67 100.42 10.85 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 120.83 1.65 . . . . 0.0 113.218 -174.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -165.38 171.93 12.84 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-O 122.222 1.011 . . . . 0.0 111.802 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 94.8 m -81.89 118.24 22.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.013 -1.054 . . . . 0.0 109.274 165.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -113.57 121.86 45.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.403 -0.811 . . . . 0.0 112.333 -170.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -96.79 124.97 40.92 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.467 1.107 . . . . 0.0 110.459 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tt -71.82 112.9 8.31 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.079 -1.013 . . . . 0.0 112.484 176.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.4 p -90.42 -46.22 8.49 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -143.93 136.19 26.7 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 119.193 0.906 . . . . 0.0 110.276 -175.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.3 p -118.8 136.98 53.71 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -94.2 -126.44 0.11 Allowed 'General case' 0 CA--C 1.573 1.848 0 O-C-N 121.611 -0.681 . . . . 0.0 110.326 172.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -83.82 54.05 2.76 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 119.571 -1.956 . . . . 0.0 114.848 -172.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -74.04 -36.18 64.37 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -48.35 -56.24 8.62 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 174.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -65.59 -42.32 91.81 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 169.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -52.91 -47.48 67.95 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 171.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 78.1 mtm -59.74 -48.68 80.72 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.06 -46.99 72.09 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 167.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.2 90.2 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 173.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mp -63.25 -35.9 81.88 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 166.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.11 41.42 0.9 Allowed Glycine 0 N--CA 1.487 2.051 0 N-CA-C 117.197 1.639 . . . . 0.0 117.197 177.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.5 m -71.22 158.06 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-N 119.323 1.561 . . . . 0.0 113.288 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.5 157.83 49.69 Favored Glycine 0 CA--C 1.553 2.437 0 O-C-N 120.767 -1.208 . . . . 0.0 115.89 162.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -64.57 -38.49 91.2 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.28 -44.33 97.41 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 160.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.7 m -58.54 -43.35 89.25 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -57.81 -47.98 81.06 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 167.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -63.04 -43.78 97.7 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 172.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.9 t -49.84 -61.15 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 163.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.93 -34.92 62.25 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 119.173 2.429 . . . . 0.0 119.173 174.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -66.33 -43.14 86.98 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 170.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.0 m -78.53 -33.35 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 116.361 1.985 . . . . 0.0 116.361 176.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 t -94.46 136.05 35.2 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 120.318 1.417 . . . . 0.0 113.997 -162.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -92.93 109.26 38.2 Favored Pre-proline 0 CA--C 1.576 1.96 0 CA-C-O 118.338 -0.839 . . . . 0.0 110.937 167.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.55 138.68 24.56 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 C-N-CA 122.635 2.223 . . . . 0.0 113.854 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.4 m -85.62 102.49 13.61 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.71 100.2 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -169.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.9 mt -90.82 102.75 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.175 -0.953 . . . . 0.0 108.529 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.5 mt -93.01 125.96 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.9 p -148.91 126.79 11.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.41 -0.806 . . . . 0.0 112.298 -169.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -81.42 109.32 15.79 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.682 -1.261 . . . . 0.0 110.426 168.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -104.11 86.66 2.6 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -173.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.19 -73.69 2.31 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 115.5 0.96 . . . . 0.0 115.5 -174.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -122.52 -53.85 1.88 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.889 0.876 . . . . 0.0 112.088 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -80.66 151.92 28.72 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -172.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.2 t -85.21 121.12 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.2 t -111.5 108.18 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.3 mt -89.75 116.11 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 172.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.8 mtm-85 -100.11 104.3 15.84 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 119.493 1.042 . . . . 0.0 109.73 169.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.7 m -90.11 102.52 15.24 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 77.3 mt -120.08 94.82 4.51 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 122.585 0.354 . . . . 0.0 110.397 -169.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.0 p -93.05 171.04 9.2 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.86 -1.15 . . . . 0.0 112.021 165.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.5 t -72.2 31.59 0.06 Allowed 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 165.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -155.68 -60.57 0.11 Allowed 'General case' 0 CA--C 1.571 1.756 0 C-N-CA 125.182 1.393 . . . . 0.0 109.404 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 46.7 mmtt -109.9 123.37 49.49 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.403 1.081 . . . . 0.0 109.902 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -124.14 98.29 5.71 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 123.337 0.655 . . . . 0.0 110.683 176.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.0 t -129.98 166.97 18.98 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 123.507 0.723 . . . . 0.0 112.054 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -138.18 153.0 49.2 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.9 mt -124.02 104.36 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.629 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -177.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 91.2 p -99.95 114.9 28.49 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.79 0.836 . . . . 0.0 112.178 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -145.14 152.93 40.81 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -171.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -103.68 141.98 35.12 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 123.463 0.705 . . . . 0.0 109.325 168.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -67.38 129.25 39.32 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.634 -1.291 . . . . 0.0 113.908 -173.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.79 -15.69 45.98 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 119.141 2.416 . . . . 0.0 119.141 -167.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -91.53 127.3 36.92 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 119.945 1.873 . . . . 0.0 111.58 -173.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -79.71 126.66 31.23 Favored 'General case' 0 CA--C 1.569 1.68 0 C-N-CA 122.885 0.474 . . . . 0.0 111.917 177.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -140.25 149.6 43.05 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.447 0.699 . . . . 0.0 111.916 -171.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -78.81 138.11 38.03 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.788 -1.195 . . . . 0.0 113.035 174.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -146.3 132.41 19.34 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.198 0.599 . . . . 0.0 110.959 174.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.3 m -98.51 119.77 37.78 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.487 0.66 . . . . 0.0 109.457 170.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 44.7 p -90.34 172.24 8.89 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -168.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.27 -21.37 33.91 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 118.595 2.813 . . . . 0.0 118.595 165.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -65.73 -14.68 61.78 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 158.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.291 10.1 m-20 62.38 46.86 5.58 Favored 'General case' 0 CA--C 1.574 1.873 0 CA-C-N 120.245 1.384 . . . . 0.0 114.69 -164.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.18 131.83 53.83 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.666 1.186 . . . . 0.0 108.702 172.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -86.78 120.31 27.94 Favored 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 122.806 0.442 . . . . 0.0 111.716 173.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.6 p -119.72 143.8 47.58 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.49 0.662 . . . . 0.0 112.725 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -79.13 105.11 10.23 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 121.966 0.889 . . . . 0.0 109.15 157.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.2 m -98.55 136.76 38.2 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.636 0.775 . . . . 0.0 112.245 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.6 p -134.3 129.89 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 123.537 0.735 . . . . 0.0 109.35 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.4 t -118.41 119.14 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.104 -0.998 . . . . 0.0 109.428 -169.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.7 p -117.69 131.62 56.6 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.576 0.75 . . . . 0.0 112.191 -176.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 tt -99.93 108.21 20.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.903 . . . . 0.0 110.301 177.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -88.78 -21.38 23.82 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 116.946 2.202 . . . . 0.0 116.946 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -178.43 -93.53 0.09 OUTLIER Glycine 0 N--CA 1.49 2.251 0 CA-C-N 120.289 1.404 . . . . 0.0 111.108 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -107.41 60.54 0.62 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 117.842 0.821 . . . . 0.0 109.915 151.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -155.25 114.76 3.67 Favored 'General case' 0 CA--C 1.563 1.46 0 O-C-N 121.416 -0.803 . . . . 0.0 110.576 174.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.5 mt -84.7 118.87 24.68 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.722 -0.611 . . . . 0.0 109.57 166.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.2 t -105.98 99.65 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -178.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -90.68 103.66 16.34 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.411 0.684 . . . . 0.0 110.151 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.3 mt -93.91 117.06 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -175.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -108.68 120.56 42.84 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 119.005 0.82 . . . . 0.0 110.464 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -112.41 120.82 42.98 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.889 0.876 . . . . 0.0 110.663 -176.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -151.58 134.28 15.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.395 -0.815 . . . . 0.0 110.591 -175.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 50.48 43.02 27.19 Favored 'General case' 0 N--CA 1.509 2.489 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 166.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.67 22.2 76.64 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 119.82 2.688 . . . . 0.0 119.82 -167.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -137.25 137.4 39.01 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 119.257 1.529 . . . . 0.0 109.506 -168.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -131.66 125.57 32.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.609 -0.682 . . . . 0.0 111.197 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.8 t -125.76 137.86 53.83 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.56 0.744 . . . . 0.0 110.377 175.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.258 11.6 p30 -120.11 135.34 54.99 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.81 105.19 15.55 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -174.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.5 t -89.91 95.88 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 CA-C-N 119.681 1.128 . . . . 0.0 108.199 -178.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.4 ' CG ' ' SD ' ' A' ' 113' ' ' MET . 41.8 ttm180 -95.35 106.25 18.28 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.021 0.928 . . . . 0.0 111.059 -173.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -126.34 144.38 50.83 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.179 0.592 . . . . 0.0 112.568 -176.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.6 mm -82.99 120.35 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -127.91 98.48 5.17 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.7 t70 53.15 58.26 5.46 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -176.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.19 -48.97 3.22 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 116.883 1.513 . . . . 0.0 116.883 -172.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -80.84 145.37 31.43 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 118.265 1.033 . . . . 0.0 113.085 -173.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.4 ' SD ' ' CG ' ' A' ' 106' ' ' ARG . 25.0 tpp -80.18 108.26 13.64 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 121.618 0.723 . . . . 0.0 109.378 161.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 93.6 t -100.75 100.41 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 30.4 ttm -98.49 102.84 14.7 Favored 'General case' 0 CA--C 1.561 1.372 0 O-C-N 122.049 -0.407 . . . . 0.0 110.751 -165.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.9 m -97.41 96.21 8.2 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.579 1.181 . . . . 0.0 110.119 -170.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.638 HD13 HH22 ' A' ' 126' ' ' ARG . 11.0 mp -93.83 106.83 18.78 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.217 1.007 . . . . 0.0 111.137 -176.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.0 t -101.45 118.04 36.15 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.582 0.753 . . . . 0.0 111.11 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -103.14 77.11 1.51 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 159.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 63.97 -109.52 2.84 Favored Glycine 0 CA--C 1.547 2.093 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 -170.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -76.54 -22.11 54.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 171.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.9 t -86.21 102.82 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 120.777 1.626 . . . . 0.0 108.867 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 61.6 t -110.26 108.56 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -172.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.45 135.86 39.41 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.477 0.711 . . . . 0.0 111.696 174.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.0 t -131.95 115.68 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.638 HH22 HD13 ' A' ' 117' ' ' LEU . 3.6 mtm105 -120.8 140.85 51.14 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 122.363 1.078 . . . . 0.0 113.013 176.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -110.21 100.16 9.1 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.541 -1.208 . . . . 0.0 108.662 -164.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -103.52 132.3 49.9 Favored 'General case' 0 CA--C 1.565 1.543 0 O-C-N 121.429 -0.795 . . . . 0.0 111.802 -169.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -103.16 151.53 22.49 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 172.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -74.09 135.25 42.96 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.295 -0.878 . . . . 0.0 113.177 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.079 -0.962 . . . . 0.0 111.491 164.851 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 . . . . . 0 N--CA 1.495 1.811 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.96 -28.67 64.54 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 169.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -77.39 -15.94 59.11 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 166.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.2 t -76.77 98.64 4.87 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 122.478 2.399 . . . . 0.0 114.302 -172.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -168.4 167.6 11.78 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.161 0.982 . . . . 0.0 112.23 -177.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.7 m -81.64 116.87 21.58 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.846 -1.159 . . . . 0.0 108.661 159.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -107.34 119.67 40.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.346 -0.847 . . . . 0.0 110.672 -174.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -101.93 131.92 48.04 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.638 0.732 . . . . 0.0 110.917 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -69.13 132.63 46.87 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.3 p -102.15 -41.29 6.46 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 173.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -156.76 129.47 7.68 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 119.552 1.069 . . . . 0.0 109.807 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.1 p -110.86 106.0 15.0 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.503 0.721 . . . . 0.0 110.913 172.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -70.65 -58.82 3.26 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 -160.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -120.57 46.4 2.01 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.318 -0.864 . . . . 0.0 112.287 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -75.79 -43.65 45.28 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -167.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -46.96 -52.64 14.17 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 163.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.55 -43.16 85.85 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 176.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -52.77 -53.25 50.86 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 120.203 1.365 . . . . 0.0 114.42 162.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 76.9 mtm -62.03 -43.7 98.28 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 176.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.5 -40.8 92.67 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 168.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.03 -39.97 95.27 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 165.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.5 tp -59.08 -37.29 76.75 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 172.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.45 50.8 0.84 Allowed Glycine 0 N--CA 1.485 1.938 0 N-CA-C 115.434 0.934 . . . . 0.0 115.434 -176.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.3 m -91.21 157.81 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 118.379 1.089 . . . . 0.0 112.545 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.6 158.68 53.61 Favored Glycine 0 CA--C 1.552 2.348 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 162.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -59.13 -41.05 87.33 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.92 -38.98 73.61 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 168.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.9 m -61.23 -48.2 82.56 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 169.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.257 8.2 ptm180 -63.22 -32.67 74.12 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 173.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -62.75 -58.02 8.92 Favored 'General case' 0 CA--C 1.571 1.758 0 CA-C-N 119.066 0.848 . . . . 0.0 113.182 162.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.6 t -54.06 -58.51 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.07 -21.24 58.99 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 120.253 2.861 . . . . 0.0 120.253 -177.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -91.11 -38.41 12.78 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 169.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -68.88 -39.87 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 CA-C-N 121.326 1.876 . . . . 0.0 115.846 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.7 t -85.03 153.32 22.81 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 119.474 1.034 . . . . 0.0 113.274 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -98.66 93.96 2.21 Favored Pre-proline 0 CA--C 1.575 1.906 0 O-C-N 121.46 -0.775 . . . . 0.0 110.335 169.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.19 118.49 5.64 Favored 'Trans proline' 0 C--N 1.374 1.904 0 CA-C-N 123.109 2.146 . . . . 0.0 113.466 -175.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 91.2 m -88.82 122.16 31.92 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.395 -173.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.7 t -105.32 100.75 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.711 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -166.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.0 mt -89.1 105.84 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.7 mt -97.27 115.05 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 92.1 p -144.48 124.82 13.82 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.748 0.419 . . . . 0.0 111.219 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -78.97 115.62 18.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.593 -0.692 . . . . 0.0 111.677 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -126.2 84.08 2.23 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.223 0.535 . . . . 0.0 110.371 -170.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.75 72.25 1.05 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 115.435 0.934 . . . . 0.0 115.435 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.29 7.3 t70 70.71 -51.94 0.67 Allowed 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -171.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -76.18 148.98 37.37 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.1 t -88.91 116.61 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.55 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 172.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.0 t -99.55 114.69 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.9 mt -103.43 112.94 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 173.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.6 116.24 30.41 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.284 1.034 . . . . 0.0 110.668 -177.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.1 m -102.22 100.5 10.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.69 -0.631 . . . . 0.0 109.44 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.3 mt -99.64 100.63 11.65 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.101 0.56 . . . . 0.0 109.998 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.1 p -98.36 1.9 47.45 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 118.24 2.681 . . . . 0.0 118.24 176.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.396 31.8 p 78.69 -57.35 0.44 Allowed 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 124.871 1.268 . . . . 0.0 113.316 -167.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -77.92 -61.88 1.85 Allowed 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 124.354 1.062 . . . . 0.0 112.267 177.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -105.62 117.58 34.38 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.988 0.915 . . . . 0.0 109.428 176.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -121.07 85.5 2.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.412 -0.805 . . . . 0.0 109.833 -172.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.2 t -113.18 176.37 5.05 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 122.3 1.048 . . . . 0.0 113.478 -173.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -146.66 156.08 42.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.847 -1.158 . . . . 0.0 113.093 173.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.3 pt -121.68 132.0 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 123.899 0.88 . . . . 0.0 109.508 171.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 92.6 p -124.17 109.49 13.5 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.509 0.723 . . . . 0.0 110.408 -176.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -141.49 139.48 33.31 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -165.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -93.34 23.91 4.21 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.7 mt 67.41 105.21 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 125.179 1.392 . . . . 0.0 113.769 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.58 -20.09 12.69 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 118.483 2.153 . . . . 0.0 118.483 -166.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -78.66 123.37 27.07 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 119.158 1.479 . . . . 0.0 111.666 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -84.77 131.48 34.54 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 121.86 0.838 . . . . 0.0 112.24 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -131.52 157.31 43.9 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 124.247 1.019 . . . . 0.0 111.181 -173.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.65 136.07 33.41 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.63 -1.294 . . . . 0.0 110.98 175.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -140.71 118.72 11.88 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 122.533 0.333 . . . . 0.0 111.114 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 85.1 m -82.96 113.13 20.34 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 163.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.6 p -87.08 164.9 16.17 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -165.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.54 -24.35 8.0 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 118.824 2.898 . . . . 0.0 118.824 164.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -78.56 -0.51 29.96 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 167.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.262 10.7 t70 68.01 65.97 0.36 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 120.358 1.436 . . . . 0.0 113.151 -171.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -161.04 130.34 4.75 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.821 0.848 . . . . 0.0 109.146 -177.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -89.94 127.23 35.98 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.234 0.614 . . . . 0.0 112.392 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 21.0 p -132.0 148.76 52.53 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -81.2 101.63 9.81 Favored 'General case' 0 CA--C 1.565 1.537 0 CA-C-N 115.018 -0.992 . . . . 0.0 108.784 164.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.6 m -100.77 130.41 46.79 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.228 1.011 . . . . 0.0 112.35 -171.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.2 p -137.57 131.49 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.67 -0.644 . . . . 0.0 110.333 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 t -115.69 121.28 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.272 -0.893 . . . . 0.0 109.571 -176.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.9 p -110.77 130.07 55.67 Favored 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 123.612 0.765 . . . . 0.0 112.015 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 tt -92.68 100.86 13.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 110.584 176.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -93.1 75.6 4.69 Favored 'General case' 0 CA--C 1.568 1.657 0 O-C-N 121.325 -0.859 . . . . 0.0 111.681 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.75 -84.27 1.59 Allowed Glycine 0 N--CA 1.492 2.411 0 O-C-N 121.718 -0.613 . . . . 0.0 113.674 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -136.39 53.9 1.91 Allowed 'General case' 0 CA--C 1.571 1.78 0 CA-C-O 121.131 0.491 . . . . 0.0 111.911 161.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -145.64 119.54 9.32 Favored 'General case' 0 CA--C 1.562 1.411 0 O-C-N 121.072 -1.017 . . . . 0.0 111.303 172.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 47.2 mt -87.32 105.32 17.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.788 -0.57 . . . . 0.0 110.62 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.4 t -95.27 102.0 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -177.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -89.97 107.64 19.24 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.255 0.622 . . . . 0.0 110.61 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.3 mt -96.41 121.07 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 124.297 1.039 . . . . 0.0 108.493 -177.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -112.71 120.57 41.96 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 118.754 0.706 . . . . 0.0 110.23 173.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -111.42 123.03 49.39 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.639 0.776 . . . . 0.0 110.654 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -156.23 133.52 10.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.498 -0.751 . . . . 0.0 110.192 -175.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 64.39 15.07 9.27 Favored 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 117.446 2.387 . . . . 0.0 117.446 176.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.32 -3.13 82.89 Favored Glycine 0 CA--C 1.559 2.808 0 N-CA-C 119.082 2.393 . . . . 0.0 119.082 -158.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -105.55 147.51 28.3 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-N 119.337 1.569 . . . . 0.0 111.013 -176.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -136.06 127.07 27.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.738 -0.601 . . . . 0.0 112.075 -175.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.9 t -112.67 138.39 49.54 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.524 0.73 . . . . 0.0 109.47 164.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.88 122.39 40.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.242 0.617 . . . . 0.0 110.025 175.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -105.25 106.0 16.29 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -172.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.3 t -90.65 98.45 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -171.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 25.8 ttm105 -93.58 111.12 22.73 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.291 0.636 . . . . 0.0 110.641 -177.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -129.63 134.63 47.8 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 119.3 0.955 . . . . 0.0 112.621 -175.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.3 mm -81.46 127.11 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.206 -0.934 . . . . 0.0 109.528 174.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -101.6 -86.61 0.41 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.982 -0.449 . . . . 0.0 110.098 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -143.33 95.4 2.75 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 171.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.17 -41.97 2.96 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 117.354 1.701 . . . . 0.0 117.354 -167.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -92.81 148.57 21.92 Favored 'General case' 0 CA--C 1.558 1.28 0 CA-C-N 118.549 1.175 . . . . 0.0 113.219 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -90.76 109.56 20.75 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.704 158.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.6 t -85.28 104.27 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 170.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 39.5 ttm -93.97 114.52 26.73 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.6 m -101.7 99.46 9.72 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.9 mp -93.33 107.31 19.16 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -174.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.261 13.5 t -131.79 134.61 46.01 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -172.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -110.76 80.03 1.26 Allowed 'General case' 0 CA--C 1.564 1.511 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.994 174.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 69.89 -90.25 0.32 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 115.92 1.128 . . . . 0.0 115.92 -177.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -87.6 -34.49 18.5 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.4 t -87.65 132.35 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 119.459 1.027 . . . . 0.0 109.823 -170.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.7 t -128.42 112.83 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 C-N-CA 123.288 0.635 . . . . 0.0 109.453 -169.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -105.24 114.5 28.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.423 -0.798 . . . . 0.0 112.135 171.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.9 t -92.93 112.58 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.428 -0.795 . . . . 0.0 109.032 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -101.12 120.74 40.65 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.974 0.892 . . . . 0.0 111.219 175.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -102.66 102.92 13.16 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.464 0.706 . . . . 0.0 109.44 -168.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -105.77 127.58 53.18 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.132 -0.98 . . . . 0.0 112.413 -171.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -98.21 155.71 17.04 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 123.798 0.839 . . . . 0.0 112.808 169.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -77.55 135.17 38.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.176 -0.952 . . . . 0.0 113.238 176.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.019 -0.991 . . . . 0.0 111.04 162.803 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.326 19.7 tt0 . . . . . 0 N--CA 1.496 1.874 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.56 -31.89 57.45 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 117.246 2.313 . . . . 0.0 117.246 161.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -72.27 -26.08 61.85 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 165.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.5 t -78.97 95.59 5.51 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-N 121.167 1.803 . . . . 0.0 113.269 -173.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -169.11 172.37 7.49 Favored 'General case' 0 CA--C 1.571 1.755 0 CA-C-O 122.702 1.239 . . . . 0.0 111.928 -174.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.6 m -78.83 127.38 31.97 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.135 -0.978 . . . . 0.0 110.109 165.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 99.9 m95 -124.6 111.73 15.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.856 -0.528 . . . . 0.0 110.267 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -104.53 129.6 52.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.58 -0.7 . . . . 0.0 110.811 -175.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -70.72 134.54 47.56 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 60.9 p -106.9 -39.97 5.62 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 175.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -153.77 123.04 6.54 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 119.528 1.058 . . . . 0.0 109.607 -174.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.4 p -103.07 100.22 10.13 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 122.925 0.49 . . . . 0.0 111.705 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -76.68 120.61 22.1 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 123.664 0.786 . . . . 0.0 111.405 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 4.8 t-20 60.12 38.08 20.56 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -76.0 -41.02 52.45 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.35 -50.76 70.58 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 174.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -55.47 -48.29 74.75 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 167.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -51.94 -47.1 64.88 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 169.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.465 ' SD ' ' HA ' ' A' ' 30' ' ' ARG . 72.7 mtm -64.06 -40.77 96.99 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 174.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -58.67 -51.52 69.59 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 161.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.54 -43.83 96.76 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 tt -66.31 -32.13 73.35 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.861 1.801 . . . . 0.0 115.861 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.69 55.45 1.9 Allowed Glycine 0 N--CA 1.485 1.923 0 N-CA-C 115.604 1.002 . . . . 0.0 115.604 -172.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.7 m -87.82 154.27 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 CA-C-N 118.129 0.964 . . . . 0.0 111.005 168.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.83 168.66 31.97 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 116.662 1.425 . . . . 0.0 116.662 174.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -83.54 59.43 5.1 Favored 'General case' 0 CA--C 1.577 1.991 0 CA-C-O 122.681 1.229 . . . . 0.0 112.812 177.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -160.76 -58.32 0.05 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.064 1.346 . . . . 0.0 109.758 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.8 m -61.0 -31.53 71.13 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 169.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.465 ' HA ' ' SD ' ' A' ' 20' ' ' MET . 18.5 ptp180 -57.29 -42.77 82.32 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 164.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -60.62 -48.53 81.37 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 167.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.5 t -49.94 -60.56 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 167.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.81 -38.31 53.74 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 119.349 2.5 . . . . 0.0 119.349 175.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -66.84 -42.44 85.76 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 168.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -77.96 -35.32 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 177.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 t -95.73 138.55 33.23 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 120.277 1.399 . . . . 0.0 113.846 -164.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -103.82 101.36 24.39 Favored Pre-proline 0 CA--C 1.575 1.91 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.335 173.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.55 150.82 46.39 Favored 'Trans proline' 0 CA--C 1.564 1.998 0 CA-C-N 123.011 2.111 . . . . 0.0 117.086 -170.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.7 m -102.9 103.85 14.03 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.113 173.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.2 t -96.58 102.26 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -174.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.2 mt -93.94 102.68 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.4 mt -87.91 113.52 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.4 p -129.58 120.44 25.29 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.839 0.456 . . . . 0.0 111.91 -170.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -85.55 103.52 14.47 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.04 -1.038 . . . . 0.0 110.146 176.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -106.3 88.16 2.72 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.36 0.6 . . . . 0.0 109.801 -168.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.75 -76.33 2.02 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 115.147 0.819 . . . . 0.0 115.147 -176.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -123.89 -50.34 1.83 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.514 0.725 . . . . 0.0 112.647 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -81.11 157.81 25.22 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -176.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.76 115.49 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.595 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 173.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.0 t -105.91 104.98 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.2 mt -94.18 118.78 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -101.59 101.96 12.6 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.1 m -85.38 95.8 9.36 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.9 mt -99.06 92.57 5.55 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -173.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.4 p -85.57 11.22 11.11 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 175.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.391 39.7 p 74.05 -57.97 0.6 Allowed 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 125.136 1.375 . . . . 0.0 113.536 -168.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -76.7 -62.08 1.75 Allowed 'General case' 0 CA--C 1.571 1.776 0 C-N-CA 124.498 1.119 . . . . 0.0 112.285 176.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -106.2 120.93 43.12 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.93 0.892 . . . . 0.0 109.583 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -123.73 84.32 2.26 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -169.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.9 t -108.74 147.65 31.66 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -166.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.43 135.31 47.06 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 124.134 0.974 . . . . 0.0 113.136 -174.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.0 mt -124.66 101.32 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -174.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 90.1 p -110.24 112.87 25.11 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.693 0.797 . . . . 0.0 111.833 -173.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -141.2 139.29 33.79 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.007 0.908 . . . . 0.0 113.423 -173.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -88.33 26.15 1.49 Allowed 'General case' 0 CA--C 1.582 2.194 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 173.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 75.4 mt 63.42 100.49 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 125.347 1.459 . . . . 0.0 113.094 -172.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.71 2.38 88.72 Favored Glycine 0 CA--C 1.556 2.635 0 N-CA-C 119.111 2.405 . . . . 0.0 119.111 -167.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -89.28 129.4 35.84 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-N 119.537 1.669 . . . . 0.0 111.205 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -89.61 111.57 22.56 Favored 'General case' 0 CA--C 1.563 1.447 0 CA-C-O 121.288 0.566 . . . . 0.0 111.374 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -113.8 150.18 33.85 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.27 1.028 . . . . 0.0 110.606 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.45 131.18 35.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.266 -1.521 . . . . 0.0 111.59 171.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -122.56 108.25 12.91 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.596 0.758 . . . . 0.0 109.74 -172.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.7 m -77.97 100.99 6.66 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.219 1.009 . . . . 0.0 109.26 172.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 74.4 p -79.18 -178.69 6.3 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -164.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.45 -8.64 0.56 Allowed 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 119.823 3.268 . . . . 0.0 119.823 162.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -109.5 19.02 19.75 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 158.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.438 2.2 p30 56.36 12.25 0.99 Allowed 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 119.794 3.257 . . . . 0.0 119.794 -171.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -77.11 126.14 30.47 Favored 'General case' 0 CA--C 1.561 1.403 0 O-C-N 120.888 -1.132 . . . . 0.0 110.053 170.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -83.99 101.34 11.66 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.476 0.711 . . . . 0.0 111.314 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 83.4 m -100.83 128.2 46.96 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.617 -0.677 . . . . 0.0 112.492 -171.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -72.46 99.4 2.47 Favored 'General case' 0 CA--C 1.563 1.456 0 CA-C-O 122.275 1.036 . . . . 0.0 109.382 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.2 m -115.96 117.23 29.58 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.916 -156.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 p -122.13 129.53 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 123.379 0.672 . . . . 0.0 109.895 -176.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.1 t -121.96 113.36 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -171.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 63.3 m -112.44 131.13 55.72 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.396 0.678 . . . . 0.0 110.923 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.0 tt -91.36 103.37 16.02 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.571 0.701 . . . . 0.0 110.244 175.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -87.28 80.09 8.33 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 123.46 0.704 . . . . 0.0 111.382 -177.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.9 -81.01 1.54 Allowed Glycine 0 N--CA 1.493 2.47 0 O-C-N 121.564 -0.71 . . . . 0.0 114.338 -176.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -135.33 56.12 1.85 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.271 0.558 . . . . 0.0 111.767 163.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -153.28 100.56 2.46 Favored 'General case' 0 CA--C 1.564 1.498 0 O-C-N 121.218 -0.926 . . . . 0.0 110.277 -170.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 24.4 mt -77.68 114.49 16.57 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.093 -1.004 . . . . 0.0 111.835 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.06 102.31 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -87.59 110.03 20.08 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.065 0.546 . . . . 0.0 110.606 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 69.1 mt -102.09 110.5 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -95.62 124.67 39.76 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 118.671 0.669 . . . . 0.0 111.517 172.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -111.38 124.05 51.47 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.977 0.911 . . . . 0.0 110.321 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.6 p90 -154.49 126.97 7.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.806 -1.184 . . . . 0.0 110.595 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 58.53 31.9 21.54 Favored 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 117.244 2.312 . . . . 0.0 117.244 169.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.09 -20.14 8.87 Favored Glycine 0 CA--C 1.556 2.649 0 N-CA-C 119.012 2.365 . . . . 0.0 119.012 -163.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -91.18 143.49 26.61 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 119.667 1.734 . . . . 0.0 111.657 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -133.42 134.24 43.38 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.174 0.59 . . . . 0.0 111.032 -178.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.0 t -126.48 134.75 50.85 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 123.072 0.549 . . . . 0.0 111.065 173.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -116.03 129.56 56.42 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 123.258 0.623 . . . . 0.0 111.997 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -111.34 102.15 10.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.233 -0.917 . . . . 0.0 108.623 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.9 t -91.77 111.12 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -171.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -110.45 119.41 39.12 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.416 0.686 . . . . 0.0 111.18 -171.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -129.41 144.78 51.39 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 122.996 0.518 . . . . 0.0 112.043 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.6 mm -88.18 106.0 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -103.49 101.09 10.97 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 123.511 0.725 . . . . 0.0 109.221 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.3 t70 50.74 53.95 12.08 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 -175.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.45 -35.15 3.65 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 118.645 2.218 . . . . 0.0 118.645 -170.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -95.76 146.39 24.57 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 119.373 1.587 . . . . 0.0 112.056 -172.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 34.1 ttm -86.06 116.08 24.05 Favored 'General case' 0 CA--C 1.566 1.568 0 O-C-N 120.868 -1.145 . . . . 0.0 111.61 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.4 t -94.79 108.11 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 169.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 13.7 ttt -110.17 101.63 10.39 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.506 0.67 . . . . 0.0 109.607 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.8 m -94.8 106.7 18.7 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.527 0.731 . . . . 0.0 109.355 -174.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.4 mp -91.53 113.9 26.29 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.8 m -120.89 119.78 33.62 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.544 0.688 . . . . 0.0 109.869 -167.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -107.61 77.85 1.16 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.372 0.606 . . . . 0.0 109.367 170.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 64.21 -94.98 0.16 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 115.306 0.882 . . . . 0.0 115.306 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -83.54 -32.73 25.71 Favored 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 170.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.2 t -87.05 109.95 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 120.444 1.475 . . . . 0.0 109.406 -171.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.3 t -114.19 118.27 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 124.086 0.954 . . . . 0.0 108.489 -169.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -123.21 127.63 48.89 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 123.265 0.626 . . . . 0.0 111.878 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 37.7 t -105.74 115.56 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.956 -1.09 . . . . 0.0 110.306 -172.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.8 124.06 40.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.054 -1.029 . . . . 0.0 111.716 169.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -102.05 105.78 16.57 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.726 0.81 . . . . 0.0 109.724 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -107.59 129.68 54.96 Favored 'General case' 0 CA--C 1.563 1.474 0 O-C-N 121.303 -0.873 . . . . 0.0 111.731 -169.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -98.35 158.09 15.79 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.399 1.095 . . . . 0.0 112.499 170.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -89.9 130.58 36.1 Favored 'General case' 0 CA--C 1.563 1.471 0 O-C-N 121.394 -0.816 . . . . 0.0 112.758 -169.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . 0.309 . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.277 8.1 p . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -55.71 -39.17 70.71 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 118.746 2.869 . . . . 0.0 118.746 -173.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.81 -22.28 61.99 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 168.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -80.71 -12.66 59.44 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 168.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 82.3 m -80.36 91.87 5.73 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 122.207 2.276 . . . . 0.0 113.044 -175.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -165.78 167.0 17.37 Favored 'General case' 0 CA--C 1.569 1.701 0 CA-C-O 122.467 1.127 . . . . 0.0 113.124 -172.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.8 m -80.07 111.01 16.02 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.422 -0.799 . . . . 0.0 109.38 165.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -107.57 111.08 23.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.533 -0.729 . . . . 0.0 111.193 -173.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -102.14 132.92 47.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.209 -0.932 . . . . 0.0 110.898 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 tt -70.87 113.85 8.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.717 -0.615 . . . . 0.0 112.574 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.7 p -99.44 -35.66 9.83 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 -175.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -141.72 120.45 12.62 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 120.432 1.469 . . . . 0.0 109.58 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.4 p -108.77 104.49 13.78 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -81.11 122.39 27.28 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.896 -0.503 . . . . 0.0 110.291 164.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 54.58 70.43 0.62 Allowed 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -110.6 61.83 0.61 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.831 -1.168 . . . . 0.0 112.095 163.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -155.51 -64.92 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.237 1.015 . . . . 0.0 109.52 173.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -62.29 -37.5 85.76 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -50.5 -51.09 50.47 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.535 1.516 . . . . 0.0 114.793 167.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 73.5 mtm -57.08 -50.14 73.68 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 170.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -58.19 -40.72 82.26 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 116.134 1.902 . . . . 0.0 116.134 172.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.95 -41.97 90.59 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 169.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.2 tp -61.83 -23.3 66.16 Favored 'General case' 0 CA--C 1.574 1.875 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 176.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.86 55.58 1.61 Allowed Glycine 0 N--CA 1.485 1.906 0 C-N-CA 123.868 0.747 . . . . 0.0 114.795 -176.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.3 m -83.07 153.95 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.93 138.36 34.94 Favored Glycine 0 CA--C 1.555 2.532 0 O-C-N 120.956 -1.09 . . . . 0.0 113.494 149.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -57.56 -33.55 68.26 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -171.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.37 -41.79 66.22 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 164.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.1 m -60.1 -40.6 90.22 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 165.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.335 0.0 OUTLIER -60.18 -42.56 95.27 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 168.326 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -58.61 -51.76 68.57 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 166.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.1 t -56.02 -55.88 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 173.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.81 -24.72 57.99 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 119.854 2.702 . . . . 0.0 119.854 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -73.77 -45.66 50.41 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 164.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.7 m -78.23 -30.4 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 t -105.11 141.1 37.27 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 120.803 1.638 . . . . 0.0 114.276 -162.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -89.66 119.74 69.5 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.197 172.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.05 129.73 8.04 Favored 'Trans proline' 0 CA--C 1.564 2.02 0 C-N-CA 122.454 2.102 . . . . 0.0 114.044 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 56.6 m -95.69 106.91 19.07 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 169.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 81.0 t -99.43 95.91 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -174.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.8 mp -89.43 98.82 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.521 -1.362 . . . . 0.0 108.359 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.5 mt -84.04 116.46 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.6 p -141.78 121.27 13.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.832 -0.543 . . . . 0.0 112.36 -168.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -79.89 102.99 9.48 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.86 -1.15 . . . . 0.0 110.543 169.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -103.3 96.92 7.08 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -169.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.09 -74.8 2.46 Favored Glycine 0 N--CA 1.488 2.163 0 O-C-N 121.777 -0.577 . . . . 0.0 114.144 -173.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -132.77 -53.24 0.93 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.425 0.69 . . . . 0.0 111.927 171.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -81.3 160.18 24.27 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -173.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.2 t -84.29 114.56 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 123.635 0.774 . . . . 0.0 109.117 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.3 t -106.92 107.68 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.558 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 59.0 mt -91.6 122.18 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 172.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -106.03 106.82 17.5 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.151 0.58 . . . . 0.0 110.23 174.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.5 m -92.87 103.73 16.04 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.506 -0.746 . . . . 0.0 109.374 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 72.0 mt -121.32 117.64 27.49 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.085 0.554 . . . . 0.0 110.231 -170.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 t -127.65 171.87 11.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.026 -1.046 . . . . 0.0 111.26 165.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -70.38 24.24 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 118.585 2.809 . . . . 0.0 118.585 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -150.23 -58.14 0.18 Allowed 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 125.194 1.398 . . . . 0.0 108.705 175.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -101.49 130.89 47.84 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.185 0.994 . . . . 0.0 110.949 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -137.54 110.57 7.76 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.077 0.551 . . . . 0.0 110.834 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.3 t -137.7 155.2 49.36 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 123.569 0.748 . . . . 0.0 111.907 -176.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -140.01 146.85 39.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.808 -1.183 . . . . 0.0 113.941 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.8 pt -130.14 122.63 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-O 121.522 0.677 . . . . 0.0 111.108 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.4 p -105.1 116.93 32.78 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.287 1.035 . . . . 0.0 110.877 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -144.79 141.11 28.93 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 114.517 1.302 . . . . 0.0 114.517 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -79.32 155.52 28.43 Favored 'General case' 0 CA--C 1.571 1.781 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.619 149.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.9 mt -70.78 114.53 8.95 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.58 -1.325 . . . . 0.0 111.588 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.07 -7.61 54.92 Favored Glycine 0 CA--C 1.555 2.536 0 N-CA-C 118.567 2.187 . . . . 0.0 118.567 -162.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -68.72 122.48 18.64 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 120.734 2.267 . . . . 0.0 112.432 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -89.33 118.51 29.06 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 122.979 0.512 . . . . 0.0 110.451 169.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -136.43 135.71 38.92 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 123.433 0.693 . . . . 0.0 110.844 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.17 129.1 36.25 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.487 -1.383 . . . . 0.0 111.047 172.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -130.9 109.71 10.75 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.75 -167.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.7 m -75.24 102.17 4.92 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.65 0.738 . . . . 0.0 110.487 174.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.0 p -85.29 161.85 19.36 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -171.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.45 -23.68 4.19 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 119.015 2.969 . . . . 0.0 119.015 166.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -54.24 -30.74 51.37 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 117.629 2.455 . . . . 0.0 117.629 160.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.316 9.8 t70 78.13 63.21 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.723 0 C-N-CA 125.869 1.668 . . . . 0.0 112.172 -159.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.5 ptt-85 -152.85 136.95 16.41 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.95 0.9 . . . . 0.0 109.14 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.284 0.5 OUTLIER -90.32 112.02 23.44 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 119.535 1.062 . . . . 0.0 110.795 168.17 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.3 p -107.64 130.28 54.92 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -65.6 99.12 0.42 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.442 1.097 . . . . 0.0 110.064 168.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.1 m -107.21 119.93 40.73 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.066 -164.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 51.8 t -111.38 120.18 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.9 t -111.74 129.26 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.538 -0.726 . . . . 0.0 109.718 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 65.6 m -153.57 152.45 30.91 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.778 -1.201 . . . . 0.0 112.25 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.9 mp -83.32 123.19 29.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.063 -1.023 . . . . 0.0 110.538 167.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -84.7 -63.68 1.29 Allowed 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -149.98 80.55 0.2 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 174.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.4 t70 52.42 37.23 22.13 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -160.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -147.16 120.89 9.21 Favored 'General case' 0 CA--C 1.56 1.352 0 O-C-N 121.278 -0.889 . . . . 0.0 109.461 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.87 112.5 22.56 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.242 1.017 . . . . 0.0 110.758 -171.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.03 109.91 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -167.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -93.92 98.85 11.32 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 123.436 0.695 . . . . 0.0 110.999 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.0 mt -90.41 109.19 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 C-N-CA 124.159 0.983 . . . . 0.0 109.003 -174.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -105.46 118.35 36.33 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 118.968 0.804 . . . . 0.0 110.193 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -115.45 122.53 46.06 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 123.634 0.774 . . . . 0.0 111.199 -173.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 8.5 p90 -151.36 130.0 12.29 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.96 -1.088 . . . . 0.0 110.5 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 58.38 27.51 15.5 Favored 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 117.498 2.407 . . . . 0.0 117.498 170.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.23 -19.23 23.87 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 118.97 2.348 . . . . 0.0 118.97 -162.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -89.4 148.11 23.67 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-N 119.443 1.622 . . . . 0.0 112.541 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -132.01 141.01 49.11 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.879 0.847 . . . . 0.0 111.463 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.9 t -129.91 143.51 50.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.63 -0.669 . . . . 0.0 109.419 158.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.266 13.3 p30 -124.52 132.82 53.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 111.171 173.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -100.66 103.75 15.04 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.2 t -88.24 98.93 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 91.1 mtm-85 -89.1 114.04 25.25 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.895 0.878 . . . . 0.0 110.35 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.48 132.95 49.91 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 119.119 0.872 . . . . 0.0 112.718 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.7 mm -80.25 106.56 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.382 -0.824 . . . . 0.0 110.244 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -103.09 98.27 8.24 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 169.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.0 t70 51.46 60.8 3.6 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.32 0.1 56.24 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 120.034 2.774 . . . . 0.0 120.034 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -118.78 122.56 42.69 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 119.837 1.818 . . . . 0.0 109.71 -171.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 51.2 ttp -82.42 104.78 12.96 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 122.029 0.919 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.14 103.61 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 31.6 ttm -85.6 108.14 17.84 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 84.4 m -98.71 101.17 12.5 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.0 mp -92.2 98.95 11.84 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.568 0.747 . . . . 0.0 108.988 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.7 t -89.97 117.58 28.88 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.53 0.681 . . . . 0.0 110.322 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -100.59 75.71 1.77 Allowed 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 155.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.57 -111.24 3.3 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 114.85 0.7 . . . . 0.0 114.85 -166.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -81.2 -9.69 59.74 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 171.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 50.0 t -90.36 99.61 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 121.969 2.168 . . . . 0.0 107.422 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.6 t -113.64 119.93 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -168.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.81 130.92 54.43 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 171.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.9 t -111.79 103.83 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -114.96 118.71 34.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.353 -0.842 . . . . 0.0 109.947 -171.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -99.77 98.8 9.57 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.599 0.714 . . . . 0.0 109.982 -162.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -94.23 131.92 39.32 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.507 0.723 . . . . 0.0 110.9 -173.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -116.76 158.52 23.74 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.532 0.682 . . . . 0.0 110.754 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -75.44 103.89 5.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.023 -1.048 . . . . 0.0 111.877 -174.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . 0.286 . . . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -173.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.311 9.8 p . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.05 -42.04 97.73 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.93 -24.44 66.04 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 117.84 2.533 . . . . 0.0 117.84 165.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -76.91 -21.65 54.57 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 168.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 80.8 m -73.81 88.86 1.8 Allowed 'General case' 0 CA--C 1.572 1.811 0 CA-C-N 121.885 2.13 . . . . 0.0 114.344 -173.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.59 168.06 20.48 Favored 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 124.552 1.141 . . . . 0.0 111.781 -174.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.6 m -77.27 134.85 38.45 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.868 -1.145 . . . . 0.0 109.319 158.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -123.91 120.75 33.46 Favored 'General case' 0 CA--C 1.562 1.412 0 O-C-N 121.519 -0.738 . . . . 0.0 110.048 -175.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 mtpm? -100.35 130.79 46.49 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.609 0.764 . . . . 0.0 111.422 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 tt -71.79 118.57 14.8 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.562 -0.711 . . . . 0.0 112.909 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 65.2 p -92.22 -49.75 6.02 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -141.18 113.91 8.33 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.757 0.823 . . . . 0.0 109.875 -173.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.0 p -98.62 98.81 9.92 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.318 0.647 . . . . 0.0 111.883 175.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -83.5 122.81 29.04 Favored 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 123.492 0.717 . . . . 0.0 111.16 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.256 1.3 t30 57.7 30.08 18.33 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 171.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -72.38 -38.36 68.51 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -54.77 -53.16 58.78 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 175.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.26 -41.78 80.33 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 171.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -58.15 -48.08 81.36 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 165.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 65.0 mtm -58.02 -48.28 80.52 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -60.78 -42.58 97.8 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 166.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.64 97.55 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 171.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.6 tp -64.25 -22.33 66.91 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 116.925 2.195 . . . . 0.0 116.925 169.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.73 55.56 1.75 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 115.615 1.006 . . . . 0.0 115.615 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 m -107.86 149.84 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 118.197 0.999 . . . . 0.0 111.553 172.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.17 165.54 21.4 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 116.647 1.419 . . . . 0.0 116.647 172.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -64.84 -40.57 95.38 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.71 -42.46 79.2 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 164.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.6 m -62.4 -43.96 97.58 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 169.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -54.4 -47.53 72.64 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 164.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -58.87 -52.33 66.19 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 119.989 1.268 . . . . 0.0 114.1 170.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.2 t -49.01 -51.5 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 167.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.33 -32.77 84.73 Favored Glycine 0 CA--C 1.55 2.234 0 N-CA-C 119.596 2.599 . . . . 0.0 119.596 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -79.69 -42.93 23.67 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 173.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.4 m -70.32 -35.07 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 117.022 2.231 . . . . 0.0 117.022 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.0 t -102.89 175.32 5.52 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -166.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.44 84.38 0.74 Allowed Pre-proline 0 CA--C 1.579 2.086 0 C-N-CA 123.703 0.801 . . . . 0.0 110.96 169.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.26 117.63 5.23 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.71 2.274 . . . . 0.0 113.395 -175.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.1 m -100.06 123.83 44.74 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.418 -161.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.8 t -106.46 105.56 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -167.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.4 mt -89.05 105.75 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.438 -1.414 . . . . 0.0 107.714 170.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 55.8 mt -89.71 124.6 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 168.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.1 p -150.71 122.19 7.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -0.914 . . . . 0.0 112.739 -169.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -78.99 104.83 9.9 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.666 -1.271 . . . . 0.0 110.512 166.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -105.95 99.8 9.37 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -171.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.13 -72.45 2.77 Favored Glycine 0 N--CA 1.491 2.328 0 O-C-N 121.689 -0.632 . . . . 0.0 114.157 -169.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -139.41 -59.87 0.57 Allowed 'General case' 0 CA--C 1.566 1.575 0 C-N-CA 123.366 0.667 . . . . 0.0 111.303 173.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -79.03 159.85 27.4 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -172.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.8 t -79.77 116.71 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.568 0 CA-C-O 121.725 0.774 . . . . 0.0 109.46 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 65.0 t -104.08 107.43 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 68.7 mt -89.64 120.56 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 167.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -102.88 103.82 14.02 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 166.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.4 m -90.55 99.25 12.31 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 170.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 mp -92.1 101.16 13.68 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.593 0.757 . . . . 0.0 108.978 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.9 t -78.24 26.9 0.2 Allowed 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.352 70.8 p 65.17 -53.87 0.33 Allowed 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -164.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -81.17 -31.88 33.85 Favored 'General case' 0 CA--C 1.577 2.018 0 C-N-CA 125.575 1.55 . . . . 0.0 115.163 174.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -136.62 127.05 26.7 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 119.763 1.165 . . . . 0.0 111.31 -173.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -88.48 104.33 16.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.329 -0.857 . . . . 0.0 110.611 171.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.6 p -102.03 99.95 10.17 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.5 0.667 . . . . 0.0 110.109 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -98.07 126.79 43.67 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.706 0.802 . . . . 0.0 112.259 -175.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.4 pt -131.47 116.84 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 C-N-CA 123.168 0.587 . . . . 0.0 111.159 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.8 p -98.54 129.86 45.1 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.896 0.879 . . . . 0.0 112.351 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -156.64 144.35 19.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.379 -0.826 . . . . 0.0 112.633 -175.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -84.81 158.54 20.64 Favored 'General case' 0 CA--C 1.57 1.722 0 O-C-N 120.861 -1.149 . . . . 0.0 110.935 156.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.32 116.37 9.67 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.67 -1.269 . . . . 0.0 111.839 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.05 -4.29 77.82 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 119.214 2.445 . . . . 0.0 119.214 -163.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -82.42 126.57 32.36 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 120.633 2.217 . . . . 0.0 111.929 -176.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -83.34 112.94 20.36 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-O 121.067 0.46 . . . . 0.0 111.424 172.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -121.53 140.45 52.19 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.763 0.825 . . . . 0.0 111.207 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.3 130.89 38.8 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.241 1.019 . . . . 0.0 111.532 171.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.447 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 19.6 tt0 -132.99 103.28 5.97 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.146 -171.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.0 m -91.23 107.19 19.04 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 174.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.7 p -80.14 162.29 24.82 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -169.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.21 -23.79 23.94 Favored 'General case' 0 CA--C 1.576 1.942 0 N-CA-C 118.825 2.898 . . . . 0.0 118.825 169.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -82.96 2.2 35.87 Favored 'General case' 0 CA--C 1.582 2.204 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 165.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.286 21.3 m-20 70.02 70.13 0.22 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 120.584 1.538 . . . . 0.0 113.128 -174.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.5 ptp85 -145.88 125.99 13.76 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 166.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -91.8 105.41 17.69 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.463 0.705 . . . . 0.0 111.132 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 72' ' ' GLU . 28.7 p -109.22 135.23 50.65 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -74.47 101.7 4.23 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-O 121.835 0.826 . . . . 0.0 109.441 164.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.0 m -102.63 128.85 49.14 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.542 0.737 . . . . 0.0 112.63 -170.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 49.4 t -122.98 121.91 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.9 t -104.46 109.47 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.227 -0.92 . . . . 0.0 109.594 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.3 p -110.46 130.06 55.64 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.796 0.838 . . . . 0.0 111.912 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.7 tt -87.84 99.63 12.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.147 -0.971 . . . . 0.0 110.605 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -101.3 75.72 1.65 Allowed 'General case' 0 CA--C 1.567 1.613 0 C-N-CA 123.481 0.712 . . . . 0.0 111.122 -176.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.34 68.15 1.76 Allowed Glycine 0 N--CA 1.495 2.597 0 N-CA-C 116.258 1.263 . . . . 0.0 116.258 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.256 23.7 m-20 60.38 22.33 11.89 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 117.222 2.305 . . . . 0.0 117.222 -166.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -133.58 107.52 8.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.938 -1.101 . . . . 0.0 109.893 -175.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.6 mt -83.09 103.32 12.43 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.793 0.837 . . . . 0.0 111.626 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 37.2 t -97.52 100.5 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -173.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -84.68 107.52 16.93 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.339 0.656 . . . . 0.0 110.204 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 70.3 mt -99.5 103.82 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -91.01 118.94 30.79 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 118.43 0.559 . . . . 0.0 111.317 176.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -112.53 112.03 23.29 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.019 0.528 . . . . 0.0 110.46 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -139.21 125.62 20.37 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.438 -0.789 . . . . 0.0 110.683 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 50.92 49.94 20.11 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 167.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.86 4.6 62.61 Favored Glycine 0 CA--C 1.558 2.739 0 N-CA-C 120.212 2.845 . . . . 0.0 120.212 -168.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -123.59 140.31 53.13 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 119.653 1.726 . . . . 0.0 110.266 -168.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -135.01 123.61 23.57 Favored 'General case' 0 CA--C 1.564 1.499 0 O-C-N 121.692 -0.63 . . . . 0.0 111.783 -175.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.0 t -115.89 137.34 52.19 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.294 0.569 . . . . 0.0 109.964 165.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.19 128.07 54.74 Favored 'General case' 0 CA--C 1.567 1.629 0 C-N-CA 123.109 0.564 . . . . 0.0 110.996 171.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -105.84 110.18 22.39 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 53.2 t -91.97 100.79 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -176.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.18 111.09 19.49 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.562 0.745 . . . . 0.0 110.677 173.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.57 129.83 43.28 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 118.96 0.8 . . . . 0.0 112.631 -174.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.9 mm -75.86 112.93 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.044 -1.035 . . . . 0.0 108.953 173.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -133.24 96.5 3.75 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -169.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.7 t70 50.37 61.1 3.38 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -169.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.07 -48.08 3.88 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 117.84 1.896 . . . . 0.0 117.84 -173.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -82.06 146.42 29.67 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 118.231 1.015 . . . . 0.0 113.086 -174.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -82.38 104.74 12.9 Favored 'General case' 0 CA--C 1.56 1.365 0 CA-C-O 121.966 0.888 . . . . 0.0 109.429 166.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 80.3 t -91.79 102.31 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 40.9 ttm -83.15 108.4 16.38 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.422 0.689 . . . . 0.0 109.8 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.1 m -99.82 115.07 28.72 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.871 0.843 . . . . 0.0 109.135 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mp -111.18 117.46 33.28 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -171.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.305 10.6 t -137.21 138.2 39.92 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 177.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -124.01 99.89 6.47 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.952 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 73.07 -90.76 0.6 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 115.299 0.88 . . . . 0.0 115.299 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -134.31 52.77 2.04 Favored 'General case' 0 CA--C 1.575 1.909 0 CA-C-O 121.482 0.658 . . . . 0.0 112.064 167.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.4 t -139.91 124.04 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 51.2 t -123.4 127.18 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-N 119.001 0.818 . . . . 0.0 109.837 -170.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -117.18 150.7 38.3 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 123.633 0.773 . . . . 0.0 112.329 163.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.8 t -131.92 114.22 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.192 -0.942 . . . . 0.0 108.947 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 mtp-105 -110.9 114.44 27.77 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.205 -0.934 . . . . 0.0 109.876 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -96.63 108.63 21.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.647 -0.658 . . . . 0.0 110.111 -167.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -103.55 132.47 49.78 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.108 -0.995 . . . . 0.0 112.4 -171.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.39 160.66 15.22 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 175.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -76.1 141.03 42.1 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -175.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.25 0 CA-C-O 117.404 -1.284 . . . . 0.0 112.447 176.427 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.8 m . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -67.22 -51.0 58.67 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -171.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.38 -23.83 66.06 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 117.755 2.502 . . . . 0.0 117.755 168.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -87.92 -21.81 24.71 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 172.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.5 t -76.83 95.63 4.11 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 121.197 1.817 . . . . 0.0 112.905 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -166.39 167.61 15.66 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-O 122.565 1.174 . . . . 0.0 112.333 -172.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.7 m -86.85 107.1 18.17 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.829 0.852 . . . . 0.0 108.718 173.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -105.22 109.42 21.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.972 . . . . 0.0 111.623 -169.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -95.36 129.33 42.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.281 -0.887 . . . . 0.0 111.089 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.0 tt -75.86 122.29 23.88 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -173.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 69.0 p -91.84 -52.47 4.72 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 176.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -137.97 114.54 10.45 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.739 0.815 . . . . 0.0 110.233 -173.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.7 p -101.18 78.03 1.86 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.409 1.1 . . . . 0.0 112.419 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -79.99 133.25 36.15 Favored 'General case' 0 CA--C 1.56 1.354 0 O-C-N 120.97 -1.081 . . . . 0.0 113.804 -171.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.252 1.1 t30 57.44 23.34 8.94 Favored 'General case' 0 CA--C 1.584 2.251 0 N-CA-C 117.189 2.292 . . . . 0.0 117.189 -174.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -69.46 -46.41 66.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.238 -1.539 . . . . 0.0 115.054 -175.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -47.64 -51.3 21.99 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -68.33 -40.02 81.76 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -50.5 -52.96 33.72 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 160.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.6 mtp -59.03 -43.46 91.63 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 175.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -47.75 83.58 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 164.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.02 -39.03 86.95 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.65 -47.57 85.67 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 163.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.88 48.22 1.51 Allowed Glycine 0 N--CA 1.482 1.738 0 CA-C-O 118.978 -0.901 . . . . 0.0 115.315 -175.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.7 m -80.56 151.63 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 118.822 1.311 . . . . 0.0 111.443 172.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.38 150.05 30.73 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 116.955 1.542 . . . . 0.0 116.955 173.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -55.53 -43.37 75.71 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.12 -44.9 68.06 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 166.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.3 m -64.04 -40.26 95.91 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 171.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -61.05 -49.16 78.48 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 121.691 2.041 . . . . 0.0 115.923 167.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.6 mp0 -71.14 -28.74 64.5 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.1 t -70.77 -62.13 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 119.536 1.062 . . . . 0.0 112.11 159.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.76 -31.37 71.41 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 119.903 2.721 . . . . 0.0 119.903 -166.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -73.4 -32.11 64.26 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 170.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.2 m -82.68 -34.7 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.0 t -81.5 126.4 31.64 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 120.857 1.662 . . . . 0.0 112.352 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -103.55 92.7 4.3 Favored Pre-proline 0 CA--C 1.573 1.828 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -71.91 155.65 57.46 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.384 2.056 . . . . 0.0 116.64 -171.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.1 m -88.73 100.31 13.03 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.371 -1.286 . . . . 0.0 107.64 169.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.6 t -95.65 98.43 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -171.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.1 mt -88.81 102.21 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -86.41 116.97 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 171.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.2 p -153.81 121.31 5.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.718 -0.614 . . . . 0.0 111.337 -165.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -80.24 128.69 33.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 0.0 113.098 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -120.24 90.28 3.3 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 174.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.9 68.99 1.48 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 115.613 1.005 . . . . 0.0 115.613 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.293 13.0 t70 70.94 -57.27 0.6 Allowed 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -169.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -72.59 147.84 45.47 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-O 122.568 1.175 . . . . 0.0 114.141 -172.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.0 t -96.2 122.54 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.857 -169.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.9 t -104.22 110.87 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.0 mt -92.73 99.76 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 172.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.0 mtm-85 -85.92 101.93 13.3 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.867 0.867 . . . . 0.0 111.022 173.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.6 m -89.81 101.05 13.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.591 -0.693 . . . . 0.0 109.708 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 73.2 mt -101.26 108.82 20.57 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.791 0.805 . . . . 0.0 111.618 -167.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.1 t -138.29 147.61 43.79 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 124.546 1.138 . . . . 0.0 109.369 173.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 51.1 p -76.94 53.38 0.93 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 120.634 -1.291 . . . . 0.0 113.857 173.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -161.37 -65.8 0.06 Allowed 'General case' 0 CA--C 1.571 1.784 0 C-N-CA 125.435 1.494 . . . . 0.0 107.898 -172.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -127.94 96.51 4.51 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -96.23 82.16 3.41 Favored 'General case' 0 CA--C 1.568 1.67 0 O-C-N 121.721 -0.612 . . . . 0.0 110.803 -176.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -108.35 146.23 33.3 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -170.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -131.77 127.83 37.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.275 -0.891 . . . . 0.0 113.151 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.4 mt -112.77 110.59 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.3 p -92.09 120.27 32.55 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.546 0.739 . . . . 0.0 112.393 170.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -143.96 147.4 33.88 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -174.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -87.52 1.78 52.56 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 118.59 2.811 . . . . 0.0 118.59 -172.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.4 mt 69.75 120.01 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 125.455 1.502 . . . . 0.0 112.775 -172.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.39 -32.08 4.27 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 118.142 2.017 . . . . 0.0 118.142 -171.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -73.97 136.42 43.22 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 119.309 1.555 . . . . 0.0 113.021 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -88.88 120.76 30.58 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.198 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -130.75 150.64 51.83 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.801 0.84 . . . . 0.0 111.65 -172.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -79.55 133.5 36.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.932 -1.105 . . . . 0.0 111.615 171.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -142.44 126.03 16.86 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.0 0.428 . . . . 0.0 111.992 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.2 m -73.36 132.4 42.99 Favored 'General case' 0 CA--C 1.57 1.731 0 CA-C-O 121.43 0.633 . . . . 0.0 110.478 162.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.9 p -108.82 166.47 10.78 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -169.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.15 -11.5 6.29 Favored 'General case' 0 CA--C 1.579 2.082 0 N-CA-C 119.452 3.13 . . . . 0.0 119.452 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -73.62 -25.33 60.26 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 159.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.305 4.8 m-20 82.1 65.87 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 120.738 1.608 . . . . 0.0 111.235 -162.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.9 ptt85 -162.87 142.2 8.89 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.162 0.985 . . . . 0.0 109.43 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -83.02 134.62 35.03 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 169.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.9 p -129.89 148.63 51.77 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 172.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -79.15 101.63 8.03 Favored 'General case' 0 CA--C 1.563 1.447 0 CA-C-O 122.145 0.974 . . . . 0.0 109.814 162.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.0 m -97.59 124.77 41.99 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.919 0.888 . . . . 0.0 111.96 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.01 124.59 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -115.43 116.38 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.446 -0.784 . . . . 0.0 109.574 -174.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.7 m -115.65 132.41 56.64 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.464 0.706 . . . . 0.0 112.554 -176.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.8 tt -89.11 102.1 14.76 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 123.286 0.634 . . . . 0.0 109.974 171.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -96.1 80.71 3.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.135 -0.978 . . . . 0.0 110.943 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.56 -86.03 1.15 Allowed Glycine 0 N--CA 1.494 2.523 0 O-C-N 121.184 -0.948 . . . . 0.0 114.042 -176.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -136.86 65.14 1.52 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.878 0.847 . . . . 0.0 110.179 154.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -145.81 106.8 4.14 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.6 100.67 13.27 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 121.432 -0.793 . . . . 0.0 110.695 -173.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.1 t -104.03 104.34 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -170.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -90.27 121.68 32.51 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.398 0.679 . . . . 0.0 109.792 173.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.5 mt -113.9 110.23 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -92.83 129.73 38.66 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 122.918 0.487 . . . . 0.0 111.536 171.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -122.07 123.41 41.52 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.553 0.741 . . . . 0.0 110.007 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 17.3 p90 -150.46 123.89 9.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.218 -0.926 . . . . 0.0 110.27 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 53.5 38.21 27.53 Favored 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 117.258 2.318 . . . . 0.0 117.258 174.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.46 -25.39 3.85 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 119.148 2.419 . . . . 0.0 119.148 -165.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -81.77 142.46 32.59 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 119.134 1.467 . . . . 0.0 112.307 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -139.21 123.48 18.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.872 -0.517 . . . . 0.0 111.86 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.3 t -112.66 144.15 42.65 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 123.383 0.673 . . . . 0.0 110.623 167.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -121.34 142.16 50.24 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 172.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -122.3 102.92 8.4 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -175.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 68.8 t -99.35 103.13 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -168.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -97.89 117.21 31.71 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.398 0.679 . . . . 0.0 111.406 -175.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -135.24 133.83 39.39 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.114 0.566 . . . . 0.0 111.378 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.2 mm -83.07 121.05 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.145 -0.972 . . . . 0.0 109.245 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.16 -77.02 0.41 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.796 0.438 . . . . 0.0 111.367 -175.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -133.98 82.83 2.0 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 77.06 -33.73 1.49 Allowed Glycine 0 N--CA 1.497 2.74 0 N-CA-C 118.66 2.224 . . . . 0.0 118.66 -166.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -92.05 142.31 27.66 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 118.329 1.065 . . . . 0.0 111.73 -173.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 9.9 tpp -84.24 115.37 22.42 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 121.802 0.811 . . . . 0.0 110.493 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.5 t -91.23 107.56 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.623 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 167.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 18.8 ttt -99.43 108.19 20.6 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.721 -0.612 . . . . 0.0 109.369 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.0 m -95.86 114.5 26.23 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.5 0.667 . . . . 0.0 109.28 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.1 mp -103.57 120.98 41.94 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.263 8.7 t -136.46 138.47 41.49 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 177.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -106.54 77.66 1.21 Allowed 'General case' 0 CA--C 1.565 1.545 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.058 168.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 69.89 -89.45 0.31 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 115.962 1.145 . . . . 0.0 115.962 -175.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -88.56 -35.49 16.89 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 175.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.8 t -87.27 129.71 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 119.677 1.126 . . . . 0.0 109.616 -170.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 44.9 t -123.79 125.89 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 C-N-CA 123.401 0.68 . . . . 0.0 109.512 -169.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.34 151.69 34.16 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.966 0.906 . . . . 0.0 111.943 164.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 92.2 t -124.19 117.07 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 120.778 -1.201 . . . . 0.0 108.915 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.2 mtp180 -96.62 108.75 21.41 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.275 0.63 . . . . 0.0 109.611 170.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -85.46 136.94 33.23 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.287 0.635 . . . . 0.0 111.753 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -134.37 132.45 39.46 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.653 -0.654 . . . . 0.0 111.799 -173.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -100.69 151.26 21.86 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.288 0.635 . . . . 0.0 112.38 169.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -71.34 128.65 36.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.597 -0.689 . . . . 0.0 111.901 170.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.487 0 C-N-CA 123.833 0.853 . . . . 0.0 112.564 177.713 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.293 8.6 p . . . . . 0 CA--C 1.569 1.709 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.72 -40.47 95.4 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 -175.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.38 -30.21 62.43 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 117.754 2.502 . . . . 0.0 117.754 167.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -74.6 -17.93 60.64 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 117.184 2.29 . . . . 0.0 117.184 167.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 22.6 t -89.29 94.61 9.97 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 120.525 1.511 . . . . 0.0 112.667 -169.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.91 171.34 16.77 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-O 122.059 0.933 . . . . 0.0 112.509 -174.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.2 m -82.22 118.42 23.09 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.695 -1.253 . . . . 0.0 108.779 164.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -114.03 114.71 26.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.474 -0.766 . . . . 0.0 110.704 -172.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -98.82 131.89 44.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.455 -0.778 . . . . 0.0 110.933 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.11 117.38 11.6 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.4 p -89.71 -47.67 7.77 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -142.18 119.22 11.32 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 118.945 0.793 . . . . 0.0 109.91 -173.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.7 p -104.67 99.22 8.89 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.207 0.603 . . . . 0.0 111.559 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -81.87 122.92 28.34 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 123.438 0.695 . . . . 0.0 111.236 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.252 1.9 t30 59.07 23.99 12.24 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 117.818 2.525 . . . . 0.0 117.818 174.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -68.38 -45.53 72.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 119.77 -1.831 . . . . 0.0 115.582 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -46.92 -51.98 15.6 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 170.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.69 -43.81 95.55 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 173.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -51.01 -50.18 59.01 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 164.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.8 mtp -61.75 -39.78 92.81 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 174.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -59.75 -50.34 74.21 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 165.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.77 -38.97 83.32 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 116.933 2.197 . . . . 0.0 116.933 172.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.31 -23.99 67.49 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 171.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.66 35.42 8.49 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 118.088 1.995 . . . . 0.0 118.088 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.7 m -93.08 171.07 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 119.406 1.603 . . . . 0.0 112.062 173.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.54 162.33 54.0 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 117.125 1.61 . . . . 0.0 117.125 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -64.28 -46.06 85.34 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 173.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.67 -40.6 63.03 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 167.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.6 m -64.6 -42.79 95.33 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 169.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.9 mtm-85 -57.99 -43.05 86.36 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 164.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -56.46 -54.61 43.72 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.27 1.395 . . . . 0.0 113.941 167.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.0 t -50.6 -60.64 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 169.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.11 -20.98 58.76 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 120.181 2.832 . . . . 0.0 120.181 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -85.72 -41.12 15.41 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 165.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.254 17.6 m -75.04 -37.3 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 CA-C-N 121.421 1.918 . . . . 0.0 116.008 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 t -97.33 146.81 24.79 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 120.035 1.288 . . . . 0.0 112.682 -174.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 105.33 18.55 Favored Pre-proline 0 CA--C 1.578 2.037 0 O-C-N 121.379 -0.825 . . . . 0.0 111.362 174.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.1 141.68 29.85 Favored 'Trans proline' 0 CA--C 1.564 1.989 0 C-N-CA 122.566 2.177 . . . . 0.0 114.898 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.6 m -108.5 112.66 25.16 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.154 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.9 t -106.35 102.2 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -172.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.3 mt -85.4 103.54 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.1 mt -91.54 105.26 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 175.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.4 p -124.45 165.54 17.59 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 123.849 0.86 . . . . 0.0 112.035 -171.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -126.81 126.19 42.97 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.95 -1.094 . . . . 0.0 110.851 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -114.31 81.51 1.55 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.631 0.729 . . . . 0.0 110.024 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.9 -95.96 0.84 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -89.85 -27.52 19.87 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -102.84 149.38 24.55 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-N 119.826 1.193 . . . . 0.0 113.312 -174.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.5 t -86.64 125.37 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.772 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 165.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.0 106.17 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.2 mt -92.59 120.67 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -103.19 100.97 10.9 Favored 'General case' 0 CA--C 1.561 1.39 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 169.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 50.8 m -87.32 99.14 11.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.639 -0.663 . . . . 0.0 109.384 172.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.7 mp -97.29 97.29 9.02 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.6 t -89.26 34.09 0.8 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 174.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.347 73.0 p 67.78 -58.45 0.44 Allowed 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 -174.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -91.66 -61.27 1.67 Allowed 'General case' 0 CA--C 1.569 1.679 0 C-N-CA 124.923 1.289 . . . . 0.0 110.48 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -87.53 104.9 16.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.514 -0.741 . . . . 0.0 110.542 173.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -108.22 106.91 17.31 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.545 0.688 . . . . 0.0 109.34 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.4 p -119.66 135.52 54.78 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 123.433 0.693 . . . . 0.0 111.458 -157.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -127.02 133.68 50.48 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.096 -1.003 . . . . 0.0 113.501 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.4 pt -133.77 120.37 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 C-N-CA 123.484 0.713 . . . . 0.0 110.851 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 90.1 p -106.77 125.51 51.09 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 124.254 1.022 . . . . 0.0 111.858 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -156.54 148.62 23.09 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.297 -0.877 . . . . 0.0 112.795 -168.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -98.61 21.71 10.91 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 117.623 2.453 . . . . 0.0 117.623 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.7 mt 67.62 112.73 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 125.138 1.375 . . . . 0.0 114.027 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.19 -26.04 4.04 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 117.998 1.959 . . . . 0.0 117.998 -162.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -75.91 126.94 31.95 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 124.711 1.204 . . . . 0.0 111.941 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -72.87 141.64 47.93 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -141.76 143.61 33.57 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.934 0.894 . . . . 0.0 110.306 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.85 134.81 35.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.536 -1.352 . . . . 0.0 111.516 172.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -133.13 105.56 7.1 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.058 0.543 . . . . 0.0 110.554 -172.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.7 m -76.31 104.72 6.97 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.423 -0.798 . . . . 0.0 108.958 167.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.0 p -78.82 -178.1 5.82 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -165.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.2 -12.63 3.76 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 118.968 2.951 . . . . 0.0 118.968 168.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -120.19 43.33 2.73 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 119.572 -1.955 . . . . 0.0 113.421 155.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.285 10.5 t70 65.91 -1.22 1.15 Allowed 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 119.374 3.101 . . . . 0.0 119.374 168.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.3 ptt85 -76.46 123.21 25.67 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.37 -1.456 . . . . 0.0 110.978 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -80.12 106.06 11.85 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.888 0.875 . . . . 0.0 112.819 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.0 m -110.03 117.92 35.03 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -167.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -67.6 103.05 1.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.812 0.845 . . . . 0.0 110.338 169.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.6 m -115.92 122.48 45.44 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 121.843 -0.535 . . . . 0.0 111.68 -158.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 99.3 t -115.25 116.0 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.4 t -96.42 108.75 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 173.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.4 p -112.01 117.16 31.92 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.536 0.735 . . . . 0.0 111.599 -173.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tt -84.1 96.49 8.93 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.086 -1.009 . . . . 0.0 110.135 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -91.27 73.76 6.19 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 121.433 -0.792 . . . . 0.0 111.62 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.34 -86.88 1.49 Allowed Glycine 0 N--CA 1.49 2.274 0 O-C-N 121.828 -0.545 . . . . 0.0 113.441 -175.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -132.24 50.62 2.22 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 168.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -153.6 121.12 5.89 Favored 'General case' 0 CA--C 1.564 1.509 0 O-C-N 120.61 -1.306 . . . . 0.0 110.511 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.8 mt -83.56 106.91 15.67 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.758 0.823 . . . . 0.0 111.116 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.2 t -103.21 100.02 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -173.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -86.34 104.46 15.87 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.745 0.818 . . . . 0.0 110.895 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.4 mt -99.31 100.47 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -172.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -87.4 125.67 34.41 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 118.835 0.743 . . . . 0.0 111.53 174.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -116.54 117.88 31.11 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 123.839 0.856 . . . . 0.0 110.387 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.3 p90 -148.42 129.78 14.74 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.866 -1.146 . . . . 0.0 110.716 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 53.69 42.13 31.91 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 166.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.03 17.03 71.33 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 119.893 2.717 . . . . 0.0 119.893 -166.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -132.66 143.13 49.44 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 119.243 1.521 . . . . 0.0 110.042 -170.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -138.55 131.45 29.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.525 -0.734 . . . . 0.0 112.245 -174.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 t -128.07 129.98 47.49 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.563 0.745 . . . . 0.0 109.309 169.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.24 128.78 54.74 Favored 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 123.122 0.569 . . . . 0.0 111.111 174.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -106.58 106.95 17.72 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.1 t -88.78 109.45 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -105.69 102.23 11.69 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.989 0.916 . . . . 0.0 110.374 -174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.49 141.82 51.75 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.788 0.835 . . . . 0.0 112.532 -168.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.8 mm -80.77 117.93 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 120.82 -1.175 . . . . 0.0 109.619 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.45 89.87 3.17 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 171.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.5 t70 50.15 66.12 1.24 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.6 -48.5 3.33 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 117.435 1.734 . . . . 0.0 117.435 -171.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -83.36 142.87 30.72 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 118.904 1.352 . . . . 0.0 112.818 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.0 ttt -90.65 111.46 22.81 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.843 0.83 . . . . 0.0 110.303 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 69.4 t -93.93 108.6 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.56 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 23.9 ttt -89.65 112.52 23.79 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.704 0.802 . . . . 0.0 109.78 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.2 m -100.44 111.24 23.48 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mp -104.79 112.64 25.82 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.428 1.091 . . . . 0.0 108.139 -172.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.267 13.2 t -131.47 142.0 49.9 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -122.75 81.42 1.86 Allowed 'General case' 0 CA--C 1.564 1.507 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.76 173.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 71.18 -92.98 0.5 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 115.579 0.992 . . . . 0.0 115.579 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -86.89 -37.01 18.09 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.3 t -82.01 134.28 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-N 119.343 0.974 . . . . 0.0 110.157 -171.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.5 t -129.4 121.22 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -175.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.14 154.45 23.29 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 123.548 0.739 . . . . 0.0 112.44 164.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.3 t -132.41 113.47 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.146 -0.971 . . . . 0.0 109.25 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -106.12 124.33 49.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.176 -0.953 . . . . 0.0 110.856 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -108.62 115.68 30.55 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 123.252 0.621 . . . . 0.0 110.602 -165.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -114.69 133.21 56.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.794 -1.191 . . . . 0.0 113.22 -166.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -98.94 153.81 18.54 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 123.338 0.655 . . . . 0.0 112.626 166.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -74.27 135.29 42.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.176 0 CA-C-O 117.923 -1.037 . . . . 0.0 112.225 170.598 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.456 HG22 ' H ' ' A' ' 2' ' ' GLU 0.302 4.1 p . . . . . 0 CA--C 1.575 1.926 0 CA-C-O 121.734 0.778 . . . . 0.0 112.102 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.456 ' H ' HG22 ' A' ' 1' ' ' VAL 0.358 9.0 tt0 77.07 -57.95 0.51 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 172.128 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.28 -29.35 68.76 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 153.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -82.12 -6.28 59.06 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 169.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.6 t -74.86 91.34 2.44 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-N 122.194 2.27 . . . . 0.0 113.644 -172.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -168.29 169.2 10.96 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-O 122.243 1.02 . . . . 0.0 112.27 -170.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.6 m -86.71 123.09 31.49 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.238 -0.914 . . . . 0.0 108.907 167.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -118.37 118.69 32.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.427 -0.796 . . . . 0.0 111.026 -171.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -104.15 136.98 42.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.04 -1.037 . . . . 0.0 111.113 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.25 121.04 14.8 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.1 p -108.93 -26.07 10.41 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -150.61 113.82 4.85 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 121.037 1.744 . . . . 0.0 109.484 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.7 p -94.47 89.38 5.82 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 122.454 1.121 . . . . 0.0 111.936 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -88.76 110.22 20.82 Favored 'General case' 0 CA--C 1.563 1.45 0 O-C-N 121.079 -1.013 . . . . 0.0 110.93 -170.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.262 56.4 t30 62.88 35.37 13.57 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 -174.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -83.17 66.08 8.55 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 123.747 1.737 . . . . 0.0 111.845 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -165.07 -68.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.99 -1.459 . . . . 0.0 107.728 -156.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -65.61 -42.32 91.73 Favored 'General case' 0 CA--C 1.565 1.525 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 172.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -46.41 -52.41 13.04 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 163.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.481 ' SD ' HG11 ' A' ' 25' ' ' VAL . 22.8 mmt -60.22 -49.98 75.48 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 175.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.5 -46.43 76.95 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 168.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.41 -35.88 76.19 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 117.581 2.437 . . . . 0.0 117.581 175.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 tt -62.81 -39.19 93.51 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 171.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.63 55.68 1.31 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 114.808 0.683 . . . . 0.0 114.808 -169.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.481 HG11 ' SD ' ' A' ' 20' ' ' MET . 26.9 m -90.42 163.24 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-O 122.329 1.061 . . . . 0.0 112.055 173.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.88 142.04 31.37 Favored Glycine 0 CA--C 1.55 2.249 0 O-C-N 121.007 -1.058 . . . . 0.0 113.444 160.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -59.37 -41.16 88.66 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.96 -41.15 64.26 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 165.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.0 m -58.39 -50.36 73.96 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 120.201 1.364 . . . . 0.0 114.231 170.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.269 5.7 ptt180 -62.44 -36.25 81.82 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 172.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -63.16 -50.9 68.56 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 166.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.4 t -46.57 -48.96 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.81 -30.22 66.29 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 119.404 2.521 . . . . 0.0 119.404 170.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -76.68 -46.42 25.69 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 119.8 1.8 . . . . 0.0 115.238 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.259 28.3 m -89.16 47.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 CA-C-N 121.254 1.843 . . . . 0.0 113.715 175.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.6 t -145.18 161.72 38.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.116 -0.99 . . . . 0.0 111.922 172.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -102.27 91.32 2.51 Favored Pre-proline 0 CA--C 1.574 1.868 0 O-C-N 121.38 -0.825 . . . . 0.0 109.545 162.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.44 123.68 7.23 Favored 'Trans proline' 0 C--N 1.373 1.825 0 CA-C-N 122.684 1.994 . . . . 0.0 112.827 -174.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.0 m -101.01 102.74 13.8 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -173.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.6 t -95.85 102.96 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -171.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.0 mt -90.7 110.79 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.0 mt -94.29 122.64 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 170.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.7 p -134.83 143.8 47.24 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.178 0.591 . . . . 0.0 112.298 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -99.35 113.29 25.53 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.019 -1.051 . . . . 0.0 109.157 168.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -113.33 90.55 3.37 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.468 -0.77 . . . . 0.0 110.316 -174.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.84 -77.39 1.79 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 115.317 0.887 . . . . 0.0 115.317 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -117.96 -54.94 2.3 Favored 'General case' 0 CA--C 1.567 1.614 0 C-N-CA 123.712 0.805 . . . . 0.0 111.819 171.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -79.2 157.9 27.76 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -173.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.9 t -89.81 124.7 42.62 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.601 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.0 t -114.42 105.7 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 76.9 mt -97.05 120.64 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -106.37 101.69 11.14 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.62 0.724 . . . . 0.0 109.837 171.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.3 m -84.33 98.54 10.07 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 170.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 63.9 mt -94.24 93.52 7.8 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -174.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.8 t -79.57 18.04 0.8 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 118.313 2.708 . . . . 0.0 118.313 -174.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.441 7.4 p 63.61 -60.72 0.17 Allowed 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 125.26 1.424 . . . . 0.0 114.739 -163.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -66.03 -46.17 78.83 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 173.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.69 119.78 7.73 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 119.125 0.875 . . . . 0.0 110.216 -165.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -104.52 112.52 25.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.318 -0.864 . . . . 0.0 111.901 -166.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 p -105.82 110.67 23.04 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.714 -0.616 . . . . 0.0 110.808 -170.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -109.35 107.66 17.93 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.21 1.004 . . . . 0.0 110.64 -175.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.5 pt -109.55 121.15 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 C-N-CA 123.491 0.716 . . . . 0.0 110.496 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 97.2 p -110.72 111.44 22.63 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.228 1.011 . . . . 0.0 110.882 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -148.37 151.4 35.24 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.062 0.934 . . . . 0.0 112.89 -165.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -86.3 148.7 25.5 Favored 'General case' 0 CA--C 1.571 1.765 0 O-C-N 121.211 -0.931 . . . . 0.0 111.06 162.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 73.3 mt -71.05 124.67 24.93 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.237 -1.539 . . . . 0.0 111.922 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.35 -3.45 86.57 Favored Glycine 0 CA--C 1.556 2.628 0 N-CA-C 119.081 2.392 . . . . 0.0 119.081 -162.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -86.95 124.57 33.3 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 120.066 1.933 . . . . 0.0 110.761 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -87.25 107.85 18.68 Favored 'General case' 0 CA--C 1.565 1.535 0 O-C-N 121.877 -0.515 . . . . 0.0 110.91 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -112.88 159.88 18.6 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.379 1.072 . . . . 0.0 111.825 -175.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -83.3 137.67 33.88 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.423 -1.423 . . . . 0.0 111.952 171.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -129.96 111.71 12.8 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.287 0.635 . . . . 0.0 109.798 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.8 m -74.89 96.59 3.15 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 122.023 0.916 . . . . 0.0 109.709 170.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 80.5 p -74.08 173.99 9.28 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -167.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.18 -5.43 1.08 Allowed 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 119.442 3.126 . . . . 0.0 119.442 167.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -95.17 -8.28 36.77 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 159.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.318 3.2 m-20 80.5 12.22 0.94 Allowed 'General case' 0 N--CA 1.507 2.417 0 CA-C-N 121.513 1.96 . . . . 0.0 116.18 -166.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -91.78 130.48 37.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.444 -1.41 . . . . 0.0 110.176 173.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -82.32 110.99 17.97 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.15 0.5 . . . . 0.0 110.973 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 93.4 m -103.71 118.95 37.91 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -173.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -69.81 104.95 2.6 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.906 0.86 . . . . 0.0 110.56 171.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.3 m -120.22 117.61 28.32 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.894 -156.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.2 p -109.01 118.45 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.225 0.536 . . . . 0.0 109.757 175.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.6 t -96.81 110.5 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 173.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 79.6 p -110.44 131.19 55.27 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.706 0.802 . . . . 0.0 110.906 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -83.15 120.39 25.73 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.957 -1.089 . . . . 0.0 109.787 161.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -122.91 72.55 1.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.108 -169.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.61 60.81 8.23 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 117.071 1.588 . . . . 0.0 117.071 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.347 5.5 m-20 92.08 -31.74 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 -167.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -97.28 124.17 41.31 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 120.897 1.68 . . . . 0.0 112.322 -170.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.8 mt -81.03 103.75 11.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.162 -0.961 . . . . 0.0 110.745 170.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.0 t -104.72 106.04 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.715 -1.241 . . . . 0.0 107.733 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -93.87 105.79 17.79 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.029 0.932 . . . . 0.0 110.148 177.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.33 104.46 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 123.354 0.661 . . . . 0.0 109.383 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -85.15 125.61 32.95 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 118.887 0.767 . . . . 0.0 111.626 171.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -116.08 126.42 53.73 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.317 0.647 . . . . 0.0 110.575 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 15.6 p90 -150.18 124.49 9.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.351 -0.843 . . . . 0.0 110.492 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 55.99 33.72 22.33 Favored 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 117.087 2.254 . . . . 0.0 117.087 173.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.8 -18.23 21.84 Favored Glycine 0 CA--C 1.559 2.805 0 N-CA-C 119.325 2.49 . . . . 0.0 119.325 -164.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -89.17 145.46 25.41 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-N 119.489 1.644 . . . . 0.0 112.836 -175.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -130.25 129.29 43.12 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.747 0.819 . . . . 0.0 110.709 -174.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.2 t -123.9 129.01 50.29 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.643 -0.66 . . . . 0.0 109.327 159.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -112.95 127.01 56.1 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.412 0.685 . . . . 0.0 110.709 175.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -106.43 102.39 11.79 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -175.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.4 t -88.19 102.8 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -173.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -108.35 110.47 22.04 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.076 0.95 . . . . 0.0 109.015 -169.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -129.73 137.68 50.7 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -170.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.1 mm -77.0 99.38 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 171.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -109.99 111.09 22.27 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.8 t70 47.12 52.83 11.45 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -171.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.02 -23.99 4.18 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 119.599 2.6 . . . . 0.0 119.599 -170.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -94.06 136.24 34.56 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 119.522 1.661 . . . . 0.0 111.454 -172.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 50.1 ttp -81.01 102.72 10.36 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.253 1.025 . . . . 0.0 110.167 172.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 87.5 t -89.52 101.76 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 46.6 ttm -87.37 101.02 13.16 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.536 0.735 . . . . 0.0 109.476 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 93.1 m -91.56 101.42 14.06 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.888 0.851 . . . . 0.0 108.737 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 mp -88.83 117.87 28.13 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.307 6.5 t -137.94 133.66 34.01 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 175.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -99.01 89.9 4.44 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.342 171.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 71.86 -86.75 0.46 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 114.952 0.741 . . . . 0.0 114.952 -172.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -127.75 3.67 6.07 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 174.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.4 125.11 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-N 121.82 2.1 . . . . 0.0 107.994 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.1 t -120.6 130.56 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.816 -0.553 . . . . 0.0 111.139 -162.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.28 148.59 35.31 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 123.484 0.714 . . . . 0.0 111.588 156.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.3 t -125.64 107.5 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 120.743 -1.223 . . . . 0.0 108.807 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -95.62 120.26 35.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.213 -0.929 . . . . 0.0 111.139 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -97.73 97.91 9.41 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.367 0.603 . . . . 0.0 110.131 -172.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -94.53 135.62 35.77 Favored 'General case' 0 CA--C 1.561 1.403 0 O-C-N 121.353 -0.842 . . . . 0.0 112.024 -174.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -122.66 154.87 37.46 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.481 0.712 . . . . 0.0 111.454 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -72.02 136.86 46.85 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -172.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.194 0 C-N-CA 124.183 0.993 . . . . 0.0 111.363 170.321 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.276 4.1 p . . . . . 0 CA--C 1.577 1.99 0 N-CA-C 116.617 2.081 . . . . 0.0 116.617 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -59.53 -39.68 84.72 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 116.358 1.984 . . . . 0.0 116.358 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.11 -29.38 30.5 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 118.201 2.667 . . . . 0.0 118.201 164.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -82.49 -9.78 59.28 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 169.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.6 t -73.59 102.62 3.93 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-N 122.054 2.206 . . . . 0.0 114.004 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -172.17 163.59 5.9 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 122.211 1.005 . . . . 0.0 111.788 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.2 m -78.84 122.64 26.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.015 -1.053 . . . . 0.0 108.375 153.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -106.14 115.79 30.82 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.085 -1.01 . . . . 0.0 110.218 -175.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -92.5 129.8 38.34 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.646 0.778 . . . . 0.0 111.272 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 tt -73.05 113.21 9.84 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-O 121.353 0.597 . . . . 0.0 112.526 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.0 p -85.25 -45.84 11.6 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -148.51 117.33 6.69 Favored 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 123.785 0.834 . . . . 0.0 109.734 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.7 p -99.91 98.54 9.3 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.126 0.57 . . . . 0.0 111.535 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -80.05 122.1 26.34 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 123.437 0.695 . . . . 0.0 111.261 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 t30 55.32 38.19 29.98 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 118.15 2.648 . . . . 0.0 118.15 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -78.97 -35.94 42.27 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -176.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -50.18 -59.56 3.81 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 172.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -59.06 -37.66 77.57 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 171.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -57.66 -48.39 79.63 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 115.448 1.648 . . . . 0.0 115.448 168.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -57.85 -49.4 76.8 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 167.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -44.26 65.32 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 168.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.61 -41.33 98.32 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 170.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.37 -13.0 24.55 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 118.406 2.743 . . . . 0.0 118.406 170.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.75 55.61 1.75 Allowed Glycine 0 N--CA 1.485 1.931 0 CA-C-N 119.329 0.968 . . . . 0.0 115.342 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.3 m -95.44 146.43 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 117.565 0.682 . . . . 0.0 112.221 175.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.23 144.95 35.38 Favored Glycine 0 CA--C 1.551 2.298 0 N-CA-C 115.277 0.871 . . . . 0.0 115.277 169.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -78.92 60.75 2.95 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 123.311 1.529 . . . . 0.0 114.237 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -165.57 -55.24 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 126.418 1.887 . . . . 0.0 108.63 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.1 m -40.46 -40.0 1.12 Allowed 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 160.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.329 0.0 OUTLIER -94.01 -2.38 53.11 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 119.436 3.124 . . . . 0.0 119.436 172.767 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -65.37 -46.5 79.9 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 120.815 1.643 . . . . 0.0 112.599 151.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.7 t -52.29 -55.01 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 160.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.97 -40.64 91.3 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 120.548 2.979 . . . . 0.0 120.548 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -72.06 -33.45 67.97 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 175.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.3 m -69.81 -35.45 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.6 t -86.96 137.44 32.36 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -91.22 117.57 67.94 Favored Pre-proline 0 CA--C 1.576 1.963 0 CA-C-O 117.851 -1.071 . . . . 0.0 111.0 166.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -76.06 127.31 9.88 Favored 'Trans proline' 0 CA--C 1.562 1.907 0 CA-C-N 123.404 2.251 . . . . 0.0 115.356 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.9 m -99.28 123.24 43.41 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.079 0.952 . . . . 0.0 109.015 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.9 t -105.82 106.51 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.55 -0.718 . . . . 0.0 109.537 -168.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.8 mt -90.79 106.66 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 120.141 -1.599 . . . . 0.0 108.273 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 81.6 mt -90.38 111.55 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.2 p -135.67 119.76 17.63 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -169.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -90.9 116.72 28.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.324 -0.86 . . . . 0.0 111.842 -171.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -114.55 79.97 1.34 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.477 0.656 . . . . 0.0 110.543 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.2 -97.35 0.66 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 115.509 0.964 . . . . 0.0 115.509 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.36 -41.55 69.6 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 170.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -113.08 153.36 28.31 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-O 122.164 0.983 . . . . 0.0 113.41 -160.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.2 t -89.23 115.67 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.651 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 167.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.22 100.86 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 175.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 58.9 mt -94.28 114.25 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -98.91 102.97 14.88 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 122.979 0.512 . . . . 0.0 110.054 174.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.8 m -87.89 101.48 13.77 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.534 0.683 . . . . 0.0 109.187 173.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.6 mt -96.74 96.88 8.89 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.385 0.674 . . . . 0.0 109.396 -175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -83.73 22.38 1.12 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 175.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.418 20.5 p 63.23 -62.1 0.14 Allowed 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 125.59 1.556 . . . . 0.0 114.755 -167.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -76.76 -37.79 55.27 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 173.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -120.5 124.81 46.3 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 119.49 1.041 . . . . 0.0 110.945 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -93.83 104.33 16.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.034 -1.041 . . . . 0.0 109.207 164.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.255 13.6 t -107.57 87.07 2.42 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.013 0.911 . . . . 0.0 109.617 174.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -106.2 142.63 35.57 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -172.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.9 pt -133.83 123.01 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 C-N-CA 123.044 0.537 . . . . 0.0 111.711 -168.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.9 p -109.99 107.63 17.58 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.812 0.845 . . . . 0.0 110.742 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -140.91 150.47 43.21 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.597 0.713 . . . . 0.0 112.543 -169.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -95.8 98.23 10.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.159 -0.963 . . . . 0.0 109.819 170.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.7 mt -6.07 109.12 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 120.513 3.523 . . . . 0.0 120.513 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.92 -18.83 45.41 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 118.97 2.348 . . . . 0.0 118.97 -167.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.36 127.76 33.87 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 119.716 1.758 . . . . 0.0 111.834 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -79.03 127.77 32.42 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -137.67 150.43 47.35 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.698 0.761 . . . . 0.0 111.42 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -75.85 132.98 40.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.899 -1.126 . . . . 0.0 112.101 170.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -133.09 111.05 10.63 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.238 0.615 . . . . 0.0 110.149 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 95.0 m -82.19 109.66 16.68 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 165.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 51.2 p -82.96 -177.64 6.84 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -165.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.02 -16.6 32.36 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 118.773 2.879 . . . . 0.0 118.773 168.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -79.55 -14.93 58.51 Favored 'General case' 0 CA--C 1.579 2.068 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 157.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.331 5.0 t70 75.88 14.83 2.6 Favored 'General case' 0 CA--C 1.58 2.129 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -160.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.0 ptt-85 -83.34 124.1 30.29 Favored 'General case' 0 CA--C 1.565 1.553 0 O-C-N 120.084 -1.635 . . . . 0.0 109.737 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -85.7 118.07 24.97 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.149 0.58 . . . . 0.0 112.417 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.9 p -122.33 145.64 48.06 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -76.81 105.05 7.64 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.807 0.813 . . . . 0.0 109.709 160.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.7 m -99.53 124.92 45.15 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.536 0.735 . . . . 0.0 112.324 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.31 118.01 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 36.1 t -119.71 95.25 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.36 -0.838 . . . . 0.0 109.073 -171.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.7 m -113.64 130.32 56.42 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.648 0.779 . . . . 0.0 111.612 -169.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 tt -85.29 109.07 18.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.12 -0.988 . . . . 0.0 110.456 170.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -90.57 -16.51 28.63 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 -176.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 176.86 -88.05 0.08 OUTLIER Glycine 0 N--CA 1.49 2.235 0 CA-C-N 120.075 1.307 . . . . 0.0 110.954 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -101.92 32.12 3.58 Favored 'General case' 0 CA--C 1.579 2.071 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 158.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -146.23 114.18 6.52 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.874 0.761 . . . . 0.0 109.951 -159.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 mt -90.2 102.27 14.99 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 123.72 0.808 . . . . 0.0 109.625 172.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.6 t -100.12 105.45 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.149 -0.969 . . . . 0.0 108.603 -170.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -95.04 101.07 12.8 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.427 0.691 . . . . 0.0 110.369 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 59.4 mt -89.47 122.79 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 C-N-CA 123.959 0.903 . . . . 0.0 108.76 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -111.37 123.42 50.18 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 119.477 1.035 . . . . 0.0 110.732 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -113.34 117.84 32.93 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.959 0.904 . . . . 0.0 109.771 -176.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -150.65 127.05 10.71 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.648 -1.282 . . . . 0.0 111.496 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 56.63 32.27 20.69 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 174.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.68 -27.15 4.9 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 118.432 2.133 . . . . 0.0 118.432 -162.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -80.99 140.71 35.03 Favored 'General case' 0 CA--C 1.562 1.426 0 CA-C-N 119.121 1.461 . . . . 0.0 112.158 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -131.26 126.71 36.14 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.235 0.614 . . . . 0.0 110.128 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.7 t -122.3 156.26 34.23 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.413 0.685 . . . . 0.0 110.743 171.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.283 9.7 p30 -135.47 146.24 47.98 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 170.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -120.16 106.14 11.66 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.7 t -90.82 98.38 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -92.23 97.7 11.06 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -176.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -117.08 130.54 56.72 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -168.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.1 mm -74.94 111.04 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.12 -91.05 0.18 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 119.399 -0.334 . . . . 0.0 110.14 -173.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -104.7 70.43 0.93 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 119.342 0.974 . . . . 0.0 108.851 164.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.64 -39.95 2.85 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 118.128 2.011 . . . . 0.0 118.128 -169.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -84.34 144.9 28.54 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.256 1.028 . . . . 0.0 113.262 -173.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 55.8 ttp -84.05 100.32 11.02 Favored 'General case' 0 CA--C 1.561 1.394 0 CA-C-O 122.291 1.043 . . . . 0.0 110.204 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.1 t -85.38 102.76 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 43.1 ttm -86.89 101.36 13.31 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.213 0.605 . . . . 0.0 109.676 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.7 m -90.87 110.1 21.32 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 174.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.5 mp -99.37 119.75 38.46 Favored 'General case' 0 CA--C 1.56 1.339 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -176.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.0 t -125.56 124.2 40.75 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 119.406 1.003 . . . . 0.0 112.646 -171.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -137.19 97.14 3.42 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 123.816 0.846 . . . . 0.0 110.51 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 77.32 -94.2 1.13 Allowed Glycine 0 N--CA 1.492 2.374 0 O-C-N 121.433 -0.792 . . . . 0.0 114.084 170.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -128.39 42.84 3.25 Favored 'General case' 0 CA--C 1.578 2.033 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 160.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 81.4 t -136.88 118.94 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 -177.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.84 131.09 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.05 157.07 21.19 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 123.088 0.555 . . . . 0.0 112.481 163.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.3 t -132.58 109.21 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.032 -1.043 . . . . 0.0 108.99 175.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -100.24 114.41 27.84 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.804 0.811 . . . . 0.0 110.748 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -95.83 106.01 18.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.66 -0.65 . . . . 0.0 110.145 -170.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -105.58 128.19 53.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.889 -1.132 . . . . 0.0 113.391 -168.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -99.41 156.52 16.97 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 124.062 0.945 . . . . 0.0 113.352 173.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -77.72 130.05 36.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.152 -0.967 . . . . 0.0 113.285 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.166 0 C-N-CA 124.493 1.117 . . . . 0.0 110.859 162.693 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.295 8.8 p . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -61.48 -46.9 88.06 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.12 -23.78 62.43 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 166.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -78.71 -18.07 54.89 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 167.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 71.9 m -73.94 92.16 2.08 Favored 'General case' 0 CA--C 1.568 1.671 0 CA-C-N 122.284 2.311 . . . . 0.0 113.855 -173.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.66 166.6 13.83 Favored 'General case' 0 CA--C 1.571 1.754 0 CA-C-O 122.423 1.106 . . . . 0.0 112.328 -170.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.3 m -84.86 111.87 20.03 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.342 -0.849 . . . . 0.0 109.18 166.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -105.87 118.68 37.22 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.912 0.485 . . . . 0.0 110.603 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -103.32 137.83 40.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.14 -0.975 . . . . 0.0 111.628 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -72.78 129.94 39.34 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.0 p -102.18 -37.5 8.1 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -158.15 117.57 3.21 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 119.602 1.092 . . . . 0.0 109.33 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.1 p -97.02 89.4 4.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.726 -0.609 . . . . 0.0 111.562 171.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.99 124.32 29.67 Favored 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 123.763 0.825 . . . . 0.0 111.283 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.307 11.3 t-20 61.89 10.29 3.45 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 118.316 2.71 . . . . 0.0 118.316 -174.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -62.2 -33.61 74.88 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 116.635 2.087 . . . . 0.0 116.635 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -51.99 -52.67 49.03 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 166.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -63.81 -42.98 97.56 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 172.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -52.49 -52.31 55.09 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 166.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 78.9 mtm -58.98 -48.79 80.3 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 173.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -54.24 -48.3 71.28 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 169.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.3 -38.21 82.93 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 tp -72.3 -1.92 17.17 Favored 'General case' 0 CA--C 1.579 2.061 0 N-CA-C 117.905 2.557 . . . . 0.0 117.905 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.22 48.9 5.2 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 117.101 1.6 . . . . 0.0 117.101 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.468 HG21 ' HB2' ' A' ' 30' ' ' ARG . 24.1 m -82.42 131.49 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 173.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.64 58.04 4.9 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 116.65 1.42 . . . . 0.0 116.65 173.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.288 25.8 t80 63.35 -58.33 0.17 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.647 2.091 . . . . 0.0 116.647 -175.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.33 -46.97 76.34 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 116.939 2.2 . . . . 0.0 116.939 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.2 m -63.9 -33.47 75.78 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 172.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.468 ' HB2' HG21 ' A' ' 25' ' ' VAL . 3.7 tmt_? -60.17 -53.75 53.96 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 162.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.89 -37.25 86.69 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.5 t -53.68 -62.27 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 C-N-CA 123.804 0.841 . . . . 0.0 112.684 156.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.54 -35.45 45.08 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 120.337 2.895 . . . . 0.0 120.337 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -69.47 -47.49 63.76 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 172.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.3 m -78.04 -33.35 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.5 t -83.39 147.14 28.06 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 119.274 0.943 . . . . 0.0 113.203 -172.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -107.21 91.11 6.28 Favored Pre-proline 0 CA--C 1.572 1.811 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -77.68 118.25 4.48 Favored 'Trans proline' 0 C--N 1.372 1.793 0 CA-C-N 122.463 1.915 . . . . 0.0 113.616 -169.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.4 m -88.15 123.15 32.52 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.913 0.863 . . . . 0.0 110.577 -172.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.0 t -100.48 101.64 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -173.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 64.9 mt -92.76 111.31 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.2 mt -101.84 121.36 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.2 t -143.24 -172.73 3.75 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-O 122.509 1.147 . . . . 0.0 111.819 173.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -135.28 118.19 16.26 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.334 1.054 . . . . 0.0 109.472 -176.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -100.49 91.75 4.83 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.65 0.738 . . . . 0.0 110.953 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.55 -74.8 1.48 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 115.904 1.122 . . . . 0.0 115.904 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -121.58 -45.97 2.28 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -88.3 155.94 19.45 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 120.368 1.44 . . . . 0.0 114.148 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.0 t -90.4 133.46 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 C-N-CA 123.47 0.708 . . . . 0.0 109.305 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 93.7 t -114.7 117.42 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.9 mt -95.28 107.88 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.693 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 162.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -78.91 149.75 32.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.65 -1.281 . . . . 0.0 110.161 156.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.6 m -147.63 99.52 3.12 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.282 -1.511 . . . . 0.0 107.93 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.8 mt -117.97 103.28 9.77 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.703 0.763 . . . . 0.0 110.443 -154.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.7 t -82.36 163.15 21.91 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 122.27 1.033 . . . . 0.0 112.655 168.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.8 p -57.36 15.19 0.0 OUTLIER 'General case' 0 CA--C 1.591 2.556 0 N-CA-C 118.003 2.594 . . . . 0.0 118.003 153.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -146.32 -69.09 0.26 Allowed 'General case' 0 CA--C 1.57 1.744 0 C-N-CA 124.977 1.311 . . . . 0.0 107.877 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -100.34 121.71 41.95 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.944 0.898 . . . . 0.0 111.867 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -96.54 82.26 3.33 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.848 0.832 . . . . 0.0 111.043 174.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.5 p -85.41 155.91 21.07 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -168.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -142.67 134.24 26.55 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.479 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 8.2 mt -128.98 102.72 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 -174.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 92.0 p -104.75 123.47 47.7 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 123.923 0.889 . . . . 0.0 111.83 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -148.77 142.37 25.44 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.116 0.96 . . . . 0.0 112.773 -168.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -84.76 11.95 8.17 Favored 'General case' 0 CA--C 1.58 2.1 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.263 65.0 mt 64.85 105.54 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 125.556 1.542 . . . . 0.0 113.35 -168.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.16 35.87 36.9 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 118.352 2.101 . . . . 0.0 118.352 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -135.4 135.49 40.66 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 118.467 1.134 . . . . 0.0 110.089 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -89.45 116.61 27.76 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -171.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.479 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 46.4 p90 -116.42 141.25 48.42 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.889 0.876 . . . . 0.0 111.054 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.61 135.38 43.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.567 -1.333 . . . . 0.0 111.907 170.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -134.11 105.21 6.57 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -171.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.2 m -79.83 100.52 8.04 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 122.106 0.955 . . . . 0.0 109.31 172.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 77.8 p -76.38 174.64 9.98 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -169.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.84 -2.53 0.57 Allowed 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 119.885 3.291 . . . . 0.0 119.885 167.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -103.02 4.1 36.92 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 115.594 1.702 . . . . 0.0 115.594 158.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.29 3.4 t70 62.65 25.9 15.37 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 -166.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.8 ptp85 -89.65 126.01 35.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.642 -1.286 . . . . 0.0 109.117 166.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -85.66 101.49 12.78 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-O 121.811 0.815 . . . . 0.0 111.384 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 99.0 m -102.19 116.79 33.4 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 121.395 0.616 . . . . 0.0 112.654 -169.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -66.19 102.47 0.84 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.24 1.016 . . . . 0.0 110.37 169.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.5 m -114.09 125.24 53.75 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 121.849 -0.532 . . . . 0.0 111.48 -156.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.78 122.15 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.8 t -109.03 121.86 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.224 -0.922 . . . . 0.0 109.337 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 94.7 p -118.0 140.92 49.05 Favored 'General case' 0 CA--C 1.564 1.504 0 C-N-CA 123.956 0.902 . . . . 0.0 111.963 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.8 tp -92.91 98.37 11.33 Favored 'General case' 0 CA--C 1.566 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 110.302 174.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -91.59 73.55 5.92 Favored 'General case' 0 CA--C 1.569 1.691 0 O-C-N 121.364 -0.835 . . . . 0.0 111.795 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.25 62.44 4.42 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 116.398 1.319 . . . . 0.0 116.398 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.256 6.6 t70 54.06 47.19 23.88 Favored 'General case' 0 CA--C 1.579 2.086 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -163.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -143.82 107.02 4.52 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.0 mt -82.08 95.2 7.39 Favored 'General case' 0 CA--C 1.568 1.648 0 CA-C-O 121.835 0.826 . . . . 0.0 111.7 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.7 t -97.03 103.18 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -84.93 125.71 32.9 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.035 0.534 . . . . 0.0 110.089 172.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.6 mt -112.39 118.12 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -101.79 126.29 48.63 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 119.296 0.953 . . . . 0.0 111.343 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -114.8 123.14 48.46 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.962 0.905 . . . . 0.0 110.496 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -149.67 122.71 8.83 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.421 -1.424 . . . . 0.0 110.581 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 54.26 39.9 31.24 Favored 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.1 -25.38 4.23 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 118.936 2.335 . . . . 0.0 118.936 -165.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -83.17 141.11 32.17 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-N 119.354 1.577 . . . . 0.0 112.115 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -134.18 125.89 28.81 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 122.969 0.507 . . . . 0.0 111.166 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.9 t -118.98 154.66 32.69 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.764 0.826 . . . . 0.0 110.612 169.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.31 10.8 p30 -134.77 152.42 51.75 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 171.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -126.87 102.91 7.22 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -169.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.8 t -95.19 94.02 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -168.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -81.9 123.67 29.04 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.95 0.9 . . . . 0.0 110.771 176.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -144.31 123.56 13.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.667 -0.646 . . . . 0.0 109.945 -167.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.3 mm -78.09 103.76 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.429 -0.795 . . . . 0.0 109.132 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -131.05 113.86 14.47 Favored 'General case' 0 CA--C 1.558 1.287 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -170.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.5 t70 47.93 50.53 15.64 Favored 'General case' 0 CA--C 1.579 2.094 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -168.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.75 -43.48 3.17 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 -169.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.2 mtmp? -85.75 150.88 24.27 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 118.463 1.132 . . . . 0.0 113.602 -171.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 59.1 ttp -85.23 98.65 10.61 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 121.83 0.824 . . . . 0.0 109.499 171.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.1 81.81 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 120.954 -1.092 . . . . 0.0 108.73 -171.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 23.2 ttp -76.97 112.94 14.13 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.078 0.551 . . . . 0.0 111.58 -166.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.4 m -98.44 114.02 26.23 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.803 0.811 . . . . 0.0 109.777 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.34 106.54 17.72 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 124.238 1.015 . . . . 0.0 108.788 -173.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.7 t -115.6 118.84 34.23 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.407 0.622 . . . . 0.0 111.754 -175.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -105.37 81.68 1.73 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 165.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 68.68 -89.25 0.22 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 115.439 0.936 . . . . 0.0 115.439 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -95.94 -25.4 15.98 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 169.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.2 110.86 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-N 121.038 1.745 . . . . 0.0 109.305 -171.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.7 t -113.07 112.42 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 123.514 0.725 . . . . 0.0 109.273 -172.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -102.16 158.86 15.87 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 165.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.3 t -131.27 110.49 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.022 -1.048 . . . . 0.0 109.14 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -95.23 108.69 20.85 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.891 0.853 . . . . 0.0 110.411 172.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -88.46 104.31 16.68 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.586 0.754 . . . . 0.0 110.497 -171.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -101.57 120.29 40.09 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -0.903 . . . . 0.0 112.639 -172.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -87.05 163.51 16.99 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 167.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -74.14 151.0 40.15 Favored 'General case' 0 CA--C 1.571 1.773 0 O-C-N 120.894 -1.129 . . . . 0.0 112.279 162.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.269 166.407 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 N--CA 1.499 1.992 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -62.75 -52.16 64.33 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 -170.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.54 -21.38 52.26 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 118.394 2.739 . . . . 0.0 118.394 169.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -83.1 -17.48 42.94 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 169.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 87.6 m -71.18 93.96 1.12 Allowed 'General case' 0 CA--C 1.566 1.56 0 CA-C-N 121.563 1.983 . . . . 0.0 113.695 -174.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -170.61 162.95 8.13 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-O 122.485 1.136 . . . . 0.0 111.958 -167.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 92.9 m -86.7 113.62 22.7 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.436 169.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -107.26 111.93 24.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.615 -0.678 . . . . 0.0 111.064 -172.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -101.18 132.97 46.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.253 -0.904 . . . . 0.0 111.501 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -72.05 133.29 45.17 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.7 p -105.7 -40.34 5.78 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 175.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -155.96 123.86 5.67 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 119.474 1.034 . . . . 0.0 109.326 -174.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.8 p -104.86 102.55 12.08 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.373 0.669 . . . . 0.0 110.986 172.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -68.46 -56.29 8.92 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 116.543 2.053 . . . . 0.0 116.543 -159.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -126.21 54.28 1.56 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 119.042 0.837 . . . . 0.0 111.671 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -78.39 -53.05 7.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -172.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -50.62 -43.21 56.86 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 117.767 2.506 . . . . 0.0 117.767 172.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.13 -49.12 78.9 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 166.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -50.73 -46.67 59.23 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 164.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.501 ' SD ' HG21 ' A' ' 25' ' ' VAL . 32.9 mmt -57.66 -42.34 83.31 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 170.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -60.29 -47.18 87.1 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 166.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.97 -39.17 93.88 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 172.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.5 tp -69.17 -23.77 63.97 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.6 45.63 6.37 Favored Glycine 0 CA--C 1.548 2.118 0 N-CA-C 117.169 1.628 . . . . 0.0 117.169 -173.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.501 HG21 ' SD ' ' A' ' 20' ' ' MET . 34.6 m -102.05 153.7 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 118.428 1.114 . . . . 0.0 111.709 173.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.08 -167.66 16.51 Favored Glycine 0 N--CA 1.491 2.303 0 O-C-N 120.646 -1.284 . . . . 0.0 115.835 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -84.84 59.73 5.75 Favored 'General case' 0 CA--C 1.576 1.967 0 O-C-N 121.433 -1.039 . . . . 0.0 112.025 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.3 -73.09 0.31 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.723 0.809 . . . . 0.0 109.702 -175.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.1 m -57.74 -34.3 69.37 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 169.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -62.63 -39.19 93.07 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 117.342 2.349 . . . . 0.0 117.342 167.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -67.14 -56.81 8.38 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.034 1.288 . . . . 0.0 112.269 165.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.5 t -56.13 -45.52 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.91 -15.04 79.95 Favored Glycine 0 CA--C 1.552 2.368 0 N-CA-C 118.79 2.276 . . . . 0.0 118.79 175.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -94.09 -52.0 4.59 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.111 1.956 . . . . 0.0 113.991 171.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.256 34.3 m -80.95 -31.14 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.468 0 CA-C-N 121.657 2.026 . . . . 0.0 115.472 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.08 140.69 32.03 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-O 122.082 0.944 . . . . 0.0 110.206 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -98.18 103.25 16.85 Favored Pre-proline 0 CA--C 1.574 1.895 0 CA-C-O 118.075 -0.964 . . . . 0.0 109.791 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.51 146.87 35.43 Favored 'Trans proline' 0 CA--C 1.561 1.841 0 C-N-CA 122.565 2.177 . . . . 0.0 115.391 -176.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 88.7 m -100.68 100.63 11.35 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.362 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.3 t -95.23 101.98 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -173.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.5 mt -91.56 106.29 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 85.2 mt -84.87 120.34 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 170.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.8 p -137.16 133.06 34.83 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.856 0.462 . . . . 0.0 111.647 -172.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -92.7 101.08 13.48 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.992 -1.068 . . . . 0.0 109.35 172.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -104.97 83.13 1.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.837 0.827 . . . . 0.0 109.713 -170.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.76 -106.35 2.52 Favored Glycine 0 N--CA 1.487 2.098 0 CA-C-N 116.006 -0.543 . . . . 0.0 113.985 -175.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -88.74 -28.11 20.74 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -110.1 153.88 24.05 Favored 'General case' 0 CA--C 1.564 1.507 0 CA-C-O 122.804 1.288 . . . . 0.0 113.818 -170.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.46 118.91 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.604 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 170.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.3 t -111.09 107.54 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.4 mt -93.93 112.81 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -100.99 98.14 8.63 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.2 m -86.8 94.59 9.58 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.4 mt -89.02 89.36 7.95 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.651 0.739 . . . . 0.0 109.356 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.3 t -97.2 27.38 4.17 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.342 66.6 p 68.87 -53.22 0.57 Allowed 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -174.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -92.96 -54.97 3.52 Favored 'General case' 0 CA--C 1.571 1.751 0 C-N-CA 124.821 1.248 . . . . 0.0 111.703 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -107.38 108.88 20.45 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.778 0.831 . . . . 0.0 109.665 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -100.29 86.76 3.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.587 -0.695 . . . . 0.0 112.116 175.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -95.62 127.08 41.35 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.366 -0.834 . . . . 0.0 112.916 -173.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -109.52 97.96 7.43 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.921 0.888 . . . . 0.0 110.834 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.3 pt -95.85 108.99 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.078 -1.014 . . . . 0.0 111.051 -174.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 85.4 p -102.43 113.04 26.04 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.12 0.968 . . . . 0.0 112.076 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -148.64 148.88 30.61 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.22 0.534 . . . . 0.0 111.954 -170.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -86.93 156.62 19.74 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.519 -1.363 . . . . 0.0 111.925 163.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.9 mt -70.51 124.13 23.47 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.373 -1.454 . . . . 0.0 112.491 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.16 -4.24 83.9 Favored Glycine 0 CA--C 1.554 2.506 0 N-CA-C 118.97 2.348 . . . . 0.0 118.97 -163.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -85.33 131.87 34.34 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-N 120.223 2.012 . . . . 0.0 112.229 -175.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -72.42 136.5 46.06 Favored 'General case' 0 CA--C 1.571 1.773 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.928 165.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -145.8 149.04 33.6 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.671 0.788 . . . . 0.0 110.937 175.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.74 134.91 34.32 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.728 -1.233 . . . . 0.0 110.864 169.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.49 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 38.5 tt0 -132.15 109.44 9.96 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.912 -174.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.2 m -78.28 107.1 10.64 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 167.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.4 p -79.91 168.81 18.75 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -167.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.23 -8.51 1.66 Allowed 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 119.716 3.228 . . . . 0.0 119.716 172.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -116.89 28.63 8.41 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 120.833 1.651 . . . . 0.0 114.875 162.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.253 17.1 m-20 63.07 42.16 7.55 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 176.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -119.52 132.22 55.72 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.989 0.916 . . . . 0.0 109.041 167.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -92.62 115.27 27.95 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.158 0.583 . . . . 0.0 110.558 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 72' ' ' GLU . 25.2 p -110.69 143.38 41.25 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -76.48 100.86 5.39 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 122.272 1.034 . . . . 0.0 109.338 160.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.3 m -96.22 130.07 43.38 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 124.235 1.014 . . . . 0.0 112.735 -176.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 p -134.95 124.59 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 123.172 0.589 . . . . 0.0 109.506 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.4 t -112.67 110.9 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.486 -0.759 . . . . 0.0 109.641 -172.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.8 p -104.58 132.11 51.21 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 123.635 0.774 . . . . 0.0 112.467 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.7 tt -88.87 99.67 12.57 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.607 0.718 . . . . 0.0 109.464 168.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -97.25 76.91 2.64 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.443 -0.785 . . . . 0.0 110.587 -173.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.96 58.22 15.71 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 117.99 1.956 . . . . 0.0 117.99 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.348 5.5 m-20 91.14 -35.6 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -163.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -90.01 113.97 25.75 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-N 120.572 1.533 . . . . 0.0 112.659 -171.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.1 mt -80.7 123.42 28.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.921 -1.112 . . . . 0.0 112.006 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.4 t -124.87 106.6 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -174.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -94.28 101.29 13.25 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 123.472 0.709 . . . . 0.0 110.098 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.3 mt -87.21 112.59 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 123.89 0.876 . . . . 0.0 108.707 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -100.14 121.17 41.0 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.061 0.545 . . . . 0.0 110.189 172.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -114.32 118.15 33.1 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.2 0.6 . . . . 0.0 110.531 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 15.6 p90 -142.96 125.12 15.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.25 -0.906 . . . . 0.0 110.197 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 55.17 37.67 29.26 Favored 'General case' 0 N--CA 1.507 2.424 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 173.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.91 -22.58 6.61 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 119.142 2.417 . . . . 0.0 119.142 -165.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -86.48 142.24 28.51 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 119.024 1.412 . . . . 0.0 112.645 -175.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -131.01 123.42 28.71 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.548 0.739 . . . . 0.0 110.616 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.1 t -121.7 139.84 53.06 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 123.278 0.631 . . . . 0.0 109.911 165.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -118.49 132.66 56.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.848 -0.533 . . . . 0.0 112.079 174.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -102.29 104.86 15.42 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.8 t -87.6 96.58 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.93 116.22 28.72 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 123.964 0.906 . . . . 0.0 110.072 175.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.6 128.38 20.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.865 -0.522 . . . . 0.0 110.754 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.7 mm -80.89 121.65 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.625 -0.672 . . . . 0.0 109.664 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -101.5 -107.89 0.23 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 119.222 -0.418 . . . . 0.0 109.904 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -86.63 66.91 9.69 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 120.306 1.412 . . . . 0.0 111.06 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 79.21 -30.18 2.14 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 118.726 2.25 . . . . 0.0 118.726 -167.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -93.77 147.33 23.15 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 118.548 1.174 . . . . 0.0 112.1 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 14.6 tpp -77.48 113.08 14.92 Favored 'General case' 0 CA--C 1.563 1.476 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.606 169.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.9 t -88.64 105.53 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.638 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 164.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 22.3 ttt -101.4 103.4 14.32 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.119 0.568 . . . . 0.0 109.485 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.7 m -103.36 104.37 14.47 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.378 0.671 . . . . 0.0 109.275 -172.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mp -94.86 106.0 17.96 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.463 0.705 . . . . 0.0 109.346 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.9 t -102.7 134.12 46.59 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.736 0.779 . . . . 0.0 112.286 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -116.18 79.68 1.34 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 161.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 68.64 -94.02 0.33 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -175.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -88.22 -30.71 19.5 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 172.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.1 t -90.34 112.33 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-N 120.237 1.38 . . . . 0.0 109.363 -169.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.8 t -115.22 113.13 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 123.435 0.694 . . . . 0.0 109.525 -168.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -100.91 111.86 24.17 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.428 -0.795 . . . . 0.0 112.386 175.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.36 109.17 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.465 -0.772 . . . . 0.0 109.018 -177.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.5 mtp85 -98.19 120.37 38.48 Favored 'General case' 0 CA--C 1.563 1.446 0 CA-C-O 121.915 0.864 . . . . 0.0 110.541 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -99.56 104.99 16.83 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.398 0.679 . . . . 0.0 109.709 -169.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -109.76 125.55 52.81 Favored 'General case' 0 CA--C 1.568 1.635 0 O-C-N 121.623 -0.673 . . . . 0.0 111.458 -170.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -96.62 155.84 16.6 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.374 0.67 . . . . 0.0 112.416 171.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -72.41 131.27 42.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.306 -0.871 . . . . 0.0 112.234 171.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.501 0 C-N-CA 123.254 0.622 . . . . 0.0 112.487 170.561 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 94.1 t . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.257 93.4 mt-10 -135.01 -42.03 0.74 Allowed 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 176.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.2 -37.3 45.9 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 116.748 2.129 . . . . 0.0 116.748 154.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -75.0 -11.74 60.17 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 168.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 66.2 m -76.7 100.53 5.44 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 122.853 2.57 . . . . 0.0 112.871 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -168.76 163.31 11.88 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-O 122.592 1.187 . . . . 0.0 112.313 -172.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.9 m -82.67 103.47 12.2 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.948 0.899 . . . . 0.0 108.796 169.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -99.0 110.32 22.94 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.694 -1.254 . . . . 0.0 112.158 -170.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -96.64 131.48 43.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.423 -0.798 . . . . 0.0 111.822 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.92 120.42 14.18 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.3 p -93.32 -46.62 7.28 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 174.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -145.62 115.21 7.23 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.826 0.851 . . . . 0.0 109.437 -171.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 76.3 p -104.15 94.18 5.24 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.434 0.694 . . . . 0.0 111.472 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -84.09 120.7 26.47 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.957 0.503 . . . . 0.0 111.194 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.297 3.8 t-20 62.58 20.67 12.16 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 118.248 2.684 . . . . 0.0 118.248 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -67.45 -38.05 83.88 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -55.57 -47.29 76.66 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 169.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -58.91 -47.91 83.32 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 169.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -51.21 -49.79 60.36 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 166.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 75.8 mtm -62.15 -44.01 97.56 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 175.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -62.86 -42.97 99.95 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 166.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.61 -43.75 98.28 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 tp -64.3 -32.81 74.56 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 168.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.85 46.94 5.78 Favored Glycine 0 CA--C 1.543 1.831 0 N-CA-C 116.231 1.252 . . . . 0.0 116.231 -171.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.266 22.9 m -83.08 64.2 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 CA-C-N 119.413 1.607 . . . . 0.0 112.15 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 56.1 -162.54 5.98 Favored Glycine 0 CA--C 1.553 2.425 0 N-CA-C 117.957 1.943 . . . . 0.0 117.957 -175.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -99.73 -43.58 6.4 Favored 'General case' 0 CA--C 1.572 1.795 0 CA-C-N 114.713 -0.744 . . . . 0.0 112.587 154.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.49 -49.8 69.93 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 174.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.0 m -59.25 -41.65 89.28 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 120.303 1.411 . . . . 0.0 114.723 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -59.43 -44.57 92.88 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 169.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -68.74 -40.56 79.77 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 172.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.7 t -50.41 -55.6 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 CA-C-N 119.798 1.181 . . . . 0.0 113.481 160.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.97 -39.68 41.19 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 119.33 2.492 . . . . 0.0 119.33 168.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -67.91 -46.25 72.09 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 170.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.0 m -75.55 -29.65 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 t -79.53 145.91 32.92 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 120.313 1.415 . . . . 0.0 114.259 -173.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -95.96 99.28 4.83 Favored Pre-proline 0 CA--C 1.574 1.883 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 159.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.14 131.23 10.73 Favored 'Trans proline' 0 CA--C 1.562 1.895 0 C-N-CA 122.499 2.132 . . . . 0.0 113.149 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.4 m -97.71 110.73 23.24 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.6 t -97.33 96.88 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -175.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.2 mt -95.22 105.6 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.5 -1.375 . . . . 0.0 108.817 -172.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.3 mt -93.1 123.21 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.5 p -146.18 149.29 33.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.345 -0.847 . . . . 0.0 112.778 169.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -90.99 121.22 32.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.511 -0.743 . . . . 0.0 111.105 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -110.95 85.73 2.17 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.347 0.594 . . . . 0.0 109.925 -175.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.54 -67.72 2.53 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 116.58 1.392 . . . . 0.0 116.58 -177.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -131.69 -44.01 0.99 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 124.137 0.975 . . . . 0.0 112.876 172.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -75.93 152.79 37.01 Favored 'General case' 0 CA--C 1.565 1.526 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.3 t -91.52 125.14 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.611 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 169.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -111.88 111.32 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.8 mt -105.96 106.11 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 54.2 mtm-85 -92.05 97.37 10.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.872 -0.517 . . . . 0.0 109.977 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.1 m -85.65 97.04 9.88 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.765 0.793 . . . . 0.0 109.553 174.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.1 mt -111.92 127.55 55.89 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.157 -165.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.6 m -123.76 164.28 19.48 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.329 0.652 . . . . 0.0 111.265 163.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 49.0 p -74.73 55.34 0.67 Allowed 'General case' 0 N--CA 1.508 2.46 0 O-C-N 120.553 -1.342 . . . . 0.0 113.194 171.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 178.86 -56.66 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.873 0 C-N-CA 125.174 1.39 . . . . 0.0 108.529 -149.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -140.07 127.25 21.09 Favored 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 124.271 1.028 . . . . 0.0 109.939 -169.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -104.91 100.16 9.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.538 -0.726 . . . . 0.0 109.388 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.9 p -114.3 91.54 3.66 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.223 0.535 . . . . 0.0 110.564 -172.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -94.65 126.91 40.26 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.06 -1.025 . . . . 0.0 113.718 -176.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.487 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 11.3 mt -113.92 97.84 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -173.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 95.5 p -102.73 116.37 32.44 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.996 0.919 . . . . 0.0 112.038 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -151.45 149.38 29.19 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -172.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -87.21 150.7 23.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.697 -1.252 . . . . 0.0 110.423 152.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 27.2 mt -62.16 121.37 12.92 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.285 -1.509 . . . . 0.0 113.628 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.83 -9.88 72.45 Favored Glycine 0 CA--C 1.558 2.734 0 N-CA-C 119.129 2.411 . . . . 0.0 119.129 -165.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.91 125.23 30.49 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 120.041 1.92 . . . . 0.0 111.003 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -84.48 129.08 34.89 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.487 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 42.7 p90 -129.72 154.51 47.11 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.174 0.99 . . . . 0.0 111.701 -175.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.55 135.01 35.58 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.37 -1.456 . . . . 0.0 111.473 166.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -127.7 106.72 9.34 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.5 m -79.97 100.77 8.26 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.724 0.773 . . . . 0.0 109.915 174.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.7 p -85.07 167.02 16.18 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -169.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.4 -14.01 10.56 Favored 'General case' 0 CA--C 1.576 1.978 0 N-CA-C 118.9 2.926 . . . . 0.0 118.9 167.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -73.48 -13.49 61.06 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 160.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.287 21.7 t70 68.96 69.72 0.28 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 121.267 1.849 . . . . 0.0 112.931 -166.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.2 ptt85 -160.89 127.71 4.11 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -86.03 90.1 8.0 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 123.11 0.564 . . . . 0.0 111.472 172.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.4 p -81.86 129.12 34.65 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -72.75 97.16 2.15 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 123.101 1.429 . . . . 0.0 110.157 173.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.9 m -109.91 123.86 50.35 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.96 -159.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.0 p -121.72 134.65 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.173 0.511 . . . . 0.0 110.144 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.5 t -123.49 123.48 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -175.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.0 m -131.73 146.46 52.18 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.948 0.88 . . . . 0.0 111.842 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.6 mt -84.92 112.57 20.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.874 . . . . 0.0 111.604 172.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -106.11 76.53 1.17 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.398 0.679 . . . . 0.0 111.041 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.64 61.89 5.52 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 116.686 1.434 . . . . 0.0 116.686 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.259 6.5 t70 52.36 43.5 30.78 Favored 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -162.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -137.15 112.41 9.17 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 mt -82.64 87.04 6.73 Favored 'General case' 0 CA--C 1.567 1.622 0 O-C-N 121.381 -0.824 . . . . 0.0 111.2 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.4 t -87.66 107.92 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -170.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -84.64 136.73 33.63 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.787 0.435 . . . . 0.0 110.413 168.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 59.7 mt -126.76 112.86 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -101.76 121.09 41.41 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.578 1.081 . . . . 0.0 110.186 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -116.74 126.67 53.48 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.307 0.575 . . . . 0.0 111.463 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.6 p90 -152.96 133.4 13.65 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.158 -0.964 . . . . 0.0 109.967 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 59.24 23.37 11.73 Favored 'General case' 0 N--CA 1.51 2.567 0 N-CA-C 118.439 2.755 . . . . 0.0 118.439 166.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.9 10.62 82.76 Favored Glycine 0 CA--C 1.558 2.72 0 N-CA-C 119.28 2.472 . . . . 0.0 119.28 -162.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -121.17 141.73 50.56 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-N 119.676 1.738 . . . . 0.0 110.44 -176.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -130.6 122.78 28.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.765 -0.584 . . . . 0.0 110.922 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.7 t -116.7 140.36 49.5 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 123.133 0.573 . . . . 0.0 110.759 166.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.16 140.68 49.98 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.99 -0.444 . . . . 0.0 110.99 -170.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -130.99 101.15 5.49 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.057 -1.027 . . . . 0.0 108.392 -163.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.3 t -93.56 97.18 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -170.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -90.33 108.51 19.81 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 123.55 0.74 . . . . 0.0 110.79 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.86 134.06 53.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.492 -0.755 . . . . 0.0 112.55 -172.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.4 mm -75.11 104.7 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.259 -0.901 . . . . 0.0 109.772 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -103.62 88.12 3.0 Favored 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.0 t70 51.16 59.41 4.63 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.662 1.726 . . . . 0.0 115.662 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.28 -40.36 2.62 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 117.678 1.831 . . . . 0.0 117.678 -171.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -93.47 136.83 33.36 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.276 1.538 . . . . 0.0 113.02 -173.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 56.1 ttp -82.74 104.49 13.02 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.897 0.856 . . . . 0.0 109.765 171.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 84.1 t -93.85 103.55 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 5.2 ttp -93.41 110.11 21.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.41 0.684 . . . . 0.0 110.862 -175.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 96.0 m -96.8 112.5 24.23 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mp -99.62 101.83 13.14 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 124.131 0.973 . . . . 0.0 109.771 -171.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.4 t -101.15 112.82 25.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.591 -0.693 . . . . 0.0 109.965 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -96.25 78.57 3.09 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 152.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.78 -116.33 9.12 Favored Glycine 0 CA--C 1.549 2.204 0 N-CA-C 114.778 0.671 . . . . 0.0 114.778 -168.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -73.31 -19.56 61.01 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 117.02 2.229 . . . . 0.0 117.02 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.2 t -84.75 105.48 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-N 121.143 1.792 . . . . 0.0 108.519 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.4 t -115.67 110.69 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -171.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -99.46 159.21 15.19 Favored 'General case' 0 CA--C 1.562 1.405 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 167.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.1 t -132.17 111.42 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.067 -1.02 . . . . 0.0 109.059 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 56.9 mtm180 -102.17 121.26 41.88 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.75 0.786 . . . . 0.0 111.595 174.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -101.58 111.1 23.23 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.289 0.635 . . . . 0.0 110.525 -171.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -107.48 130.09 54.88 Favored 'General case' 0 CA--C 1.565 1.547 0 O-C-N 121.143 -0.973 . . . . 0.0 112.612 -170.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -97.53 152.74 18.71 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 169.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -75.46 127.94 34.22 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.605 -0.684 . . . . 0.0 112.014 172.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.047 -0.978 . . . . 0.0 112.788 -178.258 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 96.0 t . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 121.504 0.668 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -97.47 -58.74 1.93 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.086 -1.008 . . . . 0.0 113.11 -175.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.17 -22.21 38.78 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 171.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -82.85 -19.91 36.61 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 168.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 44.4 t -73.33 96.46 2.32 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-N 122.663 2.483 . . . . 0.0 113.569 -172.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -174.84 171.04 3.22 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 124.719 1.208 . . . . 0.0 111.466 -168.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 94.3 m -84.1 141.67 30.94 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.802 -1.186 . . . . 0.0 110.021 162.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -133.59 120.66 21.01 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.722 -1.236 . . . . 0.0 110.847 -170.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -108.2 117.91 35.38 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.779 0.832 . . . . 0.0 109.8 -168.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 tt -70.54 115.86 10.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.397 -0.814 . . . . 0.0 112.851 -173.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.8 p -90.22 -49.35 6.6 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -140.88 129.43 22.67 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.936 0.895 . . . . 0.0 109.684 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.8 p -106.33 93.73 4.77 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.077 0.551 . . . . 0.0 110.587 170.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -72.05 124.85 25.84 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.713 0.805 . . . . 0.0 112.026 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 4.9 t-20 52.19 27.99 5.14 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 118.72 2.859 . . . . 0.0 118.72 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -70.46 -44.05 68.57 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -174.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -49.27 -48.57 45.86 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 168.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -59.66 -50.11 75.14 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 170.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -49.28 -49.36 43.95 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 164.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.1 mtp -60.17 -46.25 90.33 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 175.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -55.39 -46.71 76.53 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 167.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.67 -37.34 86.99 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 117.063 2.245 . . . . 0.0 117.063 170.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.4 tp -67.42 -21.69 65.56 Favored 'General case' 0 CA--C 1.573 1.862 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 175.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.24 70.36 1.25 Allowed Glycine 0 N--CA 1.482 1.741 0 CA-C-N 119.026 0.83 . . . . 0.0 113.349 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.2 m -97.1 141.68 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 172.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.03 48.35 4.04 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 117.849 1.9 . . . . 0.0 117.849 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.336 16.6 t80 60.58 -56.69 0.08 Allowed 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 177.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.12 -44.06 64.28 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 173.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.4 m -66.67 -35.21 79.6 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.268 9.7 ptm180 -66.14 -40.85 90.94 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 121.858 2.117 . . . . 0.0 116.301 164.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -60.11 -42.89 95.7 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 169.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.72 -60.75 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-N 119.237 0.926 . . . . 0.0 112.692 166.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.19 -26.24 58.44 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 121.138 3.215 . . . . 0.0 121.138 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -73.68 -38.79 64.8 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 119.527 1.664 . . . . 0.0 115.166 166.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.0 m -77.11 -34.74 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 172.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.0 t -90.65 127.5 36.31 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 120.28 1.4 . . . . 0.0 112.801 -174.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.93 94.88 4.05 Favored Pre-proline 0 CA--C 1.575 1.934 0 CA-C-O 118.119 -0.943 . . . . 0.0 108.881 173.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.66 144.94 56.18 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.52 2.147 . . . . 0.0 116.022 -174.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.2 m -86.86 111.42 20.76 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 114.766 -1.107 . . . . 0.0 109.335 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.3 t -95.65 104.9 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -175.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.9 mt -94.85 104.09 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 80.1 mt -91.21 114.97 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 85.9 p -128.25 128.01 43.89 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 122.869 0.467 . . . . 0.0 111.881 -174.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -85.79 125.19 33.06 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.896 -1.128 . . . . 0.0 109.371 168.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -133.34 90.25 2.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.796 -1.19 . . . . 0.0 110.792 -166.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.76 -68.93 3.13 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 115.783 1.073 . . . . 0.0 115.783 176.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -131.02 -46.94 1.01 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.83 0.852 . . . . 0.0 112.101 168.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -88.31 161.56 17.08 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -173.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.8 t -94.9 124.89 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.1 t -120.12 105.91 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -172.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 61.0 mt -103.62 121.91 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -103.57 113.89 27.75 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 122.709 0.404 . . . . 0.0 111.309 173.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.0 m -94.61 103.4 15.34 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 123.366 0.666 . . . . 0.0 109.351 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.9 mt -112.03 101.45 9.74 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.599 0.714 . . . . 0.0 111.445 -167.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.5 t -87.44 156.0 19.76 Favored 'General case' 0 CA--C 1.563 1.459 0 O-C-N 121.846 -0.534 . . . . 0.0 111.874 162.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.0 t -67.73 34.35 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 157.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -150.63 -61.89 0.19 Allowed 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 125.364 1.465 . . . . 0.0 108.774 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -122.44 122.75 39.71 Favored 'General case' 0 CA--C 1.568 1.636 0 C-N-CA 123.949 0.9 . . . . 0.0 110.239 -177.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -84.48 115.6 22.66 Favored 'General case' 0 CA--C 1.567 1.628 0 C-N-CA 123.422 0.689 . . . . 0.0 110.222 167.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -131.97 144.91 51.15 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.985 0.898 . . . . 0.0 111.198 172.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.57 149.84 30.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.992 -1.068 . . . . 0.0 113.421 -175.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.4 pt -125.67 130.97 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 124.051 0.94 . . . . 0.0 110.259 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.9 p -122.25 114.57 21.0 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.658 0.783 . . . . 0.0 109.773 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -145.6 143.6 29.97 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -166.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -98.76 22.37 10.15 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 174.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 70.4 mt 68.82 110.7 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 125.17 1.388 . . . . 0.0 113.568 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.82 -7.22 56.01 Favored Glycine 0 CA--C 1.557 2.71 0 N-CA-C 119.255 2.462 . . . . 0.0 119.255 -167.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -82.85 125.95 31.9 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-N 119.201 1.501 . . . . 0.0 110.77 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -80.91 126.08 30.92 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -137.19 137.07 38.76 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 123.514 0.726 . . . . 0.0 110.761 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.67 130.2 38.35 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.501 -1.375 . . . . 0.0 111.431 173.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -130.55 106.46 8.53 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 122.725 0.41 . . . . 0.0 111.124 -171.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 54.5 m -68.94 106.91 2.9 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.324 1.059 . . . . 0.0 110.908 176.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.7 p -78.88 173.24 12.73 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.478 -173.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.73 3.37 0.15 Allowed 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 119.169 3.026 . . . . 0.0 119.169 168.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -109.37 -0.29 19.09 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 159.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.347 4.7 m-20 88.82 -5.59 0.46 Allowed 'General case' 0 N--CA 1.508 2.453 0 N-CA-C 116.748 2.129 . . . . 0.0 116.748 -173.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.94 122.36 24.75 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 120.621 1.555 . . . . 0.0 110.622 176.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.281 5.1 p30 -90.94 97.44 11.18 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.392 0.615 . . . . 0.0 111.458 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 82.5 m -93.73 131.55 38.96 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-O 121.486 0.66 . . . . 0.0 112.673 -168.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -69.9 102.24 1.93 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.579 1.151 . . . . 0.0 109.698 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.2 m -110.74 123.31 49.8 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.611 -157.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.1 t -122.98 113.33 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.8 t -99.32 116.91 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.153 -0.967 . . . . 0.0 109.937 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.1 t -112.49 131.61 55.49 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.279 0.632 . . . . 0.0 112.332 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 tt -91.61 100.48 13.21 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.419 0.688 . . . . 0.0 110.383 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -93.76 84.21 4.56 Favored 'General case' 0 CA--C 1.567 1.601 0 O-C-N 121.35 -0.843 . . . . 0.0 110.111 175.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.73 -82.34 0.96 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 115.411 0.924 . . . . 0.0 115.411 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -138.89 53.8 1.75 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.56 0.695 . . . . 0.0 112.293 161.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -142.37 121.25 12.75 Favored 'General case' 0 CA--C 1.561 1.388 0 O-C-N 121.299 -0.875 . . . . 0.0 110.468 168.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.5 mt -89.46 106.9 18.76 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.424 0.63 . . . . 0.0 110.112 176.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 52.4 t -96.72 100.33 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -85.57 101.22 12.5 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.458 0.703 . . . . 0.0 110.21 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 56.5 mt -90.78 110.53 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -175.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -102.84 118.34 36.6 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 119.077 0.853 . . . . 0.0 110.766 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -109.17 129.94 55.49 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 124.191 0.996 . . . . 0.0 111.216 -177.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.6 p90 -152.09 123.16 7.6 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.556 -1.34 . . . . 0.0 110.611 177.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 54.48 37.04 27.06 Favored 'General case' 0 N--CA 1.507 2.391 0 N-CA-C 117.306 2.335 . . . . 0.0 117.306 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.26 -26.57 4.39 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 118.757 2.263 . . . . 0.0 118.757 -164.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -82.24 142.99 31.66 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-N 119.11 1.455 . . . . 0.0 112.158 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -138.71 129.44 26.33 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.229 0.538 . . . . 0.0 111.547 -176.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.1 t -114.8 150.95 34.64 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.266 0.627 . . . . 0.0 109.754 162.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.293 11.1 p30 -127.32 135.84 51.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.015 -1.053 . . . . 0.0 112.582 166.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -105.09 100.85 10.43 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -176.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.1 t -85.21 98.03 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -174.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.9 ttm-85 -91.08 106.66 18.68 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.434 0.694 . . . . 0.0 109.909 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -123.9 141.11 52.33 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 119.235 0.925 . . . . 0.0 112.555 -175.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.5 mm -79.2 119.66 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.057 -1.027 . . . . 0.0 109.317 172.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -137.15 113.25 9.81 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.034 0.534 . . . . 0.0 109.617 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.6 t70 45.39 55.91 6.11 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.5 -36.78 3.07 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 118.314 2.086 . . . . 0.0 118.314 -169.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -82.94 152.94 25.29 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 119.02 1.41 . . . . 0.0 114.011 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.3 tmm? -91.65 109.0 20.3 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.848 158.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 82.5 t -94.79 106.27 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 38.0 ttm -89.41 106.67 18.6 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 173.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.1 m -95.98 110.64 22.82 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mp -98.61 102.94 14.83 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.981 0.912 . . . . 0.0 109.164 -170.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.1 t -108.92 112.97 25.48 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.332 0.587 . . . . 0.0 111.205 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -98.18 80.13 2.65 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 164.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 64.29 -100.84 0.44 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 114.891 0.716 . . . . 0.0 114.891 -172.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -85.7 -23.56 27.33 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 171.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.6 t -89.48 113.77 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-N 120.907 1.685 . . . . 0.0 109.242 -173.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.7 t -117.43 118.37 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 123.271 0.628 . . . . 0.0 109.59 -170.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -104.22 161.14 14.29 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 163.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.9 t -133.26 112.59 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 120.785 -1.197 . . . . 0.0 109.827 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -99.6 116.34 31.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.026 -1.046 . . . . 0.0 110.305 174.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -102.84 108.49 19.72 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.434 0.694 . . . . 0.0 111.06 -167.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -107.9 127.2 53.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.907 -1.121 . . . . 0.0 112.025 -170.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -90.15 153.53 20.46 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 171.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -88.12 137.41 32.35 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -166.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.257 0 CA-C-O 117.444 -1.265 . . . . 0.0 111.646 176.509 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.285 6.2 p . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -61.82 -37.13 83.29 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -176.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.68 -26.19 63.59 Favored 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 117.938 2.57 . . . . 0.0 117.938 167.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -81.19 -17.0 51.19 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 165.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.7 t -77.37 90.09 3.79 Favored 'General case' 0 CA--C 1.569 1.674 0 CA-C-N 122.105 2.229 . . . . 0.0 113.365 -173.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -166.27 172.55 10.99 Favored 'General case' 0 CA--C 1.572 1.796 0 C-N-CA 124.509 1.123 . . . . 0.0 111.736 -173.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 m -85.51 130.4 34.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.944 -1.098 . . . . 0.0 109.677 164.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -124.44 116.36 22.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.647 -0.658 . . . . 0.0 111.327 -170.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -101.95 127.25 48.88 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.468 0.707 . . . . 0.0 110.93 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.7 119.78 15.35 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -176.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.3 p -92.32 -47.4 7.21 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 176.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -140.16 110.81 6.78 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.876 0.87 . . . . 0.0 109.08 -174.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -94.03 80.24 4.09 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.905 1.336 . . . . 0.0 111.807 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -85.77 108.38 18.06 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.186 -0.946 . . . . 0.0 111.104 -161.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.29 1.8 t30 69.27 28.7 4.78 Favored 'General case' 0 CA--C 1.584 2.261 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -168.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -73.07 -41.0 64.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 119.709 -1.87 . . . . 0.0 115.897 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -48.86 -53.72 18.25 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 171.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.45 -43.57 98.5 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 173.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -54.75 -47.39 73.91 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 166.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 71.2 mtm -60.19 -37.62 80.79 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 172.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -62.41 -50.28 72.14 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 161.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.07 -44.16 91.83 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 176.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.3 tp -75.35 -14.07 60.45 Favored 'General case' 0 CA--C 1.58 2.124 0 N-CA-C 116.28 1.956 . . . . 0.0 116.28 169.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.01 32.12 15.4 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 119.511 2.564 . . . . 0.0 119.511 172.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.5 m -79.64 69.24 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 CA-C-N 120.806 2.303 . . . . 0.0 113.54 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 58.85 -160.96 13.7 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -96.36 -51.27 4.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 122.027 -0.69 . . . . 0.0 111.864 148.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.61 -39.37 84.02 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 33.7 m -68.94 -33.33 73.55 Favored 'General case' 0 CA--C 1.577 1.985 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 171.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -57.06 -49.99 74.14 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-N 121.235 1.834 . . . . 0.0 115.085 159.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -54.24 -51.37 64.7 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 171.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.7 t -51.32 -60.92 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 C-N-CA 124.488 1.115 . . . . 0.0 113.991 166.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.83 -29.06 54.17 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 119.78 2.672 . . . . 0.0 119.78 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -74.61 -47.29 33.1 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 167.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 m -75.88 -34.05 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.5 t -91.99 144.19 25.71 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 120.229 1.377 . . . . 0.0 113.648 -170.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -92.87 112.9 58.01 Favored Pre-proline 0 CA--C 1.574 1.867 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.402 170.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.16 123.28 9.1 Favored 'Trans proline' 0 CA--C 1.561 1.84 0 CA-C-N 122.878 2.064 . . . . 0.0 113.425 170.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 91.0 m -92.61 97.43 10.8 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 172.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.9 t -93.56 101.17 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -168.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.6 mt -88.91 104.08 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 177.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -90.2 114.41 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 172.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.7 p -136.52 129.91 31.69 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.728 0.411 . . . . 0.0 111.573 -170.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -87.21 95.05 9.84 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.159 -0.963 . . . . 0.0 110.39 174.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -101.19 76.18 1.7 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.414 0.626 . . . . 0.0 110.698 -171.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.4 80.72 0.33 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 115.107 0.803 . . . . 0.0 115.107 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.326 34.4 t70 72.0 -56.24 0.65 Allowed 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -175.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -76.26 146.2 39.15 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -177.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.1 t -88.56 125.26 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 173.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.3 t -112.56 111.9 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.501 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.1 mt -90.63 115.56 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -108.46 95.64 5.8 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.5 m -84.9 91.7 8.1 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.399 0.619 . . . . 0.0 109.353 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.9 mt -103.65 95.8 6.29 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -172.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 p -111.03 27.27 9.85 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 -173.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.404 8.5 t 47.27 18.61 0.1 Allowed 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 119.891 3.293 . . . . 0.0 119.891 -164.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -155.39 -61.87 0.11 Allowed 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.724 1.21 . . . . 0.0 109.667 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -70.9 -61.49 1.74 Allowed 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.05 0.94 . . . . 0.0 113.439 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 59.62 63.77 1.45 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.4 t -118.88 122.72 42.96 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.268 0.627 . . . . 0.0 111.503 -170.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -109.15 112.93 25.36 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.526 0.731 . . . . 0.0 111.96 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 pt -112.53 114.75 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 C-N-CA 123.476 0.711 . . . . 0.0 110.84 -174.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 92.9 p -105.86 118.65 37.14 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.112 0.965 . . . . 0.0 112.648 -174.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -149.3 156.35 41.95 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.769 0.795 . . . . 0.0 112.206 -169.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -92.59 150.97 20.39 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.125 0.964 . . . . 0.0 110.876 161.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 41.1 mt -67.83 127.35 32.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.099 -1.001 . . . . 0.0 113.481 -176.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.13 -6.36 71.9 Favored Glycine 0 CA--C 1.556 2.605 0 N-CA-C 118.969 2.348 . . . . 0.0 118.969 -164.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.22 127.11 34.69 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 120.332 2.066 . . . . 0.0 110.953 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -78.88 124.78 28.57 Favored 'General case' 0 CA--C 1.569 1.708 0 CA-C-O 121.477 0.656 . . . . 0.0 111.609 171.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -131.01 145.14 51.95 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.947 0.899 . . . . 0.0 110.698 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -73.88 134.28 43.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.242 -1.536 . . . . 0.0 111.961 170.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -133.62 124.54 27.01 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.248 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.1 m -70.16 128.46 36.36 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-O 122.835 1.302 . . . . 0.0 110.361 158.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 80.7 p -97.88 170.36 9.01 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 122.042 0.925 . . . . 0.0 112.491 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.54 -23.9 4.66 Favored 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 119.205 3.039 . . . . 0.0 119.205 168.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -76.49 -15.77 59.81 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 166.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.321 34.9 m-20 66.66 33.97 6.1 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -156.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.73 133.63 46.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.027 -1.046 . . . . 0.0 108.668 162.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -94.01 112.61 24.47 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.002 0.521 . . . . 0.0 110.595 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.2 m -110.48 141.37 43.69 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.456 0.702 . . . . 0.0 112.626 -173.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -73.76 109.79 7.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.523 -0.736 . . . . 0.0 110.356 166.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.2 m -109.26 125.98 52.85 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.921 0.888 . . . . 0.0 111.315 -169.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 p -126.05 126.0 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-O 121.213 0.53 . . . . 0.0 109.916 174.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.0 t -114.17 116.08 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -176.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.5 p -129.86 148.11 51.7 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 20.1 mt -86.02 117.39 24.83 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.499 0.666 . . . . 0.0 112.626 174.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -106.31 62.69 0.65 Allowed 'General case' 0 CA--C 1.574 1.869 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.901 174.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.51 66.61 1.97 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 115.786 1.074 . . . . 0.0 115.786 -174.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.266 18.3 t70 50.77 49.84 20.19 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 115.718 1.748 . . . . 0.0 115.718 -163.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -147.15 103.44 3.59 Favored 'General case' 0 CA--C 1.558 1.255 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -174.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.454 HD13 HH21 ' A' ' 106' ' ' ARG . 53.1 mt -84.18 105.79 15.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.659 -0.651 . . . . 0.0 110.969 -177.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.15 103.33 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -174.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.16 106.43 18.48 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.341 0.656 . . . . 0.0 110.36 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.1 mt -99.29 108.7 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -173.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -98.07 120.75 39.03 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 119.19 0.905 . . . . 0.0 110.088 176.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -117.75 121.27 40.37 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.666 0.787 . . . . 0.0 110.528 -174.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -149.12 133.1 17.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.319 -0.863 . . . . 0.0 110.368 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 59.79 24.82 13.8 Favored 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 118.598 2.814 . . . . 0.0 118.598 166.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.73 10.02 85.66 Favored Glycine 0 CA--C 1.558 2.763 0 N-CA-C 119.201 2.441 . . . . 0.0 119.201 -162.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -120.62 142.11 49.71 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-N 119.393 1.597 . . . . 0.0 110.199 -176.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -132.31 130.04 40.31 Favored 'General case' 0 CA--C 1.562 1.432 0 O-C-N 121.738 -0.601 . . . . 0.0 111.024 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.0 t -120.53 133.98 55.33 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 123.072 0.549 . . . . 0.0 109.715 163.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -116.46 134.44 54.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.773 -0.579 . . . . 0.0 112.167 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -107.59 97.82 7.5 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -174.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 78.2 t -85.85 99.92 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -172.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.454 HH21 HD13 ' A' ' 91' ' ' LEU . 31.3 ttp180 -101.78 113.9 27.49 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.084 0.554 . . . . 0.0 110.992 -172.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -127.27 143.84 51.16 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.1 mm -86.01 109.09 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.146 -0.971 . . . . 0.0 109.403 175.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.01 89.91 3.29 Favored 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 123.758 0.823 . . . . 0.0 109.29 176.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.9 t70 51.53 57.68 6.31 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 94.82 -38.29 3.17 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 117.942 1.937 . . . . 0.0 117.942 -170.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.9 mtmm -92.7 140.44 29.53 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 119.526 1.663 . . . . 0.0 113.35 -176.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 57.9 ttp -90.46 108.39 19.76 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 121.978 0.894 . . . . 0.0 109.984 175.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.1 t -94.54 107.01 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 23.2 ttt -101.98 106.51 17.45 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.048 0.539 . . . . 0.0 110.542 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.5 m -99.02 99.07 10.05 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.657 0.783 . . . . 0.0 109.37 -174.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.9 mp -90.67 108.22 19.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.873 0.869 . . . . 0.0 110.12 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.0 t -108.26 135.11 50.14 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.571 0.7 . . . . 0.0 112.35 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -127.13 98.43 5.3 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.392 0.677 . . . . 0.0 109.176 166.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 73.68 -91.67 0.68 Allowed Glycine 0 N--CA 1.49 2.249 0 O-C-N 121.861 -0.524 . . . . 0.0 113.901 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -124.25 11.62 8.78 Favored 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 160.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 36.2 t -92.02 107.77 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-N 121.56 1.982 . . . . 0.0 107.825 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.5 t -112.57 115.76 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 123.259 0.624 . . . . 0.0 109.568 -169.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -104.17 123.44 47.31 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.597 -0.689 . . . . 0.0 112.604 169.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.7 t -105.32 104.66 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -93.56 115.72 28.22 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.636 0.732 . . . . 0.0 110.765 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -99.12 109.79 22.45 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.208 0.603 . . . . 0.0 110.4 -171.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -108.73 128.48 54.91 Favored 'General case' 0 CA--C 1.565 1.525 0 O-C-N 121.188 -0.945 . . . . 0.0 111.937 -170.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -95.52 153.55 17.65 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.656 0.741 . . . . 0.0 112.337 167.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -72.08 134.78 46.0 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.49 0 C-N-CA 123.328 0.651 . . . . 0.0 111.17 159.842 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.497 1.891 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.95 -52.41 36.36 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -166.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.55 -24.3 63.59 Favored 'General case' 0 CA--C 1.574 1.87 0 N-CA-C 117.904 2.557 . . . . 0.0 117.904 167.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -85.97 -13.24 48.23 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 172.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.7 t -79.43 96.62 6.1 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 121.157 1.799 . . . . 0.0 112.667 -170.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -169.41 163.65 10.55 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.133 0.968 . . . . 0.0 112.492 -166.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.4 m -81.08 119.0 22.99 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.355 -0.84 . . . . 0.0 109.363 163.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -111.48 107.43 16.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.498 -0.751 . . . . 0.0 111.264 -172.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -91.7 129.74 37.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.511 -0.743 . . . . 0.0 111.272 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -68.85 133.63 48.54 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-O 122.524 1.154 . . . . 0.0 113.904 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.1 p -110.29 -34.73 6.27 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -156.9 112.46 2.89 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 119.69 1.132 . . . . 0.0 108.45 -172.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.9 p -104.05 91.0 3.77 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.916 0.865 . . . . 0.0 111.577 175.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -80.26 125.8 30.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 111.869 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.252 1.7 t30 61.92 21.32 12.21 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 117.565 2.432 . . . . 0.0 117.565 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -72.93 -34.5 66.63 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -175.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -55.04 -56.12 23.34 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 165.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.45 -31.86 71.83 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 173.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -61.65 -51.36 68.77 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 162.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.4 mtt -58.62 -44.5 89.99 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 116.797 2.147 . . . . 0.0 116.797 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -40.48 95.06 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 116.858 2.169 . . . . 0.0 116.858 164.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.72 -46.44 88.1 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 168.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.8 tp -61.66 -27.97 69.06 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.27 49.94 2.51 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 115.866 1.106 . . . . 0.0 115.866 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.2 m -107.52 140.08 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-N 118.944 1.372 . . . . 0.0 110.341 165.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.65 -168.63 9.84 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 116.814 1.486 . . . . 0.0 116.814 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -80.74 61.91 4.58 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.533 1.159 . . . . 0.0 112.709 177.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -148.05 -69.49 0.23 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.111 0.964 . . . . 0.0 109.16 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.2 m -58.7 -35.63 72.94 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 170.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -61.79 -32.96 73.28 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 165.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -83.51 14.72 3.52 Favored 'General case' 0 CA--C 1.58 2.105 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 164.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.3 t -118.58 -61.85 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 C-N-CA 125.419 1.488 . . . . 0.0 108.614 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.21 -23.54 68.16 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 119.668 2.627 . . . . 0.0 119.668 -177.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -88.74 -37.26 15.62 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 174.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.4 m -80.34 -33.21 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.4 t -107.91 177.16 4.9 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 119.709 1.141 . . . . 0.0 112.669 -178.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -97.69 99.67 7.02 Favored Pre-proline 0 CA--C 1.573 1.849 0 CA-C-O 118.042 -0.98 . . . . 0.0 111.003 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.92 127.24 15.77 Favored 'Trans proline' 0 CA--C 1.564 2.022 0 CA-C-N 122.903 2.072 . . . . 0.0 113.965 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.0 m -110.45 102.86 11.44 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.004 -172.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.3 t -102.82 101.32 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.553 -0.717 . . . . 0.0 109.141 -164.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.9 mt -87.47 103.35 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.242 -0.911 . . . . 0.0 108.812 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.6 mt -88.04 111.81 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.8 p -136.15 117.96 15.12 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.671 0.389 . . . . 0.0 111.853 -169.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -83.38 116.46 22.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.099 -1.001 . . . . 0.0 111.432 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -116.62 96.23 5.41 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.269 0.557 . . . . 0.0 109.639 -172.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.48 -75.75 2.32 Favored Glycine 0 N--CA 1.492 2.371 0 O-C-N 121.694 -0.629 . . . . 0.0 114.265 -172.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -133.43 -52.14 0.88 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 169.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -62.69 154.34 29.69 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.6 t -94.06 109.73 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.53 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.367 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.5 t -93.88 101.4 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 176.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.2 mt -95.05 116.61 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -101.64 99.74 10.06 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.157 0.583 . . . . 0.0 110.102 175.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.2 m -86.35 96.15 9.89 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.757 0.789 . . . . 0.0 109.4 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 71.3 mt -102.31 86.54 2.84 Favored 'General case' 0 CA--C 1.559 1.318 0 CA-C-O 121.856 0.836 . . . . 0.0 110.329 -170.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.2 t -79.38 144.64 33.96 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.56 -0.713 . . . . 0.0 110.326 159.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.4 p -70.09 33.62 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.463 0 N-CA-C 116.823 2.156 . . . . 0.0 116.823 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -155.89 -57.39 0.09 Allowed 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 126.194 1.797 . . . . 0.0 108.189 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -107.75 100.57 9.94 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 123.978 0.911 . . . . 0.0 109.394 177.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -96.77 88.18 4.52 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.53 -0.731 . . . . 0.0 110.314 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.8 t -105.22 139.55 39.7 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 123.475 0.71 . . . . 0.0 112.444 -171.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -134.68 145.74 48.83 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.8 pt -134.15 129.5 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 C-N-CA 123.771 0.828 . . . . 0.0 110.347 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.0 m -118.37 117.79 30.03 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.843 -0.536 . . . . 0.0 110.371 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -150.65 152.54 34.14 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.675 0.75 . . . . 0.0 112.3 -165.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -94.73 151.02 19.61 Favored 'General case' 0 CA--C 1.573 1.831 0 O-C-N 120.972 -1.08 . . . . 0.0 110.888 169.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.6 mt -67.55 123.39 20.3 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.26 -1.525 . . . . 0.0 112.872 -177.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.06 -20.02 23.07 Favored Glycine 0 CA--C 1.555 2.555 0 N-CA-C 118.678 2.231 . . . . 0.0 118.678 -166.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -79.64 126.64 31.17 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-N 119.387 1.594 . . . . 0.0 111.653 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -81.14 144.24 31.82 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-O 121.563 0.696 . . . . 0.0 112.423 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -142.38 141.26 32.27 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.107 0.963 . . . . 0.0 110.459 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -78.95 129.04 34.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.525 -1.359 . . . . 0.0 111.19 171.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -125.34 103.25 7.82 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.852 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.4 m -79.7 103.28 9.49 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 170.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 71.4 p -78.15 167.88 20.73 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -168.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.98 -11.85 0.72 Allowed 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 120.236 3.421 . . . . 0.0 120.236 170.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -122.22 35.84 4.78 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 120.892 1.678 . . . . 0.0 114.555 160.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.269 31.0 m-20 63.07 54.63 2.09 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 116.543 2.053 . . . . 0.0 116.543 168.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -120.38 128.4 53.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.528 -0.732 . . . . 0.0 109.207 159.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -90.26 90.56 8.13 Favored 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 123.535 0.734 . . . . 0.0 111.189 173.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.5 p -96.85 134.72 39.8 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -173.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.68 94.17 2.66 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-O 122.524 1.154 . . . . 0.0 109.284 172.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.1 m -100.94 119.34 38.56 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.676 -165.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.1 p -121.7 125.36 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 123.182 0.593 . . . . 0.0 109.707 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.3 t -109.23 118.38 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -175.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.9 p -118.75 133.86 55.55 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.668 0.787 . . . . 0.0 112.055 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 tt -89.66 98.16 11.61 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 109.933 175.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -94.11 81.07 4.07 Favored 'General case' 0 CA--C 1.567 1.62 0 O-C-N 121.512 -0.743 . . . . 0.0 110.796 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.88 -90.79 0.5 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 115.563 0.985 . . . . 0.0 115.563 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -99.13 4.57 46.93 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 166.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -121.85 119.88 32.91 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 120.452 1.478 . . . . 0.0 111.086 -162.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.2 mt -82.97 100.47 10.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.92 -1.112 . . . . 0.0 110.222 167.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 41.0 t -101.13 101.45 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -170.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.34 107.24 19.02 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.506 0.722 . . . . 0.0 110.791 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 53.9 mt -100.14 103.28 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -173.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -94.66 123.1 37.9 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 118.7 0.682 . . . . 0.0 110.839 176.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -116.39 121.15 41.05 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 123.44 0.696 . . . . 0.0 111.943 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.3 p90 -150.65 128.89 11.97 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.53 -1.357 . . . . 0.0 110.969 -177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 50.52 48.09 23.08 Favored 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 166.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.86 16.23 72.23 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 119.995 2.758 . . . . 0.0 119.995 -168.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -133.59 140.46 47.15 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 119.531 1.666 . . . . 0.0 109.858 -170.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -134.65 130.49 36.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.669 -0.644 . . . . 0.0 111.543 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.8 t -119.4 123.5 44.26 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.358 0.663 . . . . 0.0 109.368 167.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -107.52 122.01 45.79 Favored 'General case' 0 CA--C 1.563 1.475 0 C-N-CA 123.26 0.624 . . . . 0.0 110.605 172.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -103.62 108.38 19.63 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -175.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 82.4 t -93.44 104.08 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -169.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -110.34 99.15 8.23 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.03 0.532 . . . . 0.0 110.314 -166.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.12 149.97 43.83 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -171.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.4 mm -82.18 111.38 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.872 -0.517 . . . . 0.0 110.01 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -105.19 86.98 2.52 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 171.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.9 t70 48.23 60.19 3.78 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.65 -37.86 3.29 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 117.95 1.94 . . . . 0.0 117.95 -171.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -88.02 140.96 28.96 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 119.659 1.73 . . . . 0.0 112.979 -177.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 34.1 ttm -84.83 112.41 20.51 Favored 'General case' 0 CA--C 1.564 1.503 0 O-C-N 121.266 -0.897 . . . . 0.0 109.297 165.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.8 t -89.64 104.36 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 169.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 28.1 ttt -90.95 101.38 14.15 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.998 0.519 . . . . 0.0 109.777 172.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.6 m -92.05 111.06 22.46 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 175.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.9 mp -95.93 121.21 37.43 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.4 t -126.12 122.64 36.32 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-N 120.31 1.414 . . . . 0.0 112.357 174.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -114.38 80.68 1.43 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.824 0.85 . . . . 0.0 108.786 174.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 66.97 -98.55 0.43 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 115.062 0.785 . . . . 0.0 115.062 -174.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -83.98 -30.85 25.89 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 171.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.5 t -89.38 119.86 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 119.715 1.143 . . . . 0.0 109.443 -169.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.5 t -115.97 124.94 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -175.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -117.58 156.22 28.47 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.483 0.713 . . . . 0.0 112.742 167.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.3 t -134.01 112.44 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.318 -0.863 . . . . 0.0 109.074 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -99.63 122.5 42.75 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.52 0.676 . . . . 0.0 111.769 172.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -104.46 114.36 28.54 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.322 0.649 . . . . 0.0 110.663 -172.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -114.97 131.39 56.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.437 -0.79 . . . . 0.0 112.11 -169.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -101.51 152.3 20.93 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 123.452 0.701 . . . . 0.0 112.405 169.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -74.1 131.83 41.69 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.296 -0.877 . . . . 0.0 112.815 175.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.518 0 C-N-CA 124.188 0.995 . . . . 0.0 111.995 175.205 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.268 35.0 m . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.669 0.747 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -74.61 -51.73 13.69 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -172.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.94 -27.09 40.79 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 117.592 2.442 . . . . 0.0 117.592 166.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -85.7 -6.68 59.1 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 171.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 52.8 t -80.56 93.22 6.04 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-N 121.876 2.125 . . . . 0.0 113.85 -172.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.69 172.32 9.37 Favored 'General case' 0 CA--C 1.571 1.787 0 CA-C-O 122.425 1.107 . . . . 0.0 112.435 -177.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.0 m -89.87 116.72 28.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.175 -0.953 . . . . 0.0 108.998 165.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -114.76 108.52 16.88 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 122.956 0.502 . . . . 0.0 110.38 -169.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -95.45 136.55 35.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.05 -1.031 . . . . 0.0 111.651 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.96 130.61 43.71 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.666 0.988 . . . . 0.0 113.666 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 45.8 p -116.34 -24.83 7.75 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -157.22 121.66 4.37 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 120.574 1.534 . . . . 0.0 108.922 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.3 p -113.07 92.82 4.14 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.967 0.889 . . . . 0.0 111.805 178.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -88.34 116.34 26.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.967 -1.083 . . . . 0.0 110.513 -170.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.291 3.8 t-20 68.63 25.86 6.43 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -173.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -72.76 -48.23 40.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 119.994 -1.691 . . . . 0.0 115.392 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -46.97 -50.66 18.67 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.739 2.125 . . . . 0.0 116.739 169.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -58.69 -45.32 89.74 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 171.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -55.73 -48.55 75.01 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 165.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 31.0 mmm -58.56 -49.61 76.82 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -60.3 -42.26 95.15 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 167.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.53 -40.26 95.28 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 172.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.4 tp -61.31 -25.13 66.91 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 168.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.91 56.17 1.33 Allowed Glycine 0 N--CA 1.484 1.893 0 N-CA-C 115.72 1.048 . . . . 0.0 115.72 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.255 4.5 m -100.25 148.03 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-N 118.451 1.126 . . . . 0.0 112.875 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.96 170.12 14.86 Favored Glycine 0 CA--C 1.551 2.329 0 N-CA-C 117.357 1.703 . . . . 0.0 117.357 171.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -67.95 -43.35 79.3 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.32 -44.97 94.98 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 164.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.0 m -61.36 -42.63 99.02 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 175.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -63.76 -39.68 94.85 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 116.512 2.041 . . . . 0.0 116.512 167.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.72 -48.81 80.13 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 120.035 1.289 . . . . 0.0 114.337 167.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.5 t -57.22 -60.94 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-N 119.627 1.103 . . . . 0.0 113.445 170.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.74 -27.81 70.61 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 120.115 2.806 . . . . 0.0 120.115 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -73.48 -42.01 62.43 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 167.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.4 m -70.46 -36.88 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.2 t -88.31 138.92 31.01 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 119.815 1.189 . . . . 0.0 113.194 -174.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -85.68 114.41 56.55 Favored Pre-proline 0 CA--C 1.575 1.92 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.665 167.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -69.11 130.35 19.97 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 CA-C-N 123.345 2.23 . . . . 0.0 114.813 176.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 93.4 m -97.12 101.47 13.04 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.8 t -99.71 99.45 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -166.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.6 mt -86.34 105.98 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.9 mt -99.02 115.03 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 174.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.5 t -144.76 159.59 42.61 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 123.539 1.637 . . . . 0.0 112.65 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.67 135.29 40.39 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.206 177.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.13 103.62 6.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.619 -0.676 . . . . 0.0 109.987 175.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.28 -78.57 0.96 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 115.977 1.151 . . . . 0.0 115.977 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -127.6 -39.16 1.85 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 170.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -77.12 154.05 33.64 Favored 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.9 t -94.79 129.97 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.64 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.7 t -109.29 119.08 58.03 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.3 mt -102.29 115.44 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 168.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -104.16 96.07 6.4 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.904 0.859 . . . . 0.0 109.888 170.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.6 m -83.25 92.83 7.56 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.52 174.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.3 mt -104.52 101.47 11.13 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.547 0.739 . . . . 0.0 109.438 -170.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.6 p -99.46 26.98 5.57 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 117.16 2.281 . . . . 0.0 117.16 -175.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.492 2.0 t 63.03 -54.07 0.18 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -169.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -82.71 -60.46 2.17 Favored 'General case' 0 CA--C 1.569 1.698 0 C-N-CA 124.025 0.93 . . . . 0.0 111.582 173.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -98.14 103.16 15.08 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -105.84 93.16 4.49 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.677 0.751 . . . . 0.0 110.186 -171.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 39.1 p -100.94 149.09 24.26 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -167.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -145.16 120.95 10.56 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.112 -0.992 . . . . 0.0 112.5 176.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.2 pt -122.97 129.59 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 C-N-CA 123.699 0.8 . . . . 0.0 110.792 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 85.1 p -120.8 116.39 25.12 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.889 0.876 . . . . 0.0 111.641 -175.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -145.77 146.1 31.08 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.91 0.862 . . . . 0.0 113.073 -164.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -101.62 76.32 1.65 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.138 -0.976 . . . . 0.0 110.816 177.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.4 mt 17.81 96.93 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 120.158 3.392 . . . . 0.0 120.158 174.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.15 -12.73 63.66 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 118.374 2.109 . . . . 0.0 118.374 -166.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -77.62 136.24 38.22 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 119.718 1.759 . . . . 0.0 112.45 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -80.21 115.19 19.63 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.146 171.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -118.99 152.24 36.74 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 122.05 0.929 . . . . 0.0 110.95 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.06 138.08 31.81 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.877 -1.14 . . . . 0.0 111.465 174.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -145.24 124.34 12.86 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.369 0.604 . . . . 0.0 110.53 169.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 84.9 m -77.04 121.42 23.51 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 158.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.5 p -87.43 -179.99 6.47 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -169.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.68 -29.33 38.28 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 118.698 2.851 . . . . 0.0 118.698 165.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -84.66 10.46 11.16 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 163.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.281 3.1 t0 60.95 22.06 12.29 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 -174.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -95.42 129.72 42.48 Favored 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 124.697 1.199 . . . . 0.0 110.168 175.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -84.88 105.09 15.39 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.157 0.983 . . . . 0.0 112.942 -176.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 4.8 p -99.86 127.52 46.03 Favored 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -76.01 104.43 6.54 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 159.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.0 m -111.37 123.6 50.55 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.23 0.612 . . . . 0.0 112.206 -164.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.4 t -110.99 113.03 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 172.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.6 t -95.97 104.74 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 169.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.9 t -109.74 137.0 48.19 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.65 0.738 . . . . 0.0 112.111 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 tt -85.93 103.72 14.91 Favored 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 123.057 0.543 . . . . 0.0 110.474 174.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -96.11 80.66 3.29 Favored 'General case' 0 CA--C 1.567 1.627 0 O-C-N 121.399 -0.813 . . . . 0.0 111.015 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.74 -83.49 1.14 Allowed Glycine 0 N--CA 1.493 2.451 0 O-C-N 121.013 -1.055 . . . . 0.0 114.26 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -137.9 53.89 1.82 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.106 0.479 . . . . 0.0 112.19 162.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -150.57 130.14 13.07 Favored 'General case' 0 CA--C 1.567 1.626 0 O-C-N 120.754 -1.216 . . . . 0.0 111.673 173.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 16.6 mt -93.29 108.22 19.9 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.33 1.052 . . . . 0.0 111.438 -174.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.02 103.6 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.314 -0.866 . . . . 0.0 108.902 -167.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -89.51 94.3 9.82 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 123.321 0.649 . . . . 0.0 112.413 -178.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 61.2 mt -87.26 98.11 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.7 0.8 . . . . 0.0 109.141 -172.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -92.65 117.94 30.51 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 118.984 0.811 . . . . 0.0 109.958 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -117.46 122.57 44.11 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.148 0.579 . . . . 0.0 110.607 -175.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.7 p90 -153.35 126.93 8.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.503 -0.748 . . . . 0.0 110.509 -172.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 48.46 49.97 17.46 Favored 'General case' 0 N--CA 1.507 2.387 0 N-CA-C 117.214 2.301 . . . . 0.0 117.214 169.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.04 7.08 69.96 Favored Glycine 0 CA--C 1.558 2.758 0 N-CA-C 120.332 2.893 . . . . 0.0 120.332 -168.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -123.73 143.62 50.17 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 120.031 1.916 . . . . 0.0 110.901 -169.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -133.02 131.21 40.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.685 -0.635 . . . . 0.0 111.238 -177.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.4 t -130.88 137.44 49.35 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 123.236 0.614 . . . . 0.0 110.296 166.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.276 11.5 p30 -119.41 128.88 54.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.566 -0.709 . . . . 0.0 112.499 175.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 m-30 -99.77 105.32 17.09 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 84.5 t -90.0 97.52 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -174.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.96 108.37 19.53 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.227 1.011 . . . . 0.0 111.495 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -118.29 148.87 42.01 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.6 mm -85.58 99.77 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 170.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.72 93.25 5.47 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.556 0.742 . . . . 0.0 109.55 -178.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.7 t70 51.51 55.89 8.72 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -174.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.31 -28.57 4.66 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 119.008 2.363 . . . . 0.0 119.008 -169.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -92.18 145.21 24.68 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 119.883 1.841 . . . . 0.0 112.905 -172.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -85.98 100.77 12.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.174 -0.954 . . . . 0.0 110.42 175.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.8 t -100.49 110.9 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 26.7 ttp -100.13 115.08 28.97 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.19 0.596 . . . . 0.0 110.095 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 96.2 m -103.1 104.96 15.17 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mp -96.66 101.51 13.13 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.444 0.698 . . . . 0.0 109.759 -174.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.7 t -90.09 125.07 35.3 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.449 -0.782 . . . . 0.0 111.757 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -109.5 77.24 1.05 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 156.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 64.78 -112.45 5.02 Favored Glycine 0 CA--C 1.548 2.141 0 N-CA-C 114.485 0.554 . . . . 0.0 114.485 -170.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -78.24 -21.05 50.49 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 172.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.6 t -87.93 111.71 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 120.868 1.667 . . . . 0.0 108.662 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 58.2 t -123.07 114.1 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -168.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -94.22 118.01 30.94 Favored 'General case' 0 CA--C 1.562 1.439 0 O-C-N 121.724 -0.61 . . . . 0.0 112.458 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.4 t -100.82 106.48 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -109.96 117.84 34.85 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.427 0.632 . . . . 0.0 111.008 -173.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -91.87 119.97 32.13 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.368 0.604 . . . . 0.0 111.01 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -117.34 133.4 56.03 Favored 'General case' 0 CA--C 1.561 1.404 0 CA-C-O 121.931 0.872 . . . . 0.0 109.51 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -122.95 153.7 39.37 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.671 0.748 . . . . 0.0 110.659 -176.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -68.16 132.29 46.92 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -172.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.231 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.396 172.717 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.254 5.1 p . . . . . 0 CA--C 1.571 1.785 0 CA-C-O 121.828 0.823 . . . . 0.0 112.274 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.338 22.4 tt0 74.46 -53.14 0.68 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -175.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.2 -31.1 41.23 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.638 2.459 . . . . 0.0 117.638 161.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -73.67 -18.51 61.01 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 117.322 2.341 . . . . 0.0 117.322 167.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 44.3 t -75.59 90.94 2.8 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-N 122.331 2.332 . . . . 0.0 114.112 -169.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -168.03 170.47 10.41 Favored 'General case' 0 CA--C 1.569 1.705 0 C-N-CA 124.317 1.047 . . . . 0.0 111.902 -171.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.0 m -78.02 135.23 37.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.819 -1.176 . . . . 0.0 109.162 160.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -120.02 116.7 26.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.775 -1.203 . . . . 0.0 109.682 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -102.2 128.09 48.86 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.662 0.785 . . . . 0.0 110.513 -174.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tt -69.89 117.91 12.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.537 -0.727 . . . . 0.0 112.816 -174.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 46.2 p -97.71 -44.7 6.65 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -147.78 118.04 7.34 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 119.513 1.051 . . . . 0.0 110.232 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.7 p -97.38 95.56 7.76 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.212 0.605 . . . . 0.0 111.951 174.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -79.89 117.52 20.83 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 123.526 0.73 . . . . 0.0 111.027 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.6 t30 60.73 23.26 13.16 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -66.37 -39.12 88.91 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -175.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -52.98 -55.67 21.79 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 171.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -66.73 -34.68 78.37 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -53.6 -53.98 44.0 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-N 120.442 1.473 . . . . 0.0 113.695 161.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 79.4 mtm -57.59 -46.53 83.91 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 115.556 1.688 . . . . 0.0 115.556 174.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -57.32 -46.92 82.74 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 168.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.53 -41.73 99.06 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 171.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.1 tp -57.02 -18.84 15.45 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 168.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.03 60.37 1.77 Allowed Glycine 0 N--CA 1.481 1.665 0 O-C-N 121.3 -0.875 . . . . 0.0 114.402 -176.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.6 m -95.05 155.47 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 CA-C-O 121.886 0.85 . . . . 0.0 111.856 167.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.53 164.47 54.12 Favored Glycine 0 CA--C 1.552 2.349 0 O-C-N 121.326 -0.859 . . . . 0.0 114.279 154.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -55.48 -38.22 68.84 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.7 -48.87 66.29 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.0 m -65.23 -41.31 94.51 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 173.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.284 22.7 ptt180 -66.25 -42.26 88.81 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 121.617 2.008 . . . . 0.0 115.644 169.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -59.21 -48.66 80.79 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 171.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.4 t -57.89 -60.66 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 124.334 1.053 . . . . 0.0 113.141 166.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.54 -30.6 50.82 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 120.392 2.917 . . . . 0.0 120.392 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.23 -42.4 31.36 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 168.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.251 20.8 m -73.54 -42.47 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 CA-C-N 120.765 1.621 . . . . 0.0 115.125 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.1 t -91.42 148.09 22.56 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 119.46 1.027 . . . . 0.0 111.836 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -99.62 98.42 7.03 Favored Pre-proline 0 CA--C 1.571 1.778 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.493 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.17 117.48 5.07 Favored 'Trans proline' 0 CA--C 1.56 1.798 0 C-N-CA 122.547 2.165 . . . . 0.0 113.729 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.1 m -91.79 125.5 36.53 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.139 0.975 . . . . 0.0 109.323 -176.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.1 t -108.29 100.07 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -165.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.9 mt -90.32 109.38 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.521 -1.362 . . . . 0.0 108.322 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.1 mt -88.95 110.17 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 174.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 82.1 p -124.77 117.46 24.23 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.032 0.533 . . . . 0.0 111.769 -171.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -85.27 122.11 28.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.312 -0.868 . . . . 0.0 111.454 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.23 89.59 2.88 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.488 0.661 . . . . 0.0 110.706 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.64 -106.64 2.46 Favored Glycine 0 N--CA 1.487 2.069 0 O-C-N 121.781 -0.575 . . . . 0.0 113.604 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -95.67 -34.85 11.81 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 171.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -86.01 146.49 26.63 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-O 123.368 1.556 . . . . 0.0 114.491 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 64.4 t -96.22 115.61 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.584 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.7 t -102.05 102.8 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.7 mt -91.36 118.19 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.2 mtt-85 -109.4 107.61 17.84 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.447 0.699 . . . . 0.0 109.345 -173.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.2 m -89.84 100.43 13.24 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.5 mt -115.76 119.41 35.94 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.476 0.71 . . . . 0.0 109.856 -169.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 m -121.08 -177.62 3.55 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 122.116 0.96 . . . . 0.0 111.906 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.3 p -61.73 -30.31 70.69 Favored 'General case' 0 N--CA 1.505 2.317 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 158.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -120.69 -54.04 2.07 Favored 'General case' 0 CA--C 1.572 1.8 0 C-N-CA 124.115 0.966 . . . . 0.0 112.174 -175.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -83.32 138.26 33.62 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -137.3 108.62 6.86 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 171.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.0 t -143.21 140.79 30.88 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.632 -0.667 . . . . 0.0 111.508 173.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -136.74 137.93 40.41 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.0 -1.063 . . . . 0.0 113.263 -174.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.3 pt -123.21 124.79 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 C-N-CA 123.16 0.584 . . . . 0.0 112.261 -169.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.3 p -110.69 106.64 15.94 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 123.607 0.763 . . . . 0.0 112.47 -174.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -134.25 140.28 46.34 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -169.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -101.9 39.05 1.52 Allowed 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.0 mt 60.55 97.58 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 125.031 1.332 . . . . 0.0 114.334 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.91 -0.61 82.46 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 118.902 2.321 . . . . 0.0 118.902 -165.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -70.93 125.05 25.8 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 119.341 1.571 . . . . 0.0 111.825 173.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -91.47 123.54 34.96 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.785 0.434 . . . . 0.0 110.664 169.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -147.16 144.43 28.97 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.336 0.654 . . . . 0.0 111.998 -172.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.66 142.16 44.54 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.416 -1.428 . . . . 0.0 112.586 166.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -149.27 137.05 20.42 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.461 0.648 . . . . 0.0 112.596 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.4 m -82.25 103.47 11.86 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 122.066 0.936 . . . . 0.0 110.206 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.3 p -72.91 174.83 7.22 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.98 -9.36 3.0 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 119.762 3.245 . . . . 0.0 119.762 170.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -110.39 20.33 17.88 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 120.741 1.61 . . . . 0.0 114.518 159.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.273 6.6 m-20 54.68 31.56 15.52 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 117.658 2.466 . . . . 0.0 117.658 -174.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 ptp85 -87.32 128.59 35.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.873 -1.142 . . . . 0.0 108.967 165.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -79.05 92.55 5.01 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.679 0.752 . . . . 0.0 111.558 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 68.7 m -85.99 118.43 25.46 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -171.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -69.72 99.43 1.33 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.148 0.979 . . . . 0.0 109.558 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.7 m -115.54 120.4 39.34 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.595 -155.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.1 p -117.45 116.11 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 123.11 0.564 . . . . 0.0 109.733 176.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.6 t -102.92 112.7 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.432 -0.793 . . . . 0.0 109.372 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 86.0 p -113.45 123.11 49.26 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.63 0.772 . . . . 0.0 111.395 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tt -89.65 98.76 11.95 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 118.992 0.815 . . . . 0.0 111.601 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -97.15 68.7 2.27 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 123.353 0.661 . . . . 0.0 111.955 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.09 82.41 0.13 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 116.075 1.19 . . . . 0.0 116.075 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.269 24.2 t0 63.64 0.52 0.89 Allowed 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 -164.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -118.12 99.73 7.07 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 121.119 1.782 . . . . 0.0 110.373 -172.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.8 mt -76.72 99.43 5.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.303 -0.873 . . . . 0.0 110.722 171.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.1 t -99.66 99.41 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.866 -1.146 . . . . 0.0 108.265 -172.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -85.49 100.6 12.01 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.297 0.639 . . . . 0.0 110.814 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.2 mt -90.65 105.48 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -176.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -93.61 122.82 36.46 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 118.45 0.568 . . . . 0.0 110.865 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -112.01 132.8 54.57 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.859 0.863 . . . . 0.0 110.5 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -157.5 124.94 5.22 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.675 -1.266 . . . . 0.0 110.362 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 58.2 24.82 11.83 Favored 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 172.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.93 -24.14 17.01 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 118.425 2.13 . . . . 0.0 118.425 -162.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -82.67 144.72 30.06 Favored 'General case' 0 CA--C 1.565 1.548 0 CA-C-N 119.486 1.643 . . . . 0.0 112.247 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -138.9 129.97 26.66 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.19 0.519 . . . . 0.0 111.543 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.4 t -117.88 154.64 31.51 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 123.577 0.751 . . . . 0.0 110.401 165.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.282 11.6 p30 -130.12 141.26 50.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.131 -0.981 . . . . 0.0 113.54 165.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -111.07 103.49 11.95 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -177.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.7 t -85.82 102.52 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -104.97 108.7 20.36 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.849 0.86 . . . . 0.0 108.857 -169.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -135.74 136.41 40.77 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -169.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 26.7 mm -82.7 113.92 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.718 -0.614 . . . . 0.0 109.52 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -120.79 108.83 14.43 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.7 t70 50.3 54.34 11.31 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 116.582 2.067 . . . . 0.0 116.582 -176.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 64.05 19.64 63.86 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 119.662 2.625 . . . . 0.0 119.662 -169.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -129.27 129.75 45.32 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 119.246 1.523 . . . . 0.0 108.908 -175.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 ttt -82.66 104.78 13.17 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-O 122.067 0.937 . . . . 0.0 109.922 176.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.1 t -86.88 104.41 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 174.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 55.2 ttm -93.48 104.25 16.4 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.8 m -93.69 110.17 21.79 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.526 0.679 . . . . 0.0 109.329 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mp -95.82 105.61 17.64 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 124.184 0.994 . . . . 0.0 108.897 -173.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.7 t -115.26 114.91 25.82 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 119.229 0.922 . . . . 0.0 111.949 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -98.45 74.8 2.18 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.473 0.654 . . . . 0.0 109.251 164.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 66.37 -91.94 0.17 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 115.444 0.938 . . . . 0.0 115.444 -175.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.98 -34.96 20.69 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 172.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.9 t -87.17 117.95 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-N 120.099 1.318 . . . . 0.0 109.732 -171.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.4 t -116.28 127.08 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 C-N-CA 123.493 0.717 . . . . 0.0 109.772 -173.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.67 160.24 18.11 Favored 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 123.264 0.626 . . . . 0.0 112.593 161.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.5 t -131.28 110.7 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.976 -1.078 . . . . 0.0 108.753 176.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -94.56 119.19 32.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.129 -0.982 . . . . 0.0 110.613 169.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -92.54 105.24 17.45 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.387 0.675 . . . . 0.0 109.542 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -106.27 122.98 47.32 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.438 0.695 . . . . 0.0 111.057 -172.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -95.65 157.28 15.97 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.982 -1.073 . . . . 0.0 113.618 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -81.05 141.13 34.66 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -173.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.307 0 CA-C-O 117.364 -1.303 . . . . 0.0 111.975 -179.062 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.35 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.034 0 CA-C-O 122.137 0.97 . . . . 0.0 112.478 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -66.74 -48.44 69.14 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 -165.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.26 -27.18 54.28 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 166.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -83.4 -23.81 32.21 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 172.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 71.7 m -78.12 99.48 6.18 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 121.758 2.072 . . . . 0.0 112.998 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.66 168.77 12.37 Favored 'General case' 0 CA--C 1.57 1.717 0 CA-C-O 122.284 1.04 . . . . 0.0 112.245 -173.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.0 m -85.39 102.65 13.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.203 -0.936 . . . . 0.0 108.901 173.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -101.59 108.66 20.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.788 -1.195 . . . . 0.0 112.027 -169.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -94.13 128.36 40.49 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.428 -0.795 . . . . 0.0 110.94 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.95 117.35 14.56 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.528 0.68 . . . . 0.0 112.704 -175.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.7 p -88.68 -47.82 7.98 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -145.17 112.17 5.98 Favored 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 123.51 0.724 . . . . 0.0 109.662 -171.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.0 p -101.25 95.25 6.4 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.474 0.709 . . . . 0.0 111.406 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -91.0 116.39 28.75 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 122.893 0.477 . . . . 0.0 110.736 -166.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 0.7 OUTLIER 64.01 39.82 7.64 Favored 'General case' 0 CA--C 1.582 2.174 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -173.825 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -78.87 -44.58 22.52 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -53.67 -51.12 64.21 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 116.763 2.134 . . . . 0.0 116.763 175.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -66.52 -38.96 88.32 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -50.14 -53.94 24.11 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 160.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 31.5 mtp -58.41 -42.28 86.86 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 174.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -59.33 -51.4 70.11 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 165.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.4 -38.07 89.73 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 116.743 2.127 . . . . 0.0 116.743 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 tt -61.92 -32.59 73.0 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 165.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.71 49.95 1.89 Allowed Glycine 0 N--CA 1.484 1.88 0 N-CA-C 115.919 1.128 . . . . 0.0 115.919 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 m -93.16 156.69 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-N 118.792 1.296 . . . . 0.0 112.173 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.44 156.85 50.46 Favored Glycine 0 CA--C 1.551 2.318 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 171.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -62.07 -41.27 97.99 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.94 -41.78 71.47 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 165.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.5 m -60.7 -46.62 89.68 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 168.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.5 mtm180 -54.36 -48.75 71.11 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 165.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -60.48 -42.12 95.61 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.8 t -52.95 -60.38 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-N 119.909 1.231 . . . . 0.0 113.101 163.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.0 -31.51 68.71 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 119.822 2.689 . . . . 0.0 119.822 176.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -67.48 -45.7 75.15 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 167.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.6 m -79.33 -32.59 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.23 146.56 34.02 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 120.19 1.359 . . . . 0.0 113.798 -163.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -91.66 116.86 67.27 Favored Pre-proline 0 CA--C 1.577 1.994 0 O-C-N 121.665 -0.647 . . . . 0.0 110.902 161.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.91 128.51 9.26 Favored 'Trans proline' 0 CA--C 1.561 1.836 0 C-N-CA 122.492 2.128 . . . . 0.0 112.735 168.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 56.2 m -85.68 115.93 23.65 Favored 'General case' 0 CA--C 1.562 1.441 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.9 t -102.83 94.25 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -173.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.52 102.58 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.957 -1.089 . . . . 0.0 108.108 -175.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.5 mt -91.15 128.41 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.3 p -142.62 157.49 44.64 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.388 0.675 . . . . 0.0 111.917 -177.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -114.91 111.12 20.68 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.246 -0.909 . . . . 0.0 108.644 166.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -82.01 -57.45 3.4 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -177.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.24 87.61 0.14 Allowed Glycine 0 N--CA 1.483 1.83 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.292 12.0 t70 70.93 -57.43 0.6 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -164.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -78.89 152.92 30.92 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -175.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.1 t -89.48 126.07 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.6 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.872 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.7 t -112.23 109.73 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.3 mt -99.85 130.11 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 174.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.8 mtt85 -107.8 107.8 18.72 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.344 0.658 . . . . 0.0 110.072 173.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.1 m -91.63 103.51 16.09 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.519 -0.738 . . . . 0.0 109.302 173.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 65.2 mt -125.73 119.96 29.35 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 122.817 0.447 . . . . 0.0 110.873 -169.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.26 178.44 6.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.987 -1.071 . . . . 0.0 110.498 159.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.7 p -77.99 48.56 0.73 Allowed 'General case' 0 N--CA 1.51 2.572 0 O-C-N 119.594 -1.941 . . . . 0.0 114.089 173.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -165.79 -58.12 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 125.152 1.381 . . . . 0.0 109.419 -165.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -131.84 132.14 43.43 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.206 1.002 . . . . 0.0 109.285 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -134.06 97.77 3.96 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -172.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.2 t -127.93 128.7 45.58 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 123.178 0.591 . . . . 0.0 111.076 -175.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -119.76 138.85 53.08 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.2 pt -135.28 116.37 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-O 121.313 0.578 . . . . 0.0 111.055 -163.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.1 p -100.63 121.93 42.45 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.064 0.946 . . . . 0.0 112.048 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -147.86 139.2 23.6 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -173.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -81.59 6.86 13.72 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.258 50.9 mt 70.29 105.63 0.06 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 125.188 1.395 . . . . 0.0 111.746 -168.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.69 0.88 89.22 Favored Glycine 0 CA--C 1.556 2.636 0 N-CA-C 119.139 2.416 . . . . 0.0 119.139 -161.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -81.97 122.77 28.2 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-N 120.179 1.99 . . . . 0.0 111.136 174.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -86.45 113.37 22.33 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 122.711 0.405 . . . . 0.0 110.944 172.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -125.25 146.33 49.58 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.842 0.857 . . . . 0.0 111.541 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.98 139.9 36.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.743 -1.223 . . . . 0.0 112.507 168.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -146.5 130.78 17.53 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.192 0.52 . . . . 0.0 110.516 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.4 m -71.47 124.91 25.68 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-O 121.694 0.759 . . . . 0.0 110.656 164.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.1 p -96.65 174.94 6.57 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -176.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.52 -17.63 14.78 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 119.386 3.106 . . . . 0.0 119.386 166.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -81.59 -5.64 58.23 Favored 'General case' 0 CA--C 1.58 2.118 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 161.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.273 23.2 t70 65.34 66.16 0.55 Allowed 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 121.151 1.796 . . . . 0.0 112.992 -170.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -154.55 138.47 16.32 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.87 0.868 . . . . 0.0 109.467 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -79.52 114.9 18.81 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 174.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 2.4 p -99.64 122.83 43.25 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.854 -0.529 . . . . 0.0 112.241 173.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -72.83 96.95 2.15 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.7 m -109.17 118.23 36.21 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.025 -160.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.5 p -121.79 119.88 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.2 t -107.29 118.22 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.486 -0.759 . . . . 0.0 109.686 -173.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.9 m -111.95 125.99 54.64 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.36 0.664 . . . . 0.0 111.568 -177.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.4 tt -83.73 99.66 10.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.428 -0.795 . . . . 0.0 109.825 170.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -91.51 78.44 5.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.454 -0.779 . . . . 0.0 110.651 -175.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.88 -79.24 1.6 Allowed Glycine 0 N--CA 1.492 2.424 0 O-C-N 121.3 -0.875 . . . . 0.0 114.541 -174.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -139.9 60.17 1.56 Allowed 'General case' 0 CA--C 1.572 1.796 0 C-N-CA 122.877 0.471 . . . . 0.0 110.063 164.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -156.9 106.98 2.28 Favored 'General case' 0 CA--C 1.566 1.559 0 O-C-N 121.315 -0.866 . . . . 0.0 109.307 -168.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.0 mt -86.94 101.0 13.0 Favored 'General case' 0 CA--C 1.57 1.719 0 O-C-N 121.349 -0.845 . . . . 0.0 112.373 -174.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.9 t -102.45 102.82 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.132 -0.98 . . . . 0.0 109.025 -171.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -88.12 106.24 18.04 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 123.197 0.599 . . . . 0.0 110.759 177.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.6 mt -92.81 107.23 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -90.88 125.25 35.69 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 118.948 0.794 . . . . 0.0 110.951 171.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -120.77 126.27 49.71 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.396 0.679 . . . . 0.0 110.832 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.0 p90 -152.73 123.72 7.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.943 -1.098 . . . . 0.0 110.483 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 54.31 33.46 18.41 Favored 'General case' 0 N--CA 1.51 2.566 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.93 -26.34 4.88 Favored Glycine 0 CA--C 1.557 2.702 0 N-CA-C 118.809 2.284 . . . . 0.0 118.809 -164.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -75.92 143.59 41.57 Favored 'General case' 0 CA--C 1.566 1.583 0 CA-C-N 119.494 1.647 . . . . 0.0 113.002 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -132.48 134.21 44.76 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.361 0.664 . . . . 0.0 111.039 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.8 t -132.94 130.85 40.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.676 -0.64 . . . . 0.0 111.455 162.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -107.73 130.66 54.93 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 123.16 0.584 . . . . 0.0 112.299 174.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -107.34 103.81 13.26 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.8 t -92.22 94.14 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -170.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.9 mtt85 -81.86 115.2 20.95 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.997 0.919 . . . . 0.0 111.294 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -127.26 144.46 51.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.681 -0.637 . . . . 0.0 111.637 172.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.2 mm -83.75 116.12 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.186 -0.946 . . . . 0.0 109.054 174.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.72 85.4 2.24 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.9 t70 49.69 61.54 3.11 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -178.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.92 -44.07 1.86 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 117.135 1.614 . . . . 0.0 117.135 -173.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -85.8 151.56 23.72 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 118.655 1.227 . . . . 0.0 113.121 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 38.7 tpp -85.73 116.96 24.31 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 160.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.4 t -94.09 106.8 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 165.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 18.2 ttt -102.05 111.51 23.81 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.5 m -100.75 106.8 18.25 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -177.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.0 mp -101.02 105.82 17.06 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -174.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.3 t -106.07 139.15 41.05 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.772 0.796 . . . . 0.0 112.052 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -101.09 79.61 2.03 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 162.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 70.37 -94.6 0.48 Allowed Glycine 0 N--CA 1.489 2.211 0 O-C-N 121.663 -0.648 . . . . 0.0 113.322 -163.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -127.99 57.16 1.56 Allowed 'General case' 0 CA--C 1.573 1.845 0 C-N-CA 122.972 0.509 . . . . 0.0 111.938 169.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.2 t -136.13 110.41 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 170.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.3 t -117.63 125.18 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.671 -0.643 . . . . 0.0 111.203 -151.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -107.37 124.97 50.6 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.317 0.647 . . . . 0.0 112.054 165.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.2 t -109.19 105.4 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.318 -0.864 . . . . 0.0 108.809 -174.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 -103.49 114.1 28.11 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 123.898 0.879 . . . . 0.0 111.495 -173.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -96.61 116.54 29.27 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.53 0.732 . . . . 0.0 111.244 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -110.37 138.68 46.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.528 -0.733 . . . . 0.0 111.283 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -99.18 152.78 19.5 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.682 0.753 . . . . 0.0 112.453 167.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -72.46 128.98 37.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.795 -0.566 . . . . 0.0 111.998 171.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.631 179.964 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.507 0.67 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -74.34 -52.68 11.5 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -171.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.58 -25.36 52.26 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 117.963 2.579 . . . . 0.0 117.963 168.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -82.92 -15.81 49.91 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 171.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 41.5 t -79.98 92.79 5.61 Favored 'General case' 0 CA--C 1.565 1.531 0 CA-C-N 121.472 1.942 . . . . 0.0 113.725 -169.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -166.61 168.53 14.46 Favored 'General case' 0 CA--C 1.569 1.687 0 C-N-CA 124.118 0.967 . . . . 0.0 111.826 -174.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.1 m -78.32 124.05 27.66 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.973 -1.079 . . . . 0.0 108.884 159.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -113.09 119.66 38.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 110.66 -177.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -99.85 129.93 45.99 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.81 0.844 . . . . 0.0 111.023 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tt -73.18 121.25 19.99 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -176.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.3 p -92.41 -50.29 5.71 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 175.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -141.74 117.35 10.32 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 119.254 0.934 . . . . 0.0 109.934 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.1 p -107.01 109.04 20.83 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.486 0.714 . . . . 0.0 112.82 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -94.16 131.15 39.99 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.468 0.707 . . . . 0.0 111.454 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.284 3.9 t-20 61.31 25.82 15.73 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 118.359 2.726 . . . . 0.0 118.359 176.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -70.23 -42.8 71.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 119.794 -1.817 . . . . 0.0 115.537 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -49.51 -53.63 22.32 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 169.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.69 -39.06 84.45 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -53.22 -55.77 21.72 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 162.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 74.3 mtm -54.51 -48.57 71.76 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 173.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -41.93 90.07 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 172.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.77 -35.67 81.37 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 117.251 2.315 . . . . 0.0 117.251 167.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 tp -67.72 -27.09 66.51 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.81 65.41 0.65 Allowed Glycine 0 N--CA 1.484 1.863 0 C-N-CA 123.675 0.655 . . . . 0.0 114.202 -173.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.429 HG21 ' HB3' ' A' ' 30' ' ' ARG . 23.8 m -105.56 145.82 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 C-N-CA 123.501 0.721 . . . . 0.0 111.865 168.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.54 176.07 51.07 Favored Glycine 0 N--CA 1.49 2.281 0 O-C-N 121.367 -0.833 . . . . 0.0 114.276 152.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -77.3 61.62 2.19 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 123.071 1.415 . . . . 0.0 113.384 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -158.21 -61.75 0.08 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.049 1.34 . . . . 0.0 109.055 -175.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.8 m -57.44 -42.0 81.57 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 164.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.429 ' HB3' HG21 ' A' ' 25' ' ' VAL . 7.2 ptm180 -61.44 -38.53 87.53 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 164.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -62.9 -42.32 99.74 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 120.469 1.486 . . . . 0.0 114.902 170.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 70.4 t -48.12 -65.28 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 CA-C-N 119.84 1.2 . . . . 0.0 112.796 160.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.19 -33.91 61.9 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 119.782 2.673 . . . . 0.0 119.782 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -67.97 -46.46 71.3 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 169.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.8 m -79.7 -30.8 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.4 t -120.77 153.78 36.57 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 120.293 1.406 . . . . 0.0 113.579 -167.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.0 111.83 60.28 Favored Pre-proline 0 CA--C 1.575 1.933 0 CA-C-O 117.883 -1.056 . . . . 0.0 111.494 178.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.57 123.99 8.51 Favored 'Trans proline' 0 CA--C 1.559 1.763 0 CA-C-N 123.523 2.294 . . . . 0.0 115.424 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.4 m -96.69 118.76 33.84 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.097 0.959 . . . . 0.0 108.483 -175.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.5 t -106.11 105.44 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -169.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.5 mt -95.35 103.45 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -85.5 111.46 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 171.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.5 p -127.71 122.81 33.87 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.097 0.559 . . . . 0.0 111.358 -172.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -89.21 99.06 12.13 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -98.15 -44.52 6.57 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -161.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.06 104.83 0.19 Allowed Glycine 0 N--CA 1.483 1.82 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -173.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.292 13.8 t70 71.66 -52.34 0.69 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -165.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -126.59 162.09 26.51 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 122.562 1.172 . . . . 0.0 113.881 -163.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.9 t -86.06 122.8 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.6 t -115.47 108.15 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 -175.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 56.6 mt -91.85 117.35 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 173.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -97.58 102.16 13.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 169.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.4 m -88.56 104.78 17.15 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.2 mt -102.94 99.46 9.36 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.6 t -87.74 39.3 0.88 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 171.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.328 69.8 p 64.0 -58.71 0.2 Allowed 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -172.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -93.47 -44.35 8.28 Favored 'General case' 0 CA--C 1.574 1.872 0 C-N-CA 125.413 1.485 . . . . 0.0 112.652 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -100.02 117.81 35.08 Favored 'General case' 0 CA--C 1.566 1.588 0 C-N-CA 124.094 0.958 . . . . 0.0 110.817 -176.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -98.57 104.08 16.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.59 -0.694 . . . . 0.0 109.86 168.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.252 5.0 t -103.15 82.6 2.09 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.902 0.858 . . . . 0.0 110.495 169.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.95 131.19 34.7 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 pt -131.62 130.55 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 123.366 0.666 . . . . 0.0 111.364 -170.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 90.2 p -116.87 131.64 56.9 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 123.881 0.872 . . . . 0.0 111.922 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -158.84 144.86 16.72 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.141 -0.974 . . . . 0.0 113.307 -169.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -94.4 26.5 3.36 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 175.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 69.2 mt 69.02 108.31 0.05 Allowed 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 125.203 1.401 . . . . 0.0 113.547 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.41 -10.49 58.85 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 118.656 2.222 . . . . 0.0 118.656 -162.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -73.72 123.85 24.9 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 118.962 1.381 . . . . 0.0 112.327 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -76.0 122.08 23.68 Favored 'General case' 0 CA--C 1.566 1.558 0 CA-C-O 121.306 0.574 . . . . 0.0 111.317 168.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -124.81 154.54 40.82 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.84 0.856 . . . . 0.0 110.586 173.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.09 136.7 32.85 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.951 -1.093 . . . . 0.0 110.973 171.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -134.45 108.79 8.34 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.904 0.482 . . . . 0.0 110.194 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 88.5 m -79.51 102.37 8.77 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 167.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.9 p -82.08 171.04 14.82 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -167.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.56 -13.53 2.45 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 119.834 3.272 . . . . 0.0 119.834 169.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.42 -16.09 50.27 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 163.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.306 28.6 m-20 73.94 72.17 0.12 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 125.073 1.349 . . . . 0.0 111.995 -160.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -157.01 129.12 7.28 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 124.128 0.971 . . . . 0.0 108.427 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -84.93 115.28 22.7 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 123.268 0.627 . . . . 0.0 112.077 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 72.8 m -110.58 119.72 40.08 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -174.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -71.06 105.87 3.5 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.381 0.61 . . . . 0.0 109.754 165.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.1 m -117.89 119.09 33.81 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.779 -158.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.2 t -117.23 117.77 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.75 108.19 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.391 -0.818 . . . . 0.0 109.598 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 86.5 p -106.78 126.36 52.19 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 123.682 0.793 . . . . 0.0 112.697 -177.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.8 tt -83.33 102.83 12.26 Favored 'General case' 0 CA--C 1.569 1.698 0 C-N-CA 123.21 0.604 . . . . 0.0 110.824 172.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -92.47 76.41 5.12 Favored 'General case' 0 CA--C 1.57 1.719 0 O-C-N 121.107 -0.995 . . . . 0.0 111.443 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.07 -74.67 2.4 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 115.022 0.769 . . . . 0.0 115.022 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.09 65.66 1.21 Allowed 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 122.415 1.102 . . . . 0.0 110.632 153.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -147.5 106.61 3.87 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 mt -89.04 100.1 12.95 Favored 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 123.443 0.697 . . . . 0.0 110.684 -172.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.7 t -106.21 104.01 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -167.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -87.44 102.11 14.23 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 123.387 0.675 . . . . 0.0 111.419 176.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.3 mt -91.23 103.63 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -177.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -90.06 127.42 36.07 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 118.788 0.722 . . . . 0.0 111.114 171.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -121.18 120.39 35.08 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 123.193 0.597 . . . . 0.0 110.887 176.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -145.46 126.91 15.0 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.369 -0.832 . . . . 0.0 110.242 -175.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 55.14 31.92 17.34 Favored 'General case' 0 N--CA 1.511 2.58 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 174.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.9 -21.29 7.99 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 119.166 2.426 . . . . 0.0 119.166 -163.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -86.01 141.38 29.53 Favored 'General case' 0 CA--C 1.57 1.712 0 CA-C-N 119.016 1.408 . . . . 0.0 111.509 -177.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -134.88 125.19 26.27 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.482 0.713 . . . . 0.0 111.023 -173.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.4 t -122.48 144.33 49.13 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.335 0.654 . . . . 0.0 110.733 167.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.279 9.7 p30 -124.9 127.95 47.89 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-O 121.321 0.581 . . . . 0.0 112.415 174.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.3 101.24 12.64 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -174.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.5 t -92.43 96.55 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -168.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 -85.03 107.69 17.27 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.499 0.72 . . . . 0.0 110.181 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.91 129.62 48.54 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 123.035 0.534 . . . . 0.0 111.723 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.2 mm -81.45 120.2 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.339 -0.851 . . . . 0.0 110.177 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.75 89.52 3.13 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.7 t70 51.12 67.1 1.0 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.0 -48.46 3.23 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 117.38 1.712 . . . . 0.0 117.38 -174.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -86.32 143.94 27.63 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 118.643 1.222 . . . . 0.0 112.309 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 32.5 ttm -88.35 118.81 28.23 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-O 121.714 0.769 . . . . 0.0 109.823 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.6 t -89.08 100.51 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 169.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 36.5 ttm -94.94 100.41 12.27 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.369 0.604 . . . . 0.0 110.182 -173.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 84.3 m -98.02 99.79 11.08 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.813 0.816 . . . . 0.0 108.976 -172.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.5 mp -89.98 105.17 17.63 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.8 t -108.3 116.34 31.78 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.52 0.676 . . . . 0.0 110.993 -176.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -97.13 79.75 2.87 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 121.267 0.556 . . . . 0.0 109.509 166.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 63.16 -98.04 0.21 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 115.434 0.934 . . . . 0.0 115.434 -175.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -86.7 -17.21 34.25 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 169.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.8 t -91.96 101.63 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-N 121.774 2.079 . . . . 0.0 108.481 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 57.8 t -104.07 115.19 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -171.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.64 129.16 55.99 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.809 -0.557 . . . . 0.0 112.015 177.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.5 t -115.8 118.56 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.483 -0.761 . . . . 0.0 109.157 -168.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -111.25 125.55 53.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.415 -0.803 . . . . 0.0 111.505 175.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -95.84 109.47 21.8 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.893 0.477 . . . . 0.0 110.291 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -109.63 129.12 55.62 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 123.551 0.74 . . . . 0.0 112.295 -168.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -97.23 150.92 20.37 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 124.2 1.0 . . . . 0.0 112.836 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -74.78 134.52 41.8 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.3 -0.875 . . . . 0.0 113.134 172.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.519 0 C-N-CA 124.101 0.961 . . . . 0.0 111.63 161.441 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.309 8.6 p . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -64.06 -32.26 73.75 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 117.206 2.299 . . . . 0.0 117.206 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.81 -31.33 48.73 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 117.964 2.579 . . . . 0.0 117.964 164.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -75.5 -18.21 59.89 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.779 2.141 . . . . 0.0 116.779 168.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 93.8 m -76.47 97.72 4.4 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 122.383 2.356 . . . . 0.0 113.417 -175.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.09 167.65 14.3 Favored 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 124.376 1.07 . . . . 0.0 111.556 -174.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 98.6 m -81.53 114.54 20.32 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.195 -0.941 . . . . 0.0 109.162 163.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -106.03 115.06 29.58 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.758 -0.589 . . . . 0.0 110.204 -176.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -95.98 132.97 40.75 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.328 0.651 . . . . 0.0 110.842 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -71.07 127.84 33.92 Favored 'General case' 0 CA--C 1.565 1.526 0 CA-C-O 122.303 1.049 . . . . 0.0 113.322 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.1 p -98.92 -39.98 8.3 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 176.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -154.73 121.29 5.4 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 119.534 1.061 . . . . 0.0 109.598 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.2 p -101.39 96.32 7.08 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.23 0.612 . . . . 0.0 111.741 174.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -72.62 124.52 25.44 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.386 0.675 . . . . 0.0 111.805 174.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.274 4.4 t-20 51.04 27.37 3.25 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 119.133 3.012 . . . . 0.0 119.133 177.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -70.92 -46.04 63.2 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -173.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -49.79 -50.06 46.22 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 168.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -58.19 -42.28 85.78 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 170.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -58.55 -48.61 80.3 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 165.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.2 mtp -57.39 -47.04 82.72 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -61.07 -42.28 98.2 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 166.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.52 -43.53 98.69 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 171.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.1 tp -62.24 -17.27 57.9 Favored 'General case' 0 CA--C 1.58 2.105 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 166.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.92 52.15 3.2 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 116.287 1.275 . . . . 0.0 116.287 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.268 9.5 m -92.65 143.51 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 118.57 1.185 . . . . 0.0 113.028 176.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.64 166.22 17.06 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 116.99 1.556 . . . . 0.0 116.99 166.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -64.51 -43.95 92.47 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.85 -46.6 87.35 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 166.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.4 m -58.14 -39.36 78.56 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 172.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.347 0.2 OUTLIER -62.38 -37.74 86.93 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 167.689 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -57.93 -47.19 83.59 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 120.999 1.727 . . . . 0.0 114.592 162.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 70.0 t -56.87 -34.26 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 117.125 2.268 . . . . 0.0 117.125 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.67 -16.64 41.59 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 119.377 2.511 . . . . 0.0 119.377 166.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -88.23 -44.22 11.02 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.573 2.187 . . . . 0.0 114.43 171.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.0 m -93.78 42.71 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 CA-C-N 122.032 2.196 . . . . 0.0 114.041 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.3 m -175.97 145.69 0.66 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.244 1.418 . . . . 0.0 107.892 -176.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -86.8 104.56 6.09 Favored Pre-proline 0 CA--C 1.576 1.977 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.574 170.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.63 113.22 3.74 Favored 'Trans proline' 0 C--N 1.374 1.883 0 CA-C-N 123.158 2.164 . . . . 0.0 112.298 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 93.1 m -95.95 115.29 27.21 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.501 -161.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -92.25 99.69 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -169.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.7 mt -93.21 99.91 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 62.0 mt -89.11 124.97 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.2 p -146.87 116.61 7.16 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.842 -0.536 . . . . 0.0 111.552 -168.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -84.27 117.97 23.89 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.945 -1.097 . . . . 0.0 112.024 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -109.4 82.58 1.62 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.936 0.874 . . . . 0.0 109.424 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.9 -100.58 1.48 Allowed Glycine 0 N--CA 1.489 2.18 0 O-C-N 121.884 -0.51 . . . . 0.0 114.219 -175.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -94.58 -24.44 17.22 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 173.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -98.37 146.32 25.82 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 120.786 1.63 . . . . 0.0 112.941 -174.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.65 115.11 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.671 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 170.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.9 t -99.85 106.35 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.0 mt -95.71 117.84 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 175.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -106.38 95.61 5.88 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.946 174.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.7 m -89.69 101.52 14.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.658 -0.651 . . . . 0.0 109.601 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.4 mt -107.47 105.25 15.07 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.275 -168.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 m -79.96 152.0 29.76 Favored 'General case' 0 CA--C 1.568 1.642 0 O-C-N 121.424 -0.798 . . . . 0.0 110.425 151.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.5 p -38.39 -51.13 1.54 Allowed 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 160.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -80.45 -47.51 14.22 Favored 'General case' 0 CA--C 1.572 1.804 0 C-N-CA 124.379 1.072 . . . . 0.0 113.599 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -115.0 109.77 18.6 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.845 0.858 . . . . 0.0 111.062 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -95.14 89.84 5.68 Favored 'General case' 0 CA--C 1.566 1.568 0 C-N-CA 123.193 0.597 . . . . 0.0 110.366 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.3 p -92.93 146.9 23.28 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -171.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -150.21 116.28 5.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.196 -0.94 . . . . 0.0 112.036 -166.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.2 pt -129.27 116.51 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.668 -0.645 . . . . 0.0 111.93 -175.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.8 p -103.58 113.17 26.48 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.24 1.016 . . . . 0.0 111.975 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -147.29 150.15 34.24 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.829 0.823 . . . . 0.0 113.119 -169.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -86.92 149.37 24.85 Favored 'General case' 0 CA--C 1.572 1.808 0 O-C-N 121.028 -1.045 . . . . 0.0 111.018 162.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.8 mt -68.21 123.97 22.16 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.059 -1.651 . . . . 0.0 112.546 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.38 -16.76 60.63 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 118.707 2.243 . . . . 0.0 118.707 -162.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -80.91 125.82 30.6 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-N 119.935 1.867 . . . . 0.0 112.005 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -86.62 127.69 34.94 Favored 'General case' 0 CA--C 1.569 1.693 0 CA-C-O 121.291 0.567 . . . . 0.0 111.901 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -133.93 148.64 51.22 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.154 0.982 . . . . 0.0 111.331 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.09 131.99 37.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.482 -1.387 . . . . 0.0 111.435 171.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -126.46 104.11 7.97 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.041 0.537 . . . . 0.0 110.139 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.4 m -74.1 104.52 4.95 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.223 1.011 . . . . 0.0 110.033 171.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 75.3 p -84.48 172.79 11.38 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -168.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.56 -6.73 0.76 Allowed 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 119.589 3.181 . . . . 0.0 119.589 166.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -96.45 0.43 50.37 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 160.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.313 18.3 t70 63.48 27.2 15.08 Favored 'General case' 0 CA--C 1.582 2.19 0 N-CA-C 116.949 2.203 . . . . 0.0 116.949 -166.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 -94.02 131.6 39.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.574 -1.329 . . . . 0.0 109.196 162.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.298 0.3 OUTLIER -88.72 108.93 19.74 Favored 'General case' 0 CA--C 1.569 1.676 0 CA-C-O 121.041 0.448 . . . . 0.0 110.361 171.493 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 92.4 m -95.33 120.82 36.23 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -173.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -69.88 100.12 1.51 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.811 0.815 . . . . 0.0 109.953 171.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.4 m -114.89 112.67 23.08 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.114 -156.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.8 p -111.71 119.12 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.368 0.604 . . . . 0.0 109.618 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.4 t -105.1 119.85 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -174.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.4 p -130.26 127.68 40.05 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.414 0.685 . . . . 0.0 111.661 -177.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 tt -91.12 111.28 22.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.133 -0.979 . . . . 0.0 110.632 177.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -113.7 74.92 0.89 Allowed 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 123.203 0.601 . . . . 0.0 111.373 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 65.84 77.9 0.25 Allowed Glycine 0 N--CA 1.496 2.678 0 N-CA-C 116.623 1.409 . . . . 0.0 116.623 172.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.271 23.4 t0 62.81 11.87 5.29 Favored 'General case' 0 CA--C 1.582 2.194 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 -164.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.7 mtmt -128.2 105.58 8.45 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 120.914 1.688 . . . . 0.0 109.532 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.78 93.45 8.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -0.968 . . . . 0.0 109.965 177.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 22.3 t -97.03 107.87 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.036 -1.04 . . . . 0.0 108.973 -166.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -93.26 103.25 15.52 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.576 0.75 . . . . 0.0 110.38 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.2 mt -92.84 105.04 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -176.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -94.29 122.06 36.45 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 118.561 0.619 . . . . 0.0 110.672 173.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -118.36 127.18 53.44 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.366 0.666 . . . . 0.0 110.442 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.4 p90 -149.49 122.68 8.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.03 -1.044 . . . . 0.0 110.055 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 54.85 36.65 27.05 Favored 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 176.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.92 -24.94 4.93 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 118.985 2.354 . . . . 0.0 118.985 -164.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -81.2 144.4 31.64 Favored 'General case' 0 CA--C 1.565 1.552 0 CA-C-N 119.075 1.437 . . . . 0.0 112.84 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -134.45 132.72 39.65 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.316 0.646 . . . . 0.0 111.287 -176.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.7 t -126.2 134.15 51.33 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 161.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -119.97 123.5 43.66 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.934 0.494 . . . . 0.0 110.813 176.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -102.72 108.9 20.32 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -171.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.0 t -92.8 96.39 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -174.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -88.32 116.88 26.85 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -133.3 133.53 42.7 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.8 mm -76.69 114.74 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -148.38 124.11 10.51 Favored 'General case' 0 CA--C 1.565 1.544 0 C-N-CA 124.225 1.01 . . . . 0.0 108.717 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 t70 55.85 50.5 13.93 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.27 18.68 65.47 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 119.66 2.624 . . . . 0.0 119.66 -172.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -144.31 152.02 40.18 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.486 1.143 . . . . 0.0 110.184 -169.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 7.7 ttm -85.2 115.32 22.92 Favored 'General case' 0 CA--C 1.564 1.516 0 O-C-N 121.26 -0.9 . . . . 0.0 108.984 159.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.9 t -88.46 105.42 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 27.2 ttt -95.22 103.22 15.07 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.771 -0.58 . . . . 0.0 110.3 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 92.1 m -92.33 115.19 27.87 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.656 0.741 . . . . 0.0 109.405 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mp -105.41 105.82 16.04 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -174.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.9 t -121.95 125.79 47.15 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 119.098 0.863 . . . . 0.0 113.321 -175.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -109.04 92.29 3.99 Favored 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 123.802 0.841 . . . . 0.0 108.758 171.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 69.5 -82.26 0.28 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 115.9 1.12 . . . . 0.0 115.9 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -121.72 -7.21 9.08 Favored 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 167.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.7 t -87.66 116.36 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-N 121.748 2.067 . . . . 0.0 108.565 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.1 t -115.4 121.0 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 C-N-CA 123.482 0.713 . . . . 0.0 109.655 -169.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -107.29 157.9 17.56 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 123.281 0.633 . . . . 0.0 112.446 161.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.4 t -132.44 110.59 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.01 -1.056 . . . . 0.0 109.274 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -97.5 121.26 39.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.028 -1.045 . . . . 0.0 111.273 174.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -99.37 110.56 23.05 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.427 0.691 . . . . 0.0 109.937 -171.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -110.61 128.01 55.49 Favored 'General case' 0 CA--C 1.563 1.454 0 O-C-N 121.378 -0.826 . . . . 0.0 111.99 -168.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -103.07 154.26 19.45 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 123.246 0.618 . . . . 0.0 112.543 168.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -74.1 134.97 42.93 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.251 -0.906 . . . . 0.0 113.027 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.519 0 C-N-CA 123.799 0.84 . . . . 0.0 111.837 168.948 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 CA--C 1.569 1.68 0 CA-C-O 121.615 0.722 . . . . 0.0 112.073 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.329 17.5 tt0 73.6 -55.51 0.67 Allowed 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.31 -26.57 61.12 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 165.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -71.18 -22.75 61.99 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 116.801 2.149 . . . . 0.0 116.801 165.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.7 m -83.67 100.42 10.85 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 120.83 1.65 . . . . 0.0 113.218 -174.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -165.38 171.93 12.84 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-O 122.222 1.011 . . . . 0.0 111.802 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 94.8 m -81.89 118.24 22.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.013 -1.054 . . . . 0.0 109.274 165.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -113.57 121.86 45.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.403 -0.811 . . . . 0.0 112.333 -170.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -96.79 124.97 40.92 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.467 1.107 . . . . 0.0 110.459 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tt -71.82 112.9 8.31 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.079 -1.013 . . . . 0.0 112.484 176.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.4 p -90.42 -46.22 8.49 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -143.93 136.19 26.7 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 119.193 0.906 . . . . 0.0 110.276 -175.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.3 p -118.8 136.98 53.71 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -94.2 -126.44 0.11 Allowed 'General case' 0 CA--C 1.573 1.848 0 O-C-N 121.611 -0.681 . . . . 0.0 110.326 172.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -83.82 54.05 2.76 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 119.571 -1.956 . . . . 0.0 114.848 -172.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -74.04 -36.18 64.37 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -48.35 -56.24 8.62 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 174.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -65.59 -42.32 91.81 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 169.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -52.91 -47.48 67.95 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 171.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 78.1 mtm -59.74 -48.68 80.72 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.06 -46.99 72.09 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 167.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.2 90.2 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 173.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mp -63.25 -35.9 81.88 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 166.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.11 41.42 0.9 Allowed Glycine 0 N--CA 1.487 2.051 0 N-CA-C 117.197 1.639 . . . . 0.0 117.197 177.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.5 m -71.22 158.06 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-N 119.323 1.561 . . . . 0.0 113.288 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.5 157.83 49.69 Favored Glycine 0 CA--C 1.553 2.437 0 O-C-N 120.767 -1.208 . . . . 0.0 115.89 162.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -64.57 -38.49 91.2 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.28 -44.33 97.41 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 160.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.7 m -58.54 -43.35 89.25 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -57.81 -47.98 81.06 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 167.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -63.04 -43.78 97.7 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 172.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.9 t -49.84 -61.15 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 163.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.93 -34.92 62.25 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 119.173 2.429 . . . . 0.0 119.173 174.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -66.33 -43.14 86.98 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 170.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.0 m -78.53 -33.35 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 116.361 1.985 . . . . 0.0 116.361 176.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 t -94.46 136.05 35.2 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 120.318 1.417 . . . . 0.0 113.997 -162.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -92.93 109.26 38.2 Favored Pre-proline 0 CA--C 1.576 1.96 0 CA-C-O 118.338 -0.839 . . . . 0.0 110.937 167.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.55 138.68 24.56 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 C-N-CA 122.635 2.223 . . . . 0.0 113.854 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.4 m -85.62 102.49 13.61 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.71 100.2 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -169.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.9 mt -90.82 102.75 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.175 -0.953 . . . . 0.0 108.529 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.5 mt -93.01 125.96 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.9 p -148.91 126.79 11.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.41 -0.806 . . . . 0.0 112.298 -169.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -81.42 109.32 15.79 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.682 -1.261 . . . . 0.0 110.426 168.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -104.11 86.66 2.6 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -173.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.19 -73.69 2.31 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 115.5 0.96 . . . . 0.0 115.5 -174.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -122.52 -53.85 1.88 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.889 0.876 . . . . 0.0 112.088 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -80.66 151.92 28.72 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -172.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.2 t -85.21 121.12 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.2 t -111.5 108.18 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.3 mt -89.75 116.11 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 172.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.8 mtm-85 -100.11 104.3 15.84 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 119.493 1.042 . . . . 0.0 109.73 169.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.7 m -90.11 102.52 15.24 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 77.3 mt -120.08 94.82 4.51 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 122.585 0.354 . . . . 0.0 110.397 -169.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.0 p -93.05 171.04 9.2 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.86 -1.15 . . . . 0.0 112.021 165.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.5 t -72.2 31.59 0.06 Allowed 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 165.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -155.68 -60.57 0.11 Allowed 'General case' 0 CA--C 1.571 1.756 0 C-N-CA 125.182 1.393 . . . . 0.0 109.404 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 46.7 mmtt -109.9 123.37 49.49 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.403 1.081 . . . . 0.0 109.902 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -124.14 98.29 5.71 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 123.337 0.655 . . . . 0.0 110.683 176.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.0 t -129.98 166.97 18.98 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 123.507 0.723 . . . . 0.0 112.054 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -138.18 153.0 49.2 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.9 mt -124.02 104.36 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.629 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -177.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 91.2 p -99.95 114.9 28.49 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.79 0.836 . . . . 0.0 112.178 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -145.14 152.93 40.81 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -171.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -103.68 141.98 35.12 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 123.463 0.705 . . . . 0.0 109.325 168.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -67.38 129.25 39.32 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.634 -1.291 . . . . 0.0 113.908 -173.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.79 -15.69 45.98 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 119.141 2.416 . . . . 0.0 119.141 -167.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -91.53 127.3 36.92 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 119.945 1.873 . . . . 0.0 111.58 -173.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -79.71 126.66 31.23 Favored 'General case' 0 CA--C 1.569 1.68 0 C-N-CA 122.885 0.474 . . . . 0.0 111.917 177.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -140.25 149.6 43.05 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.447 0.699 . . . . 0.0 111.916 -171.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -78.81 138.11 38.03 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.788 -1.195 . . . . 0.0 113.035 174.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -146.3 132.41 19.34 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.198 0.599 . . . . 0.0 110.959 174.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.3 m -98.51 119.77 37.78 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.487 0.66 . . . . 0.0 109.457 170.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 44.7 p -90.34 172.24 8.89 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -168.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.27 -21.37 33.91 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 118.595 2.813 . . . . 0.0 118.595 165.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -65.73 -14.68 61.78 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 158.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.291 10.1 m-20 62.38 46.86 5.58 Favored 'General case' 0 CA--C 1.574 1.873 0 CA-C-N 120.245 1.384 . . . . 0.0 114.69 -164.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.18 131.83 53.83 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.666 1.186 . . . . 0.0 108.702 172.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -86.78 120.31 27.94 Favored 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 122.806 0.442 . . . . 0.0 111.716 173.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.6 p -119.72 143.8 47.58 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.49 0.662 . . . . 0.0 112.725 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -79.13 105.11 10.23 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 121.966 0.889 . . . . 0.0 109.15 157.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.2 m -98.55 136.76 38.2 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.636 0.775 . . . . 0.0 112.245 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.6 p -134.3 129.89 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 123.537 0.735 . . . . 0.0 109.35 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.4 t -118.41 119.14 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.104 -0.998 . . . . 0.0 109.428 -169.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.7 p -117.69 131.62 56.6 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.576 0.75 . . . . 0.0 112.191 -176.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 tt -99.93 108.21 20.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.903 . . . . 0.0 110.301 177.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -88.78 -21.38 23.82 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 116.946 2.202 . . . . 0.0 116.946 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -178.43 -93.53 0.09 OUTLIER Glycine 0 N--CA 1.49 2.251 0 CA-C-N 120.289 1.404 . . . . 0.0 111.108 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -107.41 60.54 0.62 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 117.842 0.821 . . . . 0.0 109.915 151.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -155.25 114.76 3.67 Favored 'General case' 0 CA--C 1.563 1.46 0 O-C-N 121.416 -0.803 . . . . 0.0 110.576 174.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.5 mt -84.7 118.87 24.68 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.722 -0.611 . . . . 0.0 109.57 166.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.2 t -105.98 99.65 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -178.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -90.68 103.66 16.34 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.411 0.684 . . . . 0.0 110.151 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.3 mt -93.91 117.06 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -175.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -108.68 120.56 42.84 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 119.005 0.82 . . . . 0.0 110.464 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -112.41 120.82 42.98 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.889 0.876 . . . . 0.0 110.663 -176.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -151.58 134.28 15.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.395 -0.815 . . . . 0.0 110.591 -175.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 50.48 43.02 27.19 Favored 'General case' 0 N--CA 1.509 2.489 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 166.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.67 22.2 76.64 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 119.82 2.688 . . . . 0.0 119.82 -167.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -137.25 137.4 39.01 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 119.257 1.529 . . . . 0.0 109.506 -168.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -131.66 125.57 32.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.609 -0.682 . . . . 0.0 111.197 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.8 t -125.76 137.86 53.83 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.56 0.744 . . . . 0.0 110.377 175.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.258 11.6 p30 -120.11 135.34 54.99 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.81 105.19 15.55 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -174.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.5 t -89.91 95.88 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 CA-C-N 119.681 1.128 . . . . 0.0 108.199 -178.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.4 ' CG ' ' SD ' ' A' ' 113' ' ' MET . 41.8 ttm180 -95.35 106.25 18.28 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.021 0.928 . . . . 0.0 111.059 -173.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -126.34 144.38 50.83 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.179 0.592 . . . . 0.0 112.568 -176.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.6 mm -82.99 120.35 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -127.91 98.48 5.17 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.7 t70 53.15 58.26 5.46 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -176.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.19 -48.97 3.22 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 116.883 1.513 . . . . 0.0 116.883 -172.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -80.84 145.37 31.43 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 118.265 1.033 . . . . 0.0 113.085 -173.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.4 ' SD ' ' CG ' ' A' ' 106' ' ' ARG . 25.0 tpp -80.18 108.26 13.64 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 121.618 0.723 . . . . 0.0 109.378 161.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 93.6 t -100.75 100.41 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 30.4 ttm -98.49 102.84 14.7 Favored 'General case' 0 CA--C 1.561 1.372 0 O-C-N 122.049 -0.407 . . . . 0.0 110.751 -165.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.9 m -97.41 96.21 8.2 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.579 1.181 . . . . 0.0 110.119 -170.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.638 HD13 HH22 ' A' ' 126' ' ' ARG . 11.0 mp -93.83 106.83 18.78 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.217 1.007 . . . . 0.0 111.137 -176.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.0 t -101.45 118.04 36.15 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.582 0.753 . . . . 0.0 111.11 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -103.14 77.11 1.51 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 159.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 63.97 -109.52 2.84 Favored Glycine 0 CA--C 1.547 2.093 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 -170.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -76.54 -22.11 54.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 171.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.9 t -86.21 102.82 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 120.777 1.626 . . . . 0.0 108.867 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 61.6 t -110.26 108.56 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -172.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.45 135.86 39.41 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.477 0.711 . . . . 0.0 111.696 174.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.0 t -131.95 115.68 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.638 HH22 HD13 ' A' ' 117' ' ' LEU . 3.6 mtm105 -120.8 140.85 51.14 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 122.363 1.078 . . . . 0.0 113.013 176.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -110.21 100.16 9.1 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.541 -1.208 . . . . 0.0 108.662 -164.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -103.52 132.3 49.9 Favored 'General case' 0 CA--C 1.565 1.543 0 O-C-N 121.429 -0.795 . . . . 0.0 111.802 -169.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -103.16 151.53 22.49 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 172.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -74.09 135.25 42.96 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.295 -0.878 . . . . 0.0 113.177 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.079 -0.962 . . . . 0.0 111.491 164.851 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.293 8.4 p . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -65.56 -38.47 89.65 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 174.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.96 -28.67 64.54 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 169.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -77.39 -15.94 59.11 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 166.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.2 t -76.77 98.64 4.87 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 122.478 2.399 . . . . 0.0 114.302 -172.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -168.4 167.6 11.78 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.161 0.982 . . . . 0.0 112.23 -177.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.7 m -81.64 116.87 21.58 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.846 -1.159 . . . . 0.0 108.661 159.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -107.34 119.67 40.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.346 -0.847 . . . . 0.0 110.672 -174.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -101.93 131.92 48.04 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.638 0.732 . . . . 0.0 110.917 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -69.13 132.63 46.87 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.3 p -102.15 -41.29 6.46 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 173.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -156.76 129.47 7.68 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 119.552 1.069 . . . . 0.0 109.807 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.1 p -110.86 106.0 15.0 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.503 0.721 . . . . 0.0 110.913 172.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -70.65 -58.82 3.26 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 -160.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -120.57 46.4 2.01 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.318 -0.864 . . . . 0.0 112.287 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -75.79 -43.65 45.28 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -167.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -46.96 -52.64 14.17 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 163.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.55 -43.16 85.85 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 176.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -52.77 -53.25 50.86 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 120.203 1.365 . . . . 0.0 114.42 162.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 76.9 mtm -62.03 -43.7 98.28 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 176.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.5 -40.8 92.67 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 168.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.03 -39.97 95.27 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 165.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.5 tp -59.08 -37.29 76.75 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 172.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.45 50.8 0.84 Allowed Glycine 0 N--CA 1.485 1.938 0 N-CA-C 115.434 0.934 . . . . 0.0 115.434 -176.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.3 m -91.21 157.81 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 118.379 1.089 . . . . 0.0 112.545 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.6 158.68 53.61 Favored Glycine 0 CA--C 1.552 2.348 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 162.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -59.13 -41.05 87.33 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.92 -38.98 73.61 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 168.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.9 m -61.23 -48.2 82.56 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 169.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.257 8.2 ptm180 -63.22 -32.67 74.12 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 173.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -62.75 -58.02 8.92 Favored 'General case' 0 CA--C 1.571 1.758 0 CA-C-N 119.066 0.848 . . . . 0.0 113.182 162.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.6 t -54.06 -58.51 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.07 -21.24 58.99 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 120.253 2.861 . . . . 0.0 120.253 -177.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -91.11 -38.41 12.78 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 169.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -68.88 -39.87 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 CA-C-N 121.326 1.876 . . . . 0.0 115.846 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.7 t -85.03 153.32 22.81 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 119.474 1.034 . . . . 0.0 113.274 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -98.66 93.96 2.21 Favored Pre-proline 0 CA--C 1.575 1.906 0 O-C-N 121.46 -0.775 . . . . 0.0 110.335 169.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.19 118.49 5.64 Favored 'Trans proline' 0 C--N 1.374 1.904 0 CA-C-N 123.109 2.146 . . . . 0.0 113.466 -175.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 91.2 m -88.82 122.16 31.92 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.395 -173.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.7 t -105.32 100.75 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.711 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -166.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.0 mt -89.1 105.84 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.7 mt -97.27 115.05 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 92.1 p -144.48 124.82 13.82 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.748 0.419 . . . . 0.0 111.219 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -78.97 115.62 18.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.593 -0.692 . . . . 0.0 111.677 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -126.2 84.08 2.23 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.223 0.535 . . . . 0.0 110.371 -170.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.75 72.25 1.05 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 115.435 0.934 . . . . 0.0 115.435 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.29 7.3 t70 70.71 -51.94 0.67 Allowed 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -171.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -76.18 148.98 37.37 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.1 t -88.91 116.61 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.55 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 172.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.0 t -99.55 114.69 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.9 mt -103.43 112.94 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 173.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.6 116.24 30.41 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.284 1.034 . . . . 0.0 110.668 -177.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.1 m -102.22 100.5 10.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.69 -0.631 . . . . 0.0 109.44 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.3 mt -99.64 100.63 11.65 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.101 0.56 . . . . 0.0 109.998 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.1 p -98.36 1.9 47.45 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 118.24 2.681 . . . . 0.0 118.24 176.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.396 31.8 p 78.69 -57.35 0.44 Allowed 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 124.871 1.268 . . . . 0.0 113.316 -167.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -77.92 -61.88 1.85 Allowed 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 124.354 1.062 . . . . 0.0 112.267 177.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -105.62 117.58 34.38 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.988 0.915 . . . . 0.0 109.428 176.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -121.07 85.5 2.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.412 -0.805 . . . . 0.0 109.833 -172.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.2 t -113.18 176.37 5.05 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 122.3 1.048 . . . . 0.0 113.478 -173.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -146.66 156.08 42.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.847 -1.158 . . . . 0.0 113.093 173.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.3 pt -121.68 132.0 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 123.899 0.88 . . . . 0.0 109.508 171.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 92.6 p -124.17 109.49 13.5 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.509 0.723 . . . . 0.0 110.408 -176.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -141.49 139.48 33.31 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -165.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -93.34 23.91 4.21 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.7 mt 67.41 105.21 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 125.179 1.392 . . . . 0.0 113.769 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.58 -20.09 12.69 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 118.483 2.153 . . . . 0.0 118.483 -166.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -78.66 123.37 27.07 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 119.158 1.479 . . . . 0.0 111.666 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -84.77 131.48 34.54 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 121.86 0.838 . . . . 0.0 112.24 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -131.52 157.31 43.9 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 124.247 1.019 . . . . 0.0 111.181 -173.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.65 136.07 33.41 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.63 -1.294 . . . . 0.0 110.98 175.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -140.71 118.72 11.88 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 122.533 0.333 . . . . 0.0 111.114 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 85.1 m -82.96 113.13 20.34 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 163.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.6 p -87.08 164.9 16.17 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -165.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.54 -24.35 8.0 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 118.824 2.898 . . . . 0.0 118.824 164.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -78.56 -0.51 29.96 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 167.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.262 10.7 t70 68.01 65.97 0.36 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 120.358 1.436 . . . . 0.0 113.151 -171.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -161.04 130.34 4.75 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.821 0.848 . . . . 0.0 109.146 -177.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -89.94 127.23 35.98 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.234 0.614 . . . . 0.0 112.392 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 21.0 p -132.0 148.76 52.53 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -81.2 101.63 9.81 Favored 'General case' 0 CA--C 1.565 1.537 0 CA-C-N 115.018 -0.992 . . . . 0.0 108.784 164.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.6 m -100.77 130.41 46.79 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.228 1.011 . . . . 0.0 112.35 -171.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.2 p -137.57 131.49 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.67 -0.644 . . . . 0.0 110.333 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 t -115.69 121.28 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.272 -0.893 . . . . 0.0 109.571 -176.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.9 p -110.77 130.07 55.67 Favored 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 123.612 0.765 . . . . 0.0 112.015 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 tt -92.68 100.86 13.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 110.584 176.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -93.1 75.6 4.69 Favored 'General case' 0 CA--C 1.568 1.657 0 O-C-N 121.325 -0.859 . . . . 0.0 111.681 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.75 -84.27 1.59 Allowed Glycine 0 N--CA 1.492 2.411 0 O-C-N 121.718 -0.613 . . . . 0.0 113.674 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -136.39 53.9 1.91 Allowed 'General case' 0 CA--C 1.571 1.78 0 CA-C-O 121.131 0.491 . . . . 0.0 111.911 161.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -145.64 119.54 9.32 Favored 'General case' 0 CA--C 1.562 1.411 0 O-C-N 121.072 -1.017 . . . . 0.0 111.303 172.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 47.2 mt -87.32 105.32 17.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.788 -0.57 . . . . 0.0 110.62 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.4 t -95.27 102.0 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -177.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -89.97 107.64 19.24 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.255 0.622 . . . . 0.0 110.61 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.3 mt -96.41 121.07 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 124.297 1.039 . . . . 0.0 108.493 -177.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -112.71 120.57 41.96 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 118.754 0.706 . . . . 0.0 110.23 173.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -111.42 123.03 49.39 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.639 0.776 . . . . 0.0 110.654 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -156.23 133.52 10.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.498 -0.751 . . . . 0.0 110.192 -175.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 64.39 15.07 9.27 Favored 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 117.446 2.387 . . . . 0.0 117.446 176.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.32 -3.13 82.89 Favored Glycine 0 CA--C 1.559 2.808 0 N-CA-C 119.082 2.393 . . . . 0.0 119.082 -158.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -105.55 147.51 28.3 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-N 119.337 1.569 . . . . 0.0 111.013 -176.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -136.06 127.07 27.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.738 -0.601 . . . . 0.0 112.075 -175.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.9 t -112.67 138.39 49.54 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.524 0.73 . . . . 0.0 109.47 164.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.88 122.39 40.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.242 0.617 . . . . 0.0 110.025 175.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -105.25 106.0 16.29 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -172.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.3 t -90.65 98.45 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -171.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 25.8 ttm105 -93.58 111.12 22.73 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.291 0.636 . . . . 0.0 110.641 -177.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -129.63 134.63 47.8 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 119.3 0.955 . . . . 0.0 112.621 -175.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.3 mm -81.46 127.11 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.206 -0.934 . . . . 0.0 109.528 174.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -101.6 -86.61 0.41 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.982 -0.449 . . . . 0.0 110.098 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -143.33 95.4 2.75 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 171.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.17 -41.97 2.96 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 117.354 1.701 . . . . 0.0 117.354 -167.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -92.81 148.57 21.92 Favored 'General case' 0 CA--C 1.558 1.28 0 CA-C-N 118.549 1.175 . . . . 0.0 113.219 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -90.76 109.56 20.75 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.704 158.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.6 t -85.28 104.27 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 170.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 39.5 ttm -93.97 114.52 26.73 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.6 m -101.7 99.46 9.72 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.9 mp -93.33 107.31 19.16 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -174.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.261 13.5 t -131.79 134.61 46.01 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -172.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -110.76 80.03 1.26 Allowed 'General case' 0 CA--C 1.564 1.511 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.994 174.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 69.89 -90.25 0.32 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 115.92 1.128 . . . . 0.0 115.92 -177.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -87.6 -34.49 18.5 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.4 t -87.65 132.35 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 119.459 1.027 . . . . 0.0 109.823 -170.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.7 t -128.42 112.83 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 C-N-CA 123.288 0.635 . . . . 0.0 109.453 -169.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -105.24 114.5 28.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.423 -0.798 . . . . 0.0 112.135 171.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.9 t -92.93 112.58 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.428 -0.795 . . . . 0.0 109.032 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -101.12 120.74 40.65 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.974 0.892 . . . . 0.0 111.219 175.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -102.66 102.92 13.16 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.464 0.706 . . . . 0.0 109.44 -168.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -105.77 127.58 53.18 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.132 -0.98 . . . . 0.0 112.413 -171.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -98.21 155.71 17.04 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 123.798 0.839 . . . . 0.0 112.808 169.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -77.55 135.17 38.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.176 -0.952 . . . . 0.0 113.238 176.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.019 -0.991 . . . . 0.0 111.04 162.803 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 CA--C 1.569 1.692 0 CA-C-O 121.653 0.74 . . . . 0.0 112.057 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.326 19.7 tt0 74.01 -52.81 0.69 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.56 -31.89 57.45 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 117.246 2.313 . . . . 0.0 117.246 161.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -72.27 -26.08 61.85 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 165.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.5 t -78.97 95.59 5.51 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-N 121.167 1.803 . . . . 0.0 113.269 -173.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -169.11 172.37 7.49 Favored 'General case' 0 CA--C 1.571 1.755 0 CA-C-O 122.702 1.239 . . . . 0.0 111.928 -174.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.6 m -78.83 127.38 31.97 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.135 -0.978 . . . . 0.0 110.109 165.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 99.9 m95 -124.6 111.73 15.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.856 -0.528 . . . . 0.0 110.267 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -104.53 129.6 52.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.58 -0.7 . . . . 0.0 110.811 -175.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -70.72 134.54 47.56 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 60.9 p -106.9 -39.97 5.62 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 175.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -153.77 123.04 6.54 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 119.528 1.058 . . . . 0.0 109.607 -174.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.4 p -103.07 100.22 10.13 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 122.925 0.49 . . . . 0.0 111.705 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -76.68 120.61 22.1 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 123.664 0.786 . . . . 0.0 111.405 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 4.8 t-20 60.12 38.08 20.56 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -76.0 -41.02 52.45 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.35 -50.76 70.58 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 174.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -55.47 -48.29 74.75 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 167.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -51.94 -47.1 64.88 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 169.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.465 ' SD ' ' HA ' ' A' ' 30' ' ' ARG . 72.7 mtm -64.06 -40.77 96.99 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 174.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -58.67 -51.52 69.59 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 161.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.54 -43.83 96.76 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 tt -66.31 -32.13 73.35 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.861 1.801 . . . . 0.0 115.861 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.69 55.45 1.9 Allowed Glycine 0 N--CA 1.485 1.923 0 N-CA-C 115.604 1.002 . . . . 0.0 115.604 -172.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.7 m -87.82 154.27 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 CA-C-N 118.129 0.964 . . . . 0.0 111.005 168.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.83 168.66 31.97 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 116.662 1.425 . . . . 0.0 116.662 174.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -83.54 59.43 5.1 Favored 'General case' 0 CA--C 1.577 1.991 0 CA-C-O 122.681 1.229 . . . . 0.0 112.812 177.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -160.76 -58.32 0.05 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.064 1.346 . . . . 0.0 109.758 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.8 m -61.0 -31.53 71.13 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 169.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.465 ' HA ' ' SD ' ' A' ' 20' ' ' MET . 18.5 ptp180 -57.29 -42.77 82.32 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 164.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -60.62 -48.53 81.37 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 167.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.5 t -49.94 -60.56 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 167.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.81 -38.31 53.74 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 119.349 2.5 . . . . 0.0 119.349 175.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -66.84 -42.44 85.76 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 168.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -77.96 -35.32 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 177.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 t -95.73 138.55 33.23 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 120.277 1.399 . . . . 0.0 113.846 -164.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -103.82 101.36 24.39 Favored Pre-proline 0 CA--C 1.575 1.91 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.335 173.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.55 150.82 46.39 Favored 'Trans proline' 0 CA--C 1.564 1.998 0 CA-C-N 123.011 2.111 . . . . 0.0 117.086 -170.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.7 m -102.9 103.85 14.03 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.113 173.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.2 t -96.58 102.26 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -174.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.2 mt -93.94 102.68 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.4 mt -87.91 113.52 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.4 p -129.58 120.44 25.29 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.839 0.456 . . . . 0.0 111.91 -170.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -85.55 103.52 14.47 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.04 -1.038 . . . . 0.0 110.146 176.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -106.3 88.16 2.72 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.36 0.6 . . . . 0.0 109.801 -168.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.75 -76.33 2.02 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 115.147 0.819 . . . . 0.0 115.147 -176.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -123.89 -50.34 1.83 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.514 0.725 . . . . 0.0 112.647 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -81.11 157.81 25.22 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -176.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.76 115.49 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.595 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 173.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.0 t -105.91 104.98 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.2 mt -94.18 118.78 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -101.59 101.96 12.6 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.1 m -85.38 95.8 9.36 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.9 mt -99.06 92.57 5.55 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -173.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.4 p -85.57 11.22 11.11 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 175.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.391 39.7 p 74.05 -57.97 0.6 Allowed 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 125.136 1.375 . . . . 0.0 113.536 -168.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -76.7 -62.08 1.75 Allowed 'General case' 0 CA--C 1.571 1.776 0 C-N-CA 124.498 1.119 . . . . 0.0 112.285 176.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -106.2 120.93 43.12 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.93 0.892 . . . . 0.0 109.583 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -123.73 84.32 2.26 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -169.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.9 t -108.74 147.65 31.66 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -166.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.43 135.31 47.06 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 124.134 0.974 . . . . 0.0 113.136 -174.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.0 mt -124.66 101.32 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -174.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 90.1 p -110.24 112.87 25.11 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.693 0.797 . . . . 0.0 111.833 -173.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -141.2 139.29 33.79 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.007 0.908 . . . . 0.0 113.423 -173.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -88.33 26.15 1.49 Allowed 'General case' 0 CA--C 1.582 2.194 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 173.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 75.4 mt 63.42 100.49 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 125.347 1.459 . . . . 0.0 113.094 -172.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.71 2.38 88.72 Favored Glycine 0 CA--C 1.556 2.635 0 N-CA-C 119.111 2.405 . . . . 0.0 119.111 -167.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -89.28 129.4 35.84 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-N 119.537 1.669 . . . . 0.0 111.205 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -89.61 111.57 22.56 Favored 'General case' 0 CA--C 1.563 1.447 0 CA-C-O 121.288 0.566 . . . . 0.0 111.374 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -113.8 150.18 33.85 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.27 1.028 . . . . 0.0 110.606 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.45 131.18 35.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.266 -1.521 . . . . 0.0 111.59 171.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -122.56 108.25 12.91 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.596 0.758 . . . . 0.0 109.74 -172.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.7 m -77.97 100.99 6.66 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.219 1.009 . . . . 0.0 109.26 172.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 74.4 p -79.18 -178.69 6.3 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -164.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.45 -8.64 0.56 Allowed 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 119.823 3.268 . . . . 0.0 119.823 162.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -109.5 19.02 19.75 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 158.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.438 2.2 p30 56.36 12.25 0.99 Allowed 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 119.794 3.257 . . . . 0.0 119.794 -171.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -77.11 126.14 30.47 Favored 'General case' 0 CA--C 1.561 1.403 0 O-C-N 120.888 -1.132 . . . . 0.0 110.053 170.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -83.99 101.34 11.66 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.476 0.711 . . . . 0.0 111.314 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 83.4 m -100.83 128.2 46.96 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.617 -0.677 . . . . 0.0 112.492 -171.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -72.46 99.4 2.47 Favored 'General case' 0 CA--C 1.563 1.456 0 CA-C-O 122.275 1.036 . . . . 0.0 109.382 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.2 m -115.96 117.23 29.58 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.916 -156.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 p -122.13 129.53 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 123.379 0.672 . . . . 0.0 109.895 -176.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.1 t -121.96 113.36 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -171.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 63.3 m -112.44 131.13 55.72 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.396 0.678 . . . . 0.0 110.923 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.0 tt -91.36 103.37 16.02 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.571 0.701 . . . . 0.0 110.244 175.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -87.28 80.09 8.33 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 123.46 0.704 . . . . 0.0 111.382 -177.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.9 -81.01 1.54 Allowed Glycine 0 N--CA 1.493 2.47 0 O-C-N 121.564 -0.71 . . . . 0.0 114.338 -176.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -135.33 56.12 1.85 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.271 0.558 . . . . 0.0 111.767 163.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -153.28 100.56 2.46 Favored 'General case' 0 CA--C 1.564 1.498 0 O-C-N 121.218 -0.926 . . . . 0.0 110.277 -170.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 24.4 mt -77.68 114.49 16.57 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.093 -1.004 . . . . 0.0 111.835 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.06 102.31 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -87.59 110.03 20.08 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.065 0.546 . . . . 0.0 110.606 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 69.1 mt -102.09 110.5 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -95.62 124.67 39.76 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 118.671 0.669 . . . . 0.0 111.517 172.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -111.38 124.05 51.47 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.977 0.911 . . . . 0.0 110.321 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.6 p90 -154.49 126.97 7.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.806 -1.184 . . . . 0.0 110.595 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 58.53 31.9 21.54 Favored 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 117.244 2.312 . . . . 0.0 117.244 169.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.09 -20.14 8.87 Favored Glycine 0 CA--C 1.556 2.649 0 N-CA-C 119.012 2.365 . . . . 0.0 119.012 -163.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -91.18 143.49 26.61 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 119.667 1.734 . . . . 0.0 111.657 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -133.42 134.24 43.38 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.174 0.59 . . . . 0.0 111.032 -178.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.0 t -126.48 134.75 50.85 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 123.072 0.549 . . . . 0.0 111.065 173.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -116.03 129.56 56.42 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 123.258 0.623 . . . . 0.0 111.997 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -111.34 102.15 10.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.233 -0.917 . . . . 0.0 108.623 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.9 t -91.77 111.12 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -171.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -110.45 119.41 39.12 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.416 0.686 . . . . 0.0 111.18 -171.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -129.41 144.78 51.39 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 122.996 0.518 . . . . 0.0 112.043 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.6 mm -88.18 106.0 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -103.49 101.09 10.97 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 123.511 0.725 . . . . 0.0 109.221 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.3 t70 50.74 53.95 12.08 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 -175.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.45 -35.15 3.65 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 118.645 2.218 . . . . 0.0 118.645 -170.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -95.76 146.39 24.57 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 119.373 1.587 . . . . 0.0 112.056 -172.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 34.1 ttm -86.06 116.08 24.05 Favored 'General case' 0 CA--C 1.566 1.568 0 O-C-N 120.868 -1.145 . . . . 0.0 111.61 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.4 t -94.79 108.11 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 169.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 13.7 ttt -110.17 101.63 10.39 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.506 0.67 . . . . 0.0 109.607 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.8 m -94.8 106.7 18.7 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.527 0.731 . . . . 0.0 109.355 -174.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.4 mp -91.53 113.9 26.29 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.8 m -120.89 119.78 33.62 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.544 0.688 . . . . 0.0 109.869 -167.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -107.61 77.85 1.16 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.372 0.606 . . . . 0.0 109.367 170.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 64.21 -94.98 0.16 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 115.306 0.882 . . . . 0.0 115.306 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -83.54 -32.73 25.71 Favored 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 170.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.2 t -87.05 109.95 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 120.444 1.475 . . . . 0.0 109.406 -171.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.3 t -114.19 118.27 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 124.086 0.954 . . . . 0.0 108.489 -169.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -123.21 127.63 48.89 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 123.265 0.626 . . . . 0.0 111.878 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 37.7 t -105.74 115.56 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.956 -1.09 . . . . 0.0 110.306 -172.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.8 124.06 40.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.054 -1.029 . . . . 0.0 111.716 169.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -102.05 105.78 16.57 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.726 0.81 . . . . 0.0 109.724 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -107.59 129.68 54.96 Favored 'General case' 0 CA--C 1.563 1.474 0 O-C-N 121.303 -0.873 . . . . 0.0 111.731 -169.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -98.35 158.09 15.79 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.399 1.095 . . . . 0.0 112.499 170.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -89.9 130.58 36.1 Favored 'General case' 0 CA--C 1.563 1.471 0 O-C-N 121.394 -0.816 . . . . 0.0 112.758 -169.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . 0.309 . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 118.746 2.869 . . . . 0.0 118.746 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.81 -22.28 61.99 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 168.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -80.71 -12.66 59.44 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 168.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 82.3 m -80.36 91.87 5.73 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 122.207 2.276 . . . . 0.0 113.044 -175.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -165.78 167.0 17.37 Favored 'General case' 0 CA--C 1.569 1.701 0 CA-C-O 122.467 1.127 . . . . 0.0 113.124 -172.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.8 m -80.07 111.01 16.02 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.422 -0.799 . . . . 0.0 109.38 165.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -107.57 111.08 23.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.533 -0.729 . . . . 0.0 111.193 -173.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -102.14 132.92 47.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.209 -0.932 . . . . 0.0 110.898 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 tt -70.87 113.85 8.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.717 -0.615 . . . . 0.0 112.574 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.7 p -99.44 -35.66 9.83 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 -175.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -141.72 120.45 12.62 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 120.432 1.469 . . . . 0.0 109.58 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.4 p -108.77 104.49 13.78 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -81.11 122.39 27.28 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.896 -0.503 . . . . 0.0 110.291 164.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 54.58 70.43 0.62 Allowed 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -110.6 61.83 0.61 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.831 -1.168 . . . . 0.0 112.095 163.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -155.51 -64.92 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.237 1.015 . . . . 0.0 109.52 173.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -62.29 -37.5 85.76 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -50.5 -51.09 50.47 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.535 1.516 . . . . 0.0 114.793 167.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 73.5 mtm -57.08 -50.14 73.68 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 170.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -58.19 -40.72 82.26 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 116.134 1.902 . . . . 0.0 116.134 172.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.95 -41.97 90.59 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 169.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.2 tp -61.83 -23.3 66.16 Favored 'General case' 0 CA--C 1.574 1.875 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 176.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.86 55.58 1.61 Allowed Glycine 0 N--CA 1.485 1.906 0 C-N-CA 123.868 0.747 . . . . 0.0 114.795 -176.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.3 m -83.07 153.95 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.93 138.36 34.94 Favored Glycine 0 CA--C 1.555 2.532 0 O-C-N 120.956 -1.09 . . . . 0.0 113.494 149.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -57.56 -33.55 68.26 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -171.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.37 -41.79 66.22 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 164.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.1 m -60.1 -40.6 90.22 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 165.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.335 0.0 OUTLIER -60.18 -42.56 95.27 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 168.326 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -58.61 -51.76 68.57 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 166.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.1 t -56.02 -55.88 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 173.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.81 -24.72 57.99 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 119.854 2.702 . . . . 0.0 119.854 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -73.77 -45.66 50.41 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 164.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.7 m -78.23 -30.4 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 t -105.11 141.1 37.27 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 120.803 1.638 . . . . 0.0 114.276 -162.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -89.66 119.74 69.5 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.197 172.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.05 129.73 8.04 Favored 'Trans proline' 0 CA--C 1.564 2.02 0 C-N-CA 122.454 2.102 . . . . 0.0 114.044 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 56.6 m -95.69 106.91 19.07 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 169.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 81.0 t -99.43 95.91 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -174.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.8 mp -89.43 98.82 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.521 -1.362 . . . . 0.0 108.359 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.5 mt -84.04 116.46 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.6 p -141.78 121.27 13.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.832 -0.543 . . . . 0.0 112.36 -168.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -79.89 102.99 9.48 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.86 -1.15 . . . . 0.0 110.543 169.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -103.3 96.92 7.08 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -169.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.09 -74.8 2.46 Favored Glycine 0 N--CA 1.488 2.163 0 O-C-N 121.777 -0.577 . . . . 0.0 114.144 -173.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -132.77 -53.24 0.93 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.425 0.69 . . . . 0.0 111.927 171.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -81.3 160.18 24.27 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -173.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.2 t -84.29 114.56 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 123.635 0.774 . . . . 0.0 109.117 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.3 t -106.92 107.68 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.558 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 59.0 mt -91.6 122.18 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 172.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -106.03 106.82 17.5 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.151 0.58 . . . . 0.0 110.23 174.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.5 m -92.87 103.73 16.04 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.506 -0.746 . . . . 0.0 109.374 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 72.0 mt -121.32 117.64 27.49 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.085 0.554 . . . . 0.0 110.231 -170.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 t -127.65 171.87 11.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.026 -1.046 . . . . 0.0 111.26 165.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -70.38 24.24 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 118.585 2.809 . . . . 0.0 118.585 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -150.23 -58.14 0.18 Allowed 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 125.194 1.398 . . . . 0.0 108.705 175.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -101.49 130.89 47.84 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.185 0.994 . . . . 0.0 110.949 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -137.54 110.57 7.76 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.077 0.551 . . . . 0.0 110.834 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.3 t -137.7 155.2 49.36 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 123.569 0.748 . . . . 0.0 111.907 -176.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -140.01 146.85 39.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.808 -1.183 . . . . 0.0 113.941 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.8 pt -130.14 122.63 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-O 121.522 0.677 . . . . 0.0 111.108 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.4 p -105.1 116.93 32.78 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.287 1.035 . . . . 0.0 110.877 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -144.79 141.11 28.93 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 114.517 1.302 . . . . 0.0 114.517 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -79.32 155.52 28.43 Favored 'General case' 0 CA--C 1.571 1.781 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.619 149.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.9 mt -70.78 114.53 8.95 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.58 -1.325 . . . . 0.0 111.588 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.07 -7.61 54.92 Favored Glycine 0 CA--C 1.555 2.536 0 N-CA-C 118.567 2.187 . . . . 0.0 118.567 -162.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -68.72 122.48 18.64 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 120.734 2.267 . . . . 0.0 112.432 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -89.33 118.51 29.06 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 122.979 0.512 . . . . 0.0 110.451 169.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -136.43 135.71 38.92 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 123.433 0.693 . . . . 0.0 110.844 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.17 129.1 36.25 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.487 -1.383 . . . . 0.0 111.047 172.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -130.9 109.71 10.75 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.75 -167.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.7 m -75.24 102.17 4.92 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.65 0.738 . . . . 0.0 110.487 174.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.0 p -85.29 161.85 19.36 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -171.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.45 -23.68 4.19 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 119.015 2.969 . . . . 0.0 119.015 166.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -54.24 -30.74 51.37 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 117.629 2.455 . . . . 0.0 117.629 160.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.316 9.8 t70 78.13 63.21 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.723 0 C-N-CA 125.869 1.668 . . . . 0.0 112.172 -159.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.5 ptt-85 -152.85 136.95 16.41 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.95 0.9 . . . . 0.0 109.14 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.284 0.5 OUTLIER -90.32 112.02 23.44 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 119.535 1.062 . . . . 0.0 110.795 168.17 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.3 p -107.64 130.28 54.92 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -65.6 99.12 0.42 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.442 1.097 . . . . 0.0 110.064 168.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.1 m -107.21 119.93 40.73 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.066 -164.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 51.8 t -111.38 120.18 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.9 t -111.74 129.26 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.538 -0.726 . . . . 0.0 109.718 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 65.6 m -153.57 152.45 30.91 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.778 -1.201 . . . . 0.0 112.25 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.9 mp -83.32 123.19 29.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.063 -1.023 . . . . 0.0 110.538 167.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -84.7 -63.68 1.29 Allowed 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -149.98 80.55 0.2 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 174.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.4 t70 52.42 37.23 22.13 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -160.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -147.16 120.89 9.21 Favored 'General case' 0 CA--C 1.56 1.352 0 O-C-N 121.278 -0.889 . . . . 0.0 109.461 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.87 112.5 22.56 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.242 1.017 . . . . 0.0 110.758 -171.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.03 109.91 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -167.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -93.92 98.85 11.32 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 123.436 0.695 . . . . 0.0 110.999 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.0 mt -90.41 109.19 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 C-N-CA 124.159 0.983 . . . . 0.0 109.003 -174.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -105.46 118.35 36.33 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 118.968 0.804 . . . . 0.0 110.193 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -115.45 122.53 46.06 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 123.634 0.774 . . . . 0.0 111.199 -173.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 8.5 p90 -151.36 130.0 12.29 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.96 -1.088 . . . . 0.0 110.5 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 58.38 27.51 15.5 Favored 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 117.498 2.407 . . . . 0.0 117.498 170.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.23 -19.23 23.87 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 118.97 2.348 . . . . 0.0 118.97 -162.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -89.4 148.11 23.67 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-N 119.443 1.622 . . . . 0.0 112.541 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -132.01 141.01 49.11 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.879 0.847 . . . . 0.0 111.463 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.9 t -129.91 143.51 50.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.63 -0.669 . . . . 0.0 109.419 158.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.266 13.3 p30 -124.52 132.82 53.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 111.171 173.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -100.66 103.75 15.04 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.2 t -88.24 98.93 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 91.1 mtm-85 -89.1 114.04 25.25 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.895 0.878 . . . . 0.0 110.35 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.48 132.95 49.91 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 119.119 0.872 . . . . 0.0 112.718 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.7 mm -80.25 106.56 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.382 -0.824 . . . . 0.0 110.244 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -103.09 98.27 8.24 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 169.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.0 t70 51.46 60.8 3.6 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.32 0.1 56.24 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 120.034 2.774 . . . . 0.0 120.034 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -118.78 122.56 42.69 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 119.837 1.818 . . . . 0.0 109.71 -171.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 51.2 ttp -82.42 104.78 12.96 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 122.029 0.919 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.14 103.61 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 31.6 ttm -85.6 108.14 17.84 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 84.4 m -98.71 101.17 12.5 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.0 mp -92.2 98.95 11.84 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.568 0.747 . . . . 0.0 108.988 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.7 t -89.97 117.58 28.88 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.53 0.681 . . . . 0.0 110.322 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -100.59 75.71 1.77 Allowed 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 155.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.57 -111.24 3.3 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 114.85 0.7 . . . . 0.0 114.85 -166.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -81.2 -9.69 59.74 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 171.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 50.0 t -90.36 99.61 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 121.969 2.168 . . . . 0.0 107.422 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.6 t -113.64 119.93 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -168.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.81 130.92 54.43 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 171.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.9 t -111.79 103.83 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -114.96 118.71 34.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.353 -0.842 . . . . 0.0 109.947 -171.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -99.77 98.8 9.57 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.599 0.714 . . . . 0.0 109.982 -162.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -94.23 131.92 39.32 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.507 0.723 . . . . 0.0 110.9 -173.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -116.76 158.52 23.74 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.532 0.682 . . . . 0.0 110.754 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -75.44 103.89 5.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.023 -1.048 . . . . 0.0 111.877 -174.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . 0.286 . . . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -173.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.93 -24.44 66.04 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 117.84 2.533 . . . . 0.0 117.84 165.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -76.91 -21.65 54.57 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 168.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 80.8 m -73.81 88.86 1.8 Allowed 'General case' 0 CA--C 1.572 1.811 0 CA-C-N 121.885 2.13 . . . . 0.0 114.344 -173.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.59 168.06 20.48 Favored 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 124.552 1.141 . . . . 0.0 111.781 -174.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.6 m -77.27 134.85 38.45 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.868 -1.145 . . . . 0.0 109.319 158.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -123.91 120.75 33.46 Favored 'General case' 0 CA--C 1.562 1.412 0 O-C-N 121.519 -0.738 . . . . 0.0 110.048 -175.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 mtpm? -100.35 130.79 46.49 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.609 0.764 . . . . 0.0 111.422 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 tt -71.79 118.57 14.8 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.562 -0.711 . . . . 0.0 112.909 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 65.2 p -92.22 -49.75 6.02 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -141.18 113.91 8.33 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.757 0.823 . . . . 0.0 109.875 -173.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.0 p -98.62 98.81 9.92 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.318 0.647 . . . . 0.0 111.883 175.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -83.5 122.81 29.04 Favored 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 123.492 0.717 . . . . 0.0 111.16 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.256 1.3 t30 57.7 30.08 18.33 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 171.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -72.38 -38.36 68.51 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -54.77 -53.16 58.78 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 175.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.26 -41.78 80.33 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 171.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -58.15 -48.08 81.36 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 165.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 65.0 mtm -58.02 -48.28 80.52 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -60.78 -42.58 97.8 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 166.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.64 97.55 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 171.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.6 tp -64.25 -22.33 66.91 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 116.925 2.195 . . . . 0.0 116.925 169.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.73 55.56 1.75 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 115.615 1.006 . . . . 0.0 115.615 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 m -107.86 149.84 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 118.197 0.999 . . . . 0.0 111.553 172.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.17 165.54 21.4 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 116.647 1.419 . . . . 0.0 116.647 172.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -64.84 -40.57 95.38 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.71 -42.46 79.2 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 164.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.6 m -62.4 -43.96 97.58 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 169.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -54.4 -47.53 72.64 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 164.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -58.87 -52.33 66.19 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 119.989 1.268 . . . . 0.0 114.1 170.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.2 t -49.01 -51.5 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 167.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.33 -32.77 84.73 Favored Glycine 0 CA--C 1.55 2.234 0 N-CA-C 119.596 2.599 . . . . 0.0 119.596 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -79.69 -42.93 23.67 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 173.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.4 m -70.32 -35.07 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 117.022 2.231 . . . . 0.0 117.022 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.0 t -102.89 175.32 5.52 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -166.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.44 84.38 0.74 Allowed Pre-proline 0 CA--C 1.579 2.086 0 C-N-CA 123.703 0.801 . . . . 0.0 110.96 169.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.26 117.63 5.23 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.71 2.274 . . . . 0.0 113.395 -175.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.1 m -100.06 123.83 44.74 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.418 -161.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.8 t -106.46 105.56 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -167.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.4 mt -89.05 105.75 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.438 -1.414 . . . . 0.0 107.714 170.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 55.8 mt -89.71 124.6 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 168.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.1 p -150.71 122.19 7.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -0.914 . . . . 0.0 112.739 -169.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -78.99 104.83 9.9 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.666 -1.271 . . . . 0.0 110.512 166.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -105.95 99.8 9.37 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -171.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.13 -72.45 2.77 Favored Glycine 0 N--CA 1.491 2.328 0 O-C-N 121.689 -0.632 . . . . 0.0 114.157 -169.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -139.41 -59.87 0.57 Allowed 'General case' 0 CA--C 1.566 1.575 0 C-N-CA 123.366 0.667 . . . . 0.0 111.303 173.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -79.03 159.85 27.4 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -172.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.8 t -79.77 116.71 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.568 0 CA-C-O 121.725 0.774 . . . . 0.0 109.46 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 65.0 t -104.08 107.43 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 68.7 mt -89.64 120.56 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 167.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -102.88 103.82 14.02 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 166.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.4 m -90.55 99.25 12.31 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 170.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 mp -92.1 101.16 13.68 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.593 0.757 . . . . 0.0 108.978 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.9 t -78.24 26.9 0.2 Allowed 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.352 70.8 p 65.17 -53.87 0.33 Allowed 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -164.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -81.17 -31.88 33.85 Favored 'General case' 0 CA--C 1.577 2.018 0 C-N-CA 125.575 1.55 . . . . 0.0 115.163 174.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -136.62 127.05 26.7 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 119.763 1.165 . . . . 0.0 111.31 -173.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -88.48 104.33 16.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.329 -0.857 . . . . 0.0 110.611 171.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.6 p -102.03 99.95 10.17 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.5 0.667 . . . . 0.0 110.109 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -98.07 126.79 43.67 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.706 0.802 . . . . 0.0 112.259 -175.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.4 pt -131.47 116.84 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 C-N-CA 123.168 0.587 . . . . 0.0 111.159 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.8 p -98.54 129.86 45.1 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.896 0.879 . . . . 0.0 112.351 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -156.64 144.35 19.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.379 -0.826 . . . . 0.0 112.633 -175.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -84.81 158.54 20.64 Favored 'General case' 0 CA--C 1.57 1.722 0 O-C-N 120.861 -1.149 . . . . 0.0 110.935 156.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.32 116.37 9.67 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.67 -1.269 . . . . 0.0 111.839 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.05 -4.29 77.82 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 119.214 2.445 . . . . 0.0 119.214 -163.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -82.42 126.57 32.36 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 120.633 2.217 . . . . 0.0 111.929 -176.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -83.34 112.94 20.36 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-O 121.067 0.46 . . . . 0.0 111.424 172.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -121.53 140.45 52.19 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.763 0.825 . . . . 0.0 111.207 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.3 130.89 38.8 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.241 1.019 . . . . 0.0 111.532 171.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.447 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 19.6 tt0 -132.99 103.28 5.97 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.146 -171.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.0 m -91.23 107.19 19.04 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 174.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.7 p -80.14 162.29 24.82 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -169.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.21 -23.79 23.94 Favored 'General case' 0 CA--C 1.576 1.942 0 N-CA-C 118.825 2.898 . . . . 0.0 118.825 169.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -82.96 2.2 35.87 Favored 'General case' 0 CA--C 1.582 2.204 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 165.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.286 21.3 m-20 70.02 70.13 0.22 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 120.584 1.538 . . . . 0.0 113.128 -174.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.5 ptp85 -145.88 125.99 13.76 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 166.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -91.8 105.41 17.69 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.463 0.705 . . . . 0.0 111.132 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 72' ' ' GLU . 28.7 p -109.22 135.23 50.65 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -74.47 101.7 4.23 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-O 121.835 0.826 . . . . 0.0 109.441 164.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.0 m -102.63 128.85 49.14 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.542 0.737 . . . . 0.0 112.63 -170.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 49.4 t -122.98 121.91 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.9 t -104.46 109.47 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.227 -0.92 . . . . 0.0 109.594 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.3 p -110.46 130.06 55.64 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.796 0.838 . . . . 0.0 111.912 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.7 tt -87.84 99.63 12.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.147 -0.971 . . . . 0.0 110.605 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -101.3 75.72 1.65 Allowed 'General case' 0 CA--C 1.567 1.613 0 C-N-CA 123.481 0.712 . . . . 0.0 111.122 -176.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.34 68.15 1.76 Allowed Glycine 0 N--CA 1.495 2.597 0 N-CA-C 116.258 1.263 . . . . 0.0 116.258 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.256 23.7 m-20 60.38 22.33 11.89 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 117.222 2.305 . . . . 0.0 117.222 -166.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -133.58 107.52 8.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.938 -1.101 . . . . 0.0 109.893 -175.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.6 mt -83.09 103.32 12.43 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.793 0.837 . . . . 0.0 111.626 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 37.2 t -97.52 100.5 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -173.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -84.68 107.52 16.93 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.339 0.656 . . . . 0.0 110.204 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 70.3 mt -99.5 103.82 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -91.01 118.94 30.79 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 118.43 0.559 . . . . 0.0 111.317 176.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -112.53 112.03 23.29 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.019 0.528 . . . . 0.0 110.46 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -139.21 125.62 20.37 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.438 -0.789 . . . . 0.0 110.683 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 50.92 49.94 20.11 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 167.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.86 4.6 62.61 Favored Glycine 0 CA--C 1.558 2.739 0 N-CA-C 120.212 2.845 . . . . 0.0 120.212 -168.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -123.59 140.31 53.13 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 119.653 1.726 . . . . 0.0 110.266 -168.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -135.01 123.61 23.57 Favored 'General case' 0 CA--C 1.564 1.499 0 O-C-N 121.692 -0.63 . . . . 0.0 111.783 -175.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.0 t -115.89 137.34 52.19 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.294 0.569 . . . . 0.0 109.964 165.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.19 128.07 54.74 Favored 'General case' 0 CA--C 1.567 1.629 0 C-N-CA 123.109 0.564 . . . . 0.0 110.996 171.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -105.84 110.18 22.39 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 53.2 t -91.97 100.79 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -176.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.18 111.09 19.49 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.562 0.745 . . . . 0.0 110.677 173.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.57 129.83 43.28 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 118.96 0.8 . . . . 0.0 112.631 -174.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.9 mm -75.86 112.93 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.044 -1.035 . . . . 0.0 108.953 173.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -133.24 96.5 3.75 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -169.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.7 t70 50.37 61.1 3.38 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -169.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.07 -48.08 3.88 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 117.84 1.896 . . . . 0.0 117.84 -173.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -82.06 146.42 29.67 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 118.231 1.015 . . . . 0.0 113.086 -174.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -82.38 104.74 12.9 Favored 'General case' 0 CA--C 1.56 1.365 0 CA-C-O 121.966 0.888 . . . . 0.0 109.429 166.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 80.3 t -91.79 102.31 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 40.9 ttm -83.15 108.4 16.38 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.422 0.689 . . . . 0.0 109.8 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.1 m -99.82 115.07 28.72 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.871 0.843 . . . . 0.0 109.135 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mp -111.18 117.46 33.28 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -171.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.305 10.6 t -137.21 138.2 39.92 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 177.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -124.01 99.89 6.47 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.952 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 73.07 -90.76 0.6 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 115.299 0.88 . . . . 0.0 115.299 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -134.31 52.77 2.04 Favored 'General case' 0 CA--C 1.575 1.909 0 CA-C-O 121.482 0.658 . . . . 0.0 112.064 167.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.4 t -139.91 124.04 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 51.2 t -123.4 127.18 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-N 119.001 0.818 . . . . 0.0 109.837 -170.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -117.18 150.7 38.3 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 123.633 0.773 . . . . 0.0 112.329 163.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.8 t -131.92 114.22 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.192 -0.942 . . . . 0.0 108.947 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 mtp-105 -110.9 114.44 27.77 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.205 -0.934 . . . . 0.0 109.876 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -96.63 108.63 21.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.647 -0.658 . . . . 0.0 110.111 -167.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -103.55 132.47 49.78 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.108 -0.995 . . . . 0.0 112.4 -171.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.39 160.66 15.22 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 175.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -76.1 141.03 42.1 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -175.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.25 0 CA-C-O 117.404 -1.284 . . . . 0.0 112.447 176.427 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 . . . . . 0 N--CA 1.499 2.008 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.38 -23.83 66.06 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 117.755 2.502 . . . . 0.0 117.755 168.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -87.92 -21.81 24.71 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 172.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.5 t -76.83 95.63 4.11 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 121.197 1.817 . . . . 0.0 112.905 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -166.39 167.61 15.66 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-O 122.565 1.174 . . . . 0.0 112.333 -172.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.7 m -86.85 107.1 18.17 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.829 0.852 . . . . 0.0 108.718 173.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -105.22 109.42 21.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.972 . . . . 0.0 111.623 -169.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -95.36 129.33 42.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.281 -0.887 . . . . 0.0 111.089 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.0 tt -75.86 122.29 23.88 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -173.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 69.0 p -91.84 -52.47 4.72 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 176.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -137.97 114.54 10.45 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.739 0.815 . . . . 0.0 110.233 -173.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.7 p -101.18 78.03 1.86 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.409 1.1 . . . . 0.0 112.419 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -79.99 133.25 36.15 Favored 'General case' 0 CA--C 1.56 1.354 0 O-C-N 120.97 -1.081 . . . . 0.0 113.804 -171.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.252 1.1 t30 57.44 23.34 8.94 Favored 'General case' 0 CA--C 1.584 2.251 0 N-CA-C 117.189 2.292 . . . . 0.0 117.189 -174.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -69.46 -46.41 66.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.238 -1.539 . . . . 0.0 115.054 -175.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -47.64 -51.3 21.99 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -68.33 -40.02 81.76 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -50.5 -52.96 33.72 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 160.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.6 mtp -59.03 -43.46 91.63 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 175.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -47.75 83.58 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 164.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.02 -39.03 86.95 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.65 -47.57 85.67 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 163.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.88 48.22 1.51 Allowed Glycine 0 N--CA 1.482 1.738 0 CA-C-O 118.978 -0.901 . . . . 0.0 115.315 -175.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.7 m -80.56 151.63 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 118.822 1.311 . . . . 0.0 111.443 172.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.38 150.05 30.73 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 116.955 1.542 . . . . 0.0 116.955 173.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -55.53 -43.37 75.71 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.12 -44.9 68.06 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 166.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.3 m -64.04 -40.26 95.91 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 171.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -61.05 -49.16 78.48 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 121.691 2.041 . . . . 0.0 115.923 167.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.6 mp0 -71.14 -28.74 64.5 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.1 t -70.77 -62.13 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 119.536 1.062 . . . . 0.0 112.11 159.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.76 -31.37 71.41 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 119.903 2.721 . . . . 0.0 119.903 -166.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -73.4 -32.11 64.26 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 170.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.2 m -82.68 -34.7 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.0 t -81.5 126.4 31.64 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 120.857 1.662 . . . . 0.0 112.352 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -103.55 92.7 4.3 Favored Pre-proline 0 CA--C 1.573 1.828 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -71.91 155.65 57.46 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.384 2.056 . . . . 0.0 116.64 -171.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.1 m -88.73 100.31 13.03 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.371 -1.286 . . . . 0.0 107.64 169.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.6 t -95.65 98.43 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -171.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.1 mt -88.81 102.21 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -86.41 116.97 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 171.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.2 p -153.81 121.31 5.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.718 -0.614 . . . . 0.0 111.337 -165.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -80.24 128.69 33.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 0.0 113.098 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -120.24 90.28 3.3 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 174.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.9 68.99 1.48 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 115.613 1.005 . . . . 0.0 115.613 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.293 13.0 t70 70.94 -57.27 0.6 Allowed 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -169.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -72.59 147.84 45.47 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-O 122.568 1.175 . . . . 0.0 114.141 -172.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.0 t -96.2 122.54 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.857 -169.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.9 t -104.22 110.87 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.0 mt -92.73 99.76 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 172.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.0 mtm-85 -85.92 101.93 13.3 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.867 0.867 . . . . 0.0 111.022 173.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.6 m -89.81 101.05 13.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.591 -0.693 . . . . 0.0 109.708 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 73.2 mt -101.26 108.82 20.57 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.791 0.805 . . . . 0.0 111.618 -167.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.1 t -138.29 147.61 43.79 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 124.546 1.138 . . . . 0.0 109.369 173.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 51.1 p -76.94 53.38 0.93 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 120.634 -1.291 . . . . 0.0 113.857 173.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -161.37 -65.8 0.06 Allowed 'General case' 0 CA--C 1.571 1.784 0 C-N-CA 125.435 1.494 . . . . 0.0 107.898 -172.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -127.94 96.51 4.51 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -96.23 82.16 3.41 Favored 'General case' 0 CA--C 1.568 1.67 0 O-C-N 121.721 -0.612 . . . . 0.0 110.803 -176.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -108.35 146.23 33.3 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -170.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -131.77 127.83 37.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.275 -0.891 . . . . 0.0 113.151 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.4 mt -112.77 110.59 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.3 p -92.09 120.27 32.55 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.546 0.739 . . . . 0.0 112.393 170.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -143.96 147.4 33.88 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -174.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -87.52 1.78 52.56 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 118.59 2.811 . . . . 0.0 118.59 -172.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.4 mt 69.75 120.01 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 125.455 1.502 . . . . 0.0 112.775 -172.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.39 -32.08 4.27 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 118.142 2.017 . . . . 0.0 118.142 -171.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -73.97 136.42 43.22 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 119.309 1.555 . . . . 0.0 113.021 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -88.88 120.76 30.58 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.198 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -130.75 150.64 51.83 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.801 0.84 . . . . 0.0 111.65 -172.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -79.55 133.5 36.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.932 -1.105 . . . . 0.0 111.615 171.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -142.44 126.03 16.86 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.0 0.428 . . . . 0.0 111.992 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.2 m -73.36 132.4 42.99 Favored 'General case' 0 CA--C 1.57 1.731 0 CA-C-O 121.43 0.633 . . . . 0.0 110.478 162.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.9 p -108.82 166.47 10.78 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -169.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.15 -11.5 6.29 Favored 'General case' 0 CA--C 1.579 2.082 0 N-CA-C 119.452 3.13 . . . . 0.0 119.452 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -73.62 -25.33 60.26 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 159.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.305 4.8 m-20 82.1 65.87 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 120.738 1.608 . . . . 0.0 111.235 -162.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.9 ptt85 -162.87 142.2 8.89 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.162 0.985 . . . . 0.0 109.43 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -83.02 134.62 35.03 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 169.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.9 p -129.89 148.63 51.77 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 172.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -79.15 101.63 8.03 Favored 'General case' 0 CA--C 1.563 1.447 0 CA-C-O 122.145 0.974 . . . . 0.0 109.814 162.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.0 m -97.59 124.77 41.99 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.919 0.888 . . . . 0.0 111.96 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.01 124.59 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -115.43 116.38 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.446 -0.784 . . . . 0.0 109.574 -174.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.7 m -115.65 132.41 56.64 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.464 0.706 . . . . 0.0 112.554 -176.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.8 tt -89.11 102.1 14.76 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 123.286 0.634 . . . . 0.0 109.974 171.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -96.1 80.71 3.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.135 -0.978 . . . . 0.0 110.943 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.56 -86.03 1.15 Allowed Glycine 0 N--CA 1.494 2.523 0 O-C-N 121.184 -0.948 . . . . 0.0 114.042 -176.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -136.86 65.14 1.52 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.878 0.847 . . . . 0.0 110.179 154.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -145.81 106.8 4.14 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.6 100.67 13.27 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 121.432 -0.793 . . . . 0.0 110.695 -173.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.1 t -104.03 104.34 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -170.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -90.27 121.68 32.51 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.398 0.679 . . . . 0.0 109.792 173.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.5 mt -113.9 110.23 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -92.83 129.73 38.66 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 122.918 0.487 . . . . 0.0 111.536 171.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -122.07 123.41 41.52 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.553 0.741 . . . . 0.0 110.007 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 17.3 p90 -150.46 123.89 9.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.218 -0.926 . . . . 0.0 110.27 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 53.5 38.21 27.53 Favored 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 117.258 2.318 . . . . 0.0 117.258 174.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.46 -25.39 3.85 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 119.148 2.419 . . . . 0.0 119.148 -165.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -81.77 142.46 32.59 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 119.134 1.467 . . . . 0.0 112.307 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -139.21 123.48 18.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.872 -0.517 . . . . 0.0 111.86 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.3 t -112.66 144.15 42.65 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 123.383 0.673 . . . . 0.0 110.623 167.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -121.34 142.16 50.24 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 172.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -122.3 102.92 8.4 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -175.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 68.8 t -99.35 103.13 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -168.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -97.89 117.21 31.71 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.398 0.679 . . . . 0.0 111.406 -175.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -135.24 133.83 39.39 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.114 0.566 . . . . 0.0 111.378 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.2 mm -83.07 121.05 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.145 -0.972 . . . . 0.0 109.245 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.16 -77.02 0.41 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.796 0.438 . . . . 0.0 111.367 -175.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -133.98 82.83 2.0 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 77.06 -33.73 1.49 Allowed Glycine 0 N--CA 1.497 2.74 0 N-CA-C 118.66 2.224 . . . . 0.0 118.66 -166.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -92.05 142.31 27.66 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 118.329 1.065 . . . . 0.0 111.73 -173.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 9.9 tpp -84.24 115.37 22.42 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 121.802 0.811 . . . . 0.0 110.493 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.5 t -91.23 107.56 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.623 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 167.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 18.8 ttt -99.43 108.19 20.6 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.721 -0.612 . . . . 0.0 109.369 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.0 m -95.86 114.5 26.23 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.5 0.667 . . . . 0.0 109.28 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.1 mp -103.57 120.98 41.94 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.263 8.7 t -136.46 138.47 41.49 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 177.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -106.54 77.66 1.21 Allowed 'General case' 0 CA--C 1.565 1.545 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.058 168.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 69.89 -89.45 0.31 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 115.962 1.145 . . . . 0.0 115.962 -175.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -88.56 -35.49 16.89 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 175.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.8 t -87.27 129.71 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 119.677 1.126 . . . . 0.0 109.616 -170.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 44.9 t -123.79 125.89 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 C-N-CA 123.401 0.68 . . . . 0.0 109.512 -169.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.34 151.69 34.16 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.966 0.906 . . . . 0.0 111.943 164.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 92.2 t -124.19 117.07 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 120.778 -1.201 . . . . 0.0 108.915 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.2 mtp180 -96.62 108.75 21.41 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.275 0.63 . . . . 0.0 109.611 170.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -85.46 136.94 33.23 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.287 0.635 . . . . 0.0 111.753 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -134.37 132.45 39.46 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.653 -0.654 . . . . 0.0 111.799 -173.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -100.69 151.26 21.86 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.288 0.635 . . . . 0.0 112.38 169.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -71.34 128.65 36.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.597 -0.689 . . . . 0.0 111.901 170.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.487 0 C-N-CA 123.833 0.853 . . . . 0.0 112.564 177.713 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 N--CA 1.498 1.925 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.38 -30.21 62.43 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 117.754 2.502 . . . . 0.0 117.754 167.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -74.6 -17.93 60.64 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 117.184 2.29 . . . . 0.0 117.184 167.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 22.6 t -89.29 94.61 9.97 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 120.525 1.511 . . . . 0.0 112.667 -169.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.91 171.34 16.77 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-O 122.059 0.933 . . . . 0.0 112.509 -174.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.2 m -82.22 118.42 23.09 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.695 -1.253 . . . . 0.0 108.779 164.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -114.03 114.71 26.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.474 -0.766 . . . . 0.0 110.704 -172.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -98.82 131.89 44.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.455 -0.778 . . . . 0.0 110.933 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.11 117.38 11.6 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.4 p -89.71 -47.67 7.77 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -142.18 119.22 11.32 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 118.945 0.793 . . . . 0.0 109.91 -173.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.7 p -104.67 99.22 8.89 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.207 0.603 . . . . 0.0 111.559 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -81.87 122.92 28.34 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 123.438 0.695 . . . . 0.0 111.236 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.252 1.9 t30 59.07 23.99 12.24 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 117.818 2.525 . . . . 0.0 117.818 174.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -68.38 -45.53 72.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 119.77 -1.831 . . . . 0.0 115.582 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -46.92 -51.98 15.6 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 170.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.69 -43.81 95.55 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 173.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -51.01 -50.18 59.01 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 164.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.8 mtp -61.75 -39.78 92.81 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 174.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -59.75 -50.34 74.21 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 165.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.77 -38.97 83.32 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 116.933 2.197 . . . . 0.0 116.933 172.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.31 -23.99 67.49 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 171.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.66 35.42 8.49 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 118.088 1.995 . . . . 0.0 118.088 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.7 m -93.08 171.07 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 119.406 1.603 . . . . 0.0 112.062 173.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.54 162.33 54.0 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 117.125 1.61 . . . . 0.0 117.125 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -64.28 -46.06 85.34 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 173.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.67 -40.6 63.03 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 167.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.6 m -64.6 -42.79 95.33 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 169.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.9 mtm-85 -57.99 -43.05 86.36 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 164.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -56.46 -54.61 43.72 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.27 1.395 . . . . 0.0 113.941 167.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.0 t -50.6 -60.64 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 169.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.11 -20.98 58.76 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 120.181 2.832 . . . . 0.0 120.181 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -85.72 -41.12 15.41 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 165.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.254 17.6 m -75.04 -37.3 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 CA-C-N 121.421 1.918 . . . . 0.0 116.008 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 t -97.33 146.81 24.79 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 120.035 1.288 . . . . 0.0 112.682 -174.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 105.33 18.55 Favored Pre-proline 0 CA--C 1.578 2.037 0 O-C-N 121.379 -0.825 . . . . 0.0 111.362 174.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.1 141.68 29.85 Favored 'Trans proline' 0 CA--C 1.564 1.989 0 C-N-CA 122.566 2.177 . . . . 0.0 114.898 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.6 m -108.5 112.66 25.16 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.154 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.9 t -106.35 102.2 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -172.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.3 mt -85.4 103.54 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.1 mt -91.54 105.26 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 175.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.4 p -124.45 165.54 17.59 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 123.849 0.86 . . . . 0.0 112.035 -171.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -126.81 126.19 42.97 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.95 -1.094 . . . . 0.0 110.851 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -114.31 81.51 1.55 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.631 0.729 . . . . 0.0 110.024 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.9 -95.96 0.84 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -89.85 -27.52 19.87 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -102.84 149.38 24.55 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-N 119.826 1.193 . . . . 0.0 113.312 -174.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.5 t -86.64 125.37 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.772 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 165.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.0 106.17 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.2 mt -92.59 120.67 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -103.19 100.97 10.9 Favored 'General case' 0 CA--C 1.561 1.39 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 169.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 50.8 m -87.32 99.14 11.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.639 -0.663 . . . . 0.0 109.384 172.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.7 mp -97.29 97.29 9.02 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.6 t -89.26 34.09 0.8 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 174.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.347 73.0 p 67.78 -58.45 0.44 Allowed 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 -174.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -91.66 -61.27 1.67 Allowed 'General case' 0 CA--C 1.569 1.679 0 C-N-CA 124.923 1.289 . . . . 0.0 110.48 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -87.53 104.9 16.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.514 -0.741 . . . . 0.0 110.542 173.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -108.22 106.91 17.31 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.545 0.688 . . . . 0.0 109.34 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.4 p -119.66 135.52 54.78 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 123.433 0.693 . . . . 0.0 111.458 -157.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -127.02 133.68 50.48 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.096 -1.003 . . . . 0.0 113.501 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.4 pt -133.77 120.37 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 C-N-CA 123.484 0.713 . . . . 0.0 110.851 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 90.1 p -106.77 125.51 51.09 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 124.254 1.022 . . . . 0.0 111.858 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -156.54 148.62 23.09 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.297 -0.877 . . . . 0.0 112.795 -168.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -98.61 21.71 10.91 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 117.623 2.453 . . . . 0.0 117.623 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.7 mt 67.62 112.73 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 125.138 1.375 . . . . 0.0 114.027 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.19 -26.04 4.04 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 117.998 1.959 . . . . 0.0 117.998 -162.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -75.91 126.94 31.95 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 124.711 1.204 . . . . 0.0 111.941 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -72.87 141.64 47.93 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -141.76 143.61 33.57 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.934 0.894 . . . . 0.0 110.306 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.85 134.81 35.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.536 -1.352 . . . . 0.0 111.516 172.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -133.13 105.56 7.1 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.058 0.543 . . . . 0.0 110.554 -172.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.7 m -76.31 104.72 6.97 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.423 -0.798 . . . . 0.0 108.958 167.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.0 p -78.82 -178.1 5.82 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -165.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.2 -12.63 3.76 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 118.968 2.951 . . . . 0.0 118.968 168.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -120.19 43.33 2.73 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 119.572 -1.955 . . . . 0.0 113.421 155.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.285 10.5 t70 65.91 -1.22 1.15 Allowed 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 119.374 3.101 . . . . 0.0 119.374 168.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.3 ptt85 -76.46 123.21 25.67 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.37 -1.456 . . . . 0.0 110.978 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -80.12 106.06 11.85 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.888 0.875 . . . . 0.0 112.819 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.0 m -110.03 117.92 35.03 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -167.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -67.6 103.05 1.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.812 0.845 . . . . 0.0 110.338 169.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.6 m -115.92 122.48 45.44 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 121.843 -0.535 . . . . 0.0 111.68 -158.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 99.3 t -115.25 116.0 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.4 t -96.42 108.75 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 173.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.4 p -112.01 117.16 31.92 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.536 0.735 . . . . 0.0 111.599 -173.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tt -84.1 96.49 8.93 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.086 -1.009 . . . . 0.0 110.135 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -91.27 73.76 6.19 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 121.433 -0.792 . . . . 0.0 111.62 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.34 -86.88 1.49 Allowed Glycine 0 N--CA 1.49 2.274 0 O-C-N 121.828 -0.545 . . . . 0.0 113.441 -175.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -132.24 50.62 2.22 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 168.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -153.6 121.12 5.89 Favored 'General case' 0 CA--C 1.564 1.509 0 O-C-N 120.61 -1.306 . . . . 0.0 110.511 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.8 mt -83.56 106.91 15.67 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.758 0.823 . . . . 0.0 111.116 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.2 t -103.21 100.02 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -173.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -86.34 104.46 15.87 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.745 0.818 . . . . 0.0 110.895 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.4 mt -99.31 100.47 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -172.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -87.4 125.67 34.41 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 118.835 0.743 . . . . 0.0 111.53 174.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -116.54 117.88 31.11 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 123.839 0.856 . . . . 0.0 110.387 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.3 p90 -148.42 129.78 14.74 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.866 -1.146 . . . . 0.0 110.716 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 53.69 42.13 31.91 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 166.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.03 17.03 71.33 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 119.893 2.717 . . . . 0.0 119.893 -166.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -132.66 143.13 49.44 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 119.243 1.521 . . . . 0.0 110.042 -170.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -138.55 131.45 29.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.525 -0.734 . . . . 0.0 112.245 -174.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 t -128.07 129.98 47.49 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.563 0.745 . . . . 0.0 109.309 169.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.24 128.78 54.74 Favored 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 123.122 0.569 . . . . 0.0 111.111 174.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -106.58 106.95 17.72 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.1 t -88.78 109.45 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -105.69 102.23 11.69 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.989 0.916 . . . . 0.0 110.374 -174.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.49 141.82 51.75 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.788 0.835 . . . . 0.0 112.532 -168.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.8 mm -80.77 117.93 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 120.82 -1.175 . . . . 0.0 109.619 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.45 89.87 3.17 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 171.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.5 t70 50.15 66.12 1.24 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.6 -48.5 3.33 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 117.435 1.734 . . . . 0.0 117.435 -171.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -83.36 142.87 30.72 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 118.904 1.352 . . . . 0.0 112.818 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.0 ttt -90.65 111.46 22.81 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.843 0.83 . . . . 0.0 110.303 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 69.4 t -93.93 108.6 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.56 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 23.9 ttt -89.65 112.52 23.79 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.704 0.802 . . . . 0.0 109.78 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.2 m -100.44 111.24 23.48 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mp -104.79 112.64 25.82 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.428 1.091 . . . . 0.0 108.139 -172.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.267 13.2 t -131.47 142.0 49.9 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -122.75 81.42 1.86 Allowed 'General case' 0 CA--C 1.564 1.507 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.76 173.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 71.18 -92.98 0.5 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 115.579 0.992 . . . . 0.0 115.579 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -86.89 -37.01 18.09 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.3 t -82.01 134.28 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-N 119.343 0.974 . . . . 0.0 110.157 -171.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.5 t -129.4 121.22 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -175.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.14 154.45 23.29 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 123.548 0.739 . . . . 0.0 112.44 164.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.3 t -132.41 113.47 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.146 -0.971 . . . . 0.0 109.25 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -106.12 124.33 49.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.176 -0.953 . . . . 0.0 110.856 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -108.62 115.68 30.55 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 123.252 0.621 . . . . 0.0 110.602 -165.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -114.69 133.21 56.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.794 -1.191 . . . . 0.0 113.22 -166.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -98.94 153.81 18.54 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 123.338 0.655 . . . . 0.0 112.626 166.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -74.27 135.29 42.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.176 0 CA-C-O 117.923 -1.037 . . . . 0.0 112.225 170.598 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.358 9.0 tt0 . . . . . 0 N--CA 1.497 1.891 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.28 -29.35 68.76 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 153.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -82.12 -6.28 59.06 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 169.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.6 t -74.86 91.34 2.44 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-N 122.194 2.27 . . . . 0.0 113.644 -172.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -168.29 169.2 10.96 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-O 122.243 1.02 . . . . 0.0 112.27 -170.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.6 m -86.71 123.09 31.49 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.238 -0.914 . . . . 0.0 108.907 167.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -118.37 118.69 32.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.427 -0.796 . . . . 0.0 111.026 -171.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -104.15 136.98 42.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.04 -1.037 . . . . 0.0 111.113 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.25 121.04 14.8 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.1 p -108.93 -26.07 10.41 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -150.61 113.82 4.85 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 121.037 1.744 . . . . 0.0 109.484 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.7 p -94.47 89.38 5.82 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 122.454 1.121 . . . . 0.0 111.936 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -88.76 110.22 20.82 Favored 'General case' 0 CA--C 1.563 1.45 0 O-C-N 121.079 -1.013 . . . . 0.0 110.93 -170.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.262 56.4 t30 62.88 35.37 13.57 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 -174.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -83.17 66.08 8.55 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 123.747 1.737 . . . . 0.0 111.845 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -165.07 -68.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.99 -1.459 . . . . 0.0 107.728 -156.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -65.61 -42.32 91.73 Favored 'General case' 0 CA--C 1.565 1.525 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 172.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -46.41 -52.41 13.04 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 163.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.481 ' SD ' HG11 ' A' ' 25' ' ' VAL . 22.8 mmt -60.22 -49.98 75.48 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 175.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.5 -46.43 76.95 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 168.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.41 -35.88 76.19 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 117.581 2.437 . . . . 0.0 117.581 175.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 tt -62.81 -39.19 93.51 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 171.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.63 55.68 1.31 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 114.808 0.683 . . . . 0.0 114.808 -169.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.481 HG11 ' SD ' ' A' ' 20' ' ' MET . 26.9 m -90.42 163.24 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-O 122.329 1.061 . . . . 0.0 112.055 173.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.88 142.04 31.37 Favored Glycine 0 CA--C 1.55 2.249 0 O-C-N 121.007 -1.058 . . . . 0.0 113.444 160.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -59.37 -41.16 88.66 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.96 -41.15 64.26 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 165.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.0 m -58.39 -50.36 73.96 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 120.201 1.364 . . . . 0.0 114.231 170.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.269 5.7 ptt180 -62.44 -36.25 81.82 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 172.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -63.16 -50.9 68.56 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 166.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.4 t -46.57 -48.96 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.81 -30.22 66.29 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 119.404 2.521 . . . . 0.0 119.404 170.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -76.68 -46.42 25.69 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 119.8 1.8 . . . . 0.0 115.238 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.259 28.3 m -89.16 47.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 CA-C-N 121.254 1.843 . . . . 0.0 113.715 175.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.6 t -145.18 161.72 38.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.116 -0.99 . . . . 0.0 111.922 172.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -102.27 91.32 2.51 Favored Pre-proline 0 CA--C 1.574 1.868 0 O-C-N 121.38 -0.825 . . . . 0.0 109.545 162.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.44 123.68 7.23 Favored 'Trans proline' 0 C--N 1.373 1.825 0 CA-C-N 122.684 1.994 . . . . 0.0 112.827 -174.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.0 m -101.01 102.74 13.8 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -173.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.6 t -95.85 102.96 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -171.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.0 mt -90.7 110.79 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.0 mt -94.29 122.64 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 170.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.7 p -134.83 143.8 47.24 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.178 0.591 . . . . 0.0 112.298 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -99.35 113.29 25.53 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.019 -1.051 . . . . 0.0 109.157 168.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -113.33 90.55 3.37 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.468 -0.77 . . . . 0.0 110.316 -174.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.84 -77.39 1.79 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 115.317 0.887 . . . . 0.0 115.317 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -117.96 -54.94 2.3 Favored 'General case' 0 CA--C 1.567 1.614 0 C-N-CA 123.712 0.805 . . . . 0.0 111.819 171.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -79.2 157.9 27.76 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -173.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.9 t -89.81 124.7 42.62 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.601 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.0 t -114.42 105.7 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 76.9 mt -97.05 120.64 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -106.37 101.69 11.14 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.62 0.724 . . . . 0.0 109.837 171.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.3 m -84.33 98.54 10.07 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 170.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 63.9 mt -94.24 93.52 7.8 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -174.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.8 t -79.57 18.04 0.8 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 118.313 2.708 . . . . 0.0 118.313 -174.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.441 7.4 p 63.61 -60.72 0.17 Allowed 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 125.26 1.424 . . . . 0.0 114.739 -163.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -66.03 -46.17 78.83 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 173.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.69 119.78 7.73 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 119.125 0.875 . . . . 0.0 110.216 -165.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -104.52 112.52 25.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.318 -0.864 . . . . 0.0 111.901 -166.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 p -105.82 110.67 23.04 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.714 -0.616 . . . . 0.0 110.808 -170.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -109.35 107.66 17.93 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.21 1.004 . . . . 0.0 110.64 -175.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.5 pt -109.55 121.15 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 C-N-CA 123.491 0.716 . . . . 0.0 110.496 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 97.2 p -110.72 111.44 22.63 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.228 1.011 . . . . 0.0 110.882 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -148.37 151.4 35.24 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.062 0.934 . . . . 0.0 112.89 -165.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -86.3 148.7 25.5 Favored 'General case' 0 CA--C 1.571 1.765 0 O-C-N 121.211 -0.931 . . . . 0.0 111.06 162.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 73.3 mt -71.05 124.67 24.93 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.237 -1.539 . . . . 0.0 111.922 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.35 -3.45 86.57 Favored Glycine 0 CA--C 1.556 2.628 0 N-CA-C 119.081 2.392 . . . . 0.0 119.081 -162.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -86.95 124.57 33.3 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 120.066 1.933 . . . . 0.0 110.761 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -87.25 107.85 18.68 Favored 'General case' 0 CA--C 1.565 1.535 0 O-C-N 121.877 -0.515 . . . . 0.0 110.91 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -112.88 159.88 18.6 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.379 1.072 . . . . 0.0 111.825 -175.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -83.3 137.67 33.88 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.423 -1.423 . . . . 0.0 111.952 171.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -129.96 111.71 12.8 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.287 0.635 . . . . 0.0 109.798 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.8 m -74.89 96.59 3.15 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 122.023 0.916 . . . . 0.0 109.709 170.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 80.5 p -74.08 173.99 9.28 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -167.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.18 -5.43 1.08 Allowed 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 119.442 3.126 . . . . 0.0 119.442 167.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -95.17 -8.28 36.77 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 159.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.318 3.2 m-20 80.5 12.22 0.94 Allowed 'General case' 0 N--CA 1.507 2.417 0 CA-C-N 121.513 1.96 . . . . 0.0 116.18 -166.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -91.78 130.48 37.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.444 -1.41 . . . . 0.0 110.176 173.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -82.32 110.99 17.97 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.15 0.5 . . . . 0.0 110.973 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 93.4 m -103.71 118.95 37.91 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -173.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -69.81 104.95 2.6 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.906 0.86 . . . . 0.0 110.56 171.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.3 m -120.22 117.61 28.32 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.894 -156.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.2 p -109.01 118.45 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.225 0.536 . . . . 0.0 109.757 175.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.6 t -96.81 110.5 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 173.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 79.6 p -110.44 131.19 55.27 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.706 0.802 . . . . 0.0 110.906 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -83.15 120.39 25.73 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.957 -1.089 . . . . 0.0 109.787 161.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -122.91 72.55 1.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.108 -169.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.61 60.81 8.23 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 117.071 1.588 . . . . 0.0 117.071 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.347 5.5 m-20 92.08 -31.74 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 -167.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -97.28 124.17 41.31 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 120.897 1.68 . . . . 0.0 112.322 -170.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.8 mt -81.03 103.75 11.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.162 -0.961 . . . . 0.0 110.745 170.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.0 t -104.72 106.04 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.715 -1.241 . . . . 0.0 107.733 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -93.87 105.79 17.79 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.029 0.932 . . . . 0.0 110.148 177.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.33 104.46 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 123.354 0.661 . . . . 0.0 109.383 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -85.15 125.61 32.95 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 118.887 0.767 . . . . 0.0 111.626 171.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -116.08 126.42 53.73 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.317 0.647 . . . . 0.0 110.575 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 15.6 p90 -150.18 124.49 9.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.351 -0.843 . . . . 0.0 110.492 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 55.99 33.72 22.33 Favored 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 117.087 2.254 . . . . 0.0 117.087 173.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.8 -18.23 21.84 Favored Glycine 0 CA--C 1.559 2.805 0 N-CA-C 119.325 2.49 . . . . 0.0 119.325 -164.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -89.17 145.46 25.41 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-N 119.489 1.644 . . . . 0.0 112.836 -175.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -130.25 129.29 43.12 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.747 0.819 . . . . 0.0 110.709 -174.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.2 t -123.9 129.01 50.29 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.643 -0.66 . . . . 0.0 109.327 159.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.95 127.01 56.1 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.412 0.685 . . . . 0.0 110.709 175.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -106.43 102.39 11.79 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -175.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.4 t -88.19 102.8 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -173.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -108.35 110.47 22.04 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.076 0.95 . . . . 0.0 109.015 -169.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -129.73 137.68 50.7 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -170.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.1 mm -77.0 99.38 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 171.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -109.99 111.09 22.27 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.8 t70 47.12 52.83 11.45 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -171.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.02 -23.99 4.18 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 119.599 2.6 . . . . 0.0 119.599 -170.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -94.06 136.24 34.56 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 119.522 1.661 . . . . 0.0 111.454 -172.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 50.1 ttp -81.01 102.72 10.36 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.253 1.025 . . . . 0.0 110.167 172.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 87.5 t -89.52 101.76 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 46.6 ttm -87.37 101.02 13.16 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.536 0.735 . . . . 0.0 109.476 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 93.1 m -91.56 101.42 14.06 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.888 0.851 . . . . 0.0 108.737 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 mp -88.83 117.87 28.13 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.307 6.5 t -137.94 133.66 34.01 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 175.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -99.01 89.9 4.44 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.342 171.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 71.86 -86.75 0.46 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 114.952 0.741 . . . . 0.0 114.952 -172.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -127.75 3.67 6.07 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 174.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.4 125.11 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-N 121.82 2.1 . . . . 0.0 107.994 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.1 t -120.6 130.56 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.816 -0.553 . . . . 0.0 111.139 -162.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.28 148.59 35.31 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 123.484 0.714 . . . . 0.0 111.588 156.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.3 t -125.64 107.5 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 120.743 -1.223 . . . . 0.0 108.807 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -95.62 120.26 35.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.213 -0.929 . . . . 0.0 111.139 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -97.73 97.91 9.41 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.367 0.603 . . . . 0.0 110.131 -172.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -94.53 135.62 35.77 Favored 'General case' 0 CA--C 1.561 1.403 0 O-C-N 121.353 -0.842 . . . . 0.0 112.024 -174.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -122.66 154.87 37.46 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.481 0.712 . . . . 0.0 111.454 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -72.02 136.86 46.85 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -172.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.194 0 C-N-CA 124.183 0.993 . . . . 0.0 111.363 170.321 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 N--CA 1.499 2.007 0 N-CA-C 116.358 1.984 . . . . 0.0 116.358 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.11 -29.38 30.5 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 118.201 2.667 . . . . 0.0 118.201 164.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -82.49 -9.78 59.28 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 169.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.6 t -73.59 102.62 3.93 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-N 122.054 2.206 . . . . 0.0 114.004 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -172.17 163.59 5.9 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 122.211 1.005 . . . . 0.0 111.788 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.2 m -78.84 122.64 26.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.015 -1.053 . . . . 0.0 108.375 153.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -106.14 115.79 30.82 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.085 -1.01 . . . . 0.0 110.218 -175.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -92.5 129.8 38.34 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.646 0.778 . . . . 0.0 111.272 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 tt -73.05 113.21 9.84 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-O 121.353 0.597 . . . . 0.0 112.526 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.0 p -85.25 -45.84 11.6 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -148.51 117.33 6.69 Favored 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 123.785 0.834 . . . . 0.0 109.734 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.7 p -99.91 98.54 9.3 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.126 0.57 . . . . 0.0 111.535 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -80.05 122.1 26.34 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 123.437 0.695 . . . . 0.0 111.261 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 t30 55.32 38.19 29.98 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 118.15 2.648 . . . . 0.0 118.15 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -78.97 -35.94 42.27 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -176.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -50.18 -59.56 3.81 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 172.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -59.06 -37.66 77.57 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 171.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -57.66 -48.39 79.63 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 115.448 1.648 . . . . 0.0 115.448 168.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -57.85 -49.4 76.8 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 167.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -44.26 65.32 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 168.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.61 -41.33 98.32 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 170.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.37 -13.0 24.55 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 118.406 2.743 . . . . 0.0 118.406 170.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.75 55.61 1.75 Allowed Glycine 0 N--CA 1.485 1.931 0 CA-C-N 119.329 0.968 . . . . 0.0 115.342 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.3 m -95.44 146.43 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 117.565 0.682 . . . . 0.0 112.221 175.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.23 144.95 35.38 Favored Glycine 0 CA--C 1.551 2.298 0 N-CA-C 115.277 0.871 . . . . 0.0 115.277 169.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -78.92 60.75 2.95 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 123.311 1.529 . . . . 0.0 114.237 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -165.57 -55.24 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 126.418 1.887 . . . . 0.0 108.63 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.1 m -40.46 -40.0 1.12 Allowed 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 160.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.329 0.0 OUTLIER -94.01 -2.38 53.11 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 119.436 3.124 . . . . 0.0 119.436 172.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -65.37 -46.5 79.9 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 120.815 1.643 . . . . 0.0 112.599 151.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.7 t -52.29 -55.01 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 160.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.97 -40.64 91.3 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 120.548 2.979 . . . . 0.0 120.548 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -72.06 -33.45 67.97 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 175.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.3 m -69.81 -35.45 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.6 t -86.96 137.44 32.36 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -91.22 117.57 67.94 Favored Pre-proline 0 CA--C 1.576 1.963 0 CA-C-O 117.851 -1.071 . . . . 0.0 111.0 166.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -76.06 127.31 9.88 Favored 'Trans proline' 0 CA--C 1.562 1.907 0 CA-C-N 123.404 2.251 . . . . 0.0 115.356 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.9 m -99.28 123.24 43.41 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.079 0.952 . . . . 0.0 109.015 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.9 t -105.82 106.51 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.55 -0.718 . . . . 0.0 109.537 -168.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.8 mt -90.79 106.66 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 120.141 -1.599 . . . . 0.0 108.273 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 81.6 mt -90.38 111.55 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.2 p -135.67 119.76 17.63 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -169.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -90.9 116.72 28.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.324 -0.86 . . . . 0.0 111.842 -171.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -114.55 79.97 1.34 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.477 0.656 . . . . 0.0 110.543 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.2 -97.35 0.66 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 115.509 0.964 . . . . 0.0 115.509 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.36 -41.55 69.6 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 170.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -113.08 153.36 28.31 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-O 122.164 0.983 . . . . 0.0 113.41 -160.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.2 t -89.23 115.67 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.651 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 167.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.22 100.86 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 175.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 58.9 mt -94.28 114.25 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -98.91 102.97 14.88 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 122.979 0.512 . . . . 0.0 110.054 174.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.8 m -87.89 101.48 13.77 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.534 0.683 . . . . 0.0 109.187 173.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.6 mt -96.74 96.88 8.89 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.385 0.674 . . . . 0.0 109.396 -175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -83.73 22.38 1.12 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 175.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.418 20.5 p 63.23 -62.1 0.14 Allowed 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 125.59 1.556 . . . . 0.0 114.755 -167.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -76.76 -37.79 55.27 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 173.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -120.5 124.81 46.3 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 119.49 1.041 . . . . 0.0 110.945 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -93.83 104.33 16.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.034 -1.041 . . . . 0.0 109.207 164.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.255 13.6 t -107.57 87.07 2.42 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.013 0.911 . . . . 0.0 109.617 174.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -106.2 142.63 35.57 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -172.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.9 pt -133.83 123.01 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 C-N-CA 123.044 0.537 . . . . 0.0 111.711 -168.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.9 p -109.99 107.63 17.58 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.812 0.845 . . . . 0.0 110.742 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -140.91 150.47 43.21 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.597 0.713 . . . . 0.0 112.543 -169.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -95.8 98.23 10.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.159 -0.963 . . . . 0.0 109.819 170.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.7 mt -6.07 109.12 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 120.513 3.523 . . . . 0.0 120.513 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.92 -18.83 45.41 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 118.97 2.348 . . . . 0.0 118.97 -167.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.36 127.76 33.87 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 119.716 1.758 . . . . 0.0 111.834 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -79.03 127.77 32.42 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -137.67 150.43 47.35 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.698 0.761 . . . . 0.0 111.42 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -75.85 132.98 40.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.899 -1.126 . . . . 0.0 112.101 170.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -133.09 111.05 10.63 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.238 0.615 . . . . 0.0 110.149 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 95.0 m -82.19 109.66 16.68 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 165.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 51.2 p -82.96 -177.64 6.84 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -165.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.02 -16.6 32.36 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 118.773 2.879 . . . . 0.0 118.773 168.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -79.55 -14.93 58.51 Favored 'General case' 0 CA--C 1.579 2.068 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 157.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.331 5.0 t70 75.88 14.83 2.6 Favored 'General case' 0 CA--C 1.58 2.129 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -160.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.0 ptt-85 -83.34 124.1 30.29 Favored 'General case' 0 CA--C 1.565 1.553 0 O-C-N 120.084 -1.635 . . . . 0.0 109.737 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -85.7 118.07 24.97 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.149 0.58 . . . . 0.0 112.417 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.9 p -122.33 145.64 48.06 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -76.81 105.05 7.64 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.807 0.813 . . . . 0.0 109.709 160.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.7 m -99.53 124.92 45.15 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.536 0.735 . . . . 0.0 112.324 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.31 118.01 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 36.1 t -119.71 95.25 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.36 -0.838 . . . . 0.0 109.073 -171.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.7 m -113.64 130.32 56.42 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.648 0.779 . . . . 0.0 111.612 -169.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 tt -85.29 109.07 18.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.12 -0.988 . . . . 0.0 110.456 170.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -90.57 -16.51 28.63 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 -176.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 176.86 -88.05 0.08 OUTLIER Glycine 0 N--CA 1.49 2.235 0 CA-C-N 120.075 1.307 . . . . 0.0 110.954 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -101.92 32.12 3.58 Favored 'General case' 0 CA--C 1.579 2.071 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 158.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -146.23 114.18 6.52 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.874 0.761 . . . . 0.0 109.951 -159.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 mt -90.2 102.27 14.99 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 123.72 0.808 . . . . 0.0 109.625 172.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.6 t -100.12 105.45 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.149 -0.969 . . . . 0.0 108.603 -170.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -95.04 101.07 12.8 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.427 0.691 . . . . 0.0 110.369 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 59.4 mt -89.47 122.79 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 C-N-CA 123.959 0.903 . . . . 0.0 108.76 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -111.37 123.42 50.18 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 119.477 1.035 . . . . 0.0 110.732 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -113.34 117.84 32.93 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.959 0.904 . . . . 0.0 109.771 -176.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -150.65 127.05 10.71 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.648 -1.282 . . . . 0.0 111.496 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 56.63 32.27 20.69 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 174.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.68 -27.15 4.9 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 118.432 2.133 . . . . 0.0 118.432 -162.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -80.99 140.71 35.03 Favored 'General case' 0 CA--C 1.562 1.426 0 CA-C-N 119.121 1.461 . . . . 0.0 112.158 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -131.26 126.71 36.14 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.235 0.614 . . . . 0.0 110.128 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.7 t -122.3 156.26 34.23 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.413 0.685 . . . . 0.0 110.743 171.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.283 9.7 p30 -135.47 146.24 47.98 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 170.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -120.16 106.14 11.66 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.7 t -90.82 98.38 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -92.23 97.7 11.06 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -176.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -117.08 130.54 56.72 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -168.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.1 mm -74.94 111.04 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.12 -91.05 0.18 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 119.399 -0.334 . . . . 0.0 110.14 -173.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -104.7 70.43 0.93 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 119.342 0.974 . . . . 0.0 108.851 164.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.64 -39.95 2.85 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 118.128 2.011 . . . . 0.0 118.128 -169.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -84.34 144.9 28.54 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.256 1.028 . . . . 0.0 113.262 -173.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 55.8 ttp -84.05 100.32 11.02 Favored 'General case' 0 CA--C 1.561 1.394 0 CA-C-O 122.291 1.043 . . . . 0.0 110.204 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.1 t -85.38 102.76 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 43.1 ttm -86.89 101.36 13.31 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.213 0.605 . . . . 0.0 109.676 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.7 m -90.87 110.1 21.32 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 174.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.5 mp -99.37 119.75 38.46 Favored 'General case' 0 CA--C 1.56 1.339 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -176.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.0 t -125.56 124.2 40.75 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 119.406 1.003 . . . . 0.0 112.646 -171.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -137.19 97.14 3.42 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 123.816 0.846 . . . . 0.0 110.51 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 77.32 -94.2 1.13 Allowed Glycine 0 N--CA 1.492 2.374 0 O-C-N 121.433 -0.792 . . . . 0.0 114.084 170.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -128.39 42.84 3.25 Favored 'General case' 0 CA--C 1.578 2.033 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 160.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 81.4 t -136.88 118.94 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 -177.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.84 131.09 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.05 157.07 21.19 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 123.088 0.555 . . . . 0.0 112.481 163.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.3 t -132.58 109.21 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.032 -1.043 . . . . 0.0 108.99 175.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -100.24 114.41 27.84 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.804 0.811 . . . . 0.0 110.748 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -95.83 106.01 18.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.66 -0.65 . . . . 0.0 110.145 -170.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -105.58 128.19 53.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.889 -1.132 . . . . 0.0 113.391 -168.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -99.41 156.52 16.97 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 124.062 0.945 . . . . 0.0 113.352 173.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -77.72 130.05 36.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.152 -0.967 . . . . 0.0 113.285 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.166 0 C-N-CA 124.493 1.117 . . . . 0.0 110.859 162.693 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.12 -23.78 62.43 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 166.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -78.71 -18.07 54.89 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 167.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 71.9 m -73.94 92.16 2.08 Favored 'General case' 0 CA--C 1.568 1.671 0 CA-C-N 122.284 2.311 . . . . 0.0 113.855 -173.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.66 166.6 13.83 Favored 'General case' 0 CA--C 1.571 1.754 0 CA-C-O 122.423 1.106 . . . . 0.0 112.328 -170.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.3 m -84.86 111.87 20.03 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.342 -0.849 . . . . 0.0 109.18 166.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -105.87 118.68 37.22 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.912 0.485 . . . . 0.0 110.603 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -103.32 137.83 40.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.14 -0.975 . . . . 0.0 111.628 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -72.78 129.94 39.34 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.0 p -102.18 -37.5 8.1 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -158.15 117.57 3.21 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 119.602 1.092 . . . . 0.0 109.33 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.1 p -97.02 89.4 4.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.726 -0.609 . . . . 0.0 111.562 171.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.99 124.32 29.67 Favored 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 123.763 0.825 . . . . 0.0 111.283 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.307 11.3 t-20 61.89 10.29 3.45 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 118.316 2.71 . . . . 0.0 118.316 -174.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -62.2 -33.61 74.88 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 116.635 2.087 . . . . 0.0 116.635 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -51.99 -52.67 49.03 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 166.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -63.81 -42.98 97.56 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 172.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -52.49 -52.31 55.09 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 166.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 78.9 mtm -58.98 -48.79 80.3 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 173.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -54.24 -48.3 71.28 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 169.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.3 -38.21 82.93 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 tp -72.3 -1.92 17.17 Favored 'General case' 0 CA--C 1.579 2.061 0 N-CA-C 117.905 2.557 . . . . 0.0 117.905 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.22 48.9 5.2 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 117.101 1.6 . . . . 0.0 117.101 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.468 HG21 ' HB2' ' A' ' 30' ' ' ARG . 24.1 m -82.42 131.49 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 173.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.64 58.04 4.9 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 116.65 1.42 . . . . 0.0 116.65 173.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.288 25.8 t80 63.35 -58.33 0.17 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.647 2.091 . . . . 0.0 116.647 -175.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.33 -46.97 76.34 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 116.939 2.2 . . . . 0.0 116.939 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.2 m -63.9 -33.47 75.78 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 172.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.468 ' HB2' HG21 ' A' ' 25' ' ' VAL . 3.7 tmt_? -60.17 -53.75 53.96 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 162.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.89 -37.25 86.69 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.5 t -53.68 -62.27 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 C-N-CA 123.804 0.841 . . . . 0.0 112.684 156.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.54 -35.45 45.08 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 120.337 2.895 . . . . 0.0 120.337 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -69.47 -47.49 63.76 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 172.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.3 m -78.04 -33.35 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.5 t -83.39 147.14 28.06 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 119.274 0.943 . . . . 0.0 113.203 -172.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -107.21 91.11 6.28 Favored Pre-proline 0 CA--C 1.572 1.811 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -77.68 118.25 4.48 Favored 'Trans proline' 0 C--N 1.372 1.793 0 CA-C-N 122.463 1.915 . . . . 0.0 113.616 -169.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.4 m -88.15 123.15 32.52 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.913 0.863 . . . . 0.0 110.577 -172.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.0 t -100.48 101.64 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -173.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 64.9 mt -92.76 111.31 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.2 mt -101.84 121.36 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.2 t -143.24 -172.73 3.75 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-O 122.509 1.147 . . . . 0.0 111.819 173.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -135.28 118.19 16.26 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.334 1.054 . . . . 0.0 109.472 -176.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -100.49 91.75 4.83 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.65 0.738 . . . . 0.0 110.953 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.55 -74.8 1.48 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 115.904 1.122 . . . . 0.0 115.904 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -121.58 -45.97 2.28 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -88.3 155.94 19.45 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 120.368 1.44 . . . . 0.0 114.148 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.0 t -90.4 133.46 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 C-N-CA 123.47 0.708 . . . . 0.0 109.305 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 93.7 t -114.7 117.42 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.9 mt -95.28 107.88 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.693 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 162.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -78.91 149.75 32.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.65 -1.281 . . . . 0.0 110.161 156.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.6 m -147.63 99.52 3.12 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.282 -1.511 . . . . 0.0 107.93 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.8 mt -117.97 103.28 9.77 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.703 0.763 . . . . 0.0 110.443 -154.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.7 t -82.36 163.15 21.91 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 122.27 1.033 . . . . 0.0 112.655 168.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.8 p -57.36 15.19 0.0 OUTLIER 'General case' 0 CA--C 1.591 2.556 0 N-CA-C 118.003 2.594 . . . . 0.0 118.003 153.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -146.32 -69.09 0.26 Allowed 'General case' 0 CA--C 1.57 1.744 0 C-N-CA 124.977 1.311 . . . . 0.0 107.877 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -100.34 121.71 41.95 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.944 0.898 . . . . 0.0 111.867 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -96.54 82.26 3.33 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.848 0.832 . . . . 0.0 111.043 174.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.5 p -85.41 155.91 21.07 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -168.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -142.67 134.24 26.55 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.479 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 8.2 mt -128.98 102.72 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 -174.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 92.0 p -104.75 123.47 47.7 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 123.923 0.889 . . . . 0.0 111.83 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -148.77 142.37 25.44 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.116 0.96 . . . . 0.0 112.773 -168.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -84.76 11.95 8.17 Favored 'General case' 0 CA--C 1.58 2.1 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.263 65.0 mt 64.85 105.54 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 125.556 1.542 . . . . 0.0 113.35 -168.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.16 35.87 36.9 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 118.352 2.101 . . . . 0.0 118.352 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -135.4 135.49 40.66 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 118.467 1.134 . . . . 0.0 110.089 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -89.45 116.61 27.76 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -171.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.479 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 46.4 p90 -116.42 141.25 48.42 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.889 0.876 . . . . 0.0 111.054 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.61 135.38 43.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.567 -1.333 . . . . 0.0 111.907 170.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -134.11 105.21 6.57 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -171.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.2 m -79.83 100.52 8.04 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 122.106 0.955 . . . . 0.0 109.31 172.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 77.8 p -76.38 174.64 9.98 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -169.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.84 -2.53 0.57 Allowed 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 119.885 3.291 . . . . 0.0 119.885 167.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -103.02 4.1 36.92 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 115.594 1.702 . . . . 0.0 115.594 158.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.29 3.4 t70 62.65 25.9 15.37 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 -166.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.8 ptp85 -89.65 126.01 35.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.642 -1.286 . . . . 0.0 109.117 166.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -85.66 101.49 12.78 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-O 121.811 0.815 . . . . 0.0 111.384 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 99.0 m -102.19 116.79 33.4 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 121.395 0.616 . . . . 0.0 112.654 -169.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -66.19 102.47 0.84 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.24 1.016 . . . . 0.0 110.37 169.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.5 m -114.09 125.24 53.75 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 121.849 -0.532 . . . . 0.0 111.48 -156.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.78 122.15 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.8 t -109.03 121.86 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.224 -0.922 . . . . 0.0 109.337 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 94.7 p -118.0 140.92 49.05 Favored 'General case' 0 CA--C 1.564 1.504 0 C-N-CA 123.956 0.902 . . . . 0.0 111.963 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.8 tp -92.91 98.37 11.33 Favored 'General case' 0 CA--C 1.566 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 110.302 174.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -91.59 73.55 5.92 Favored 'General case' 0 CA--C 1.569 1.691 0 O-C-N 121.364 -0.835 . . . . 0.0 111.795 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.25 62.44 4.42 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 116.398 1.319 . . . . 0.0 116.398 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.256 6.6 t70 54.06 47.19 23.88 Favored 'General case' 0 CA--C 1.579 2.086 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -163.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -143.82 107.02 4.52 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.0 mt -82.08 95.2 7.39 Favored 'General case' 0 CA--C 1.568 1.648 0 CA-C-O 121.835 0.826 . . . . 0.0 111.7 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.7 t -97.03 103.18 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -84.93 125.71 32.9 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.035 0.534 . . . . 0.0 110.089 172.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.6 mt -112.39 118.12 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -101.79 126.29 48.63 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 119.296 0.953 . . . . 0.0 111.343 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -114.8 123.14 48.46 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.962 0.905 . . . . 0.0 110.496 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -149.67 122.71 8.83 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.421 -1.424 . . . . 0.0 110.581 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 54.26 39.9 31.24 Favored 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.1 -25.38 4.23 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 118.936 2.335 . . . . 0.0 118.936 -165.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -83.17 141.11 32.17 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-N 119.354 1.577 . . . . 0.0 112.115 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -134.18 125.89 28.81 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 122.969 0.507 . . . . 0.0 111.166 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.9 t -118.98 154.66 32.69 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.764 0.826 . . . . 0.0 110.612 169.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.31 10.8 p30 -134.77 152.42 51.75 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 171.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -126.87 102.91 7.22 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -169.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.8 t -95.19 94.02 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -168.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -81.9 123.67 29.04 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.95 0.9 . . . . 0.0 110.771 176.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -144.31 123.56 13.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.667 -0.646 . . . . 0.0 109.945 -167.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.3 mm -78.09 103.76 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.429 -0.795 . . . . 0.0 109.132 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -131.05 113.86 14.47 Favored 'General case' 0 CA--C 1.558 1.287 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -170.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.5 t70 47.93 50.53 15.64 Favored 'General case' 0 CA--C 1.579 2.094 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -168.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.75 -43.48 3.17 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 -169.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.2 mtmp? -85.75 150.88 24.27 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 118.463 1.132 . . . . 0.0 113.602 -171.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 59.1 ttp -85.23 98.65 10.61 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 121.83 0.824 . . . . 0.0 109.499 171.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.1 81.81 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 120.954 -1.092 . . . . 0.0 108.73 -171.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 23.2 ttp -76.97 112.94 14.13 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.078 0.551 . . . . 0.0 111.58 -166.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.4 m -98.44 114.02 26.23 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.803 0.811 . . . . 0.0 109.777 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.34 106.54 17.72 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 124.238 1.015 . . . . 0.0 108.788 -173.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.7 t -115.6 118.84 34.23 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.407 0.622 . . . . 0.0 111.754 -175.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -105.37 81.68 1.73 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 165.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 68.68 -89.25 0.22 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 115.439 0.936 . . . . 0.0 115.439 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -95.94 -25.4 15.98 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 169.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.2 110.86 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-N 121.038 1.745 . . . . 0.0 109.305 -171.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.7 t -113.07 112.42 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 123.514 0.725 . . . . 0.0 109.273 -172.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -102.16 158.86 15.87 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 165.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.3 t -131.27 110.49 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.022 -1.048 . . . . 0.0 109.14 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -95.23 108.69 20.85 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.891 0.853 . . . . 0.0 110.411 172.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -88.46 104.31 16.68 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.586 0.754 . . . . 0.0 110.497 -171.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -101.57 120.29 40.09 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -0.903 . . . . 0.0 112.639 -172.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -87.05 163.51 16.99 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 167.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -74.14 151.0 40.15 Favored 'General case' 0 CA--C 1.571 1.773 0 O-C-N 120.894 -1.129 . . . . 0.0 112.279 162.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.269 166.407 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 . . . . . 0 N--CA 1.499 2.023 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.54 -21.38 52.26 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 118.394 2.739 . . . . 0.0 118.394 169.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -83.1 -17.48 42.94 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 169.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 87.6 m -71.18 93.96 1.12 Allowed 'General case' 0 CA--C 1.566 1.56 0 CA-C-N 121.563 1.983 . . . . 0.0 113.695 -174.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -170.61 162.95 8.13 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-O 122.485 1.136 . . . . 0.0 111.958 -167.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 92.9 m -86.7 113.62 22.7 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.436 169.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -107.26 111.93 24.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.615 -0.678 . . . . 0.0 111.064 -172.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -101.18 132.97 46.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.253 -0.904 . . . . 0.0 111.501 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -72.05 133.29 45.17 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.7 p -105.7 -40.34 5.78 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 175.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -155.96 123.86 5.67 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 119.474 1.034 . . . . 0.0 109.326 -174.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.8 p -104.86 102.55 12.08 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.373 0.669 . . . . 0.0 110.986 172.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -68.46 -56.29 8.92 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 116.543 2.053 . . . . 0.0 116.543 -159.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -126.21 54.28 1.56 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 119.042 0.837 . . . . 0.0 111.671 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -78.39 -53.05 7.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -172.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -50.62 -43.21 56.86 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 117.767 2.506 . . . . 0.0 117.767 172.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.13 -49.12 78.9 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 166.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -50.73 -46.67 59.23 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 164.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.501 ' SD ' HG21 ' A' ' 25' ' ' VAL . 32.9 mmt -57.66 -42.34 83.31 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 170.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -60.29 -47.18 87.1 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 166.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.97 -39.17 93.88 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 172.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.5 tp -69.17 -23.77 63.97 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.6 45.63 6.37 Favored Glycine 0 CA--C 1.548 2.118 0 N-CA-C 117.169 1.628 . . . . 0.0 117.169 -173.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.501 HG21 ' SD ' ' A' ' 20' ' ' MET . 34.6 m -102.05 153.7 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 118.428 1.114 . . . . 0.0 111.709 173.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.08 -167.66 16.51 Favored Glycine 0 N--CA 1.491 2.303 0 O-C-N 120.646 -1.284 . . . . 0.0 115.835 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -84.84 59.73 5.75 Favored 'General case' 0 CA--C 1.576 1.967 0 O-C-N 121.433 -1.039 . . . . 0.0 112.025 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.3 -73.09 0.31 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.723 0.809 . . . . 0.0 109.702 -175.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.1 m -57.74 -34.3 69.37 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 169.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -62.63 -39.19 93.07 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 117.342 2.349 . . . . 0.0 117.342 167.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -67.14 -56.81 8.38 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.034 1.288 . . . . 0.0 112.269 165.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.5 t -56.13 -45.52 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.91 -15.04 79.95 Favored Glycine 0 CA--C 1.552 2.368 0 N-CA-C 118.79 2.276 . . . . 0.0 118.79 175.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -94.09 -52.0 4.59 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.111 1.956 . . . . 0.0 113.991 171.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.256 34.3 m -80.95 -31.14 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.468 0 CA-C-N 121.657 2.026 . . . . 0.0 115.472 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.08 140.69 32.03 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-O 122.082 0.944 . . . . 0.0 110.206 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -98.18 103.25 16.85 Favored Pre-proline 0 CA--C 1.574 1.895 0 CA-C-O 118.075 -0.964 . . . . 0.0 109.791 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.51 146.87 35.43 Favored 'Trans proline' 0 CA--C 1.561 1.841 0 C-N-CA 122.565 2.177 . . . . 0.0 115.391 -176.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 88.7 m -100.68 100.63 11.35 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.362 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.3 t -95.23 101.98 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -173.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.5 mt -91.56 106.29 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 85.2 mt -84.87 120.34 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 170.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.8 p -137.16 133.06 34.83 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.856 0.462 . . . . 0.0 111.647 -172.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -92.7 101.08 13.48 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.992 -1.068 . . . . 0.0 109.35 172.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -104.97 83.13 1.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.837 0.827 . . . . 0.0 109.713 -170.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.76 -106.35 2.52 Favored Glycine 0 N--CA 1.487 2.098 0 CA-C-N 116.006 -0.543 . . . . 0.0 113.985 -175.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -88.74 -28.11 20.74 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -110.1 153.88 24.05 Favored 'General case' 0 CA--C 1.564 1.507 0 CA-C-O 122.804 1.288 . . . . 0.0 113.818 -170.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.46 118.91 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.604 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 170.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.3 t -111.09 107.54 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.4 mt -93.93 112.81 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -100.99 98.14 8.63 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.2 m -86.8 94.59 9.58 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.4 mt -89.02 89.36 7.95 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.651 0.739 . . . . 0.0 109.356 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.3 t -97.2 27.38 4.17 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.342 66.6 p 68.87 -53.22 0.57 Allowed 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -174.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -92.96 -54.97 3.52 Favored 'General case' 0 CA--C 1.571 1.751 0 C-N-CA 124.821 1.248 . . . . 0.0 111.703 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -107.38 108.88 20.45 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.778 0.831 . . . . 0.0 109.665 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -100.29 86.76 3.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.587 -0.695 . . . . 0.0 112.116 175.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -95.62 127.08 41.35 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.366 -0.834 . . . . 0.0 112.916 -173.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -109.52 97.96 7.43 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.921 0.888 . . . . 0.0 110.834 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.3 pt -95.85 108.99 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.078 -1.014 . . . . 0.0 111.051 -174.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 85.4 p -102.43 113.04 26.04 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.12 0.968 . . . . 0.0 112.076 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -148.64 148.88 30.61 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.22 0.534 . . . . 0.0 111.954 -170.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -86.93 156.62 19.74 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.519 -1.363 . . . . 0.0 111.925 163.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.9 mt -70.51 124.13 23.47 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.373 -1.454 . . . . 0.0 112.491 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.16 -4.24 83.9 Favored Glycine 0 CA--C 1.554 2.506 0 N-CA-C 118.97 2.348 . . . . 0.0 118.97 -163.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -85.33 131.87 34.34 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-N 120.223 2.012 . . . . 0.0 112.229 -175.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -72.42 136.5 46.06 Favored 'General case' 0 CA--C 1.571 1.773 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.928 165.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -145.8 149.04 33.6 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.671 0.788 . . . . 0.0 110.937 175.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.74 134.91 34.32 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.728 -1.233 . . . . 0.0 110.864 169.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.49 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 38.5 tt0 -132.15 109.44 9.96 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.912 -174.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.2 m -78.28 107.1 10.64 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 167.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.4 p -79.91 168.81 18.75 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -167.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.23 -8.51 1.66 Allowed 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 119.716 3.228 . . . . 0.0 119.716 172.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -116.89 28.63 8.41 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 120.833 1.651 . . . . 0.0 114.875 162.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.253 17.1 m-20 63.07 42.16 7.55 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 176.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -119.52 132.22 55.72 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.989 0.916 . . . . 0.0 109.041 167.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -92.62 115.27 27.95 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.158 0.583 . . . . 0.0 110.558 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 72' ' ' GLU . 25.2 p -110.69 143.38 41.25 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -76.48 100.86 5.39 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 122.272 1.034 . . . . 0.0 109.338 160.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.3 m -96.22 130.07 43.38 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 124.235 1.014 . . . . 0.0 112.735 -176.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 p -134.95 124.59 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 123.172 0.589 . . . . 0.0 109.506 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.4 t -112.67 110.9 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.486 -0.759 . . . . 0.0 109.641 -172.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.8 p -104.58 132.11 51.21 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 123.635 0.774 . . . . 0.0 112.467 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.7 tt -88.87 99.67 12.57 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.607 0.718 . . . . 0.0 109.464 168.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -97.25 76.91 2.64 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.443 -0.785 . . . . 0.0 110.587 -173.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.96 58.22 15.71 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 117.99 1.956 . . . . 0.0 117.99 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.348 5.5 m-20 91.14 -35.6 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -163.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -90.01 113.97 25.75 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-N 120.572 1.533 . . . . 0.0 112.659 -171.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.1 mt -80.7 123.42 28.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.921 -1.112 . . . . 0.0 112.006 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.4 t -124.87 106.6 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -174.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -94.28 101.29 13.25 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 123.472 0.709 . . . . 0.0 110.098 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.3 mt -87.21 112.59 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 123.89 0.876 . . . . 0.0 108.707 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -100.14 121.17 41.0 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.061 0.545 . . . . 0.0 110.189 172.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -114.32 118.15 33.1 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.2 0.6 . . . . 0.0 110.531 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 15.6 p90 -142.96 125.12 15.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.25 -0.906 . . . . 0.0 110.197 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 55.17 37.67 29.26 Favored 'General case' 0 N--CA 1.507 2.424 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 173.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.91 -22.58 6.61 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 119.142 2.417 . . . . 0.0 119.142 -165.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -86.48 142.24 28.51 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 119.024 1.412 . . . . 0.0 112.645 -175.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -131.01 123.42 28.71 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.548 0.739 . . . . 0.0 110.616 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.1 t -121.7 139.84 53.06 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 123.278 0.631 . . . . 0.0 109.911 165.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -118.49 132.66 56.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.848 -0.533 . . . . 0.0 112.079 174.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -102.29 104.86 15.42 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.8 t -87.6 96.58 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.93 116.22 28.72 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 123.964 0.906 . . . . 0.0 110.072 175.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.6 128.38 20.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.865 -0.522 . . . . 0.0 110.754 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.7 mm -80.89 121.65 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.625 -0.672 . . . . 0.0 109.664 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -101.5 -107.89 0.23 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 119.222 -0.418 . . . . 0.0 109.904 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -86.63 66.91 9.69 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 120.306 1.412 . . . . 0.0 111.06 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 79.21 -30.18 2.14 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 118.726 2.25 . . . . 0.0 118.726 -167.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -93.77 147.33 23.15 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 118.548 1.174 . . . . 0.0 112.1 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 14.6 tpp -77.48 113.08 14.92 Favored 'General case' 0 CA--C 1.563 1.476 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.606 169.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.9 t -88.64 105.53 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.638 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 164.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 22.3 ttt -101.4 103.4 14.32 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.119 0.568 . . . . 0.0 109.485 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.7 m -103.36 104.37 14.47 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.378 0.671 . . . . 0.0 109.275 -172.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mp -94.86 106.0 17.96 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.463 0.705 . . . . 0.0 109.346 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.9 t -102.7 134.12 46.59 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.736 0.779 . . . . 0.0 112.286 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -116.18 79.68 1.34 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 161.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 68.64 -94.02 0.33 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -175.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -88.22 -30.71 19.5 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 172.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.1 t -90.34 112.33 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-N 120.237 1.38 . . . . 0.0 109.363 -169.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.8 t -115.22 113.13 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 123.435 0.694 . . . . 0.0 109.525 -168.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -100.91 111.86 24.17 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.428 -0.795 . . . . 0.0 112.386 175.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.36 109.17 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.465 -0.772 . . . . 0.0 109.018 -177.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.5 mtp85 -98.19 120.37 38.48 Favored 'General case' 0 CA--C 1.563 1.446 0 CA-C-O 121.915 0.864 . . . . 0.0 110.541 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -99.56 104.99 16.83 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.398 0.679 . . . . 0.0 109.709 -169.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -109.76 125.55 52.81 Favored 'General case' 0 CA--C 1.568 1.635 0 O-C-N 121.623 -0.673 . . . . 0.0 111.458 -170.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -96.62 155.84 16.6 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.374 0.67 . . . . 0.0 112.416 171.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -72.41 131.27 42.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.306 -0.871 . . . . 0.0 112.234 171.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.501 0 C-N-CA 123.254 0.622 . . . . 0.0 112.487 170.561 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.257 93.4 mt-10 . . . . . 0 N--CA 1.504 2.255 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.2 -37.3 45.9 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 116.748 2.129 . . . . 0.0 116.748 154.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -75.0 -11.74 60.17 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 168.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 66.2 m -76.7 100.53 5.44 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 122.853 2.57 . . . . 0.0 112.871 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -168.76 163.31 11.88 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-O 122.592 1.187 . . . . 0.0 112.313 -172.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.9 m -82.67 103.47 12.2 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.948 0.899 . . . . 0.0 108.796 169.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -99.0 110.32 22.94 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.694 -1.254 . . . . 0.0 112.158 -170.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -96.64 131.48 43.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.423 -0.798 . . . . 0.0 111.822 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.92 120.42 14.18 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.3 p -93.32 -46.62 7.28 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 174.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -145.62 115.21 7.23 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.826 0.851 . . . . 0.0 109.437 -171.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 76.3 p -104.15 94.18 5.24 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.434 0.694 . . . . 0.0 111.472 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -84.09 120.7 26.47 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.957 0.503 . . . . 0.0 111.194 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.297 3.8 t-20 62.58 20.67 12.16 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 118.248 2.684 . . . . 0.0 118.248 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -67.45 -38.05 83.88 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -55.57 -47.29 76.66 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 169.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -58.91 -47.91 83.32 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 169.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -51.21 -49.79 60.36 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 166.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 75.8 mtm -62.15 -44.01 97.56 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 175.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -62.86 -42.97 99.95 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 166.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.61 -43.75 98.28 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 tp -64.3 -32.81 74.56 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 168.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.85 46.94 5.78 Favored Glycine 0 CA--C 1.543 1.831 0 N-CA-C 116.231 1.252 . . . . 0.0 116.231 -171.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.266 22.9 m -83.08 64.2 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 CA-C-N 119.413 1.607 . . . . 0.0 112.15 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 56.1 -162.54 5.98 Favored Glycine 0 CA--C 1.553 2.425 0 N-CA-C 117.957 1.943 . . . . 0.0 117.957 -175.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -99.73 -43.58 6.4 Favored 'General case' 0 CA--C 1.572 1.795 0 CA-C-N 114.713 -0.744 . . . . 0.0 112.587 154.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.49 -49.8 69.93 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 174.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.0 m -59.25 -41.65 89.28 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 120.303 1.411 . . . . 0.0 114.723 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -59.43 -44.57 92.88 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 169.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -68.74 -40.56 79.77 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 172.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.7 t -50.41 -55.6 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 CA-C-N 119.798 1.181 . . . . 0.0 113.481 160.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.97 -39.68 41.19 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 119.33 2.492 . . . . 0.0 119.33 168.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -67.91 -46.25 72.09 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 170.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.0 m -75.55 -29.65 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 t -79.53 145.91 32.92 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 120.313 1.415 . . . . 0.0 114.259 -173.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -95.96 99.28 4.83 Favored Pre-proline 0 CA--C 1.574 1.883 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 159.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.14 131.23 10.73 Favored 'Trans proline' 0 CA--C 1.562 1.895 0 C-N-CA 122.499 2.132 . . . . 0.0 113.149 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.4 m -97.71 110.73 23.24 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.6 t -97.33 96.88 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -175.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.2 mt -95.22 105.6 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.5 -1.375 . . . . 0.0 108.817 -172.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.3 mt -93.1 123.21 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.5 p -146.18 149.29 33.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.345 -0.847 . . . . 0.0 112.778 169.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -90.99 121.22 32.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.511 -0.743 . . . . 0.0 111.105 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -110.95 85.73 2.17 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.347 0.594 . . . . 0.0 109.925 -175.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.54 -67.72 2.53 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 116.58 1.392 . . . . 0.0 116.58 -177.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -131.69 -44.01 0.99 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 124.137 0.975 . . . . 0.0 112.876 172.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -75.93 152.79 37.01 Favored 'General case' 0 CA--C 1.565 1.526 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.3 t -91.52 125.14 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.611 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 169.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -111.88 111.32 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.8 mt -105.96 106.11 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 54.2 mtm-85 -92.05 97.37 10.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.872 -0.517 . . . . 0.0 109.977 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.1 m -85.65 97.04 9.88 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.765 0.793 . . . . 0.0 109.553 174.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.1 mt -111.92 127.55 55.89 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.157 -165.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.6 m -123.76 164.28 19.48 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.329 0.652 . . . . 0.0 111.265 163.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 49.0 p -74.73 55.34 0.67 Allowed 'General case' 0 N--CA 1.508 2.46 0 O-C-N 120.553 -1.342 . . . . 0.0 113.194 171.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 178.86 -56.66 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.873 0 C-N-CA 125.174 1.39 . . . . 0.0 108.529 -149.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -140.07 127.25 21.09 Favored 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 124.271 1.028 . . . . 0.0 109.939 -169.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -104.91 100.16 9.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.538 -0.726 . . . . 0.0 109.388 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.9 p -114.3 91.54 3.66 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.223 0.535 . . . . 0.0 110.564 -172.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -94.65 126.91 40.26 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.06 -1.025 . . . . 0.0 113.718 -176.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.487 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 11.3 mt -113.92 97.84 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -173.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 95.5 p -102.73 116.37 32.44 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.996 0.919 . . . . 0.0 112.038 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -151.45 149.38 29.19 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -172.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -87.21 150.7 23.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.697 -1.252 . . . . 0.0 110.423 152.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 27.2 mt -62.16 121.37 12.92 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.285 -1.509 . . . . 0.0 113.628 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.83 -9.88 72.45 Favored Glycine 0 CA--C 1.558 2.734 0 N-CA-C 119.129 2.411 . . . . 0.0 119.129 -165.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.91 125.23 30.49 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 120.041 1.92 . . . . 0.0 111.003 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -84.48 129.08 34.89 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.487 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 42.7 p90 -129.72 154.51 47.11 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.174 0.99 . . . . 0.0 111.701 -175.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.55 135.01 35.58 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.37 -1.456 . . . . 0.0 111.473 166.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -127.7 106.72 9.34 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.5 m -79.97 100.77 8.26 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.724 0.773 . . . . 0.0 109.915 174.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.7 p -85.07 167.02 16.18 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -169.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.4 -14.01 10.56 Favored 'General case' 0 CA--C 1.576 1.978 0 N-CA-C 118.9 2.926 . . . . 0.0 118.9 167.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -73.48 -13.49 61.06 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 160.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.287 21.7 t70 68.96 69.72 0.28 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 121.267 1.849 . . . . 0.0 112.931 -166.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.2 ptt85 -160.89 127.71 4.11 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -86.03 90.1 8.0 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 123.11 0.564 . . . . 0.0 111.472 172.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.4 p -81.86 129.12 34.65 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -72.75 97.16 2.15 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 123.101 1.429 . . . . 0.0 110.157 173.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.9 m -109.91 123.86 50.35 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.96 -159.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.0 p -121.72 134.65 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.173 0.511 . . . . 0.0 110.144 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.5 t -123.49 123.48 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -175.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.0 m -131.73 146.46 52.18 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.948 0.88 . . . . 0.0 111.842 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.6 mt -84.92 112.57 20.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.874 . . . . 0.0 111.604 172.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -106.11 76.53 1.17 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.398 0.679 . . . . 0.0 111.041 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.64 61.89 5.52 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 116.686 1.434 . . . . 0.0 116.686 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.259 6.5 t70 52.36 43.5 30.78 Favored 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -162.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -137.15 112.41 9.17 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 mt -82.64 87.04 6.73 Favored 'General case' 0 CA--C 1.567 1.622 0 O-C-N 121.381 -0.824 . . . . 0.0 111.2 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.4 t -87.66 107.92 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -170.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -84.64 136.73 33.63 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.787 0.435 . . . . 0.0 110.413 168.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 59.7 mt -126.76 112.86 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -101.76 121.09 41.41 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.578 1.081 . . . . 0.0 110.186 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -116.74 126.67 53.48 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.307 0.575 . . . . 0.0 111.463 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.6 p90 -152.96 133.4 13.65 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.158 -0.964 . . . . 0.0 109.967 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 59.24 23.37 11.73 Favored 'General case' 0 N--CA 1.51 2.567 0 N-CA-C 118.439 2.755 . . . . 0.0 118.439 166.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.9 10.62 82.76 Favored Glycine 0 CA--C 1.558 2.72 0 N-CA-C 119.28 2.472 . . . . 0.0 119.28 -162.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -121.17 141.73 50.56 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-N 119.676 1.738 . . . . 0.0 110.44 -176.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -130.6 122.78 28.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.765 -0.584 . . . . 0.0 110.922 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.7 t -116.7 140.36 49.5 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 123.133 0.573 . . . . 0.0 110.759 166.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.16 140.68 49.98 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.99 -0.444 . . . . 0.0 110.99 -170.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -130.99 101.15 5.49 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.057 -1.027 . . . . 0.0 108.392 -163.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.3 t -93.56 97.18 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -170.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -90.33 108.51 19.81 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 123.55 0.74 . . . . 0.0 110.79 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.86 134.06 53.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.492 -0.755 . . . . 0.0 112.55 -172.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.4 mm -75.11 104.7 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.259 -0.901 . . . . 0.0 109.772 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -103.62 88.12 3.0 Favored 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.0 t70 51.16 59.41 4.63 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.662 1.726 . . . . 0.0 115.662 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.28 -40.36 2.62 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 117.678 1.831 . . . . 0.0 117.678 -171.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -93.47 136.83 33.36 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.276 1.538 . . . . 0.0 113.02 -173.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 56.1 ttp -82.74 104.49 13.02 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.897 0.856 . . . . 0.0 109.765 171.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 84.1 t -93.85 103.55 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 5.2 ttp -93.41 110.11 21.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.41 0.684 . . . . 0.0 110.862 -175.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 96.0 m -96.8 112.5 24.23 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mp -99.62 101.83 13.14 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 124.131 0.973 . . . . 0.0 109.771 -171.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.4 t -101.15 112.82 25.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.591 -0.693 . . . . 0.0 109.965 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -96.25 78.57 3.09 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 152.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.78 -116.33 9.12 Favored Glycine 0 CA--C 1.549 2.204 0 N-CA-C 114.778 0.671 . . . . 0.0 114.778 -168.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -73.31 -19.56 61.01 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 117.02 2.229 . . . . 0.0 117.02 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.2 t -84.75 105.48 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-N 121.143 1.792 . . . . 0.0 108.519 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.4 t -115.67 110.69 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -171.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -99.46 159.21 15.19 Favored 'General case' 0 CA--C 1.562 1.405 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 167.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.1 t -132.17 111.42 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.067 -1.02 . . . . 0.0 109.059 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 56.9 mtm180 -102.17 121.26 41.88 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.75 0.786 . . . . 0.0 111.595 174.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -101.58 111.1 23.23 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.289 0.635 . . . . 0.0 110.525 -171.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -107.48 130.09 54.88 Favored 'General case' 0 CA--C 1.565 1.547 0 O-C-N 121.143 -0.973 . . . . 0.0 112.612 -170.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -97.53 152.74 18.71 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 169.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -75.46 127.94 34.22 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.605 -0.684 . . . . 0.0 112.014 172.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.047 -0.978 . . . . 0.0 112.788 -178.258 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.17 -22.21 38.78 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 171.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -82.85 -19.91 36.61 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 168.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 44.4 t -73.33 96.46 2.32 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-N 122.663 2.483 . . . . 0.0 113.569 -172.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -174.84 171.04 3.22 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 124.719 1.208 . . . . 0.0 111.466 -168.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 94.3 m -84.1 141.67 30.94 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.802 -1.186 . . . . 0.0 110.021 162.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -133.59 120.66 21.01 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.722 -1.236 . . . . 0.0 110.847 -170.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -108.2 117.91 35.38 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.779 0.832 . . . . 0.0 109.8 -168.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 tt -70.54 115.86 10.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.397 -0.814 . . . . 0.0 112.851 -173.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.8 p -90.22 -49.35 6.6 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -140.88 129.43 22.67 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.936 0.895 . . . . 0.0 109.684 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.8 p -106.33 93.73 4.77 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.077 0.551 . . . . 0.0 110.587 170.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -72.05 124.85 25.84 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.713 0.805 . . . . 0.0 112.026 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 4.9 t-20 52.19 27.99 5.14 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 118.72 2.859 . . . . 0.0 118.72 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -70.46 -44.05 68.57 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -174.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -49.27 -48.57 45.86 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 168.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -59.66 -50.11 75.14 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 170.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -49.28 -49.36 43.95 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 164.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.1 mtp -60.17 -46.25 90.33 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 175.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -55.39 -46.71 76.53 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 167.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.67 -37.34 86.99 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 117.063 2.245 . . . . 0.0 117.063 170.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.4 tp -67.42 -21.69 65.56 Favored 'General case' 0 CA--C 1.573 1.862 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 175.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.24 70.36 1.25 Allowed Glycine 0 N--CA 1.482 1.741 0 CA-C-N 119.026 0.83 . . . . 0.0 113.349 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.2 m -97.1 141.68 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 172.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.03 48.35 4.04 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 117.849 1.9 . . . . 0.0 117.849 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.336 16.6 t80 60.58 -56.69 0.08 Allowed 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 177.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.12 -44.06 64.28 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 173.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.4 m -66.67 -35.21 79.6 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.268 9.7 ptm180 -66.14 -40.85 90.94 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 121.858 2.117 . . . . 0.0 116.301 164.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -60.11 -42.89 95.7 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 169.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.72 -60.75 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-N 119.237 0.926 . . . . 0.0 112.692 166.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.19 -26.24 58.44 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 121.138 3.215 . . . . 0.0 121.138 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -73.68 -38.79 64.8 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 119.527 1.664 . . . . 0.0 115.166 166.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.0 m -77.11 -34.74 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 172.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.0 t -90.65 127.5 36.31 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 120.28 1.4 . . . . 0.0 112.801 -174.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.93 94.88 4.05 Favored Pre-proline 0 CA--C 1.575 1.934 0 CA-C-O 118.119 -0.943 . . . . 0.0 108.881 173.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.66 144.94 56.18 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.52 2.147 . . . . 0.0 116.022 -174.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.2 m -86.86 111.42 20.76 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 114.766 -1.107 . . . . 0.0 109.335 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.3 t -95.65 104.9 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -175.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.9 mt -94.85 104.09 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 80.1 mt -91.21 114.97 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 85.9 p -128.25 128.01 43.89 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 122.869 0.467 . . . . 0.0 111.881 -174.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -85.79 125.19 33.06 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.896 -1.128 . . . . 0.0 109.371 168.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -133.34 90.25 2.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.796 -1.19 . . . . 0.0 110.792 -166.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.76 -68.93 3.13 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 115.783 1.073 . . . . 0.0 115.783 176.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -131.02 -46.94 1.01 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.83 0.852 . . . . 0.0 112.101 168.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -88.31 161.56 17.08 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -173.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.8 t -94.9 124.89 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.1 t -120.12 105.91 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -172.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 61.0 mt -103.62 121.91 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -103.57 113.89 27.75 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 122.709 0.404 . . . . 0.0 111.309 173.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.0 m -94.61 103.4 15.34 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 123.366 0.666 . . . . 0.0 109.351 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.9 mt -112.03 101.45 9.74 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.599 0.714 . . . . 0.0 111.445 -167.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.5 t -87.44 156.0 19.76 Favored 'General case' 0 CA--C 1.563 1.459 0 O-C-N 121.846 -0.534 . . . . 0.0 111.874 162.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.0 t -67.73 34.35 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 157.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -150.63 -61.89 0.19 Allowed 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 125.364 1.465 . . . . 0.0 108.774 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -122.44 122.75 39.71 Favored 'General case' 0 CA--C 1.568 1.636 0 C-N-CA 123.949 0.9 . . . . 0.0 110.239 -177.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -84.48 115.6 22.66 Favored 'General case' 0 CA--C 1.567 1.628 0 C-N-CA 123.422 0.689 . . . . 0.0 110.222 167.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -131.97 144.91 51.15 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.985 0.898 . . . . 0.0 111.198 172.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.57 149.84 30.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.992 -1.068 . . . . 0.0 113.421 -175.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.4 pt -125.67 130.97 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 124.051 0.94 . . . . 0.0 110.259 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.9 p -122.25 114.57 21.0 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.658 0.783 . . . . 0.0 109.773 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -145.6 143.6 29.97 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -166.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -98.76 22.37 10.15 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 174.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 70.4 mt 68.82 110.7 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 125.17 1.388 . . . . 0.0 113.568 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.82 -7.22 56.01 Favored Glycine 0 CA--C 1.557 2.71 0 N-CA-C 119.255 2.462 . . . . 0.0 119.255 -167.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -82.85 125.95 31.9 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-N 119.201 1.501 . . . . 0.0 110.77 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -80.91 126.08 30.92 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -137.19 137.07 38.76 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 123.514 0.726 . . . . 0.0 110.761 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.67 130.2 38.35 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.501 -1.375 . . . . 0.0 111.431 173.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -130.55 106.46 8.53 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 122.725 0.41 . . . . 0.0 111.124 -171.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 54.5 m -68.94 106.91 2.9 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.324 1.059 . . . . 0.0 110.908 176.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.7 p -78.88 173.24 12.73 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.478 -173.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.73 3.37 0.15 Allowed 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 119.169 3.026 . . . . 0.0 119.169 168.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -109.37 -0.29 19.09 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 159.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.347 4.7 m-20 88.82 -5.59 0.46 Allowed 'General case' 0 N--CA 1.508 2.453 0 N-CA-C 116.748 2.129 . . . . 0.0 116.748 -173.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.94 122.36 24.75 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 120.621 1.555 . . . . 0.0 110.622 176.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.281 5.1 p30 -90.94 97.44 11.18 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.392 0.615 . . . . 0.0 111.458 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 82.5 m -93.73 131.55 38.96 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-O 121.486 0.66 . . . . 0.0 112.673 -168.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -69.9 102.24 1.93 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.579 1.151 . . . . 0.0 109.698 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.2 m -110.74 123.31 49.8 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.611 -157.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.1 t -122.98 113.33 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.8 t -99.32 116.91 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.153 -0.967 . . . . 0.0 109.937 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.1 t -112.49 131.61 55.49 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.279 0.632 . . . . 0.0 112.332 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 tt -91.61 100.48 13.21 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.419 0.688 . . . . 0.0 110.383 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -93.76 84.21 4.56 Favored 'General case' 0 CA--C 1.567 1.601 0 O-C-N 121.35 -0.843 . . . . 0.0 110.111 175.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.73 -82.34 0.96 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 115.411 0.924 . . . . 0.0 115.411 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -138.89 53.8 1.75 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.56 0.695 . . . . 0.0 112.293 161.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -142.37 121.25 12.75 Favored 'General case' 0 CA--C 1.561 1.388 0 O-C-N 121.299 -0.875 . . . . 0.0 110.468 168.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.5 mt -89.46 106.9 18.76 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.424 0.63 . . . . 0.0 110.112 176.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 52.4 t -96.72 100.33 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -85.57 101.22 12.5 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.458 0.703 . . . . 0.0 110.21 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 56.5 mt -90.78 110.53 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -175.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -102.84 118.34 36.6 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 119.077 0.853 . . . . 0.0 110.766 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -109.17 129.94 55.49 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 124.191 0.996 . . . . 0.0 111.216 -177.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.6 p90 -152.09 123.16 7.6 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.556 -1.34 . . . . 0.0 110.611 177.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 54.48 37.04 27.06 Favored 'General case' 0 N--CA 1.507 2.391 0 N-CA-C 117.306 2.335 . . . . 0.0 117.306 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.26 -26.57 4.39 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 118.757 2.263 . . . . 0.0 118.757 -164.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -82.24 142.99 31.66 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-N 119.11 1.455 . . . . 0.0 112.158 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -138.71 129.44 26.33 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.229 0.538 . . . . 0.0 111.547 -176.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.1 t -114.8 150.95 34.64 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.266 0.627 . . . . 0.0 109.754 162.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.293 11.1 p30 -127.32 135.84 51.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.015 -1.053 . . . . 0.0 112.582 166.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -105.09 100.85 10.43 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -176.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.1 t -85.21 98.03 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -174.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.9 ttm-85 -91.08 106.66 18.68 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.434 0.694 . . . . 0.0 109.909 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -123.9 141.11 52.33 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 119.235 0.925 . . . . 0.0 112.555 -175.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.5 mm -79.2 119.66 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.057 -1.027 . . . . 0.0 109.317 172.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -137.15 113.25 9.81 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.034 0.534 . . . . 0.0 109.617 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.6 t70 45.39 55.91 6.11 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.5 -36.78 3.07 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 118.314 2.086 . . . . 0.0 118.314 -169.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -82.94 152.94 25.29 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 119.02 1.41 . . . . 0.0 114.011 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.3 tmm? -91.65 109.0 20.3 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.848 158.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 82.5 t -94.79 106.27 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 38.0 ttm -89.41 106.67 18.6 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 173.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.1 m -95.98 110.64 22.82 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mp -98.61 102.94 14.83 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.981 0.912 . . . . 0.0 109.164 -170.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.1 t -108.92 112.97 25.48 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.332 0.587 . . . . 0.0 111.205 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -98.18 80.13 2.65 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 164.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 64.29 -100.84 0.44 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 114.891 0.716 . . . . 0.0 114.891 -172.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -85.7 -23.56 27.33 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 171.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.6 t -89.48 113.77 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-N 120.907 1.685 . . . . 0.0 109.242 -173.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.7 t -117.43 118.37 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 123.271 0.628 . . . . 0.0 109.59 -170.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -104.22 161.14 14.29 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 163.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.9 t -133.26 112.59 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 120.785 -1.197 . . . . 0.0 109.827 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -99.6 116.34 31.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.026 -1.046 . . . . 0.0 110.305 174.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -102.84 108.49 19.72 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.434 0.694 . . . . 0.0 111.06 -167.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -107.9 127.2 53.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.907 -1.121 . . . . 0.0 112.025 -170.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -90.15 153.53 20.46 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 171.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -88.12 137.41 32.35 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -166.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.257 0 CA-C-O 117.444 -1.265 . . . . 0.0 111.646 176.509 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 N--CA 1.498 1.953 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.68 -26.19 63.59 Favored 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 117.938 2.57 . . . . 0.0 117.938 167.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -81.19 -17.0 51.19 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 165.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.7 t -77.37 90.09 3.79 Favored 'General case' 0 CA--C 1.569 1.674 0 CA-C-N 122.105 2.229 . . . . 0.0 113.365 -173.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -166.27 172.55 10.99 Favored 'General case' 0 CA--C 1.572 1.796 0 C-N-CA 124.509 1.123 . . . . 0.0 111.736 -173.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 m -85.51 130.4 34.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.944 -1.098 . . . . 0.0 109.677 164.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -124.44 116.36 22.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.647 -0.658 . . . . 0.0 111.327 -170.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -101.95 127.25 48.88 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.468 0.707 . . . . 0.0 110.93 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.7 119.78 15.35 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -176.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.3 p -92.32 -47.4 7.21 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 176.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -140.16 110.81 6.78 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.876 0.87 . . . . 0.0 109.08 -174.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -94.03 80.24 4.09 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.905 1.336 . . . . 0.0 111.807 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -85.77 108.38 18.06 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.186 -0.946 . . . . 0.0 111.104 -161.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.29 1.8 t30 69.27 28.7 4.78 Favored 'General case' 0 CA--C 1.584 2.261 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -168.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -73.07 -41.0 64.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 119.709 -1.87 . . . . 0.0 115.897 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -48.86 -53.72 18.25 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 171.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.45 -43.57 98.5 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 173.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -54.75 -47.39 73.91 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 166.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 71.2 mtm -60.19 -37.62 80.79 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 172.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -62.41 -50.28 72.14 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 161.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.07 -44.16 91.83 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 176.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.3 tp -75.35 -14.07 60.45 Favored 'General case' 0 CA--C 1.58 2.124 0 N-CA-C 116.28 1.956 . . . . 0.0 116.28 169.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.01 32.12 15.4 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 119.511 2.564 . . . . 0.0 119.511 172.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.5 m -79.64 69.24 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 CA-C-N 120.806 2.303 . . . . 0.0 113.54 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 58.85 -160.96 13.7 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -96.36 -51.27 4.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 122.027 -0.69 . . . . 0.0 111.864 148.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.61 -39.37 84.02 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 33.7 m -68.94 -33.33 73.55 Favored 'General case' 0 CA--C 1.577 1.985 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 171.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -57.06 -49.99 74.14 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-N 121.235 1.834 . . . . 0.0 115.085 159.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -54.24 -51.37 64.7 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 171.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.7 t -51.32 -60.92 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 C-N-CA 124.488 1.115 . . . . 0.0 113.991 166.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.83 -29.06 54.17 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 119.78 2.672 . . . . 0.0 119.78 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -74.61 -47.29 33.1 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 167.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 m -75.88 -34.05 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.5 t -91.99 144.19 25.71 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 120.229 1.377 . . . . 0.0 113.648 -170.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -92.87 112.9 58.01 Favored Pre-proline 0 CA--C 1.574 1.867 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.402 170.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.16 123.28 9.1 Favored 'Trans proline' 0 CA--C 1.561 1.84 0 CA-C-N 122.878 2.064 . . . . 0.0 113.425 170.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 91.0 m -92.61 97.43 10.8 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 172.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.9 t -93.56 101.17 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -168.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.6 mt -88.91 104.08 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 177.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -90.2 114.41 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 172.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.7 p -136.52 129.91 31.69 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.728 0.411 . . . . 0.0 111.573 -170.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -87.21 95.05 9.84 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.159 -0.963 . . . . 0.0 110.39 174.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -101.19 76.18 1.7 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.414 0.626 . . . . 0.0 110.698 -171.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.4 80.72 0.33 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 115.107 0.803 . . . . 0.0 115.107 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.326 34.4 t70 72.0 -56.24 0.65 Allowed 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -175.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -76.26 146.2 39.15 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -177.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.1 t -88.56 125.26 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 173.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.3 t -112.56 111.9 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.501 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.1 mt -90.63 115.56 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -108.46 95.64 5.8 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.5 m -84.9 91.7 8.1 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.399 0.619 . . . . 0.0 109.353 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.9 mt -103.65 95.8 6.29 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -172.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 p -111.03 27.27 9.85 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 -173.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.404 8.5 t 47.27 18.61 0.1 Allowed 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 119.891 3.293 . . . . 0.0 119.891 -164.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -155.39 -61.87 0.11 Allowed 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.724 1.21 . . . . 0.0 109.667 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -70.9 -61.49 1.74 Allowed 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.05 0.94 . . . . 0.0 113.439 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 59.62 63.77 1.45 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.4 t -118.88 122.72 42.96 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.268 0.627 . . . . 0.0 111.503 -170.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -109.15 112.93 25.36 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.526 0.731 . . . . 0.0 111.96 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 pt -112.53 114.75 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 C-N-CA 123.476 0.711 . . . . 0.0 110.84 -174.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 92.9 p -105.86 118.65 37.14 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.112 0.965 . . . . 0.0 112.648 -174.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -149.3 156.35 41.95 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.769 0.795 . . . . 0.0 112.206 -169.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -92.59 150.97 20.39 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.125 0.964 . . . . 0.0 110.876 161.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 41.1 mt -67.83 127.35 32.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.099 -1.001 . . . . 0.0 113.481 -176.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.13 -6.36 71.9 Favored Glycine 0 CA--C 1.556 2.605 0 N-CA-C 118.969 2.348 . . . . 0.0 118.969 -164.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.22 127.11 34.69 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 120.332 2.066 . . . . 0.0 110.953 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -78.88 124.78 28.57 Favored 'General case' 0 CA--C 1.569 1.708 0 CA-C-O 121.477 0.656 . . . . 0.0 111.609 171.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -131.01 145.14 51.95 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.947 0.899 . . . . 0.0 110.698 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -73.88 134.28 43.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.242 -1.536 . . . . 0.0 111.961 170.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -133.62 124.54 27.01 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.248 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.1 m -70.16 128.46 36.36 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-O 122.835 1.302 . . . . 0.0 110.361 158.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 80.7 p -97.88 170.36 9.01 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 122.042 0.925 . . . . 0.0 112.491 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.54 -23.9 4.66 Favored 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 119.205 3.039 . . . . 0.0 119.205 168.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -76.49 -15.77 59.81 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 166.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.321 34.9 m-20 66.66 33.97 6.1 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -156.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.73 133.63 46.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.027 -1.046 . . . . 0.0 108.668 162.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -94.01 112.61 24.47 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.002 0.521 . . . . 0.0 110.595 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.2 m -110.48 141.37 43.69 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.456 0.702 . . . . 0.0 112.626 -173.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -73.76 109.79 7.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.523 -0.736 . . . . 0.0 110.356 166.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.2 m -109.26 125.98 52.85 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.921 0.888 . . . . 0.0 111.315 -169.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 p -126.05 126.0 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-O 121.213 0.53 . . . . 0.0 109.916 174.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.0 t -114.17 116.08 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -176.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.5 p -129.86 148.11 51.7 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 20.1 mt -86.02 117.39 24.83 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.499 0.666 . . . . 0.0 112.626 174.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -106.31 62.69 0.65 Allowed 'General case' 0 CA--C 1.574 1.869 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.901 174.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.51 66.61 1.97 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 115.786 1.074 . . . . 0.0 115.786 -174.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.266 18.3 t70 50.77 49.84 20.19 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 115.718 1.748 . . . . 0.0 115.718 -163.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -147.15 103.44 3.59 Favored 'General case' 0 CA--C 1.558 1.255 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -174.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.454 HD13 HH21 ' A' ' 106' ' ' ARG . 53.1 mt -84.18 105.79 15.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.659 -0.651 . . . . 0.0 110.969 -177.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.15 103.33 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -174.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.16 106.43 18.48 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.341 0.656 . . . . 0.0 110.36 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.1 mt -99.29 108.7 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -173.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -98.07 120.75 39.03 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 119.19 0.905 . . . . 0.0 110.088 176.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -117.75 121.27 40.37 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.666 0.787 . . . . 0.0 110.528 -174.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -149.12 133.1 17.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.319 -0.863 . . . . 0.0 110.368 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 59.79 24.82 13.8 Favored 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 118.598 2.814 . . . . 0.0 118.598 166.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.73 10.02 85.66 Favored Glycine 0 CA--C 1.558 2.763 0 N-CA-C 119.201 2.441 . . . . 0.0 119.201 -162.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -120.62 142.11 49.71 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-N 119.393 1.597 . . . . 0.0 110.199 -176.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -132.31 130.04 40.31 Favored 'General case' 0 CA--C 1.562 1.432 0 O-C-N 121.738 -0.601 . . . . 0.0 111.024 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.0 t -120.53 133.98 55.33 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 123.072 0.549 . . . . 0.0 109.715 163.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -116.46 134.44 54.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.773 -0.579 . . . . 0.0 112.167 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -107.59 97.82 7.5 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -174.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 78.2 t -85.85 99.92 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -172.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.454 HH21 HD13 ' A' ' 91' ' ' LEU . 31.3 ttp180 -101.78 113.9 27.49 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.084 0.554 . . . . 0.0 110.992 -172.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -127.27 143.84 51.16 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.1 mm -86.01 109.09 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.146 -0.971 . . . . 0.0 109.403 175.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.01 89.91 3.29 Favored 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 123.758 0.823 . . . . 0.0 109.29 176.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.9 t70 51.53 57.68 6.31 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 94.82 -38.29 3.17 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 117.942 1.937 . . . . 0.0 117.942 -170.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.9 mtmm -92.7 140.44 29.53 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 119.526 1.663 . . . . 0.0 113.35 -176.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 57.9 ttp -90.46 108.39 19.76 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 121.978 0.894 . . . . 0.0 109.984 175.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.1 t -94.54 107.01 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 23.2 ttt -101.98 106.51 17.45 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.048 0.539 . . . . 0.0 110.542 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.5 m -99.02 99.07 10.05 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.657 0.783 . . . . 0.0 109.37 -174.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.9 mp -90.67 108.22 19.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.873 0.869 . . . . 0.0 110.12 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.0 t -108.26 135.11 50.14 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.571 0.7 . . . . 0.0 112.35 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -127.13 98.43 5.3 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.392 0.677 . . . . 0.0 109.176 166.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 73.68 -91.67 0.68 Allowed Glycine 0 N--CA 1.49 2.249 0 O-C-N 121.861 -0.524 . . . . 0.0 113.901 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -124.25 11.62 8.78 Favored 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 160.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 36.2 t -92.02 107.77 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-N 121.56 1.982 . . . . 0.0 107.825 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.5 t -112.57 115.76 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 123.259 0.624 . . . . 0.0 109.568 -169.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -104.17 123.44 47.31 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.597 -0.689 . . . . 0.0 112.604 169.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.7 t -105.32 104.66 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -93.56 115.72 28.22 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.636 0.732 . . . . 0.0 110.765 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -99.12 109.79 22.45 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.208 0.603 . . . . 0.0 110.4 -171.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -108.73 128.48 54.91 Favored 'General case' 0 CA--C 1.565 1.525 0 O-C-N 121.188 -0.945 . . . . 0.0 111.937 -170.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -95.52 153.55 17.65 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.656 0.741 . . . . 0.0 112.337 167.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -72.08 134.78 46.0 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.49 0 C-N-CA 123.328 0.651 . . . . 0.0 111.17 159.842 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 N--CA 1.499 2.022 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.55 -24.3 63.59 Favored 'General case' 0 CA--C 1.574 1.87 0 N-CA-C 117.904 2.557 . . . . 0.0 117.904 167.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -85.97 -13.24 48.23 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 172.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.7 t -79.43 96.62 6.1 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 121.157 1.799 . . . . 0.0 112.667 -170.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -169.41 163.65 10.55 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.133 0.968 . . . . 0.0 112.492 -166.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.4 m -81.08 119.0 22.99 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.355 -0.84 . . . . 0.0 109.363 163.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -111.48 107.43 16.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.498 -0.751 . . . . 0.0 111.264 -172.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -91.7 129.74 37.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.511 -0.743 . . . . 0.0 111.272 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -68.85 133.63 48.54 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-O 122.524 1.154 . . . . 0.0 113.904 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.1 p -110.29 -34.73 6.27 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -156.9 112.46 2.89 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 119.69 1.132 . . . . 0.0 108.45 -172.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.9 p -104.05 91.0 3.77 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.916 0.865 . . . . 0.0 111.577 175.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -80.26 125.8 30.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 111.869 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.252 1.7 t30 61.92 21.32 12.21 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 117.565 2.432 . . . . 0.0 117.565 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -72.93 -34.5 66.63 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -175.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -55.04 -56.12 23.34 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 165.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.45 -31.86 71.83 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 173.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -61.65 -51.36 68.77 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 162.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.4 mtt -58.62 -44.5 89.99 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 116.797 2.147 . . . . 0.0 116.797 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -40.48 95.06 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 116.858 2.169 . . . . 0.0 116.858 164.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.72 -46.44 88.1 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 168.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.8 tp -61.66 -27.97 69.06 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.27 49.94 2.51 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 115.866 1.106 . . . . 0.0 115.866 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.2 m -107.52 140.08 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-N 118.944 1.372 . . . . 0.0 110.341 165.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.65 -168.63 9.84 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 116.814 1.486 . . . . 0.0 116.814 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -80.74 61.91 4.58 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.533 1.159 . . . . 0.0 112.709 177.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -148.05 -69.49 0.23 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.111 0.964 . . . . 0.0 109.16 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.2 m -58.7 -35.63 72.94 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 170.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -61.79 -32.96 73.28 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 165.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -83.51 14.72 3.52 Favored 'General case' 0 CA--C 1.58 2.105 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 164.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.3 t -118.58 -61.85 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 C-N-CA 125.419 1.488 . . . . 0.0 108.614 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.21 -23.54 68.16 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 119.668 2.627 . . . . 0.0 119.668 -177.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -88.74 -37.26 15.62 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 174.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.4 m -80.34 -33.21 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.4 t -107.91 177.16 4.9 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 119.709 1.141 . . . . 0.0 112.669 -178.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -97.69 99.67 7.02 Favored Pre-proline 0 CA--C 1.573 1.849 0 CA-C-O 118.042 -0.98 . . . . 0.0 111.003 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.92 127.24 15.77 Favored 'Trans proline' 0 CA--C 1.564 2.022 0 CA-C-N 122.903 2.072 . . . . 0.0 113.965 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.0 m -110.45 102.86 11.44 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.004 -172.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.3 t -102.82 101.32 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.553 -0.717 . . . . 0.0 109.141 -164.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.9 mt -87.47 103.35 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.242 -0.911 . . . . 0.0 108.812 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.6 mt -88.04 111.81 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.8 p -136.15 117.96 15.12 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.671 0.389 . . . . 0.0 111.853 -169.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -83.38 116.46 22.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.099 -1.001 . . . . 0.0 111.432 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -116.62 96.23 5.41 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.269 0.557 . . . . 0.0 109.639 -172.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.48 -75.75 2.32 Favored Glycine 0 N--CA 1.492 2.371 0 O-C-N 121.694 -0.629 . . . . 0.0 114.265 -172.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -133.43 -52.14 0.88 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 169.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -62.69 154.34 29.69 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.6 t -94.06 109.73 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.53 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.367 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.5 t -93.88 101.4 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 176.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.2 mt -95.05 116.61 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -101.64 99.74 10.06 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.157 0.583 . . . . 0.0 110.102 175.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.2 m -86.35 96.15 9.89 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.757 0.789 . . . . 0.0 109.4 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 71.3 mt -102.31 86.54 2.84 Favored 'General case' 0 CA--C 1.559 1.318 0 CA-C-O 121.856 0.836 . . . . 0.0 110.329 -170.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.2 t -79.38 144.64 33.96 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.56 -0.713 . . . . 0.0 110.326 159.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.4 p -70.09 33.62 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.463 0 N-CA-C 116.823 2.156 . . . . 0.0 116.823 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -155.89 -57.39 0.09 Allowed 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 126.194 1.797 . . . . 0.0 108.189 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -107.75 100.57 9.94 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 123.978 0.911 . . . . 0.0 109.394 177.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -96.77 88.18 4.52 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.53 -0.731 . . . . 0.0 110.314 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.8 t -105.22 139.55 39.7 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 123.475 0.71 . . . . 0.0 112.444 -171.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -134.68 145.74 48.83 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.8 pt -134.15 129.5 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 C-N-CA 123.771 0.828 . . . . 0.0 110.347 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.0 m -118.37 117.79 30.03 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.843 -0.536 . . . . 0.0 110.371 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -150.65 152.54 34.14 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.675 0.75 . . . . 0.0 112.3 -165.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -94.73 151.02 19.61 Favored 'General case' 0 CA--C 1.573 1.831 0 O-C-N 120.972 -1.08 . . . . 0.0 110.888 169.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.6 mt -67.55 123.39 20.3 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.26 -1.525 . . . . 0.0 112.872 -177.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.06 -20.02 23.07 Favored Glycine 0 CA--C 1.555 2.555 0 N-CA-C 118.678 2.231 . . . . 0.0 118.678 -166.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -79.64 126.64 31.17 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-N 119.387 1.594 . . . . 0.0 111.653 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -81.14 144.24 31.82 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-O 121.563 0.696 . . . . 0.0 112.423 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -142.38 141.26 32.27 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.107 0.963 . . . . 0.0 110.459 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -78.95 129.04 34.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.525 -1.359 . . . . 0.0 111.19 171.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -125.34 103.25 7.82 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.852 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.4 m -79.7 103.28 9.49 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 170.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 71.4 p -78.15 167.88 20.73 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -168.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.98 -11.85 0.72 Allowed 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 120.236 3.421 . . . . 0.0 120.236 170.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -122.22 35.84 4.78 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 120.892 1.678 . . . . 0.0 114.555 160.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.269 31.0 m-20 63.07 54.63 2.09 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 116.543 2.053 . . . . 0.0 116.543 168.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -120.38 128.4 53.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.528 -0.732 . . . . 0.0 109.207 159.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -90.26 90.56 8.13 Favored 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 123.535 0.734 . . . . 0.0 111.189 173.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.5 p -96.85 134.72 39.8 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -173.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.68 94.17 2.66 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-O 122.524 1.154 . . . . 0.0 109.284 172.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.1 m -100.94 119.34 38.56 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.676 -165.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.1 p -121.7 125.36 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 123.182 0.593 . . . . 0.0 109.707 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.3 t -109.23 118.38 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -175.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.9 p -118.75 133.86 55.55 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.668 0.787 . . . . 0.0 112.055 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 tt -89.66 98.16 11.61 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 109.933 175.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -94.11 81.07 4.07 Favored 'General case' 0 CA--C 1.567 1.62 0 O-C-N 121.512 -0.743 . . . . 0.0 110.796 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.88 -90.79 0.5 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 115.563 0.985 . . . . 0.0 115.563 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -99.13 4.57 46.93 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 166.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -121.85 119.88 32.91 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 120.452 1.478 . . . . 0.0 111.086 -162.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.2 mt -82.97 100.47 10.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.92 -1.112 . . . . 0.0 110.222 167.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 41.0 t -101.13 101.45 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -170.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.34 107.24 19.02 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.506 0.722 . . . . 0.0 110.791 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 53.9 mt -100.14 103.28 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -173.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -94.66 123.1 37.9 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 118.7 0.682 . . . . 0.0 110.839 176.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -116.39 121.15 41.05 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 123.44 0.696 . . . . 0.0 111.943 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.3 p90 -150.65 128.89 11.97 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.53 -1.357 . . . . 0.0 110.969 -177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 50.52 48.09 23.08 Favored 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 166.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.86 16.23 72.23 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 119.995 2.758 . . . . 0.0 119.995 -168.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -133.59 140.46 47.15 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 119.531 1.666 . . . . 0.0 109.858 -170.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -134.65 130.49 36.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.669 -0.644 . . . . 0.0 111.543 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.8 t -119.4 123.5 44.26 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.358 0.663 . . . . 0.0 109.368 167.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -107.52 122.01 45.79 Favored 'General case' 0 CA--C 1.563 1.475 0 C-N-CA 123.26 0.624 . . . . 0.0 110.605 172.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -103.62 108.38 19.63 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -175.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 82.4 t -93.44 104.08 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -169.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -110.34 99.15 8.23 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.03 0.532 . . . . 0.0 110.314 -166.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.12 149.97 43.83 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -171.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.4 mm -82.18 111.38 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.872 -0.517 . . . . 0.0 110.01 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -105.19 86.98 2.52 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 171.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.9 t70 48.23 60.19 3.78 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.65 -37.86 3.29 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 117.95 1.94 . . . . 0.0 117.95 -171.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -88.02 140.96 28.96 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 119.659 1.73 . . . . 0.0 112.979 -177.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 34.1 ttm -84.83 112.41 20.51 Favored 'General case' 0 CA--C 1.564 1.503 0 O-C-N 121.266 -0.897 . . . . 0.0 109.297 165.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.8 t -89.64 104.36 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 169.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 28.1 ttt -90.95 101.38 14.15 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.998 0.519 . . . . 0.0 109.777 172.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.6 m -92.05 111.06 22.46 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 175.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.9 mp -95.93 121.21 37.43 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.4 t -126.12 122.64 36.32 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-N 120.31 1.414 . . . . 0.0 112.357 174.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -114.38 80.68 1.43 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.824 0.85 . . . . 0.0 108.786 174.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 66.97 -98.55 0.43 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 115.062 0.785 . . . . 0.0 115.062 -174.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -83.98 -30.85 25.89 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 171.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.5 t -89.38 119.86 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 119.715 1.143 . . . . 0.0 109.443 -169.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.5 t -115.97 124.94 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -175.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -117.58 156.22 28.47 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.483 0.713 . . . . 0.0 112.742 167.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.3 t -134.01 112.44 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.318 -0.863 . . . . 0.0 109.074 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -99.63 122.5 42.75 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.52 0.676 . . . . 0.0 111.769 172.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -104.46 114.36 28.54 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.322 0.649 . . . . 0.0 110.663 -172.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -114.97 131.39 56.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.437 -0.79 . . . . 0.0 112.11 -169.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -101.51 152.3 20.93 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 123.452 0.701 . . . . 0.0 112.405 169.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -74.1 131.83 41.69 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.296 -0.877 . . . . 0.0 112.815 175.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.518 0 C-N-CA 124.188 0.995 . . . . 0.0 111.995 175.205 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.94 -27.09 40.79 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 117.592 2.442 . . . . 0.0 117.592 166.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -85.7 -6.68 59.1 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 171.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 52.8 t -80.56 93.22 6.04 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-N 121.876 2.125 . . . . 0.0 113.85 -172.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.69 172.32 9.37 Favored 'General case' 0 CA--C 1.571 1.787 0 CA-C-O 122.425 1.107 . . . . 0.0 112.435 -177.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.0 m -89.87 116.72 28.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.175 -0.953 . . . . 0.0 108.998 165.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -114.76 108.52 16.88 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 122.956 0.502 . . . . 0.0 110.38 -169.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -95.45 136.55 35.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.05 -1.031 . . . . 0.0 111.651 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.96 130.61 43.71 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.666 0.988 . . . . 0.0 113.666 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 45.8 p -116.34 -24.83 7.75 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -157.22 121.66 4.37 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 120.574 1.534 . . . . 0.0 108.922 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.3 p -113.07 92.82 4.14 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.967 0.889 . . . . 0.0 111.805 178.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -88.34 116.34 26.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.967 -1.083 . . . . 0.0 110.513 -170.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.291 3.8 t-20 68.63 25.86 6.43 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -173.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -72.76 -48.23 40.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 119.994 -1.691 . . . . 0.0 115.392 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -46.97 -50.66 18.67 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.739 2.125 . . . . 0.0 116.739 169.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -58.69 -45.32 89.74 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 171.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -55.73 -48.55 75.01 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 165.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 31.0 mmm -58.56 -49.61 76.82 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -60.3 -42.26 95.15 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 167.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.53 -40.26 95.28 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 172.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.4 tp -61.31 -25.13 66.91 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 168.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.91 56.17 1.33 Allowed Glycine 0 N--CA 1.484 1.893 0 N-CA-C 115.72 1.048 . . . . 0.0 115.72 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.255 4.5 m -100.25 148.03 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-N 118.451 1.126 . . . . 0.0 112.875 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.96 170.12 14.86 Favored Glycine 0 CA--C 1.551 2.329 0 N-CA-C 117.357 1.703 . . . . 0.0 117.357 171.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -67.95 -43.35 79.3 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.32 -44.97 94.98 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 164.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.0 m -61.36 -42.63 99.02 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 175.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -63.76 -39.68 94.85 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 116.512 2.041 . . . . 0.0 116.512 167.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.72 -48.81 80.13 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 120.035 1.289 . . . . 0.0 114.337 167.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.5 t -57.22 -60.94 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-N 119.627 1.103 . . . . 0.0 113.445 170.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.74 -27.81 70.61 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 120.115 2.806 . . . . 0.0 120.115 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -73.48 -42.01 62.43 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 167.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.4 m -70.46 -36.88 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.2 t -88.31 138.92 31.01 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 119.815 1.189 . . . . 0.0 113.194 -174.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -85.68 114.41 56.55 Favored Pre-proline 0 CA--C 1.575 1.92 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.665 167.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -69.11 130.35 19.97 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 CA-C-N 123.345 2.23 . . . . 0.0 114.813 176.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 93.4 m -97.12 101.47 13.04 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.8 t -99.71 99.45 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -166.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.6 mt -86.34 105.98 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.9 mt -99.02 115.03 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 174.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.5 t -144.76 159.59 42.61 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 123.539 1.637 . . . . 0.0 112.65 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -98.67 135.29 40.39 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.206 177.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.13 103.62 6.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.619 -0.676 . . . . 0.0 109.987 175.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.28 -78.57 0.96 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 115.977 1.151 . . . . 0.0 115.977 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -127.6 -39.16 1.85 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 170.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -77.12 154.05 33.64 Favored 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.9 t -94.79 129.97 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.64 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.7 t -109.29 119.08 58.03 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.3 mt -102.29 115.44 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 168.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -104.16 96.07 6.4 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.904 0.859 . . . . 0.0 109.888 170.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.6 m -83.25 92.83 7.56 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.52 174.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.3 mt -104.52 101.47 11.13 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.547 0.739 . . . . 0.0 109.438 -170.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.6 p -99.46 26.98 5.57 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 117.16 2.281 . . . . 0.0 117.16 -175.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.492 2.0 t 63.03 -54.07 0.18 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -169.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -82.71 -60.46 2.17 Favored 'General case' 0 CA--C 1.569 1.698 0 C-N-CA 124.025 0.93 . . . . 0.0 111.582 173.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -98.14 103.16 15.08 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -105.84 93.16 4.49 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.677 0.751 . . . . 0.0 110.186 -171.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 39.1 p -100.94 149.09 24.26 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -167.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -145.16 120.95 10.56 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.112 -0.992 . . . . 0.0 112.5 176.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.2 pt -122.97 129.59 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 C-N-CA 123.699 0.8 . . . . 0.0 110.792 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 85.1 p -120.8 116.39 25.12 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.889 0.876 . . . . 0.0 111.641 -175.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -145.77 146.1 31.08 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.91 0.862 . . . . 0.0 113.073 -164.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -101.62 76.32 1.65 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.138 -0.976 . . . . 0.0 110.816 177.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.4 mt 17.81 96.93 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 120.158 3.392 . . . . 0.0 120.158 174.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.15 -12.73 63.66 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 118.374 2.109 . . . . 0.0 118.374 -166.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -77.62 136.24 38.22 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 119.718 1.759 . . . . 0.0 112.45 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -80.21 115.19 19.63 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.146 171.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -118.99 152.24 36.74 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 122.05 0.929 . . . . 0.0 110.95 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.06 138.08 31.81 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.877 -1.14 . . . . 0.0 111.465 174.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -145.24 124.34 12.86 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.369 0.604 . . . . 0.0 110.53 169.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 84.9 m -77.04 121.42 23.51 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 158.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.5 p -87.43 -179.99 6.47 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -169.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.68 -29.33 38.28 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 118.698 2.851 . . . . 0.0 118.698 165.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -84.66 10.46 11.16 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 163.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.281 3.1 t0 60.95 22.06 12.29 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 -174.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -95.42 129.72 42.48 Favored 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 124.697 1.199 . . . . 0.0 110.168 175.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -84.88 105.09 15.39 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.157 0.983 . . . . 0.0 112.942 -176.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 4.8 p -99.86 127.52 46.03 Favored 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -76.01 104.43 6.54 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 159.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.0 m -111.37 123.6 50.55 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.23 0.612 . . . . 0.0 112.206 -164.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.4 t -110.99 113.03 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 172.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.6 t -95.97 104.74 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 169.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.9 t -109.74 137.0 48.19 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.65 0.738 . . . . 0.0 112.111 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 tt -85.93 103.72 14.91 Favored 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 123.057 0.543 . . . . 0.0 110.474 174.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -96.11 80.66 3.29 Favored 'General case' 0 CA--C 1.567 1.627 0 O-C-N 121.399 -0.813 . . . . 0.0 111.015 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.74 -83.49 1.14 Allowed Glycine 0 N--CA 1.493 2.451 0 O-C-N 121.013 -1.055 . . . . 0.0 114.26 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -137.9 53.89 1.82 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.106 0.479 . . . . 0.0 112.19 162.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -150.57 130.14 13.07 Favored 'General case' 0 CA--C 1.567 1.626 0 O-C-N 120.754 -1.216 . . . . 0.0 111.673 173.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 16.6 mt -93.29 108.22 19.9 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.33 1.052 . . . . 0.0 111.438 -174.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.02 103.6 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.314 -0.866 . . . . 0.0 108.902 -167.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -89.51 94.3 9.82 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 123.321 0.649 . . . . 0.0 112.413 -178.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 61.2 mt -87.26 98.11 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.7 0.8 . . . . 0.0 109.141 -172.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -92.65 117.94 30.51 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 118.984 0.811 . . . . 0.0 109.958 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -117.46 122.57 44.11 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.148 0.579 . . . . 0.0 110.607 -175.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.7 p90 -153.35 126.93 8.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.503 -0.748 . . . . 0.0 110.509 -172.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 48.46 49.97 17.46 Favored 'General case' 0 N--CA 1.507 2.387 0 N-CA-C 117.214 2.301 . . . . 0.0 117.214 169.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.04 7.08 69.96 Favored Glycine 0 CA--C 1.558 2.758 0 N-CA-C 120.332 2.893 . . . . 0.0 120.332 -168.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -123.73 143.62 50.17 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 120.031 1.916 . . . . 0.0 110.901 -169.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -133.02 131.21 40.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.685 -0.635 . . . . 0.0 111.238 -177.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.4 t -130.88 137.44 49.35 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 123.236 0.614 . . . . 0.0 110.296 166.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.276 11.5 p30 -119.41 128.88 54.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.566 -0.709 . . . . 0.0 112.499 175.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 m-30 -99.77 105.32 17.09 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 84.5 t -90.0 97.52 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -174.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.96 108.37 19.53 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.227 1.011 . . . . 0.0 111.495 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -118.29 148.87 42.01 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.6 mm -85.58 99.77 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 170.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.72 93.25 5.47 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.556 0.742 . . . . 0.0 109.55 -178.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.7 t70 51.51 55.89 8.72 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -174.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.31 -28.57 4.66 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 119.008 2.363 . . . . 0.0 119.008 -169.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -92.18 145.21 24.68 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 119.883 1.841 . . . . 0.0 112.905 -172.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -85.98 100.77 12.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.174 -0.954 . . . . 0.0 110.42 175.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.8 t -100.49 110.9 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 26.7 ttp -100.13 115.08 28.97 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.19 0.596 . . . . 0.0 110.095 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 96.2 m -103.1 104.96 15.17 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mp -96.66 101.51 13.13 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.444 0.698 . . . . 0.0 109.759 -174.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.7 t -90.09 125.07 35.3 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.449 -0.782 . . . . 0.0 111.757 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -109.5 77.24 1.05 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 156.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 64.78 -112.45 5.02 Favored Glycine 0 CA--C 1.548 2.141 0 N-CA-C 114.485 0.554 . . . . 0.0 114.485 -170.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -78.24 -21.05 50.49 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 172.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.6 t -87.93 111.71 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 120.868 1.667 . . . . 0.0 108.662 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 58.2 t -123.07 114.1 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -168.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -94.22 118.01 30.94 Favored 'General case' 0 CA--C 1.562 1.439 0 O-C-N 121.724 -0.61 . . . . 0.0 112.458 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.4 t -100.82 106.48 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -109.96 117.84 34.85 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.427 0.632 . . . . 0.0 111.008 -173.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -91.87 119.97 32.13 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.368 0.604 . . . . 0.0 111.01 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -117.34 133.4 56.03 Favored 'General case' 0 CA--C 1.561 1.404 0 CA-C-O 121.931 0.872 . . . . 0.0 109.51 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -122.95 153.7 39.37 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.671 0.748 . . . . 0.0 110.659 -176.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -68.16 132.29 46.92 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -172.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.231 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.396 172.717 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.338 22.4 tt0 . . . . . 0 N--CA 1.497 1.913 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.2 -31.1 41.23 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.638 2.459 . . . . 0.0 117.638 161.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -73.67 -18.51 61.01 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 117.322 2.341 . . . . 0.0 117.322 167.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 44.3 t -75.59 90.94 2.8 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-N 122.331 2.332 . . . . 0.0 114.112 -169.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -168.03 170.47 10.41 Favored 'General case' 0 CA--C 1.569 1.705 0 C-N-CA 124.317 1.047 . . . . 0.0 111.902 -171.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.0 m -78.02 135.23 37.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.819 -1.176 . . . . 0.0 109.162 160.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -120.02 116.7 26.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.775 -1.203 . . . . 0.0 109.682 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -102.2 128.09 48.86 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.662 0.785 . . . . 0.0 110.513 -174.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tt -69.89 117.91 12.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.537 -0.727 . . . . 0.0 112.816 -174.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 46.2 p -97.71 -44.7 6.65 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -147.78 118.04 7.34 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 119.513 1.051 . . . . 0.0 110.232 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.7 p -97.38 95.56 7.76 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.212 0.605 . . . . 0.0 111.951 174.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -79.89 117.52 20.83 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 123.526 0.73 . . . . 0.0 111.027 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.6 t30 60.73 23.26 13.16 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -66.37 -39.12 88.91 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -175.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -52.98 -55.67 21.79 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 171.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -66.73 -34.68 78.37 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -53.6 -53.98 44.0 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-N 120.442 1.473 . . . . 0.0 113.695 161.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 79.4 mtm -57.59 -46.53 83.91 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 115.556 1.688 . . . . 0.0 115.556 174.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -57.32 -46.92 82.74 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 168.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.53 -41.73 99.06 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 171.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.1 tp -57.02 -18.84 15.45 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 168.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.03 60.37 1.77 Allowed Glycine 0 N--CA 1.481 1.665 0 O-C-N 121.3 -0.875 . . . . 0.0 114.402 -176.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.6 m -95.05 155.47 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 CA-C-O 121.886 0.85 . . . . 0.0 111.856 167.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.53 164.47 54.12 Favored Glycine 0 CA--C 1.552 2.349 0 O-C-N 121.326 -0.859 . . . . 0.0 114.279 154.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -55.48 -38.22 68.84 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.7 -48.87 66.29 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.0 m -65.23 -41.31 94.51 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 173.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.284 22.7 ptt180 -66.25 -42.26 88.81 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 121.617 2.008 . . . . 0.0 115.644 169.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -59.21 -48.66 80.79 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 171.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.4 t -57.89 -60.66 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 124.334 1.053 . . . . 0.0 113.141 166.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.54 -30.6 50.82 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 120.392 2.917 . . . . 0.0 120.392 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.23 -42.4 31.36 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 168.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.251 20.8 m -73.54 -42.47 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 CA-C-N 120.765 1.621 . . . . 0.0 115.125 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.1 t -91.42 148.09 22.56 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 119.46 1.027 . . . . 0.0 111.836 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -99.62 98.42 7.03 Favored Pre-proline 0 CA--C 1.571 1.778 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.493 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.17 117.48 5.07 Favored 'Trans proline' 0 CA--C 1.56 1.798 0 C-N-CA 122.547 2.165 . . . . 0.0 113.729 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.1 m -91.79 125.5 36.53 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.139 0.975 . . . . 0.0 109.323 -176.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.1 t -108.29 100.07 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -165.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.9 mt -90.32 109.38 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.521 -1.362 . . . . 0.0 108.322 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.1 mt -88.95 110.17 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 174.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 82.1 p -124.77 117.46 24.23 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.032 0.533 . . . . 0.0 111.769 -171.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -85.27 122.11 28.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.312 -0.868 . . . . 0.0 111.454 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.23 89.59 2.88 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.488 0.661 . . . . 0.0 110.706 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.64 -106.64 2.46 Favored Glycine 0 N--CA 1.487 2.069 0 O-C-N 121.781 -0.575 . . . . 0.0 113.604 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -95.67 -34.85 11.81 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 171.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -86.01 146.49 26.63 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-O 123.368 1.556 . . . . 0.0 114.491 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 64.4 t -96.22 115.61 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.584 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.7 t -102.05 102.8 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.7 mt -91.36 118.19 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.2 mtt-85 -109.4 107.61 17.84 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.447 0.699 . . . . 0.0 109.345 -173.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.2 m -89.84 100.43 13.24 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.5 mt -115.76 119.41 35.94 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.476 0.71 . . . . 0.0 109.856 -169.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 m -121.08 -177.62 3.55 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 122.116 0.96 . . . . 0.0 111.906 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.3 p -61.73 -30.31 70.69 Favored 'General case' 0 N--CA 1.505 2.317 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 158.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -120.69 -54.04 2.07 Favored 'General case' 0 CA--C 1.572 1.8 0 C-N-CA 124.115 0.966 . . . . 0.0 112.174 -175.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -83.32 138.26 33.62 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -137.3 108.62 6.86 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 171.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.0 t -143.21 140.79 30.88 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.632 -0.667 . . . . 0.0 111.508 173.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -136.74 137.93 40.41 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.0 -1.063 . . . . 0.0 113.263 -174.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.3 pt -123.21 124.79 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 C-N-CA 123.16 0.584 . . . . 0.0 112.261 -169.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.3 p -110.69 106.64 15.94 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 123.607 0.763 . . . . 0.0 112.47 -174.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -134.25 140.28 46.34 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -169.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -101.9 39.05 1.52 Allowed 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.0 mt 60.55 97.58 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 125.031 1.332 . . . . 0.0 114.334 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.91 -0.61 82.46 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 118.902 2.321 . . . . 0.0 118.902 -165.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -70.93 125.05 25.8 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 119.341 1.571 . . . . 0.0 111.825 173.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -91.47 123.54 34.96 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.785 0.434 . . . . 0.0 110.664 169.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -147.16 144.43 28.97 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.336 0.654 . . . . 0.0 111.998 -172.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.66 142.16 44.54 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.416 -1.428 . . . . 0.0 112.586 166.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -149.27 137.05 20.42 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.461 0.648 . . . . 0.0 112.596 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.4 m -82.25 103.47 11.86 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 122.066 0.936 . . . . 0.0 110.206 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.3 p -72.91 174.83 7.22 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.98 -9.36 3.0 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 119.762 3.245 . . . . 0.0 119.762 170.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -110.39 20.33 17.88 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 120.741 1.61 . . . . 0.0 114.518 159.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.273 6.6 m-20 54.68 31.56 15.52 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 117.658 2.466 . . . . 0.0 117.658 -174.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 ptp85 -87.32 128.59 35.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.873 -1.142 . . . . 0.0 108.967 165.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -79.05 92.55 5.01 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.679 0.752 . . . . 0.0 111.558 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 68.7 m -85.99 118.43 25.46 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -171.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -69.72 99.43 1.33 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.148 0.979 . . . . 0.0 109.558 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.7 m -115.54 120.4 39.34 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.595 -155.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.1 p -117.45 116.11 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 123.11 0.564 . . . . 0.0 109.733 176.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.6 t -102.92 112.7 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.432 -0.793 . . . . 0.0 109.372 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 86.0 p -113.45 123.11 49.26 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.63 0.772 . . . . 0.0 111.395 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tt -89.65 98.76 11.95 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 118.992 0.815 . . . . 0.0 111.601 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -97.15 68.7 2.27 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 123.353 0.661 . . . . 0.0 111.955 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.09 82.41 0.13 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 116.075 1.19 . . . . 0.0 116.075 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.269 24.2 t0 63.64 0.52 0.89 Allowed 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 -164.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -118.12 99.73 7.07 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 121.119 1.782 . . . . 0.0 110.373 -172.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.8 mt -76.72 99.43 5.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.303 -0.873 . . . . 0.0 110.722 171.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.1 t -99.66 99.41 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.866 -1.146 . . . . 0.0 108.265 -172.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -85.49 100.6 12.01 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.297 0.639 . . . . 0.0 110.814 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.2 mt -90.65 105.48 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -176.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -93.61 122.82 36.46 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 118.45 0.568 . . . . 0.0 110.865 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -112.01 132.8 54.57 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.859 0.863 . . . . 0.0 110.5 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -157.5 124.94 5.22 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.675 -1.266 . . . . 0.0 110.362 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 58.2 24.82 11.83 Favored 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 172.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.93 -24.14 17.01 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 118.425 2.13 . . . . 0.0 118.425 -162.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -82.67 144.72 30.06 Favored 'General case' 0 CA--C 1.565 1.548 0 CA-C-N 119.486 1.643 . . . . 0.0 112.247 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -138.9 129.97 26.66 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.19 0.519 . . . . 0.0 111.543 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.4 t -117.88 154.64 31.51 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 123.577 0.751 . . . . 0.0 110.401 165.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.282 11.6 p30 -130.12 141.26 50.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.131 -0.981 . . . . 0.0 113.54 165.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -111.07 103.49 11.95 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -177.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.7 t -85.82 102.52 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -104.97 108.7 20.36 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.849 0.86 . . . . 0.0 108.857 -169.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -135.74 136.41 40.77 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -169.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 26.7 mm -82.7 113.92 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.718 -0.614 . . . . 0.0 109.52 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -120.79 108.83 14.43 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.7 t70 50.3 54.34 11.31 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 116.582 2.067 . . . . 0.0 116.582 -176.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 64.05 19.64 63.86 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 119.662 2.625 . . . . 0.0 119.662 -169.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -129.27 129.75 45.32 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 119.246 1.523 . . . . 0.0 108.908 -175.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 ttt -82.66 104.78 13.17 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-O 122.067 0.937 . . . . 0.0 109.922 176.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.1 t -86.88 104.41 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 174.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 55.2 ttm -93.48 104.25 16.4 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.8 m -93.69 110.17 21.79 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.526 0.679 . . . . 0.0 109.329 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mp -95.82 105.61 17.64 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 124.184 0.994 . . . . 0.0 108.897 -173.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.7 t -115.26 114.91 25.82 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 119.229 0.922 . . . . 0.0 111.949 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -98.45 74.8 2.18 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.473 0.654 . . . . 0.0 109.251 164.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 66.37 -91.94 0.17 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 115.444 0.938 . . . . 0.0 115.444 -175.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.98 -34.96 20.69 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 172.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.9 t -87.17 117.95 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-N 120.099 1.318 . . . . 0.0 109.732 -171.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.4 t -116.28 127.08 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 C-N-CA 123.493 0.717 . . . . 0.0 109.772 -173.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.67 160.24 18.11 Favored 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 123.264 0.626 . . . . 0.0 112.593 161.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.5 t -131.28 110.7 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.976 -1.078 . . . . 0.0 108.753 176.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -94.56 119.19 32.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.129 -0.982 . . . . 0.0 110.613 169.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -92.54 105.24 17.45 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.387 0.675 . . . . 0.0 109.542 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -106.27 122.98 47.32 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.438 0.695 . . . . 0.0 111.057 -172.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -95.65 157.28 15.97 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.982 -1.073 . . . . 0.0 113.618 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -81.05 141.13 34.66 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -173.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.307 0 CA-C-O 117.364 -1.303 . . . . 0.0 111.975 -179.062 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.26 -27.18 54.28 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 166.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -83.4 -23.81 32.21 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 172.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 71.7 m -78.12 99.48 6.18 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 121.758 2.072 . . . . 0.0 112.998 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.66 168.77 12.37 Favored 'General case' 0 CA--C 1.57 1.717 0 CA-C-O 122.284 1.04 . . . . 0.0 112.245 -173.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.0 m -85.39 102.65 13.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.203 -0.936 . . . . 0.0 108.901 173.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -101.59 108.66 20.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.788 -1.195 . . . . 0.0 112.027 -169.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -94.13 128.36 40.49 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.428 -0.795 . . . . 0.0 110.94 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.95 117.35 14.56 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.528 0.68 . . . . 0.0 112.704 -175.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.7 p -88.68 -47.82 7.98 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -145.17 112.17 5.98 Favored 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 123.51 0.724 . . . . 0.0 109.662 -171.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.0 p -101.25 95.25 6.4 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.474 0.709 . . . . 0.0 111.406 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -91.0 116.39 28.75 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 122.893 0.477 . . . . 0.0 110.736 -166.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 0.7 OUTLIER 64.01 39.82 7.64 Favored 'General case' 0 CA--C 1.582 2.174 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -173.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -78.87 -44.58 22.52 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -53.67 -51.12 64.21 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 116.763 2.134 . . . . 0.0 116.763 175.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -66.52 -38.96 88.32 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -50.14 -53.94 24.11 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 160.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 31.5 mtp -58.41 -42.28 86.86 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 174.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -59.33 -51.4 70.11 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 165.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.4 -38.07 89.73 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 116.743 2.127 . . . . 0.0 116.743 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 tt -61.92 -32.59 73.0 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 165.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.71 49.95 1.89 Allowed Glycine 0 N--CA 1.484 1.88 0 N-CA-C 115.919 1.128 . . . . 0.0 115.919 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 m -93.16 156.69 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-N 118.792 1.296 . . . . 0.0 112.173 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.44 156.85 50.46 Favored Glycine 0 CA--C 1.551 2.318 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 171.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -62.07 -41.27 97.99 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.94 -41.78 71.47 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 165.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.5 m -60.7 -46.62 89.68 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 168.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.5 mtm180 -54.36 -48.75 71.11 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 165.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -60.48 -42.12 95.61 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.8 t -52.95 -60.38 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-N 119.909 1.231 . . . . 0.0 113.101 163.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.0 -31.51 68.71 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 119.822 2.689 . . . . 0.0 119.822 176.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -67.48 -45.7 75.15 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 167.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.6 m -79.33 -32.59 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.23 146.56 34.02 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 120.19 1.359 . . . . 0.0 113.798 -163.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -91.66 116.86 67.27 Favored Pre-proline 0 CA--C 1.577 1.994 0 O-C-N 121.665 -0.647 . . . . 0.0 110.902 161.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.91 128.51 9.26 Favored 'Trans proline' 0 CA--C 1.561 1.836 0 C-N-CA 122.492 2.128 . . . . 0.0 112.735 168.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 56.2 m -85.68 115.93 23.65 Favored 'General case' 0 CA--C 1.562 1.441 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.9 t -102.83 94.25 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -173.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.52 102.58 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.957 -1.089 . . . . 0.0 108.108 -175.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.5 mt -91.15 128.41 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.3 p -142.62 157.49 44.64 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.388 0.675 . . . . 0.0 111.917 -177.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -114.91 111.12 20.68 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.246 -0.909 . . . . 0.0 108.644 166.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -82.01 -57.45 3.4 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -177.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.24 87.61 0.14 Allowed Glycine 0 N--CA 1.483 1.83 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.292 12.0 t70 70.93 -57.43 0.6 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -164.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -78.89 152.92 30.92 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -175.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.1 t -89.48 126.07 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.6 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.872 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.7 t -112.23 109.73 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.3 mt -99.85 130.11 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 174.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.8 mtt85 -107.8 107.8 18.72 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.344 0.658 . . . . 0.0 110.072 173.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.1 m -91.63 103.51 16.09 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.519 -0.738 . . . . 0.0 109.302 173.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 65.2 mt -125.73 119.96 29.35 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 122.817 0.447 . . . . 0.0 110.873 -169.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.26 178.44 6.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.987 -1.071 . . . . 0.0 110.498 159.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.7 p -77.99 48.56 0.73 Allowed 'General case' 0 N--CA 1.51 2.572 0 O-C-N 119.594 -1.941 . . . . 0.0 114.089 173.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -165.79 -58.12 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 125.152 1.381 . . . . 0.0 109.419 -165.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -131.84 132.14 43.43 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.206 1.002 . . . . 0.0 109.285 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -134.06 97.77 3.96 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -172.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.2 t -127.93 128.7 45.58 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 123.178 0.591 . . . . 0.0 111.076 -175.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -119.76 138.85 53.08 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.2 pt -135.28 116.37 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-O 121.313 0.578 . . . . 0.0 111.055 -163.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.1 p -100.63 121.93 42.45 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.064 0.946 . . . . 0.0 112.048 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -147.86 139.2 23.6 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -173.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -81.59 6.86 13.72 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.258 50.9 mt 70.29 105.63 0.06 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 125.188 1.395 . . . . 0.0 111.746 -168.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.69 0.88 89.22 Favored Glycine 0 CA--C 1.556 2.636 0 N-CA-C 119.139 2.416 . . . . 0.0 119.139 -161.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -81.97 122.77 28.2 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-N 120.179 1.99 . . . . 0.0 111.136 174.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -86.45 113.37 22.33 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 122.711 0.405 . . . . 0.0 110.944 172.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -125.25 146.33 49.58 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.842 0.857 . . . . 0.0 111.541 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.98 139.9 36.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.743 -1.223 . . . . 0.0 112.507 168.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -146.5 130.78 17.53 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.192 0.52 . . . . 0.0 110.516 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.4 m -71.47 124.91 25.68 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-O 121.694 0.759 . . . . 0.0 110.656 164.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.1 p -96.65 174.94 6.57 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -176.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.52 -17.63 14.78 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 119.386 3.106 . . . . 0.0 119.386 166.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -81.59 -5.64 58.23 Favored 'General case' 0 CA--C 1.58 2.118 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 161.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.273 23.2 t70 65.34 66.16 0.55 Allowed 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 121.151 1.796 . . . . 0.0 112.992 -170.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -154.55 138.47 16.32 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.87 0.868 . . . . 0.0 109.467 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -79.52 114.9 18.81 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 174.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 2.4 p -99.64 122.83 43.25 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.854 -0.529 . . . . 0.0 112.241 173.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -72.83 96.95 2.15 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.7 m -109.17 118.23 36.21 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.025 -160.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.5 p -121.79 119.88 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.2 t -107.29 118.22 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.486 -0.759 . . . . 0.0 109.686 -173.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.9 m -111.95 125.99 54.64 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.36 0.664 . . . . 0.0 111.568 -177.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.4 tt -83.73 99.66 10.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.428 -0.795 . . . . 0.0 109.825 170.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -91.51 78.44 5.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.454 -0.779 . . . . 0.0 110.651 -175.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.88 -79.24 1.6 Allowed Glycine 0 N--CA 1.492 2.424 0 O-C-N 121.3 -0.875 . . . . 0.0 114.541 -174.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -139.9 60.17 1.56 Allowed 'General case' 0 CA--C 1.572 1.796 0 C-N-CA 122.877 0.471 . . . . 0.0 110.063 164.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -156.9 106.98 2.28 Favored 'General case' 0 CA--C 1.566 1.559 0 O-C-N 121.315 -0.866 . . . . 0.0 109.307 -168.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.0 mt -86.94 101.0 13.0 Favored 'General case' 0 CA--C 1.57 1.719 0 O-C-N 121.349 -0.845 . . . . 0.0 112.373 -174.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.9 t -102.45 102.82 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.132 -0.98 . . . . 0.0 109.025 -171.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -88.12 106.24 18.04 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 123.197 0.599 . . . . 0.0 110.759 177.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.6 mt -92.81 107.23 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -90.88 125.25 35.69 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 118.948 0.794 . . . . 0.0 110.951 171.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -120.77 126.27 49.71 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.396 0.679 . . . . 0.0 110.832 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.0 p90 -152.73 123.72 7.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.943 -1.098 . . . . 0.0 110.483 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 54.31 33.46 18.41 Favored 'General case' 0 N--CA 1.51 2.566 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.93 -26.34 4.88 Favored Glycine 0 CA--C 1.557 2.702 0 N-CA-C 118.809 2.284 . . . . 0.0 118.809 -164.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -75.92 143.59 41.57 Favored 'General case' 0 CA--C 1.566 1.583 0 CA-C-N 119.494 1.647 . . . . 0.0 113.002 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -132.48 134.21 44.76 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.361 0.664 . . . . 0.0 111.039 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.8 t -132.94 130.85 40.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.676 -0.64 . . . . 0.0 111.455 162.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -107.73 130.66 54.93 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 123.16 0.584 . . . . 0.0 112.299 174.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -107.34 103.81 13.26 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.8 t -92.22 94.14 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -170.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.9 mtt85 -81.86 115.2 20.95 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.997 0.919 . . . . 0.0 111.294 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -127.26 144.46 51.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.681 -0.637 . . . . 0.0 111.637 172.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.2 mm -83.75 116.12 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.186 -0.946 . . . . 0.0 109.054 174.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.72 85.4 2.24 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.9 t70 49.69 61.54 3.11 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -178.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.92 -44.07 1.86 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 117.135 1.614 . . . . 0.0 117.135 -173.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -85.8 151.56 23.72 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 118.655 1.227 . . . . 0.0 113.121 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 38.7 tpp -85.73 116.96 24.31 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 160.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.4 t -94.09 106.8 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 165.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 18.2 ttt -102.05 111.51 23.81 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.5 m -100.75 106.8 18.25 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -177.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.0 mp -101.02 105.82 17.06 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -174.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.3 t -106.07 139.15 41.05 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.772 0.796 . . . . 0.0 112.052 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -101.09 79.61 2.03 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 162.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 70.37 -94.6 0.48 Allowed Glycine 0 N--CA 1.489 2.211 0 O-C-N 121.663 -0.648 . . . . 0.0 113.322 -163.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -127.99 57.16 1.56 Allowed 'General case' 0 CA--C 1.573 1.845 0 C-N-CA 122.972 0.509 . . . . 0.0 111.938 169.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.2 t -136.13 110.41 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 170.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.3 t -117.63 125.18 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.671 -0.643 . . . . 0.0 111.203 -151.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -107.37 124.97 50.6 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.317 0.647 . . . . 0.0 112.054 165.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.2 t -109.19 105.4 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.318 -0.864 . . . . 0.0 108.809 -174.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 -103.49 114.1 28.11 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 123.898 0.879 . . . . 0.0 111.495 -173.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -96.61 116.54 29.27 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.53 0.732 . . . . 0.0 111.244 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -110.37 138.68 46.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.528 -0.733 . . . . 0.0 111.283 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -99.18 152.78 19.5 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.682 0.753 . . . . 0.0 112.453 167.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -72.46 128.98 37.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.795 -0.566 . . . . 0.0 111.998 171.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.631 179.964 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 . . . . . 0 N--CA 1.497 1.89 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.58 -25.36 52.26 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 117.963 2.579 . . . . 0.0 117.963 168.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -82.92 -15.81 49.91 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 171.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 41.5 t -79.98 92.79 5.61 Favored 'General case' 0 CA--C 1.565 1.531 0 CA-C-N 121.472 1.942 . . . . 0.0 113.725 -169.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -166.61 168.53 14.46 Favored 'General case' 0 CA--C 1.569 1.687 0 C-N-CA 124.118 0.967 . . . . 0.0 111.826 -174.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.1 m -78.32 124.05 27.66 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.973 -1.079 . . . . 0.0 108.884 159.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -113.09 119.66 38.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 110.66 -177.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -99.85 129.93 45.99 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.81 0.844 . . . . 0.0 111.023 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tt -73.18 121.25 19.99 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -176.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.3 p -92.41 -50.29 5.71 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 175.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -141.74 117.35 10.32 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 119.254 0.934 . . . . 0.0 109.934 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.1 p -107.01 109.04 20.83 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.486 0.714 . . . . 0.0 112.82 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -94.16 131.15 39.99 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.468 0.707 . . . . 0.0 111.454 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.284 3.9 t-20 61.31 25.82 15.73 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 118.359 2.726 . . . . 0.0 118.359 176.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -70.23 -42.8 71.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 119.794 -1.817 . . . . 0.0 115.537 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -49.51 -53.63 22.32 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 169.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.69 -39.06 84.45 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -53.22 -55.77 21.72 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 162.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 74.3 mtm -54.51 -48.57 71.76 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 173.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -41.93 90.07 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 172.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.77 -35.67 81.37 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 117.251 2.315 . . . . 0.0 117.251 167.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 tp -67.72 -27.09 66.51 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.81 65.41 0.65 Allowed Glycine 0 N--CA 1.484 1.863 0 C-N-CA 123.675 0.655 . . . . 0.0 114.202 -173.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.429 HG21 ' HB3' ' A' ' 30' ' ' ARG . 23.8 m -105.56 145.82 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 C-N-CA 123.501 0.721 . . . . 0.0 111.865 168.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.54 176.07 51.07 Favored Glycine 0 N--CA 1.49 2.281 0 O-C-N 121.367 -0.833 . . . . 0.0 114.276 152.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -77.3 61.62 2.19 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 123.071 1.415 . . . . 0.0 113.384 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -158.21 -61.75 0.08 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.049 1.34 . . . . 0.0 109.055 -175.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.8 m -57.44 -42.0 81.57 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 164.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.429 ' HB3' HG21 ' A' ' 25' ' ' VAL . 7.2 ptm180 -61.44 -38.53 87.53 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 164.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -62.9 -42.32 99.74 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 120.469 1.486 . . . . 0.0 114.902 170.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 70.4 t -48.12 -65.28 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 CA-C-N 119.84 1.2 . . . . 0.0 112.796 160.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.19 -33.91 61.9 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 119.782 2.673 . . . . 0.0 119.782 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -67.97 -46.46 71.3 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 169.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.8 m -79.7 -30.8 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.4 t -120.77 153.78 36.57 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 120.293 1.406 . . . . 0.0 113.579 -167.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.0 111.83 60.28 Favored Pre-proline 0 CA--C 1.575 1.933 0 CA-C-O 117.883 -1.056 . . . . 0.0 111.494 178.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.57 123.99 8.51 Favored 'Trans proline' 0 CA--C 1.559 1.763 0 CA-C-N 123.523 2.294 . . . . 0.0 115.424 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.4 m -96.69 118.76 33.84 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.097 0.959 . . . . 0.0 108.483 -175.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.5 t -106.11 105.44 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -169.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.5 mt -95.35 103.45 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -85.5 111.46 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 171.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.5 p -127.71 122.81 33.87 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.097 0.559 . . . . 0.0 111.358 -172.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -89.21 99.06 12.13 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -98.15 -44.52 6.57 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -161.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.06 104.83 0.19 Allowed Glycine 0 N--CA 1.483 1.82 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -173.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.292 13.8 t70 71.66 -52.34 0.69 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -165.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -126.59 162.09 26.51 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 122.562 1.172 . . . . 0.0 113.881 -163.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.9 t -86.06 122.8 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.6 t -115.47 108.15 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 -175.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 56.6 mt -91.85 117.35 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 173.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -97.58 102.16 13.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 169.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.4 m -88.56 104.78 17.15 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.2 mt -102.94 99.46 9.36 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.6 t -87.74 39.3 0.88 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 171.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.328 69.8 p 64.0 -58.71 0.2 Allowed 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -172.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -93.47 -44.35 8.28 Favored 'General case' 0 CA--C 1.574 1.872 0 C-N-CA 125.413 1.485 . . . . 0.0 112.652 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -100.02 117.81 35.08 Favored 'General case' 0 CA--C 1.566 1.588 0 C-N-CA 124.094 0.958 . . . . 0.0 110.817 -176.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -98.57 104.08 16.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.59 -0.694 . . . . 0.0 109.86 168.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.252 5.0 t -103.15 82.6 2.09 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.902 0.858 . . . . 0.0 110.495 169.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.95 131.19 34.7 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 pt -131.62 130.55 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 123.366 0.666 . . . . 0.0 111.364 -170.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 90.2 p -116.87 131.64 56.9 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 123.881 0.872 . . . . 0.0 111.922 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -158.84 144.86 16.72 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.141 -0.974 . . . . 0.0 113.307 -169.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -94.4 26.5 3.36 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 175.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 69.2 mt 69.02 108.31 0.05 Allowed 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 125.203 1.401 . . . . 0.0 113.547 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.41 -10.49 58.85 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 118.656 2.222 . . . . 0.0 118.656 -162.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -73.72 123.85 24.9 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 118.962 1.381 . . . . 0.0 112.327 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -76.0 122.08 23.68 Favored 'General case' 0 CA--C 1.566 1.558 0 CA-C-O 121.306 0.574 . . . . 0.0 111.317 168.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -124.81 154.54 40.82 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.84 0.856 . . . . 0.0 110.586 173.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.09 136.7 32.85 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.951 -1.093 . . . . 0.0 110.973 171.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -134.45 108.79 8.34 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.904 0.482 . . . . 0.0 110.194 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 88.5 m -79.51 102.37 8.77 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 167.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.9 p -82.08 171.04 14.82 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -167.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.56 -13.53 2.45 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 119.834 3.272 . . . . 0.0 119.834 169.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.42 -16.09 50.27 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 163.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.306 28.6 m-20 73.94 72.17 0.12 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 125.073 1.349 . . . . 0.0 111.995 -160.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -157.01 129.12 7.28 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 124.128 0.971 . . . . 0.0 108.427 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -84.93 115.28 22.7 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 123.268 0.627 . . . . 0.0 112.077 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 72.8 m -110.58 119.72 40.08 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -174.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -71.06 105.87 3.5 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.381 0.61 . . . . 0.0 109.754 165.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.1 m -117.89 119.09 33.81 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.779 -158.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.2 t -117.23 117.77 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.75 108.19 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.391 -0.818 . . . . 0.0 109.598 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 86.5 p -106.78 126.36 52.19 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 123.682 0.793 . . . . 0.0 112.697 -177.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.8 tt -83.33 102.83 12.26 Favored 'General case' 0 CA--C 1.569 1.698 0 C-N-CA 123.21 0.604 . . . . 0.0 110.824 172.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -92.47 76.41 5.12 Favored 'General case' 0 CA--C 1.57 1.719 0 O-C-N 121.107 -0.995 . . . . 0.0 111.443 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.07 -74.67 2.4 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 115.022 0.769 . . . . 0.0 115.022 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.09 65.66 1.21 Allowed 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 122.415 1.102 . . . . 0.0 110.632 153.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -147.5 106.61 3.87 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 mt -89.04 100.1 12.95 Favored 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 123.443 0.697 . . . . 0.0 110.684 -172.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.7 t -106.21 104.01 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -167.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -87.44 102.11 14.23 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 123.387 0.675 . . . . 0.0 111.419 176.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.3 mt -91.23 103.63 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -177.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -90.06 127.42 36.07 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 118.788 0.722 . . . . 0.0 111.114 171.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -121.18 120.39 35.08 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 123.193 0.597 . . . . 0.0 110.887 176.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -145.46 126.91 15.0 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.369 -0.832 . . . . 0.0 110.242 -175.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 55.14 31.92 17.34 Favored 'General case' 0 N--CA 1.511 2.58 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 174.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.9 -21.29 7.99 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 119.166 2.426 . . . . 0.0 119.166 -163.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -86.01 141.38 29.53 Favored 'General case' 0 CA--C 1.57 1.712 0 CA-C-N 119.016 1.408 . . . . 0.0 111.509 -177.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -134.88 125.19 26.27 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.482 0.713 . . . . 0.0 111.023 -173.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.4 t -122.48 144.33 49.13 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.335 0.654 . . . . 0.0 110.733 167.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.279 9.7 p30 -124.9 127.95 47.89 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-O 121.321 0.581 . . . . 0.0 112.415 174.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.3 101.24 12.64 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -174.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.5 t -92.43 96.55 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -168.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 -85.03 107.69 17.27 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.499 0.72 . . . . 0.0 110.181 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.91 129.62 48.54 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 123.035 0.534 . . . . 0.0 111.723 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.2 mm -81.45 120.2 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.339 -0.851 . . . . 0.0 110.177 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.75 89.52 3.13 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.7 t70 51.12 67.1 1.0 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.0 -48.46 3.23 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 117.38 1.712 . . . . 0.0 117.38 -174.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -86.32 143.94 27.63 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 118.643 1.222 . . . . 0.0 112.309 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 32.5 ttm -88.35 118.81 28.23 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-O 121.714 0.769 . . . . 0.0 109.823 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.6 t -89.08 100.51 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 169.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 36.5 ttm -94.94 100.41 12.27 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.369 0.604 . . . . 0.0 110.182 -173.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 84.3 m -98.02 99.79 11.08 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.813 0.816 . . . . 0.0 108.976 -172.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.5 mp -89.98 105.17 17.63 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.8 t -108.3 116.34 31.78 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.52 0.676 . . . . 0.0 110.993 -176.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -97.13 79.75 2.87 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 121.267 0.556 . . . . 0.0 109.509 166.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 63.16 -98.04 0.21 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 115.434 0.934 . . . . 0.0 115.434 -175.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -86.7 -17.21 34.25 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 169.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.8 t -91.96 101.63 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-N 121.774 2.079 . . . . 0.0 108.481 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 57.8 t -104.07 115.19 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -171.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.64 129.16 55.99 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.809 -0.557 . . . . 0.0 112.015 177.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.5 t -115.8 118.56 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.483 -0.761 . . . . 0.0 109.157 -168.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -111.25 125.55 53.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.415 -0.803 . . . . 0.0 111.505 175.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -95.84 109.47 21.8 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.893 0.477 . . . . 0.0 110.291 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -109.63 129.12 55.62 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 123.551 0.74 . . . . 0.0 112.295 -168.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -97.23 150.92 20.37 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 124.2 1.0 . . . . 0.0 112.836 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -74.78 134.52 41.8 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.3 -0.875 . . . . 0.0 113.134 172.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.519 0 C-N-CA 124.101 0.961 . . . . 0.0 111.63 161.441 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 . . . . . 0 CA--C 1.571 1.766 0 N-CA-C 117.206 2.299 . . . . 0.0 117.206 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.81 -31.33 48.73 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 117.964 2.579 . . . . 0.0 117.964 164.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -75.5 -18.21 59.89 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.779 2.141 . . . . 0.0 116.779 168.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 93.8 m -76.47 97.72 4.4 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 122.383 2.356 . . . . 0.0 113.417 -175.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.09 167.65 14.3 Favored 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 124.376 1.07 . . . . 0.0 111.556 -174.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 98.6 m -81.53 114.54 20.32 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.195 -0.941 . . . . 0.0 109.162 163.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -106.03 115.06 29.58 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.758 -0.589 . . . . 0.0 110.204 -176.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -95.98 132.97 40.75 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.328 0.651 . . . . 0.0 110.842 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -71.07 127.84 33.92 Favored 'General case' 0 CA--C 1.565 1.526 0 CA-C-O 122.303 1.049 . . . . 0.0 113.322 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.1 p -98.92 -39.98 8.3 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 176.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -154.73 121.29 5.4 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 119.534 1.061 . . . . 0.0 109.598 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.2 p -101.39 96.32 7.08 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.23 0.612 . . . . 0.0 111.741 174.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -72.62 124.52 25.44 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.386 0.675 . . . . 0.0 111.805 174.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.274 4.4 t-20 51.04 27.37 3.25 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 119.133 3.012 . . . . 0.0 119.133 177.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -70.92 -46.04 63.2 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -173.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -49.79 -50.06 46.22 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 168.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -58.19 -42.28 85.78 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 170.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -58.55 -48.61 80.3 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 165.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.2 mtp -57.39 -47.04 82.72 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -61.07 -42.28 98.2 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 166.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.52 -43.53 98.69 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 171.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.1 tp -62.24 -17.27 57.9 Favored 'General case' 0 CA--C 1.58 2.105 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 166.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.92 52.15 3.2 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 116.287 1.275 . . . . 0.0 116.287 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.268 9.5 m -92.65 143.51 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 118.57 1.185 . . . . 0.0 113.028 176.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.64 166.22 17.06 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 116.99 1.556 . . . . 0.0 116.99 166.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -64.51 -43.95 92.47 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.85 -46.6 87.35 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 166.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.4 m -58.14 -39.36 78.56 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 172.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.347 0.2 OUTLIER -62.38 -37.74 86.93 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 167.689 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -57.93 -47.19 83.59 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 120.999 1.727 . . . . 0.0 114.592 162.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 70.0 t -56.87 -34.26 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 117.125 2.268 . . . . 0.0 117.125 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.67 -16.64 41.59 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 119.377 2.511 . . . . 0.0 119.377 166.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -88.23 -44.22 11.02 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.573 2.187 . . . . 0.0 114.43 171.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.0 m -93.78 42.71 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 CA-C-N 122.032 2.196 . . . . 0.0 114.041 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.3 m -175.97 145.69 0.66 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.244 1.418 . . . . 0.0 107.892 -176.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -86.8 104.56 6.09 Favored Pre-proline 0 CA--C 1.576 1.977 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.574 170.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.63 113.22 3.74 Favored 'Trans proline' 0 C--N 1.374 1.883 0 CA-C-N 123.158 2.164 . . . . 0.0 112.298 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 93.1 m -95.95 115.29 27.21 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.501 -161.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -92.25 99.69 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -169.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.7 mt -93.21 99.91 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 62.0 mt -89.11 124.97 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.2 p -146.87 116.61 7.16 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.842 -0.536 . . . . 0.0 111.552 -168.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -84.27 117.97 23.89 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.945 -1.097 . . . . 0.0 112.024 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -109.4 82.58 1.62 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.936 0.874 . . . . 0.0 109.424 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.9 -100.58 1.48 Allowed Glycine 0 N--CA 1.489 2.18 0 O-C-N 121.884 -0.51 . . . . 0.0 114.219 -175.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -94.58 -24.44 17.22 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 173.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -98.37 146.32 25.82 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 120.786 1.63 . . . . 0.0 112.941 -174.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.65 115.11 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.671 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 170.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.9 t -99.85 106.35 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.0 mt -95.71 117.84 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 175.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -106.38 95.61 5.88 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.946 174.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.7 m -89.69 101.52 14.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.658 -0.651 . . . . 0.0 109.601 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.4 mt -107.47 105.25 15.07 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.275 -168.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 m -79.96 152.0 29.76 Favored 'General case' 0 CA--C 1.568 1.642 0 O-C-N 121.424 -0.798 . . . . 0.0 110.425 151.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.5 p -38.39 -51.13 1.54 Allowed 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 160.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -80.45 -47.51 14.22 Favored 'General case' 0 CA--C 1.572 1.804 0 C-N-CA 124.379 1.072 . . . . 0.0 113.599 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -115.0 109.77 18.6 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.845 0.858 . . . . 0.0 111.062 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -95.14 89.84 5.68 Favored 'General case' 0 CA--C 1.566 1.568 0 C-N-CA 123.193 0.597 . . . . 0.0 110.366 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.3 p -92.93 146.9 23.28 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -171.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -150.21 116.28 5.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.196 -0.94 . . . . 0.0 112.036 -166.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.2 pt -129.27 116.51 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.668 -0.645 . . . . 0.0 111.93 -175.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.8 p -103.58 113.17 26.48 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.24 1.016 . . . . 0.0 111.975 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -147.29 150.15 34.24 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.829 0.823 . . . . 0.0 113.119 -169.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -86.92 149.37 24.85 Favored 'General case' 0 CA--C 1.572 1.808 0 O-C-N 121.028 -1.045 . . . . 0.0 111.018 162.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.8 mt -68.21 123.97 22.16 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.059 -1.651 . . . . 0.0 112.546 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.38 -16.76 60.63 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 118.707 2.243 . . . . 0.0 118.707 -162.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -80.91 125.82 30.6 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-N 119.935 1.867 . . . . 0.0 112.005 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -86.62 127.69 34.94 Favored 'General case' 0 CA--C 1.569 1.693 0 CA-C-O 121.291 0.567 . . . . 0.0 111.901 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -133.93 148.64 51.22 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.154 0.982 . . . . 0.0 111.331 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.09 131.99 37.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.482 -1.387 . . . . 0.0 111.435 171.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -126.46 104.11 7.97 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.041 0.537 . . . . 0.0 110.139 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.4 m -74.1 104.52 4.95 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.223 1.011 . . . . 0.0 110.033 171.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 75.3 p -84.48 172.79 11.38 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -168.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.56 -6.73 0.76 Allowed 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 119.589 3.181 . . . . 0.0 119.589 166.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -96.45 0.43 50.37 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 160.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.313 18.3 t70 63.48 27.2 15.08 Favored 'General case' 0 CA--C 1.582 2.19 0 N-CA-C 116.949 2.203 . . . . 0.0 116.949 -166.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 -94.02 131.6 39.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.574 -1.329 . . . . 0.0 109.196 162.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.298 0.3 OUTLIER -88.72 108.93 19.74 Favored 'General case' 0 CA--C 1.569 1.676 0 CA-C-O 121.041 0.448 . . . . 0.0 110.361 171.493 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 92.4 m -95.33 120.82 36.23 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -173.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -69.88 100.12 1.51 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.811 0.815 . . . . 0.0 109.953 171.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.4 m -114.89 112.67 23.08 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.114 -156.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.8 p -111.71 119.12 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.368 0.604 . . . . 0.0 109.618 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.4 t -105.1 119.85 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -174.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.4 p -130.26 127.68 40.05 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.414 0.685 . . . . 0.0 111.661 -177.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 tt -91.12 111.28 22.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.133 -0.979 . . . . 0.0 110.632 177.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -113.7 74.92 0.89 Allowed 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 123.203 0.601 . . . . 0.0 111.373 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 65.84 77.9 0.25 Allowed Glycine 0 N--CA 1.496 2.678 0 N-CA-C 116.623 1.409 . . . . 0.0 116.623 172.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.271 23.4 t0 62.81 11.87 5.29 Favored 'General case' 0 CA--C 1.582 2.194 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 -164.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.7 mtmt -128.2 105.58 8.45 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 120.914 1.688 . . . . 0.0 109.532 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.78 93.45 8.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -0.968 . . . . 0.0 109.965 177.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 22.3 t -97.03 107.87 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.036 -1.04 . . . . 0.0 108.973 -166.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -93.26 103.25 15.52 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.576 0.75 . . . . 0.0 110.38 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.2 mt -92.84 105.04 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -176.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -94.29 122.06 36.45 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 118.561 0.619 . . . . 0.0 110.672 173.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -118.36 127.18 53.44 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.366 0.666 . . . . 0.0 110.442 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.4 p90 -149.49 122.68 8.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.03 -1.044 . . . . 0.0 110.055 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 54.85 36.65 27.05 Favored 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 176.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.92 -24.94 4.93 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 118.985 2.354 . . . . 0.0 118.985 -164.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -81.2 144.4 31.64 Favored 'General case' 0 CA--C 1.565 1.552 0 CA-C-N 119.075 1.437 . . . . 0.0 112.84 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -134.45 132.72 39.65 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.316 0.646 . . . . 0.0 111.287 -176.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.7 t -126.2 134.15 51.33 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 161.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.97 123.5 43.66 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.934 0.494 . . . . 0.0 110.813 176.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -102.72 108.9 20.32 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -171.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.0 t -92.8 96.39 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -174.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -88.32 116.88 26.85 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -133.3 133.53 42.7 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.8 mm -76.69 114.74 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -148.38 124.11 10.51 Favored 'General case' 0 CA--C 1.565 1.544 0 C-N-CA 124.225 1.01 . . . . 0.0 108.717 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 t70 55.85 50.5 13.93 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.27 18.68 65.47 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 119.66 2.624 . . . . 0.0 119.66 -172.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -144.31 152.02 40.18 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.486 1.143 . . . . 0.0 110.184 -169.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 7.7 ttm -85.2 115.32 22.92 Favored 'General case' 0 CA--C 1.564 1.516 0 O-C-N 121.26 -0.9 . . . . 0.0 108.984 159.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.9 t -88.46 105.42 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 27.2 ttt -95.22 103.22 15.07 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.771 -0.58 . . . . 0.0 110.3 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 92.1 m -92.33 115.19 27.87 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.656 0.741 . . . . 0.0 109.405 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mp -105.41 105.82 16.04 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -174.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.9 t -121.95 125.79 47.15 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 119.098 0.863 . . . . 0.0 113.321 -175.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -109.04 92.29 3.99 Favored 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 123.802 0.841 . . . . 0.0 108.758 171.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 69.5 -82.26 0.28 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 115.9 1.12 . . . . 0.0 115.9 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -121.72 -7.21 9.08 Favored 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 167.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.7 t -87.66 116.36 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-N 121.748 2.067 . . . . 0.0 108.565 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.1 t -115.4 121.0 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 C-N-CA 123.482 0.713 . . . . 0.0 109.655 -169.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -107.29 157.9 17.56 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 123.281 0.633 . . . . 0.0 112.446 161.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.4 t -132.44 110.59 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.01 -1.056 . . . . 0.0 109.274 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -97.5 121.26 39.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.028 -1.045 . . . . 0.0 111.273 174.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -99.37 110.56 23.05 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.427 0.691 . . . . 0.0 109.937 -171.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -110.61 128.01 55.49 Favored 'General case' 0 CA--C 1.563 1.454 0 O-C-N 121.378 -0.826 . . . . 0.0 111.99 -168.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -103.07 154.26 19.45 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 123.246 0.618 . . . . 0.0 112.543 168.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -74.1 134.97 42.93 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.251 -0.906 . . . . 0.0 113.027 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.519 0 C-N-CA 123.799 0.84 . . . . 0.0 111.837 168.948 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.329 17.5 tt0 . . . . . 0 N--CA 1.497 1.899 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.31 -26.57 61.12 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 165.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -71.18 -22.75 61.99 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 116.801 2.149 . . . . 0.0 116.801 165.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.7 m -83.67 100.42 10.85 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 120.83 1.65 . . . . 0.0 113.218 -174.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -165.38 171.93 12.84 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-O 122.222 1.011 . . . . 0.0 111.802 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 94.8 m -81.89 118.24 22.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.013 -1.054 . . . . 0.0 109.274 165.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -113.57 121.86 45.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.403 -0.811 . . . . 0.0 112.333 -170.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -96.79 124.97 40.92 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.467 1.107 . . . . 0.0 110.459 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tt -71.82 112.9 8.31 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.079 -1.013 . . . . 0.0 112.484 176.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.4 p -90.42 -46.22 8.49 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -143.93 136.19 26.7 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 119.193 0.906 . . . . 0.0 110.276 -175.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.3 p -118.8 136.98 53.71 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -94.2 -126.44 0.11 Allowed 'General case' 0 CA--C 1.573 1.848 0 O-C-N 121.611 -0.681 . . . . 0.0 110.326 172.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -83.82 54.05 2.76 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 119.571 -1.956 . . . . 0.0 114.848 -172.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -74.04 -36.18 64.37 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -48.35 -56.24 8.62 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 174.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -65.59 -42.32 91.81 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 169.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -52.91 -47.48 67.95 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 171.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 78.1 mtm -59.74 -48.68 80.72 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.06 -46.99 72.09 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 167.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.2 90.2 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 173.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mp -63.25 -35.9 81.88 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 166.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.11 41.42 0.9 Allowed Glycine 0 N--CA 1.487 2.051 0 N-CA-C 117.197 1.639 . . . . 0.0 117.197 177.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.5 m -71.22 158.06 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-N 119.323 1.561 . . . . 0.0 113.288 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.5 157.83 49.69 Favored Glycine 0 CA--C 1.553 2.437 0 O-C-N 120.767 -1.208 . . . . 0.0 115.89 162.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -64.57 -38.49 91.2 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.28 -44.33 97.41 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 160.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.7 m -58.54 -43.35 89.25 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -57.81 -47.98 81.06 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 167.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -63.04 -43.78 97.7 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 172.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.9 t -49.84 -61.15 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 163.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.93 -34.92 62.25 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 119.173 2.429 . . . . 0.0 119.173 174.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -66.33 -43.14 86.98 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 170.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.0 m -78.53 -33.35 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 116.361 1.985 . . . . 0.0 116.361 176.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 t -94.46 136.05 35.2 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 120.318 1.417 . . . . 0.0 113.997 -162.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -92.93 109.26 38.2 Favored Pre-proline 0 CA--C 1.576 1.96 0 CA-C-O 118.338 -0.839 . . . . 0.0 110.937 167.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.55 138.68 24.56 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 C-N-CA 122.635 2.223 . . . . 0.0 113.854 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.4 m -85.62 102.49 13.61 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.71 100.2 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -169.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.9 mt -90.82 102.75 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.175 -0.953 . . . . 0.0 108.529 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.5 mt -93.01 125.96 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.9 p -148.91 126.79 11.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.41 -0.806 . . . . 0.0 112.298 -169.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -81.42 109.32 15.79 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.682 -1.261 . . . . 0.0 110.426 168.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -104.11 86.66 2.6 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -173.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.19 -73.69 2.31 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 115.5 0.96 . . . . 0.0 115.5 -174.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -122.52 -53.85 1.88 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.889 0.876 . . . . 0.0 112.088 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -80.66 151.92 28.72 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -172.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.2 t -85.21 121.12 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.2 t -111.5 108.18 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.3 mt -89.75 116.11 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 172.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.8 mtm-85 -100.11 104.3 15.84 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 119.493 1.042 . . . . 0.0 109.73 169.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.7 m -90.11 102.52 15.24 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 77.3 mt -120.08 94.82 4.51 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 122.585 0.354 . . . . 0.0 110.397 -169.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.0 p -93.05 171.04 9.2 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.86 -1.15 . . . . 0.0 112.021 165.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.5 t -72.2 31.59 0.06 Allowed 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 165.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -155.68 -60.57 0.11 Allowed 'General case' 0 CA--C 1.571 1.756 0 C-N-CA 125.182 1.393 . . . . 0.0 109.404 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 46.7 mmtt -109.9 123.37 49.49 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.403 1.081 . . . . 0.0 109.902 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -124.14 98.29 5.71 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 123.337 0.655 . . . . 0.0 110.683 176.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.0 t -129.98 166.97 18.98 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 123.507 0.723 . . . . 0.0 112.054 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -138.18 153.0 49.2 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.9 mt -124.02 104.36 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.629 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -177.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 91.2 p -99.95 114.9 28.49 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.79 0.836 . . . . 0.0 112.178 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -145.14 152.93 40.81 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -171.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -103.68 141.98 35.12 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 123.463 0.705 . . . . 0.0 109.325 168.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -67.38 129.25 39.32 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.634 -1.291 . . . . 0.0 113.908 -173.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.79 -15.69 45.98 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 119.141 2.416 . . . . 0.0 119.141 -167.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -91.53 127.3 36.92 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 119.945 1.873 . . . . 0.0 111.58 -173.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -79.71 126.66 31.23 Favored 'General case' 0 CA--C 1.569 1.68 0 C-N-CA 122.885 0.474 . . . . 0.0 111.917 177.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -140.25 149.6 43.05 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.447 0.699 . . . . 0.0 111.916 -171.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -78.81 138.11 38.03 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.788 -1.195 . . . . 0.0 113.035 174.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -146.3 132.41 19.34 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.198 0.599 . . . . 0.0 110.959 174.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.3 m -98.51 119.77 37.78 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.487 0.66 . . . . 0.0 109.457 170.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 44.7 p -90.34 172.24 8.89 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -168.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.27 -21.37 33.91 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 118.595 2.813 . . . . 0.0 118.595 165.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -65.73 -14.68 61.78 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 158.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.291 10.1 m-20 62.38 46.86 5.58 Favored 'General case' 0 CA--C 1.574 1.873 0 CA-C-N 120.245 1.384 . . . . 0.0 114.69 -164.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.18 131.83 53.83 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.666 1.186 . . . . 0.0 108.702 172.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -86.78 120.31 27.94 Favored 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 122.806 0.442 . . . . 0.0 111.716 173.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.6 p -119.72 143.8 47.58 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.49 0.662 . . . . 0.0 112.725 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -79.13 105.11 10.23 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 121.966 0.889 . . . . 0.0 109.15 157.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.2 m -98.55 136.76 38.2 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.636 0.775 . . . . 0.0 112.245 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.6 p -134.3 129.89 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 123.537 0.735 . . . . 0.0 109.35 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.4 t -118.41 119.14 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.104 -0.998 . . . . 0.0 109.428 -169.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.7 p -117.69 131.62 56.6 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.576 0.75 . . . . 0.0 112.191 -176.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 tt -99.93 108.21 20.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.903 . . . . 0.0 110.301 177.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -88.78 -21.38 23.82 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 116.946 2.202 . . . . 0.0 116.946 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -178.43 -93.53 0.09 OUTLIER Glycine 0 N--CA 1.49 2.251 0 CA-C-N 120.289 1.404 . . . . 0.0 111.108 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -107.41 60.54 0.62 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 117.842 0.821 . . . . 0.0 109.915 151.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -155.25 114.76 3.67 Favored 'General case' 0 CA--C 1.563 1.46 0 O-C-N 121.416 -0.803 . . . . 0.0 110.576 174.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.5 mt -84.7 118.87 24.68 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.722 -0.611 . . . . 0.0 109.57 166.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.2 t -105.98 99.65 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -178.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -90.68 103.66 16.34 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.411 0.684 . . . . 0.0 110.151 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.3 mt -93.91 117.06 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -175.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -108.68 120.56 42.84 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 119.005 0.82 . . . . 0.0 110.464 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -112.41 120.82 42.98 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.889 0.876 . . . . 0.0 110.663 -176.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -151.58 134.28 15.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.395 -0.815 . . . . 0.0 110.591 -175.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 50.48 43.02 27.19 Favored 'General case' 0 N--CA 1.509 2.489 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 166.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.67 22.2 76.64 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 119.82 2.688 . . . . 0.0 119.82 -167.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -137.25 137.4 39.01 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 119.257 1.529 . . . . 0.0 109.506 -168.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -131.66 125.57 32.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.609 -0.682 . . . . 0.0 111.197 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.8 t -125.76 137.86 53.83 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.56 0.744 . . . . 0.0 110.377 175.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.258 11.6 p30 -120.11 135.34 54.99 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.81 105.19 15.55 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -174.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.5 t -89.91 95.88 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 CA-C-N 119.681 1.128 . . . . 0.0 108.199 -178.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.4 ' CG ' ' SD ' ' A' ' 113' ' ' MET . 41.8 ttm180 -95.35 106.25 18.28 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.021 0.928 . . . . 0.0 111.059 -173.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -126.34 144.38 50.83 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.179 0.592 . . . . 0.0 112.568 -176.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.6 mm -82.99 120.35 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -127.91 98.48 5.17 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.7 t70 53.15 58.26 5.46 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -176.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.19 -48.97 3.22 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 116.883 1.513 . . . . 0.0 116.883 -172.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -80.84 145.37 31.43 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 118.265 1.033 . . . . 0.0 113.085 -173.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.4 ' SD ' ' CG ' ' A' ' 106' ' ' ARG . 25.0 tpp -80.18 108.26 13.64 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 121.618 0.723 . . . . 0.0 109.378 161.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 93.6 t -100.75 100.41 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 30.4 ttm -98.49 102.84 14.7 Favored 'General case' 0 CA--C 1.561 1.372 0 O-C-N 122.049 -0.407 . . . . 0.0 110.751 -165.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.9 m -97.41 96.21 8.2 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.579 1.181 . . . . 0.0 110.119 -170.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.638 HD13 HH22 ' A' ' 126' ' ' ARG . 11.0 mp -93.83 106.83 18.78 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.217 1.007 . . . . 0.0 111.137 -176.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.0 t -101.45 118.04 36.15 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.582 0.753 . . . . 0.0 111.11 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -103.14 77.11 1.51 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 159.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 63.97 -109.52 2.84 Favored Glycine 0 CA--C 1.547 2.093 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 -170.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -76.54 -22.11 54.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 171.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.9 t -86.21 102.82 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 120.777 1.626 . . . . 0.0 108.867 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 61.6 t -110.26 108.56 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -172.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.45 135.86 39.41 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.477 0.711 . . . . 0.0 111.696 174.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.0 t -131.95 115.68 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.638 HH22 HD13 ' A' ' 117' ' ' LEU . 3.6 mtm105 -120.8 140.85 51.14 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 122.363 1.078 . . . . 0.0 113.013 176.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -110.21 100.16 9.1 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.541 -1.208 . . . . 0.0 108.662 -164.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -103.52 132.3 49.9 Favored 'General case' 0 CA--C 1.565 1.543 0 O-C-N 121.429 -0.795 . . . . 0.0 111.802 -169.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -103.16 151.53 22.49 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 172.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -74.09 135.25 42.96 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.295 -0.878 . . . . 0.0 113.177 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.079 -0.962 . . . . 0.0 111.491 164.851 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 . . . . . 0 N--CA 1.495 1.811 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.96 -28.67 64.54 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 169.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -77.39 -15.94 59.11 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 166.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.2 t -76.77 98.64 4.87 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 122.478 2.399 . . . . 0.0 114.302 -172.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -168.4 167.6 11.78 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.161 0.982 . . . . 0.0 112.23 -177.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.7 m -81.64 116.87 21.58 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.846 -1.159 . . . . 0.0 108.661 159.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -107.34 119.67 40.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.346 -0.847 . . . . 0.0 110.672 -174.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -101.93 131.92 48.04 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.638 0.732 . . . . 0.0 110.917 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -69.13 132.63 46.87 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.3 p -102.15 -41.29 6.46 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 173.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -156.76 129.47 7.68 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 119.552 1.069 . . . . 0.0 109.807 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.1 p -110.86 106.0 15.0 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.503 0.721 . . . . 0.0 110.913 172.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -70.65 -58.82 3.26 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 -160.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -120.57 46.4 2.01 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.318 -0.864 . . . . 0.0 112.287 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -75.79 -43.65 45.28 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -167.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -46.96 -52.64 14.17 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 163.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.55 -43.16 85.85 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 176.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -52.77 -53.25 50.86 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 120.203 1.365 . . . . 0.0 114.42 162.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 76.9 mtm -62.03 -43.7 98.28 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 176.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.5 -40.8 92.67 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 168.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.03 -39.97 95.27 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 165.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.5 tp -59.08 -37.29 76.75 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 172.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.45 50.8 0.84 Allowed Glycine 0 N--CA 1.485 1.938 0 N-CA-C 115.434 0.934 . . . . 0.0 115.434 -176.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.3 m -91.21 157.81 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 118.379 1.089 . . . . 0.0 112.545 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.6 158.68 53.61 Favored Glycine 0 CA--C 1.552 2.348 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 162.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -59.13 -41.05 87.33 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.92 -38.98 73.61 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 168.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.9 m -61.23 -48.2 82.56 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 169.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.257 8.2 ptm180 -63.22 -32.67 74.12 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 173.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -62.75 -58.02 8.92 Favored 'General case' 0 CA--C 1.571 1.758 0 CA-C-N 119.066 0.848 . . . . 0.0 113.182 162.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.6 t -54.06 -58.51 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.07 -21.24 58.99 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 120.253 2.861 . . . . 0.0 120.253 -177.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -91.11 -38.41 12.78 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 169.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -68.88 -39.87 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 CA-C-N 121.326 1.876 . . . . 0.0 115.846 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.7 t -85.03 153.32 22.81 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 119.474 1.034 . . . . 0.0 113.274 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -98.66 93.96 2.21 Favored Pre-proline 0 CA--C 1.575 1.906 0 O-C-N 121.46 -0.775 . . . . 0.0 110.335 169.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.19 118.49 5.64 Favored 'Trans proline' 0 C--N 1.374 1.904 0 CA-C-N 123.109 2.146 . . . . 0.0 113.466 -175.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 91.2 m -88.82 122.16 31.92 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.395 -173.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.7 t -105.32 100.75 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.711 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -166.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.0 mt -89.1 105.84 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.7 mt -97.27 115.05 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 92.1 p -144.48 124.82 13.82 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.748 0.419 . . . . 0.0 111.219 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -78.97 115.62 18.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.593 -0.692 . . . . 0.0 111.677 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -126.2 84.08 2.23 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.223 0.535 . . . . 0.0 110.371 -170.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.75 72.25 1.05 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 115.435 0.934 . . . . 0.0 115.435 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.29 7.3 t70 70.71 -51.94 0.67 Allowed 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -171.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -76.18 148.98 37.37 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.1 t -88.91 116.61 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.55 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 172.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.0 t -99.55 114.69 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.9 mt -103.43 112.94 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 173.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.6 116.24 30.41 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.284 1.034 . . . . 0.0 110.668 -177.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.1 m -102.22 100.5 10.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.69 -0.631 . . . . 0.0 109.44 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.3 mt -99.64 100.63 11.65 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.101 0.56 . . . . 0.0 109.998 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.1 p -98.36 1.9 47.45 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 118.24 2.681 . . . . 0.0 118.24 176.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.396 31.8 p 78.69 -57.35 0.44 Allowed 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 124.871 1.268 . . . . 0.0 113.316 -167.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -77.92 -61.88 1.85 Allowed 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 124.354 1.062 . . . . 0.0 112.267 177.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -105.62 117.58 34.38 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.988 0.915 . . . . 0.0 109.428 176.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -121.07 85.5 2.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.412 -0.805 . . . . 0.0 109.833 -172.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.2 t -113.18 176.37 5.05 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 122.3 1.048 . . . . 0.0 113.478 -173.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -146.66 156.08 42.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.847 -1.158 . . . . 0.0 113.093 173.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.3 pt -121.68 132.0 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 123.899 0.88 . . . . 0.0 109.508 171.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 92.6 p -124.17 109.49 13.5 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.509 0.723 . . . . 0.0 110.408 -176.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -141.49 139.48 33.31 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -165.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -93.34 23.91 4.21 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.7 mt 67.41 105.21 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 125.179 1.392 . . . . 0.0 113.769 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.58 -20.09 12.69 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 118.483 2.153 . . . . 0.0 118.483 -166.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -78.66 123.37 27.07 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 119.158 1.479 . . . . 0.0 111.666 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -84.77 131.48 34.54 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 121.86 0.838 . . . . 0.0 112.24 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -131.52 157.31 43.9 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 124.247 1.019 . . . . 0.0 111.181 -173.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.65 136.07 33.41 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.63 -1.294 . . . . 0.0 110.98 175.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -140.71 118.72 11.88 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 122.533 0.333 . . . . 0.0 111.114 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 85.1 m -82.96 113.13 20.34 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 163.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.6 p -87.08 164.9 16.17 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -165.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.54 -24.35 8.0 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 118.824 2.898 . . . . 0.0 118.824 164.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -78.56 -0.51 29.96 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 167.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.262 10.7 t70 68.01 65.97 0.36 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 120.358 1.436 . . . . 0.0 113.151 -171.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -161.04 130.34 4.75 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.821 0.848 . . . . 0.0 109.146 -177.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -89.94 127.23 35.98 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.234 0.614 . . . . 0.0 112.392 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 21.0 p -132.0 148.76 52.53 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -81.2 101.63 9.81 Favored 'General case' 0 CA--C 1.565 1.537 0 CA-C-N 115.018 -0.992 . . . . 0.0 108.784 164.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.6 m -100.77 130.41 46.79 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.228 1.011 . . . . 0.0 112.35 -171.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.2 p -137.57 131.49 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.67 -0.644 . . . . 0.0 110.333 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 t -115.69 121.28 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.272 -0.893 . . . . 0.0 109.571 -176.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.9 p -110.77 130.07 55.67 Favored 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 123.612 0.765 . . . . 0.0 112.015 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 tt -92.68 100.86 13.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 110.584 176.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -93.1 75.6 4.69 Favored 'General case' 0 CA--C 1.568 1.657 0 O-C-N 121.325 -0.859 . . . . 0.0 111.681 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.75 -84.27 1.59 Allowed Glycine 0 N--CA 1.492 2.411 0 O-C-N 121.718 -0.613 . . . . 0.0 113.674 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -136.39 53.9 1.91 Allowed 'General case' 0 CA--C 1.571 1.78 0 CA-C-O 121.131 0.491 . . . . 0.0 111.911 161.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -145.64 119.54 9.32 Favored 'General case' 0 CA--C 1.562 1.411 0 O-C-N 121.072 -1.017 . . . . 0.0 111.303 172.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 47.2 mt -87.32 105.32 17.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.788 -0.57 . . . . 0.0 110.62 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.4 t -95.27 102.0 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -177.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -89.97 107.64 19.24 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.255 0.622 . . . . 0.0 110.61 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.3 mt -96.41 121.07 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 124.297 1.039 . . . . 0.0 108.493 -177.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -112.71 120.57 41.96 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 118.754 0.706 . . . . 0.0 110.23 173.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -111.42 123.03 49.39 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.639 0.776 . . . . 0.0 110.654 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -156.23 133.52 10.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.498 -0.751 . . . . 0.0 110.192 -175.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 64.39 15.07 9.27 Favored 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 117.446 2.387 . . . . 0.0 117.446 176.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.32 -3.13 82.89 Favored Glycine 0 CA--C 1.559 2.808 0 N-CA-C 119.082 2.393 . . . . 0.0 119.082 -158.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -105.55 147.51 28.3 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-N 119.337 1.569 . . . . 0.0 111.013 -176.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -136.06 127.07 27.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.738 -0.601 . . . . 0.0 112.075 -175.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.9 t -112.67 138.39 49.54 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.524 0.73 . . . . 0.0 109.47 164.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.88 122.39 40.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.242 0.617 . . . . 0.0 110.025 175.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -105.25 106.0 16.29 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -172.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.3 t -90.65 98.45 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -171.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 25.8 ttm105 -93.58 111.12 22.73 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.291 0.636 . . . . 0.0 110.641 -177.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -129.63 134.63 47.8 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 119.3 0.955 . . . . 0.0 112.621 -175.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.3 mm -81.46 127.11 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.206 -0.934 . . . . 0.0 109.528 174.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -101.6 -86.61 0.41 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.982 -0.449 . . . . 0.0 110.098 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -143.33 95.4 2.75 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 171.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.17 -41.97 2.96 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 117.354 1.701 . . . . 0.0 117.354 -167.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -92.81 148.57 21.92 Favored 'General case' 0 CA--C 1.558 1.28 0 CA-C-N 118.549 1.175 . . . . 0.0 113.219 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -90.76 109.56 20.75 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.704 158.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.6 t -85.28 104.27 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 170.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 39.5 ttm -93.97 114.52 26.73 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.6 m -101.7 99.46 9.72 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.9 mp -93.33 107.31 19.16 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -174.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.261 13.5 t -131.79 134.61 46.01 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -172.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -110.76 80.03 1.26 Allowed 'General case' 0 CA--C 1.564 1.511 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.994 174.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 69.89 -90.25 0.32 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 115.92 1.128 . . . . 0.0 115.92 -177.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -87.6 -34.49 18.5 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.4 t -87.65 132.35 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 119.459 1.027 . . . . 0.0 109.823 -170.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.7 t -128.42 112.83 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 C-N-CA 123.288 0.635 . . . . 0.0 109.453 -169.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -105.24 114.5 28.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.423 -0.798 . . . . 0.0 112.135 171.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.9 t -92.93 112.58 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.428 -0.795 . . . . 0.0 109.032 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -101.12 120.74 40.65 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.974 0.892 . . . . 0.0 111.219 175.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -102.66 102.92 13.16 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.464 0.706 . . . . 0.0 109.44 -168.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -105.77 127.58 53.18 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.132 -0.98 . . . . 0.0 112.413 -171.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -98.21 155.71 17.04 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 123.798 0.839 . . . . 0.0 112.808 169.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -77.55 135.17 38.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.176 -0.952 . . . . 0.0 113.238 176.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.019 -0.991 . . . . 0.0 111.04 162.803 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.326 19.7 tt0 . . . . . 0 N--CA 1.496 1.874 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.56 -31.89 57.45 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 117.246 2.313 . . . . 0.0 117.246 161.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -72.27 -26.08 61.85 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 165.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.5 t -78.97 95.59 5.51 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-N 121.167 1.803 . . . . 0.0 113.269 -173.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -169.11 172.37 7.49 Favored 'General case' 0 CA--C 1.571 1.755 0 CA-C-O 122.702 1.239 . . . . 0.0 111.928 -174.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.6 m -78.83 127.38 31.97 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.135 -0.978 . . . . 0.0 110.109 165.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 99.9 m95 -124.6 111.73 15.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.856 -0.528 . . . . 0.0 110.267 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -104.53 129.6 52.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.58 -0.7 . . . . 0.0 110.811 -175.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -70.72 134.54 47.56 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 60.9 p -106.9 -39.97 5.62 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 175.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -153.77 123.04 6.54 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 119.528 1.058 . . . . 0.0 109.607 -174.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.4 p -103.07 100.22 10.13 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 122.925 0.49 . . . . 0.0 111.705 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -76.68 120.61 22.1 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 123.664 0.786 . . . . 0.0 111.405 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 4.8 t-20 60.12 38.08 20.56 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -76.0 -41.02 52.45 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.35 -50.76 70.58 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 174.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -55.47 -48.29 74.75 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 167.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -51.94 -47.1 64.88 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 169.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.465 ' SD ' ' HA ' ' A' ' 30' ' ' ARG . 72.7 mtm -64.06 -40.77 96.99 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 174.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -58.67 -51.52 69.59 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 161.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.54 -43.83 96.76 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 tt -66.31 -32.13 73.35 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.861 1.801 . . . . 0.0 115.861 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.69 55.45 1.9 Allowed Glycine 0 N--CA 1.485 1.923 0 N-CA-C 115.604 1.002 . . . . 0.0 115.604 -172.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.7 m -87.82 154.27 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 CA-C-N 118.129 0.964 . . . . 0.0 111.005 168.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.83 168.66 31.97 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 116.662 1.425 . . . . 0.0 116.662 174.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -83.54 59.43 5.1 Favored 'General case' 0 CA--C 1.577 1.991 0 CA-C-O 122.681 1.229 . . . . 0.0 112.812 177.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -160.76 -58.32 0.05 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.064 1.346 . . . . 0.0 109.758 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.8 m -61.0 -31.53 71.13 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 169.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.465 ' HA ' ' SD ' ' A' ' 20' ' ' MET . 18.5 ptp180 -57.29 -42.77 82.32 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 164.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -60.62 -48.53 81.37 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 167.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.5 t -49.94 -60.56 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 167.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.81 -38.31 53.74 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 119.349 2.5 . . . . 0.0 119.349 175.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -66.84 -42.44 85.76 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 168.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -77.96 -35.32 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 177.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 t -95.73 138.55 33.23 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 120.277 1.399 . . . . 0.0 113.846 -164.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -103.82 101.36 24.39 Favored Pre-proline 0 CA--C 1.575 1.91 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.335 173.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.55 150.82 46.39 Favored 'Trans proline' 0 CA--C 1.564 1.998 0 CA-C-N 123.011 2.111 . . . . 0.0 117.086 -170.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.7 m -102.9 103.85 14.03 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.113 173.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.2 t -96.58 102.26 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -174.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.2 mt -93.94 102.68 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.4 mt -87.91 113.52 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.4 p -129.58 120.44 25.29 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.839 0.456 . . . . 0.0 111.91 -170.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -85.55 103.52 14.47 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.04 -1.038 . . . . 0.0 110.146 176.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -106.3 88.16 2.72 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.36 0.6 . . . . 0.0 109.801 -168.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.75 -76.33 2.02 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 115.147 0.819 . . . . 0.0 115.147 -176.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -123.89 -50.34 1.83 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.514 0.725 . . . . 0.0 112.647 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -81.11 157.81 25.22 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -176.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.76 115.49 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.595 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 173.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.0 t -105.91 104.98 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.2 mt -94.18 118.78 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -101.59 101.96 12.6 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.1 m -85.38 95.8 9.36 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.9 mt -99.06 92.57 5.55 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -173.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.4 p -85.57 11.22 11.11 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 175.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.391 39.7 p 74.05 -57.97 0.6 Allowed 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 125.136 1.375 . . . . 0.0 113.536 -168.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -76.7 -62.08 1.75 Allowed 'General case' 0 CA--C 1.571 1.776 0 C-N-CA 124.498 1.119 . . . . 0.0 112.285 176.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -106.2 120.93 43.12 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.93 0.892 . . . . 0.0 109.583 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -123.73 84.32 2.26 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -169.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.9 t -108.74 147.65 31.66 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -166.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.43 135.31 47.06 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 124.134 0.974 . . . . 0.0 113.136 -174.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.0 mt -124.66 101.32 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -174.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 90.1 p -110.24 112.87 25.11 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.693 0.797 . . . . 0.0 111.833 -173.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -141.2 139.29 33.79 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.007 0.908 . . . . 0.0 113.423 -173.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -88.33 26.15 1.49 Allowed 'General case' 0 CA--C 1.582 2.194 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 173.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 75.4 mt 63.42 100.49 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 125.347 1.459 . . . . 0.0 113.094 -172.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.71 2.38 88.72 Favored Glycine 0 CA--C 1.556 2.635 0 N-CA-C 119.111 2.405 . . . . 0.0 119.111 -167.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -89.28 129.4 35.84 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-N 119.537 1.669 . . . . 0.0 111.205 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -89.61 111.57 22.56 Favored 'General case' 0 CA--C 1.563 1.447 0 CA-C-O 121.288 0.566 . . . . 0.0 111.374 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -113.8 150.18 33.85 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.27 1.028 . . . . 0.0 110.606 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.45 131.18 35.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.266 -1.521 . . . . 0.0 111.59 171.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -122.56 108.25 12.91 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.596 0.758 . . . . 0.0 109.74 -172.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.7 m -77.97 100.99 6.66 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.219 1.009 . . . . 0.0 109.26 172.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 74.4 p -79.18 -178.69 6.3 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -164.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.45 -8.64 0.56 Allowed 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 119.823 3.268 . . . . 0.0 119.823 162.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -109.5 19.02 19.75 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 158.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.438 2.2 p30 56.36 12.25 0.99 Allowed 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 119.794 3.257 . . . . 0.0 119.794 -171.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -77.11 126.14 30.47 Favored 'General case' 0 CA--C 1.561 1.403 0 O-C-N 120.888 -1.132 . . . . 0.0 110.053 170.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -83.99 101.34 11.66 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.476 0.711 . . . . 0.0 111.314 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 83.4 m -100.83 128.2 46.96 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.617 -0.677 . . . . 0.0 112.492 -171.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -72.46 99.4 2.47 Favored 'General case' 0 CA--C 1.563 1.456 0 CA-C-O 122.275 1.036 . . . . 0.0 109.382 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.2 m -115.96 117.23 29.58 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.916 -156.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 p -122.13 129.53 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 123.379 0.672 . . . . 0.0 109.895 -176.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.1 t -121.96 113.36 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -171.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 63.3 m -112.44 131.13 55.72 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.396 0.678 . . . . 0.0 110.923 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.0 tt -91.36 103.37 16.02 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.571 0.701 . . . . 0.0 110.244 175.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -87.28 80.09 8.33 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 123.46 0.704 . . . . 0.0 111.382 -177.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.9 -81.01 1.54 Allowed Glycine 0 N--CA 1.493 2.47 0 O-C-N 121.564 -0.71 . . . . 0.0 114.338 -176.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -135.33 56.12 1.85 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.271 0.558 . . . . 0.0 111.767 163.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -153.28 100.56 2.46 Favored 'General case' 0 CA--C 1.564 1.498 0 O-C-N 121.218 -0.926 . . . . 0.0 110.277 -170.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 24.4 mt -77.68 114.49 16.57 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.093 -1.004 . . . . 0.0 111.835 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.06 102.31 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -87.59 110.03 20.08 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.065 0.546 . . . . 0.0 110.606 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 69.1 mt -102.09 110.5 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -95.62 124.67 39.76 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 118.671 0.669 . . . . 0.0 111.517 172.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -111.38 124.05 51.47 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.977 0.911 . . . . 0.0 110.321 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.6 p90 -154.49 126.97 7.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.806 -1.184 . . . . 0.0 110.595 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 58.53 31.9 21.54 Favored 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 117.244 2.312 . . . . 0.0 117.244 169.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.09 -20.14 8.87 Favored Glycine 0 CA--C 1.556 2.649 0 N-CA-C 119.012 2.365 . . . . 0.0 119.012 -163.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -91.18 143.49 26.61 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 119.667 1.734 . . . . 0.0 111.657 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -133.42 134.24 43.38 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.174 0.59 . . . . 0.0 111.032 -178.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.0 t -126.48 134.75 50.85 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 123.072 0.549 . . . . 0.0 111.065 173.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -116.03 129.56 56.42 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 123.258 0.623 . . . . 0.0 111.997 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -111.34 102.15 10.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.233 -0.917 . . . . 0.0 108.623 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.9 t -91.77 111.12 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -171.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -110.45 119.41 39.12 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.416 0.686 . . . . 0.0 111.18 -171.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -129.41 144.78 51.39 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 122.996 0.518 . . . . 0.0 112.043 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.6 mm -88.18 106.0 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -103.49 101.09 10.97 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 123.511 0.725 . . . . 0.0 109.221 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.3 t70 50.74 53.95 12.08 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 -175.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.45 -35.15 3.65 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 118.645 2.218 . . . . 0.0 118.645 -170.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -95.76 146.39 24.57 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 119.373 1.587 . . . . 0.0 112.056 -172.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 34.1 ttm -86.06 116.08 24.05 Favored 'General case' 0 CA--C 1.566 1.568 0 O-C-N 120.868 -1.145 . . . . 0.0 111.61 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.4 t -94.79 108.11 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 169.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 13.7 ttt -110.17 101.63 10.39 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.506 0.67 . . . . 0.0 109.607 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.8 m -94.8 106.7 18.7 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.527 0.731 . . . . 0.0 109.355 -174.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.4 mp -91.53 113.9 26.29 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.8 m -120.89 119.78 33.62 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.544 0.688 . . . . 0.0 109.869 -167.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -107.61 77.85 1.16 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.372 0.606 . . . . 0.0 109.367 170.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 64.21 -94.98 0.16 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 115.306 0.882 . . . . 0.0 115.306 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -83.54 -32.73 25.71 Favored 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 170.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.2 t -87.05 109.95 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 120.444 1.475 . . . . 0.0 109.406 -171.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.3 t -114.19 118.27 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 124.086 0.954 . . . . 0.0 108.489 -169.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -123.21 127.63 48.89 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 123.265 0.626 . . . . 0.0 111.878 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 37.7 t -105.74 115.56 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.956 -1.09 . . . . 0.0 110.306 -172.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.8 124.06 40.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.054 -1.029 . . . . 0.0 111.716 169.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -102.05 105.78 16.57 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.726 0.81 . . . . 0.0 109.724 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -107.59 129.68 54.96 Favored 'General case' 0 CA--C 1.563 1.474 0 O-C-N 121.303 -0.873 . . . . 0.0 111.731 -169.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -98.35 158.09 15.79 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.399 1.095 . . . . 0.0 112.499 170.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -89.9 130.58 36.1 Favored 'General case' 0 CA--C 1.563 1.471 0 O-C-N 121.394 -0.816 . . . . 0.0 112.758 -169.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . 0.309 . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.277 8.1 p . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -55.71 -39.17 70.71 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 118.746 2.869 . . . . 0.0 118.746 -173.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.81 -22.28 61.99 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 168.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -80.71 -12.66 59.44 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 168.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 82.3 m -80.36 91.87 5.73 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 122.207 2.276 . . . . 0.0 113.044 -175.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -165.78 167.0 17.37 Favored 'General case' 0 CA--C 1.569 1.701 0 CA-C-O 122.467 1.127 . . . . 0.0 113.124 -172.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.8 m -80.07 111.01 16.02 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.422 -0.799 . . . . 0.0 109.38 165.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -107.57 111.08 23.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.533 -0.729 . . . . 0.0 111.193 -173.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -102.14 132.92 47.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.209 -0.932 . . . . 0.0 110.898 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 tt -70.87 113.85 8.34 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.717 -0.615 . . . . 0.0 112.574 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.7 p -99.44 -35.66 9.83 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 -175.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -141.72 120.45 12.62 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 120.432 1.469 . . . . 0.0 109.58 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.4 p -108.77 104.49 13.78 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -81.11 122.39 27.28 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.896 -0.503 . . . . 0.0 110.291 164.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 54.58 70.43 0.62 Allowed 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -110.6 61.83 0.61 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.831 -1.168 . . . . 0.0 112.095 163.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -155.51 -64.92 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.237 1.015 . . . . 0.0 109.52 173.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -62.29 -37.5 85.76 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.972 1.841 . . . . 0.0 115.972 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -50.5 -51.09 50.47 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.535 1.516 . . . . 0.0 114.793 167.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 73.5 mtm -57.08 -50.14 73.68 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 170.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -58.19 -40.72 82.26 Favored 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 116.134 1.902 . . . . 0.0 116.134 172.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.95 -41.97 90.59 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 169.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.2 tp -61.83 -23.3 66.16 Favored 'General case' 0 CA--C 1.574 1.875 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 176.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.86 55.58 1.61 Allowed Glycine 0 N--CA 1.485 1.906 0 C-N-CA 123.868 0.747 . . . . 0.0 114.795 -176.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.3 m -83.07 153.95 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.93 138.36 34.94 Favored Glycine 0 CA--C 1.555 2.532 0 O-C-N 120.956 -1.09 . . . . 0.0 113.494 149.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -57.56 -33.55 68.26 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -171.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.37 -41.79 66.22 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 164.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.1 m -60.1 -40.6 90.22 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 165.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.335 0.0 OUTLIER -60.18 -42.56 95.27 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 168.326 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -58.61 -51.76 68.57 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 166.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.1 t -56.02 -55.88 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 173.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.81 -24.72 57.99 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 119.854 2.702 . . . . 0.0 119.854 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -73.77 -45.66 50.41 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 164.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.7 m -78.23 -30.4 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 t -105.11 141.1 37.27 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 120.803 1.638 . . . . 0.0 114.276 -162.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -89.66 119.74 69.5 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.197 172.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.05 129.73 8.04 Favored 'Trans proline' 0 CA--C 1.564 2.02 0 C-N-CA 122.454 2.102 . . . . 0.0 114.044 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 56.6 m -95.69 106.91 19.07 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 169.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 81.0 t -99.43 95.91 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -174.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.8 mp -89.43 98.82 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.521 -1.362 . . . . 0.0 108.359 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.5 mt -84.04 116.46 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 81.6 p -141.78 121.27 13.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.832 -0.543 . . . . 0.0 112.36 -168.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -79.89 102.99 9.48 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.86 -1.15 . . . . 0.0 110.543 169.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -103.3 96.92 7.08 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -169.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.09 -74.8 2.46 Favored Glycine 0 N--CA 1.488 2.163 0 O-C-N 121.777 -0.577 . . . . 0.0 114.144 -173.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -132.77 -53.24 0.93 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.425 0.69 . . . . 0.0 111.927 171.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -81.3 160.18 24.27 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -173.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.2 t -84.29 114.56 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 123.635 0.774 . . . . 0.0 109.117 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.3 t -106.92 107.68 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.558 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 59.0 mt -91.6 122.18 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 172.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -106.03 106.82 17.5 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.151 0.58 . . . . 0.0 110.23 174.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.5 m -92.87 103.73 16.04 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.506 -0.746 . . . . 0.0 109.374 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 72.0 mt -121.32 117.64 27.49 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.085 0.554 . . . . 0.0 110.231 -170.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 t -127.65 171.87 11.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.026 -1.046 . . . . 0.0 111.26 165.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -70.38 24.24 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 118.585 2.809 . . . . 0.0 118.585 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -150.23 -58.14 0.18 Allowed 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 125.194 1.398 . . . . 0.0 108.705 175.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -101.49 130.89 47.84 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.185 0.994 . . . . 0.0 110.949 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -137.54 110.57 7.76 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.077 0.551 . . . . 0.0 110.834 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.3 t -137.7 155.2 49.36 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 123.569 0.748 . . . . 0.0 111.907 -176.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -140.01 146.85 39.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.808 -1.183 . . . . 0.0 113.941 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.8 pt -130.14 122.63 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-O 121.522 0.677 . . . . 0.0 111.108 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.4 p -105.1 116.93 32.78 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.287 1.035 . . . . 0.0 110.877 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -144.79 141.11 28.93 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 114.517 1.302 . . . . 0.0 114.517 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -79.32 155.52 28.43 Favored 'General case' 0 CA--C 1.571 1.781 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.619 149.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.9 mt -70.78 114.53 8.95 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.58 -1.325 . . . . 0.0 111.588 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.07 -7.61 54.92 Favored Glycine 0 CA--C 1.555 2.536 0 N-CA-C 118.567 2.187 . . . . 0.0 118.567 -162.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -68.72 122.48 18.64 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 120.734 2.267 . . . . 0.0 112.432 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -89.33 118.51 29.06 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 122.979 0.512 . . . . 0.0 110.451 169.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -136.43 135.71 38.92 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 123.433 0.693 . . . . 0.0 110.844 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.17 129.1 36.25 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.487 -1.383 . . . . 0.0 111.047 172.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -130.9 109.71 10.75 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.75 -167.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.7 m -75.24 102.17 4.92 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.65 0.738 . . . . 0.0 110.487 174.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.0 p -85.29 161.85 19.36 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -171.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.45 -23.68 4.19 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 119.015 2.969 . . . . 0.0 119.015 166.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -54.24 -30.74 51.37 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 117.629 2.455 . . . . 0.0 117.629 160.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.316 9.8 t70 78.13 63.21 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.723 0 C-N-CA 125.869 1.668 . . . . 0.0 112.172 -159.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.5 ptt-85 -152.85 136.95 16.41 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.95 0.9 . . . . 0.0 109.14 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.284 0.5 OUTLIER -90.32 112.02 23.44 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 119.535 1.062 . . . . 0.0 110.795 168.17 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.3 p -107.64 130.28 54.92 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -65.6 99.12 0.42 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.442 1.097 . . . . 0.0 110.064 168.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.1 m -107.21 119.93 40.73 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.066 -164.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 51.8 t -111.38 120.18 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.9 t -111.74 129.26 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.538 -0.726 . . . . 0.0 109.718 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 65.6 m -153.57 152.45 30.91 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.778 -1.201 . . . . 0.0 112.25 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.9 mp -83.32 123.19 29.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.063 -1.023 . . . . 0.0 110.538 167.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -84.7 -63.68 1.29 Allowed 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -149.98 80.55 0.2 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 174.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.4 t70 52.42 37.23 22.13 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -160.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -147.16 120.89 9.21 Favored 'General case' 0 CA--C 1.56 1.352 0 O-C-N 121.278 -0.889 . . . . 0.0 109.461 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.87 112.5 22.56 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 124.242 1.017 . . . . 0.0 110.758 -171.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.03 109.91 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -167.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -93.92 98.85 11.32 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 123.436 0.695 . . . . 0.0 110.999 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.0 mt -90.41 109.19 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 C-N-CA 124.159 0.983 . . . . 0.0 109.003 -174.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -105.46 118.35 36.33 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 118.968 0.804 . . . . 0.0 110.193 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -115.45 122.53 46.06 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 123.634 0.774 . . . . 0.0 111.199 -173.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 8.5 p90 -151.36 130.0 12.29 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.96 -1.088 . . . . 0.0 110.5 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 58.38 27.51 15.5 Favored 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 117.498 2.407 . . . . 0.0 117.498 170.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.23 -19.23 23.87 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 118.97 2.348 . . . . 0.0 118.97 -162.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -89.4 148.11 23.67 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-N 119.443 1.622 . . . . 0.0 112.541 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -132.01 141.01 49.11 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.879 0.847 . . . . 0.0 111.463 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.9 t -129.91 143.51 50.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.63 -0.669 . . . . 0.0 109.419 158.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.266 13.3 p30 -124.52 132.82 53.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 111.171 173.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -100.66 103.75 15.04 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.2 t -88.24 98.93 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 91.1 mtm-85 -89.1 114.04 25.25 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.895 0.878 . . . . 0.0 110.35 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -127.48 132.95 49.91 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 119.119 0.872 . . . . 0.0 112.718 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.7 mm -80.25 106.56 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.382 -0.824 . . . . 0.0 110.244 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -103.09 98.27 8.24 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 169.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.0 t70 51.46 60.8 3.6 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 74.32 0.1 56.24 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 120.034 2.774 . . . . 0.0 120.034 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -118.78 122.56 42.69 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 119.837 1.818 . . . . 0.0 109.71 -171.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 51.2 ttp -82.42 104.78 12.96 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 122.029 0.919 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.14 103.61 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 31.6 ttm -85.6 108.14 17.84 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 84.4 m -98.71 101.17 12.5 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.0 mp -92.2 98.95 11.84 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.568 0.747 . . . . 0.0 108.988 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.7 t -89.97 117.58 28.88 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.53 0.681 . . . . 0.0 110.322 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -100.59 75.71 1.77 Allowed 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 155.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.57 -111.24 3.3 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 114.85 0.7 . . . . 0.0 114.85 -166.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -81.2 -9.69 59.74 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 171.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 50.0 t -90.36 99.61 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 121.969 2.168 . . . . 0.0 107.422 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.6 t -113.64 119.93 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -168.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.81 130.92 54.43 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 171.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.9 t -111.79 103.83 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -114.96 118.71 34.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.353 -0.842 . . . . 0.0 109.947 -171.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -99.77 98.8 9.57 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.599 0.714 . . . . 0.0 109.982 -162.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -94.23 131.92 39.32 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.507 0.723 . . . . 0.0 110.9 -173.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -116.76 158.52 23.74 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.532 0.682 . . . . 0.0 110.754 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -75.44 103.89 5.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.023 -1.048 . . . . 0.0 111.877 -174.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . 0.286 . . . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -173.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.311 9.8 p . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.05 -42.04 97.73 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.93 -24.44 66.04 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 117.84 2.533 . . . . 0.0 117.84 165.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -76.91 -21.65 54.57 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 168.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 80.8 m -73.81 88.86 1.8 Allowed 'General case' 0 CA--C 1.572 1.811 0 CA-C-N 121.885 2.13 . . . . 0.0 114.344 -173.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.59 168.06 20.48 Favored 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 124.552 1.141 . . . . 0.0 111.781 -174.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.6 m -77.27 134.85 38.45 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.868 -1.145 . . . . 0.0 109.319 158.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -123.91 120.75 33.46 Favored 'General case' 0 CA--C 1.562 1.412 0 O-C-N 121.519 -0.738 . . . . 0.0 110.048 -175.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 mtpm? -100.35 130.79 46.49 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.609 0.764 . . . . 0.0 111.422 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 tt -71.79 118.57 14.8 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.562 -0.711 . . . . 0.0 112.909 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 65.2 p -92.22 -49.75 6.02 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -141.18 113.91 8.33 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.757 0.823 . . . . 0.0 109.875 -173.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.0 p -98.62 98.81 9.92 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.318 0.647 . . . . 0.0 111.883 175.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -83.5 122.81 29.04 Favored 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 123.492 0.717 . . . . 0.0 111.16 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.256 1.3 t30 57.7 30.08 18.33 Favored 'General case' 0 N--CA 1.504 2.226 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 171.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -72.38 -38.36 68.51 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -54.77 -53.16 58.78 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 175.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -57.26 -41.78 80.33 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 171.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -58.15 -48.08 81.36 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 165.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 65.0 mtm -58.02 -48.28 80.52 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -60.78 -42.58 97.8 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 166.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.64 97.55 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 171.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.6 tp -64.25 -22.33 66.91 Favored 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 116.925 2.195 . . . . 0.0 116.925 169.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.73 55.56 1.75 Allowed Glycine 0 N--CA 1.485 1.939 0 N-CA-C 115.615 1.006 . . . . 0.0 115.615 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 m -107.86 149.84 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 118.197 0.999 . . . . 0.0 111.553 172.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.17 165.54 21.4 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 116.647 1.419 . . . . 0.0 116.647 172.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -64.84 -40.57 95.38 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.71 -42.46 79.2 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 164.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.6 m -62.4 -43.96 97.58 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 169.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -54.4 -47.53 72.64 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 164.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -58.87 -52.33 66.19 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 119.989 1.268 . . . . 0.0 114.1 170.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.2 t -49.01 -51.5 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 167.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.33 -32.77 84.73 Favored Glycine 0 CA--C 1.55 2.234 0 N-CA-C 119.596 2.599 . . . . 0.0 119.596 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -79.69 -42.93 23.67 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 173.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.4 m -70.32 -35.07 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 N-CA-C 117.022 2.231 . . . . 0.0 117.022 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.0 t -102.89 175.32 5.52 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -166.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.44 84.38 0.74 Allowed Pre-proline 0 CA--C 1.579 2.086 0 C-N-CA 123.703 0.801 . . . . 0.0 110.96 169.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.26 117.63 5.23 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.71 2.274 . . . . 0.0 113.395 -175.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.1 m -100.06 123.83 44.74 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.418 -161.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.8 t -106.46 105.56 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -167.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.4 mt -89.05 105.75 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.438 -1.414 . . . . 0.0 107.714 170.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 55.8 mt -89.71 124.6 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 168.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.1 p -150.71 122.19 7.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -0.914 . . . . 0.0 112.739 -169.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -78.99 104.83 9.9 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.666 -1.271 . . . . 0.0 110.512 166.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -105.95 99.8 9.37 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -171.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.13 -72.45 2.77 Favored Glycine 0 N--CA 1.491 2.328 0 O-C-N 121.689 -0.632 . . . . 0.0 114.157 -169.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -139.41 -59.87 0.57 Allowed 'General case' 0 CA--C 1.566 1.575 0 C-N-CA 123.366 0.667 . . . . 0.0 111.303 173.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -79.03 159.85 27.4 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -172.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.8 t -79.77 116.71 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.568 0 CA-C-O 121.725 0.774 . . . . 0.0 109.46 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 65.0 t -104.08 107.43 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 68.7 mt -89.64 120.56 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 167.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -102.88 103.82 14.02 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 166.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.4 m -90.55 99.25 12.31 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 170.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 mp -92.1 101.16 13.68 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.593 0.757 . . . . 0.0 108.978 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.9 t -78.24 26.9 0.2 Allowed 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.352 70.8 p 65.17 -53.87 0.33 Allowed 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -164.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -81.17 -31.88 33.85 Favored 'General case' 0 CA--C 1.577 2.018 0 C-N-CA 125.575 1.55 . . . . 0.0 115.163 174.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -136.62 127.05 26.7 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 119.763 1.165 . . . . 0.0 111.31 -173.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -88.48 104.33 16.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.329 -0.857 . . . . 0.0 110.611 171.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.6 p -102.03 99.95 10.17 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.5 0.667 . . . . 0.0 110.109 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -98.07 126.79 43.67 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.706 0.802 . . . . 0.0 112.259 -175.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.4 pt -131.47 116.84 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 C-N-CA 123.168 0.587 . . . . 0.0 111.159 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.8 p -98.54 129.86 45.1 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.896 0.879 . . . . 0.0 112.351 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -156.64 144.35 19.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.379 -0.826 . . . . 0.0 112.633 -175.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -84.81 158.54 20.64 Favored 'General case' 0 CA--C 1.57 1.722 0 O-C-N 120.861 -1.149 . . . . 0.0 110.935 156.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.32 116.37 9.67 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.67 -1.269 . . . . 0.0 111.839 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.05 -4.29 77.82 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 119.214 2.445 . . . . 0.0 119.214 -163.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -82.42 126.57 32.36 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 120.633 2.217 . . . . 0.0 111.929 -176.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -83.34 112.94 20.36 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-O 121.067 0.46 . . . . 0.0 111.424 172.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -121.53 140.45 52.19 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.763 0.825 . . . . 0.0 111.207 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.3 130.89 38.8 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.241 1.019 . . . . 0.0 111.532 171.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.447 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 19.6 tt0 -132.99 103.28 5.97 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.146 -171.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.0 m -91.23 107.19 19.04 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 174.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.7 p -80.14 162.29 24.82 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -169.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.21 -23.79 23.94 Favored 'General case' 0 CA--C 1.576 1.942 0 N-CA-C 118.825 2.898 . . . . 0.0 118.825 169.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -82.96 2.2 35.87 Favored 'General case' 0 CA--C 1.582 2.204 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 165.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.286 21.3 m-20 70.02 70.13 0.22 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 120.584 1.538 . . . . 0.0 113.128 -174.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.5 ptp85 -145.88 125.99 13.76 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 166.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -91.8 105.41 17.69 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.463 0.705 . . . . 0.0 111.132 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 72' ' ' GLU . 28.7 p -109.22 135.23 50.65 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -74.47 101.7 4.23 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-O 121.835 0.826 . . . . 0.0 109.441 164.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.0 m -102.63 128.85 49.14 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.542 0.737 . . . . 0.0 112.63 -170.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 49.4 t -122.98 121.91 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.9 t -104.46 109.47 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.227 -0.92 . . . . 0.0 109.594 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 93.3 p -110.46 130.06 55.64 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.796 0.838 . . . . 0.0 111.912 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.7 tt -87.84 99.63 12.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.147 -0.971 . . . . 0.0 110.605 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -101.3 75.72 1.65 Allowed 'General case' 0 CA--C 1.567 1.613 0 C-N-CA 123.481 0.712 . . . . 0.0 111.122 -176.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 66.34 68.15 1.76 Allowed Glycine 0 N--CA 1.495 2.597 0 N-CA-C 116.258 1.263 . . . . 0.0 116.258 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.256 23.7 m-20 60.38 22.33 11.89 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 117.222 2.305 . . . . 0.0 117.222 -166.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -133.58 107.52 8.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.938 -1.101 . . . . 0.0 109.893 -175.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.6 mt -83.09 103.32 12.43 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.793 0.837 . . . . 0.0 111.626 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 37.2 t -97.52 100.5 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -173.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -84.68 107.52 16.93 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.339 0.656 . . . . 0.0 110.204 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 70.3 mt -99.5 103.82 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -91.01 118.94 30.79 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 118.43 0.559 . . . . 0.0 111.317 176.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -112.53 112.03 23.29 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.019 0.528 . . . . 0.0 110.46 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -139.21 125.62 20.37 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.438 -0.789 . . . . 0.0 110.683 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 50.92 49.94 20.11 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 167.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.86 4.6 62.61 Favored Glycine 0 CA--C 1.558 2.739 0 N-CA-C 120.212 2.845 . . . . 0.0 120.212 -168.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -123.59 140.31 53.13 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 119.653 1.726 . . . . 0.0 110.266 -168.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -135.01 123.61 23.57 Favored 'General case' 0 CA--C 1.564 1.499 0 O-C-N 121.692 -0.63 . . . . 0.0 111.783 -175.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.0 t -115.89 137.34 52.19 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.294 0.569 . . . . 0.0 109.964 165.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.19 128.07 54.74 Favored 'General case' 0 CA--C 1.567 1.629 0 C-N-CA 123.109 0.564 . . . . 0.0 110.996 171.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -105.84 110.18 22.39 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 53.2 t -91.97 100.79 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -176.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.18 111.09 19.49 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.562 0.745 . . . . 0.0 110.677 173.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.57 129.83 43.28 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 118.96 0.8 . . . . 0.0 112.631 -174.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.9 mm -75.86 112.93 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.044 -1.035 . . . . 0.0 108.953 173.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -133.24 96.5 3.75 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -169.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.7 t70 50.37 61.1 3.38 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -169.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.07 -48.08 3.88 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 117.84 1.896 . . . . 0.0 117.84 -173.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -82.06 146.42 29.67 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 118.231 1.015 . . . . 0.0 113.086 -174.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -82.38 104.74 12.9 Favored 'General case' 0 CA--C 1.56 1.365 0 CA-C-O 121.966 0.888 . . . . 0.0 109.429 166.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 80.3 t -91.79 102.31 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 40.9 ttm -83.15 108.4 16.38 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.422 0.689 . . . . 0.0 109.8 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.1 m -99.82 115.07 28.72 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.871 0.843 . . . . 0.0 109.135 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mp -111.18 117.46 33.28 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -171.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.305 10.6 t -137.21 138.2 39.92 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 177.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -124.01 99.89 6.47 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.952 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 73.07 -90.76 0.6 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 115.299 0.88 . . . . 0.0 115.299 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -134.31 52.77 2.04 Favored 'General case' 0 CA--C 1.575 1.909 0 CA-C-O 121.482 0.658 . . . . 0.0 112.064 167.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.4 t -139.91 124.04 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 51.2 t -123.4 127.18 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-N 119.001 0.818 . . . . 0.0 109.837 -170.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -117.18 150.7 38.3 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 123.633 0.773 . . . . 0.0 112.329 163.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.8 t -131.92 114.22 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.192 -0.942 . . . . 0.0 108.947 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 mtp-105 -110.9 114.44 27.77 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.205 -0.934 . . . . 0.0 109.876 -177.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -96.63 108.63 21.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.647 -0.658 . . . . 0.0 110.111 -167.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -103.55 132.47 49.78 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.108 -0.995 . . . . 0.0 112.4 -171.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.39 160.66 15.22 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 175.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -76.1 141.03 42.1 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -175.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.25 0 CA-C-O 117.404 -1.284 . . . . 0.0 112.447 176.427 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.8 m . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -67.22 -51.0 58.67 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -171.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.38 -23.83 66.06 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 117.755 2.502 . . . . 0.0 117.755 168.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -87.92 -21.81 24.71 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 172.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.5 t -76.83 95.63 4.11 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 121.197 1.817 . . . . 0.0 112.905 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -166.39 167.61 15.66 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-O 122.565 1.174 . . . . 0.0 112.333 -172.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.7 m -86.85 107.1 18.17 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.829 0.852 . . . . 0.0 108.718 173.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -105.22 109.42 21.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.972 . . . . 0.0 111.623 -169.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -95.36 129.33 42.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.281 -0.887 . . . . 0.0 111.089 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.0 tt -75.86 122.29 23.88 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -173.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 69.0 p -91.84 -52.47 4.72 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 176.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -137.97 114.54 10.45 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.739 0.815 . . . . 0.0 110.233 -173.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.7 p -101.18 78.03 1.86 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.409 1.1 . . . . 0.0 112.419 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -79.99 133.25 36.15 Favored 'General case' 0 CA--C 1.56 1.354 0 O-C-N 120.97 -1.081 . . . . 0.0 113.804 -171.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.252 1.1 t30 57.44 23.34 8.94 Favored 'General case' 0 CA--C 1.584 2.251 0 N-CA-C 117.189 2.292 . . . . 0.0 117.189 -174.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -69.46 -46.41 66.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.238 -1.539 . . . . 0.0 115.054 -175.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -47.64 -51.3 21.99 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -68.33 -40.02 81.76 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -50.5 -52.96 33.72 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 160.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.6 mtp -59.03 -43.46 91.63 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 175.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -47.75 83.58 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 164.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.02 -39.03 86.95 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.65 -47.57 85.67 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 163.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.88 48.22 1.51 Allowed Glycine 0 N--CA 1.482 1.738 0 CA-C-O 118.978 -0.901 . . . . 0.0 115.315 -175.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.7 m -80.56 151.63 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 118.822 1.311 . . . . 0.0 111.443 172.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.38 150.05 30.73 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 116.955 1.542 . . . . 0.0 116.955 173.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -55.53 -43.37 75.71 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.12 -44.9 68.06 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 166.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.3 m -64.04 -40.26 95.91 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 171.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -61.05 -49.16 78.48 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 121.691 2.041 . . . . 0.0 115.923 167.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.6 mp0 -71.14 -28.74 64.5 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.1 t -70.77 -62.13 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-N 119.536 1.062 . . . . 0.0 112.11 159.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.76 -31.37 71.41 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 119.903 2.721 . . . . 0.0 119.903 -166.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -73.4 -32.11 64.26 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 170.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.2 m -82.68 -34.7 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.0 t -81.5 126.4 31.64 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 120.857 1.662 . . . . 0.0 112.352 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -103.55 92.7 4.3 Favored Pre-proline 0 CA--C 1.573 1.828 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 169.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -71.91 155.65 57.46 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.384 2.056 . . . . 0.0 116.64 -171.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.1 m -88.73 100.31 13.03 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.371 -1.286 . . . . 0.0 107.64 169.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.6 t -95.65 98.43 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -171.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.1 mt -88.81 102.21 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -86.41 116.97 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 171.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.2 p -153.81 121.31 5.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.718 -0.614 . . . . 0.0 111.337 -165.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -80.24 128.69 33.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 0.0 113.098 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -120.24 90.28 3.3 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 174.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.9 68.99 1.48 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 115.613 1.005 . . . . 0.0 115.613 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.293 13.0 t70 70.94 -57.27 0.6 Allowed 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -169.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -72.59 147.84 45.47 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-O 122.568 1.175 . . . . 0.0 114.141 -172.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.0 t -96.2 122.54 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.857 -169.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.9 t -104.22 110.87 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.0 mt -92.73 99.76 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 172.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.0 mtm-85 -85.92 101.93 13.3 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.867 0.867 . . . . 0.0 111.022 173.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.6 m -89.81 101.05 13.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.591 -0.693 . . . . 0.0 109.708 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 73.2 mt -101.26 108.82 20.57 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.791 0.805 . . . . 0.0 111.618 -167.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.1 t -138.29 147.61 43.79 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 124.546 1.138 . . . . 0.0 109.369 173.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 51.1 p -76.94 53.38 0.93 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 120.634 -1.291 . . . . 0.0 113.857 173.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -161.37 -65.8 0.06 Allowed 'General case' 0 CA--C 1.571 1.784 0 C-N-CA 125.435 1.494 . . . . 0.0 107.898 -172.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -127.94 96.51 4.51 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -96.23 82.16 3.41 Favored 'General case' 0 CA--C 1.568 1.67 0 O-C-N 121.721 -0.612 . . . . 0.0 110.803 -176.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -108.35 146.23 33.3 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -170.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -131.77 127.83 37.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.275 -0.891 . . . . 0.0 113.151 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.4 mt -112.77 110.59 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.3 p -92.09 120.27 32.55 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.546 0.739 . . . . 0.0 112.393 170.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -143.96 147.4 33.88 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -174.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -87.52 1.78 52.56 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 118.59 2.811 . . . . 0.0 118.59 -172.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.4 mt 69.75 120.01 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 125.455 1.502 . . . . 0.0 112.775 -172.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.39 -32.08 4.27 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 118.142 2.017 . . . . 0.0 118.142 -171.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -73.97 136.42 43.22 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 119.309 1.555 . . . . 0.0 113.021 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -88.88 120.76 30.58 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.198 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -130.75 150.64 51.83 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.801 0.84 . . . . 0.0 111.65 -172.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -79.55 133.5 36.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.932 -1.105 . . . . 0.0 111.615 171.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -142.44 126.03 16.86 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.0 0.428 . . . . 0.0 111.992 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.2 m -73.36 132.4 42.99 Favored 'General case' 0 CA--C 1.57 1.731 0 CA-C-O 121.43 0.633 . . . . 0.0 110.478 162.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.9 p -108.82 166.47 10.78 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -169.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.15 -11.5 6.29 Favored 'General case' 0 CA--C 1.579 2.082 0 N-CA-C 119.452 3.13 . . . . 0.0 119.452 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -73.62 -25.33 60.26 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 159.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.305 4.8 m-20 82.1 65.87 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 120.738 1.608 . . . . 0.0 111.235 -162.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.9 ptt85 -162.87 142.2 8.89 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.162 0.985 . . . . 0.0 109.43 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -83.02 134.62 35.03 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 169.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 5.9 p -129.89 148.63 51.77 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 172.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -79.15 101.63 8.03 Favored 'General case' 0 CA--C 1.563 1.447 0 CA-C-O 122.145 0.974 . . . . 0.0 109.814 162.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.0 m -97.59 124.77 41.99 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.919 0.888 . . . . 0.0 111.96 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.01 124.59 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -115.43 116.38 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.446 -0.784 . . . . 0.0 109.574 -174.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.7 m -115.65 132.41 56.64 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.464 0.706 . . . . 0.0 112.554 -176.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.8 tt -89.11 102.1 14.76 Favored 'General case' 0 CA--C 1.567 1.626 0 C-N-CA 123.286 0.634 . . . . 0.0 109.974 171.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -96.1 80.71 3.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.135 -0.978 . . . . 0.0 110.943 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.56 -86.03 1.15 Allowed Glycine 0 N--CA 1.494 2.523 0 O-C-N 121.184 -0.948 . . . . 0.0 114.042 -176.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -136.86 65.14 1.52 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.878 0.847 . . . . 0.0 110.179 154.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -145.81 106.8 4.14 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.6 100.67 13.27 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 121.432 -0.793 . . . . 0.0 110.695 -173.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.1 t -104.03 104.34 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -170.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -90.27 121.68 32.51 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.398 0.679 . . . . 0.0 109.792 173.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.5 mt -113.9 110.23 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -92.83 129.73 38.66 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 122.918 0.487 . . . . 0.0 111.536 171.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -122.07 123.41 41.52 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.553 0.741 . . . . 0.0 110.007 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 17.3 p90 -150.46 123.89 9.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.218 -0.926 . . . . 0.0 110.27 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 53.5 38.21 27.53 Favored 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 117.258 2.318 . . . . 0.0 117.258 174.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.46 -25.39 3.85 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 119.148 2.419 . . . . 0.0 119.148 -165.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -81.77 142.46 32.59 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 119.134 1.467 . . . . 0.0 112.307 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -139.21 123.48 18.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.872 -0.517 . . . . 0.0 111.86 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.3 t -112.66 144.15 42.65 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 123.383 0.673 . . . . 0.0 110.623 167.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -121.34 142.16 50.24 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 172.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -122.3 102.92 8.4 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -175.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 68.8 t -99.35 103.13 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -168.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -97.89 117.21 31.71 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.398 0.679 . . . . 0.0 111.406 -175.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -135.24 133.83 39.39 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.114 0.566 . . . . 0.0 111.378 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.2 mm -83.07 121.05 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.145 -0.972 . . . . 0.0 109.245 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.16 -77.02 0.41 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.796 0.438 . . . . 0.0 111.367 -175.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -133.98 82.83 2.0 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 77.06 -33.73 1.49 Allowed Glycine 0 N--CA 1.497 2.74 0 N-CA-C 118.66 2.224 . . . . 0.0 118.66 -166.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -92.05 142.31 27.66 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 118.329 1.065 . . . . 0.0 111.73 -173.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 9.9 tpp -84.24 115.37 22.42 Favored 'General case' 0 CA--C 1.564 1.493 0 CA-C-O 121.802 0.811 . . . . 0.0 110.493 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.5 t -91.23 107.56 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.623 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 167.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 18.8 ttt -99.43 108.19 20.6 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.721 -0.612 . . . . 0.0 109.369 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.0 m -95.86 114.5 26.23 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.5 0.667 . . . . 0.0 109.28 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.1 mp -103.57 120.98 41.94 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.263 8.7 t -136.46 138.47 41.49 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 177.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -106.54 77.66 1.21 Allowed 'General case' 0 CA--C 1.565 1.545 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.058 168.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 69.89 -89.45 0.31 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 115.962 1.145 . . . . 0.0 115.962 -175.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -88.56 -35.49 16.89 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 175.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.8 t -87.27 129.71 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 119.677 1.126 . . . . 0.0 109.616 -170.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 44.9 t -123.79 125.89 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 C-N-CA 123.401 0.68 . . . . 0.0 109.512 -169.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.34 151.69 34.16 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.966 0.906 . . . . 0.0 111.943 164.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 92.2 t -124.19 117.07 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 120.778 -1.201 . . . . 0.0 108.915 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.2 mtp180 -96.62 108.75 21.41 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.275 0.63 . . . . 0.0 109.611 170.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -85.46 136.94 33.23 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.287 0.635 . . . . 0.0 111.753 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -134.37 132.45 39.46 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.653 -0.654 . . . . 0.0 111.799 -173.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -100.69 151.26 21.86 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.288 0.635 . . . . 0.0 112.38 169.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -71.34 128.65 36.58 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.597 -0.689 . . . . 0.0 111.901 170.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.487 0 C-N-CA 123.833 0.853 . . . . 0.0 112.564 177.713 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.293 8.6 p . . . . . 0 CA--C 1.569 1.709 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.72 -40.47 95.4 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 -175.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.38 -30.21 62.43 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 117.754 2.502 . . . . 0.0 117.754 167.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -74.6 -17.93 60.64 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 117.184 2.29 . . . . 0.0 117.184 167.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 22.6 t -89.29 94.61 9.97 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 120.525 1.511 . . . . 0.0 112.667 -169.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.91 171.34 16.77 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-O 122.059 0.933 . . . . 0.0 112.509 -174.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.2 m -82.22 118.42 23.09 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.695 -1.253 . . . . 0.0 108.779 164.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -114.03 114.71 26.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.474 -0.766 . . . . 0.0 110.704 -172.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -98.82 131.89 44.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.455 -0.778 . . . . 0.0 110.933 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.11 117.38 11.6 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.4 p -89.71 -47.67 7.77 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -142.18 119.22 11.32 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 118.945 0.793 . . . . 0.0 109.91 -173.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.7 p -104.67 99.22 8.89 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.207 0.603 . . . . 0.0 111.559 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -81.87 122.92 28.34 Favored 'General case' 0 CA--C 1.564 1.485 0 C-N-CA 123.438 0.695 . . . . 0.0 111.236 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.252 1.9 t30 59.07 23.99 12.24 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 117.818 2.525 . . . . 0.0 117.818 174.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -68.38 -45.53 72.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 119.77 -1.831 . . . . 0.0 115.582 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -46.92 -51.98 15.6 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 170.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.69 -43.81 95.55 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 173.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -51.01 -50.18 59.01 Favored 'General case' 0 CA--C 1.573 1.851 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 164.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.8 mtp -61.75 -39.78 92.81 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 174.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -59.75 -50.34 74.21 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 165.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.77 -38.97 83.32 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 116.933 2.197 . . . . 0.0 116.933 172.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.31 -23.99 67.49 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 171.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.66 35.42 8.49 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 118.088 1.995 . . . . 0.0 118.088 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.7 m -93.08 171.07 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 119.406 1.603 . . . . 0.0 112.062 173.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.54 162.33 54.0 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 117.125 1.61 . . . . 0.0 117.125 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -64.28 -46.06 85.34 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 173.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.67 -40.6 63.03 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 167.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.6 m -64.6 -42.79 95.33 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 169.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.9 mtm-85 -57.99 -43.05 86.36 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 164.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -56.46 -54.61 43.72 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.27 1.395 . . . . 0.0 113.941 167.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.0 t -50.6 -60.64 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 169.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.11 -20.98 58.76 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 120.181 2.832 . . . . 0.0 120.181 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -85.72 -41.12 15.41 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 165.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.254 17.6 m -75.04 -37.3 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 CA-C-N 121.421 1.918 . . . . 0.0 116.008 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 t -97.33 146.81 24.79 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 120.035 1.288 . . . . 0.0 112.682 -174.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 105.33 18.55 Favored Pre-proline 0 CA--C 1.578 2.037 0 O-C-N 121.379 -0.825 . . . . 0.0 111.362 174.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.1 141.68 29.85 Favored 'Trans proline' 0 CA--C 1.564 1.989 0 C-N-CA 122.566 2.177 . . . . 0.0 114.898 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.6 m -108.5 112.66 25.16 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.154 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.9 t -106.35 102.2 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -172.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.3 mt -85.4 103.54 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.1 mt -91.54 105.26 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 175.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.4 p -124.45 165.54 17.59 Favored 'General case' 0 CA--C 1.561 1.368 0 C-N-CA 123.849 0.86 . . . . 0.0 112.035 -171.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -126.81 126.19 42.97 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.95 -1.094 . . . . 0.0 110.851 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -114.31 81.51 1.55 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.631 0.729 . . . . 0.0 110.024 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.9 -95.96 0.84 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -89.85 -27.52 19.87 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -102.84 149.38 24.55 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-N 119.826 1.193 . . . . 0.0 113.312 -174.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.5 t -86.64 125.37 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.772 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 165.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.0 106.17 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.2 mt -92.59 120.67 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -103.19 100.97 10.9 Favored 'General case' 0 CA--C 1.561 1.39 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 169.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 50.8 m -87.32 99.14 11.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.639 -0.663 . . . . 0.0 109.384 172.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.7 mp -97.29 97.29 9.02 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.6 t -89.26 34.09 0.8 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 174.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.347 73.0 p 67.78 -58.45 0.44 Allowed 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 -174.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -91.66 -61.27 1.67 Allowed 'General case' 0 CA--C 1.569 1.679 0 C-N-CA 124.923 1.289 . . . . 0.0 110.48 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -87.53 104.9 16.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.514 -0.741 . . . . 0.0 110.542 173.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -108.22 106.91 17.31 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.545 0.688 . . . . 0.0 109.34 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.4 p -119.66 135.52 54.78 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 123.433 0.693 . . . . 0.0 111.458 -157.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -127.02 133.68 50.48 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.096 -1.003 . . . . 0.0 113.501 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.4 pt -133.77 120.37 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 C-N-CA 123.484 0.713 . . . . 0.0 110.851 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 90.1 p -106.77 125.51 51.09 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 124.254 1.022 . . . . 0.0 111.858 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -156.54 148.62 23.09 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.297 -0.877 . . . . 0.0 112.795 -168.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -98.61 21.71 10.91 Favored 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 117.623 2.453 . . . . 0.0 117.623 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.7 mt 67.62 112.73 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 125.138 1.375 . . . . 0.0 114.027 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.19 -26.04 4.04 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 117.998 1.959 . . . . 0.0 117.998 -162.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -75.91 126.94 31.95 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 124.711 1.204 . . . . 0.0 111.941 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -72.87 141.64 47.93 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -141.76 143.61 33.57 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.934 0.894 . . . . 0.0 110.306 176.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.85 134.81 35.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.536 -1.352 . . . . 0.0 111.516 172.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -133.13 105.56 7.1 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.058 0.543 . . . . 0.0 110.554 -172.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.7 m -76.31 104.72 6.97 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.423 -0.798 . . . . 0.0 108.958 167.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.0 p -78.82 -178.1 5.82 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -165.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.2 -12.63 3.76 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 118.968 2.951 . . . . 0.0 118.968 168.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -120.19 43.33 2.73 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 119.572 -1.955 . . . . 0.0 113.421 155.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.285 10.5 t70 65.91 -1.22 1.15 Allowed 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 119.374 3.101 . . . . 0.0 119.374 168.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.3 ptt85 -76.46 123.21 25.67 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.37 -1.456 . . . . 0.0 110.978 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -80.12 106.06 11.85 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.888 0.875 . . . . 0.0 112.819 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.0 m -110.03 117.92 35.03 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -167.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -67.6 103.05 1.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.812 0.845 . . . . 0.0 110.338 169.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.6 m -115.92 122.48 45.44 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 121.843 -0.535 . . . . 0.0 111.68 -158.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 99.3 t -115.25 116.0 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.4 t -96.42 108.75 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 173.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.4 p -112.01 117.16 31.92 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.536 0.735 . . . . 0.0 111.599 -173.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 tt -84.1 96.49 8.93 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.086 -1.009 . . . . 0.0 110.135 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -91.27 73.76 6.19 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 121.433 -0.792 . . . . 0.0 111.62 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.34 -86.88 1.49 Allowed Glycine 0 N--CA 1.49 2.274 0 O-C-N 121.828 -0.545 . . . . 0.0 113.441 -175.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -132.24 50.62 2.22 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 168.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -153.6 121.12 5.89 Favored 'General case' 0 CA--C 1.564 1.509 0 O-C-N 120.61 -1.306 . . . . 0.0 110.511 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.8 mt -83.56 106.91 15.67 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.758 0.823 . . . . 0.0 111.116 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.2 t -103.21 100.02 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -173.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -86.34 104.46 15.87 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.745 0.818 . . . . 0.0 110.895 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.4 mt -99.31 100.47 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -172.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -87.4 125.67 34.41 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 118.835 0.743 . . . . 0.0 111.53 174.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -116.54 117.88 31.11 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 123.839 0.856 . . . . 0.0 110.387 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.3 p90 -148.42 129.78 14.74 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.866 -1.146 . . . . 0.0 110.716 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 53.69 42.13 31.91 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 166.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.03 17.03 71.33 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 119.893 2.717 . . . . 0.0 119.893 -166.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -132.66 143.13 49.44 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 119.243 1.521 . . . . 0.0 110.042 -170.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -138.55 131.45 29.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.525 -0.734 . . . . 0.0 112.245 -174.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 t -128.07 129.98 47.49 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.563 0.745 . . . . 0.0 109.309 169.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.24 128.78 54.74 Favored 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 123.122 0.569 . . . . 0.0 111.111 174.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -106.58 106.95 17.72 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.1 t -88.78 109.45 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -105.69 102.23 11.69 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.989 0.916 . . . . 0.0 110.374 -174.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.49 141.82 51.75 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.788 0.835 . . . . 0.0 112.532 -168.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.8 mm -80.77 117.93 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 120.82 -1.175 . . . . 0.0 109.619 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.45 89.87 3.17 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 171.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.5 t70 50.15 66.12 1.24 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.6 -48.5 3.33 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 117.435 1.734 . . . . 0.0 117.435 -171.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -83.36 142.87 30.72 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 118.904 1.352 . . . . 0.0 112.818 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.0 ttt -90.65 111.46 22.81 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.843 0.83 . . . . 0.0 110.303 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 69.4 t -93.93 108.6 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.56 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 23.9 ttt -89.65 112.52 23.79 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.704 0.802 . . . . 0.0 109.78 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.2 m -100.44 111.24 23.48 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mp -104.79 112.64 25.82 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.428 1.091 . . . . 0.0 108.139 -172.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.267 13.2 t -131.47 142.0 49.9 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -122.75 81.42 1.86 Allowed 'General case' 0 CA--C 1.564 1.507 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.76 173.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 71.18 -92.98 0.5 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 115.579 0.992 . . . . 0.0 115.579 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -86.89 -37.01 18.09 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.3 t -82.01 134.28 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-N 119.343 0.974 . . . . 0.0 110.157 -171.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.5 t -129.4 121.22 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -175.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.14 154.45 23.29 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 123.548 0.739 . . . . 0.0 112.44 164.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.3 t -132.41 113.47 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.146 -0.971 . . . . 0.0 109.25 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -106.12 124.33 49.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.176 -0.953 . . . . 0.0 110.856 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -108.62 115.68 30.55 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 123.252 0.621 . . . . 0.0 110.602 -165.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -114.69 133.21 56.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.794 -1.191 . . . . 0.0 113.22 -166.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -98.94 153.81 18.54 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 123.338 0.655 . . . . 0.0 112.626 166.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -74.27 135.29 42.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.176 0 CA-C-O 117.923 -1.037 . . . . 0.0 112.225 170.598 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.456 HG22 ' H ' ' A' ' 2' ' ' GLU 0.302 4.1 p . . . . . 0 CA--C 1.575 1.926 0 CA-C-O 121.734 0.778 . . . . 0.0 112.102 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.456 ' H ' HG22 ' A' ' 1' ' ' VAL 0.358 9.0 tt0 77.07 -57.95 0.51 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 172.128 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.28 -29.35 68.76 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 153.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -82.12 -6.28 59.06 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 169.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.6 t -74.86 91.34 2.44 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-N 122.194 2.27 . . . . 0.0 113.644 -172.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -168.29 169.2 10.96 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-O 122.243 1.02 . . . . 0.0 112.27 -170.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.6 m -86.71 123.09 31.49 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.238 -0.914 . . . . 0.0 108.907 167.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -118.37 118.69 32.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.427 -0.796 . . . . 0.0 111.026 -171.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -104.15 136.98 42.75 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.04 -1.037 . . . . 0.0 111.113 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.25 121.04 14.8 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.1 p -108.93 -26.07 10.41 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -150.61 113.82 4.85 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 121.037 1.744 . . . . 0.0 109.484 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 87.7 p -94.47 89.38 5.82 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 122.454 1.121 . . . . 0.0 111.936 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -88.76 110.22 20.82 Favored 'General case' 0 CA--C 1.563 1.45 0 O-C-N 121.079 -1.013 . . . . 0.0 110.93 -170.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.262 56.4 t30 62.88 35.37 13.57 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 -174.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -83.17 66.08 8.55 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 123.747 1.737 . . . . 0.0 111.845 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -165.07 -68.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.99 -1.459 . . . . 0.0 107.728 -156.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -65.61 -42.32 91.73 Favored 'General case' 0 CA--C 1.565 1.525 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 172.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -46.41 -52.41 13.04 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 163.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.481 ' SD ' HG11 ' A' ' 25' ' ' VAL . 22.8 mmt -60.22 -49.98 75.48 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 175.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.5 -46.43 76.95 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 168.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.41 -35.88 76.19 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 117.581 2.437 . . . . 0.0 117.581 175.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 tt -62.81 -39.19 93.51 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 171.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.63 55.68 1.31 Allowed Glycine 0 N--CA 1.486 1.974 0 N-CA-C 114.808 0.683 . . . . 0.0 114.808 -169.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.481 HG11 ' SD ' ' A' ' 20' ' ' MET . 26.9 m -90.42 163.24 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 CA-C-O 122.329 1.061 . . . . 0.0 112.055 173.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.88 142.04 31.37 Favored Glycine 0 CA--C 1.55 2.249 0 O-C-N 121.007 -1.058 . . . . 0.0 113.444 160.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -59.37 -41.16 88.66 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.96 -41.15 64.26 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 165.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.0 m -58.39 -50.36 73.96 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 120.201 1.364 . . . . 0.0 114.231 170.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.269 5.7 ptt180 -62.44 -36.25 81.82 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 172.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -63.16 -50.9 68.56 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 166.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.4 t -46.57 -48.96 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.81 -30.22 66.29 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 119.404 2.521 . . . . 0.0 119.404 170.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -76.68 -46.42 25.69 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 119.8 1.8 . . . . 0.0 115.238 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.259 28.3 m -89.16 47.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 CA-C-N 121.254 1.843 . . . . 0.0 113.715 175.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.6 t -145.18 161.72 38.85 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.116 -0.99 . . . . 0.0 111.922 172.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -102.27 91.32 2.51 Favored Pre-proline 0 CA--C 1.574 1.868 0 O-C-N 121.38 -0.825 . . . . 0.0 109.545 162.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.44 123.68 7.23 Favored 'Trans proline' 0 C--N 1.373 1.825 0 CA-C-N 122.684 1.994 . . . . 0.0 112.827 -174.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.0 m -101.01 102.74 13.8 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -173.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.6 t -95.85 102.96 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -171.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.0 mt -90.7 110.79 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.0 mt -94.29 122.64 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 170.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.7 p -134.83 143.8 47.24 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.178 0.591 . . . . 0.0 112.298 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -99.35 113.29 25.53 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.019 -1.051 . . . . 0.0 109.157 168.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -113.33 90.55 3.37 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.468 -0.77 . . . . 0.0 110.316 -174.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.84 -77.39 1.79 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 115.317 0.887 . . . . 0.0 115.317 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -117.96 -54.94 2.3 Favored 'General case' 0 CA--C 1.567 1.614 0 C-N-CA 123.712 0.805 . . . . 0.0 111.819 171.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -79.2 157.9 27.76 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -173.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.9 t -89.81 124.7 42.62 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.601 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.0 t -114.42 105.7 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 76.9 mt -97.05 120.64 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -106.37 101.69 11.14 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.62 0.724 . . . . 0.0 109.837 171.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.3 m -84.33 98.54 10.07 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 170.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 63.9 mt -94.24 93.52 7.8 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -174.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.8 t -79.57 18.04 0.8 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 118.313 2.708 . . . . 0.0 118.313 -174.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.441 7.4 p 63.61 -60.72 0.17 Allowed 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 125.26 1.424 . . . . 0.0 114.739 -163.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -66.03 -46.17 78.83 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 173.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.69 119.78 7.73 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 119.125 0.875 . . . . 0.0 110.216 -165.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -104.52 112.52 25.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.318 -0.864 . . . . 0.0 111.901 -166.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 p -105.82 110.67 23.04 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.714 -0.616 . . . . 0.0 110.808 -170.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -109.35 107.66 17.93 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.21 1.004 . . . . 0.0 110.64 -175.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.5 pt -109.55 121.15 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 C-N-CA 123.491 0.716 . . . . 0.0 110.496 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 97.2 p -110.72 111.44 22.63 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.228 1.011 . . . . 0.0 110.882 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -148.37 151.4 35.24 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.062 0.934 . . . . 0.0 112.89 -165.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -86.3 148.7 25.5 Favored 'General case' 0 CA--C 1.571 1.765 0 O-C-N 121.211 -0.931 . . . . 0.0 111.06 162.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 73.3 mt -71.05 124.67 24.93 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.237 -1.539 . . . . 0.0 111.922 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.35 -3.45 86.57 Favored Glycine 0 CA--C 1.556 2.628 0 N-CA-C 119.081 2.392 . . . . 0.0 119.081 -162.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -86.95 124.57 33.3 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 120.066 1.933 . . . . 0.0 110.761 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -87.25 107.85 18.68 Favored 'General case' 0 CA--C 1.565 1.535 0 O-C-N 121.877 -0.515 . . . . 0.0 110.91 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -112.88 159.88 18.6 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.379 1.072 . . . . 0.0 111.825 -175.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -83.3 137.67 33.88 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.423 -1.423 . . . . 0.0 111.952 171.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -129.96 111.71 12.8 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.287 0.635 . . . . 0.0 109.798 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.8 m -74.89 96.59 3.15 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 122.023 0.916 . . . . 0.0 109.709 170.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 80.5 p -74.08 173.99 9.28 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -167.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.18 -5.43 1.08 Allowed 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 119.442 3.126 . . . . 0.0 119.442 167.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -95.17 -8.28 36.77 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 159.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.318 3.2 m-20 80.5 12.22 0.94 Allowed 'General case' 0 N--CA 1.507 2.417 0 CA-C-N 121.513 1.96 . . . . 0.0 116.18 -166.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -91.78 130.48 37.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.444 -1.41 . . . . 0.0 110.176 173.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -82.32 110.99 17.97 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.15 0.5 . . . . 0.0 110.973 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 93.4 m -103.71 118.95 37.91 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -173.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -69.81 104.95 2.6 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.906 0.86 . . . . 0.0 110.56 171.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.3 m -120.22 117.61 28.32 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.894 -156.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.2 p -109.01 118.45 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.225 0.536 . . . . 0.0 109.757 175.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.6 t -96.81 110.5 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 173.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 79.6 p -110.44 131.19 55.27 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.706 0.802 . . . . 0.0 110.906 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -83.15 120.39 25.73 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.957 -1.089 . . . . 0.0 109.787 161.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -122.91 72.55 1.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.108 -169.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 58.61 60.81 8.23 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 117.071 1.588 . . . . 0.0 117.071 -177.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.347 5.5 m-20 92.08 -31.74 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 -167.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -97.28 124.17 41.31 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 120.897 1.68 . . . . 0.0 112.322 -170.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.8 mt -81.03 103.75 11.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.162 -0.961 . . . . 0.0 110.745 170.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.0 t -104.72 106.04 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.715 -1.241 . . . . 0.0 107.733 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -93.87 105.79 17.79 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.029 0.932 . . . . 0.0 110.148 177.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.33 104.46 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 123.354 0.661 . . . . 0.0 109.383 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -85.15 125.61 32.95 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 118.887 0.767 . . . . 0.0 111.626 171.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -116.08 126.42 53.73 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.317 0.647 . . . . 0.0 110.575 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 15.6 p90 -150.18 124.49 9.52 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.351 -0.843 . . . . 0.0 110.492 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 55.99 33.72 22.33 Favored 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 117.087 2.254 . . . . 0.0 117.087 173.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.8 -18.23 21.84 Favored Glycine 0 CA--C 1.559 2.805 0 N-CA-C 119.325 2.49 . . . . 0.0 119.325 -164.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -89.17 145.46 25.41 Favored 'General case' 0 CA--C 1.567 1.618 0 CA-C-N 119.489 1.644 . . . . 0.0 112.836 -175.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -130.25 129.29 43.12 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.747 0.819 . . . . 0.0 110.709 -174.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.2 t -123.9 129.01 50.29 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.643 -0.66 . . . . 0.0 109.327 159.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.95 127.01 56.1 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.412 0.685 . . . . 0.0 110.709 175.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -106.43 102.39 11.79 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -175.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.4 t -88.19 102.8 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -173.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -108.35 110.47 22.04 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.076 0.95 . . . . 0.0 109.015 -169.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -129.73 137.68 50.7 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -170.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.1 mm -77.0 99.38 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 171.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -109.99 111.09 22.27 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.8 t70 47.12 52.83 11.45 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -171.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.02 -23.99 4.18 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 119.599 2.6 . . . . 0.0 119.599 -170.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -94.06 136.24 34.56 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 119.522 1.661 . . . . 0.0 111.454 -172.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 50.1 ttp -81.01 102.72 10.36 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.253 1.025 . . . . 0.0 110.167 172.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 87.5 t -89.52 101.76 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 46.6 ttm -87.37 101.02 13.16 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.536 0.735 . . . . 0.0 109.476 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 93.1 m -91.56 101.42 14.06 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.888 0.851 . . . . 0.0 108.737 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 mp -88.83 117.87 28.13 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.307 6.5 t -137.94 133.66 34.01 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 175.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -99.01 89.9 4.44 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.342 171.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 71.86 -86.75 0.46 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 114.952 0.741 . . . . 0.0 114.952 -172.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -127.75 3.67 6.07 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 174.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.4 125.11 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-N 121.82 2.1 . . . . 0.0 107.994 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.1 t -120.6 130.56 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.816 -0.553 . . . . 0.0 111.139 -162.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.28 148.59 35.31 Favored 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 123.484 0.714 . . . . 0.0 111.588 156.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.3 t -125.64 107.5 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 120.743 -1.223 . . . . 0.0 108.807 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -95.62 120.26 35.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.213 -0.929 . . . . 0.0 111.139 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -97.73 97.91 9.41 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.367 0.603 . . . . 0.0 110.131 -172.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -94.53 135.62 35.77 Favored 'General case' 0 CA--C 1.561 1.403 0 O-C-N 121.353 -0.842 . . . . 0.0 112.024 -174.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -122.66 154.87 37.46 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.481 0.712 . . . . 0.0 111.454 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -72.02 136.86 46.85 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -172.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.194 0 C-N-CA 124.183 0.993 . . . . 0.0 111.363 170.321 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.276 4.1 p . . . . . 0 CA--C 1.577 1.99 0 N-CA-C 116.617 2.081 . . . . 0.0 116.617 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -59.53 -39.68 84.72 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 116.358 1.984 . . . . 0.0 116.358 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.11 -29.38 30.5 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 118.201 2.667 . . . . 0.0 118.201 164.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -82.49 -9.78 59.28 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 169.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.6 t -73.59 102.62 3.93 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-N 122.054 2.206 . . . . 0.0 114.004 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -172.17 163.59 5.9 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 122.211 1.005 . . . . 0.0 111.788 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.2 m -78.84 122.64 26.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.015 -1.053 . . . . 0.0 108.375 153.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -106.14 115.79 30.82 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.085 -1.01 . . . . 0.0 110.218 -175.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -92.5 129.8 38.34 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.646 0.778 . . . . 0.0 111.272 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 tt -73.05 113.21 9.84 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-O 121.353 0.597 . . . . 0.0 112.526 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.0 p -85.25 -45.84 11.6 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -148.51 117.33 6.69 Favored 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 123.785 0.834 . . . . 0.0 109.734 -177.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.7 p -99.91 98.54 9.3 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.126 0.57 . . . . 0.0 111.535 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -80.05 122.1 26.34 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 123.437 0.695 . . . . 0.0 111.261 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 t30 55.32 38.19 29.98 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 118.15 2.648 . . . . 0.0 118.15 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -78.97 -35.94 42.27 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -176.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -50.18 -59.56 3.81 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 172.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -59.06 -37.66 77.57 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 171.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -57.66 -48.39 79.63 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 115.448 1.648 . . . . 0.0 115.448 168.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -57.85 -49.4 76.8 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 167.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -44.26 65.32 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 168.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.61 -41.33 98.32 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 170.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.37 -13.0 24.55 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 118.406 2.743 . . . . 0.0 118.406 170.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.75 55.61 1.75 Allowed Glycine 0 N--CA 1.485 1.931 0 CA-C-N 119.329 0.968 . . . . 0.0 115.342 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.3 m -95.44 146.43 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 117.565 0.682 . . . . 0.0 112.221 175.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.23 144.95 35.38 Favored Glycine 0 CA--C 1.551 2.298 0 N-CA-C 115.277 0.871 . . . . 0.0 115.277 169.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -78.92 60.75 2.95 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 123.311 1.529 . . . . 0.0 114.237 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -165.57 -55.24 0.03 OUTLIER 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 126.418 1.887 . . . . 0.0 108.63 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.1 m -40.46 -40.0 1.12 Allowed 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 160.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.329 0.0 OUTLIER -94.01 -2.38 53.11 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 119.436 3.124 . . . . 0.0 119.436 172.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -65.37 -46.5 79.9 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 120.815 1.643 . . . . 0.0 112.599 151.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.7 t -52.29 -55.01 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 160.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.97 -40.64 91.3 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 120.548 2.979 . . . . 0.0 120.548 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -72.06 -33.45 67.97 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 175.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.3 m -69.81 -35.45 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.6 t -86.96 137.44 32.36 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -91.22 117.57 67.94 Favored Pre-proline 0 CA--C 1.576 1.963 0 CA-C-O 117.851 -1.071 . . . . 0.0 111.0 166.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -76.06 127.31 9.88 Favored 'Trans proline' 0 CA--C 1.562 1.907 0 CA-C-N 123.404 2.251 . . . . 0.0 115.356 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.9 m -99.28 123.24 43.41 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.079 0.952 . . . . 0.0 109.015 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.9 t -105.82 106.51 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.55 -0.718 . . . . 0.0 109.537 -168.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.8 mt -90.79 106.66 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 120.141 -1.599 . . . . 0.0 108.273 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 81.6 mt -90.38 111.55 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.2 p -135.67 119.76 17.63 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -169.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -90.9 116.72 28.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.324 -0.86 . . . . 0.0 111.842 -171.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -114.55 79.97 1.34 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.477 0.656 . . . . 0.0 110.543 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.2 -97.35 0.66 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 115.509 0.964 . . . . 0.0 115.509 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.36 -41.55 69.6 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 170.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -113.08 153.36 28.31 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-O 122.164 0.983 . . . . 0.0 113.41 -160.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.2 t -89.23 115.67 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.651 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 167.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.22 100.86 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 175.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 58.9 mt -94.28 114.25 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -98.91 102.97 14.88 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 122.979 0.512 . . . . 0.0 110.054 174.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.8 m -87.89 101.48 13.77 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.534 0.683 . . . . 0.0 109.187 173.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.6 mt -96.74 96.88 8.89 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.385 0.674 . . . . 0.0 109.396 -175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -83.73 22.38 1.12 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 175.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.418 20.5 p 63.23 -62.1 0.14 Allowed 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 125.59 1.556 . . . . 0.0 114.755 -167.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -76.76 -37.79 55.27 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 173.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -120.5 124.81 46.3 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 119.49 1.041 . . . . 0.0 110.945 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -93.83 104.33 16.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.034 -1.041 . . . . 0.0 109.207 164.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.255 13.6 t -107.57 87.07 2.42 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.013 0.911 . . . . 0.0 109.617 174.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -106.2 142.63 35.57 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -172.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.9 pt -133.83 123.01 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 C-N-CA 123.044 0.537 . . . . 0.0 111.711 -168.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.9 p -109.99 107.63 17.58 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.812 0.845 . . . . 0.0 110.742 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -140.91 150.47 43.21 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.597 0.713 . . . . 0.0 112.543 -169.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -95.8 98.23 10.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.159 -0.963 . . . . 0.0 109.819 170.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.7 mt -6.07 109.12 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 120.513 3.523 . . . . 0.0 120.513 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.92 -18.83 45.41 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 118.97 2.348 . . . . 0.0 118.97 -167.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.36 127.76 33.87 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 119.716 1.758 . . . . 0.0 111.834 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -79.03 127.77 32.42 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -137.67 150.43 47.35 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.698 0.761 . . . . 0.0 111.42 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -75.85 132.98 40.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.899 -1.126 . . . . 0.0 112.101 170.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -133.09 111.05 10.63 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.238 0.615 . . . . 0.0 110.149 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 95.0 m -82.19 109.66 16.68 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 165.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 51.2 p -82.96 -177.64 6.84 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -165.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.02 -16.6 32.36 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 118.773 2.879 . . . . 0.0 118.773 168.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -79.55 -14.93 58.51 Favored 'General case' 0 CA--C 1.579 2.068 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 157.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.331 5.0 t70 75.88 14.83 2.6 Favored 'General case' 0 CA--C 1.58 2.129 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -160.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.0 ptt-85 -83.34 124.1 30.29 Favored 'General case' 0 CA--C 1.565 1.553 0 O-C-N 120.084 -1.635 . . . . 0.0 109.737 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -85.7 118.07 24.97 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.149 0.58 . . . . 0.0 112.417 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.9 p -122.33 145.64 48.06 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -76.81 105.05 7.64 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.807 0.813 . . . . 0.0 109.709 160.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.7 m -99.53 124.92 45.15 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.536 0.735 . . . . 0.0 112.324 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.31 118.01 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 36.1 t -119.71 95.25 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.36 -0.838 . . . . 0.0 109.073 -171.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.7 m -113.64 130.32 56.42 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.648 0.779 . . . . 0.0 111.612 -169.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.3 tt -85.29 109.07 18.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.12 -0.988 . . . . 0.0 110.456 170.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -90.57 -16.51 28.63 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 -176.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 176.86 -88.05 0.08 OUTLIER Glycine 0 N--CA 1.49 2.235 0 CA-C-N 120.075 1.307 . . . . 0.0 110.954 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -101.92 32.12 3.58 Favored 'General case' 0 CA--C 1.579 2.071 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 158.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -146.23 114.18 6.52 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.874 0.761 . . . . 0.0 109.951 -159.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 mt -90.2 102.27 14.99 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 123.72 0.808 . . . . 0.0 109.625 172.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.6 t -100.12 105.45 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.149 -0.969 . . . . 0.0 108.603 -170.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -95.04 101.07 12.8 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.427 0.691 . . . . 0.0 110.369 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 59.4 mt -89.47 122.79 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 C-N-CA 123.959 0.903 . . . . 0.0 108.76 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -111.37 123.42 50.18 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 119.477 1.035 . . . . 0.0 110.732 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -113.34 117.84 32.93 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.959 0.904 . . . . 0.0 109.771 -176.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -150.65 127.05 10.71 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.648 -1.282 . . . . 0.0 111.496 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 56.63 32.27 20.69 Favored 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 117.332 2.345 . . . . 0.0 117.332 174.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.68 -27.15 4.9 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 118.432 2.133 . . . . 0.0 118.432 -162.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -80.99 140.71 35.03 Favored 'General case' 0 CA--C 1.562 1.426 0 CA-C-N 119.121 1.461 . . . . 0.0 112.158 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -131.26 126.71 36.14 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.235 0.614 . . . . 0.0 110.128 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.7 t -122.3 156.26 34.23 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.413 0.685 . . . . 0.0 110.743 171.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.283 9.7 p30 -135.47 146.24 47.98 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 170.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -120.16 106.14 11.66 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.7 t -90.82 98.38 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -92.23 97.7 11.06 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -176.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -117.08 130.54 56.72 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -168.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.1 mm -74.94 111.04 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.12 -91.05 0.18 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 119.399 -0.334 . . . . 0.0 110.14 -173.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -104.7 70.43 0.93 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 119.342 0.974 . . . . 0.0 108.851 164.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.64 -39.95 2.85 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 118.128 2.011 . . . . 0.0 118.128 -169.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -84.34 144.9 28.54 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.256 1.028 . . . . 0.0 113.262 -173.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 55.8 ttp -84.05 100.32 11.02 Favored 'General case' 0 CA--C 1.561 1.394 0 CA-C-O 122.291 1.043 . . . . 0.0 110.204 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.1 t -85.38 102.76 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 43.1 ttm -86.89 101.36 13.31 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.213 0.605 . . . . 0.0 109.676 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.7 m -90.87 110.1 21.32 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 174.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.5 mp -99.37 119.75 38.46 Favored 'General case' 0 CA--C 1.56 1.339 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -176.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.0 t -125.56 124.2 40.75 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 119.406 1.003 . . . . 0.0 112.646 -171.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -137.19 97.14 3.42 Favored 'General case' 0 CA--C 1.565 1.547 0 C-N-CA 123.816 0.846 . . . . 0.0 110.51 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 77.32 -94.2 1.13 Allowed Glycine 0 N--CA 1.492 2.374 0 O-C-N 121.433 -0.792 . . . . 0.0 114.084 170.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -128.39 42.84 3.25 Favored 'General case' 0 CA--C 1.578 2.033 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 160.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 81.4 t -136.88 118.94 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 -177.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.84 131.09 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.05 157.07 21.19 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 123.088 0.555 . . . . 0.0 112.481 163.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.3 t -132.58 109.21 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.032 -1.043 . . . . 0.0 108.99 175.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -100.24 114.41 27.84 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.804 0.811 . . . . 0.0 110.748 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -95.83 106.01 18.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.66 -0.65 . . . . 0.0 110.145 -170.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -105.58 128.19 53.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.889 -1.132 . . . . 0.0 113.391 -168.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -99.41 156.52 16.97 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 124.062 0.945 . . . . 0.0 113.352 173.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -77.72 130.05 36.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.152 -0.967 . . . . 0.0 113.285 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.166 0 C-N-CA 124.493 1.117 . . . . 0.0 110.859 162.693 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.295 8.8 p . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -61.48 -46.9 88.06 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.12 -23.78 62.43 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 166.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -78.71 -18.07 54.89 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 167.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 71.9 m -73.94 92.16 2.08 Favored 'General case' 0 CA--C 1.568 1.671 0 CA-C-N 122.284 2.311 . . . . 0.0 113.855 -173.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.66 166.6 13.83 Favored 'General case' 0 CA--C 1.571 1.754 0 CA-C-O 122.423 1.106 . . . . 0.0 112.328 -170.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.3 m -84.86 111.87 20.03 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.342 -0.849 . . . . 0.0 109.18 166.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -105.87 118.68 37.22 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.912 0.485 . . . . 0.0 110.603 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -103.32 137.83 40.91 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.14 -0.975 . . . . 0.0 111.628 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -72.78 129.94 39.34 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.0 p -102.18 -37.5 8.1 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -158.15 117.57 3.21 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 119.602 1.092 . . . . 0.0 109.33 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.1 p -97.02 89.4 4.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.726 -0.609 . . . . 0.0 111.562 171.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.99 124.32 29.67 Favored 'General case' 0 CA--C 1.564 1.503 0 C-N-CA 123.763 0.825 . . . . 0.0 111.283 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.307 11.3 t-20 61.89 10.29 3.45 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 118.316 2.71 . . . . 0.0 118.316 -174.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -62.2 -33.61 74.88 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 116.635 2.087 . . . . 0.0 116.635 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -51.99 -52.67 49.03 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 166.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -63.81 -42.98 97.56 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 172.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -52.49 -52.31 55.09 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 166.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 78.9 mtm -58.98 -48.79 80.3 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 173.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -54.24 -48.3 71.28 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 169.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.3 -38.21 82.93 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 tp -72.3 -1.92 17.17 Favored 'General case' 0 CA--C 1.579 2.061 0 N-CA-C 117.905 2.557 . . . . 0.0 117.905 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.22 48.9 5.2 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 117.101 1.6 . . . . 0.0 117.101 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.468 HG21 ' HB2' ' A' ' 30' ' ' ARG . 24.1 m -82.42 131.49 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 173.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.64 58.04 4.9 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 116.65 1.42 . . . . 0.0 116.65 173.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.288 25.8 t80 63.35 -58.33 0.17 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.647 2.091 . . . . 0.0 116.647 -175.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.33 -46.97 76.34 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 116.939 2.2 . . . . 0.0 116.939 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.2 m -63.9 -33.47 75.78 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 172.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.468 ' HB2' HG21 ' A' ' 25' ' ' VAL . 3.7 tmt_? -60.17 -53.75 53.96 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 162.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.89 -37.25 86.69 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 177.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.5 t -53.68 -62.27 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 C-N-CA 123.804 0.841 . . . . 0.0 112.684 156.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.54 -35.45 45.08 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 120.337 2.895 . . . . 0.0 120.337 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -69.47 -47.49 63.76 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 172.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.3 m -78.04 -33.35 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.5 t -83.39 147.14 28.06 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 119.274 0.943 . . . . 0.0 113.203 -172.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -107.21 91.11 6.28 Favored Pre-proline 0 CA--C 1.572 1.811 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 173.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -77.68 118.25 4.48 Favored 'Trans proline' 0 C--N 1.372 1.793 0 CA-C-N 122.463 1.915 . . . . 0.0 113.616 -169.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.4 m -88.15 123.15 32.52 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.913 0.863 . . . . 0.0 110.577 -172.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.0 t -100.48 101.64 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -173.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 64.9 mt -92.76 111.31 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.2 mt -101.84 121.36 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.2 t -143.24 -172.73 3.75 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-O 122.509 1.147 . . . . 0.0 111.819 173.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -135.28 118.19 16.26 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.334 1.054 . . . . 0.0 109.472 -176.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -100.49 91.75 4.83 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.65 0.738 . . . . 0.0 110.953 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.55 -74.8 1.48 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 115.904 1.122 . . . . 0.0 115.904 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -121.58 -45.97 2.28 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -88.3 155.94 19.45 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 120.368 1.44 . . . . 0.0 114.148 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.0 t -90.4 133.46 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 C-N-CA 123.47 0.708 . . . . 0.0 109.305 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 93.7 t -114.7 117.42 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.9 mt -95.28 107.88 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.693 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 162.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -78.91 149.75 32.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.65 -1.281 . . . . 0.0 110.161 156.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.6 m -147.63 99.52 3.12 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.282 -1.511 . . . . 0.0 107.93 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.8 mt -117.97 103.28 9.77 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.703 0.763 . . . . 0.0 110.443 -154.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.7 t -82.36 163.15 21.91 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 122.27 1.033 . . . . 0.0 112.655 168.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.8 p -57.36 15.19 0.0 OUTLIER 'General case' 0 CA--C 1.591 2.556 0 N-CA-C 118.003 2.594 . . . . 0.0 118.003 153.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -146.32 -69.09 0.26 Allowed 'General case' 0 CA--C 1.57 1.744 0 C-N-CA 124.977 1.311 . . . . 0.0 107.877 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -100.34 121.71 41.95 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.944 0.898 . . . . 0.0 111.867 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -96.54 82.26 3.33 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.848 0.832 . . . . 0.0 111.043 174.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.5 p -85.41 155.91 21.07 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -168.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -142.67 134.24 26.55 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.479 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 8.2 mt -128.98 102.72 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 -174.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 92.0 p -104.75 123.47 47.7 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 123.923 0.889 . . . . 0.0 111.83 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -148.77 142.37 25.44 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.116 0.96 . . . . 0.0 112.773 -168.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -84.76 11.95 8.17 Favored 'General case' 0 CA--C 1.58 2.1 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.263 65.0 mt 64.85 105.54 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 125.556 1.542 . . . . 0.0 113.35 -168.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.16 35.87 36.9 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 118.352 2.101 . . . . 0.0 118.352 -172.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -135.4 135.49 40.66 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 118.467 1.134 . . . . 0.0 110.089 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -89.45 116.61 27.76 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -171.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.479 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 46.4 p90 -116.42 141.25 48.42 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.889 0.876 . . . . 0.0 111.054 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.61 135.38 43.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.567 -1.333 . . . . 0.0 111.907 170.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -134.11 105.21 6.57 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -171.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 91.2 m -79.83 100.52 8.04 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 122.106 0.955 . . . . 0.0 109.31 172.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 77.8 p -76.38 174.64 9.98 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -169.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.84 -2.53 0.57 Allowed 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 119.885 3.291 . . . . 0.0 119.885 167.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -103.02 4.1 36.92 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 115.594 1.702 . . . . 0.0 115.594 158.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.29 3.4 t70 62.65 25.9 15.37 Favored 'General case' 0 CA--C 1.581 2.137 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 -166.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.8 ptp85 -89.65 126.01 35.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.642 -1.286 . . . . 0.0 109.117 166.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -85.66 101.49 12.78 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-O 121.811 0.815 . . . . 0.0 111.384 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 99.0 m -102.19 116.79 33.4 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 121.395 0.616 . . . . 0.0 112.654 -169.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -66.19 102.47 0.84 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.24 1.016 . . . . 0.0 110.37 169.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.5 m -114.09 125.24 53.75 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 121.849 -0.532 . . . . 0.0 111.48 -156.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.78 122.15 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.8 t -109.03 121.86 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.224 -0.922 . . . . 0.0 109.337 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 94.7 p -118.0 140.92 49.05 Favored 'General case' 0 CA--C 1.564 1.504 0 C-N-CA 123.956 0.902 . . . . 0.0 111.963 177.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.8 tp -92.91 98.37 11.33 Favored 'General case' 0 CA--C 1.566 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 110.302 174.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -91.59 73.55 5.92 Favored 'General case' 0 CA--C 1.569 1.691 0 O-C-N 121.364 -0.835 . . . . 0.0 111.795 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.25 62.44 4.42 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 116.398 1.319 . . . . 0.0 116.398 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.256 6.6 t70 54.06 47.19 23.88 Favored 'General case' 0 CA--C 1.579 2.086 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -163.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -143.82 107.02 4.52 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.0 mt -82.08 95.2 7.39 Favored 'General case' 0 CA--C 1.568 1.648 0 CA-C-O 121.835 0.826 . . . . 0.0 111.7 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.7 t -97.03 103.18 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -84.93 125.71 32.9 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.035 0.534 . . . . 0.0 110.089 172.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.6 mt -112.39 118.12 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -101.79 126.29 48.63 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 119.296 0.953 . . . . 0.0 111.343 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -114.8 123.14 48.46 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.962 0.905 . . . . 0.0 110.496 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -149.67 122.71 8.83 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.421 -1.424 . . . . 0.0 110.581 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 54.26 39.9 31.24 Favored 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.1 -25.38 4.23 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 118.936 2.335 . . . . 0.0 118.936 -165.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -83.17 141.11 32.17 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-N 119.354 1.577 . . . . 0.0 112.115 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -134.18 125.89 28.81 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 122.969 0.507 . . . . 0.0 111.166 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.9 t -118.98 154.66 32.69 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.764 0.826 . . . . 0.0 110.612 169.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.31 10.8 p30 -134.77 152.42 51.75 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 171.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -126.87 102.91 7.22 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -169.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.8 t -95.19 94.02 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -168.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -81.9 123.67 29.04 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.95 0.9 . . . . 0.0 110.771 176.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -144.31 123.56 13.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.667 -0.646 . . . . 0.0 109.945 -167.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.3 mm -78.09 103.76 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.429 -0.795 . . . . 0.0 109.132 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -131.05 113.86 14.47 Favored 'General case' 0 CA--C 1.558 1.287 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -170.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.5 t70 47.93 50.53 15.64 Favored 'General case' 0 CA--C 1.579 2.094 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 -168.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.75 -43.48 3.17 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 -169.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.2 mtmp? -85.75 150.88 24.27 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 118.463 1.132 . . . . 0.0 113.602 -171.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 59.1 ttp -85.23 98.65 10.61 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 121.83 0.824 . . . . 0.0 109.499 171.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.1 81.81 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 120.954 -1.092 . . . . 0.0 108.73 -171.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 23.2 ttp -76.97 112.94 14.13 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.078 0.551 . . . . 0.0 111.58 -166.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.4 m -98.44 114.02 26.23 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.803 0.811 . . . . 0.0 109.777 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.34 106.54 17.72 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 124.238 1.015 . . . . 0.0 108.788 -173.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.7 t -115.6 118.84 34.23 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.407 0.622 . . . . 0.0 111.754 -175.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -105.37 81.68 1.73 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 165.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 68.68 -89.25 0.22 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 115.439 0.936 . . . . 0.0 115.439 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -95.94 -25.4 15.98 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 169.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.2 110.86 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-N 121.038 1.745 . . . . 0.0 109.305 -171.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.7 t -113.07 112.42 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 123.514 0.725 . . . . 0.0 109.273 -172.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -102.16 158.86 15.87 Favored 'General case' 0 CA--C 1.561 1.389 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 165.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.3 t -131.27 110.49 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.022 -1.048 . . . . 0.0 109.14 178.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -95.23 108.69 20.85 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.891 0.853 . . . . 0.0 110.411 172.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -88.46 104.31 16.68 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.586 0.754 . . . . 0.0 110.497 -171.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -101.57 120.29 40.09 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -0.903 . . . . 0.0 112.639 -172.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -87.05 163.51 16.99 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 167.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -74.14 151.0 40.15 Favored 'General case' 0 CA--C 1.571 1.773 0 O-C-N 120.894 -1.129 . . . . 0.0 112.279 162.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.269 166.407 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 N--CA 1.499 1.992 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -62.75 -52.16 64.33 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 -170.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.54 -21.38 52.26 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 118.394 2.739 . . . . 0.0 118.394 169.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -83.1 -17.48 42.94 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 116.413 2.005 . . . . 0.0 116.413 169.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 87.6 m -71.18 93.96 1.12 Allowed 'General case' 0 CA--C 1.566 1.56 0 CA-C-N 121.563 1.983 . . . . 0.0 113.695 -174.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -170.61 162.95 8.13 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-O 122.485 1.136 . . . . 0.0 111.958 -167.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 92.9 m -86.7 113.62 22.7 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.436 169.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -107.26 111.93 24.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.615 -0.678 . . . . 0.0 111.064 -172.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -101.18 132.97 46.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.253 -0.904 . . . . 0.0 111.501 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -72.05 133.29 45.17 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.7 p -105.7 -40.34 5.78 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 175.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -155.96 123.86 5.67 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 119.474 1.034 . . . . 0.0 109.326 -174.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.8 p -104.86 102.55 12.08 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.373 0.669 . . . . 0.0 110.986 172.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -68.46 -56.29 8.92 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 116.543 2.053 . . . . 0.0 116.543 -159.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -126.21 54.28 1.56 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 119.042 0.837 . . . . 0.0 111.671 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -78.39 -53.05 7.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -172.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -50.62 -43.21 56.86 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 117.767 2.506 . . . . 0.0 117.767 172.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.13 -49.12 78.9 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 166.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -50.73 -46.67 59.23 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 164.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.501 ' SD ' HG21 ' A' ' 25' ' ' VAL . 32.9 mmt -57.66 -42.34 83.31 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 170.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -60.29 -47.18 87.1 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 166.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.97 -39.17 93.88 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 172.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.5 tp -69.17 -23.77 63.97 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.6 45.63 6.37 Favored Glycine 0 CA--C 1.548 2.118 0 N-CA-C 117.169 1.628 . . . . 0.0 117.169 -173.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.501 HG21 ' SD ' ' A' ' 20' ' ' MET . 34.6 m -102.05 153.7 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 118.428 1.114 . . . . 0.0 111.709 173.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.08 -167.66 16.51 Favored Glycine 0 N--CA 1.491 2.303 0 O-C-N 120.646 -1.284 . . . . 0.0 115.835 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -84.84 59.73 5.75 Favored 'General case' 0 CA--C 1.576 1.967 0 O-C-N 121.433 -1.039 . . . . 0.0 112.025 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.3 -73.09 0.31 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.723 0.809 . . . . 0.0 109.702 -175.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.1 m -57.74 -34.3 69.37 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 169.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -62.63 -39.19 93.07 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 117.342 2.349 . . . . 0.0 117.342 167.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -67.14 -56.81 8.38 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.034 1.288 . . . . 0.0 112.269 165.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.5 t -56.13 -45.52 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.91 -15.04 79.95 Favored Glycine 0 CA--C 1.552 2.368 0 N-CA-C 118.79 2.276 . . . . 0.0 118.79 175.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -94.09 -52.0 4.59 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.111 1.956 . . . . 0.0 113.991 171.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.256 34.3 m -80.95 -31.14 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.468 0 CA-C-N 121.657 2.026 . . . . 0.0 115.472 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.08 140.69 32.03 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-O 122.082 0.944 . . . . 0.0 110.206 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -98.18 103.25 16.85 Favored Pre-proline 0 CA--C 1.574 1.895 0 CA-C-O 118.075 -0.964 . . . . 0.0 109.791 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.51 146.87 35.43 Favored 'Trans proline' 0 CA--C 1.561 1.841 0 C-N-CA 122.565 2.177 . . . . 0.0 115.391 -176.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 88.7 m -100.68 100.63 11.35 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.362 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.3 t -95.23 101.98 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -173.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.5 mt -91.56 106.29 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 85.2 mt -84.87 120.34 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 170.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.8 p -137.16 133.06 34.83 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.856 0.462 . . . . 0.0 111.647 -172.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -92.7 101.08 13.48 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.992 -1.068 . . . . 0.0 109.35 172.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -104.97 83.13 1.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.837 0.827 . . . . 0.0 109.713 -170.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.76 -106.35 2.52 Favored Glycine 0 N--CA 1.487 2.098 0 CA-C-N 116.006 -0.543 . . . . 0.0 113.985 -175.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -88.74 -28.11 20.74 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -110.1 153.88 24.05 Favored 'General case' 0 CA--C 1.564 1.507 0 CA-C-O 122.804 1.288 . . . . 0.0 113.818 -170.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.46 118.91 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.604 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 170.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.3 t -111.09 107.54 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.4 mt -93.93 112.81 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -100.99 98.14 8.63 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.2 m -86.8 94.59 9.58 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.4 mt -89.02 89.36 7.95 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.651 0.739 . . . . 0.0 109.356 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.3 t -97.2 27.38 4.17 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.342 66.6 p 68.87 -53.22 0.57 Allowed 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -174.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -92.96 -54.97 3.52 Favored 'General case' 0 CA--C 1.571 1.751 0 C-N-CA 124.821 1.248 . . . . 0.0 111.703 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -107.38 108.88 20.45 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.778 0.831 . . . . 0.0 109.665 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -100.29 86.76 3.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.587 -0.695 . . . . 0.0 112.116 175.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -95.62 127.08 41.35 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.366 -0.834 . . . . 0.0 112.916 -173.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -109.52 97.96 7.43 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.921 0.888 . . . . 0.0 110.834 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.3 pt -95.85 108.99 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.078 -1.014 . . . . 0.0 111.051 -174.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 85.4 p -102.43 113.04 26.04 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.12 0.968 . . . . 0.0 112.076 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -148.64 148.88 30.61 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.22 0.534 . . . . 0.0 111.954 -170.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -86.93 156.62 19.74 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.519 -1.363 . . . . 0.0 111.925 163.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.9 mt -70.51 124.13 23.47 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.373 -1.454 . . . . 0.0 112.491 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.16 -4.24 83.9 Favored Glycine 0 CA--C 1.554 2.506 0 N-CA-C 118.97 2.348 . . . . 0.0 118.97 -163.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -85.33 131.87 34.34 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-N 120.223 2.012 . . . . 0.0 112.229 -175.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -72.42 136.5 46.06 Favored 'General case' 0 CA--C 1.571 1.773 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.928 165.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -145.8 149.04 33.6 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.671 0.788 . . . . 0.0 110.937 175.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.74 134.91 34.32 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.728 -1.233 . . . . 0.0 110.864 169.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.49 ' HB3' ' SG ' ' A' ' 80' ' ' CYS . 38.5 tt0 -132.15 109.44 9.96 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.912 -174.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.2 m -78.28 107.1 10.64 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 167.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.4 p -79.91 168.81 18.75 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -167.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.23 -8.51 1.66 Allowed 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 119.716 3.228 . . . . 0.0 119.716 172.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -116.89 28.63 8.41 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 120.833 1.651 . . . . 0.0 114.875 162.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.253 17.1 m-20 63.07 42.16 7.55 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 176.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -119.52 132.22 55.72 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.989 0.916 . . . . 0.0 109.041 167.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -92.62 115.27 27.95 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.158 0.583 . . . . 0.0 110.558 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 72' ' ' GLU . 25.2 p -110.69 143.38 41.25 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -76.48 100.86 5.39 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 122.272 1.034 . . . . 0.0 109.338 160.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.3 m -96.22 130.07 43.38 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 124.235 1.014 . . . . 0.0 112.735 -176.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 p -134.95 124.59 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 123.172 0.589 . . . . 0.0 109.506 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.4 t -112.67 110.9 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.486 -0.759 . . . . 0.0 109.641 -172.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.8 p -104.58 132.11 51.21 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 123.635 0.774 . . . . 0.0 112.467 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.7 tt -88.87 99.67 12.57 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.607 0.718 . . . . 0.0 109.464 168.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -97.25 76.91 2.64 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.443 -0.785 . . . . 0.0 110.587 -173.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.96 58.22 15.71 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 117.99 1.956 . . . . 0.0 117.99 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.348 5.5 m-20 91.14 -35.6 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -163.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -90.01 113.97 25.75 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-N 120.572 1.533 . . . . 0.0 112.659 -171.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.1 mt -80.7 123.42 28.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.921 -1.112 . . . . 0.0 112.006 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.4 t -124.87 106.6 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -174.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -94.28 101.29 13.25 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 123.472 0.709 . . . . 0.0 110.098 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.3 mt -87.21 112.59 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 123.89 0.876 . . . . 0.0 108.707 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -100.14 121.17 41.0 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.061 0.545 . . . . 0.0 110.189 172.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -114.32 118.15 33.1 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.2 0.6 . . . . 0.0 110.531 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 15.6 p90 -142.96 125.12 15.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.25 -0.906 . . . . 0.0 110.197 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 55.17 37.67 29.26 Favored 'General case' 0 N--CA 1.507 2.424 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 173.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.91 -22.58 6.61 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 119.142 2.417 . . . . 0.0 119.142 -165.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -86.48 142.24 28.51 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-N 119.024 1.412 . . . . 0.0 112.645 -175.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -131.01 123.42 28.71 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.548 0.739 . . . . 0.0 110.616 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.1 t -121.7 139.84 53.06 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 123.278 0.631 . . . . 0.0 109.911 165.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -118.49 132.66 56.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.848 -0.533 . . . . 0.0 112.079 174.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -102.29 104.86 15.42 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 54.8 t -87.6 96.58 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.93 116.22 28.72 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 123.964 0.906 . . . . 0.0 110.072 175.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.6 128.38 20.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.865 -0.522 . . . . 0.0 110.754 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.7 mm -80.89 121.65 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.625 -0.672 . . . . 0.0 109.664 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -101.5 -107.89 0.23 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 119.222 -0.418 . . . . 0.0 109.904 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -86.63 66.91 9.69 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 120.306 1.412 . . . . 0.0 111.06 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 79.21 -30.18 2.14 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 118.726 2.25 . . . . 0.0 118.726 -167.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -93.77 147.33 23.15 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 118.548 1.174 . . . . 0.0 112.1 -172.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 14.6 tpp -77.48 113.08 14.92 Favored 'General case' 0 CA--C 1.563 1.476 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.606 169.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.9 t -88.64 105.53 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.638 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 164.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 22.3 ttt -101.4 103.4 14.32 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.119 0.568 . . . . 0.0 109.485 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.7 m -103.36 104.37 14.47 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.378 0.671 . . . . 0.0 109.275 -172.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mp -94.86 106.0 17.96 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.463 0.705 . . . . 0.0 109.346 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.9 t -102.7 134.12 46.59 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.736 0.779 . . . . 0.0 112.286 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -116.18 79.68 1.34 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 161.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 68.64 -94.02 0.33 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -175.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -88.22 -30.71 19.5 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 172.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.1 t -90.34 112.33 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-N 120.237 1.38 . . . . 0.0 109.363 -169.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.8 t -115.22 113.13 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 123.435 0.694 . . . . 0.0 109.525 -168.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -100.91 111.86 24.17 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.428 -0.795 . . . . 0.0 112.386 175.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.36 109.17 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.465 -0.772 . . . . 0.0 109.018 -177.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.5 mtp85 -98.19 120.37 38.48 Favored 'General case' 0 CA--C 1.563 1.446 0 CA-C-O 121.915 0.864 . . . . 0.0 110.541 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -99.56 104.99 16.83 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.398 0.679 . . . . 0.0 109.709 -169.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -109.76 125.55 52.81 Favored 'General case' 0 CA--C 1.568 1.635 0 O-C-N 121.623 -0.673 . . . . 0.0 111.458 -170.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -96.62 155.84 16.6 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.374 0.67 . . . . 0.0 112.416 171.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -72.41 131.27 42.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.306 -0.871 . . . . 0.0 112.234 171.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.501 0 C-N-CA 123.254 0.622 . . . . 0.0 112.487 170.561 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 94.1 t . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.257 93.4 mt-10 -135.01 -42.03 0.74 Allowed 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 176.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.2 -37.3 45.9 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 116.748 2.129 . . . . 0.0 116.748 154.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -75.0 -11.74 60.17 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 168.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 66.2 m -76.7 100.53 5.44 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 122.853 2.57 . . . . 0.0 112.871 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -168.76 163.31 11.88 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-O 122.592 1.187 . . . . 0.0 112.313 -172.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.9 m -82.67 103.47 12.2 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.948 0.899 . . . . 0.0 108.796 169.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -99.0 110.32 22.94 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.694 -1.254 . . . . 0.0 112.158 -170.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -96.64 131.48 43.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.423 -0.798 . . . . 0.0 111.822 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.92 120.42 14.18 Favored 'General case' 0 CA--C 1.574 1.903 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.3 p -93.32 -46.62 7.28 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 174.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -145.62 115.21 7.23 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.826 0.851 . . . . 0.0 109.437 -171.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 76.3 p -104.15 94.18 5.24 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.434 0.694 . . . . 0.0 111.472 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -84.09 120.7 26.47 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.957 0.503 . . . . 0.0 111.194 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.297 3.8 t-20 62.58 20.67 12.16 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 118.248 2.684 . . . . 0.0 118.248 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -67.45 -38.05 83.88 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -55.57 -47.29 76.66 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 169.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -58.91 -47.91 83.32 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 169.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -51.21 -49.79 60.36 Favored 'General case' 0 CA--C 1.575 1.92 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 166.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 75.8 mtm -62.15 -44.01 97.56 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 175.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -62.86 -42.97 99.95 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 166.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.61 -43.75 98.28 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 tp -64.3 -32.81 74.56 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 168.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.85 46.94 5.78 Favored Glycine 0 CA--C 1.543 1.831 0 N-CA-C 116.231 1.252 . . . . 0.0 116.231 -171.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.266 22.9 m -83.08 64.2 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 CA-C-N 119.413 1.607 . . . . 0.0 112.15 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 56.1 -162.54 5.98 Favored Glycine 0 CA--C 1.553 2.425 0 N-CA-C 117.957 1.943 . . . . 0.0 117.957 -175.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -99.73 -43.58 6.4 Favored 'General case' 0 CA--C 1.572 1.795 0 CA-C-N 114.713 -0.744 . . . . 0.0 112.587 154.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.49 -49.8 69.93 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 174.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.0 m -59.25 -41.65 89.28 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 120.303 1.411 . . . . 0.0 114.723 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -59.43 -44.57 92.88 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 169.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -68.74 -40.56 79.77 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 172.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.7 t -50.41 -55.6 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 CA-C-N 119.798 1.181 . . . . 0.0 113.481 160.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.97 -39.68 41.19 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 119.33 2.492 . . . . 0.0 119.33 168.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -67.91 -46.25 72.09 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 170.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.0 m -75.55 -29.65 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 t -79.53 145.91 32.92 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 120.313 1.415 . . . . 0.0 114.259 -173.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -95.96 99.28 4.83 Favored Pre-proline 0 CA--C 1.574 1.883 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 159.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.14 131.23 10.73 Favored 'Trans proline' 0 CA--C 1.562 1.895 0 C-N-CA 122.499 2.132 . . . . 0.0 113.149 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.4 m -97.71 110.73 23.24 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.6 t -97.33 96.88 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -175.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.2 mt -95.22 105.6 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.5 -1.375 . . . . 0.0 108.817 -172.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.3 mt -93.1 123.21 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.5 p -146.18 149.29 33.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.345 -0.847 . . . . 0.0 112.778 169.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -90.99 121.22 32.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.511 -0.743 . . . . 0.0 111.105 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -110.95 85.73 2.17 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.347 0.594 . . . . 0.0 109.925 -175.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.54 -67.72 2.53 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 116.58 1.392 . . . . 0.0 116.58 -177.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -131.69 -44.01 0.99 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 124.137 0.975 . . . . 0.0 112.876 172.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -75.93 152.79 37.01 Favored 'General case' 0 CA--C 1.565 1.526 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.3 t -91.52 125.14 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.611 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 169.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.7 t -111.88 111.32 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.8 mt -105.96 106.11 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 54.2 mtm-85 -92.05 97.37 10.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.872 -0.517 . . . . 0.0 109.977 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.1 m -85.65 97.04 9.88 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.765 0.793 . . . . 0.0 109.553 174.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.1 mt -111.92 127.55 55.89 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.157 -165.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.6 m -123.76 164.28 19.48 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.329 0.652 . . . . 0.0 111.265 163.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 49.0 p -74.73 55.34 0.67 Allowed 'General case' 0 N--CA 1.508 2.46 0 O-C-N 120.553 -1.342 . . . . 0.0 113.194 171.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 178.86 -56.66 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.873 0 C-N-CA 125.174 1.39 . . . . 0.0 108.529 -149.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -140.07 127.25 21.09 Favored 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 124.271 1.028 . . . . 0.0 109.939 -169.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -104.91 100.16 9.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.538 -0.726 . . . . 0.0 109.388 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.9 p -114.3 91.54 3.66 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.223 0.535 . . . . 0.0 110.564 -172.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -94.65 126.91 40.26 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.06 -1.025 . . . . 0.0 113.718 -176.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.487 HG23 ' CZ ' ' A' ' 70' ' ' PHE . 11.3 mt -113.92 97.84 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -173.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 95.5 p -102.73 116.37 32.44 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.996 0.919 . . . . 0.0 112.038 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -151.45 149.38 29.19 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -172.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -87.21 150.7 23.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.697 -1.252 . . . . 0.0 110.423 152.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 27.2 mt -62.16 121.37 12.92 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.285 -1.509 . . . . 0.0 113.628 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.83 -9.88 72.45 Favored Glycine 0 CA--C 1.558 2.734 0 N-CA-C 119.129 2.411 . . . . 0.0 119.129 -165.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.91 125.23 30.49 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-N 120.041 1.92 . . . . 0.0 111.003 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -84.48 129.08 34.89 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.487 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 42.7 p90 -129.72 154.51 47.11 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.174 0.99 . . . . 0.0 111.701 -175.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.55 135.01 35.58 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.37 -1.456 . . . . 0.0 111.473 166.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -127.7 106.72 9.34 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.5 m -79.97 100.77 8.26 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.724 0.773 . . . . 0.0 109.915 174.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.7 p -85.07 167.02 16.18 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -169.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.4 -14.01 10.56 Favored 'General case' 0 CA--C 1.576 1.978 0 N-CA-C 118.9 2.926 . . . . 0.0 118.9 167.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -73.48 -13.49 61.06 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 116.35 1.982 . . . . 0.0 116.35 160.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.287 21.7 t70 68.96 69.72 0.28 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 121.267 1.849 . . . . 0.0 112.931 -166.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.2 ptt85 -160.89 127.71 4.11 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -86.03 90.1 8.0 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 123.11 0.564 . . . . 0.0 111.472 172.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.4 p -81.86 129.12 34.65 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -72.75 97.16 2.15 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 123.101 1.429 . . . . 0.0 110.157 173.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.9 m -109.91 123.86 50.35 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 113.685 -1.598 . . . . 0.0 110.96 -159.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.0 p -121.72 134.65 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.173 0.511 . . . . 0.0 110.144 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.5 t -123.49 123.48 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -175.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 57.0 m -131.73 146.46 52.18 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.948 0.88 . . . . 0.0 111.842 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.6 mt -84.92 112.57 20.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.874 . . . . 0.0 111.604 172.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -106.11 76.53 1.17 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.398 0.679 . . . . 0.0 111.041 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.64 61.89 5.52 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 116.686 1.434 . . . . 0.0 116.686 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.259 6.5 t70 52.36 43.5 30.78 Favored 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -162.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -137.15 112.41 9.17 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 mt -82.64 87.04 6.73 Favored 'General case' 0 CA--C 1.567 1.622 0 O-C-N 121.381 -0.824 . . . . 0.0 111.2 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.4 t -87.66 107.92 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -170.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -84.64 136.73 33.63 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.787 0.435 . . . . 0.0 110.413 168.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 59.7 mt -126.76 112.86 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -101.76 121.09 41.41 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.578 1.081 . . . . 0.0 110.186 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -116.74 126.67 53.48 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.307 0.575 . . . . 0.0 111.463 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.6 p90 -152.96 133.4 13.65 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.158 -0.964 . . . . 0.0 109.967 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 59.24 23.37 11.73 Favored 'General case' 0 N--CA 1.51 2.567 0 N-CA-C 118.439 2.755 . . . . 0.0 118.439 166.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.9 10.62 82.76 Favored Glycine 0 CA--C 1.558 2.72 0 N-CA-C 119.28 2.472 . . . . 0.0 119.28 -162.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -121.17 141.73 50.56 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-N 119.676 1.738 . . . . 0.0 110.44 -176.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -130.6 122.78 28.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.765 -0.584 . . . . 0.0 110.922 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.7 t -116.7 140.36 49.5 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 123.133 0.573 . . . . 0.0 110.759 166.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.16 140.68 49.98 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.99 -0.444 . . . . 0.0 110.99 -170.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -130.99 101.15 5.49 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.057 -1.027 . . . . 0.0 108.392 -163.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.3 t -93.56 97.18 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -170.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -90.33 108.51 19.81 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 123.55 0.74 . . . . 0.0 110.79 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.86 134.06 53.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.492 -0.755 . . . . 0.0 112.55 -172.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.4 mm -75.11 104.7 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.259 -0.901 . . . . 0.0 109.772 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -103.62 88.12 3.0 Favored 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.0 t70 51.16 59.41 4.63 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.662 1.726 . . . . 0.0 115.662 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.28 -40.36 2.62 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 117.678 1.831 . . . . 0.0 117.678 -171.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -93.47 136.83 33.36 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.276 1.538 . . . . 0.0 113.02 -173.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 56.1 ttp -82.74 104.49 13.02 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.897 0.856 . . . . 0.0 109.765 171.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 84.1 t -93.85 103.55 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 5.2 ttp -93.41 110.11 21.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.41 0.684 . . . . 0.0 110.862 -175.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 96.0 m -96.8 112.5 24.23 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mp -99.62 101.83 13.14 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 124.131 0.973 . . . . 0.0 109.771 -171.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.4 t -101.15 112.82 25.4 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.591 -0.693 . . . . 0.0 109.965 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -96.25 78.57 3.09 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 152.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.78 -116.33 9.12 Favored Glycine 0 CA--C 1.549 2.204 0 N-CA-C 114.778 0.671 . . . . 0.0 114.778 -168.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -73.31 -19.56 61.01 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 117.02 2.229 . . . . 0.0 117.02 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.2 t -84.75 105.48 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-N 121.143 1.792 . . . . 0.0 108.519 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 59.4 t -115.67 110.69 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -171.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -99.46 159.21 15.19 Favored 'General case' 0 CA--C 1.562 1.405 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 167.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.1 t -132.17 111.42 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.067 -1.02 . . . . 0.0 109.059 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 56.9 mtm180 -102.17 121.26 41.88 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.75 0.786 . . . . 0.0 111.595 174.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -101.58 111.1 23.23 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.289 0.635 . . . . 0.0 110.525 -171.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -107.48 130.09 54.88 Favored 'General case' 0 CA--C 1.565 1.547 0 O-C-N 121.143 -0.973 . . . . 0.0 112.612 -170.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -97.53 152.74 18.71 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 169.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -75.46 127.94 34.22 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.605 -0.684 . . . . 0.0 112.014 172.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.047 -0.978 . . . . 0.0 112.788 -178.258 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 96.0 t . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 121.504 0.668 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -97.47 -58.74 1.93 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.086 -1.008 . . . . 0.0 113.11 -175.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.17 -22.21 38.78 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 171.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -82.85 -19.91 36.61 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 168.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 44.4 t -73.33 96.46 2.32 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-N 122.663 2.483 . . . . 0.0 113.569 -172.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -174.84 171.04 3.22 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 124.719 1.208 . . . . 0.0 111.466 -168.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 94.3 m -84.1 141.67 30.94 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.802 -1.186 . . . . 0.0 110.021 162.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -133.59 120.66 21.01 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.722 -1.236 . . . . 0.0 110.847 -170.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -108.2 117.91 35.38 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.779 0.832 . . . . 0.0 109.8 -168.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 tt -70.54 115.86 10.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.397 -0.814 . . . . 0.0 112.851 -173.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.8 p -90.22 -49.35 6.6 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -140.88 129.43 22.67 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.936 0.895 . . . . 0.0 109.684 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.8 p -106.33 93.73 4.77 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.077 0.551 . . . . 0.0 110.587 170.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -72.05 124.85 25.84 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.713 0.805 . . . . 0.0 112.026 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 4.9 t-20 52.19 27.99 5.14 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 118.72 2.859 . . . . 0.0 118.72 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -70.46 -44.05 68.57 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -174.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -49.27 -48.57 45.86 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 117.11 2.263 . . . . 0.0 117.11 168.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -59.66 -50.11 75.14 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 170.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -49.28 -49.36 43.95 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 164.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.1 mtp -60.17 -46.25 90.33 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 175.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -55.39 -46.71 76.53 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 167.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.67 -37.34 86.99 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 117.063 2.245 . . . . 0.0 117.063 170.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.4 tp -67.42 -21.69 65.56 Favored 'General case' 0 CA--C 1.573 1.862 0 N-CA-C 116.826 2.158 . . . . 0.0 116.826 175.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.24 70.36 1.25 Allowed Glycine 0 N--CA 1.482 1.741 0 CA-C-N 119.026 0.83 . . . . 0.0 113.349 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.2 m -97.1 141.68 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 172.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.03 48.35 4.04 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 117.849 1.9 . . . . 0.0 117.849 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . 0.336 16.6 t80 60.58 -56.69 0.08 Allowed 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 177.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.12 -44.06 64.28 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 173.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.4 m -66.67 -35.21 79.6 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.268 9.7 ptm180 -66.14 -40.85 90.94 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 121.858 2.117 . . . . 0.0 116.301 164.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -60.11 -42.89 95.7 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 169.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.0 t -65.72 -60.75 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-N 119.237 0.926 . . . . 0.0 112.692 166.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.19 -26.24 58.44 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 121.138 3.215 . . . . 0.0 121.138 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -73.68 -38.79 64.8 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 119.527 1.664 . . . . 0.0 115.166 166.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.0 m -77.11 -34.74 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 172.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.0 t -90.65 127.5 36.31 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 120.28 1.4 . . . . 0.0 112.801 -174.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.93 94.88 4.05 Favored Pre-proline 0 CA--C 1.575 1.934 0 CA-C-O 118.119 -0.943 . . . . 0.0 108.881 173.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.66 144.94 56.18 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.52 2.147 . . . . 0.0 116.022 -174.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.2 m -86.86 111.42 20.76 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 114.766 -1.107 . . . . 0.0 109.335 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.3 t -95.65 104.9 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -175.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.9 mt -94.85 104.09 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 80.1 mt -91.21 114.97 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 85.9 p -128.25 128.01 43.89 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 122.869 0.467 . . . . 0.0 111.881 -174.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -85.79 125.19 33.06 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.896 -1.128 . . . . 0.0 109.371 168.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -133.34 90.25 2.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.796 -1.19 . . . . 0.0 110.792 -166.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.76 -68.93 3.13 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 115.783 1.073 . . . . 0.0 115.783 176.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -131.02 -46.94 1.01 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.83 0.852 . . . . 0.0 112.101 168.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -88.31 161.56 17.08 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -173.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.8 t -94.9 124.89 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.1 t -120.12 105.91 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -172.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 61.0 mt -103.62 121.91 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -103.57 113.89 27.75 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 122.709 0.404 . . . . 0.0 111.309 173.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.0 m -94.61 103.4 15.34 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 123.366 0.666 . . . . 0.0 109.351 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.9 mt -112.03 101.45 9.74 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.599 0.714 . . . . 0.0 111.445 -167.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.5 t -87.44 156.0 19.76 Favored 'General case' 0 CA--C 1.563 1.459 0 O-C-N 121.846 -0.534 . . . . 0.0 111.874 162.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.0 t -67.73 34.35 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 157.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -150.63 -61.89 0.19 Allowed 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 125.364 1.465 . . . . 0.0 108.774 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -122.44 122.75 39.71 Favored 'General case' 0 CA--C 1.568 1.636 0 C-N-CA 123.949 0.9 . . . . 0.0 110.239 -177.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -84.48 115.6 22.66 Favored 'General case' 0 CA--C 1.567 1.628 0 C-N-CA 123.422 0.689 . . . . 0.0 110.222 167.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -131.97 144.91 51.15 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.985 0.898 . . . . 0.0 111.198 172.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.57 149.84 30.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.992 -1.068 . . . . 0.0 113.421 -175.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.4 pt -125.67 130.97 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 C-N-CA 124.051 0.94 . . . . 0.0 110.259 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.9 p -122.25 114.57 21.0 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.658 0.783 . . . . 0.0 109.773 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -145.6 143.6 29.97 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -166.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -98.76 22.37 10.15 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 174.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 70.4 mt 68.82 110.7 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 125.17 1.388 . . . . 0.0 113.568 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.82 -7.22 56.01 Favored Glycine 0 CA--C 1.557 2.71 0 N-CA-C 119.255 2.462 . . . . 0.0 119.255 -167.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -82.85 125.95 31.9 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-N 119.201 1.501 . . . . 0.0 110.77 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -80.91 126.08 30.92 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -137.19 137.07 38.76 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 123.514 0.726 . . . . 0.0 110.761 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.67 130.2 38.35 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.501 -1.375 . . . . 0.0 111.431 173.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -130.55 106.46 8.53 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 122.725 0.41 . . . . 0.0 111.124 -171.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 54.5 m -68.94 106.91 2.9 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.324 1.059 . . . . 0.0 110.908 176.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 67.7 p -78.88 173.24 12.73 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.478 -173.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.73 3.37 0.15 Allowed 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 119.169 3.026 . . . . 0.0 119.169 168.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -109.37 -0.29 19.09 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 159.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.347 4.7 m-20 88.82 -5.59 0.46 Allowed 'General case' 0 N--CA 1.508 2.453 0 N-CA-C 116.748 2.129 . . . . 0.0 116.748 -173.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.94 122.36 24.75 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 120.621 1.555 . . . . 0.0 110.622 176.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.281 5.1 p30 -90.94 97.44 11.18 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.392 0.615 . . . . 0.0 111.458 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 82.5 m -93.73 131.55 38.96 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-O 121.486 0.66 . . . . 0.0 112.673 -168.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -69.9 102.24 1.93 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.579 1.151 . . . . 0.0 109.698 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 71.2 m -110.74 123.31 49.8 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.611 -157.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.1 t -122.98 113.33 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.8 t -99.32 116.91 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.153 -0.967 . . . . 0.0 109.937 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.1 t -112.49 131.61 55.49 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.279 0.632 . . . . 0.0 112.332 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 tt -91.61 100.48 13.21 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.419 0.688 . . . . 0.0 110.383 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -93.76 84.21 4.56 Favored 'General case' 0 CA--C 1.567 1.601 0 O-C-N 121.35 -0.843 . . . . 0.0 110.111 175.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.73 -82.34 0.96 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 115.411 0.924 . . . . 0.0 115.411 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -138.89 53.8 1.75 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.56 0.695 . . . . 0.0 112.293 161.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -142.37 121.25 12.75 Favored 'General case' 0 CA--C 1.561 1.388 0 O-C-N 121.299 -0.875 . . . . 0.0 110.468 168.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.5 mt -89.46 106.9 18.76 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.424 0.63 . . . . 0.0 110.112 176.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 52.4 t -96.72 100.33 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -85.57 101.22 12.5 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.458 0.703 . . . . 0.0 110.21 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 56.5 mt -90.78 110.53 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -175.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -102.84 118.34 36.6 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 119.077 0.853 . . . . 0.0 110.766 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -109.17 129.94 55.49 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 124.191 0.996 . . . . 0.0 111.216 -177.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.6 p90 -152.09 123.16 7.6 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.556 -1.34 . . . . 0.0 110.611 177.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 54.48 37.04 27.06 Favored 'General case' 0 N--CA 1.507 2.391 0 N-CA-C 117.306 2.335 . . . . 0.0 117.306 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.26 -26.57 4.39 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 118.757 2.263 . . . . 0.0 118.757 -164.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -82.24 142.99 31.66 Favored 'General case' 0 CA--C 1.565 1.52 0 CA-C-N 119.11 1.455 . . . . 0.0 112.158 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -138.71 129.44 26.33 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.229 0.538 . . . . 0.0 111.547 -176.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.1 t -114.8 150.95 34.64 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.266 0.627 . . . . 0.0 109.754 162.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.293 11.1 p30 -127.32 135.84 51.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.015 -1.053 . . . . 0.0 112.582 166.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -105.09 100.85 10.43 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -176.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.1 t -85.21 98.03 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -174.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.9 ttm-85 -91.08 106.66 18.68 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.434 0.694 . . . . 0.0 109.909 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -123.9 141.11 52.33 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 119.235 0.925 . . . . 0.0 112.555 -175.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.5 mm -79.2 119.66 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.057 -1.027 . . . . 0.0 109.317 172.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -137.15 113.25 9.81 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.034 0.534 . . . . 0.0 109.617 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.6 t70 45.39 55.91 6.11 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.5 -36.78 3.07 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 118.314 2.086 . . . . 0.0 118.314 -169.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -82.94 152.94 25.29 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 119.02 1.41 . . . . 0.0 114.011 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.3 tmm? -91.65 109.0 20.3 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.848 158.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 82.5 t -94.79 106.27 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 38.0 ttm -89.41 106.67 18.6 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 173.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 85.1 m -95.98 110.64 22.82 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mp -98.61 102.94 14.83 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.981 0.912 . . . . 0.0 109.164 -170.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.1 t -108.92 112.97 25.48 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.332 0.587 . . . . 0.0 111.205 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -98.18 80.13 2.65 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 164.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 64.29 -100.84 0.44 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 114.891 0.716 . . . . 0.0 114.891 -172.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -85.7 -23.56 27.33 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 171.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.6 t -89.48 113.77 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-N 120.907 1.685 . . . . 0.0 109.242 -173.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.7 t -117.43 118.37 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 123.271 0.628 . . . . 0.0 109.59 -170.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -104.22 161.14 14.29 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 163.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.9 t -133.26 112.59 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 120.785 -1.197 . . . . 0.0 109.827 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -99.6 116.34 31.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.026 -1.046 . . . . 0.0 110.305 174.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -102.84 108.49 19.72 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.434 0.694 . . . . 0.0 111.06 -167.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -107.9 127.2 53.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.907 -1.121 . . . . 0.0 112.025 -170.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -90.15 153.53 20.46 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 171.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -88.12 137.41 32.35 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -166.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.257 0 CA-C-O 117.444 -1.265 . . . . 0.0 111.646 176.509 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.285 6.2 p . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -61.82 -37.13 83.29 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -176.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.68 -26.19 63.59 Favored 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 117.938 2.57 . . . . 0.0 117.938 167.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -81.19 -17.0 51.19 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 165.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.7 t -77.37 90.09 3.79 Favored 'General case' 0 CA--C 1.569 1.674 0 CA-C-N 122.105 2.229 . . . . 0.0 113.365 -173.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -166.27 172.55 10.99 Favored 'General case' 0 CA--C 1.572 1.796 0 C-N-CA 124.509 1.123 . . . . 0.0 111.736 -173.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 m -85.51 130.4 34.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.944 -1.098 . . . . 0.0 109.677 164.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -124.44 116.36 22.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.647 -0.658 . . . . 0.0 111.327 -170.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -101.95 127.25 48.88 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.468 0.707 . . . . 0.0 110.93 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.7 119.78 15.35 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -176.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.3 p -92.32 -47.4 7.21 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 176.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -140.16 110.81 6.78 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.876 0.87 . . . . 0.0 109.08 -174.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.1 p -94.03 80.24 4.09 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.905 1.336 . . . . 0.0 111.807 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -85.77 108.38 18.06 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.186 -0.946 . . . . 0.0 111.104 -161.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.29 1.8 t30 69.27 28.7 4.78 Favored 'General case' 0 CA--C 1.584 2.261 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -168.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -73.07 -41.0 64.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 119.709 -1.87 . . . . 0.0 115.897 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -48.86 -53.72 18.25 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 171.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.45 -43.57 98.5 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 173.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -54.75 -47.39 73.91 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 166.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 71.2 mtm -60.19 -37.62 80.79 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 172.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -62.41 -50.28 72.14 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 161.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.07 -44.16 91.83 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 176.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.3 tp -75.35 -14.07 60.45 Favored 'General case' 0 CA--C 1.58 2.124 0 N-CA-C 116.28 1.956 . . . . 0.0 116.28 169.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.01 32.12 15.4 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 119.511 2.564 . . . . 0.0 119.511 172.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.5 m -79.64 69.24 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 CA-C-N 120.806 2.303 . . . . 0.0 113.54 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 58.85 -160.96 13.7 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -96.36 -51.27 4.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 122.027 -0.69 . . . . 0.0 111.864 148.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.61 -39.37 84.02 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 33.7 m -68.94 -33.33 73.55 Favored 'General case' 0 CA--C 1.577 1.985 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 171.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -57.06 -49.99 74.14 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-N 121.235 1.834 . . . . 0.0 115.085 159.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -54.24 -51.37 64.7 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 171.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.7 t -51.32 -60.92 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 C-N-CA 124.488 1.115 . . . . 0.0 113.991 166.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.83 -29.06 54.17 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 119.78 2.672 . . . . 0.0 119.78 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -74.61 -47.29 33.1 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 167.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 m -75.88 -34.05 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.5 t -91.99 144.19 25.71 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 120.229 1.377 . . . . 0.0 113.648 -170.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -92.87 112.9 58.01 Favored Pre-proline 0 CA--C 1.574 1.867 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.402 170.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.16 123.28 9.1 Favored 'Trans proline' 0 CA--C 1.561 1.84 0 CA-C-N 122.878 2.064 . . . . 0.0 113.425 170.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 91.0 m -92.61 97.43 10.8 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 172.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.9 t -93.56 101.17 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -168.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.6 mt -88.91 104.08 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 177.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -90.2 114.41 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 172.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.7 p -136.52 129.91 31.69 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 122.728 0.411 . . . . 0.0 111.573 -170.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -87.21 95.05 9.84 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.159 -0.963 . . . . 0.0 110.39 174.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -101.19 76.18 1.7 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.414 0.626 . . . . 0.0 110.698 -171.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.4 80.72 0.33 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 115.107 0.803 . . . . 0.0 115.107 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.326 34.4 t70 72.0 -56.24 0.65 Allowed 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -175.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -76.26 146.2 39.15 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -177.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.1 t -88.56 125.26 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 173.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.3 t -112.56 111.9 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.501 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.1 mt -90.63 115.56 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -108.46 95.64 5.8 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.5 m -84.9 91.7 8.1 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.399 0.619 . . . . 0.0 109.353 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.9 mt -103.65 95.8 6.29 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -172.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 p -111.03 27.27 9.85 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 -173.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.404 8.5 t 47.27 18.61 0.1 Allowed 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 119.891 3.293 . . . . 0.0 119.891 -164.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -155.39 -61.87 0.11 Allowed 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.724 1.21 . . . . 0.0 109.667 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -70.9 -61.49 1.74 Allowed 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.05 0.94 . . . . 0.0 113.439 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 59.62 63.77 1.45 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.4 t -118.88 122.72 42.96 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.268 0.627 . . . . 0.0 111.503 -170.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -109.15 112.93 25.36 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.526 0.731 . . . . 0.0 111.96 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 pt -112.53 114.75 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 C-N-CA 123.476 0.711 . . . . 0.0 110.84 -174.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 92.9 p -105.86 118.65 37.14 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.112 0.965 . . . . 0.0 112.648 -174.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -149.3 156.35 41.95 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.769 0.795 . . . . 0.0 112.206 -169.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -92.59 150.97 20.39 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.125 0.964 . . . . 0.0 110.876 161.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 41.1 mt -67.83 127.35 32.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.099 -1.001 . . . . 0.0 113.481 -176.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.13 -6.36 71.9 Favored Glycine 0 CA--C 1.556 2.605 0 N-CA-C 118.969 2.348 . . . . 0.0 118.969 -164.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.22 127.11 34.69 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 120.332 2.066 . . . . 0.0 110.953 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -78.88 124.78 28.57 Favored 'General case' 0 CA--C 1.569 1.708 0 CA-C-O 121.477 0.656 . . . . 0.0 111.609 171.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -131.01 145.14 51.95 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.947 0.899 . . . . 0.0 110.698 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -73.88 134.28 43.23 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.242 -1.536 . . . . 0.0 111.961 170.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -133.62 124.54 27.01 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.248 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.1 m -70.16 128.46 36.36 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-O 122.835 1.302 . . . . 0.0 110.361 158.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 80.7 p -97.88 170.36 9.01 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 122.042 0.925 . . . . 0.0 112.491 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.54 -23.9 4.66 Favored 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 119.205 3.039 . . . . 0.0 119.205 168.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -76.49 -15.77 59.81 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 166.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.321 34.9 m-20 66.66 33.97 6.1 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -156.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.73 133.63 46.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.027 -1.046 . . . . 0.0 108.668 162.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -94.01 112.61 24.47 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.002 0.521 . . . . 0.0 110.595 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.2 m -110.48 141.37 43.69 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.456 0.702 . . . . 0.0 112.626 -173.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -73.76 109.79 7.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.523 -0.736 . . . . 0.0 110.356 166.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.2 m -109.26 125.98 52.85 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.921 0.888 . . . . 0.0 111.315 -169.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 p -126.05 126.0 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-O 121.213 0.53 . . . . 0.0 109.916 174.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.0 t -114.17 116.08 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -176.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.5 p -129.86 148.11 51.7 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 20.1 mt -86.02 117.39 24.83 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.499 0.666 . . . . 0.0 112.626 174.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -106.31 62.69 0.65 Allowed 'General case' 0 CA--C 1.574 1.869 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.901 174.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.51 66.61 1.97 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 115.786 1.074 . . . . 0.0 115.786 -174.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.266 18.3 t70 50.77 49.84 20.19 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 115.718 1.748 . . . . 0.0 115.718 -163.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -147.15 103.44 3.59 Favored 'General case' 0 CA--C 1.558 1.255 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -174.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.454 HD13 HH21 ' A' ' 106' ' ' ARG . 53.1 mt -84.18 105.79 15.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.659 -0.651 . . . . 0.0 110.969 -177.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.15 103.33 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -174.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -90.16 106.43 18.48 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.341 0.656 . . . . 0.0 110.36 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.1 mt -99.29 108.7 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -173.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -98.07 120.75 39.03 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 119.19 0.905 . . . . 0.0 110.088 176.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -117.75 121.27 40.37 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.666 0.787 . . . . 0.0 110.528 -174.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -149.12 133.1 17.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.319 -0.863 . . . . 0.0 110.368 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 59.79 24.82 13.8 Favored 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 118.598 2.814 . . . . 0.0 118.598 166.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.73 10.02 85.66 Favored Glycine 0 CA--C 1.558 2.763 0 N-CA-C 119.201 2.441 . . . . 0.0 119.201 -162.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -120.62 142.11 49.71 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-N 119.393 1.597 . . . . 0.0 110.199 -176.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -132.31 130.04 40.31 Favored 'General case' 0 CA--C 1.562 1.432 0 O-C-N 121.738 -0.601 . . . . 0.0 111.024 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.0 t -120.53 133.98 55.33 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 123.072 0.549 . . . . 0.0 109.715 163.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -116.46 134.44 54.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.773 -0.579 . . . . 0.0 112.167 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -107.59 97.82 7.5 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -174.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 78.2 t -85.85 99.92 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -172.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.454 HH21 HD13 ' A' ' 91' ' ' LEU . 31.3 ttp180 -101.78 113.9 27.49 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.084 0.554 . . . . 0.0 110.992 -172.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -127.27 143.84 51.16 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.1 mm -86.01 109.09 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.146 -0.971 . . . . 0.0 109.403 175.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.01 89.91 3.29 Favored 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 123.758 0.823 . . . . 0.0 109.29 176.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.9 t70 51.53 57.68 6.31 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 94.82 -38.29 3.17 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 117.942 1.937 . . . . 0.0 117.942 -170.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.9 mtmm -92.7 140.44 29.53 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 119.526 1.663 . . . . 0.0 113.35 -176.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 57.9 ttp -90.46 108.39 19.76 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 121.978 0.894 . . . . 0.0 109.984 175.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.1 t -94.54 107.01 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 23.2 ttt -101.98 106.51 17.45 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.048 0.539 . . . . 0.0 110.542 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.5 m -99.02 99.07 10.05 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.657 0.783 . . . . 0.0 109.37 -174.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.9 mp -90.67 108.22 19.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.873 0.869 . . . . 0.0 110.12 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.0 t -108.26 135.11 50.14 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.571 0.7 . . . . 0.0 112.35 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -127.13 98.43 5.3 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.392 0.677 . . . . 0.0 109.176 166.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 73.68 -91.67 0.68 Allowed Glycine 0 N--CA 1.49 2.249 0 O-C-N 121.861 -0.524 . . . . 0.0 113.901 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -124.25 11.62 8.78 Favored 'General case' 0 CA--C 1.578 2.051 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 160.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 36.2 t -92.02 107.77 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-N 121.56 1.982 . . . . 0.0 107.825 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.5 t -112.57 115.76 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 123.259 0.624 . . . . 0.0 109.568 -169.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -104.17 123.44 47.31 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.597 -0.689 . . . . 0.0 112.604 169.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.7 t -105.32 104.66 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -93.56 115.72 28.22 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.636 0.732 . . . . 0.0 110.765 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -99.12 109.79 22.45 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.208 0.603 . . . . 0.0 110.4 -171.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -108.73 128.48 54.91 Favored 'General case' 0 CA--C 1.565 1.525 0 O-C-N 121.188 -0.945 . . . . 0.0 111.937 -170.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -95.52 153.55 17.65 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.656 0.741 . . . . 0.0 112.337 167.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -72.08 134.78 46.0 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.49 0 C-N-CA 123.328 0.651 . . . . 0.0 111.17 159.842 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.497 1.891 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.95 -52.41 36.36 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -166.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.55 -24.3 63.59 Favored 'General case' 0 CA--C 1.574 1.87 0 N-CA-C 117.904 2.557 . . . . 0.0 117.904 167.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -85.97 -13.24 48.23 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 172.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.7 t -79.43 96.62 6.1 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 121.157 1.799 . . . . 0.0 112.667 -170.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -169.41 163.65 10.55 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.133 0.968 . . . . 0.0 112.492 -166.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.4 m -81.08 119.0 22.99 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.355 -0.84 . . . . 0.0 109.363 163.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -111.48 107.43 16.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.498 -0.751 . . . . 0.0 111.264 -172.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -91.7 129.74 37.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.511 -0.743 . . . . 0.0 111.272 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -68.85 133.63 48.54 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-O 122.524 1.154 . . . . 0.0 113.904 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.1 p -110.29 -34.73 6.27 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -156.9 112.46 2.89 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 119.69 1.132 . . . . 0.0 108.45 -172.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.9 p -104.05 91.0 3.77 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.916 0.865 . . . . 0.0 111.577 175.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -80.26 125.8 30.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 111.869 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.252 1.7 t30 61.92 21.32 12.21 Favored 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 117.565 2.432 . . . . 0.0 117.565 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -72.93 -34.5 66.63 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -175.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -55.04 -56.12 23.34 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 165.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.45 -31.86 71.83 Favored 'General case' 0 CA--C 1.566 1.574 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 173.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -61.65 -51.36 68.77 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 162.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.4 mtt -58.62 -44.5 89.99 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 116.797 2.147 . . . . 0.0 116.797 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -40.48 95.06 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 116.858 2.169 . . . . 0.0 116.858 164.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.72 -46.44 88.1 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 168.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.8 tp -61.66 -27.97 69.06 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.27 49.94 2.51 Favored Glycine 0 N--CA 1.483 1.794 0 N-CA-C 115.866 1.106 . . . . 0.0 115.866 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.2 m -107.52 140.08 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-N 118.944 1.372 . . . . 0.0 110.341 165.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.65 -168.63 9.84 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 116.814 1.486 . . . . 0.0 116.814 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -80.74 61.91 4.58 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.533 1.159 . . . . 0.0 112.709 177.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -148.05 -69.49 0.23 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.111 0.964 . . . . 0.0 109.16 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.2 m -58.7 -35.63 72.94 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 170.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -61.79 -32.96 73.28 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 165.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -83.51 14.72 3.52 Favored 'General case' 0 CA--C 1.58 2.105 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 164.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.3 t -118.58 -61.85 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 C-N-CA 125.419 1.488 . . . . 0.0 108.614 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.21 -23.54 68.16 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 119.668 2.627 . . . . 0.0 119.668 -177.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -88.74 -37.26 15.62 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 174.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.4 m -80.34 -33.21 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.4 t -107.91 177.16 4.9 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 119.709 1.141 . . . . 0.0 112.669 -178.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -97.69 99.67 7.02 Favored Pre-proline 0 CA--C 1.573 1.849 0 CA-C-O 118.042 -0.98 . . . . 0.0 111.003 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.92 127.24 15.77 Favored 'Trans proline' 0 CA--C 1.564 2.022 0 CA-C-N 122.903 2.072 . . . . 0.0 113.965 175.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 96.0 m -110.45 102.86 11.44 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.004 -172.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.3 t -102.82 101.32 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.553 -0.717 . . . . 0.0 109.141 -164.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.9 mt -87.47 103.35 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.242 -0.911 . . . . 0.0 108.812 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.6 mt -88.04 111.81 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.8 p -136.15 117.96 15.12 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.671 0.389 . . . . 0.0 111.853 -169.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -83.38 116.46 22.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.099 -1.001 . . . . 0.0 111.432 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -116.62 96.23 5.41 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.269 0.557 . . . . 0.0 109.639 -172.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.48 -75.75 2.32 Favored Glycine 0 N--CA 1.492 2.371 0 O-C-N 121.694 -0.629 . . . . 0.0 114.265 -172.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -133.43 -52.14 0.88 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 169.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -62.69 154.34 29.69 Favored 'General case' 0 CA--C 1.561 1.383 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.6 t -94.06 109.73 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.53 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.367 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.5 t -93.88 101.4 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 176.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.2 mt -95.05 116.61 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -101.64 99.74 10.06 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.157 0.583 . . . . 0.0 110.102 175.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.2 m -86.35 96.15 9.89 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.757 0.789 . . . . 0.0 109.4 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 71.3 mt -102.31 86.54 2.84 Favored 'General case' 0 CA--C 1.559 1.318 0 CA-C-O 121.856 0.836 . . . . 0.0 110.329 -170.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.2 t -79.38 144.64 33.96 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.56 -0.713 . . . . 0.0 110.326 159.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.4 p -70.09 33.62 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.463 0 N-CA-C 116.823 2.156 . . . . 0.0 116.823 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -155.89 -57.39 0.09 Allowed 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 126.194 1.797 . . . . 0.0 108.189 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -107.75 100.57 9.94 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 123.978 0.911 . . . . 0.0 109.394 177.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -96.77 88.18 4.52 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.53 -0.731 . . . . 0.0 110.314 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.8 t -105.22 139.55 39.7 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 123.475 0.71 . . . . 0.0 112.444 -171.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -134.68 145.74 48.83 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.8 pt -134.15 129.5 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 C-N-CA 123.771 0.828 . . . . 0.0 110.347 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.0 m -118.37 117.79 30.03 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.843 -0.536 . . . . 0.0 110.371 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -150.65 152.54 34.14 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.675 0.75 . . . . 0.0 112.3 -165.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -94.73 151.02 19.61 Favored 'General case' 0 CA--C 1.573 1.831 0 O-C-N 120.972 -1.08 . . . . 0.0 110.888 169.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.6 mt -67.55 123.39 20.3 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.26 -1.525 . . . . 0.0 112.872 -177.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.06 -20.02 23.07 Favored Glycine 0 CA--C 1.555 2.555 0 N-CA-C 118.678 2.231 . . . . 0.0 118.678 -166.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -79.64 126.64 31.17 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-N 119.387 1.594 . . . . 0.0 111.653 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -81.14 144.24 31.82 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-O 121.563 0.696 . . . . 0.0 112.423 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -142.38 141.26 32.27 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.107 0.963 . . . . 0.0 110.459 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -78.95 129.04 34.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.525 -1.359 . . . . 0.0 111.19 171.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -125.34 103.25 7.82 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.852 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.4 m -79.7 103.28 9.49 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 170.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 71.4 p -78.15 167.88 20.73 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -168.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.98 -11.85 0.72 Allowed 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 120.236 3.421 . . . . 0.0 120.236 170.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -122.22 35.84 4.78 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 120.892 1.678 . . . . 0.0 114.555 160.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.269 31.0 m-20 63.07 54.63 2.09 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 116.543 2.053 . . . . 0.0 116.543 168.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -120.38 128.4 53.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.528 -0.732 . . . . 0.0 109.207 159.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -90.26 90.56 8.13 Favored 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 123.535 0.734 . . . . 0.0 111.189 173.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.5 p -96.85 134.72 39.8 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -173.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.68 94.17 2.66 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-O 122.524 1.154 . . . . 0.0 109.284 172.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.1 m -100.94 119.34 38.56 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.676 -165.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.1 p -121.7 125.36 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 123.182 0.593 . . . . 0.0 109.707 175.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.3 t -109.23 118.38 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -175.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.9 p -118.75 133.86 55.55 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.668 0.787 . . . . 0.0 112.055 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 tt -89.66 98.16 11.61 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 109.933 175.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -94.11 81.07 4.07 Favored 'General case' 0 CA--C 1.567 1.62 0 O-C-N 121.512 -0.743 . . . . 0.0 110.796 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.88 -90.79 0.5 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 115.563 0.985 . . . . 0.0 115.563 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -99.13 4.57 46.93 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.435 2.013 . . . . 0.0 116.435 166.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -121.85 119.88 32.91 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 120.452 1.478 . . . . 0.0 111.086 -162.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.2 mt -82.97 100.47 10.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.92 -1.112 . . . . 0.0 110.222 167.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 41.0 t -101.13 101.45 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -170.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.34 107.24 19.02 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.506 0.722 . . . . 0.0 110.791 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 53.9 mt -100.14 103.28 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -173.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -94.66 123.1 37.9 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 118.7 0.682 . . . . 0.0 110.839 176.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -116.39 121.15 41.05 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 123.44 0.696 . . . . 0.0 111.943 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.3 p90 -150.65 128.89 11.97 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.53 -1.357 . . . . 0.0 110.969 -177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 50.52 48.09 23.08 Favored 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 166.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.86 16.23 72.23 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 119.995 2.758 . . . . 0.0 119.995 -168.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -133.59 140.46 47.15 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 119.531 1.666 . . . . 0.0 109.858 -170.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -134.65 130.49 36.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.669 -0.644 . . . . 0.0 111.543 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.8 t -119.4 123.5 44.26 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.358 0.663 . . . . 0.0 109.368 167.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -107.52 122.01 45.79 Favored 'General case' 0 CA--C 1.563 1.475 0 C-N-CA 123.26 0.624 . . . . 0.0 110.605 172.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -103.62 108.38 19.63 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -175.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 82.4 t -93.44 104.08 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -169.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -110.34 99.15 8.23 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.03 0.532 . . . . 0.0 110.314 -166.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.12 149.97 43.83 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -171.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.4 mm -82.18 111.38 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.872 -0.517 . . . . 0.0 110.01 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -105.19 86.98 2.52 Favored 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 171.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.9 t70 48.23 60.19 3.78 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 95.65 -37.86 3.29 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 117.95 1.94 . . . . 0.0 117.95 -171.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -88.02 140.96 28.96 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 119.659 1.73 . . . . 0.0 112.979 -177.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 34.1 ttm -84.83 112.41 20.51 Favored 'General case' 0 CA--C 1.564 1.503 0 O-C-N 121.266 -0.897 . . . . 0.0 109.297 165.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.8 t -89.64 104.36 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 169.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 28.1 ttt -90.95 101.38 14.15 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.998 0.519 . . . . 0.0 109.777 172.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.6 m -92.05 111.06 22.46 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 175.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.9 mp -95.93 121.21 37.43 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.4 t -126.12 122.64 36.32 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-N 120.31 1.414 . . . . 0.0 112.357 174.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -114.38 80.68 1.43 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.824 0.85 . . . . 0.0 108.786 174.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 66.97 -98.55 0.43 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 115.062 0.785 . . . . 0.0 115.062 -174.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -83.98 -30.85 25.89 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 171.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.5 t -89.38 119.86 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 119.715 1.143 . . . . 0.0 109.443 -169.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.5 t -115.97 124.94 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -175.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -117.58 156.22 28.47 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.483 0.713 . . . . 0.0 112.742 167.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.3 t -134.01 112.44 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.318 -0.863 . . . . 0.0 109.074 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -99.63 122.5 42.75 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.52 0.676 . . . . 0.0 111.769 172.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -104.46 114.36 28.54 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.322 0.649 . . . . 0.0 110.663 -172.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -114.97 131.39 56.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.437 -0.79 . . . . 0.0 112.11 -169.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -101.51 152.3 20.93 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 123.452 0.701 . . . . 0.0 112.405 169.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -74.1 131.83 41.69 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.296 -0.877 . . . . 0.0 112.815 175.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.518 0 C-N-CA 124.188 0.995 . . . . 0.0 111.995 175.205 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.268 35.0 m . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.669 0.747 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -74.61 -51.73 13.69 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -172.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.94 -27.09 40.79 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 117.592 2.442 . . . . 0.0 117.592 166.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -85.7 -6.68 59.1 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 171.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 52.8 t -80.56 93.22 6.04 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-N 121.876 2.125 . . . . 0.0 113.85 -172.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.69 172.32 9.37 Favored 'General case' 0 CA--C 1.571 1.787 0 CA-C-O 122.425 1.107 . . . . 0.0 112.435 -177.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.0 m -89.87 116.72 28.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.175 -0.953 . . . . 0.0 108.998 165.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -114.76 108.52 16.88 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 122.956 0.502 . . . . 0.0 110.38 -169.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -95.45 136.55 35.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.05 -1.031 . . . . 0.0 111.651 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.96 130.61 43.71 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.666 0.988 . . . . 0.0 113.666 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 45.8 p -116.34 -24.83 7.75 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -157.22 121.66 4.37 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 120.574 1.534 . . . . 0.0 108.922 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.3 p -113.07 92.82 4.14 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.967 0.889 . . . . 0.0 111.805 178.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -88.34 116.34 26.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.967 -1.083 . . . . 0.0 110.513 -170.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.291 3.8 t-20 68.63 25.86 6.43 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -173.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -72.76 -48.23 40.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 119.994 -1.691 . . . . 0.0 115.392 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -46.97 -50.66 18.67 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.739 2.125 . . . . 0.0 116.739 169.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -58.69 -45.32 89.74 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 171.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -55.73 -48.55 75.01 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 165.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 31.0 mmm -58.56 -49.61 76.82 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -60.3 -42.26 95.15 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 167.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.53 -40.26 95.28 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 172.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.4 tp -61.31 -25.13 66.91 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 168.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.91 56.17 1.33 Allowed Glycine 0 N--CA 1.484 1.893 0 N-CA-C 115.72 1.048 . . . . 0.0 115.72 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.255 4.5 m -100.25 148.03 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-N 118.451 1.126 . . . . 0.0 112.875 175.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.96 170.12 14.86 Favored Glycine 0 CA--C 1.551 2.329 0 N-CA-C 117.357 1.703 . . . . 0.0 117.357 171.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -67.95 -43.35 79.3 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.32 -44.97 94.98 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 164.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.0 m -61.36 -42.63 99.02 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 175.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -63.76 -39.68 94.85 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 116.512 2.041 . . . . 0.0 116.512 167.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.72 -48.81 80.13 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 120.035 1.289 . . . . 0.0 114.337 167.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.5 t -57.22 -60.94 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-N 119.627 1.103 . . . . 0.0 113.445 170.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.74 -27.81 70.61 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 120.115 2.806 . . . . 0.0 120.115 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -73.48 -42.01 62.43 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 167.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.4 m -70.46 -36.88 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.2 t -88.31 138.92 31.01 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 119.815 1.189 . . . . 0.0 113.194 -174.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -85.68 114.41 56.55 Favored Pre-proline 0 CA--C 1.575 1.92 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.665 167.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -69.11 130.35 19.97 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 CA-C-N 123.345 2.23 . . . . 0.0 114.813 176.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 93.4 m -97.12 101.47 13.04 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.8 t -99.71 99.45 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -166.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.6 mt -86.34 105.98 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.9 mt -99.02 115.03 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 174.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.5 t -144.76 159.59 42.61 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 123.539 1.637 . . . . 0.0 112.65 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -98.67 135.29 40.39 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.206 177.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.13 103.62 6.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.619 -0.676 . . . . 0.0 109.987 175.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.28 -78.57 0.96 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 115.977 1.151 . . . . 0.0 115.977 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -127.6 -39.16 1.85 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 170.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -77.12 154.05 33.64 Favored 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.9 t -94.79 129.97 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.64 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.7 t -109.29 119.08 58.03 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.3 mt -102.29 115.44 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 168.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -104.16 96.07 6.4 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.904 0.859 . . . . 0.0 109.888 170.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.6 m -83.25 92.83 7.56 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.52 174.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.3 mt -104.52 101.47 11.13 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.547 0.739 . . . . 0.0 109.438 -170.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.6 p -99.46 26.98 5.57 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 117.16 2.281 . . . . 0.0 117.16 -175.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.492 2.0 t 63.03 -54.07 0.18 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -169.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -82.71 -60.46 2.17 Favored 'General case' 0 CA--C 1.569 1.698 0 C-N-CA 124.025 0.93 . . . . 0.0 111.582 173.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -98.14 103.16 15.08 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -105.84 93.16 4.49 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.677 0.751 . . . . 0.0 110.186 -171.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 39.1 p -100.94 149.09 24.26 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -167.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -145.16 120.95 10.56 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.112 -0.992 . . . . 0.0 112.5 176.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.2 pt -122.97 129.59 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 C-N-CA 123.699 0.8 . . . . 0.0 110.792 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 85.1 p -120.8 116.39 25.12 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.889 0.876 . . . . 0.0 111.641 -175.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -145.77 146.1 31.08 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.91 0.862 . . . . 0.0 113.073 -164.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -101.62 76.32 1.65 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.138 -0.976 . . . . 0.0 110.816 177.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.4 mt 17.81 96.93 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 N-CA-C 120.158 3.392 . . . . 0.0 120.158 174.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.15 -12.73 63.66 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 118.374 2.109 . . . . 0.0 118.374 -166.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -77.62 136.24 38.22 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 119.718 1.759 . . . . 0.0 112.45 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -80.21 115.19 19.63 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.146 171.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -118.99 152.24 36.74 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 122.05 0.929 . . . . 0.0 110.95 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.06 138.08 31.81 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.877 -1.14 . . . . 0.0 111.465 174.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -145.24 124.34 12.86 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.369 0.604 . . . . 0.0 110.53 169.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 84.9 m -77.04 121.42 23.51 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 158.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.5 p -87.43 -179.99 6.47 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -169.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.68 -29.33 38.28 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 118.698 2.851 . . . . 0.0 118.698 165.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -84.66 10.46 11.16 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 163.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.281 3.1 t0 60.95 22.06 12.29 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 -174.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -95.42 129.72 42.48 Favored 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 124.697 1.199 . . . . 0.0 110.168 175.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -84.88 105.09 15.39 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.157 0.983 . . . . 0.0 112.942 -176.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 4.8 p -99.86 127.52 46.03 Favored 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -76.01 104.43 6.54 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 159.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.0 m -111.37 123.6 50.55 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.23 0.612 . . . . 0.0 112.206 -164.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.4 t -110.99 113.03 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 172.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.6 t -95.97 104.74 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 169.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.9 t -109.74 137.0 48.19 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.65 0.738 . . . . 0.0 112.111 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 tt -85.93 103.72 14.91 Favored 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 123.057 0.543 . . . . 0.0 110.474 174.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -96.11 80.66 3.29 Favored 'General case' 0 CA--C 1.567 1.627 0 O-C-N 121.399 -0.813 . . . . 0.0 111.015 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.74 -83.49 1.14 Allowed Glycine 0 N--CA 1.493 2.451 0 O-C-N 121.013 -1.055 . . . . 0.0 114.26 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -137.9 53.89 1.82 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.106 0.479 . . . . 0.0 112.19 162.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -150.57 130.14 13.07 Favored 'General case' 0 CA--C 1.567 1.626 0 O-C-N 120.754 -1.216 . . . . 0.0 111.673 173.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 16.6 mt -93.29 108.22 19.9 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.33 1.052 . . . . 0.0 111.438 -174.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.02 103.6 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.314 -0.866 . . . . 0.0 108.902 -167.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -89.51 94.3 9.82 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 123.321 0.649 . . . . 0.0 112.413 -178.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 61.2 mt -87.26 98.11 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.7 0.8 . . . . 0.0 109.141 -172.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -92.65 117.94 30.51 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 118.984 0.811 . . . . 0.0 109.958 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -117.46 122.57 44.11 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.148 0.579 . . . . 0.0 110.607 -175.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.7 p90 -153.35 126.93 8.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.503 -0.748 . . . . 0.0 110.509 -172.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 48.46 49.97 17.46 Favored 'General case' 0 N--CA 1.507 2.387 0 N-CA-C 117.214 2.301 . . . . 0.0 117.214 169.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.04 7.08 69.96 Favored Glycine 0 CA--C 1.558 2.758 0 N-CA-C 120.332 2.893 . . . . 0.0 120.332 -168.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -123.73 143.62 50.17 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 120.031 1.916 . . . . 0.0 110.901 -169.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -133.02 131.21 40.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.685 -0.635 . . . . 0.0 111.238 -177.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.4 t -130.88 137.44 49.35 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 123.236 0.614 . . . . 0.0 110.296 166.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.276 11.5 p30 -119.41 128.88 54.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.566 -0.709 . . . . 0.0 112.499 175.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 m-30 -99.77 105.32 17.09 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 84.5 t -90.0 97.52 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -174.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.96 108.37 19.53 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.227 1.011 . . . . 0.0 111.495 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -118.29 148.87 42.01 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.6 mm -85.58 99.77 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 170.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.72 93.25 5.47 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.556 0.742 . . . . 0.0 109.55 -178.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.7 t70 51.51 55.89 8.72 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -174.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 85.31 -28.57 4.66 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 119.008 2.363 . . . . 0.0 119.008 -169.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -92.18 145.21 24.68 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 119.883 1.841 . . . . 0.0 112.905 -172.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -85.98 100.77 12.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.174 -0.954 . . . . 0.0 110.42 175.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.8 t -100.49 110.9 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 26.7 ttp -100.13 115.08 28.97 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.19 0.596 . . . . 0.0 110.095 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 96.2 m -103.1 104.96 15.17 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mp -96.66 101.51 13.13 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.444 0.698 . . . . 0.0 109.759 -174.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.7 t -90.09 125.07 35.3 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.449 -0.782 . . . . 0.0 111.757 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -109.5 77.24 1.05 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 156.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 64.78 -112.45 5.02 Favored Glycine 0 CA--C 1.548 2.141 0 N-CA-C 114.485 0.554 . . . . 0.0 114.485 -170.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -78.24 -21.05 50.49 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 172.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.6 t -87.93 111.71 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 120.868 1.667 . . . . 0.0 108.662 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 58.2 t -123.07 114.1 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -168.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -94.22 118.01 30.94 Favored 'General case' 0 CA--C 1.562 1.439 0 O-C-N 121.724 -0.61 . . . . 0.0 112.458 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.4 t -100.82 106.48 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -109.96 117.84 34.85 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 121.427 0.632 . . . . 0.0 111.008 -173.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -91.87 119.97 32.13 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.368 0.604 . . . . 0.0 111.01 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -117.34 133.4 56.03 Favored 'General case' 0 CA--C 1.561 1.404 0 CA-C-O 121.931 0.872 . . . . 0.0 109.51 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -122.95 153.7 39.37 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.671 0.748 . . . . 0.0 110.659 -176.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -68.16 132.29 46.92 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -172.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.231 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.396 172.717 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.254 5.1 p . . . . . 0 CA--C 1.571 1.785 0 CA-C-O 121.828 0.823 . . . . 0.0 112.274 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.338 22.4 tt0 74.46 -53.14 0.68 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -175.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.2 -31.1 41.23 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.638 2.459 . . . . 0.0 117.638 161.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -73.67 -18.51 61.01 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 117.322 2.341 . . . . 0.0 117.322 167.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 44.3 t -75.59 90.94 2.8 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-N 122.331 2.332 . . . . 0.0 114.112 -169.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -168.03 170.47 10.41 Favored 'General case' 0 CA--C 1.569 1.705 0 C-N-CA 124.317 1.047 . . . . 0.0 111.902 -171.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.0 m -78.02 135.23 37.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.819 -1.176 . . . . 0.0 109.162 160.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -120.02 116.7 26.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.775 -1.203 . . . . 0.0 109.682 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -102.2 128.09 48.86 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.662 0.785 . . . . 0.0 110.513 -174.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tt -69.89 117.91 12.07 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.537 -0.727 . . . . 0.0 112.816 -174.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 46.2 p -97.71 -44.7 6.65 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -147.78 118.04 7.34 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 119.513 1.051 . . . . 0.0 110.232 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.7 p -97.38 95.56 7.76 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.212 0.605 . . . . 0.0 111.951 174.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -79.89 117.52 20.83 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 123.526 0.73 . . . . 0.0 111.027 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.6 t30 60.73 23.26 13.16 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -66.37 -39.12 88.91 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -175.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -52.98 -55.67 21.79 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 171.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -66.73 -34.68 78.37 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -53.6 -53.98 44.0 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-N 120.442 1.473 . . . . 0.0 113.695 161.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 79.4 mtm -57.59 -46.53 83.91 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 115.556 1.688 . . . . 0.0 115.556 174.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -57.32 -46.92 82.74 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 168.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.53 -41.73 99.06 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 171.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.1 tp -57.02 -18.84 15.45 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 168.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.03 60.37 1.77 Allowed Glycine 0 N--CA 1.481 1.665 0 O-C-N 121.3 -0.875 . . . . 0.0 114.402 -176.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.6 m -95.05 155.47 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 CA-C-O 121.886 0.85 . . . . 0.0 111.856 167.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.53 164.47 54.12 Favored Glycine 0 CA--C 1.552 2.349 0 O-C-N 121.326 -0.859 . . . . 0.0 114.279 154.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -55.48 -38.22 68.84 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.7 -48.87 66.29 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.0 m -65.23 -41.31 94.51 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 173.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.284 22.7 ptt180 -66.25 -42.26 88.81 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 121.617 2.008 . . . . 0.0 115.644 169.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -59.21 -48.66 80.79 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 171.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.4 t -57.89 -60.66 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 124.334 1.053 . . . . 0.0 113.141 166.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.54 -30.6 50.82 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 120.392 2.917 . . . . 0.0 120.392 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -78.23 -42.4 31.36 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 168.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.251 20.8 m -73.54 -42.47 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 CA-C-N 120.765 1.621 . . . . 0.0 115.125 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.1 t -91.42 148.09 22.56 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 119.46 1.027 . . . . 0.0 111.836 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -99.62 98.42 7.03 Favored Pre-proline 0 CA--C 1.571 1.778 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.493 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.17 117.48 5.07 Favored 'Trans proline' 0 CA--C 1.56 1.798 0 C-N-CA 122.547 2.165 . . . . 0.0 113.729 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.1 m -91.79 125.5 36.53 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.139 0.975 . . . . 0.0 109.323 -176.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.1 t -108.29 100.07 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -165.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.9 mt -90.32 109.38 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.521 -1.362 . . . . 0.0 108.322 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.1 mt -88.95 110.17 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 174.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 82.1 p -124.77 117.46 24.23 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.032 0.533 . . . . 0.0 111.769 -171.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -85.27 122.11 28.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.312 -0.868 . . . . 0.0 111.454 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.23 89.59 2.88 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.488 0.661 . . . . 0.0 110.706 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.64 -106.64 2.46 Favored Glycine 0 N--CA 1.487 2.069 0 O-C-N 121.781 -0.575 . . . . 0.0 113.604 -176.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -95.67 -34.85 11.81 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 171.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -86.01 146.49 26.63 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-O 123.368 1.556 . . . . 0.0 114.491 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 64.4 t -96.22 115.61 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.584 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.7 t -102.05 102.8 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.7 mt -91.36 118.19 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.2 mtt-85 -109.4 107.61 17.84 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.447 0.699 . . . . 0.0 109.345 -173.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.2 m -89.84 100.43 13.24 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.5 mt -115.76 119.41 35.94 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.476 0.71 . . . . 0.0 109.856 -169.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 m -121.08 -177.62 3.55 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 122.116 0.96 . . . . 0.0 111.906 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.3 p -61.73 -30.31 70.69 Favored 'General case' 0 N--CA 1.505 2.317 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 158.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -120.69 -54.04 2.07 Favored 'General case' 0 CA--C 1.572 1.8 0 C-N-CA 124.115 0.966 . . . . 0.0 112.174 -175.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -83.32 138.26 33.62 Favored 'General case' 0 CA--C 1.566 1.58 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -137.3 108.62 6.86 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 171.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.0 t -143.21 140.79 30.88 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.632 -0.667 . . . . 0.0 111.508 173.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -136.74 137.93 40.41 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.0 -1.063 . . . . 0.0 113.263 -174.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.3 pt -123.21 124.79 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 C-N-CA 123.16 0.584 . . . . 0.0 112.261 -169.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.3 p -110.69 106.64 15.94 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 123.607 0.763 . . . . 0.0 112.47 -174.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -134.25 140.28 46.34 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -169.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -101.9 39.05 1.52 Allowed 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.0 mt 60.55 97.58 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 125.031 1.332 . . . . 0.0 114.334 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.91 -0.61 82.46 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 118.902 2.321 . . . . 0.0 118.902 -165.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -70.93 125.05 25.8 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 119.341 1.571 . . . . 0.0 111.825 173.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -91.47 123.54 34.96 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.785 0.434 . . . . 0.0 110.664 169.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -147.16 144.43 28.97 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.336 0.654 . . . . 0.0 111.998 -172.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.66 142.16 44.54 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.416 -1.428 . . . . 0.0 112.586 166.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -149.27 137.05 20.42 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.461 0.648 . . . . 0.0 112.596 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.4 m -82.25 103.47 11.86 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 122.066 0.936 . . . . 0.0 110.206 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.3 p -72.91 174.83 7.22 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.98 -9.36 3.0 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 119.762 3.245 . . . . 0.0 119.762 170.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -110.39 20.33 17.88 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 120.741 1.61 . . . . 0.0 114.518 159.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.273 6.6 m-20 54.68 31.56 15.52 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 117.658 2.466 . . . . 0.0 117.658 -174.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 ptp85 -87.32 128.59 35.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.873 -1.142 . . . . 0.0 108.967 165.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -79.05 92.55 5.01 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.679 0.752 . . . . 0.0 111.558 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 68.7 m -85.99 118.43 25.46 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -171.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -69.72 99.43 1.33 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.148 0.979 . . . . 0.0 109.558 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.7 m -115.54 120.4 39.34 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.595 -155.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.1 p -117.45 116.11 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 123.11 0.564 . . . . 0.0 109.733 176.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.6 t -102.92 112.7 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.432 -0.793 . . . . 0.0 109.372 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 86.0 p -113.45 123.11 49.26 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.63 0.772 . . . . 0.0 111.395 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tt -89.65 98.76 11.95 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 118.992 0.815 . . . . 0.0 111.601 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -97.15 68.7 2.27 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 123.353 0.661 . . . . 0.0 111.955 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 67.09 82.41 0.13 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 116.075 1.19 . . . . 0.0 116.075 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.269 24.2 t0 63.64 0.52 0.89 Allowed 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 117.255 2.317 . . . . 0.0 117.255 -164.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -118.12 99.73 7.07 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 121.119 1.782 . . . . 0.0 110.373 -172.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.8 mt -76.72 99.43 5.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.303 -0.873 . . . . 0.0 110.722 171.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.1 t -99.66 99.41 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 120.866 -1.146 . . . . 0.0 108.265 -172.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -85.49 100.6 12.01 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.297 0.639 . . . . 0.0 110.814 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.2 mt -90.65 105.48 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -176.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -93.61 122.82 36.46 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 118.45 0.568 . . . . 0.0 110.865 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -112.01 132.8 54.57 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.859 0.863 . . . . 0.0 110.5 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -157.5 124.94 5.22 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.675 -1.266 . . . . 0.0 110.362 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 58.2 24.82 11.83 Favored 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 172.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.93 -24.14 17.01 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 118.425 2.13 . . . . 0.0 118.425 -162.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -82.67 144.72 30.06 Favored 'General case' 0 CA--C 1.565 1.548 0 CA-C-N 119.486 1.643 . . . . 0.0 112.247 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -138.9 129.97 26.66 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.19 0.519 . . . . 0.0 111.543 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.4 t -117.88 154.64 31.51 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 123.577 0.751 . . . . 0.0 110.401 165.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.282 11.6 p30 -130.12 141.26 50.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.131 -0.981 . . . . 0.0 113.54 165.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -111.07 103.49 11.95 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -177.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 59.7 t -85.82 102.52 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -104.97 108.7 20.36 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.849 0.86 . . . . 0.0 108.857 -169.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -135.74 136.41 40.77 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -169.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 26.7 mm -82.7 113.92 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.718 -0.614 . . . . 0.0 109.52 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -120.79 108.83 14.43 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.7 t70 50.3 54.34 11.31 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 116.582 2.067 . . . . 0.0 116.582 -176.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 64.05 19.64 63.86 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 119.662 2.625 . . . . 0.0 119.662 -169.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -129.27 129.75 45.32 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 119.246 1.523 . . . . 0.0 108.908 -175.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.3 ttt -82.66 104.78 13.17 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-O 122.067 0.937 . . . . 0.0 109.922 176.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.1 t -86.88 104.41 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 174.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 55.2 ttm -93.48 104.25 16.4 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 66.8 m -93.69 110.17 21.79 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.526 0.679 . . . . 0.0 109.329 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mp -95.82 105.61 17.64 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 124.184 0.994 . . . . 0.0 108.897 -173.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.7 t -115.26 114.91 25.82 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 119.229 0.922 . . . . 0.0 111.949 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -98.45 74.8 2.18 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.473 0.654 . . . . 0.0 109.251 164.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 66.37 -91.94 0.17 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 115.444 0.938 . . . . 0.0 115.444 -175.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.98 -34.96 20.69 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 172.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.9 t -87.17 117.95 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-N 120.099 1.318 . . . . 0.0 109.732 -171.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.4 t -116.28 127.08 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 C-N-CA 123.493 0.717 . . . . 0.0 109.772 -173.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.67 160.24 18.11 Favored 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 123.264 0.626 . . . . 0.0 112.593 161.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.5 t -131.28 110.7 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.976 -1.078 . . . . 0.0 108.753 176.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -94.56 119.19 32.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.129 -0.982 . . . . 0.0 110.613 169.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -92.54 105.24 17.45 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.387 0.675 . . . . 0.0 109.542 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -106.27 122.98 47.32 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.438 0.695 . . . . 0.0 111.057 -172.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -95.65 157.28 15.97 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.982 -1.073 . . . . 0.0 113.618 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -81.05 141.13 34.66 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -173.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.307 0 CA-C-O 117.364 -1.303 . . . . 0.0 111.975 -179.062 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.35 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.034 0 CA-C-O 122.137 0.97 . . . . 0.0 112.478 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -66.74 -48.44 69.14 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 -165.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.26 -27.18 54.28 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 166.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -83.4 -23.81 32.21 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 172.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 71.7 m -78.12 99.48 6.18 Favored 'General case' 0 CA--C 1.566 1.581 0 CA-C-N 121.758 2.072 . . . . 0.0 112.998 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.66 168.77 12.37 Favored 'General case' 0 CA--C 1.57 1.717 0 CA-C-O 122.284 1.04 . . . . 0.0 112.245 -173.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.0 m -85.39 102.65 13.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.203 -0.936 . . . . 0.0 108.901 173.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -101.59 108.66 20.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.788 -1.195 . . . . 0.0 112.027 -169.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -94.13 128.36 40.49 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.428 -0.795 . . . . 0.0 110.94 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.95 117.35 14.56 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.528 0.68 . . . . 0.0 112.704 -175.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.7 p -88.68 -47.82 7.98 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -145.17 112.17 5.98 Favored 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 123.51 0.724 . . . . 0.0 109.662 -171.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.0 p -101.25 95.25 6.4 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.474 0.709 . . . . 0.0 111.406 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -91.0 116.39 28.75 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 122.893 0.477 . . . . 0.0 110.736 -166.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.264 0.7 OUTLIER 64.01 39.82 7.64 Favored 'General case' 0 CA--C 1.582 2.174 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -173.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -78.87 -44.58 22.52 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -53.67 -51.12 64.21 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 116.763 2.134 . . . . 0.0 116.763 175.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -66.52 -38.96 88.32 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -50.14 -53.94 24.11 Favored 'General case' 0 CA--C 1.572 1.823 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 160.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 31.5 mtp -58.41 -42.28 86.86 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 174.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.3 tmtm? -59.33 -51.4 70.11 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 165.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.4 -38.07 89.73 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 116.743 2.127 . . . . 0.0 116.743 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 tt -61.92 -32.59 73.0 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 165.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.71 49.95 1.89 Allowed Glycine 0 N--CA 1.484 1.88 0 N-CA-C 115.919 1.128 . . . . 0.0 115.919 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 m -93.16 156.69 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-N 118.792 1.296 . . . . 0.0 112.173 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.44 156.85 50.46 Favored Glycine 0 CA--C 1.551 2.318 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 171.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -62.07 -41.27 97.99 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.94 -41.78 71.47 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 165.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.5 m -60.7 -46.62 89.68 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 168.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.5 mtm180 -54.36 -48.75 71.11 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 165.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -60.48 -42.12 95.61 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.8 t -52.95 -60.38 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-N 119.909 1.231 . . . . 0.0 113.101 163.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.0 -31.51 68.71 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 119.822 2.689 . . . . 0.0 119.822 176.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -67.48 -45.7 75.15 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 167.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.6 m -79.33 -32.59 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -109.23 146.56 34.02 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 120.19 1.359 . . . . 0.0 113.798 -163.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -91.66 116.86 67.27 Favored Pre-proline 0 CA--C 1.577 1.994 0 O-C-N 121.665 -0.647 . . . . 0.0 110.902 161.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.91 128.51 9.26 Favored 'Trans proline' 0 CA--C 1.561 1.836 0 C-N-CA 122.492 2.128 . . . . 0.0 112.735 168.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 56.2 m -85.68 115.93 23.65 Favored 'General case' 0 CA--C 1.562 1.441 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.9 t -102.83 94.25 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -173.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.52 102.58 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.957 -1.089 . . . . 0.0 108.108 -175.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.5 mt -91.15 128.41 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.3 p -142.62 157.49 44.64 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.388 0.675 . . . . 0.0 111.917 -177.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -114.91 111.12 20.68 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.246 -0.909 . . . . 0.0 108.644 166.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -82.01 -57.45 3.4 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -177.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.24 87.61 0.14 Allowed Glycine 0 N--CA 1.483 1.83 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.292 12.0 t70 70.93 -57.43 0.6 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -164.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -78.89 152.92 30.92 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -175.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.1 t -89.48 126.07 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.6 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.872 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.7 t -112.23 109.73 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.3 mt -99.85 130.11 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 174.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.8 mtt85 -107.8 107.8 18.72 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.344 0.658 . . . . 0.0 110.072 173.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.1 m -91.63 103.51 16.09 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.519 -0.738 . . . . 0.0 109.302 173.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 65.2 mt -125.73 119.96 29.35 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 122.817 0.447 . . . . 0.0 110.873 -169.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.26 178.44 6.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.987 -1.071 . . . . 0.0 110.498 159.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.7 p -77.99 48.56 0.73 Allowed 'General case' 0 N--CA 1.51 2.572 0 O-C-N 119.594 -1.941 . . . . 0.0 114.089 173.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -165.79 -58.12 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 125.152 1.381 . . . . 0.0 109.419 -165.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -131.84 132.14 43.43 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.206 1.002 . . . . 0.0 109.285 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -134.06 97.77 3.96 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -172.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.2 t -127.93 128.7 45.58 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 123.178 0.591 . . . . 0.0 111.076 -175.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -119.76 138.85 53.08 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.2 pt -135.28 116.37 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-O 121.313 0.578 . . . . 0.0 111.055 -163.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.1 p -100.63 121.93 42.45 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.064 0.946 . . . . 0.0 112.048 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -147.86 139.2 23.6 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -173.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -81.59 6.86 13.72 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.258 50.9 mt 70.29 105.63 0.06 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 125.188 1.395 . . . . 0.0 111.746 -168.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.69 0.88 89.22 Favored Glycine 0 CA--C 1.556 2.636 0 N-CA-C 119.139 2.416 . . . . 0.0 119.139 -161.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -81.97 122.77 28.2 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-N 120.179 1.99 . . . . 0.0 111.136 174.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -86.45 113.37 22.33 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 122.711 0.405 . . . . 0.0 110.944 172.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -125.25 146.33 49.58 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.842 0.857 . . . . 0.0 111.541 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.98 139.9 36.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.743 -1.223 . . . . 0.0 112.507 168.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -146.5 130.78 17.53 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.192 0.52 . . . . 0.0 110.516 172.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.4 m -71.47 124.91 25.68 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-O 121.694 0.759 . . . . 0.0 110.656 164.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.1 p -96.65 174.94 6.57 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -176.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.52 -17.63 14.78 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 119.386 3.106 . . . . 0.0 119.386 166.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -81.59 -5.64 58.23 Favored 'General case' 0 CA--C 1.58 2.118 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 161.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.273 23.2 t70 65.34 66.16 0.55 Allowed 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 121.151 1.796 . . . . 0.0 112.992 -170.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -154.55 138.47 16.32 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.87 0.868 . . . . 0.0 109.467 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -79.52 114.9 18.81 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 174.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 2.4 p -99.64 122.83 43.25 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.854 -0.529 . . . . 0.0 112.241 173.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -72.83 96.95 2.15 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 168.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.7 m -109.17 118.23 36.21 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.025 -160.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.5 p -121.79 119.88 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.2 t -107.29 118.22 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.486 -0.759 . . . . 0.0 109.686 -173.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.9 m -111.95 125.99 54.64 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.36 0.664 . . . . 0.0 111.568 -177.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.4 tt -83.73 99.66 10.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.428 -0.795 . . . . 0.0 109.825 170.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -91.51 78.44 5.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.454 -0.779 . . . . 0.0 110.651 -175.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.88 -79.24 1.6 Allowed Glycine 0 N--CA 1.492 2.424 0 O-C-N 121.3 -0.875 . . . . 0.0 114.541 -174.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -139.9 60.17 1.56 Allowed 'General case' 0 CA--C 1.572 1.796 0 C-N-CA 122.877 0.471 . . . . 0.0 110.063 164.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -156.9 106.98 2.28 Favored 'General case' 0 CA--C 1.566 1.559 0 O-C-N 121.315 -0.866 . . . . 0.0 109.307 -168.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.0 mt -86.94 101.0 13.0 Favored 'General case' 0 CA--C 1.57 1.719 0 O-C-N 121.349 -0.845 . . . . 0.0 112.373 -174.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.9 t -102.45 102.82 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.132 -0.98 . . . . 0.0 109.025 -171.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -88.12 106.24 18.04 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 123.197 0.599 . . . . 0.0 110.759 177.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.6 mt -92.81 107.23 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -90.88 125.25 35.69 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 118.948 0.794 . . . . 0.0 110.951 171.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -120.77 126.27 49.71 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.396 0.679 . . . . 0.0 110.832 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.0 p90 -152.73 123.72 7.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.943 -1.098 . . . . 0.0 110.483 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 54.31 33.46 18.41 Favored 'General case' 0 N--CA 1.51 2.566 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.93 -26.34 4.88 Favored Glycine 0 CA--C 1.557 2.702 0 N-CA-C 118.809 2.284 . . . . 0.0 118.809 -164.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -75.92 143.59 41.57 Favored 'General case' 0 CA--C 1.566 1.583 0 CA-C-N 119.494 1.647 . . . . 0.0 113.002 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -132.48 134.21 44.76 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.361 0.664 . . . . 0.0 111.039 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.8 t -132.94 130.85 40.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.676 -0.64 . . . . 0.0 111.455 162.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -107.73 130.66 54.93 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 123.16 0.584 . . . . 0.0 112.299 174.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -107.34 103.81 13.26 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.8 t -92.22 94.14 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -170.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.9 mtt85 -81.86 115.2 20.95 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.997 0.919 . . . . 0.0 111.294 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -127.26 144.46 51.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.681 -0.637 . . . . 0.0 111.637 172.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.2 mm -83.75 116.12 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.186 -0.946 . . . . 0.0 109.054 174.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.72 85.4 2.24 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.9 t70 49.69 61.54 3.11 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -178.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.92 -44.07 1.86 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 117.135 1.614 . . . . 0.0 117.135 -173.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -85.8 151.56 23.72 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 118.655 1.227 . . . . 0.0 113.121 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 38.7 tpp -85.73 116.96 24.31 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 160.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.4 t -94.09 106.8 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 165.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 18.2 ttt -102.05 111.51 23.81 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.5 m -100.75 106.8 18.25 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -177.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.0 mp -101.02 105.82 17.06 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -174.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.3 t -106.07 139.15 41.05 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.772 0.796 . . . . 0.0 112.052 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -101.09 79.61 2.03 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 162.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 70.37 -94.6 0.48 Allowed Glycine 0 N--CA 1.489 2.211 0 O-C-N 121.663 -0.648 . . . . 0.0 113.322 -163.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -127.99 57.16 1.56 Allowed 'General case' 0 CA--C 1.573 1.845 0 C-N-CA 122.972 0.509 . . . . 0.0 111.938 169.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.2 t -136.13 110.41 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 170.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.3 t -117.63 125.18 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.671 -0.643 . . . . 0.0 111.203 -151.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -107.37 124.97 50.6 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.317 0.647 . . . . 0.0 112.054 165.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.2 t -109.19 105.4 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.318 -0.864 . . . . 0.0 108.809 -174.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 -103.49 114.1 28.11 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 123.898 0.879 . . . . 0.0 111.495 -173.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -96.61 116.54 29.27 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.53 0.732 . . . . 0.0 111.244 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -110.37 138.68 46.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.528 -0.733 . . . . 0.0 111.283 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -99.18 152.78 19.5 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.682 0.753 . . . . 0.0 112.453 167.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -72.46 128.98 37.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.795 -0.566 . . . . 0.0 111.998 171.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.631 179.964 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.507 0.67 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -74.34 -52.68 11.5 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -171.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.58 -25.36 52.26 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 117.963 2.579 . . . . 0.0 117.963 168.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -82.92 -15.81 49.91 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 171.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 41.5 t -79.98 92.79 5.61 Favored 'General case' 0 CA--C 1.565 1.531 0 CA-C-N 121.472 1.942 . . . . 0.0 113.725 -169.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -166.61 168.53 14.46 Favored 'General case' 0 CA--C 1.569 1.687 0 C-N-CA 124.118 0.967 . . . . 0.0 111.826 -174.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.1 m -78.32 124.05 27.66 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.973 -1.079 . . . . 0.0 108.884 159.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -113.09 119.66 38.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 110.66 -177.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -99.85 129.93 45.99 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.81 0.844 . . . . 0.0 111.023 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tt -73.18 121.25 19.99 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -176.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.3 p -92.41 -50.29 5.71 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 175.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -141.74 117.35 10.32 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 119.254 0.934 . . . . 0.0 109.934 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.1 p -107.01 109.04 20.83 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.486 0.714 . . . . 0.0 112.82 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -94.16 131.15 39.99 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.468 0.707 . . . . 0.0 111.454 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.284 3.9 t-20 61.31 25.82 15.73 Favored 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 118.359 2.726 . . . . 0.0 118.359 176.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -70.23 -42.8 71.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 119.794 -1.817 . . . . 0.0 115.537 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -49.51 -53.63 22.32 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 169.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.69 -39.06 84.45 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -53.22 -55.77 21.72 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 162.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 74.3 mtm -54.51 -48.57 71.76 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 173.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -41.93 90.07 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 172.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.77 -35.67 81.37 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 117.251 2.315 . . . . 0.0 117.251 167.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 tp -67.72 -27.09 66.51 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.81 65.41 0.65 Allowed Glycine 0 N--CA 1.484 1.863 0 C-N-CA 123.675 0.655 . . . . 0.0 114.202 -173.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.429 HG21 ' HB3' ' A' ' 30' ' ' ARG . 23.8 m -105.56 145.82 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 C-N-CA 123.501 0.721 . . . . 0.0 111.865 168.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.54 176.07 51.07 Favored Glycine 0 N--CA 1.49 2.281 0 O-C-N 121.367 -0.833 . . . . 0.0 114.276 152.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -77.3 61.62 2.19 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 123.071 1.415 . . . . 0.0 113.384 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -158.21 -61.75 0.08 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.049 1.34 . . . . 0.0 109.055 -175.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.8 m -57.44 -42.0 81.57 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 164.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.429 ' HB3' HG21 ' A' ' 25' ' ' VAL . 7.2 ptm180 -61.44 -38.53 87.53 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 164.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -62.9 -42.32 99.74 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 120.469 1.486 . . . . 0.0 114.902 170.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 70.4 t -48.12 -65.28 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 CA-C-N 119.84 1.2 . . . . 0.0 112.796 160.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.19 -33.91 61.9 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 119.782 2.673 . . . . 0.0 119.782 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -67.97 -46.46 71.3 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 169.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.8 m -79.7 -30.8 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.4 t -120.77 153.78 36.57 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 120.293 1.406 . . . . 0.0 113.579 -167.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.0 111.83 60.28 Favored Pre-proline 0 CA--C 1.575 1.933 0 CA-C-O 117.883 -1.056 . . . . 0.0 111.494 178.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.57 123.99 8.51 Favored 'Trans proline' 0 CA--C 1.559 1.763 0 CA-C-N 123.523 2.294 . . . . 0.0 115.424 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.4 m -96.69 118.76 33.84 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.097 0.959 . . . . 0.0 108.483 -175.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.5 t -106.11 105.44 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -169.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.5 mt -95.35 103.45 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mp -85.5 111.46 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 171.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.5 p -127.71 122.81 33.87 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.097 0.559 . . . . 0.0 111.358 -172.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -89.21 99.06 12.13 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -98.15 -44.52 6.57 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -161.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.06 104.83 0.19 Allowed Glycine 0 N--CA 1.483 1.82 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -173.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.292 13.8 t70 71.66 -52.34 0.69 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -165.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -126.59 162.09 26.51 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 122.562 1.172 . . . . 0.0 113.881 -163.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.9 t -86.06 122.8 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.6 t -115.47 108.15 24.57 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 -175.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 56.6 mt -91.85 117.35 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 173.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -97.58 102.16 13.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 169.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.4 m -88.56 104.78 17.15 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.2 mt -102.94 99.46 9.36 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.6 t -87.74 39.3 0.88 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 171.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.328 69.8 p 64.0 -58.71 0.2 Allowed 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -172.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -93.47 -44.35 8.28 Favored 'General case' 0 CA--C 1.574 1.872 0 C-N-CA 125.413 1.485 . . . . 0.0 112.652 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -100.02 117.81 35.08 Favored 'General case' 0 CA--C 1.566 1.588 0 C-N-CA 124.094 0.958 . . . . 0.0 110.817 -176.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -98.57 104.08 16.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.59 -0.694 . . . . 0.0 109.86 168.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.252 5.0 t -103.15 82.6 2.09 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.902 0.858 . . . . 0.0 110.495 169.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.95 131.19 34.7 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 pt -131.62 130.55 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 C-N-CA 123.366 0.666 . . . . 0.0 111.364 -170.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 90.2 p -116.87 131.64 56.9 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 123.881 0.872 . . . . 0.0 111.922 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -158.84 144.86 16.72 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.141 -0.974 . . . . 0.0 113.307 -169.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -94.4 26.5 3.36 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 175.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 69.2 mt 69.02 108.31 0.05 Allowed 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 125.203 1.401 . . . . 0.0 113.547 177.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.41 -10.49 58.85 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 118.656 2.222 . . . . 0.0 118.656 -162.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -73.72 123.85 24.9 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 118.962 1.381 . . . . 0.0 112.327 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -76.0 122.08 23.68 Favored 'General case' 0 CA--C 1.566 1.558 0 CA-C-O 121.306 0.574 . . . . 0.0 111.317 168.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -124.81 154.54 40.82 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.84 0.856 . . . . 0.0 110.586 173.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.09 136.7 32.85 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.951 -1.093 . . . . 0.0 110.973 171.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -134.45 108.79 8.34 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.904 0.482 . . . . 0.0 110.194 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 88.5 m -79.51 102.37 8.77 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 167.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.9 p -82.08 171.04 14.82 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -167.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.56 -13.53 2.45 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 119.834 3.272 . . . . 0.0 119.834 169.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.42 -16.09 50.27 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 163.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.306 28.6 m-20 73.94 72.17 0.12 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 125.073 1.349 . . . . 0.0 111.995 -160.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -157.01 129.12 7.28 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 124.128 0.971 . . . . 0.0 108.427 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -84.93 115.28 22.7 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 123.268 0.627 . . . . 0.0 112.077 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 72.8 m -110.58 119.72 40.08 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -174.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -71.06 105.87 3.5 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.381 0.61 . . . . 0.0 109.754 165.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.1 m -117.89 119.09 33.81 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.779 -158.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.2 t -117.23 117.77 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.75 108.19 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.391 -0.818 . . . . 0.0 109.598 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 86.5 p -106.78 126.36 52.19 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 123.682 0.793 . . . . 0.0 112.697 -177.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.8 tt -83.33 102.83 12.26 Favored 'General case' 0 CA--C 1.569 1.698 0 C-N-CA 123.21 0.604 . . . . 0.0 110.824 172.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -92.47 76.41 5.12 Favored 'General case' 0 CA--C 1.57 1.719 0 O-C-N 121.107 -0.995 . . . . 0.0 111.443 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.07 -74.67 2.4 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 115.022 0.769 . . . . 0.0 115.022 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.09 65.66 1.21 Allowed 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 122.415 1.102 . . . . 0.0 110.632 153.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -147.5 106.61 3.87 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 mt -89.04 100.1 12.95 Favored 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 123.443 0.697 . . . . 0.0 110.684 -172.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.7 t -106.21 104.01 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -167.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -87.44 102.11 14.23 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 123.387 0.675 . . . . 0.0 111.419 176.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.3 mt -91.23 103.63 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -177.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -90.06 127.42 36.07 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 118.788 0.722 . . . . 0.0 111.114 171.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -121.18 120.39 35.08 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 123.193 0.597 . . . . 0.0 110.887 176.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -145.46 126.91 15.0 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.369 -0.832 . . . . 0.0 110.242 -175.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 55.14 31.92 17.34 Favored 'General case' 0 N--CA 1.511 2.58 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 174.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.9 -21.29 7.99 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 119.166 2.426 . . . . 0.0 119.166 -163.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -86.01 141.38 29.53 Favored 'General case' 0 CA--C 1.57 1.712 0 CA-C-N 119.016 1.408 . . . . 0.0 111.509 -177.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -134.88 125.19 26.27 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.482 0.713 . . . . 0.0 111.023 -173.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.4 t -122.48 144.33 49.13 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.335 0.654 . . . . 0.0 110.733 167.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.279 9.7 p30 -124.9 127.95 47.89 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-O 121.321 0.581 . . . . 0.0 112.415 174.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.3 101.24 12.64 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -174.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 91.5 t -92.43 96.55 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -168.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 -85.03 107.69 17.27 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.499 0.72 . . . . 0.0 110.181 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.91 129.62 48.54 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 123.035 0.534 . . . . 0.0 111.723 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.2 mm -81.45 120.2 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.339 -0.851 . . . . 0.0 110.177 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.75 89.52 3.13 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.7 t70 51.12 67.1 1.0 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.0 -48.46 3.23 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 117.38 1.712 . . . . 0.0 117.38 -174.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -86.32 143.94 27.63 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 118.643 1.222 . . . . 0.0 112.309 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 32.5 ttm -88.35 118.81 28.23 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-O 121.714 0.769 . . . . 0.0 109.823 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.6 t -89.08 100.51 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 169.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 36.5 ttm -94.94 100.41 12.27 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.369 0.604 . . . . 0.0 110.182 -173.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 84.3 m -98.02 99.79 11.08 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.813 0.816 . . . . 0.0 108.976 -172.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.5 mp -89.98 105.17 17.63 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.8 t -108.3 116.34 31.78 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.52 0.676 . . . . 0.0 110.993 -176.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -97.13 79.75 2.87 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 121.267 0.556 . . . . 0.0 109.509 166.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 63.16 -98.04 0.21 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 115.434 0.934 . . . . 0.0 115.434 -175.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -86.7 -17.21 34.25 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 169.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.8 t -91.96 101.63 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-N 121.774 2.079 . . . . 0.0 108.481 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 57.8 t -104.07 115.19 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -171.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -116.64 129.16 55.99 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.809 -0.557 . . . . 0.0 112.015 177.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.5 t -115.8 118.56 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.483 -0.761 . . . . 0.0 109.157 -168.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -111.25 125.55 53.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.415 -0.803 . . . . 0.0 111.505 175.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -95.84 109.47 21.8 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.893 0.477 . . . . 0.0 110.291 -175.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -109.63 129.12 55.62 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 123.551 0.74 . . . . 0.0 112.295 -168.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -97.23 150.92 20.37 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 124.2 1.0 . . . . 0.0 112.836 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -74.78 134.52 41.8 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.3 -0.875 . . . . 0.0 113.134 172.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.519 0 C-N-CA 124.101 0.961 . . . . 0.0 111.63 161.441 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.309 8.6 p . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -64.06 -32.26 73.75 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 117.206 2.299 . . . . 0.0 117.206 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.81 -31.33 48.73 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 117.964 2.579 . . . . 0.0 117.964 164.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -75.5 -18.21 59.89 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.779 2.141 . . . . 0.0 116.779 168.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 93.8 m -76.47 97.72 4.4 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 122.383 2.356 . . . . 0.0 113.417 -175.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.09 167.65 14.3 Favored 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 124.376 1.07 . . . . 0.0 111.556 -174.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 98.6 m -81.53 114.54 20.32 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.195 -0.941 . . . . 0.0 109.162 163.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -106.03 115.06 29.58 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.758 -0.589 . . . . 0.0 110.204 -176.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -95.98 132.97 40.75 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.328 0.651 . . . . 0.0 110.842 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -71.07 127.84 33.92 Favored 'General case' 0 CA--C 1.565 1.526 0 CA-C-O 122.303 1.049 . . . . 0.0 113.322 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.1 p -98.92 -39.98 8.3 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 176.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -154.73 121.29 5.4 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 119.534 1.061 . . . . 0.0 109.598 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.2 p -101.39 96.32 7.08 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.23 0.612 . . . . 0.0 111.741 174.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -72.62 124.52 25.44 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.386 0.675 . . . . 0.0 111.805 174.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.274 4.4 t-20 51.04 27.37 3.25 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 119.133 3.012 . . . . 0.0 119.133 177.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -70.92 -46.04 63.2 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 -173.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -49.79 -50.06 46.22 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 168.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -58.19 -42.28 85.78 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 170.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -58.55 -48.61 80.3 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 165.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.2 mtp -57.39 -47.04 82.72 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -61.07 -42.28 98.2 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 166.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.52 -43.53 98.69 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 171.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.1 tp -62.24 -17.27 57.9 Favored 'General case' 0 CA--C 1.58 2.105 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 166.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.92 52.15 3.2 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 116.287 1.275 . . . . 0.0 116.287 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . 0.268 9.5 m -92.65 143.51 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 118.57 1.185 . . . . 0.0 113.028 176.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.64 166.22 17.06 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 116.99 1.556 . . . . 0.0 116.99 166.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -64.51 -43.95 92.47 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.85 -46.6 87.35 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 166.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.4 m -58.14 -39.36 78.56 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 172.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.347 0.2 OUTLIER -62.38 -37.74 86.93 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 167.689 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -57.93 -47.19 83.59 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 120.999 1.727 . . . . 0.0 114.592 162.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 70.0 t -56.87 -34.26 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 N-CA-C 117.125 2.268 . . . . 0.0 117.125 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.67 -16.64 41.59 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 119.377 2.511 . . . . 0.0 119.377 166.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -88.23 -44.22 11.02 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.573 2.187 . . . . 0.0 114.43 171.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.0 m -93.78 42.71 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 CA-C-N 122.032 2.196 . . . . 0.0 114.041 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.3 m -175.97 145.69 0.66 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.244 1.418 . . . . 0.0 107.892 -176.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -86.8 104.56 6.09 Favored Pre-proline 0 CA--C 1.576 1.977 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.574 170.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.63 113.22 3.74 Favored 'Trans proline' 0 C--N 1.374 1.883 0 CA-C-N 123.158 2.164 . . . . 0.0 112.298 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 93.1 m -95.95 115.29 27.21 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.501 -161.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -92.25 99.69 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -169.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.7 mt -93.21 99.91 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 62.0 mt -89.11 124.97 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.2 p -146.87 116.61 7.16 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.842 -0.536 . . . . 0.0 111.552 -168.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -84.27 117.97 23.89 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.945 -1.097 . . . . 0.0 112.024 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -109.4 82.58 1.62 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.936 0.874 . . . . 0.0 109.424 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.9 -100.58 1.48 Allowed Glycine 0 N--CA 1.489 2.18 0 O-C-N 121.884 -0.51 . . . . 0.0 114.219 -175.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -94.58 -24.44 17.22 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 173.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -98.37 146.32 25.82 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 120.786 1.63 . . . . 0.0 112.941 -174.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.65 115.11 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.671 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 170.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.9 t -99.85 106.35 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.0 mt -95.71 117.84 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 175.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -106.38 95.61 5.88 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.946 174.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.7 m -89.69 101.52 14.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.658 -0.651 . . . . 0.0 109.601 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.4 mt -107.47 105.25 15.07 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.275 -168.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 m -79.96 152.0 29.76 Favored 'General case' 0 CA--C 1.568 1.642 0 O-C-N 121.424 -0.798 . . . . 0.0 110.425 151.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.5 p -38.39 -51.13 1.54 Allowed 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 160.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -80.45 -47.51 14.22 Favored 'General case' 0 CA--C 1.572 1.804 0 C-N-CA 124.379 1.072 . . . . 0.0 113.599 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -115.0 109.77 18.6 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.845 0.858 . . . . 0.0 111.062 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -95.14 89.84 5.68 Favored 'General case' 0 CA--C 1.566 1.568 0 C-N-CA 123.193 0.597 . . . . 0.0 110.366 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.3 p -92.93 146.9 23.28 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -171.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -150.21 116.28 5.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.196 -0.94 . . . . 0.0 112.036 -166.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.2 pt -129.27 116.51 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.668 -0.645 . . . . 0.0 111.93 -175.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.8 p -103.58 113.17 26.48 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.24 1.016 . . . . 0.0 111.975 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -147.29 150.15 34.24 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.829 0.823 . . . . 0.0 113.119 -169.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -86.92 149.37 24.85 Favored 'General case' 0 CA--C 1.572 1.808 0 O-C-N 121.028 -1.045 . . . . 0.0 111.018 162.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.8 mt -68.21 123.97 22.16 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.059 -1.651 . . . . 0.0 112.546 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.38 -16.76 60.63 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 118.707 2.243 . . . . 0.0 118.707 -162.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -80.91 125.82 30.6 Favored 'General case' 0 CA--C 1.562 1.406 0 CA-C-N 119.935 1.867 . . . . 0.0 112.005 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -86.62 127.69 34.94 Favored 'General case' 0 CA--C 1.569 1.693 0 CA-C-O 121.291 0.567 . . . . 0.0 111.901 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -133.93 148.64 51.22 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.154 0.982 . . . . 0.0 111.331 -176.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.09 131.99 37.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.482 -1.387 . . . . 0.0 111.435 171.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -126.46 104.11 7.97 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.041 0.537 . . . . 0.0 110.139 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.4 m -74.1 104.52 4.95 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.223 1.011 . . . . 0.0 110.033 171.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 75.3 p -84.48 172.79 11.38 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -168.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.56 -6.73 0.76 Allowed 'General case' 0 CA--C 1.576 1.974 0 N-CA-C 119.589 3.181 . . . . 0.0 119.589 166.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -96.45 0.43 50.37 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 160.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.313 18.3 t70 63.48 27.2 15.08 Favored 'General case' 0 CA--C 1.582 2.19 0 N-CA-C 116.949 2.203 . . . . 0.0 116.949 -166.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 -94.02 131.6 39.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.574 -1.329 . . . . 0.0 109.196 162.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . 0.298 0.3 OUTLIER -88.72 108.93 19.74 Favored 'General case' 0 CA--C 1.569 1.676 0 CA-C-O 121.041 0.448 . . . . 0.0 110.361 171.493 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 92.4 m -95.33 120.82 36.23 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -173.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -69.88 100.12 1.51 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.811 0.815 . . . . 0.0 109.953 171.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.4 m -114.89 112.67 23.08 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.114 -156.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.8 p -111.71 119.12 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.368 0.604 . . . . 0.0 109.618 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.4 t -105.1 119.85 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -174.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.4 p -130.26 127.68 40.05 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.414 0.685 . . . . 0.0 111.661 -177.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 tt -91.12 111.28 22.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.133 -0.979 . . . . 0.0 110.632 177.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -113.7 74.92 0.89 Allowed 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 123.203 0.601 . . . . 0.0 111.373 -176.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 65.84 77.9 0.25 Allowed Glycine 0 N--CA 1.496 2.678 0 N-CA-C 116.623 1.409 . . . . 0.0 116.623 172.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.271 23.4 t0 62.81 11.87 5.29 Favored 'General case' 0 CA--C 1.582 2.194 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 -164.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.7 mtmt -128.2 105.58 8.45 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 120.914 1.688 . . . . 0.0 109.532 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.78 93.45 8.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -0.968 . . . . 0.0 109.965 177.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 22.3 t -97.03 107.87 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.036 -1.04 . . . . 0.0 108.973 -166.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -93.26 103.25 15.52 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.576 0.75 . . . . 0.0 110.38 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.2 mt -92.84 105.04 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -176.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -94.29 122.06 36.45 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 118.561 0.619 . . . . 0.0 110.672 173.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -118.36 127.18 53.44 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.366 0.666 . . . . 0.0 110.442 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.4 p90 -149.49 122.68 8.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.03 -1.044 . . . . 0.0 110.055 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 54.85 36.65 27.05 Favored 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 176.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.92 -24.94 4.93 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 118.985 2.354 . . . . 0.0 118.985 -164.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -81.2 144.4 31.64 Favored 'General case' 0 CA--C 1.565 1.552 0 CA-C-N 119.075 1.437 . . . . 0.0 112.84 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -134.45 132.72 39.65 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.316 0.646 . . . . 0.0 111.287 -176.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.7 t -126.2 134.15 51.33 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 161.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -119.97 123.5 43.66 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.934 0.494 . . . . 0.0 110.813 176.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -102.72 108.9 20.32 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -171.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.0 t -92.8 96.39 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -174.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -88.32 116.88 26.85 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -133.3 133.53 42.7 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 24.8 mm -76.69 114.74 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -148.38 124.11 10.51 Favored 'General case' 0 CA--C 1.565 1.544 0 C-N-CA 124.225 1.01 . . . . 0.0 108.717 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 t70 55.85 50.5 13.93 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.27 18.68 65.47 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 119.66 2.624 . . . . 0.0 119.66 -172.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -144.31 152.02 40.18 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.486 1.143 . . . . 0.0 110.184 -169.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 7.7 ttm -85.2 115.32 22.92 Favored 'General case' 0 CA--C 1.564 1.516 0 O-C-N 121.26 -0.9 . . . . 0.0 108.984 159.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.9 t -88.46 105.42 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 27.2 ttt -95.22 103.22 15.07 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.771 -0.58 . . . . 0.0 110.3 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 92.1 m -92.33 115.19 27.87 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.656 0.741 . . . . 0.0 109.405 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mp -105.41 105.82 16.04 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -174.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.9 t -121.95 125.79 47.15 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 119.098 0.863 . . . . 0.0 113.321 -175.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -109.04 92.29 3.99 Favored 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 123.802 0.841 . . . . 0.0 108.758 171.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 69.5 -82.26 0.28 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 115.9 1.12 . . . . 0.0 115.9 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -121.72 -7.21 9.08 Favored 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 167.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.7 t -87.66 116.36 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-N 121.748 2.067 . . . . 0.0 108.565 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.1 t -115.4 121.0 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 C-N-CA 123.482 0.713 . . . . 0.0 109.655 -169.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -107.29 157.9 17.56 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 123.281 0.633 . . . . 0.0 112.446 161.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.4 t -132.44 110.59 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.01 -1.056 . . . . 0.0 109.274 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -97.5 121.26 39.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.028 -1.045 . . . . 0.0 111.273 174.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -99.37 110.56 23.05 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.427 0.691 . . . . 0.0 109.937 -171.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -110.61 128.01 55.49 Favored 'General case' 0 CA--C 1.563 1.454 0 O-C-N 121.378 -0.826 . . . . 0.0 111.99 -168.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -103.07 154.26 19.45 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 123.246 0.618 . . . . 0.0 112.543 168.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -74.1 134.97 42.93 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.251 -0.906 . . . . 0.0 113.027 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.519 0 C-N-CA 123.799 0.84 . . . . 0.0 111.837 168.948 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 CA--C 1.569 1.68 0 CA-C-O 121.615 0.722 . . . . 0.0 112.073 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.329 17.5 tt0 73.6 -55.51 0.67 Allowed 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.408 1.633 . . . . 0.0 115.408 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.31 -26.57 61.12 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 165.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -71.18 -22.75 61.99 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 116.801 2.149 . . . . 0.0 116.801 165.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.7 m -83.67 100.42 10.85 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 120.83 1.65 . . . . 0.0 113.218 -174.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -165.38 171.93 12.84 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-O 122.222 1.011 . . . . 0.0 111.802 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 94.8 m -81.89 118.24 22.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.013 -1.054 . . . . 0.0 109.274 165.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -113.57 121.86 45.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.403 -0.811 . . . . 0.0 112.333 -170.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -96.79 124.97 40.92 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.467 1.107 . . . . 0.0 110.459 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 tt -71.82 112.9 8.31 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.079 -1.013 . . . . 0.0 112.484 176.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.4 p -90.42 -46.22 8.49 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -143.93 136.19 26.7 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 119.193 0.906 . . . . 0.0 110.276 -175.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.3 p -118.8 136.98 53.71 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -94.2 -126.44 0.11 Allowed 'General case' 0 CA--C 1.573 1.848 0 O-C-N 121.611 -0.681 . . . . 0.0 110.326 172.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -83.82 54.05 2.76 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 119.571 -1.956 . . . . 0.0 114.848 -172.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -74.04 -36.18 64.37 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -48.35 -56.24 8.62 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 174.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -65.59 -42.32 91.81 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 169.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -52.91 -47.48 67.95 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 171.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 78.1 mtm -59.74 -48.68 80.72 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.06 -46.99 72.09 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 167.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.2 90.2 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 173.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mp -63.25 -35.9 81.88 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 166.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.11 41.42 0.9 Allowed Glycine 0 N--CA 1.487 2.051 0 N-CA-C 117.197 1.639 . . . . 0.0 117.197 177.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.5 m -71.22 158.06 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-N 119.323 1.561 . . . . 0.0 113.288 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.5 157.83 49.69 Favored Glycine 0 CA--C 1.553 2.437 0 O-C-N 120.767 -1.208 . . . . 0.0 115.89 162.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -64.57 -38.49 91.2 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.28 -44.33 97.41 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 160.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.7 m -58.54 -43.35 89.25 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -57.81 -47.98 81.06 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 167.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -63.04 -43.78 97.7 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 172.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.9 t -49.84 -61.15 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 163.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.93 -34.92 62.25 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 119.173 2.429 . . . . 0.0 119.173 174.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -66.33 -43.14 86.98 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 170.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.0 m -78.53 -33.35 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 116.361 1.985 . . . . 0.0 116.361 176.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 t -94.46 136.05 35.2 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 120.318 1.417 . . . . 0.0 113.997 -162.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -92.93 109.26 38.2 Favored Pre-proline 0 CA--C 1.576 1.96 0 CA-C-O 118.338 -0.839 . . . . 0.0 110.937 167.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.55 138.68 24.56 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 C-N-CA 122.635 2.223 . . . . 0.0 113.854 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.4 m -85.62 102.49 13.61 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.71 100.2 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -169.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.9 mt -90.82 102.75 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.175 -0.953 . . . . 0.0 108.529 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.5 mt -93.01 125.96 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.9 p -148.91 126.79 11.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.41 -0.806 . . . . 0.0 112.298 -169.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -81.42 109.32 15.79 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.682 -1.261 . . . . 0.0 110.426 168.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -104.11 86.66 2.6 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -173.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.19 -73.69 2.31 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 115.5 0.96 . . . . 0.0 115.5 -174.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -122.52 -53.85 1.88 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.889 0.876 . . . . 0.0 112.088 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -80.66 151.92 28.72 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -172.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.2 t -85.21 121.12 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 51.2 t -111.5 108.18 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.3 mt -89.75 116.11 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 172.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.8 mtm-85 -100.11 104.3 15.84 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 119.493 1.042 . . . . 0.0 109.73 169.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.7 m -90.11 102.52 15.24 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 77.3 mt -120.08 94.82 4.51 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 122.585 0.354 . . . . 0.0 110.397 -169.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.0 p -93.05 171.04 9.2 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.86 -1.15 . . . . 0.0 112.021 165.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.5 t -72.2 31.59 0.06 Allowed 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 165.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -155.68 -60.57 0.11 Allowed 'General case' 0 CA--C 1.571 1.756 0 C-N-CA 125.182 1.393 . . . . 0.0 109.404 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 46.7 mmtt -109.9 123.37 49.49 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.403 1.081 . . . . 0.0 109.902 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -124.14 98.29 5.71 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 123.337 0.655 . . . . 0.0 110.683 176.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.0 t -129.98 166.97 18.98 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 123.507 0.723 . . . . 0.0 112.054 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -138.18 153.0 49.2 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.9 mt -124.02 104.36 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.629 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -177.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 91.2 p -99.95 114.9 28.49 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.79 0.836 . . . . 0.0 112.178 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -145.14 152.93 40.81 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -171.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -103.68 141.98 35.12 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 123.463 0.705 . . . . 0.0 109.325 168.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.3 mt -67.38 129.25 39.32 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.634 -1.291 . . . . 0.0 113.908 -173.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.79 -15.69 45.98 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 119.141 2.416 . . . . 0.0 119.141 -167.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -91.53 127.3 36.92 Favored 'General case' 0 CA--C 1.563 1.452 0 CA-C-N 119.945 1.873 . . . . 0.0 111.58 -173.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -79.71 126.66 31.23 Favored 'General case' 0 CA--C 1.569 1.68 0 C-N-CA 122.885 0.474 . . . . 0.0 111.917 177.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -140.25 149.6 43.05 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.447 0.699 . . . . 0.0 111.916 -171.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -78.81 138.11 38.03 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.788 -1.195 . . . . 0.0 113.035 174.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -146.3 132.41 19.34 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.198 0.599 . . . . 0.0 110.959 174.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.3 m -98.51 119.77 37.78 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.487 0.66 . . . . 0.0 109.457 170.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 44.7 p -90.34 172.24 8.89 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -168.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.27 -21.37 33.91 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 118.595 2.813 . . . . 0.0 118.595 165.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -65.73 -14.68 61.78 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 158.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.291 10.1 m-20 62.38 46.86 5.58 Favored 'General case' 0 CA--C 1.574 1.873 0 CA-C-N 120.245 1.384 . . . . 0.0 114.69 -164.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.18 131.83 53.83 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.666 1.186 . . . . 0.0 108.702 172.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -86.78 120.31 27.94 Favored 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 122.806 0.442 . . . . 0.0 111.716 173.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.6 p -119.72 143.8 47.58 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.49 0.662 . . . . 0.0 112.725 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -79.13 105.11 10.23 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 121.966 0.889 . . . . 0.0 109.15 157.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.2 m -98.55 136.76 38.2 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.636 0.775 . . . . 0.0 112.245 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.6 p -134.3 129.89 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 123.537 0.735 . . . . 0.0 109.35 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.4 t -118.41 119.14 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.104 -0.998 . . . . 0.0 109.428 -169.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.7 p -117.69 131.62 56.6 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.576 0.75 . . . . 0.0 112.191 -176.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 tt -99.93 108.21 20.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.903 . . . . 0.0 110.301 177.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -88.78 -21.38 23.82 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 116.946 2.202 . . . . 0.0 116.946 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -178.43 -93.53 0.09 OUTLIER Glycine 0 N--CA 1.49 2.251 0 CA-C-N 120.289 1.404 . . . . 0.0 111.108 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -107.41 60.54 0.62 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 117.842 0.821 . . . . 0.0 109.915 151.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -155.25 114.76 3.67 Favored 'General case' 0 CA--C 1.563 1.46 0 O-C-N 121.416 -0.803 . . . . 0.0 110.576 174.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.5 mt -84.7 118.87 24.68 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.722 -0.611 . . . . 0.0 109.57 166.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.2 t -105.98 99.65 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -178.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -90.68 103.66 16.34 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.411 0.684 . . . . 0.0 110.151 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.3 mt -93.91 117.06 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -175.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -108.68 120.56 42.84 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 119.005 0.82 . . . . 0.0 110.464 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -112.41 120.82 42.98 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 123.889 0.876 . . . . 0.0 110.663 -176.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -151.58 134.28 15.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.395 -0.815 . . . . 0.0 110.591 -175.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 50.48 43.02 27.19 Favored 'General case' 0 N--CA 1.509 2.489 0 N-CA-C 117.609 2.448 . . . . 0.0 117.609 166.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.67 22.2 76.64 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 119.82 2.688 . . . . 0.0 119.82 -167.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -137.25 137.4 39.01 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 119.257 1.529 . . . . 0.0 109.506 -168.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -131.66 125.57 32.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.609 -0.682 . . . . 0.0 111.197 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.8 t -125.76 137.86 53.83 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.56 0.744 . . . . 0.0 110.377 175.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.258 11.6 p30 -120.11 135.34 54.99 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.81 105.19 15.55 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -174.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.5 t -89.91 95.88 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 CA-C-N 119.681 1.128 . . . . 0.0 108.199 -178.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.4 ' CG ' ' SD ' ' A' ' 113' ' ' MET . 41.8 ttm180 -95.35 106.25 18.28 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.021 0.928 . . . . 0.0 111.059 -173.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -126.34 144.38 50.83 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.179 0.592 . . . . 0.0 112.568 -176.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.6 mm -82.99 120.35 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -127.91 98.48 5.17 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.7 t70 53.15 58.26 5.46 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -176.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.19 -48.97 3.22 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 116.883 1.513 . . . . 0.0 116.883 -172.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -80.84 145.37 31.43 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 118.265 1.033 . . . . 0.0 113.085 -173.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.4 ' SD ' ' CG ' ' A' ' 106' ' ' ARG . 25.0 tpp -80.18 108.26 13.64 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 121.618 0.723 . . . . 0.0 109.378 161.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 93.6 t -100.75 100.41 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 30.4 ttm -98.49 102.84 14.7 Favored 'General case' 0 CA--C 1.561 1.372 0 O-C-N 122.049 -0.407 . . . . 0.0 110.751 -165.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.9 m -97.41 96.21 8.2 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.579 1.181 . . . . 0.0 110.119 -170.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.638 HD13 HH22 ' A' ' 126' ' ' ARG . 11.0 mp -93.83 106.83 18.78 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.217 1.007 . . . . 0.0 111.137 -176.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.0 t -101.45 118.04 36.15 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.582 0.753 . . . . 0.0 111.11 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -103.14 77.11 1.51 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 159.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 63.97 -109.52 2.84 Favored Glycine 0 CA--C 1.547 2.093 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 -170.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -76.54 -22.11 54.79 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 171.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.9 t -86.21 102.82 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 120.777 1.626 . . . . 0.0 108.867 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 61.6 t -110.26 108.56 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -172.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -98.45 135.86 39.41 Favored 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 123.477 0.711 . . . . 0.0 111.696 174.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.0 t -131.95 115.68 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.638 HH22 HD13 ' A' ' 117' ' ' LEU . 3.6 mtm105 -120.8 140.85 51.14 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 122.363 1.078 . . . . 0.0 113.013 176.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -110.21 100.16 9.1 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.541 -1.208 . . . . 0.0 108.662 -164.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -103.52 132.3 49.9 Favored 'General case' 0 CA--C 1.565 1.543 0 O-C-N 121.429 -0.795 . . . . 0.0 111.802 -169.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -103.16 151.53 22.49 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 172.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -74.09 135.25 42.96 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.295 -0.878 . . . . 0.0 113.177 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.079 -0.962 . . . . 0.0 111.491 164.851 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.293 8.4 p . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -65.56 -38.47 89.65 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 174.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -57.96 -28.67 64.54 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 169.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -77.39 -15.94 59.11 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 166.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.2 t -76.77 98.64 4.87 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 122.478 2.399 . . . . 0.0 114.302 -172.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -168.4 167.6 11.78 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.161 0.982 . . . . 0.0 112.23 -177.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.7 m -81.64 116.87 21.58 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.846 -1.159 . . . . 0.0 108.661 159.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -107.34 119.67 40.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.346 -0.847 . . . . 0.0 110.672 -174.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -101.93 131.92 48.04 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.638 0.732 . . . . 0.0 110.917 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -69.13 132.63 46.87 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.3 p -102.15 -41.29 6.46 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 173.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -156.76 129.47 7.68 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-N 119.552 1.069 . . . . 0.0 109.807 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.1 p -110.86 106.0 15.0 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.503 0.721 . . . . 0.0 110.913 172.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -70.65 -58.82 3.26 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 -160.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -120.57 46.4 2.01 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.318 -0.864 . . . . 0.0 112.287 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -75.79 -43.65 45.28 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -167.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -46.96 -52.64 14.17 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 163.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.55 -43.16 85.85 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 176.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -52.77 -53.25 50.86 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 120.203 1.365 . . . . 0.0 114.42 162.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 76.9 mtm -62.03 -43.7 98.28 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 176.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.5 -40.8 92.67 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 168.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.03 -39.97 95.27 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 165.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.5 tp -59.08 -37.29 76.75 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 172.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.45 50.8 0.84 Allowed Glycine 0 N--CA 1.485 1.938 0 N-CA-C 115.434 0.934 . . . . 0.0 115.434 -176.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.3 m -91.21 157.81 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 118.379 1.089 . . . . 0.0 112.545 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.6 158.68 53.61 Favored Glycine 0 CA--C 1.552 2.348 0 N-CA-C 115.798 1.079 . . . . 0.0 115.798 162.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -59.13 -41.05 87.33 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.92 -38.98 73.61 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 168.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.9 m -61.23 -48.2 82.56 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 169.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.257 8.2 ptm180 -63.22 -32.67 74.12 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 173.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -62.75 -58.02 8.92 Favored 'General case' 0 CA--C 1.571 1.758 0 CA-C-N 119.066 0.848 . . . . 0.0 113.182 162.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.6 t -54.06 -58.51 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.07 -21.24 58.99 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 120.253 2.861 . . . . 0.0 120.253 -177.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -91.11 -38.41 12.78 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 169.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -68.88 -39.87 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 CA-C-N 121.326 1.876 . . . . 0.0 115.846 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.7 t -85.03 153.32 22.81 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 119.474 1.034 . . . . 0.0 113.274 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -98.66 93.96 2.21 Favored Pre-proline 0 CA--C 1.575 1.906 0 O-C-N 121.46 -0.775 . . . . 0.0 110.335 169.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.19 118.49 5.64 Favored 'Trans proline' 0 C--N 1.374 1.904 0 CA-C-N 123.109 2.146 . . . . 0.0 113.466 -175.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 91.2 m -88.82 122.16 31.92 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.395 -173.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.7 t -105.32 100.75 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.711 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -166.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.0 mt -89.1 105.84 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.7 mt -97.27 115.05 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 92.1 p -144.48 124.82 13.82 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.748 0.419 . . . . 0.0 111.219 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -78.97 115.62 18.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.593 -0.692 . . . . 0.0 111.677 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -126.2 84.08 2.23 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.223 0.535 . . . . 0.0 110.371 -170.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.75 72.25 1.05 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 115.435 0.934 . . . . 0.0 115.435 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.29 7.3 t70 70.71 -51.94 0.67 Allowed 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -171.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -76.18 148.98 37.37 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.1 t -88.91 116.61 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.55 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 172.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.0 t -99.55 114.69 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.9 mt -103.43 112.94 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 173.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.6 116.24 30.41 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.284 1.034 . . . . 0.0 110.668 -177.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.1 m -102.22 100.5 10.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.69 -0.631 . . . . 0.0 109.44 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.3 mt -99.64 100.63 11.65 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.101 0.56 . . . . 0.0 109.998 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.1 p -98.36 1.9 47.45 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 118.24 2.681 . . . . 0.0 118.24 176.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.396 31.8 p 78.69 -57.35 0.44 Allowed 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 124.871 1.268 . . . . 0.0 113.316 -167.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -77.92 -61.88 1.85 Allowed 'General case' 0 CA--C 1.572 1.811 0 C-N-CA 124.354 1.062 . . . . 0.0 112.267 177.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -105.62 117.58 34.38 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.988 0.915 . . . . 0.0 109.428 176.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -121.07 85.5 2.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.412 -0.805 . . . . 0.0 109.833 -172.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.2 t -113.18 176.37 5.05 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 122.3 1.048 . . . . 0.0 113.478 -173.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -146.66 156.08 42.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.847 -1.158 . . . . 0.0 113.093 173.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.3 pt -121.68 132.0 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 123.899 0.88 . . . . 0.0 109.508 171.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 92.6 p -124.17 109.49 13.5 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.509 0.723 . . . . 0.0 110.408 -176.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -141.49 139.48 33.31 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -165.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -93.34 23.91 4.21 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.7 mt 67.41 105.21 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 125.179 1.392 . . . . 0.0 113.769 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.58 -20.09 12.69 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 118.483 2.153 . . . . 0.0 118.483 -166.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -78.66 123.37 27.07 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 119.158 1.479 . . . . 0.0 111.666 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -84.77 131.48 34.54 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 121.86 0.838 . . . . 0.0 112.24 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -131.52 157.31 43.9 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 124.247 1.019 . . . . 0.0 111.181 -173.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.65 136.07 33.41 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.63 -1.294 . . . . 0.0 110.98 175.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -140.71 118.72 11.88 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 122.533 0.333 . . . . 0.0 111.114 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 85.1 m -82.96 113.13 20.34 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 163.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.6 p -87.08 164.9 16.17 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -165.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.54 -24.35 8.0 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 118.824 2.898 . . . . 0.0 118.824 164.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -78.56 -0.51 29.96 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 167.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.262 10.7 t70 68.01 65.97 0.36 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 120.358 1.436 . . . . 0.0 113.151 -171.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -161.04 130.34 4.75 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.821 0.848 . . . . 0.0 109.146 -177.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -89.94 127.23 35.98 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.234 0.614 . . . . 0.0 112.392 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 21.0 p -132.0 148.76 52.53 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -81.2 101.63 9.81 Favored 'General case' 0 CA--C 1.565 1.537 0 CA-C-N 115.018 -0.992 . . . . 0.0 108.784 164.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.6 m -100.77 130.41 46.79 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.228 1.011 . . . . 0.0 112.35 -171.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.2 p -137.57 131.49 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.67 -0.644 . . . . 0.0 110.333 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 t -115.69 121.28 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.272 -0.893 . . . . 0.0 109.571 -176.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.9 p -110.77 130.07 55.67 Favored 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 123.612 0.765 . . . . 0.0 112.015 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 tt -92.68 100.86 13.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 110.584 176.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -93.1 75.6 4.69 Favored 'General case' 0 CA--C 1.568 1.657 0 O-C-N 121.325 -0.859 . . . . 0.0 111.681 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.75 -84.27 1.59 Allowed Glycine 0 N--CA 1.492 2.411 0 O-C-N 121.718 -0.613 . . . . 0.0 113.674 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -136.39 53.9 1.91 Allowed 'General case' 0 CA--C 1.571 1.78 0 CA-C-O 121.131 0.491 . . . . 0.0 111.911 161.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -145.64 119.54 9.32 Favored 'General case' 0 CA--C 1.562 1.411 0 O-C-N 121.072 -1.017 . . . . 0.0 111.303 172.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 47.2 mt -87.32 105.32 17.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.788 -0.57 . . . . 0.0 110.62 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.4 t -95.27 102.0 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -177.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -89.97 107.64 19.24 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.255 0.622 . . . . 0.0 110.61 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 35.3 mt -96.41 121.07 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 124.297 1.039 . . . . 0.0 108.493 -177.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -112.71 120.57 41.96 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 118.754 0.706 . . . . 0.0 110.23 173.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -111.42 123.03 49.39 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.639 0.776 . . . . 0.0 110.654 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -156.23 133.52 10.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.498 -0.751 . . . . 0.0 110.192 -175.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 64.39 15.07 9.27 Favored 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 117.446 2.387 . . . . 0.0 117.446 176.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.32 -3.13 82.89 Favored Glycine 0 CA--C 1.559 2.808 0 N-CA-C 119.082 2.393 . . . . 0.0 119.082 -158.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -105.55 147.51 28.3 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-N 119.337 1.569 . . . . 0.0 111.013 -176.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -136.06 127.07 27.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.738 -0.601 . . . . 0.0 112.075 -175.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.9 t -112.67 138.39 49.54 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.524 0.73 . . . . 0.0 109.47 164.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.88 122.39 40.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.242 0.617 . . . . 0.0 110.025 175.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -105.25 106.0 16.29 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -172.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.3 t -90.65 98.45 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -171.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 25.8 ttm105 -93.58 111.12 22.73 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.291 0.636 . . . . 0.0 110.641 -177.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -129.63 134.63 47.8 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 119.3 0.955 . . . . 0.0 112.621 -175.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.3 mm -81.46 127.11 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.206 -0.934 . . . . 0.0 109.528 174.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -101.6 -86.61 0.41 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.982 -0.449 . . . . 0.0 110.098 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -143.33 95.4 2.75 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 171.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 83.17 -41.97 2.96 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 117.354 1.701 . . . . 0.0 117.354 -167.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -92.81 148.57 21.92 Favored 'General case' 0 CA--C 1.558 1.28 0 CA-C-N 118.549 1.175 . . . . 0.0 113.219 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -90.76 109.56 20.75 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.704 158.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 97.6 t -85.28 104.27 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 170.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 39.5 ttm -93.97 114.52 26.73 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 94.6 m -101.7 99.46 9.72 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.9 mp -93.33 107.31 19.16 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -174.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . 0.261 13.5 t -131.79 134.61 46.01 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -172.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -110.76 80.03 1.26 Allowed 'General case' 0 CA--C 1.564 1.511 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.994 174.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 69.89 -90.25 0.32 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 115.92 1.128 . . . . 0.0 115.92 -177.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -87.6 -34.49 18.5 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.4 t -87.65 132.35 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 119.459 1.027 . . . . 0.0 109.823 -170.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.7 t -128.42 112.83 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 C-N-CA 123.288 0.635 . . . . 0.0 109.453 -169.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -105.24 114.5 28.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.423 -0.798 . . . . 0.0 112.135 171.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.9 t -92.93 112.58 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.428 -0.795 . . . . 0.0 109.032 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -101.12 120.74 40.65 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.974 0.892 . . . . 0.0 111.219 175.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -102.66 102.92 13.16 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.464 0.706 . . . . 0.0 109.44 -168.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -105.77 127.58 53.18 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.132 -0.98 . . . . 0.0 112.413 -171.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -98.21 155.71 17.04 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 123.798 0.839 . . . . 0.0 112.808 169.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -77.55 135.17 38.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.176 -0.952 . . . . 0.0 113.238 176.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.019 -0.991 . . . . 0.0 111.04 162.803 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 CA--C 1.569 1.692 0 CA-C-O 121.653 0.74 . . . . 0.0 112.057 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . 0.326 19.7 tt0 74.01 -52.81 0.69 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.56 -31.89 57.45 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 117.246 2.313 . . . . 0.0 117.246 161.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -72.27 -26.08 61.85 Favored 'General case' 0 CA--C 1.57 1.714 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 165.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.5 t -78.97 95.59 5.51 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-N 121.167 1.803 . . . . 0.0 113.269 -173.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -169.11 172.37 7.49 Favored 'General case' 0 CA--C 1.571 1.755 0 CA-C-O 122.702 1.239 . . . . 0.0 111.928 -174.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.6 m -78.83 127.38 31.97 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.135 -0.978 . . . . 0.0 110.109 165.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 99.9 m95 -124.6 111.73 15.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.856 -0.528 . . . . 0.0 110.267 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -104.53 129.6 52.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.58 -0.7 . . . . 0.0 110.811 -175.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -70.72 134.54 47.56 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 60.9 p -106.9 -39.97 5.62 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 175.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -153.77 123.04 6.54 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 119.528 1.058 . . . . 0.0 109.607 -174.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.4 p -103.07 100.22 10.13 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 122.925 0.49 . . . . 0.0 111.705 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -76.68 120.61 22.1 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 123.664 0.786 . . . . 0.0 111.405 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.269 4.8 t-20 60.12 38.08 20.56 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 117.366 2.358 . . . . 0.0 117.366 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -76.0 -41.02 52.45 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -56.35 -50.76 70.58 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 174.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -55.47 -48.29 74.75 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 167.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -51.94 -47.1 64.88 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 169.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.465 ' SD ' ' HA ' ' A' ' 30' ' ' ARG . 72.7 mtm -64.06 -40.77 96.99 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 174.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -58.67 -51.52 69.59 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 161.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.54 -43.83 96.76 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 tt -66.31 -32.13 73.35 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.861 1.801 . . . . 0.0 115.861 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.69 55.45 1.9 Allowed Glycine 0 N--CA 1.485 1.923 0 N-CA-C 115.604 1.002 . . . . 0.0 115.604 -172.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.7 m -87.82 154.27 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 CA-C-N 118.129 0.964 . . . . 0.0 111.005 168.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.83 168.66 31.97 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 116.662 1.425 . . . . 0.0 116.662 174.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -83.54 59.43 5.1 Favored 'General case' 0 CA--C 1.577 1.991 0 CA-C-O 122.681 1.229 . . . . 0.0 112.812 177.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -160.76 -58.32 0.05 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.064 1.346 . . . . 0.0 109.758 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.8 m -61.0 -31.53 71.13 Favored 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 169.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.465 ' HA ' ' SD ' ' A' ' 20' ' ' MET . 18.5 ptp180 -57.29 -42.77 82.32 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 164.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -60.62 -48.53 81.37 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 167.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.5 t -49.94 -60.56 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 167.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -52.81 -38.31 53.74 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 119.349 2.5 . . . . 0.0 119.349 175.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -66.84 -42.44 85.76 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 168.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -77.96 -35.32 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 177.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 t -95.73 138.55 33.23 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 120.277 1.399 . . . . 0.0 113.846 -164.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -103.82 101.36 24.39 Favored Pre-proline 0 CA--C 1.575 1.91 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.335 173.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.55 150.82 46.39 Favored 'Trans proline' 0 CA--C 1.564 1.998 0 CA-C-N 123.011 2.111 . . . . 0.0 117.086 -170.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.7 m -102.9 103.85 14.03 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.113 173.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.2 t -96.58 102.26 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -174.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.2 mt -93.94 102.68 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 69.4 mt -87.91 113.52 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 88.4 p -129.58 120.44 25.29 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.839 0.456 . . . . 0.0 111.91 -170.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -85.55 103.52 14.47 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.04 -1.038 . . . . 0.0 110.146 176.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -106.3 88.16 2.72 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.36 0.6 . . . . 0.0 109.801 -168.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.75 -76.33 2.02 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 115.147 0.819 . . . . 0.0 115.147 -176.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -123.89 -50.34 1.83 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.514 0.725 . . . . 0.0 112.647 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -81.11 157.81 25.22 Favored 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -176.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.76 115.49 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.595 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 173.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.0 t -105.91 104.98 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 44.2 mt -94.18 118.78 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -101.59 101.96 12.6 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.1 m -85.38 95.8 9.36 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.9 mt -99.06 92.57 5.55 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -173.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.4 p -85.57 11.22 11.11 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 175.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.391 39.7 p 74.05 -57.97 0.6 Allowed 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 125.136 1.375 . . . . 0.0 113.536 -168.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -76.7 -62.08 1.75 Allowed 'General case' 0 CA--C 1.571 1.776 0 C-N-CA 124.498 1.119 . . . . 0.0 112.285 176.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -106.2 120.93 43.12 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.93 0.892 . . . . 0.0 109.583 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -123.73 84.32 2.26 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -169.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.9 t -108.74 147.65 31.66 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -166.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.43 135.31 47.06 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 124.134 0.974 . . . . 0.0 113.136 -174.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.0 mt -124.66 101.32 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -174.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 90.1 p -110.24 112.87 25.11 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.693 0.797 . . . . 0.0 111.833 -173.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -141.2 139.29 33.79 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 122.007 0.908 . . . . 0.0 113.423 -173.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -88.33 26.15 1.49 Allowed 'General case' 0 CA--C 1.582 2.194 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 173.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 75.4 mt 63.42 100.49 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 125.347 1.459 . . . . 0.0 113.094 -172.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.71 2.38 88.72 Favored Glycine 0 CA--C 1.556 2.635 0 N-CA-C 119.111 2.405 . . . . 0.0 119.111 -167.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -89.28 129.4 35.84 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-N 119.537 1.669 . . . . 0.0 111.205 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -89.61 111.57 22.56 Favored 'General case' 0 CA--C 1.563 1.447 0 CA-C-O 121.288 0.566 . . . . 0.0 111.374 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -113.8 150.18 33.85 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.27 1.028 . . . . 0.0 110.606 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.45 131.18 35.04 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.266 -1.521 . . . . 0.0 111.59 171.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -122.56 108.25 12.91 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.596 0.758 . . . . 0.0 109.74 -172.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.7 m -77.97 100.99 6.66 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.219 1.009 . . . . 0.0 109.26 172.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 74.4 p -79.18 -178.69 6.3 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -164.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.45 -8.64 0.56 Allowed 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 119.823 3.268 . . . . 0.0 119.823 162.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -109.5 19.02 19.75 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 158.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . 0.438 2.2 p30 56.36 12.25 0.99 Allowed 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 119.794 3.257 . . . . 0.0 119.794 -171.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -77.11 126.14 30.47 Favored 'General case' 0 CA--C 1.561 1.403 0 O-C-N 120.888 -1.132 . . . . 0.0 110.053 170.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -83.99 101.34 11.66 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.476 0.711 . . . . 0.0 111.314 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 83.4 m -100.83 128.2 46.96 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.617 -0.677 . . . . 0.0 112.492 -171.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -72.46 99.4 2.47 Favored 'General case' 0 CA--C 1.563 1.456 0 CA-C-O 122.275 1.036 . . . . 0.0 109.382 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.2 m -115.96 117.23 29.58 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.916 -156.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 p -122.13 129.53 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 123.379 0.672 . . . . 0.0 109.895 -176.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.1 t -121.96 113.36 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -171.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 63.3 m -112.44 131.13 55.72 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.396 0.678 . . . . 0.0 110.923 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.0 tt -91.36 103.37 16.02 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.571 0.701 . . . . 0.0 110.244 175.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -87.28 80.09 8.33 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 123.46 0.704 . . . . 0.0 111.382 -177.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.9 -81.01 1.54 Allowed Glycine 0 N--CA 1.493 2.47 0 O-C-N 121.564 -0.71 . . . . 0.0 114.338 -176.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -135.33 56.12 1.85 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.271 0.558 . . . . 0.0 111.767 163.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -153.28 100.56 2.46 Favored 'General case' 0 CA--C 1.564 1.498 0 O-C-N 121.218 -0.926 . . . . 0.0 110.277 -170.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 24.4 mt -77.68 114.49 16.57 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.093 -1.004 . . . . 0.0 111.835 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.06 102.31 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -87.59 110.03 20.08 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.065 0.546 . . . . 0.0 110.606 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 69.1 mt -102.09 110.5 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -95.62 124.67 39.76 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 118.671 0.669 . . . . 0.0 111.517 172.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -111.38 124.05 51.47 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.977 0.911 . . . . 0.0 110.321 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 9.6 p90 -154.49 126.97 7.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.806 -1.184 . . . . 0.0 110.595 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 58.53 31.9 21.54 Favored 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 117.244 2.312 . . . . 0.0 117.244 169.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.09 -20.14 8.87 Favored Glycine 0 CA--C 1.556 2.649 0 N-CA-C 119.012 2.365 . . . . 0.0 119.012 -163.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -91.18 143.49 26.61 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 119.667 1.734 . . . . 0.0 111.657 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -133.42 134.24 43.38 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.174 0.59 . . . . 0.0 111.032 -178.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.0 t -126.48 134.75 50.85 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 123.072 0.549 . . . . 0.0 111.065 173.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -116.03 129.56 56.42 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 123.258 0.623 . . . . 0.0 111.997 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -111.34 102.15 10.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.233 -0.917 . . . . 0.0 108.623 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.9 t -91.77 111.12 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -171.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -110.45 119.41 39.12 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.416 0.686 . . . . 0.0 111.18 -171.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -129.41 144.78 51.39 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 122.996 0.518 . . . . 0.0 112.043 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.6 mm -88.18 106.0 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -103.49 101.09 10.97 Favored 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 123.511 0.725 . . . . 0.0 109.221 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.3 t70 50.74 53.95 12.08 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 -175.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.45 -35.15 3.65 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 118.645 2.218 . . . . 0.0 118.645 -170.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -95.76 146.39 24.57 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 119.373 1.587 . . . . 0.0 112.056 -172.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 34.1 ttm -86.06 116.08 24.05 Favored 'General case' 0 CA--C 1.566 1.568 0 O-C-N 120.868 -1.145 . . . . 0.0 111.61 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.4 t -94.79 108.11 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 169.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 13.7 ttt -110.17 101.63 10.39 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.506 0.67 . . . . 0.0 109.607 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 87.8 m -94.8 106.7 18.7 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.527 0.731 . . . . 0.0 109.355 -174.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.4 mp -91.53 113.9 26.29 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.8 m -120.89 119.78 33.62 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.544 0.688 . . . . 0.0 109.869 -167.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -107.61 77.85 1.16 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.372 0.606 . . . . 0.0 109.367 170.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 64.21 -94.98 0.16 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 115.306 0.882 . . . . 0.0 115.306 -174.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -83.54 -32.73 25.71 Favored 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 170.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.2 t -87.05 109.95 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 120.444 1.475 . . . . 0.0 109.406 -171.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.3 t -114.19 118.27 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 124.086 0.954 . . . . 0.0 108.489 -169.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -123.21 127.63 48.89 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 123.265 0.626 . . . . 0.0 111.878 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 37.7 t -105.74 115.56 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.956 -1.09 . . . . 0.0 110.306 -172.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.8 124.06 40.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.054 -1.029 . . . . 0.0 111.716 169.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -102.05 105.78 16.57 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.726 0.81 . . . . 0.0 109.724 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -107.59 129.68 54.96 Favored 'General case' 0 CA--C 1.563 1.474 0 O-C-N 121.303 -0.873 . . . . 0.0 111.731 -169.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -98.35 158.09 15.79 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.399 1.095 . . . . 0.0 112.499 170.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -89.9 130.58 36.1 Favored 'General case' 0 CA--C 1.563 1.471 0 O-C-N 121.394 -0.816 . . . . 0.0 112.758 -169.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . 0.309 . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -179.637 . . . . . . . . 1 1 . 1 stop_ save_